Citrus Sinensis ID: 007050
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 620 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SJG9 | 606 | Mitogen-activated protein | yes | no | 0.975 | 0.998 | 0.753 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | yes | no | 0.977 | 0.991 | 0.745 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.912 | 0.994 | 0.672 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.912 | 0.994 | 0.679 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.967 | 0.857 | 0.676 | 0.0 | |
| Q9LUC3 | 598 | Mitogen-activated protein | no | no | 0.958 | 0.993 | 0.679 | 0.0 | |
| Q9C5C0 | 615 | Mitogen-activated protein | no | no | 0.969 | 0.977 | 0.648 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.869 | 0.950 | 0.670 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.829 | 0.948 | 0.690 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.754 | 0.939 | 0.731 | 0.0 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 910 bits (2351), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/621 (75%), Positives = 521/621 (83%), Gaps = 16/621 (2%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD+RKKN+ EMEFFS+YGDA+R+K+QEVIGKGSYGVVCSAIDT TGEKVAIKKIHDIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTISR VRN+KARRYLTSMRKK P+ F+QKFPNADP +L+LLERLLAF
Sbjct: 241 DLMTDLLGTPSLDTISR-VRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERR+VTKEDIRELI REILEY
Sbjct: 300 DPKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKD+MNG ++ +FLYPSAVDQFR+QFAHLEEN GK+GPV P ERKH SLPRST++H
Sbjct: 360 HPQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIH 419
Query: 421 SNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQR-FPLAKPGKVVGPV 479
S V Q L + N + ++ IP N + T+ AQQR AKP +GPV
Sbjct: 420 STAVARGGQPKLMNNTNTL------NPETTQNIPFNHA-TIQAQQRNLSAAKPSTFMGPV 472
Query: 480 VPYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVKHVPQC 539
P++N + RDAYDPR+FIRST LP + +A + GKQ+ R K Q
Sbjct: 473 APFDNGRISRDAYDPRSFIRSTNLPFSQQSAATV---AMGKQQ--ERRTTMEPEKQARQI 527
Query: 540 GMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAA 599
++A D+AIN+D+NPF M R G+NK E+I D+I IDTNLLQ + GV AAA AAA
Sbjct: 528 SQYNRYAPDVAINIDNNPFIMARTGMNKAENISDRIIIDTNLLQATAG-IGVAAAAAAAA 586
Query: 600 ATAAAHRKIGTVQYGMTTRMY 620
+AHRK+G V+YGM ++MY
Sbjct: 587 PGGSAHRKVGAVRYGM-SKMY 606
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 887 bits (2292), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/625 (74%), Positives = 516/625 (82%), Gaps = 19/625 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD RKK+S E +FF+EYGDASRYKIQEVIGKGSYGVVCSAID HTGEKVAIKKIHDIF
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN+NCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPS+DTISR VRNDKARRYL+SMRKK+P+ FSQKFP+ADP AL LL++LLAF
Sbjct: 241 DLMTDLLGTPSMDTISR-VRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALA PYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEY
Sbjct: 300 DPKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDY+NGTERT FLYPSAVDQFRKQFAHLEEN G +GPVIP +RKH SLPRSTIVH
Sbjct: 360 HPQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEEN-GGNGPVIPMDRKHTSLPRSTIVH 418
Query: 421 SNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVV 480
S +P KEQ + R + N +E + N RT A QR P A+PG+VVGPV+
Sbjct: 419 STPIPAKEQPRIGPSRDKPSDEPYSNPREFDRFSGNAPRTSQAPQRVPTARPGRVVGPVL 478
Query: 481 PYENASVRRDAYDPRTFIRSTVLP--QAIPAAYCYRK---SSTGKQEMDSEREMPSQVKH 535
PYEN + +D+YD R ++ P Q IP AY Y + S + +ER Q +
Sbjct: 479 PYENGAT-KDSYDARRLAMNSGYPPQQQIPQAYGYYQIPGKSACSELSQAERYTLHQQAY 537
Query: 536 VPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAA 595
C +A TD+A++M + PF ++ G K + E +++ +TNL T+S G AA
Sbjct: 538 T--CANSAT-VTDVALDMRAPPFHLS--GGPKSDSSE-RLAAETNLY-TRSLN---GLAA 587
Query: 596 TAAAATAAAHRKIGTVQYGMTTRMY 620
TAA A+AHRK+G V YGM +RMY
Sbjct: 588 TAAGVAASAHRKVGVVPYGM-SRMY 611
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/611 (67%), Positives = 493/611 (80%), Gaps = 45/611 (7%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAID HTG+KVAIKKIH+IFEH+SDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM++DLHQVIKANDDLT+EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQ+LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT+FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
DT++R +RN+KARRYL+SMRKKQPV FS++FP ADP+AL+LL+RLLAFDPKDRPTAEEAL
Sbjct: 241 DTVTR-IRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
ADPYFKGL+K EREPSCQPI+KMEFEFERR+VTKED++ELIFREILEYHPQLLKDYMNGT
Sbjct: 300 ADPYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGT 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 432
E+TNFLYPSA+D FR+QFA+LEEN GK+G +P +RKHVSLPR+T VHS +PPK+ QN+
Sbjct: 360 EKTNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPRTTTVHSAPIPPKDHQNI 419
Query: 433 SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAY 492
+ +P QR P + G+ PV+P+EN S Y
Sbjct: 420 TSQ-----------------VP----------QRIP-GRTGRGACPVIPFENLSA-MGPY 450
Query: 493 DPRTFIRSTVLPQAIP--AAYCY-RKSSTGKQEMDSEREMPSQVKHVPQCGMAAKFATDI 549
+ R +R+ VLP A +AY Y RKS + ++E+ E E + M AK + +
Sbjct: 451 NQRRVVRNPVLPPATTNLSAYAYHRKSDSSERELQQELEKDRMRYQPSEHFMDAKVVSHM 510
Query: 550 AINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKIG 609
+ ++ ++ +++++A + + D+ ++ +N++Q + G+ AA + K+
Sbjct: 511 SHDLRASSYYVSKAKSD----VADRAALQSNMMQGIGPFNGI-------AAVGGNYNKVS 559
Query: 610 TVQYGMTTRMY 620
TVQYG+ +RMY
Sbjct: 560 TVQYGV-SRMY 569
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/611 (67%), Positives = 481/611 (78%), Gaps = 45/611 (7%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGD+SRYKIQE++GKGSYGVVCSAID HTG+KVAIKKIH+IFEH+SDAARILRE
Sbjct: 1 MDFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM++DLHQVIKANDDLT+EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQ+LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT+FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
D ISR +RNDKARRYL+SMR+KQPV FS+KFPN DP AL+LL+RLLAFDPKDRPTAEEAL
Sbjct: 241 DAISR-IRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
ADPYFKGL+KVEREPSCQPISKMEFEFERR+VTK+DI+ELIFREILEYHPQLLKDYMNG+
Sbjct: 300 ADPYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGS 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 432
E T+FLYPSAVD FR+QFA LEEN GKSG + +RKHVSLPR+T VHS ++PP E
Sbjct: 360 ENTSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPRATTVHSTSIPPNE---- 412
Query: 433 SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAY 492
L T QR P A+PG+ VGPV+P+EN D +
Sbjct: 413 -----------------------GLDATSQVTQRIPTARPGRTVGPVLPFENPGA-ADPH 448
Query: 493 DPRTFIRSTVLPQAIP--AAYCYRKSSTGKQEMDSEREMPSQVKHVP-QCGMAAKFATDI 549
R +R+ ++P A + Y Y S E +V++ P Q M AK A D
Sbjct: 449 SARRVVRNPMVPPAAANKSGYSYNLKSDYSDRQHQEELEKDRVQYRPAQHLMDAKVAPDT 508
Query: 550 AINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKIG 609
A ++ S+ ++ TR+ + D+ ++ ++L + + G+ AA A + K+G
Sbjct: 509 APDIRSSQYYFTRSAPRT--DLTDRAALQGSMLYGIAPFNGI-------AAVAGGYSKVG 559
Query: 610 TVQYGMTTRMY 620
VQYG+ +RMY
Sbjct: 560 AVQYGV-SRMY 569
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 800 bits (2067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/624 (67%), Positives = 481/624 (77%), Gaps = 24/624 (3%)
Query: 8 KNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
+ S EFF+EYGDA+RY+IQEVIGKGSYGVVCSAID HT +KVAIKK+H+IFEH+SDAA
Sbjct: 90 RTSSAEEFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAA 149
Query: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 127
RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 150 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEH 209
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
YQFFLYQLLRALKYIHTA+VYHRDLKPKNILAN+NCKLKICDFGLARVAFNDTPTT+FWT
Sbjct: 210 YQFFLYQLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWT 269
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 270 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 329
Query: 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
GTPS+DTISR VRN+KARRYL+SMRKK PV FSQKFPNADP AL+LL+RLLAFDPKDRPT
Sbjct: 330 GTPSMDTISR-VRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPT 388
Query: 308 AEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 367
AEEAL DPYFKGLSK++REPSCQPI K+EFEFE+++++KEDIRELIF+EILEYHPQL K+
Sbjct: 389 AEEALTDPYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKN 448
Query: 368 YMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPK 427
Y NG ER FLYPSAVDQF+KQF++LEE+ G SG IP ERKH SLPRST VHS +PPK
Sbjct: 449 YRNGRERATFLYPSAVDQFKKQFSNLEESNG-SGSAIPMERKHASLPRSTTVHSTPIPPK 507
Query: 428 EQ---QNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYEN 484
EQ +L R ++E KN G N+ + Q PG+ VG V PYE
Sbjct: 508 EQPLAASLKSSRPVSDEPC-KNPWVMGGFSGNIPTSSQVSQVAKPVAPGRPVGSVFPYET 566
Query: 485 ASVRRDAYDPRTFIRSTVLP--QAIPAAYCYRK------SSTGKQEMDSEREMPSQVKHV 536
S D Y PR + S+ P Q I AY Y + Q MD+ + M SQ +
Sbjct: 567 GST-NDPYGPRGPVMSSGYPPQQQISQAYGYHQVPARMNCVEQSQAMDAYK-MHSQSQTQ 624
Query: 537 PQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAAT 596
+K D+A++M + F + N D++ T++ T+S G V AA +
Sbjct: 625 AYAYPNSKVTADVALDMRGSTFHHSAGSKNGS---LDRMVTQTDIY-TRSLNGIVAAATS 680
Query: 597 AAAATAAAHRKIGTVQYGMTTRMY 620
A T +RK+G V T+RMY
Sbjct: 681 AGVGT---NRKVGAVPIS-TSRMY 700
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/620 (67%), Positives = 480/620 (77%), Gaps = 26/620 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ+ KKN EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDT TGEKVAIKKI+D+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DL+TDLLGTP +TI+ VRN+KAR+YL MRKK V FSQKFPNADP ALRLL+RLLAF
Sbjct: 241 DLITDLLGTPKSETIAG-VRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTA EALADPYFK L+KVEREPSCQPISKMEFEFERRR+TK+DIRELI+REILEY
Sbjct: 300 DPKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDYMN +E ++FLYPSA+ RKQFA+LEEN GKSGPVIPP+RKH SLPRS VH
Sbjct: 360 HPQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSA-VH 417
Query: 421 SNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVV 480
S+ V Q +L+ + + A ++ L R P KPG+VV V
Sbjct: 418 SSAVNSNAQPSLNASDSRRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSV 477
Query: 481 PYEN-ASVRRDAYDPRT-FIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVK--HV 536
YEN +++ +YD RT + RSTVLP + CY +T QE S E SQ K V
Sbjct: 478 TYENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAASQPKPQFV 537
Query: 537 PQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAAT 596
P +AK A ++ NP+ + + ++ ID LL +SQYG A
Sbjct: 538 PTQCNSAKPA-----ELNPNPYVQS----------QHKVGIDAKLLHAQSQYG----PAG 578
Query: 597 AAAATAAAHRKIGTVQYGMT 616
AAA AAHR IG V YGM+
Sbjct: 579 AAAVAVAAHRNIGAVGYGMS 598
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 768 bits (1982), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/631 (64%), Positives = 475/631 (75%), Gaps = 30/631 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQ+ KK + EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDTHTGEKVAIKKI+D+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALK++HTANVYHRDLKPKNILANANCKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
+L+TDLLGTP +TIS VRNDKAR+YLT MRKK PV FSQKF ADP ALRLL+RLLAF
Sbjct: 241 ELITDLLGTPKSETISG-VRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPT EALADPYFKGLSK+EREPS Q ISKMEFEFERRR+TK+DIRELI+REILEY
Sbjct: 300 DPKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDYM+G+E +NF+YPSA+ R+QF +LEEN ++GPVIP ERKH SLPRST VH
Sbjct: 360 HPQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRST-VH 418
Query: 421 SNTVPPKEQQNL-SRDRQAAEEVFNKNSKESEGIPANLSRTL----PAQQRFPLAKPGKV 475
S V Q NL + D + +KN S G P+ + P + P +PG+V
Sbjct: 419 STVVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRV 478
Query: 476 VGPVVPYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSST----GKQEMDSEREMPS 531
V V YEN ++AY RS A+ + +CY + +T + +++ P
Sbjct: 479 VESSVSYENGRNLKEAY-----FRS-----AVSSPHCYFRPNTMTNPENRNIEASSFPPK 528
Query: 532 QVKHVPQCG-----MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS 586
V Q A D+ NP+F + + ++ID LLQ +S
Sbjct: 529 PQNPVHQFSPTEPPAATTNQADVETMNHPNPYFQPQLPKTDQLNNNTHMAIDAKLLQAQS 588
Query: 587 QYGGVGAAATAAAATAAAHRKIGTVQYGMTT 617
Q+G A AAA AAHR IGT+ Y +
Sbjct: 589 QFG----PAGAAAVAVAAHRNIGTISYSAAS 615
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 755 bits (1950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/564 (67%), Positives = 448/564 (79%), Gaps = 25/564 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ DHRKK+S E++FF+EYG+ SRY+I+EVIGKGSYGVVCSA DTHTGEKVAIKKI+DIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRR+F+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTD+LGTPS + I R VRN+KARRYL+SMRKK+P+ FS KFP+ DP ALRLLE++L+F
Sbjct: 241 DLMTDMLGTPSAEAIGR-VRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
+PKDRPTAEEALAD YFKGL+KVEREPS QP++K+EFEFERRR+TKED+RELI+RE LEY
Sbjct: 300 EPKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPER-KHVSLPRSTIV 419
HP++LK+Y++G+E TNF+YPSAV+ F+KQFA+LEE+ PPER +H SLPR+ ++
Sbjct: 360 HPKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVL 419
Query: 420 HSNTVPPKEQQNLS-----------RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFP 468
+S+ P QQ+ + RD + N S IP N+ +T+ Q
Sbjct: 420 YSDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSR-IPINVPQTI---QGAA 475
Query: 469 LAKPGKVVGPVVPYENA----SVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQEMD 524
+A+PGKVVG V+ Y N V R +R+ P KS+ G ++
Sbjct: 476 VARPGKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQPCKSNRGDEDCA 535
Query: 525 SEREMPSQVK----HVPQCGMAAK 544
+ E PS++K ++PQ AA+
Sbjct: 536 TAAEGPSRLKPNTQYIPQKVSAAQ 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 746 bits (1926), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/527 (69%), Positives = 431/527 (81%), Gaps = 13/527 (2%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FF+EYG+ +RYKI+EVIGKGSYGVVCSA+DTHTG+KVAIKKI+DIFEH+SDA RILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAF+DTPT IFWTDY+AT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSP 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+TISR +RN+KARRYL SMR+K+P+ F+QKFPNADP A+RLLER+LAFDPKDRP+AEEAL
Sbjct: 241 ETISR-IRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
ADPYFK ++ V+REPS QPI+K+EFEFERRR+TKEDIRELI+REILEYHP++L++++ GT
Sbjct: 300 ADPYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGT 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 432
E T F+YPSAVD F+KQFA+LEE+ K PPER+H SLPR +V+S+ P Q
Sbjct: 360 ESTGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPCVVYSDNRP---QSTA 416
Query: 433 SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVR--RD 490
S + + N+ +S+ + + +P A+PGK VG V+ Y N S
Sbjct: 417 SVTEDLSRCLIRDNNLKSQDSASVGASRIPQGA---AARPGKAVGSVLRYGNCSTSAAEQ 473
Query: 491 AYDPRTFIRSTVLP--QAIPAAYCY-RKSSTGKQEM-DSEREMPSQV 533
Y+ R +R+ + ++P Y R++ T K E D ER SQ
Sbjct: 474 QYEQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETGDVERIDSSQT 520
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/476 (73%), Positives = 411/476 (86%), Gaps = 8/476 (1%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FF+EYG+ +RYKI+EVIGKGSYGVVCSA+DTHTGEKVAIKKI+DIFEH+SDA RILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAF+DTPT IFWTDYVAT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPST 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ ISR +RN+KARRYL+SMR+K+P+ F+QKFPNADP ALRLLER+L+F+PKDRP AEEAL
Sbjct: 241 EAISR-IRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
ADPYF+ ++ V+REPS QP++K+EFEFERRR+TKEDIRELI+R+ILEYHP +L++Y+ GT
Sbjct: 300 ADPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGT 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 432
E F+YPSAVD F+KQFA+LEE+ K PPER+H SLPR ++++S+ P+ N+
Sbjct: 360 ESAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDR-PQNTANI 418
Query: 433 SRDRQAAEEVFNKNS-KESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASV 487
+ D ++ V N+ K +G + + +P A+PGKVVG + Y N S
Sbjct: 419 AED--LSKCVLGDNTQKMHQGSASVCANRVPQGG---AARPGKVVGSALRYGNCST 469
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 620 | ||||||
| 224062744 | 621 | predicted protein [Populus trichocarpa] | 0.991 | 0.990 | 0.857 | 0.0 | |
| 359485144 | 610 | PREDICTED: mitogen-activated protein kin | 0.975 | 0.991 | 0.846 | 0.0 | |
| 356567418 | 614 | PREDICTED: mitogen-activated protein kin | 0.979 | 0.988 | 0.822 | 0.0 | |
| 255575287 | 627 | big map kinase/bmk, putative [Ricinus co | 0.985 | 0.974 | 0.829 | 0.0 | |
| 356526989 | 615 | PREDICTED: mitogen-activated protein kin | 0.979 | 0.986 | 0.818 | 0.0 | |
| 399106790 | 610 | MAP kinase [Nicotiana tabacum] | 0.970 | 0.986 | 0.816 | 0.0 | |
| 357463659 | 614 | Mitogen activated protein kinase 20-4 [M | 0.979 | 0.988 | 0.808 | 0.0 | |
| 350539497 | 621 | mitogen-activated protein kinase 12 [Sol | 0.991 | 0.990 | 0.801 | 0.0 | |
| 224085324 | 577 | predicted protein [Populus trichocarpa] | 0.920 | 0.989 | 0.817 | 0.0 | |
| 115345808 | 606 | mitogen-activated protein kinase 20 [Ara | 0.962 | 0.985 | 0.793 | 0.0 |
| >gi|224062744|ref|XP_002300882.1| predicted protein [Populus trichocarpa] gi|222842608|gb|EEE80155.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/626 (85%), Positives = 582/626 (92%), Gaps = 11/626 (1%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD RKKNS EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQQDQRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
P+TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PSTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTIS +VRNDKARRYLTSMRKKQPV +QKFPNADP ALRLLERLLAF
Sbjct: 241 DLMTDLLGTPSLDTIS-LVRNDKARRYLTSMRKKQPVPLAQKFPNADPLALRLLERLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALADPYFKGL++VEREPSCQPI+KMEFEFERRRVTKED+RELIFREILEY
Sbjct: 300 DPKDRPTAEEALADPYFKGLARVEREPSCQPITKMEFEFERRRVTKEDVRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDY+NGTERTNFLYPSAVDQFRKQFAHLEEN GKSGPVIP ERKH SLPRSTIVH
Sbjct: 360 HPQLLKDYLNGTERTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHASLPRSTIVH 419
Query: 421 SNTVPPKEQQNLS--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGP 478
S+++P KEQQNL+ +DR AEE +NKN +++EGIP N+SRTL AQQR PLAKPGKVVG
Sbjct: 420 SSSIPTKEQQNLASFKDRHTAEEAYNKNPRDTEGIPVNISRTLQAQQRVPLAKPGKVVGQ 479
Query: 479 VVPYENASVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE---MDSEREMPSQVK 534
VV YEN S+ +DA DPRT+IRS VL P A P+AYCYRKS++GKQE M+++ ++ SQ K
Sbjct: 480 VVSYENGSIVKDARDPRTYIRSAVLPPHAAPSAYCYRKSNSGKQEGSTMEADSDLSSQ-K 538
Query: 535 HVPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAA 594
V QCGMAAK+A D+AIN+DSNPFFMTR GVNKVEH++D++ IDT+LLQ K+QYGG+ +
Sbjct: 539 QVQQCGMAAKYAPDVAINIDSNPFFMTRIGVNKVEHVDDRVMIDTSLLQAKAQYGGI--S 596
Query: 595 ATAAAATAAAHRKIGTVQYGMTTRMY 620
A+AAAA+ AAHRK+GTVQYGM TRMY
Sbjct: 597 ASAAAASTAAHRKVGTVQYGM-TRMY 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485144|ref|XP_002283794.2| PREDICTED: mitogen-activated protein kinase 20-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/613 (84%), Positives = 568/613 (92%), Gaps = 8/613 (1%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEV+GKGSYGVVCSA+DT TGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVVGKGSYGVVCSAVDTLTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DTPTTIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDTPTTIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
DTISR VRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFDPKDRPTAEEAL
Sbjct: 241 DTISR-VRNEKARRYLTSMRKKQPVIFAQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
ADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY+NGT
Sbjct: 300 ADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYVNGT 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 432
ERTNFLYPSAVDQFRKQFAHLEEN GK+GPVIP ERKHVSLPRST+VHSNT+P KE +
Sbjct: 360 ERTNFLYPSAVDQFRKQFAHLEENSGKTGPVIPLERKHVSLPRSTVVHSNTIPAKEPHII 419
Query: 433 S-RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDA 491
+ +DRQ AEE +++S++++GIP NLSR+L A QR P+AKPGKVVGP+ P EN S +DA
Sbjct: 420 AFKDRQIAEESCSRSSRDTDGIPGNLSRSLQASQRIPMAKPGKVVGPLAPPENGSAIKDA 479
Query: 492 YDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQEM---DSEREMPSQVKHVPQCGMAAKFAT 547
YD RT IR+ VLP QA+P AYCYR++S GKQE ++ER++ SQ K VPQCGM AK A
Sbjct: 480 YDHRTLIRNAVLPSQALPPAYCYRRTSAGKQERCVGEAERDLSSQAKQVPQCGMTAKLAP 539
Query: 548 DIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRK 607
DIAIN+D+NPF+MTRAGV KV+H++D+I+ID NLLQ K+Q+GG+G AA AAAATAAAHRK
Sbjct: 540 DIAINIDTNPFYMTRAGVTKVDHVDDRITIDANLLQAKAQFGGIG-AAAAAAATAAAHRK 598
Query: 608 IGTVQYGMTTRMY 620
+GTVQ+GM +RMY
Sbjct: 599 VGTVQFGM-SRMY 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567418|ref|XP_003551917.1| PREDICTED: mitogen-activated protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/627 (82%), Positives = 570/627 (90%), Gaps = 20/627 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQDHRKK+S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQQDHRKKSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTISR VRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLE+LLAF
Sbjct: 241 DLMTDLLGTPSLDTISR-VRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLEKLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPK+RPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEY
Sbjct: 300 DPKNRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV+P +RKHVSLPRSTIVH
Sbjct: 360 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVMPLDRKHVSLPRSTIVH 418
Query: 421 SNTVPPKEQQNL--SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGP 478
SNTV PKEQ N+ S++R AEE +NK+ +++E IP + R++ QR PLAKPGKVVGP
Sbjct: 419 SNTVHPKEQTNIASSKNRPTAEE-YNKHPRDTE-IP--VPRSMQGPQRIPLAKPGKVVGP 474
Query: 479 VVPYENASVRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVK 534
VVPYE ++ +D+YDPR+FIR +VLP Q +P AY Y++SSTG QE ++++ +P Q K
Sbjct: 475 VVPYEYGNIVKDSYDPRSFIRGSVLPTQPVPPAYYYQRSSTGNQERPSTEADKSVPLQAK 534
Query: 535 HVPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS-QYGGVGA 593
H QCG+ AK A DIAIN+D+NPFFMTRAGVNK+E DQI+I+TN+LQ K+ QYGG+
Sbjct: 535 HAQQCGVNAKMAPDIAINIDTNPFFMTRAGVNKLEQ-GDQIAIETNMLQPKAHQYGGI-- 591
Query: 594 AATAAAATAAAHRKIGTVQYGMTTRMY 620
+AAA A AHRK+G VQYGM TRM+
Sbjct: 592 ---SAAAGATAHRKVGPVQYGM-TRMF 614
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575287|ref|XP_002528547.1| big map kinase/bmk, putative [Ricinus communis] gi|223532049|gb|EEF33859.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/626 (82%), Positives = 560/626 (89%), Gaps = 15/626 (2%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
QQDHRKKNS EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE
Sbjct: 3 QQDHRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 62
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND 121
HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKAND
Sbjct: 63 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND 122
Query: 122 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP
Sbjct: 123 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 182
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
TIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD
Sbjct: 183 ATIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 242
Query: 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 301
LMTDLLGTPSLDTISR VRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFD
Sbjct: 243 LMTDLLGTPSLDTISR-VRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAFD 301
Query: 302 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 361
PKDRPTAEEALADPYFKGLSKVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYH
Sbjct: 302 PKDRPTAEEALADPYFKGLSKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 361
Query: 362 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 421
PQLLKDY+NGTERT+FLYPS VDQFR+QFAHLEEN GKSGPV+P ERKHVSLPRSTIVHS
Sbjct: 362 PQLLKDYVNGTERTHFLYPSVVDQFRRQFAHLEENCGKSGPVVPLERKHVSLPRSTIVHS 421
Query: 422 NTVPPKEQQNLSR--DRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPV 479
N VPP+E QN+S DRQ+AEE +NK+S++SEGI N+ L A QR PL K GKV GPV
Sbjct: 422 NIVPPRE-QNVSSLGDRQSAEETYNKSSRDSEGIHVNI-LALQATQRIPLDKSGKVAGPV 479
Query: 480 VPYENASVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE---MDSEREMPSQVKH 535
VPY+N ++ +D DPRTF+R T L PQA+ AY Y+KSSTG QE ++S+R++ SQ K
Sbjct: 480 VPYDNGNITKDVNDPRTFVRGTALPPQAVLPAYSYQKSSTGSQERSALESQRQLSSQ-KQ 538
Query: 536 VPQCGMA----AKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTK-SQYGG 590
QCGM+ AKFA DIAIN+DSNPFFMTR G+NKVEH++D+I+I+ +LLQ K G
Sbjct: 539 TQQCGMSEKVGAKFAPDIAINIDSNPFFMTRTGMNKVEHVDDRITINASLLQAKAQYGGI 598
Query: 591 VGAAATAAAATAAAHRKIGTVQYGMT 616
G A+A AA HRKIGTVQ GMT
Sbjct: 599 GGGGGAASATAAATHRKIGTVQCGMT 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526989|ref|XP_003532097.1| PREDICTED: mitogen-activated protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2598), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/628 (81%), Positives = 564/628 (89%), Gaps = 21/628 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQDHRKK+S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTG+KVAIKKIHDIF
Sbjct: 1 MQQDHRKKSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGDKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTISR VRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLE+LLAF
Sbjct: 241 DLMTDLLGTPSLDTISR-VRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLEKLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEY
Sbjct: 300 DPKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV+P +RKHVSLPRSTIVH
Sbjct: 360 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVMPLDRKHVSLPRSTIVH 418
Query: 421 SNTVPPKEQQN--LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGP 478
SNTV KEQ N S++R EE +NKN +++E IP + R++ QR PLAKPGKVVGP
Sbjct: 419 SNTVHSKEQTNNAASKNRPTVEE-YNKNPRDTE-IP--VPRSMQGPQRIPLAKPGKVVGP 474
Query: 479 VVPYENASVRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVK 534
VVPYE+ ++ +D+YDPR+FIR +VLP QA+P AY Y++SSTG QE ++ + +P Q K
Sbjct: 475 VVPYEHGNIVKDSYDPRSFIRGSVLPTQAVPPAYYYQRSSTGNQERPATEANKSVPLQAK 534
Query: 535 HV-PQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS-QYGGVG 592
H QCG+ AK A DIAIN+D+NPFFMTRAGVNK+E DQI+I+TN+LQ K+ QY
Sbjct: 535 HAQQQCGVNAKMAPDIAINIDTNPFFMTRAGVNKLEQ-GDQIAIETNMLQPKAHQY---- 589
Query: 593 AAATAAAATAAAHRKIGTVQYGMTTRMY 620
AAA A AHRK+G VQYGM TRM+
Sbjct: 590 -GGIGAAAGATAHRKVGPVQYGM-TRMF 615
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106790|gb|AFP20228.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2592), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/616 (81%), Positives = 554/616 (89%), Gaps = 14/616 (2%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
DTISR VRNDKARRYLTSMRKKQPV F+QKFPNADP AL+LLERLLAFDPKDRPTAEEAL
Sbjct: 241 DTISR-VRNDKARRYLTSMRKKQPVSFAQKFPNADPLALKLLERLLAFDPKDRPTAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
ADPYFKGL+K EREPSC+PISKMEFEFERRRVTKED+RELIFREILEYHPQL KDYMNG
Sbjct: 300 ADPYFKGLAKSEREPSCKPISKMEFEFERRRVTKEDLRELIFREILEYHPQLRKDYMNGV 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQ--- 429
ERTNFLYPSAVDQFRKQFAHLEEN G GPV+P +RKHVSLPRST++HSNT+P KEQ
Sbjct: 360 ERTNFLYPSAVDQFRKQFAHLEENGGNGGPVVPMDRKHVSLPRSTVLHSNTIPSKEQPIA 419
Query: 430 -QNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVR 488
N+ RDRQ EE ++N ++SEG+ +L+RT+ AQ R LAK GKVVGPV+ Y++ +
Sbjct: 420 AANM-RDRQNGEESCSRNCRDSEGLANSLTRTMQAQPRIALAKTGKVVGPVLAYDSGN-- 476
Query: 489 RDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMAAK 544
++ YDPR+ +R+TV P Q +P+AYCY +S KQE +++ER++ S K +P CGMAAK
Sbjct: 477 KEKYDPRSQVRNTVFPSQIMPSAYCYDRSGMVKQERPVVETERDVSSHAKPMPPCGMAAK 536
Query: 545 FATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAA 604
A DIAIN+DSNPF+M RAGV K + +ED+I+IDTNLLQ KSQYGG+G A AAA TAAA
Sbjct: 537 LAPDIAINIDSNPFYMMRAGVTKPDRVEDRITIDTNLLQAKSQYGGIG-VAAAAATTAAA 595
Query: 605 HRKIGTVQYGMTTRMY 620
HRK+GTVQYG+ +RMY
Sbjct: 596 HRKVGTVQYGI-SRMY 610
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463659|ref|XP_003602111.1| Mitogen activated protein kinase 20-4 [Medicago truncatula] gi|355491159|gb|AES72362.1| Mitogen activated protein kinase 20-4 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 995 bits (2573), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/627 (80%), Positives = 554/627 (88%), Gaps = 20/627 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQDHRKK S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQQDHRKKGSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTISR VRN+KARRYLTSMRKKQPV F+QKF NADP ALRLLERLLAF
Sbjct: 241 DLMTDLLGTPSLDTISR-VRNEKARRYLTSMRKKQPVPFAQKFSNADPLALRLLERLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEY
Sbjct: 300 DPKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDY+NGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV P +RKHVSLPRSTIVH
Sbjct: 360 HPQLLKDYINGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVAPLDRKHVSLPRSTIVH 418
Query: 421 SNTVPPKEQQNL--SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGP 478
SNTVP KEQ ++ S++RQ +EE +NK S+++E IP + R + QR PLAKPGKVVGP
Sbjct: 419 SNTVPQKEQTSIASSKNRQTSEE-YNKLSRDNE-IP--VPRPIQGPQRIPLAKPGKVVGP 474
Query: 479 VVPYENASVRRDAYDPRTFIRS--TVLPQAIPAAYCYRKSSTGKQE---MDSEREMPSQV 533
VVP+E +V +D+YDPR FIR PA Y R ST QE +++ +P Q
Sbjct: 475 VVPFEYGNVVKDSYDPRAFIRGPVLPPQPVPPAYYYQRPGSTANQERPTAGADKGVPLQA 534
Query: 534 KHVPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGA 593
KH QCG+ AK +IAIN+D+NPFFMTR GVNKVE +DQI+I+TNLLQ+K+QYGGVG
Sbjct: 535 KHGQQCGINAKIGHEIAINIDTNPFFMTRVGVNKVEK-DDQIAIETNLLQSKAQYGGVG- 592
Query: 594 AATAAAATAAAHRKIGTVQYGMTTRMY 620
AAA +HRK+G +QYGM TRM+
Sbjct: 593 ----AAAGTNSHRKVGPIQYGM-TRMF 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539497|ref|NP_001234664.1| mitogen-activated protein kinase 12 [Solanum lycopersicum] gi|335353080|gb|AEH42669.1| mitogen-activated protein kinase 12 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 992 bits (2565), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/626 (80%), Positives = 554/626 (88%), Gaps = 11/626 (1%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ DHRKK+S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQPDHRKKSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPS+DTISR VRNDKARRYLTSMRKKQPV F+QKFPNADP +L+LLERLLAF
Sbjct: 241 DLMTDLLGTPSMDTISR-VRNDKARRYLTSMRKKQPVSFAQKFPNADPLSLKLLERLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALADPYFKGL+K EREPSC+ ISKMEFEFERRRVTKED+RELIFREILEY
Sbjct: 300 DPKDRPTAEEALADPYFKGLAKSEREPSCKSISKMEFEFERRRVTKEDLRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQL KDY+NG ERTNFLYPSAVDQFRKQFAHLEEN G PV+P +RKHVSLPRST+VH
Sbjct: 360 HPQLRKDYLNGVERTNFLYPSAVDQFRKQFAHLEENGGNGVPVVPMDRKHVSLPRSTVVH 419
Query: 421 SNTVPPKEQQNLS--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL-AKPGKVVG 477
SN P KEQ ++ RDRQ EE ++N ++SEG+ ++L+RTL AQ R L AKPGKVVG
Sbjct: 420 SNPNPLKEQPIVANMRDRQNGEESCSRNCRDSEGLASSLTRTLQAQPRNALAAKPGKVVG 479
Query: 478 PVVPYENASVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE--MDSEREMPSQVK 534
P + Y++ + R+ YDPR+ +R+ V PQ + + Y Y +S KQE +++ER+M K
Sbjct: 480 PGLAYDSGN--REKYDPRSQVRNAVGPPQIMSSVYSYDRSGVVKQERSVETERDMNCHSK 537
Query: 535 HVPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAA 594
+ CGMAAK A DIAIN+DSNPF+M RAGV K + ++D+I+IDTNLLQ KSQYGG+G
Sbjct: 538 PMAPCGMAAKLAPDIAINIDSNPFYMMRAGVTKPDRVDDRITIDTNLLQAKSQYGGIG-V 596
Query: 595 ATAAAATAAAHRKIGTVQYGMTTRMY 620
A AAA + AAHRK+GTVQYGM +RMY
Sbjct: 597 AAAAATSGAAHRKVGTVQYGM-SRMY 621
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224085324|ref|XP_002307544.1| predicted protein [Populus trichocarpa] gi|222856993|gb|EEE94540.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2533), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/614 (81%), Positives = 539/614 (87%), Gaps = 43/614 (7%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP+TIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPSTIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV+TGKPLFPGKNVVHQLDLMTDLLGTPSL
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVITGKPLFPGKNVVHQLDLMTDLLGTPSL 240
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
DTISRV RNDKARRYLTSMRKK PV F+QKF NADP AL LLERLLAFDPKDRPTAEEAL
Sbjct: 241 DTISRV-RNDKARRYLTSMRKKAPVPFAQKFLNADPLALCLLERLLAFDPKDRPTAEEAL 299
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 372
DPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY+NGT
Sbjct: 300 GDPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYVNGT 359
Query: 373 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 432
ERTNFLYPSAVDQFRKQFAHLEEN GKSGPVIP ERKHVSLPRST+VHS+++P KEQQNL
Sbjct: 360 ERTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHVSLPRSTVVHSSSIPSKEQQNL 419
Query: 433 S--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRD 490
+ +DR +AEEV VG VVPYEN S +D
Sbjct: 420 ASFKDRHSAEEV---------------------------------VGSVVPYENGSNTKD 446
Query: 491 AYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMAAKFA 546
AYDPRT+IRSTVLP QA+P+AYCYRKSSTGK E M++ER++ SQ K V QCGMAAK+A
Sbjct: 447 AYDPRTYIRSTVLPLQAVPSAYCYRKSSTGKLERSTMEAERDLSSQ-KQVQQCGMAAKYA 505
Query: 547 TDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHR 606
D+AIN+DSNPFFMTR G +K EH++D++ IDT+ +QTK+Q G AA AA A+ AA+R
Sbjct: 506 PDVAINIDSNPFFMTRVGGSKEEHVDDRVMIDTSSMQTKAQ-YGGIGAAAAATASRAAYR 564
Query: 607 KIGTVQYGMTTRMY 620
K+GTVQYGM RMY
Sbjct: 565 KVGTVQYGM-ARMY 577
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115345808|gb|ABI95363.1| mitogen-activated protein kinase 20 [Arachis diogoi] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2509), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/629 (79%), Positives = 546/629 (86%), Gaps = 32/629 (5%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD RKK+S EMEFFS+YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKSSMEMEFFSDYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDVF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKH+M+PPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHVMMPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFTDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLLGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTISR VRNDKARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAF
Sbjct: 241 DLMTDLLGTPSLDTISR-VRNDKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTA+EALADPYFKGL+KVEREPSC PI+KMEFEFERRRVTKE+IRELIFREILEY
Sbjct: 300 DPKDRPTAQEALADPYFKGLAKVEREPSCHPITKMEFEFERRRVTKEEIRELIFREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDY+NGTER NFLYPSAVDQF+KQFAHLEEN GKS PV+P ERKHVSLPRST+VH
Sbjct: 360 HPQLLKDYINGTERANFLYPSAVDQFKKQFAHLEENGGKSSPVMPLERKHVSLPRSTVVH 419
Query: 421 SNTVPPKEQQN--LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGP 478
SN V KEQ N S++RQ AEE +N N QR P AKPGKVVGP
Sbjct: 420 SNMVAQKEQSNNASSKNRQPAEE-YNNN------------------QRIPPAKPGKVVGP 460
Query: 479 VVPYENASVRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQEMDSEREMPSQVKHVP 537
VVPYE S+ +D++DPRTFIR + +P Q +P Y Y++S+TG Q D+E+ +P + KH P
Sbjct: 461 VVPYEYGSIVKDSFDPRTFIRGSFVPSQTVPPTYYYQRSTTGHQ--DTEKGVPLKPKHGP 518
Query: 538 -QCGMAAKFATDIAINMDSNPFFMTRA-GVNKVEHIED----QISIDTNLLQTKSQYGGV 591
QCG+ AK A DIAIN+D+NPFFMTRA GVNK+E ++ +I+IDTNLLQ+K+ G
Sbjct: 519 QQCGVNAKIAPDIAINIDTNPFFMTRAIGVNKIEQDDNNNNHRIAIDTNLLQSKAHQYGG 578
Query: 592 GAAATAAAATAAAHRKIGTVQYGMTTRMY 620
AA AA A AHRK+G VQYGM TRM+
Sbjct: 579 IGAAATAATGATAHRKVGPVQYGM-TRMF 606
|
Source: Arachis diogoi Species: Arachis diogoi Genus: Arachis Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 620 | ||||||
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.974 | 0.996 | 0.712 | 2.2e-231 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.924 | 0.958 | 0.658 | 7.6e-199 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.959 | 0.967 | 0.616 | 2.4e-195 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.870 | 0.952 | 0.637 | 1.7e-185 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.688 | 0.837 | 0.738 | 3.6e-176 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.725 | 0.781 | 0.707 | 5.9e-176 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.720 | 0.758 | 0.697 | 1.3e-173 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.659 | 0.841 | 0.690 | 1.1e-158 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.524 | 0.864 | 0.492 | 2.6e-86 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.55 | 0.644 | 0.484 | 6.9e-86 |
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2232 (790.8 bits), Expect = 2.2e-231, P = 2.2e-231
Identities = 443/622 (71%), Positives = 496/622 (79%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD+RKKN+ EMEFFS+YGDA+R+K+QEVIGKGSYGVVCSAIDT TGEKVAIKKIHDIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAA HPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTDLLGTPSLDTISRV RN+KARRYLTSMRKK P+ F+QKFPNADP +L+LLERLLAF
Sbjct: 241 DLMTDLLGTPSLDTISRV-RNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERR+VTKEDIRELI REILEY
Sbjct: 300 DPKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKD+MNG ++ +FLYPSAVDQFR+QFAHLEEN GK+GPV P ERKH SLPRST++H
Sbjct: 360 HPQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIH 419
Query: 421 SNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQR-FPLAXXXXXXXXX 479
S V Q L + N + ++ IP N + T+ AQQR A
Sbjct: 420 STAVARGGQPKLMNNTNTL------NPETTQNIPFNHA-TIQAQQRNLSAAKPSTFMGPV 472
Query: 480 XXYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQ-EMDSEREMPSQVKHVPQ 538
++N + RDAYDPR+FIRST LP + +A + GKQ E + E Q + + Q
Sbjct: 473 APFDNGRISRDAYDPRSFIRSTNLPFSQQSAATV---AMGKQQERRTTMEPEKQARQISQ 529
Query: 539 CGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGXXXXXX 598
++A D+AIN+D+NPF M R G+NK E+I D+I IDTNLLQ + G V
Sbjct: 530 YN---RYAPDVAINIDNNPFIMARTGMNKAENISDRIIIDTNLLQATAGIG-VAAAAAAA 585
Query: 599 XXXXXXHRKIGTVQYGMTTRMY 620
HRK+G V+YGM+ +MY
Sbjct: 586 APGGSAHRKVGAVRYGMS-KMY 606
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1925 (682.7 bits), Expect = 7.6e-199, P = 7.6e-199
Identities = 393/597 (65%), Positives = 449/597 (75%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ+ KKN EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDT TGEKVAIKKI+D+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DL+TDLLGTP +TI+ V RN+KAR+YL MRKK V FSQKFPNADP ALRLL+RLLAF
Sbjct: 241 DLITDLLGTPKSETIAGV-RNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPTA EALADPYFK L+KVEREPSCQPISKMEFEFERRR+TK+DIRELI+REILEY
Sbjct: 300 DPKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDYMN +E ++FLYPSA+ RKQFA+LEEN GKSGPVIPP+RKH SLPRS VH
Sbjct: 360 HPQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSA-VH 417
Query: 421 SNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAXXXXXXXXXX 480
S+ V Q +L+ + + A ++ L R P
Sbjct: 418 SSAVNSNAQPSLNASDSRRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSV 477
Query: 481 XYEN-ASVRRDAYDPRT-FIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVK--HV 536
YEN +++ +YD RT + RSTVLP + CY +T QE S E SQ K V
Sbjct: 478 TYENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAASQPKPQFV 537
Query: 537 P-QCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVG 592
P QC +AK A ++ NP+ + +H ++ ID LL +SQYG G
Sbjct: 538 PTQCN-SAKPA-----ELNPNPYVQS-------QH---KVGIDAKLLHAQSQYGPAG 578
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1892 (671.1 bits), Expect = 2.4e-195, P = 2.4e-195
Identities = 388/629 (61%), Positives = 456/629 (72%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQ+ KK + EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDTHTGEKVAIKKI+D+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDA HPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALK++HTANVYHRDLKPKNILANANCKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
+L+TDLLGTP +TIS V RNDKAR+YLT MRKK PV FSQKF ADP ALRLL+RLLAF
Sbjct: 241 ELITDLLGTPKSETISGV-RNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDRPT EALADPYFKGLSK+EREPS Q ISKMEFEFERRR+TK+DIRELI+REILEY
Sbjct: 300 DPKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 420
HPQLLKDYM+G+E +NF+YPSA+ R+QF +LEEN ++GPVIP ERKH SLPRST VH
Sbjct: 360 HPQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRST-VH 418
Query: 421 SNTVPPKEQQNL-SRDRQAAEEVFNKNSKESEGIPANLS---RTLPAQQRFPLAXX-XXX 475
S V Q NL + D + +KN S G P+ + +++ R P +
Sbjct: 419 STVVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRV 478
Query: 476 XXXXXXYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSST----GKQEMDSEREMPS 531
YEN ++AY RS A+ + +CY + +T + +++ P
Sbjct: 479 VESSVSYENGRNLKEAY-----FRS-----AVSSPHCYFRPNTMTNPENRNIEASSFPPK 528
Query: 532 QVKHVPQCG-----MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQ--ISIDTNLLQT 584
V Q A D+ NP+F + + K + + + ++ID LLQ
Sbjct: 529 PQNPVHQFSPTEPPAATTNQADVETMNHPNPYFQPQ--LPKTDQLNNNTHMAIDAKLLQA 586
Query: 585 KSQYGGVGXXXXXXXXXXXXHRKIGTVQY 613
+SQ+G G HR IGT+ Y
Sbjct: 587 QSQFGPAGAAAVAVAA----HRNIGTISY 611
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1799 (638.3 bits), Expect = 1.7e-185, P = 1.7e-185
Identities = 359/563 (63%), Positives = 433/563 (76%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ DHRKK+S E++FF+EYG+ SRY+I+EVIGKGSYGVVCSA DTHTGEKVAIKKI+DIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIKHI+LPPSRR+F+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTD+LGTPS + I RV RN+KARRYL+SMRKK+P+ FS KFP+ DP ALRLLE++L+F
Sbjct: 241 DLMTDMLGTPSAEAIGRV-RNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSF 299
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
+PKDRPTAEEALAD YFKGL+KVEREPS QP++K+EFEFERRR+TKED+RELI+RE LEY
Sbjct: 300 EPKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEY 359
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERK-HVSLPRSTIV 419
HP++LK+Y++G+E TNF+YPSAV+ F+KQFA+LEE+ PPER+ H SLPR+ ++
Sbjct: 360 HPKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVL 419
Query: 420 HSNTVPPKEQQN-------LSRD--RQAAEEVFNKNSK-ESEGIPANLSRTLPAQQRFPL 469
+S+ P QQ+ LS+ R ++N++ IP N+ +T+ Q +
Sbjct: 420 YSDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSRIPINVPQTI---QGAAV 476
Query: 470 AXXXXXXXXXXXYEN--ASVRRDAYDP--RTFIRSTVLPQAIPAAYCYRKSSTGKQEMDS 525
A Y N A+ +A + R +R+ P KS+ G ++ +
Sbjct: 477 ARPGKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQPCKSNRGDEDCAT 536
Query: 526 EREMPSQVK----HVPQCGMAAK 544
E PS++K ++PQ AA+
Sbjct: 537 AAEGPSRLKPNTQYIPQKVSAAQ 559
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1711 (607.4 bits), Expect = 3.6e-176, P = 3.6e-176
Identities = 319/432 (73%), Positives = 369/432 (85%)
Query: 4 DHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
D KK + E EFF+EYG+ASRY+IQEVIGKGSYGVV SAIDTH+GEKVAIKKI+D+FEH+
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDL 123
SDA HPDIVEIKH+MLPPSRR+F+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
T EHYQFFLYQLLR LK+IHTANV+HRDLKPKNILAN++CKLKICDFGLARV+FND P+
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD+M
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 303
TDLLGTP + I+R+ RN+KARRYL +MR+K PV F+ KFP+ DP ALRLL RLLAFDPK
Sbjct: 242 TDLLGTPPPEAIARI-RNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPK 300
Query: 304 DRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 363
DRP+AEEALADPYF GL+ V+REPS QPI K+EFEFERR++TKED+RELI+REILEYHPQ
Sbjct: 301 DRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQ 360
Query: 364 LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNT 423
+L++Y+ G E+T+F+YPS VD+F++QFAHLEEN GK P +R+H SLPR +
Sbjct: 361 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERV----P 416
Query: 424 VPPKEQQNLSRD 435
P KE + + D
Sbjct: 417 APKKENGSHNHD 428
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1709 (606.7 bits), Expect = 5.9e-176, P = 5.9e-176
Identities = 324/458 (70%), Positives = 379/458 (82%)
Query: 2 QQDH---RKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD 58
Q++H KK P EFF+EYG+A+RY+IQEV+GKGSYGVV SAIDTHTGE+VAIKKI+D
Sbjct: 64 QRNHLPMEKKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKIND 123
Query: 59 IFEHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK 118
+F+HISDA HPD+VEIKHIMLPPSRR+F+D+YVVFELMESDLHQVIK
Sbjct: 124 VFDHISDATRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIK 183
Query: 119 ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
ANDDLT EH+QFFLYQLLR LKY+H ANV+HRDLKPKNILANA+CKLKICDFGLARV+FN
Sbjct: 184 ANDDLTPEHHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFN 243
Query: 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
D PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVH
Sbjct: 244 DAPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVH 303
Query: 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 298
QLD+MTD LGTP + IS++ RNDKARRYL +MRKKQPV FS+KFP ADPSALRLLERL+
Sbjct: 304 QLDIMTDFLGTPPPEAISKI-RNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLI 362
Query: 299 AFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREIL 358
AFDPKDRP+AEEALADPYF GLS REPS QPISK+EFEFER+++TK+DIRELI+REIL
Sbjct: 363 AFDPKDRPSAEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREIL 422
Query: 359 EYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTI 418
EYHPQ+L++Y+ G + +F+YPS VD+FR+QFAHLEEN G G +R+H SLPR +
Sbjct: 423 EYHPQMLEEYLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERV 482
Query: 419 VHSNTVPPKEQQN-LSRDRQAA-EEVFN--KNSKESEG 452
S +E+ N + R AA + K S+++EG
Sbjct: 483 PASKNETVEERSNDIERRTTAAVASTLDSPKASQQAEG 520
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1687 (598.9 bits), Expect = 1.3e-173, P = 1.3e-173
Identities = 318/456 (69%), Positives = 373/456 (81%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
+ D KK E EFF+EYG+A+RY+IQEV+GKGSYGVV SA+D+HTGE+VAIKKI+D+F
Sbjct: 82 LPMDPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVF 139
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPD+VEIKHIMLPPSRR+F+DIYVVFELMESDLHQVIKAN
Sbjct: 140 EHVSDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKAN 199
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKY+H ANV+HRDLKPKNILANA+CKLKICDFGLARV+FND
Sbjct: 200 DDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 259
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQL
Sbjct: 260 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQL 319
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
DLMTD LGTP ++ISR+ RN+KARRYL+SMRKKQPV FS KFP ADP ALRLLERLLAF
Sbjct: 320 DLMTDFLGTPPPESISRI-RNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAF 378
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 360
DPKDR +AE+ALADPYF GLS EREP+ QPISK+EF+FER+++ K+D+RELI+REILEY
Sbjct: 379 DPKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEY 438
Query: 361 HPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPV-----IPPERKHVSLPR 415
HPQ+L++Y+ G ++ +F+YPS VD+F++QFAHLEEN GK G R H SLPR
Sbjct: 439 HPQMLEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPR 498
Query: 416 STIVHSNTVPPKEQQNLSRDRQAAEEVFNKNSKESE 451
+ N +E ++ R R AA S+E++
Sbjct: 499 ERVPAPNGETAEESSDVER-RAAAAVASTLESEEAD 533
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
Identities = 286/414 (69%), Positives = 350/414 (84%)
Query: 12 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXX 71
E EFF+EYG+AS+Y+IQEV+GKGSYGVV SA HTG KVAIKK+ ++FEH+SDA
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 72 XXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 131
HPDIVEIKHIMLPP R++FKDIYVVFELMESDLH V+K NDDLT +H+QFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
LYQLLR LK++H+A+V+HRDLKPKNILANA+CK+KICD GLARV+F D+P+ +FWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGKNVVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
T+SR+ RN+KAR+YL +MR+K PV F+ KFPN DP AL+LL+RL+AFDPKDRP+AEEA
Sbjct: 243 PITLSRI-RNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEA 301
Query: 312 LADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNG 371
LADPYF+GL+ V+ EPS QPISK+EFEFERR++T++D+REL++REILEYHPQ+L++Y+ G
Sbjct: 302 LADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQG 361
Query: 372 TERTN--FLYPSAVDQFRKQFAHLEE-NVGKSGPVIPP-ERKHVSLPRSTIVHS 421
E N FLYPS VDQF+++FA LEE N + PP +RK+ SLPR + S
Sbjct: 362 EENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSS 415
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 164/333 (49%), Positives = 230/333 (69%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXXXXXXXXXXXHPDIVEIKHI 90
IG+G+YG+VC+A ++ TGE+VAIKKI + F++I DA H +++ +K I
Sbjct: 49 IGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDI 108
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
+ PP R +F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQLLR LKY+H+ANV HR
Sbjct: 109 IKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHR 168
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
DLKP N+L NANC LK+ DFGLAR T F T+YV TRWYRAPEL + S+YT
Sbjct: 169 DLKPSNLLLNANCDLKLGDFGLARTKSE----TDFMTEYVVTRWYRAPELLLNC-SEYTA 223
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTS 270
AIDIWS+GCI E +T +PLFPGK+ VHQL L+T+L+G+P D+ +R+D ARRY+
Sbjct: 224 AIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPD-DSSLGFLRSDNARRYVRQ 282
Query: 271 MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQ 330
+ + F+ +FPN A+ LLE++L FDP R T +EAL PY L + EP C
Sbjct: 283 LPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVC- 341
Query: 331 PISKMEFEFERRRVTKEDIRELIFREILEYHPQ 363
+ F+FE+ +T+E+I+ELI+RE ++++PQ
Sbjct: 342 -VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
Identities = 168/347 (48%), Positives = 232/347 (66%)
Query: 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXXXXXXX 76
S++ RY I + IG G+YGVVCSA D TGEKVAIKKI F+++ D
Sbjct: 141 SQFTVPRRYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLL 200
Query: 77 XXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 136
H +++ IK I+ P S+ F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+L
Sbjct: 201 RHFKHENLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQML 260
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R LK+IH+ANV HRDLKP N+L N +C LKICD GLARV D F T+YVATRWYR
Sbjct: 261 RGLKHIHSANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYR 318
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
APE+ S+ +KYT AIDIWS+GCIFAE+L KPLF GK+ +HQ+ L+ + +G+PS + I
Sbjct: 319 APEVILSW-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDIC 377
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ N++AR+++ +M + V F+ FP A+P A+ LLER+L FDP R T EEALA PY
Sbjct: 378 NIA-NEQARQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPY 436
Query: 317 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 363
F+ L EP C + K FE + ++ ++ELI+ E+L YHP+
Sbjct: 437 FQSLHDPSDEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q5ZCI1 | MPK10_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7456 | 0.9774 | 0.9918 | yes | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7372 | 0.6887 | 0.8438 | N/A | no |
| Q9SJG9 | MPK20_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7536 | 0.9758 | 0.9983 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pm.C_LG_II0282 | hypothetical protein (621 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 620 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-159 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-146 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-141 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-121 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-119 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-116 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-103 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-102 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-102 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-95 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-91 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-88 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-88 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-87 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-87 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-84 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-84 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-80 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-79 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-73 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-72 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-67 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-66 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-65 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-65 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-64 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-64 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-62 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-61 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-61 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-61 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-60 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-60 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-60 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-58 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-58 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-54 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-54 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-47 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-47 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-44 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-42 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-38 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-38 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-16 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 745 bits (1925), Expect = 0.0
Identities = 314/339 (92%), Positives = 331/339 (97%), Gaps = 1/339 (0%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI+D+FEH+SDA RILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EH+QFFLYQLLRALKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
TANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT IFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL+TDLLGTPS +TISR VRN+K
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR-VRNEK 239
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323
ARRYL+SMRKKQPV FSQKFPNADP ALRLLERLLAFDPKDRPTAEEALADPYFKGL+KV
Sbjct: 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299
Query: 324 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
EREPS QPI+K+EFEFERRR+TKED+RELI+REILEYHP
Sbjct: 300 EREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 532 bits (1372), Expect = 0.0
Identities = 187/333 (56%), Positives = 242/333 (72%), Gaps = 3/333 (0%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY++ + IG G+YGVVCSA+D TG KVAIKKI ++F+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
I+ + I+ PPS DF D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N+NC LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
S+YT AIDIWS+GCIFAE+LT KPLFPG++ + QL+L+ ++LGTPS + + + ++K
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF-ITSEK 238
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323
AR YL S+ KK S+ FP A P A+ LLE++L FDPK R TA+EALA PY L
Sbjct: 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298
Query: 324 EREPSCQPISKMEFEFERRRVTKEDIRELIFRE 356
E EP +P +F F+ +T+E+++ELI+ E
Sbjct: 299 EDEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 459 bits (1182), Expect = e-159
Identities = 188/340 (55%), Positives = 247/340 (72%), Gaps = 7/340 (2%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
++Y + IG+G+YG+VCSA ++ T EKVAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+++ IK IM PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLR LKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ANV HRDLKP N+L NANC LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTRWYRAPELLL 181
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+ S+YT AID+WS+GCIFAE+L KPLFPGK+ VHQL L+T+LLG+PS + + +RN+
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG-FIRNE 239
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
KARRY+ S+ F++ FP+A+P A+ LLE++L FDP R T EEALA PY L
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 323 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
EP CQ + F+FE +T+EDI+ELI+ E+L YHP
Sbjct: 300 PSDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 426 bits (1097), Expect = e-146
Identities = 174/342 (50%), Positives = 238/342 (69%), Gaps = 15/342 (4%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY+ IG+G+YG+VCSA TG KVAIKKI FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N NC LKICDFGLAR+A + T F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ YT AIDIWS+GCI AE+L+ +PLFPGK+ +HQL+L+ +LGTPS + ++ ++ +
Sbjct: 182 LN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII-S 239
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
+AR Y+ S+ K V +++ FPNADP AL LL+++L F+P R T EEALA PY
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY----- 294
Query: 322 KVER--EPSCQPISKMEFEFE---RRRVTKEDIRELIFREIL 358
+E+ +PS +P+++ F F+ + KE ++ELIF EI+
Sbjct: 295 -LEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 413 bits (1063), Expect = e-141
Identities = 175/335 (52%), Positives = 241/335 (71%), Gaps = 6/335 (1%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
SRYK E IG G+YGVVCSAIDT +G+KVAIKKI F+ + A R LRE+K+LR +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+I+ I+ I+ PP DFKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLR LKYI
Sbjct: 65 NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRAPELC 201
H+ANV HRDLKP N+L N +C+L+I DFG+AR ++ + T F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
S +YT AID+WS+GCIFAE+L + LFPGKN VHQL L+ +LG+PS + ++R + +
Sbjct: 184 LS-LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR-IGS 241
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
D+ R+Y+ ++ +KQPV +S+ FP A P AL LL ++L FDP++R T E+AL P+
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFRE 356
+ EP+C P +F+FE +++E ++E I +E
Sbjct: 302 DPDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 361 bits (930), Expect = e-121
Identities = 148/339 (43%), Positives = 212/339 (62%), Gaps = 12/339 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 81
+Y+I + +GKG+YG+V AID T E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
P+IV++ +++ + D KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ALKY
Sbjct: 67 PNIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKY 122
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARV--AFNDTPTTIFWTDYVATRWYRAPE 199
IH+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L GS ++YT +D+WS+GCI E+L GKPLFPG + ++QL+ + +++G PS + I
Sbjct: 183 ILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI-ES 239
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+++ A L S+ + + P A AL LL++LL F+P R TAEEAL PY
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 319 GLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 357
EP + + + +++ + R ++ EI
Sbjct: 300 QFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 356 bits (916), Expect = e-119
Identities = 164/339 (48%), Positives = 222/339 (65%), Gaps = 12/339 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLLR- 80
RY++ + +G+G+YG+VCSA + T E VAIKKI ++F A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
H +I + + M +F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L LK
Sbjct: 61 HKNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP--TTIFWTDYVATRWYRAP 198
YIH+ANV HRDLKP N+L NA+C+LKICDFGLAR F++ P F T+YVATRWYRAP
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRAP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ S F YT AID+WS+GCI AE+L KP+F GK+ V QL+ + +LGTP +T+SR
Sbjct: 179 EIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR- 236
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ + KA+ Y+ S+ F FPNA+P AL LLE+LLAFDP R + EEAL PY
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 319 GLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 357
+ EP CQ FE E + E++R++I E+
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 350 bits (899), Expect = e-116
Identities = 146/340 (42%), Positives = 210/340 (61%), Gaps = 13/340 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA DT TG KVAIKK+ F+ A R RE++LL+ + H +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + P S DF+D+Y+V LM +DL+ ++K L+ +H QF +YQ+LR LKYI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI N +C+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
++ Y +DIWS+GCI AE+LTGK LFPG + + QL + +L+GTP + + ++
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
AR Y+ S+ + F + F A+P A+ LLE++L DP R TA EALA PY
Sbjct: 248 -ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
Query: 323 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
E EP P + FE R +T ++ +EL+++EI+ + P
Sbjct: 307 PEDEPVAPP---YDQSFESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 316 bits (812), Expect = e-103
Identities = 154/336 (45%), Positives = 221/336 (65%), Gaps = 19/336 (5%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+RY + +G G++G+VCSA D TG+ VAIKKI F A R RE+KLL+ LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ+LR LKY+
Sbjct: 70 NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYV 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A V HRDLKP NIL N NC LKICDFGLAR+ T YV+TR+YRAPE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRYYRAPEIML 178
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+ + KY +DIWS GCIFAE+L GKPLFPGK+ V+Q ++TDLLGTP D I+ + ++
Sbjct: 179 T-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC-SE 236
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
R++ S+ K++PV FS+KF NADPSA+ LLE++L FDP+ R +A EALA PY
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY----LA 292
Query: 323 VEREPSCQPISKMEFE--FERRRVTKEDIRELIFRE 356
+P+ +P+++ +F+ F + + + +++ E
Sbjct: 293 PYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 311 bits (800), Expect = e-102
Identities = 125/297 (42%), Positives = 173/297 (58%), Gaps = 19/297 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--ISDAARILREIKLLRLLRHP 82
Y+ E +G+G+YGVV A D TGE VA+KKI E I A LREI LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKY 141
+IV++ ++ + +Y+VFE + DL + + L+ + +YQLLR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
H+ + HRDLKP+NIL N + LK+ DFGLAR AF +T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AF--GIPLRTYTHEVVTLWYRAPEIL 170
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
GS Y+ A+DIWS+GCIFAE++TGKPLFPG + + QL + +LGTP+ ++ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
K Y + K P + P DP + LL ++L ++P R +A+EAL PYF
Sbjct: 227 -TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (796), Expect = e-102
Identities = 133/295 (45%), Positives = 176/295 (59%), Gaps = 14/295 (4%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y+ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIH 143
+++ + R D+Y+VFE M++DL+++IK L + +LYQLL+ L + H
Sbjct: 61 IKLLDVF-----RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y+ +DIWS+GCIFAE+L+ +PLFPGK+ + QL + LGTP + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL- 229
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
AR Y S KK + + FPNA P AL LL ++L +DP R TAE+ALA PYF
Sbjct: 230 -ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 296 bits (759), Expect = 4e-95
Identities = 140/355 (39%), Positives = 207/355 (58%), Gaps = 33/355 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG G++GVV S D G++VA+KK+ ++F+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N+NC LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLT 269
A+DIWS+GCIFAE+L + LF ++ + QLDL+TDLLGTPSL+ + + AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC--EGARAHIL 241
Query: 270 SMRKKQPVQFSQKFPNADPS---ALRLLERLLAFDPKDRPTAEEALADPYFKG------- 319
K P + + + A+ LL R+L FDP R +A +ALA PY
Sbjct: 242 RGPHKPPS-LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHT 300
Query: 320 -------------LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 361
+ + EPS P E+E+ + ++E + + ILE
Sbjct: 301 CMCKCCYTTSGGRVYTSDFEPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 280 bits (720), Expect = 7e-91
Identities = 109/294 (37%), Positives = 153/294 (52%), Gaps = 41/294 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y+I E +G+GS+G V A D TG+ VAIK I + D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + + D +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKL---TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
Y A+DIWS+G I E+LTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
F + P A L+ +LL DP+ R TAEEAL P+F
Sbjct: 213 ------------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 275 bits (706), Expect = 2e-88
Identities = 116/299 (38%), Positives = 172/299 (57%), Gaps = 22/299 (7%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPD 83
YK+ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKY 141
IV++K + R+ ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 200
IH +HRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
S Y+ +DIW++GCI AE+ T +PLFPG + + QL + +LGTP+
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ A + + P Q PNA P A+ L++ +L +DPK RPTA +AL PYF
Sbjct: 227 YK--LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 3e-88
Identities = 136/341 (39%), Positives = 207/341 (60%), Gaps = 13/341 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
RY+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 83 DIVEIKHIMLPPSRRD-FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P D F D Y+V M +DL +++K ++ L+ + QF +YQ+L+ LKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N +C+LKI DFGLAR ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
++ YT +DIWS+GCI AE+LTGKPLF G + + QL + + GTPS + + + +++
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK-LQS 245
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
+ A+ Y+ + + + F PNA+P A+ +LE++L D + R TA EALA PYF+
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
E E P + F+ + E+ + L F EIL + P
Sbjct: 306 DPEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 4e-87
Identities = 137/340 (40%), Positives = 210/340 (61%), Gaps = 13/340 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N +C+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + + + + ++
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK-ISSE 248
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA YF
Sbjct: 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308
Query: 323 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
+ EP P + FE R + ++ + L + E++ + P
Sbjct: 309 PDDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 4e-87
Identities = 115/299 (38%), Positives = 171/299 (57%), Gaps = 18/299 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 82
Y+ IG+G+YG V A + TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHP 58
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL L+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
+H+ + HRD+K NIL N + LK+ DFGLAR + + + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
G+ ++Y P +D+WS+GCI AE+ GKP+F G + QL+ + +L G+P+ + V
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV-- 229
Query: 261 NDKARRYLT-SMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 317
K + +K + + F + DPSAL LL++LL DPK R +A++AL YF
Sbjct: 230 -SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 274 bits (701), Expect = 6e-87
Identities = 134/341 (39%), Positives = 199/341 (58%), Gaps = 16/341 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY + +G G+YG VCSAID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + S +F+D Y+V M++DL +++ L+ + Q+ +YQ+L LKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
++ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P + + ++ D
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL--ED 244
Query: 263 K-ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
K A+ Y+ S+ K FS FP A P A+ LLE++L D R TA EAL PYF
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
+ E QP E +++ ++ ++ I++E+ + P
Sbjct: 305 DADEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 4e-84
Identities = 137/340 (40%), Positives = 208/340 (61%), Gaps = 13/340 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + P S +F ++Y+V LM +DL+ ++K L+ EH QF +YQLLR LKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+L+I DFGLAR A ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
++ Y +DIWS+GCI AE+L GK LFPG + + QL + +++GTPS + + + + ++
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK-ISSE 246
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
AR+Y+ S+ + F A+P A+ LLE++L D R +A EALA PYF
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306
Query: 323 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
E EP +P + E + T E+ +EL + E+ + P
Sbjct: 307 PEDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 7e-84
Identities = 119/303 (39%), Positives = 162/303 (53%), Gaps = 25/303 (8%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-----ILREIKLLRL 78
RY+ + +G+G+Y VV A D TG VAIKKI +A LREIKLL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQE 58
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLR 137
L+HP+I+ + + + I +VFE ME+DL +VIK LT + ++ LR
Sbjct: 59 LKHPNIIGLLDVF---GHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRA
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRA 170
Query: 198 PELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
PEL F Y +D+WS+GCIFAE+L P PG + + QL + + LGTP+ +
Sbjct: 171 PEL---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
V + + P Q FP A AL LL+RLL +P R TA +AL P
Sbjct: 228 PGV----TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283
Query: 316 YFK 318
YF
Sbjct: 284 YFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 4e-82
Identities = 121/301 (40%), Positives = 178/301 (59%), Gaps = 23/301 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 81
RYKI IG+G++G+V A D TGE VA+KK+ + I + A LREIK L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALK 140
P +V++ + S +V E M SDL +V++ + L + ++ LL+ +
Sbjct: 59 PYVVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
Y+H + HRDLKP N+L +A+ LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 201 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT---IS 256
G+ KY P +D+W++GCIFAE+L G PLFPG+N + QL ++ LGTP+ +T ++
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ +K + +P+ + FP+A P AL LL+ LL +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 317 F 317
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 5e-80
Identities = 127/349 (36%), Positives = 198/349 (56%), Gaps = 25/349 (7%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
RY+ + IG G+ G+VC+A DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ + ++ P S +F+D+Y+V ELM+++L QVI DL E + LYQ+L +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LKI DFGLAR A T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
Y +DIWS+GCI E++ G LFPG + + Q + + + LGTPS + +SR+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL--Q 245
Query: 262 DKARRYLTSMRKKQPVQFSQKFP-------NADPSALR------LLERLLAFDPKDRPTA 308
R Y+ + K F + FP + + L+ LL ++L DP+ R +
Sbjct: 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305
Query: 309 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 357
++AL PY E P + + + R T E+ +ELI++E+
Sbjct: 306 DDALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 5e-79
Identities = 113/298 (37%), Positives = 169/298 (56%), Gaps = 15/298 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
IV +K RR + +Y+VFE +E L ++++A+ L + + +++QLL+A+ Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LC 201
H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
G + Y +D+W+IGCI AE+L G+PLFPG + + QL L+ LG N
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 262 DKARRY-LTSMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ + + ++ +++P AL L+ L DPK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLE--RRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 8e-79
Identities = 96/294 (32%), Positives = 143/294 (48%), Gaps = 35/294 (11%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + D +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + N +KI DFGLA+ + + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
+ Y P +D+WS+G I E+LTGKP F G+N++ QL +++R
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL----------------QLIRRIL 215
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
K+ + A L+++ L DP RPTAEE L P+F
Sbjct: 216 GPPLEFD---------EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 3e-77
Identities = 128/345 (37%), Positives = 183/345 (53%), Gaps = 42/345 (12%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---LREIKL 75
+ SRY +G GS G+V SA+D+ ++VA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKHIMLPPSRRD---------FKDIYVVFELMESDLHQVIKANDDLTRE 126
+R L H +IV++ ++ P +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIF 185
H + F+YQLLR LKYIH+ANV HRDLKP N+ N + LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + + Q+ L+
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-- 231
Query: 246 LLGTPSLDTISRVVRNDK----------ARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 295
L+++ V D+ R R+ P +P AL LE
Sbjct: 232 ------LESVPVVREEDRNELLNVIPSFVRNDGGEPRRP----LRDLLPGVNPEALDFLE 281
Query: 296 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 340
++L F+P DR TAEEAL PY S EP +E E +
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 2e-73
Identities = 120/300 (40%), Positives = 165/300 (55%), Gaps = 20/300 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 82
Y+ I +G+YGVV A D TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKY 141
+IV +K +++ + IY+V E +E DL +++ + + + QLL + +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGK+ + QL+ + LLGTP+
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 NDKARRYLTSMRKKQPV-QFSQKFPNADPS--ALRLLERLLAFDPKDRPTAEEALADPYF 317
A+ K P Q +KFP S LL RLL +DP R +AE+AL PYF
Sbjct: 237 LPGAK---KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 7e-72
Identities = 128/306 (41%), Positives = 171/306 (55%), Gaps = 23/306 (7%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIVEIK 88
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANV 147
+++ + I++V E E DL ++ + + + QLLR L+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFS 206
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266
YT AID+W++GCI AE+L KPL PGK+ + QLDL+ LLGTP+ ++I +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPLVG 243
Query: 267 YLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 325
T KQP KFP + LRLL LL +DPK R TAEEAL YFK E+
Sbjct: 244 KFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK-----EK 296
Query: 326 EPSCQP 331
C+P
Sbjct: 297 PLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 4e-71
Identities = 113/312 (36%), Positives = 166/312 (53%), Gaps = 25/312 (8%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLR 80
Y+I +G+G++G V A TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 81 HPDIVEIKHIML---PPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLL 136
HP++V + + + S+R +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT--------TIFWTD 188
+ Y+H ++ HRD+K NIL + LKI DFGLAR P T +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GK+ + QL L+ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 248 GTPSLDTIS--RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305
GTP+ +T R + + T+ P ++F P L LL +LL+ DP R
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTN----YPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299
Query: 306 PTAEEALADPYF 317
TA +AL PYF
Sbjct: 300 LTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 4e-67
Identities = 120/298 (40%), Positives = 165/298 (55%), Gaps = 20/298 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA--ARILREIKLLRLLRHP 82
Y+ E IG+G+YGVV A D TGE VA+KKI E + + +REI LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALK 140
+IV + ++ ++ +Y+VFE ++ DL + + L + +LYQLL+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG + + QL + LGTP D V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
Y + K S+ PN D L LL ++L +DP R +A+ AL PYF
Sbjct: 229 ---SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 222 bits (566), Expect = 7e-67
Identities = 127/367 (34%), Positives = 205/367 (55%), Gaps = 30/367 (8%)
Query: 12 EMEFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 65
+ +F+S + D++ RY+ + IG G+ G+VC+A DT G VA+KK+ F++ +
Sbjct: 4 DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLT 124
A R RE+ LL+ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI +L
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELD 121
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNF 177
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244
T YV TR+YRAPE+ Y +DIWS+GCI E++ G +F G + + Q + +
Sbjct: 178 MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235
Query: 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPS-----------ALR 292
+ LGTPS + ++R+ R Y+ + + + F + FP+ PS A
Sbjct: 236 EQLGTPSAEFMNRLQ--PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293
Query: 293 LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 352
LL ++L DP R + +EAL PY + E P + + E R E+ +EL
Sbjct: 294 LLSKMLVIDPDKRISVDEALRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKEL 352
Query: 353 IFREILE 359
I++E+++
Sbjct: 353 IYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 2e-66
Identities = 108/303 (35%), Positives = 173/303 (57%), Gaps = 31/303 (10%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD 83
YKI IG+G++ V A TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKHIML-PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY------QFFLYQLL 136
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQLL
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
++L ++H ++HRD+KP+NIL + LK+ DFG R ++ P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 197 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP +
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
+ + ++ K+ + PNA L LL++LLA+DP +R TA++AL
Sbjct: 223 LKKFRKSRHMNYNFP---SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 315 PYF 317
PYF
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 116/298 (38%), Positives = 170/298 (57%), Gaps = 20/298 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
+K E +G+G+Y V + TGE VA+K+IH D E A +REI L++ L+H +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHEN 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LTREHYQFFLYQLLRALK 140
IV + ++ ++ + +VFE M+ DL + + + L + F YQLL+ +
Sbjct: 60 IVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYRAP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
L GS Y+ +IDIWS+GCI AE++TG+PLFPG N QL + ++GTP+ T +
Sbjct: 172 LLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ + + T R P Q FP+ADP + LL RLL +P+ R +A +AL P+F
Sbjct: 230 QLPEYKP--TFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 110/303 (36%), Positives = 160/303 (52%), Gaps = 26/303 (8%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLR- 80
Y+ IG+G+YG V A D +TG VA+KK+ +S+ LREI LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 81 --HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLL 136
HP+IV + + P + +VFE ++ DL + L E + + QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYVATRWY 195
R + ++H+ + HRDLKP+NIL ++ ++KI DFGLAR+ +F T++ V T WY
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV-----VVTLWY 172
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
RAPE L S Y +D+WS+GCIFAE+ +PLF G + QLD + D++G PS +
Sbjct: 173 RAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
R V + +S P F P L LL+++L F+P R +A EAL
Sbjct: 230 WPRNVSLPR-----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
Query: 315 PYF 317
PYF
Sbjct: 285 PYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 8e-65
Identities = 121/326 (37%), Positives = 167/326 (51%), Gaps = 44/326 (13%)
Query: 22 ASRYK-IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR------------ 68
+ RY +G+G+YG V A DT TG+ VAIKK+ I E +D +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHF 65
Query: 69 -ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 127
LRE+K++ ++H +I+ + + + DF I +V ++M SDL +V+ LT
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQ 120
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------- 179
+ L Q+L L +H HRDL P NI N+ KI DFGLAR
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 180 ---TPTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG+N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYL---TSMRKKQPVQFSQKFPNADPSALR 292
+ QL + +LLGTP+ D N + L T ++P FPNA A+
Sbjct: 239 EIDQLGRIFELLGTPNED-------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAID 291
Query: 293 LLERLLAFDPKDRPTAEEALADPYFK 318
LL+ LL +P +R +A+EAL YFK
Sbjct: 292 LLQSLLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 4e-64
Identities = 116/301 (38%), Positives = 172/301 (57%), Gaps = 23/301 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRH 81
+Y+ IG+GSYGVV + TG+ VAIKK + + I A LREI++L+ L+H
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKH 59
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 140
P++V + + RR K +++VFE + + L+++ K + + ++Q L+A+
Sbjct: 60 PNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
+ H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAPEL
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPEL 171
Query: 201 -CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
G ++Y P +D+W+IGC+FAE+LTG+PL+PGK+ V QL L+ LG D I R
Sbjct: 172 LVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQ 225
Query: 260 RNDKARRYLTSMRKKQP---VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ ++ + +P KFPN AL L+ L DP +R + EE L PY
Sbjct: 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
Query: 317 F 317
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 9e-64
Identities = 120/327 (36%), Positives = 167/327 (51%), Gaps = 44/327 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRL 78
+Y+I+ IG+G+YG V A + G++ AIKK E IS +A REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-----LY 133
L+H ++V + + L + K +Y++F+ E DL Q+IK + R L+
Sbjct: 59 LKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QLLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTD- 188
Q+L + Y+H+ V HRDLKP NIL +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VH 238
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS--------QKFPNADPSA 290
QL+ + ++LGTP+ + K Y T M+ + + +K D
Sbjct: 233 QLERIFEVLGTPTEKDWPDIK---KMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289
Query: 291 LRLLERLLAFDPKDRPTAEEALADPYF 317
LL +LL +DP R TAEEAL PYF
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 4e-62
Identities = 113/293 (38%), Positives = 166/293 (56%), Gaps = 17/293 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV + TG+ VA+KKI E + +REI LL+ L+HP+IV ++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQ---VIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+++ SR +Y++FE + DL + + + E + +LYQ+L+ + + H+
Sbjct: 66 DVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 204
V HRDLKP+N+L + +K+ DFGLAR AF P ++ T V T WYRAPE L GS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLLGS- 176
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264
+Y+ +DIWSIG IFAE+ T KPLF G + + QL + +LGTP+ D V
Sbjct: 177 -PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV---TSL 232
Query: 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
Y + K + N D L LLE++L +DP R +A++AL PYF
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 7e-61
Identities = 115/292 (39%), Positives = 162/292 (55%), Gaps = 16/292 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTAN 146
++ +Y+VFE + DL + + A+ + + +L+QLL+ L + H+
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
V HRDLKP+N+L N +K+ DFGLAR AF T +T V T WYRAPE L G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPEILLGCKY 177
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP V
Sbjct: 178 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT---SLP 232
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
Y S K FS+ P D LL ++L +DP R +A+ ALA P+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 206 bits (524), Expect = 7e-61
Identities = 127/367 (34%), Positives = 206/367 (56%), Gaps = 36/367 (9%)
Query: 14 EFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
+F+S E GD++ RY+ + IG G+ G+VC+A D VAIKK+ F++ + A
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 68 RILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTRE 126
R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+ +L E
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHE 119
Query: 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186
+ LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T+
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 175
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG++ + Q + + +
Sbjct: 176 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLL 294
LGTP + + ++ R Y+ + K + F + FP++ A LL
Sbjct: 234 LGTPCPEFMKKL--QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 295 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS---CQPISKMEFEFERRRVTKEDIRE 351
++L DP R + +EAL PY V +P+ P + + + R T E+ +E
Sbjct: 292 SKMLVIDPAKRISVDEALQHPYI----NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
Query: 352 LIFREIL 358
LI++E++
Sbjct: 348 LIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 8e-61
Identities = 127/364 (34%), Positives = 201/364 (55%), Gaps = 35/364 (9%)
Query: 18 EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
E GD++ RY+ + IG G+ G+VC+A D VAIKK+ F++ + A R RE
Sbjct: 14 EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE 73
Query: 73 IKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 131
+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+ +L E +
Sbjct: 74 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYL 131
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T+ T YV
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVV 187
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q + + + LGTP
Sbjct: 188 TRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPN----AD--------PSALRLLERLLA 299
+ + ++ R Y+ + K F + FP+ AD A LL ++L
Sbjct: 246 PEFMKKL--QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 300 FDPKDRPTAEEALADPYFK---GLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFRE 356
D R + +EAL PY S+ E P P + + + R T E+ +ELI++E
Sbjct: 304 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIP----DKQLDEREHTIEEWKELIYKE 359
Query: 357 ILEY 360
+++
Sbjct: 360 VMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 1e-60
Identities = 114/301 (37%), Positives = 169/301 (56%), Gaps = 24/301 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ D E + +A LREI LL+ L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 140
+IV + ++ + + +VFE + DL + + N D+ E + F++QLL+ L
Sbjct: 59 KNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P + + V T WYR P+
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPDV 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ ++ V
Sbjct: 171 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 259 VR--NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ + K + P + + LL+ LL +P R +AEEAL PY
Sbjct: 229 SKLPDYKPYPMYPAT-----TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
Query: 317 F 317
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-60
Identities = 112/305 (36%), Positives = 166/305 (54%), Gaps = 20/305 (6%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA-RILREIKLLR 77
+G YK + +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLL 136
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLL
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L + +LK+ DFGLAR + T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT 254
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG +V QL + +LGTP+ +T
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEAL 312
V N + + Y S P P D P L + L ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 313 ADPYF 317
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 2e-60
Identities = 112/303 (36%), Positives = 166/303 (54%), Gaps = 21/303 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 82
+ I IG+G+YG V A D TGE VA+KK+ ++ + I +REIK+LR L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHR 66
Query: 83 DIVEIKHIMLPPS-----RRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLL 136
+IV +K I+ ++D Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYR 184
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
PEL G +Y PAID+WS GCI E+ T KP+F + QL+L++ L G+P
Sbjct: 185 PPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 256 SRVVRNDKARRYLTSMRKKQPVQ--FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
V++ Y +M+ K+ + ++F AL LL+ +L DP R TAEEAL
Sbjct: 243 PDVIK----LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 314 DPY 316
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 5e-60
Identities = 117/301 (38%), Positives = 171/301 (56%), Gaps = 17/301 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY--QFFLYQLLRALKY 141
IV ++ ++ R +Y+VFE ++ DL + + ++ D + + +LYQ+LR + Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 142 IHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LGTP+ +T V
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
Y ++ K P + P +P+ + LL ++L DP R TA AL YFK
Sbjct: 233 ---SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 320 L 320
L
Sbjct: 290 L 290
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 2e-58
Identities = 108/307 (35%), Positives = 157/307 (51%), Gaps = 16/307 (5%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRL 78
+ S+Y+ IG+G++G V A T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 79 LRHPDIV---EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQ 134
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV---AFNDTPTTIFWTDYVA 191
LL L YIH + HRD+K NIL + LK+ DFGLAR + N P +T+ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRVV 185
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G+
Sbjct: 186 TLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
+ + V + + ++ +K+ V+ K DP AL L+++LL DP R A+
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303
Query: 311 ALADPYF 317
AL +F
Sbjct: 304 ALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 4e-58
Identities = 114/310 (36%), Positives = 173/310 (55%), Gaps = 41/310 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI-LREIKLLRLLRHP 82
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHE 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY---------QFFLY 133
++V ++ RR K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT--P 250
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 251 SLDTISRVVRNDKARRYLTSMR---KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
I +N MR K+ ++FP L L ++ L DP DRP+
Sbjct: 223 RHQEI--FQKN----PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
Query: 308 AEEALADPYF 317
+ + L +F
Sbjct: 277 SSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 112/301 (37%), Positives = 163/301 (54%), Gaps = 17/301 (5%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PD 83
Y+ E IG+G+YG V A D +TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRA 138
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LKI D GL R AF+ P + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + + QL + LLGTP+
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
V R + +P S+ P+ P L LL+++L +DP R +A+ AL PY
Sbjct: 238 GV----SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 317 F 317
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 2e-54
Identities = 115/305 (37%), Positives = 166/305 (54%), Gaps = 17/305 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 77
+G Y E +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 136
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG V +L L+ LLGTP+ +T
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
+ ND+ + Y K QP P D + LL + L ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNYNFPKYKPQP--LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 316 YFKGL 320
YF+ L
Sbjct: 288 YFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 8e-54
Identities = 111/302 (36%), Positives = 165/302 (54%), Gaps = 17/302 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 77
+G Y + +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 136
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLL
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H + HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG V +L L+ LLGTP+ +T
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
+ N++ R YL + QP+ P D + LL LL ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYRAQPLI--NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 316 YF 317
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 1e-53
Identities = 111/307 (36%), Positives = 164/307 (53%), Gaps = 17/307 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 77
+G Y + +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 136
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLL
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ +T
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
++ N++ + Y + + P D LL +LL F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSYNYPKYRADCLH--NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 316 YFKGLSK 322
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 5e-52
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 36/295 (12%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ E++G+GS+G V A+D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV + + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL +++ +K+ DFG A+ D T T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+Y A DIWS+GC E+ TGKP + + + + + + + I
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKIGSSGEPPEI------- 225
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
P S A L + L DPK RPTA+E L P+
Sbjct: 226 -------------PEHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 7e-50
Identities = 71/196 (36%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V A D TG+KVAIK I + S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 MLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVY 148
D +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + N K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAE 223
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (440), Expect = 1e-48
Identities = 87/353 (24%), Positives = 142/353 (40%), Gaps = 36/353 (10%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA-RILREIKLLRLLRHPD 83
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LTREHYQFFLYQLLRAL 139
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDT---PTTIFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE+ G + + + DIWS+G E+LTG P F G+ + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK------------NSSATSQ 222
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
+++ + + P +A LL++LLA DPK+R ++ L+
Sbjct: 223 TLKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 315 PYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 367
L E + S + + L D
Sbjct: 276 DLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 102/297 (34%), Positives = 167/297 (56%), Gaps = 12/297 (4%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKY 141
+IVE+K RR K +Y+VFE +E ++ ++++ + + E + ++YQL++A+ +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ Y A+D+WS+GCI E+ G+PLFPG++ + QL + +LG P ++ +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG-PLPAEQMKLFYS 230
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSA-LRLLERLLAFDPKDRPTAEEALADPYF 317
+ L P +++ L L++ LL +P DR E+ L P F
Sbjct: 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 3e-47
Identities = 87/304 (28%), Positives = 141/304 (46%), Gaps = 56/304 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHP 82
+Y+I + IGKGS+G V G+ +K+I D+ + L E+K+L+ L HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHP 59
Query: 83 DIVEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQ-----FFLY 133
+I IK+ F++ + +V E + DL Q IK + + +
Sbjct: 60 NI--IKYYE------SFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFV 110
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
QL ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V + T V T
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSS--TVDLAKTVVGTP 167
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+Y +PELC + Y DIWS+GC+ E+ T K F G+N L+L
Sbjct: 168 YYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL--------- 213
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
++++ P Q+S + N L+ LL DP++RP+ + L
Sbjct: 214 ---KILKGQY---------PPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQ 254
Query: 314 DPYF 317
P+
Sbjct: 255 SPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-47
Identities = 113/338 (33%), Positives = 179/338 (52%), Gaps = 30/338 (8%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKHIMLPPS-RRDFKDIY--VVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLR 137
+ +K +++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 ALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
AL YIH+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +LGTP+ D +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADP-SALRLLERLLAFDPKDRPTAEEALAD 314
+ N ++ +P + FP P A+ + + L ++P R EALAD
Sbjct: 296 KEMNPNYADIKF----PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351
Query: 315 PYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 352
P+F L R+P + ++ + +I+E+
Sbjct: 352 PFFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 112/303 (36%), Positives = 165/303 (54%), Gaps = 16/303 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLR 77
+G A+ Y E +G+GSY V I G+ VA+K I E + A +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLK 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQ-VIKANDDLTREHYQFFLYQLL 136
L+H +IV + I+ F VFE M +DL Q +I+ L + + F++QLL
Sbjct: 59 GLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L YIH ++ HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT 254
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ DT
Sbjct: 171 PPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
V + + K Q ++ K + P A L ++L PKDR +A++AL
Sbjct: 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288
Query: 315 PYF 317
PYF
Sbjct: 289 PYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 7e-44
Identities = 82/294 (27%), Positives = 139/294 (47%), Gaps = 44/294 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
++I E IGKG +G V A TG++VAIK I E +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
V+ L +++V E L ++K+ + LT + +LL+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++ ++K+ DFGL+ +DT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y DIWS+G E+ GKP + +L P + + ++ N
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPYS------------EL---PPMKALFKIATNG 213
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ P ++S +F + L++ L +P+ RPTAE+ L P+
Sbjct: 214 -------PPGLRNPEKWSDEFKD-------FLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 107/300 (35%), Positives = 152/300 (50%), Gaps = 18/300 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--- 80
+Y+ IG G+YG V A D H+G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 81 HPDIVEIKHIMLPPSRRDFK-DIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLR 137
HP+IV + + SR D + + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDV-CATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRA 175
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P D R
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
V R S R +PVQ P + S +LL +L F+P R +A AL P+F
Sbjct: 234 DV---TLPRGAFSPRGPRPVQ--SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 90/299 (30%), Positives = 140/299 (46%), Gaps = 50/299 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRH 81
Y++ ++IG+G++GVV ++ TG+ VAIK+I I E I++EI LL+ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+IV K+I S +Y++ E E+ L Q+IK ++YQ+L+ L
Sbjct: 59 PNIV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPE 199
Y+H V HRD+K NIL + +K+ DFG+A ++ V T ++ APE
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA----SVVGTPYWMAPE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ S + A DIWS+GC E+LTG P + DL +L R+V
Sbjct: 170 VIE--MSGASTASDIWSLGCTVIELLTGNPPY------------YDLNPMAAL---FRIV 212
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYF 317
++D P L+ L + DP RPTA++ L P+
Sbjct: 213 QDDHPP-----------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 92/307 (29%), Positives = 142/307 (46%), Gaps = 59/307 (19%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
Y++ E IGKGS+G V G+ + K+I + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREHY--QFFLYQL 135
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 136 LRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
L AL H + V HRDLKP NI +AN +K+ DFGLA++ +D + F YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYV 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T +Y +PE Y DIWS+GC+ E+ P F +N QL L
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL-------- 218
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAE 309
+ ++ K RR P ++S S L +++ +L DP RP+ E
Sbjct: 219 -----ASKIKEGKFRRI--------PYRYS--------SELNEVIKSMLNVDPDKRPSTE 257
Query: 310 EALADPY 316
E L P
Sbjct: 258 ELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 7e-41
Identities = 102/301 (33%), Positives = 157/301 (52%), Gaps = 19/301 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLR-- 80
+Y+ IG+G+YG V A D G + VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKHIMLPPSRRDFK-DIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLL 136
HP++V + + SR D + + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
APE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P +
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
R V R + QP++ + + D LL + L F+P R +A AL+ PY
Sbjct: 235 RDV---ALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
Query: 317 F 317
F
Sbjct: 290 F 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 2e-40
Identities = 110/307 (35%), Positives = 166/307 (54%), Gaps = 18/307 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 78
+G A Y+ E +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L YIH + HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K++ QL+ + +LGTP+ DT
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 256 SRV--VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
V + + K R+ T K Q K + A L +LL PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERF-TLYSPKNLRQAWNKLSYVN-HAEDLASKLLQCFPKNRLSAQAALS 287
Query: 314 DPYFKGL 320
YF L
Sbjct: 288 HEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 54/301 (17%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
YK E IG+G+ G V A D TG++VAIKK+ + + I+ EI +++ +HP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 83 DIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRAL 139
+IV+ S +++VV E M+ L +I N + + ++L+ L
Sbjct: 76 NIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRA 197
+Y+H+ NV HRD+K NIL + + +K+ DFG A ++ V T ++ A
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-----VGTPYWMA 184
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y P +DIWS+G + E+ G+P + + + L L+T G P L +
Sbjct: 185 PEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKNPEK 241
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+S +F L + L DP+ RP+AEE L P+
Sbjct: 242 ---------------------WSPEF-------KDFLNKCLVKDPEKRPSAEELLQHPFL 273
Query: 318 K 318
K
Sbjct: 274 K 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 79/293 (26%), Positives = 133/293 (45%), Gaps = 49/293 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+GKGS+G V TG+ A+K + I + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
+ + + + +Y+V E +L + + E +F+ +++ AL+Y+H+ +
Sbjct: 60 Y-----AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLKP+NIL +A+ +K+ DFGLA+ ++ T + T Y APE+
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG--KG 169
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267
Y A+D WS+G + E+LTGKP F ++ + + +
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKI-------------------- 205
Query: 268 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYF 317
K P++F + P A L+ LL DP R AEE A P+F
Sbjct: 206 -----LKDPLRFPEFL---SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 110/319 (34%), Positives = 163/319 (51%), Gaps = 42/319 (13%)
Query: 31 IGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 HIMLPPSRRDFKDIYVVFELMESDL------HQVIKAND---DLTREHYQFFLYQLLRAL 139
+ L + R ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVAFNDTPTTIFWTD-YVATRW 194
Y+H V HRDLKP NIL ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLMT 244
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKK-----QPVQFSQKFP-NADPSALRLLERLL 298
+++G P+ + + + + R+ +++ +K D A LL++LL
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298
Query: 299 AFDPKDRPTAEEALADPYF 317
DP R T+E+A+ DPYF
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 9e-38
Identities = 112/319 (35%), Positives = 165/319 (51%), Gaps = 42/319 (13%)
Query: 31 IGKGSYGVVCSA--IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D ++ A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 HIMLPPSRRDFKDIYVVFELMESDL------HQVIKAND---DLTREHYQFFLYQLLRAL 139
+ L S R ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVAFNDTPTTIFWTD-YVATRW 194
Y+H V HRDLKP NIL ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLMT 244
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 245 DLLGTPS---LDTISRVVRNDKARRYL--TSMRKKQPVQFSQKFP-NADPSALRLLERLL 298
++G P+ + I ++ ++ T+ +++ +K D LL++LL
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298
Query: 299 AFDPKDRPTAEEALADPYF 317
DP R T+E+AL DPYF
Sbjct: 299 TMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 68/302 (22%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLL 79
+ + +G+G++G V +VA+K + + + I + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE---FLREARIMRKL 58
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 137
HP++V++ + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 59 DHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT----- 192
++Y+ + N HRDL +N L N +KI DFGL+R ++D DY
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKL 165
Query: 193 --RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248
RW APE S K+T D+WS G + E+ T G+ +PG
Sbjct: 166 PIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-------------- 207
Query: 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 308
S + + ++N R QP PN P L+ + A DP+DRPT
Sbjct: 208 --SNEEVLEYLKNGY--------RLPQP-------PNCPPELYDLMLQCWAEDPEDRPTF 250
Query: 309 EE 310
E
Sbjct: 251 SE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 93/321 (28%), Positives = 147/321 (45%), Gaps = 71/321 (22%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILREIKLLRLLRH 81
+K ++IG+GS+ V A + T ++ AIK K I E +I +E+ L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGH 61
Query: 82 PDIVEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLR 137
P I+++ + F+D +Y V E + +L Q I+ L + +F+ ++L
Sbjct: 62 PGIIKLYYT--------FQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV--------AFNDTPTTIFWTD- 188
AL+Y+H+ + HRDLKP+NIL + + +KI DFG A+V + T I
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 189 --------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
+V T Y +PEL + D+W++GCI ++LTGKP F G N
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN----- 226
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
+ L T ++++ + F FP P A L+E+LL
Sbjct: 227 ----EYL------TFQKILKLE--------------YSFPPNFP---PDAKDLIEKLLVL 259
Query: 301 DPKDRPTA----EEALADPYF 317
DP+DR +E A P+F
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 8e-36
Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 71/304 (23%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLL 79
+ + +G+G++G V +VA+K + + + I + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE---FLREARIMRKL 58
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLL 136
HP+IV++ + + +V E M DL ++ N L+ F Q+
Sbjct: 59 DHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT---- 192
R ++Y+ + N HRDL +N L N +KI DFGL+R ++D DY
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGK 165
Query: 193 ---RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 LPIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS------------ 209
Query: 248 GTPSLDTISRVVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 306
N + YL R +P PN P +L+ + A DP+DRP
Sbjct: 210 -------------NAEVLEYLKKGYRLPKP-------PNCPPELYKLMLQCWAEDPEDRP 249
Query: 307 TAEE 310
T E
Sbjct: 250 TFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 36/289 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG G++G V +A++ TGE +A+K+I I E+K+L LL+HP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 91 MLPPSRRDFKDIYVVFEL-MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYH 149
+ R+ +Y+ E L ++++ L + + QLL L Y+H+ + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 150 RDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL-CGSFFSK 207
RD+KP NI + N +K+ DFG A ++ N T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267
+ A DIWS+GC+ E+ TGK + +LD N+ +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW------SELD-------------------NEFQIMF 217
Query: 268 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
P L+R L DPK RPTA E L P+
Sbjct: 218 HVGA--GHKPPIPDSL-QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 82/293 (27%), Positives = 125/293 (42%), Gaps = 42/293 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 89
V+G+GS GVV TG+ A+KKIH + ++LRE+K LR P +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 90 IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANV 147
I +V E M+ L ++K + + Q+L+ L Y+HT ++
Sbjct: 67 AFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVATRWYRAPELCGSFFS 206
HRD+KP N+L N+ ++KI DFG+++V T+ + +V T Y +PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKV----LENTLDQCNTFVGTVTYMSPERIQG--E 175
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266
Y+ A DIWS+G E GK F +LM + P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL------------ 223
Query: 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
+FS +F + + L DPK RP+A E L P+ K
Sbjct: 224 --------PAEEFSPEFRD-------FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 84/302 (27%), Positives = 139/302 (46%), Gaps = 51/302 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I I ++ D R+I L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
+ S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL ++N LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
++ +D WS+GCI E L G P F G+ + I + + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEIFQNILN 215
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYFK 318
K +++ + A+ L+ +LL DP+ R A EE P+FK
Sbjct: 216 GK-------------IEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
Query: 319 GL 320
G+
Sbjct: 262 GI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 75/286 (26%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHP 82
+++ VIGKG++G VC T + A+K ++ E S +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS-VRNVLNERRILQELNHP 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+V + + S +D +++Y+V +L+ DL + + E +F++ +++ AL+Y
Sbjct: 61 FLVNLWY-----SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ + HRD+KP NIL + + I DF +A DT T T T Y APE+
Sbjct: 116 LHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAPEV- 170
Query: 202 GSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
+ Y+ A+D WS+G E L GK + G SR +R
Sbjct: 171 --LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH---------------------SRTIR 207
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDR 305
+ + T+ +P + + +LL DP+ R
Sbjct: 208 DQIRAKQETA---------DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF-FLYQLLRAL 139
P+IV + + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQG-----EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+Y+ + N HRDL +N L N +KI DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
K+T D+WS G + E+ T G+ +PG + V+ L+
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 88/305 (28%), Positives = 130/305 (42%), Gaps = 59/305 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ + E IGKGS+G V AID T + VAIK I D+ E + I +EI+ L R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
I + L + K ++++ E DL + K L + F L ++L
Sbjct: 60 YITKYYGSFL----KGSK-LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLG 110
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+Y+H HRD+K NIL + +K+ DFG V+ T T +V T ++ AP
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMAP 167
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ S Y DIWS+G E+ G+P P + L M
Sbjct: 168 EVIKQ--SGYDEKADIWSLGITAIELAKGEP--P----LSDLHPM--------------- 204
Query: 259 VRNDKARRYLTSMRKKQP-----VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
R L + K P +FS+ F + + L DPK+RP+A+E L
Sbjct: 205 -------RVLFLIPKNNPPSLEGNKFSKPFKD-------FVSLCLNKDPKERPSAKELLK 250
Query: 314 DPYFK 318
+ K
Sbjct: 251 HKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 83/304 (27%), Positives = 139/304 (45%), Gaps = 58/304 (19%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLLR 77
R++ E++G GS+G V ++ G+ A+K++ E + ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 136
L+HP+IV+ + R+ ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWY 195
L+Y+H N HRD+K NIL + N +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP---LFPGKNVVHQLDLMTDLLGTPSL 252
APE+ Y A DIWS+GC E+ TGKP G V ++ +L P
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIP-- 224
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
D +S D+A+ ++ L+ L+R DP RPTA E L
Sbjct: 225 DHLS-----DEAKDFI----------------------LKCLQR----DPSLRPTAAELL 253
Query: 313 ADPY 316
P+
Sbjct: 254 EHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 89/315 (28%), Positives = 133/315 (42%), Gaps = 77/315 (24%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI---------HDIFEHISDAARILR-EIKLLRL 78
E+IGKG+YG V A++ TGE +A+K++ HD D + LR EI+ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 79 LRHPDIV---------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ 129
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR----VAFNDTPT--- 182
FF Q+L L Y+H+ + HRDLK N+L +A+ KI DFG+++ + ND
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 183 -TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+ + + +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 301
A L + R P+ N P AL L +
Sbjct: 219 ---------------------AAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTIN 256
Query: 302 PKDRPTAEEALADPY 316
P +RPTA E L P+
Sbjct: 257 PDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
+KI++ IGKG + VV AI G VA+KK+ IFE + AR L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK--ANDDLTREHYQF--FLYQLLR 137
++ IK++ S + ++ +V EL ++ DL ++IK + QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL+++H+ + HRD+KP N+ A +K+ D GL R + T V T +Y +
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAE 223
PE + Y DIWS+GC+ E
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+ I E +G+GSYG V AI TG+ VAIK + + E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELME-------SDLHQVIKANDDLTREHYQFFLYQLLR 137
V+ S D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L+Y+H+ HRD+K NIL N + K+ DFG V+ T T + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMA 167
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y DIWS+G E+ GKP + + + + M P+L
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTL----- 219
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
P ++S +F + +++ L DP++RP+A + L P+
Sbjct: 220 ----------------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 83/308 (26%), Positives = 131/308 (42%), Gaps = 54/308 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y++ EVIG G+ VV +AI EKVAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKHIMLPPSRRDF---KDIYVVFELMES-DLHQVIK---ANDDLTREHYQFFLYQL 135
++V+ F ++++V + L ++K L L ++
Sbjct: 60 NVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRW 194
L+ L+Y+H+ HRD+K NIL + +KI DFG+ A +A T +V T
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT----- 249
+ APE+ Y DIWS G E+ TG + + M L+ T
Sbjct: 172 WMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPY------SKYPPMKVLMLTLQNDP 224
Query: 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 309
PSL+T + KK +S+ F ++ L DP RPTAE
Sbjct: 225 PSLET--------------GADYKK----YSKSFRK-------MISLCLQKDPSKRPTAE 259
Query: 310 EALADPYF 317
E L +F
Sbjct: 260 ELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 47/291 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR---ILREIKLLRLLRHPDIVEI 87
IG+GS G+VC A D TG +VA+KK+ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
L +++VV E +E I + + E +L+AL ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRD+K +IL ++ ++K+ DFG + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LP 191
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267
Y +DIWS+G + E++ G+P + P L + R +R++ +
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKR-IRDNLPPKL 235
Query: 268 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
K + S P L+R+L DP R TA E L P+
Sbjct: 236 ------KNLHKVS-------PRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIVEI 87
+G G +G V A+K + HI + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 88 KHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
R FKD ++ LME +L +++ +F++ ++ A +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+N+L ++N +K+ DFG A+ + T WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 204 FFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
+K Y ++D WS+G + E+LTG+P F
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 62/300 (20%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPD 83
+ +G+G++G V K VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN---------DDLTREHYQFFLY 133
+V + + + + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
Q+ + ++Y+ + HRDL +N L + +KI DFGL+R ++D + R
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 194 WYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPS 251
W APE S +T D+WS G + E+ T G +PG
Sbjct: 173 WM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG------------------ 210
Query: 252 LDTISRVVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
+ N++ YL R +P L+ DP+DRPT E
Sbjct: 211 -------LSNEEVLEYLRKGYRLPKP-------EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 83/308 (26%), Positives = 134/308 (43%), Gaps = 51/308 (16%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-R 80
+++ EVIG+G+YG V A TG+ VAIK + I + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 81 HPDIVEIKHIML---PPSRRDFKDIYVVFELME----SDLHQ-VIKANDDLTREHYQFFL 132
HP+I + PP D +++V EL +DL + + K L E + L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDD--QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVA 191
+ LR L Y+H V HRD+K +NIL N ++K+ DFG++ +T+ + ++
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIG 175
Query: 192 TRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
T ++ APE C + Y D+WS+G E+ GKP D+
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------CDM------ 221
Query: 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 308
+ + ++ RN K P +S+KF + + L + + RP
Sbjct: 222 -HPMRALFKIPRNP-------PPTLKSPENWSKKFND-------FISECLIKNYEQRPFM 266
Query: 309 EEALADPY 316
EE L P+
Sbjct: 267 EELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 81/301 (26%), Positives = 124/301 (41%), Gaps = 56/301 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 81
Y V+GKG++G T V K+++ + E A L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQH 58
Query: 82 PDIVE-IKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD--LTREHYQFFLYQ 134
P+I+ H F D + ME L+ I E ++L+Q
Sbjct: 59 PNIIAYYNH---------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
++ A+ YIH A + HRD+K NI +K+ DFG++++ ++ V T +
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPY 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
Y +PELC KY DIW++GC+ E+LT K F N L+L+
Sbjct: 167 YMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVV---------K 212
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
I + Y + + L+ LL DP+ RPTA+E L
Sbjct: 213 IVQGNYTPVVSVYSSELIS-------------------LVHSLLQQDPEKRPTADEVLDQ 253
Query: 315 P 315
P
Sbjct: 254 P 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 86/305 (28%), Positives = 127/305 (41%), Gaps = 63/305 (20%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-------ILREIKLLRLLRHP 82
+IG GS+G V ++ +GE +A+K++ S R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+IV+ L + YV + + L+ + L R F+ Q+L+ L Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNYL 122
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPELC 201
H + HRD+K NIL + +KI DFG++ ++ N T T R P L
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK--------TNGAR-PSLQ 173
Query: 202 GSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
GS F + YT DIWS+GC+ E+LTGK FP L
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---------------QL 218
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEA 311
I ++ N S + P N A+ LE+ D RPTA E
Sbjct: 219 QAIFKIGEN-----------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
Query: 312 LADPY 316
L P+
Sbjct: 262 LKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 80/294 (27%), Positives = 122/294 (41%), Gaps = 43/294 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G G+ GVV + TG+ +A+K I +I E I +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNSPYIVGFY 65
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-QFFLYQLLRALKYIHTA- 145
+ DI + E M+ L +++K E +L+ L Y+H
Sbjct: 66 GAFY-----NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ N T +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQG-- 173
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
+ Y+ DIWS+G E+ TG+ FP + + +V
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGI------FELLQYIVNEPP-- 221
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
P S KF P + L DP++RP+ +E L P+ K
Sbjct: 222 ----------PRLPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 81
+K+ + +GKGSYG V + A+K++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR-----EHYQFFLYQL 135
P+I+ K L D + +V E DL + I + E ++ F+ QL
Sbjct: 59 PNIISYKEAFL-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
LR L+ +H + HRDLK NIL AN +KI D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE+ Y+ DIWS+GC+ E+ T P F ++ M DL
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL--------- 209
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
R R + P +SQ N + +L PK RP ++ LA P
Sbjct: 210 ----RYKVQRGKYPPI----PPIYSQDLQN-------FIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAARILREIKLLR 77
++ + +G GS+G V +G+ A+K I EH+ + RIL+ I
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 136
RHP +V L S +D ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
AL+Y+H+ ++ +RDLKP+N+L +++ +KI DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 85/300 (28%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
+IV L RRD +++V E D++QV L+ + + L+
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L Y+H HRD+K NIL + +K+ DFG V+ T T ++ T ++ AP
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT-IS 256
E Y DIW++G E+ +P P D
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQP--------------------PMFDLHPM 210
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
R + +L S P + K P +++ L DPK RPTA + L P+
Sbjct: 211 RAL-------FLISKSNFPPPKLKDK-EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 84/304 (27%), Positives = 128/304 (42%), Gaps = 39/304 (12%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
S Y+ E+IG+G+YG V TG VA+K I ++ D + I RE+ LL LR
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQS 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I S ++++ E E + ++KA + ++ + ++L ALKY
Sbjct: 60 QPPNI--TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKY 116
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH V HRD+K NIL +K+CDFG VA + + +V T ++ APE+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
Y DIWS+G E+ TG P + + + L+ P L+
Sbjct: 174 TE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLE-------- 223
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
Y +R + A L E +PK+R +AEE L + K S
Sbjct: 224 --DNGYSKLLR--------------EFVAACLDE-----EPKERLSAEELLKSKWIKAHS 262
Query: 322 KVER 325
K
Sbjct: 263 KTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 56/301 (18%)
Query: 24 RYKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLL 79
+Y+ V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--KANDDLTREHYQFFLYQLL 136
HP+I+E L + K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 137 RALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
AL ++HT + HRDLK +NIL + + +KI DFG++++ + + V T Y
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD-T 254
+PELC Y DIW++GC+ E+ + K F N+ P+L
Sbjct: 168 ISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL-------------PALVLK 212
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
I + RY +R +L+ +L DP RP + +A
Sbjct: 213 IMSGTFAPISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQ 253
Query: 315 P 315
P
Sbjct: 254 P 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 44/294 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
++I IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALKY 141
I++ S D + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +KI D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
Y D+W++G + E TGK F N Q L I +++R
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN---QGAL------------ILKIIRG 216
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
PV SQ + +L+++ L D + RP + L +P
Sbjct: 217 -----------VFPPV--SQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + HTG++VA+KK+ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTS 270
+DIWS+G + E++ G+P + P L + R+ N R
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPR----- 237
Query: 271 MRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 329
V+ S K S LR L+ +L +P R TA+E L P+ K+ PSC
Sbjct: 238 ------VKDSHKV----SSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-----ILREIKLLRLL 79
++ +++G+G++G V D TG ++A+K++ F+ S + + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 138
+H IV+ + RD + + + E M + +KA LT + + Q+L
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ Y D+WS+GC E+LT KP P + M +
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAE----FEAMAAIFKI--------- 219
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
QP Q + P A L R + K RP+AEE L +
Sbjct: 220 --------------ATQPTNP-QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 46/227 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 75
D S I++VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
+ HP+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND +F + Q
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDG------KFTVGQ 107
Query: 135 LLRAL-------KYIHTANVYHRDLKPKNILANANCKLKICDFGLARV--AFNDTPTT-- 183
L+ L KY+ N HRDL +NIL N+N K+ DFGL+R T TT
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 184 ----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
I WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 9e-23
Identities = 85/300 (28%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 89
V+GKG+YG+V +A D T ++AIK+I + + EI L L+H +IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQY-- 70
Query: 90 IMLPPSRRDFKDIYVVFELME-------SDLHQV----IKANDDLTREHYQFFLYQLLRA 138
+ S F I+ ME S L + +K N+ F+ Q+L
Sbjct: 71 -LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTII----FYTKQILEG 120
Query: 139 LKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
LKY+H + HRD+K N+L N + +KI DFG ++ P T + T Y A
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y DIWS+GC E+ TGKP F + LG P
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP------- 217
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPY 316
+A + M K P + P + + + + R DP R +A + L DP+
Sbjct: 218 -----QAAMFKVGMFKIHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 41/287 (14%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + H+G +VA+K + + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTS 270
+DIWS+G + E++ G+P + + V + + D
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------------------- 231
Query: 271 MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
P + P LER+L +P++R TA+E L P+
Sbjct: 232 ----SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 45/298 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+I + IG+GS+G + A E IK+I + + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLY--QLLRALK 140
IV S ++ +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YIHTANVYHRDLKPKNILANANCKL-KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+IH + HRD+K +NI + N + K+ DFG+AR ND+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+C + Y DIWS+GC+ E+ T K F G N +HQL L ++
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL--------------KIC 215
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ F+ PN L+ +L P+DRP+ L P+
Sbjct: 216 QG----------------YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 67/265 (25%), Positives = 125/265 (47%), Gaps = 35/265 (13%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAARILREIKL 75
+ + +G G++G V D + A+K I ++ +H+ + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
HP I+ L + D + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
++ AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ + T WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSL 252
Y APE+ S + A+D W++G + E+L G P F N +++ L L L
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
Query: 253 DT-----ISRVVRNDKARRYLTSMR 272
D I +++ D+ RR L +M+
Sbjct: 222 DLYAKDLIKKLLVVDRTRR-LGNMK 245
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 41/287 (14%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A +G+ VA+KK+ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTS 270
+DIWS+G + E++ G+P + + + + ++ D L P L + +V
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNLHKV------------ 242
Query: 271 MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
PS L+RLL DP R TA E L P+
Sbjct: 243 ----------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 82/301 (27%), Positives = 124/301 (41%), Gaps = 50/301 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLR 80
RY +Q+ +GKGS+G V D + +K + +I + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRA 138
HP IV+ L R F I E + D L ++ L+ + QLL
Sbjct: 61 HPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYR 196
+ Y+H + HRDLK KNI N LKI DFG++R+ D TT + T +Y
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-----FTGTPYYM 172
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
+PE Y DIWS+GCI E+ F G+N L +
Sbjct: 173 SPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---------------LSVVL 215
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADP 315
R+V + P L +++ +L DP RP+A E L +P
Sbjct: 216 RIVEGP-----------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP 258
Query: 316 Y 316
+
Sbjct: 259 F 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-21
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y + V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALK 140
IV K S +Y+V E + DL Q IK + + Q+ ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
+IH V HRD+K KNI N K+K+ DFG AR+ + P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y DIWS+GCI E+ T K F
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 93/300 (31%), Positives = 132/300 (44%), Gaps = 55/300 (18%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KHIMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
K P + +Y+V + E H + DL+R +F+ +LL AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264
YT A+D W++G + E+LTG P F +NV N+
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV------------------------NEMY 202
Query: 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGLS 321
R+ L +P++F F D A LL LL+ DP R A+E P+F LS
Sbjct: 203 RKILQ-----EPLRFPDGF---DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 79/305 (25%), Positives = 128/305 (41%), Gaps = 57/305 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR----ILREIKLLRLLRHPDI 84
+ +G G++ A D TG +A+K++ + S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKHIMLPPSRRDFKDIYVVF-ELM-----ESDLHQVIKANDDLTREHYQFFLYQLLRA 138
+ ML + D + +F E M L + + + + QLLR
Sbjct: 66 IR----MLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRG 115
Query: 139 LKYIHTANVYHRDLKPKNILANANCK-LKICDFGLA-RVAFNDTPTTIFWTDYVATRWYR 196
L Y+H + HRD+K N+L ++ + L+I DFG A R+A T F + T +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL---LGTPSLD 253
APE+ +Y + D+WS+GC+ E+ T KP + + + L L+ + PS+
Sbjct: 176 APEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI- 232
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
P S P LR LE P+DRP + E L
Sbjct: 233 ----------------------PEHLS---PGLRDVTLRCLEL----QPEDRPPSRELLK 263
Query: 314 DPYFK 318
P F+
Sbjct: 264 HPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKL 75
DAS KI++VIG G +G VCS G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
+ HP+I+ ++ ++ K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 135 L---LRA----LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
L LR +KY+ HRDL +NIL N+N K+ DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 44/301 (14%)
Query: 20 GDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 78
GD + Y E IG+G+ G V +AID TG++VAIK+++ + I+ EI ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
+HP+IV L +++VV E + + + + L+A
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 127
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRA 197
L+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ A
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 184 PEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL----- 235
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ P + S F + L R L D + R +A+E L P+
Sbjct: 236 ----------------QNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFL 272
Query: 318 K 318
K
Sbjct: 273 K 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 81/296 (27%), Positives = 136/296 (45%), Gaps = 43/296 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +AID TG++VAIK+I+ + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL---------- 235
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ P + S F + L R L D + R +A+E L P+ K
Sbjct: 236 -----------QNPEKLSPIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 43/296 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +AID TG++VAIK+++ + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL---------- 235
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ P + S F + L R L D R +A+E L P+ K
Sbjct: 236 -----------QNPERLSAVFRD-------FLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 74/222 (33%), Positives = 111/222 (50%), Gaps = 33/222 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKL 75
D S KI+EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
+ HP+I+ ++ + + SR + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGV-VTKSR----PVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 135 L---LRA----LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PT-TI 184
L LR +KY+ N HRDL +NIL N+N K+ DFGL+R +DT PT T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 78/296 (26%), Positives = 135/296 (45%), Gaps = 43/296 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL---------- 236
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ P + S F + L R L D + R +A+E L + K
Sbjct: 237 -----------QNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 87/332 (26%), Positives = 137/332 (41%), Gaps = 75/332 (22%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE-IKLLRLLRH 81
+++ +VIG+G++G V D TG+ A+K + + I R I +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAER- 52
Query: 82 PDI-VEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
DI + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 53 -DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA----------------RVAFNDT 180
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 181 PTTIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFP 228
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPS 289
F +T +++ + K+ ++F P P
Sbjct: 229 PFYSDT---------------LQETYNKI------------INWKESLRFPPD-PPVSPE 260
Query: 290 ALRLLERLLAFDPKDR-PTAEEALADPYFKGL 320
A+ L+ RLL DP+DR + EE + P+FKG+
Sbjct: 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 69/210 (32%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 80
+ ++I++ IG+G + V A + VA+KK+ IFE + AR ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREH--YQFFLYQ 134
HP++ IK++ S + ++ +V EL ++ DL Q+I K L E +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L A++++H+ V HRD+KP N+ A +K+ D GL R F + TT + V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHS-LVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
Y +PE + Y DIWS+GC+ E+
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 76/304 (25%), Positives = 123/304 (40%), Gaps = 68/304 (22%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
I KG++G V A TG+ AIK +L++ ++ + ++ + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAERAI 49
Query: 91 MLPPSRRDF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
M+ + KD +Y+V E L D +IK L + + ++ +++
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y AP
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-------KFVGTPDYLAP 162
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + G D WS+GC+ E L G P F +T
Sbjct: 163 ETILGV---GDDKMSDWWSLGCVIFEFLFGYPPF-------------------HAETPDA 200
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALAD 314
V N +RR K+ P A+ L+ RLL DP R A +E +
Sbjct: 201 VFDNILSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251
Query: 315 PYFK 318
P+FK
Sbjct: 252 PFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y + IG+GS+G G++ IK+I+ + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF--FLYQLLRALK 140
IV+ + S + ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++H + HRD+K +NI + +K+ DFG+ARV + T + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVELARTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
C + Y DIW++GC+ E+ T K F N+
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 88/319 (27%), Positives = 136/319 (42%), Gaps = 64/319 (20%)
Query: 11 PEM-EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI----HDIFEHISD 65
PE+ E FS+ + IG GS+G V A D T E VAIKK+ E D
Sbjct: 2 PEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME------SDLHQVIKA 119
I++E++ L+ LRHP+ +E K L R+ + + +ME SD+ +V K
Sbjct: 62 ---IIKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK- 109
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
L + L+ L Y+H+ HRD+K NIL +K+ DFG A +
Sbjct: 110 -KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV--- 165
Query: 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVV 237
+P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 166 SPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------ 215
Query: 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 297
++ M+ L + +ND +S F N ++
Sbjct: 216 -NMNAMSALY---------HIAQNDSP--------TLSSNDWSDYFRN-------FVDSC 250
Query: 298 LAFDPKDRPTAEEALADPY 316
L P+DRP++EE L +
Sbjct: 251 LQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 49/289 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A ++HT E VA+KK+ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 90 IMLPPSRRDFKDIYVVFELME------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
L K+ + + +ME SDL +V K L + L+ L Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL ++K+ DFG A + +P F V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPANSF----VGTPYWMAPEVILA 191
Query: 204 F-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+Y +D+WS+G E+ KP L ++ + + +ND
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKP---------------PLFNMNAMSALYHIAQND 236
Query: 263 ----KARRYLTSMRKKQPVQFS-QKFPNADPSALRLLERLLAFDPKDRP 306
++ + S R V + QK P P++ LL F +DRP
Sbjct: 237 SPTLQSNEWTDSFRGF--VDYCLQKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 9e-19
Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
++I +G+G YG V A TGE VA+K++ + +++ +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V++ + + +D + +Y+ E + D ++ L+ +H +F++ ++ A+ +
Sbjct: 63 LVKLLY-----AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H HRDLKP+N L +A+ +K+ DFGL++ + + DY+ APE+
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APEVLR 171
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
Y +D WS+GC+ E L G P F G
Sbjct: 172 G--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 55/301 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
Y V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD---LTREHYQFFLYQLLRA 138
+IV + + +Y+V E DL+ +K + ++F+ Q+ A
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYR 196
L+Y+H ++ HRDLK +N+ +K+ D G+ARV N D +T+ T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+PEL F +K Y D+W++GC E+ T K F K+ M L +
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSL--------V 211
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
R++ L M K P L+ +L+ P+ RP+ + L P
Sbjct: 212 YRIIEGK-----LPPMPKDY-----------SPELGELIATMLSKRPEKRPSVKSILRQP 255
Query: 316 Y 316
Y
Sbjct: 256 Y 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI----HDIFEHISDAARILREIKLLRLLRHPDI 84
EV+GKG+YG V + T+ G+ +A+K++ ++ + ++ E+ LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V+ L D I + E + + ++ L + + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLAR----VAFNDTPTTIFWTDYVATRWYRAPE 199
V HRD+K N++ N +K+ DFG AR V + T + + + + T ++ APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ S Y DIWSIGC E+ TGKP
Sbjct: 179 VINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIH--------DIFEHISDAARILREIKL 75
Y + E +G G++G V + G+ +A+K+I+ D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIK-ANDDLTREHYQ 129
++ LRHP+IV L R +Y+V +L+E + +K T E
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 130 FFLYQLLRALKYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
Q++ AL+Y+H + HRDL P NI+ + K+ I DFGLA+ ++ T
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLTS 172
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
V T Y PE+ + Y D+W+ GCI ++ T +P F N++
Sbjct: 173 VVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 16 FSEYGDAS-RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILR 71
F + D S ++I E IGKG+YG V ++ G K A+K IHDI E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 72 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQ-VIKANDDLTRE 126
L HP++V+ + ++ +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 187 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 68/219 (31%), Positives = 116/219 (52%), Gaps = 20/219 (9%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 80
+ ++I++ IG+G + V A G VA+KK+ IF+ + AR ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREH--YQFFLYQ 134
HP++++ + + ++ +V EL ++ DL ++I K L E +++F+ Q
Sbjct: 61 HPNVIKYYASFIEDN-----ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L AL+++H+ V HRD+KP N+ A +K+ D GL R F + TT + V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHS-LVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 86/351 (24%), Positives = 149/351 (42%), Gaps = 68/351 (19%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + D+ D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
R +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLK N+L ++ +KI DFG+ + TT + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
+ Y PA+D W++G + E+L G+ F G + D + + + D+
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------------DELFQSILEDE 212
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PTAEEALAD-PYFK 318
RY + K+ A +L+ L +P+ R PT E+ + P+F+
Sbjct: 213 V-RYPRWLSKE---------------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 319 GL--SKVER---EPSCQPISKMEF-------EFERRRVTKEDIRELIFREI 357
+ K+ER +P +P K F EF + + E I R I
Sbjct: 257 EIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKL 75
D S + +G G +GVV H G+ VAIK I E + E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKV 52
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFL-- 132
+ L HP++V++ + + I++V E M + L ++ + ++ L
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDM 105
Query: 133 -YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
+ A++Y+ + HRDL +N L + +K+ DFGLAR +D T+ T +
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-P 164
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+W PE+ +S+++ D+WS G + EV + GK +
Sbjct: 165 VKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Q+VIG G +G V I G K VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRA----L 139
+ ++ ++ FK ++ E ME+ L + ++ +D E + L +LR +
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGM 120
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYRA 197
KY+ N HRDL +NIL N+N + K+ DFGL+RV D P + T + RW A
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
PE + K+T A D+WS G + EV++
Sbjct: 179 PEAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 36/214 (16%)
Query: 31 IGKGSYGVVCSA----IDTHTGEKVAIKKI-HDIFE-HISDAARILREIKLLRLLRHPDI 84
+G+G +G V + +TGE+VA+K + H E H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALK 140
V+ K + P R + ++ E + S D Q + +L R F Q+ + +
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKR--LLLFSSQICKGMD 123
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR------- 193
Y+ + HRDL +NIL + +KI DFGLA+V D DY +
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGESPI 176
Query: 194 -WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE C SK++ A D+WS G E+ T
Sbjct: 177 FWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 21 DASRYKIQ-----EVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAAR 68
D S +K+ E +G GS+G V A TGE AIK K +I +H++
Sbjct: 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS 70
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY 128
IL E L HP IV + +R F +VV + + L + + +D+ +
Sbjct: 71 ILME------LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--- 121
Query: 129 QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
F+ +L+ A +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T
Sbjct: 122 -FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------ 174
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
T Y APE+ S + A+D W++G + E + G P F
Sbjct: 175 LCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 77/308 (25%), Positives = 123/308 (39%), Gaps = 64/308 (20%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLRH 81
+GKG +G VC+ TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 138
IV + + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + ++I D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ Y ++D +++GC E++ G+ +P +V
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGR--------------------SPFRQRKEKV 201
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 313
+ + RR L V++ KF P A L E LL DP+ R +A+E
Sbjct: 202 EKEELKRRTLE-----MAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253
Query: 314 DPYFKGLS 321
P FK L+
Sbjct: 254 HPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 33/212 (15%)
Query: 31 IGKGSYGVV--C--SAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIV 85
+GKG++G V C + +TGE VA+KK+ H EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 86 EIKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLY--QLLRALKYI 142
+ K + RR+ + +V E L L ++ + + +H + LY Q+ + ++Y+
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYL 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR--------W 194
+ HRDL +NIL + ++KI DFGL +V D +Y R W
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGESPIFW 177
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
Y APE SK++ A D+WS G + E+ T
Sbjct: 178 Y-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 42/300 (14%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 91 MLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQ-LLRALKYIHTA 145
L S I + E E +++ +K E + + +L+ L Y+H+
Sbjct: 68 FLDESS---SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 204
+ HRD+KP NIL ++K+CDFG++ N T + T +Y APE + G
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQG-- 177
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFP--GKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y+ D+WS+G EV + FP G+ + ++L++ ++ P+ +
Sbjct: 178 -KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD------ 230
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
+++S++F + +++ L DP RPT + L P+ K K
Sbjct: 231 ---------EPGNGIKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-17
Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 47 TGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIVE-IKHIMLPPSRRDFKDI 102
TG +VAIK + + + AR RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--- 158
+ VFE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 159 ANANCKLKICDFGLAR----VAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 213
K+ DFG+ V D T T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 214 IWSIGCIFAEVLTGKPLFPGKNV 236
+++ G IF E LTG+ + G +V
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 26 KIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
K++ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKY 141
V++ + S + IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRW 194
+ + N HRDL +NIL N KI DFGLAR+ +D T I WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLDL 242
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 34/299 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ +G G+ G V TG +A K +H I S +ILRE++++ R
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECR 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRAL 139
P IV L + +I + E M+ L ++ K + E ++ L
Sbjct: 62 SPYIVSFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGL 116
Query: 140 KYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
Y++ + + HRD+KP NIL N+ ++K+CDFG++ N T +V T Y +P
Sbjct: 117 TYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E KYT D+WS+G E+ GK FP D D +G LD + ++
Sbjct: 172 ERIQG--GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQI 225
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
V ++ P S FP ++ L DP +RPT ++ A P F
Sbjct: 226 V------------QEPPPRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 81/287 (28%), Positives = 130/287 (45%), Gaps = 49/287 (17%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D T E VAIKK+ + ++ + I++E+K L+ ++HP+ +E K
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 90 IMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
L ++V E SDL +V K L + L+ L Y+H+ N
Sbjct: 93 CYLRE-----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-F 205
+ HRD+K NIL ++K+ DFG A +A +P F V T ++ APE+ +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSF----VGTPYWMAPEVILAMDE 198
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
+Y +D+WS+G E+ KP L ++ + + +N+
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKP---------------PLFNMNAMSALYHIAQNESP- 242
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
Q ++S F N S L+ + P+DRPT+EE L
Sbjct: 243 -------TLQSNEWSDYFRNFVDSCLQKI-------PQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLL 79
+ +++ +++G+G++G V D TG ++A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRA 138
H IV+ + P R + E M + +K+ LT + + Q+L
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
E+ Y DIWS+GC E+LT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV+ + P + I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
Y D+WS+ C E+LT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+G G +GVV H G+ KVAIK I++ D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
++ + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ HRDL +N L ++ +K+ DFG+ R +D T+ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
FSKY+ D+WS G + EV T GK F K+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEI 87
+G G+ GVV + +G +A K IH E I A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 145
+ +I + E M+ L QV+K + +LR L Y+
Sbjct: 65 YG-----AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 204
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG-- 172
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 -THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKL 75
S + + IG G +G+V G KVAIK I + D + E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEED---FIEEAQV 52
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKAND-DLTREHYQFFLY 133
+ L HP +V++ + S I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCTERS-----PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ + Y+ ++NV HRDL +N L N +K+ DFG+ R +D T+ T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 81/294 (27%), Positives = 124/294 (42%), Gaps = 42/294 (14%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V ID T E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 148
L ++ ++++ E + + L + L ++L+ L Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYL 268
DIWS+G E+ G+P + + L L+ P+L+
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEG-------------- 223
Query: 269 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
Q+S+ F +E L DP+ RPTA+E L + +K
Sbjct: 224 ---------QYSKPFKE-------FVEACLNKDPRFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 29 EVIGKGSYG---VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+V+G+GS+G +V G+ A+K + + D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
++ + + +Y++ + + DL + T E +F+L +L AL ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + +K+ DFGL++ + + + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
+T + D WS G + E+LTG F GK + + MT +L
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 30 VIGKGSYGVVCSAIDTH---TGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K K I + D A E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 85 VEIKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V++ + + +Y++ E L +L ++ + F+L ++ AL+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+NIL +A +K+ DFGL + + ++ T + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEILMR 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
S + A+D WS+G + ++LTG P F +N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLL----RHPD 83
V+G+G +G V A TGE AIK K DI D L K + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPF 63
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V + + V E DL I D + F+ ++ L+Y+
Sbjct: 64 LVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPEL 200
H + +RDLK N+L + +KI DFGL + + F D +T + T + APE+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
+ YT A+D W +G + E+L G+ FPG + + + +
Sbjct: 173 LTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----------------EEVFDSIV 214
Query: 261 NDKAR--RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
ND+ R R+L+ ++ + ++ +P ER L KD AE+ P+F+
Sbjct: 215 NDEVRYPRFLS----REAISIMRRLLRRNP------ERRLGSGEKD---AEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLR---LLRHPDIVE 86
IGKG++G V T A+K + + A + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+K S D+Y+V + M +L ++ + + +F++ +L+ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ D TT + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 55/290 (18%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D E VAIKK+ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 90 IMLPPSRRDFKDIYVVFELME------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
L + + +ME SDL +V K L + L+ L Y+H
Sbjct: 83 CYLRE--------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEVILA 185
Query: 204 F-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+Y +D+WS+G E+ KP L ++ + + +N+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP---------------PLFNMNAMSALYHIAQNE 230
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
Q +S+ F N S L+ + P+DRPT+E L
Sbjct: 231 SPAL--------QSGHWSEYFRNFVDSCLQKI-------PQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 39/294 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+++ + IG G+YG V A + +TGE AIK I E D A + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V L RRD +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG V+ T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y DIW++G E+ +P + + L LMT P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ K +++S F + ++ L +PK RPTAE+ L P+
Sbjct: 230 ---------KLKDKMKWSNSFHH-------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 53/301 (17%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
K+ R F Y + L + ++D R F+ +++ AL Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALGYLHSCDV 116
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +KI DFGL + +D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
Y A+D W +G + E++ G+ F + + +L LM ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------- 212
Query: 266 RYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKG 319
+FP P A LL LL DPK R A+E + +F
Sbjct: 213 ----------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
Query: 320 L 320
+
Sbjct: 257 I 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 90/352 (25%), Positives = 148/352 (42%), Gaps = 63/352 (17%)
Query: 8 KNSPEMEFFSEYG---DAS--RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 62
++ E F+ G D S R+KI ++G+G++G V A D E A+K + ++ ++
Sbjct: 109 QSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY 168
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD----IYVVFELMESDLHQVIK 118
DA +I EI+ + +R D + +M +R F++ + +V L I
Sbjct: 169 TRDA-KI--EIQFMEKVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIM 223
Query: 119 ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANAN--------------- 162
+ + H ++Q AL Y HT ++ H DLKP+NIL +
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 163 -CKLKICDFG------LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
C+++ICD G +R A V+TR YR+PE+ Y+ D+W
Sbjct: 284 PCRVRICDLGGCCDERHSRTAI------------VSTRHYRSPEVVLGLGWMYS--TDMW 329
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ 275
S+GCI E+ TGK L+ + + L LM LG + R ++AR S + +
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGR-CGTEEARLLYNSAGQLR 388
Query: 276 PVQFSQKFPN-----------ADPSALRLLERLLAFDPKDRPTAEEALADPY 316
P + D L+ LL +D + R A + PY
Sbjct: 389 PCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 78/332 (23%), Positives = 130/332 (39%), Gaps = 78/332 (23%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+VIG+G++G V TG A+KK+ ++ E A + E +L +P +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEADNPWVVK 65
Query: 87 IKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D +Y++ E L D+ ++ D T E +F++ + + A+ IH
Sbjct: 66 LYY-----SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGL------------ARVAFNDTPTTIFWTDY---- 189
HRD+KP N+L +A +K+ DFGL R+ + P+
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 190 -------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
V T Y APE+ + Y D WS+G I E+L G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 290
F ++ Y + K+ +QF + P P A
Sbjct: 239 F---------------------------CSDNPQETYRKIINWKETLQFPDEVP-LSPEA 270
Query: 291 LRLLERLLAFDPKDR---PTAEEALADPYFKG 319
L++RL + + R E + P+FKG
Sbjct: 271 KDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 66/250 (26%), Positives = 121/250 (48%), Gaps = 24/250 (9%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHD-IFEHISDAARILREIK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + I + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A +DT TT + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVHQLDLMTDLLGTPSLDTIS 256
Y +D W +G + E+L G P F + N++H+ ++ + +
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228
Query: 257 RVVRNDKARR 266
++ D+ RR
Sbjct: 229 ELLEKDRQRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V ID T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 148
L ++ ++++ E + + L L ++L+ L Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + + ++K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAEVLTGKP 229
DIWS+G E+ G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRH 81
+ ++ +G G +G V + +VAIK + D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 138
++ + + +Y++ ELME L +++ + L Q+
Sbjct: 62 KHLISL-FAVCSVGE----PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYR 196
+ Y+ N HRDL +NIL + K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244
APE ++ D+WS G + E+ T G+ +PG N D +T
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 20/232 (8%)
Query: 10 SPEMEFFSEYGDAS-RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISD 65
+ M GD + ++I E IGKG+YG V + G A+K I D+ E I
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-----LHQVIKAN 120
IL+ L HP++V+ + + +++V EL + ++
Sbjct: 68 EYNILQS-----LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L + LY L L+++H + HRD+K NIL +K+ DFG V+ T
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLT 179
Query: 181 PTTIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + V T ++ APE+ + Y D+WS+G E+ G P
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 79/340 (23%), Positives = 135/340 (39%), Gaps = 89/340 (26%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD--AARILREIKLLRLLR 80
+K +++GKG G V TG+ A+K + D E I R+L E ++L L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLD 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD--LTREHYQFFLYQ 134
HP + + F+ + +M+ +L ++++ L+ E +F+ +
Sbjct: 60 HPFLPTLYA--------SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE 111
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT------- 187
+L AL+Y+H + +RDLKP+NIL + + + + DF L++ + + P +
Sbjct: 112 VLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRR 170
Query: 188 --------------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEV 224
+V T Y APE+ G + A+D W++G + E+
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEM 225
Query: 225 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP 284
L G F G N R++ L K+ V F P
Sbjct: 226 LYGTTPFKGSN------------------------RDETFSNIL-----KKEVTFPGSPP 256
Query: 285 NADPSALR-LLERLLAFDPKDR----PTAEEALADPYFKG 319
S+ R L+ +LL DP R A E P+F+G
Sbjct: 257 --VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 75/301 (24%), Positives = 119/301 (39%), Gaps = 62/301 (20%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIK-KIHDIFEHISDAARILREIKLLRLLR 80
+ IG+G +G V + EK+A+ K S + L+E ++R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLR 137
HP IV+ I I P +++V EL +L ++ N L + YQL
Sbjct: 66 HPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR---- 193
AL Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y A++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YKASKGKLP 171
Query: 194 --WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDLMTDLLGT 249
W APE F ++T A D+W G E+L KP G
Sbjct: 172 IKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GV 212
Query: 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 309
+ D I R+ + R P PN P+ L+ + A+DP RP
Sbjct: 213 KNNDVIGRIENGE---------RLPMP-------PNCPPTLYSLMTKCWAYDPSKRPRFT 256
Query: 310 E 310
E
Sbjct: 257 E 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A T E AIK + D+ D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 88 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
KH L F+ +F +ME DL I+ + +F+ ++ AL ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
V +RDLK NIL +A K+ DFG+ + + TT T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLLRHPDIV 85
+++G+G++G V D TG ++A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKP 229
Y D+WS+GC E+LT KP
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 83/305 (27%), Positives = 124/305 (40%), Gaps = 70/305 (22%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A TG A K I E + + EI +L +HP+IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVG---- 66
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIK-----ANDD--------LTREHYQFFLYQLLR 137
+ Y E+ L +I+ A D LT ++ Q+L
Sbjct: 67 --------LYEAY----FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL ++H+ V HRDLK NIL + +K+ DFG V+ + T ++ T ++ A
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMA 171
Query: 198 PEL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD- 253
PE+ C +F Y DIWS+G E+ +P P H+L+ M LL +
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLKILKSEP 225
Query: 254 -TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
T+ QP ++S F + L+ L DP DRPTA E L
Sbjct: 226 PTLD------------------QPSKWSSSFND-------FLKSCLVKDPDDRPTAAELL 260
Query: 313 ADPYF 317
P+
Sbjct: 261 KHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V ID T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTR----EHYQF--FLYQLLRALKYI 142
L ++ ++++ E + + DL R + +Q L ++L+ L Y+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG------SALDLLRAGPFDEFQIATMLKEILKGLDYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
S Y DIWS+G E+ G+P
Sbjct: 175 Q--SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 12/221 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
K+ R F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +KI DFGL + D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLMTDL 246
Y A+D W +G + E++ G+ F ++ + +L LM D+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + D+ D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ P R ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N+L + K+ DFG+ + + TT + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y P++D W++G + E+L G F +N
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 56/234 (23%)
Query: 29 EVIGKGSYGVV-----CSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 81
+G+G++G V + E VA+K + + S+ AR RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQH 67
Query: 82 PDIVEIKHIML---PPSRRDFKDIYVVFELME-SDLHQVIKAND--------------DL 123
+IV+ + PP +VFE ME DL++ ++++ +L
Sbjct: 68 ENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
T Q+ + Y+ + + HRDL +N L + +KI DFG++R
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------D 171
Query: 184 IFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
++ TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 172 VYTTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 81/306 (26%), Positives = 130/306 (42%), Gaps = 50/306 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 83
++ V+GKG +G VC+ TG+ A KK+ + A L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 139
+V + + + KD + +V LM DL H N E F+ ++ L
Sbjct: 62 VVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+ +H + +RDLKP+NIL + ++I D GLA V + T V T Y APE
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI---RGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + +YT + D W +GC+ E++ GK F + +V
Sbjct: 172 VVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK--------------------EKVK 209
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALAD 314
R + RR K+ ++S+KF +A + +LL DP R AEE A
Sbjct: 210 REEVERRV-----KEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261
Query: 315 PYFKGL 320
P+F+
Sbjct: 262 PFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEI 87
E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL----YQLLRALKYIH 143
+ R D+++ E+M++ L + K D + L +++AL+Y+H
Sbjct: 66 YGALF---REG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 144 TA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ +V HRD+KP N+L N N ++K+CDFG++ + TI + Y APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPERIN 176
Query: 203 SFFSK--YTPAIDIWSIGCIFAEVLTGKPLFP 232
++ Y D+WS+G E+ TG+ FP
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 77/298 (25%), Positives = 130/298 (43%), Gaps = 48/298 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKH 89
IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 90 IMLPPSRRDFK--DIYVVFELMESDLHQVIKANDDLTREHY-QFFL----YQLLRALKYI 142
+ F+ D ++ ELM+ L + K ++ + + L ++AL Y+
Sbjct: 71 AL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 143 HTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
+ HRD+KP NIL + N +K+CDFG++ + +I T R Y APE +
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMAPERI 179
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
S Y D+WS+G EV TGK +P N V D +++VV+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV--------------FDQLTQVVK 225
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
D + + +FS PS + + L D RP +E L P+ K
Sbjct: 226 GDPPI-----LSNSEEREFS-------PSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 74/326 (22%), Positives = 124/326 (38%), Gaps = 56/326 (17%)
Query: 30 VIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
+IGK +V A T VA+KKI+ D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY---------QFFLYQLLRA 138
+ ++YVV LM + +DL + H+ F L +L A
Sbjct: 65 VTSFI-----VDSELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDF---------GLARVAFNDTPTTI----F 185
L YIH+ HR +K +IL + + K+ + G + +D P +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
W +PE+ Y DI+S+G E+ G P K++ L+
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEK 222
Query: 246 LLGT-PSLDTISRV------VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 298
+ GT P L S + ++ + R +++ F + +E L
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF---SEHFHQFVELCL 279
Query: 299 AFDPKDRPTAEEALADPYFKGLSKVE 324
DP+ RP+A + L +FK +
Sbjct: 280 QRDPESRPSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 66/256 (25%), Positives = 121/256 (47%), Gaps = 26/256 (10%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + A + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
K+ R F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
V +RD+K +N++ + + +KI DFGL + +D T + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLGTPSLDTISRVVRND 262
Y A+D W +G + E++ G+ P N H +L LM ++ +L
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRFPRTLSP-------- 220
Query: 263 KARRYLTSMRKKQPVQ 278
+A+ L + KK P Q
Sbjct: 221 EAKSLLAGLLKKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 55/297 (18%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVE 86
QE++G G+ G V A T +A+K I DI + +I+ E+++L P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIG 63
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES---DLHQVIKANDDLTREH-YQFFLYQLLRALKYI 142
+R I + E M+ D+++ I EH +++ L Y+
Sbjct: 64 FYGAFFVENR-----ISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKGLTYL 111
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ + HRD+KP N+L N ++K+CDFG++ N T YV T Y APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERIS 166
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG--KNVVHQLDLMTDLLGTPSLDTISRVVR 260
+Y D+WS+G F E+ G+ +P KN Q LM L + +V
Sbjct: 167 G--EQYGIHSDVWSLGISFMELALGRFPYPQIQKN---QGSLM-------PLQLLQCIVD 214
Query: 261 NDKARRYLTSMRKKQPV-QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
D PV QFS+KF + + + + PK+RP E + P+
Sbjct: 215 EDPPV---------LPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIK 88
IG G+ G V I TG A+K I+ E D R I REI++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKC- 137
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 148
H M + +I V+ E M+ + D+ Q+L + Y+H ++
Sbjct: 138 HDMFDHN----GEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIAYLHRRHIV 190
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDT--PTTIFWTDYVATRWYRAPE-----LC 201
HRD+KP N+L N+ +KI DFG++R+ T P V T Y +PE L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC----NSSVGTIAYMSPERINTDLN 245
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ Y A DIWS+G E G+ FP
Sbjct: 246 HGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
IGKG +G V + G+KVA+K + D + A L E ++ LRHP++V++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 89 HIMLPPSRRDFKDIYVVFELME---------SDLHQVIKANDDLTREHYQFFLYQLLRAL 139
++L +Y+V E M S VI T F + +
Sbjct: 67 GVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVCEGM 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF---WTDYVATRWYR 196
+Y+ N HRDL +N+L + + K+ DFGLA+ A + WT
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVV 237
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 13/216 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLLRHPDIVE 86
+VIGKGS+G V A G A+K + I + + LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + + +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
N+ +RDLKP+NIL ++ + + DFGL + TT + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++V D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIK-LLRLLRHPDIV 85
VIGKGS+G V A G+ A+K + + I + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHY------QFFLYQLL 136
+ + S + +Y V + + E H L RE +F+ ++
Sbjct: 60 GLHY-----SFQTADKLYFVLDYVNGGELFFH--------LQRERSFPEPRARFYAAEIA 106
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRW 194
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + + T +T + T
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPE 161
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y APE+ Y +D W +G + E+L G P F ++ D
Sbjct: 162 YLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 75/314 (23%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PD 83
+ IG G+ G V TG +A+K++ + + RIL ++ ++ L H P
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVV-LKSHDCPY 75
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF--------LYQL 135
IV+ + D D+++ ELM + L D L + +
Sbjct: 76 IVKCYGYFI----TDS-DVFICMELMSTCL-------DKLLKRIQGPIPEDILGKMTVAI 123
Query: 136 LRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA-TR 193
++AL Y+ V HRD+KP NIL +A+ +K+CDFG++ D A TR
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTR 173
Query: 194 -----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
Y APE KY D+WS+G E+ TG+ FP KN + +++T +
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKI 231
Query: 247 LGT--PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 304
L PSL ++ FS F ++ L D +
Sbjct: 232 LQEEPPSLP-------PNE--------------GFSPDF-------CSFVDLCLTKDHRK 263
Query: 305 RPTAEEALADPYFK 318
RP E L P+ +
Sbjct: 264 RPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 12/220 (5%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLL 79
A Y + +VIG+G++G V + + +KV K+ FE I SD+A E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 139
P +V+ L + +D K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
IH+ + HRD+KP N+L + + LK+ DFG D + V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
+ S Y D WS+G E+L G F ++V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 62/312 (19%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 91 MLPPSRRDFKDIYVVFELMES---------DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+Y+ E M++ + D L R Y + + L+ LK
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE 120
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-- 199
H N+ HRD+KP N+L N N ++K+CDFG++ + ++ T+ + + Y APE
Sbjct: 121 EH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN-IGCQSYMAPERI 173
Query: 200 --LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---NVVHQLDLMTDLLGTPSLDT 254
+ YT D+WS+G E+ G+ +P + N+ QL + D G P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP--- 228
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
P +S A + + L P RPT + L
Sbjct: 229 -------------------TLPSGYS-------DDAQDFVAKCLNKIPNRRPTYAQLLEH 262
Query: 315 PYFKGLSKVERE 326
P+ + +
Sbjct: 263 PWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 39/291 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y++ + +G G+YG V A + HTGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V L SR + +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL--SR---EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG VA T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y DIW++G E+ +P P M DL +L
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP--P----------MFDLHPMRAL---------- 218
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
+L S QP + K + ++ L +PK RPTAE L
Sbjct: 219 ----FLMSKSNFQPPKLKDKT-KWSSTFHNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 31 IGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHI-SDAARILREIKLLRLLRHPDIVE 86
+G G++G V + K VA+K + EHI + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + + +V EL L + +K ++ + +Q+ + Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVAT-------RWYRA 197
+ HRDL +N+L + KI DFG++R + Y AT +WY A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-------DYYRATTAGRWPLKWY-A 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKNVVHQLD 241
PE C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 167 PE-CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 42/225 (18%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL 79
+ + + E+IG+G +G V +TG+KVA+K I D+ A L E ++ L
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL 56
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLR- 137
H ++V + ++L +Y+V ELM + +L ++ TR + QLL+
Sbjct: 57 HHKNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQF 105
Query: 138 ------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV---AFNDTPTTIFWTD 188
++Y+ + + HRDL +NIL + + K+ DFGLARV +++ + WT
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT- 164
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232
APE K++ D+WS G + EV + G+ +P
Sbjct: 165 --------APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 29 EVIGKGSYGVVCSA--IDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
VIGKG +G V ID+ + A+K ++ I + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIH 143
+ I LP + + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ HRDL +N + + + +K+ DFGLAR I+ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 204 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD----IFEHISDAARILREIKLLRLLR 80
+ ++ ++G+G +G V + TG+ A+K + E +S E +L +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVS---FFEEERDILSISN 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-QFFLYQLLRA 138
P I ++++ +D ++Y+V E DL ++ +D E QF+L +L+ A
Sbjct: 60 SPWIPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ +H HRD+KP+N+L + +K+ DFG A A + V T Y AP
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAP 172
Query: 199 ELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
E+ G Y D WS+G I E++ G+ F
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ L ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +A +KI DFG+ + TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 65/293 (22%), Positives = 118/293 (40%), Gaps = 65/293 (22%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G YG V + VA+K + E + L+E +++ ++HP++V++ +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 91 ML--PPSRRDFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTA 145
PP Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 71 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWYRAP 198
N HRDL +N L N +K+ DFGL+R+ DT T I WT AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E ++K++ D+W+ G + E+ T G +PG ++ +L+
Sbjct: 175 E--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 220
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
R ++P P L+ ++P DRP+ E
Sbjct: 221 ------------GYRMERP-------EGCPPKVYELMRACWQWNPSDRPSFAE 254
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 27/257 (10%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 145
K+ R F V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + + +KI DFGL + D T + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLGTPSLDTISRVVRN 261
+ Y A+D W +G + E++ G+ P N H +L LM ++ +L +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRFPRTL--------S 220
Query: 262 DKARRYLTSMRKKQPVQ 278
+A+ L+ + KK P Q
Sbjct: 221 PEAKSLLSGLLKKDPKQ 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
E IGKG++G V + +VA+K + + L+E ++L+ HP+IV++
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKL 57
Query: 88 KHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + + IY+V EL+ S L + K + LT + ++Y+ +
Sbjct: 58 IGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LKI DFG++R T + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN--Y 169
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
+YT D+WS G + E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
++ +G G +G V + +T VA+K + D L E ++++ LRHP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLRHP--- 61
Query: 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYI 142
K I L + IY+V ELM+ L + ++ L Q+ + Y+
Sbjct: 62 --KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------TPTTIFWTDYVATRWY 195
N HRDL +N+L N K+ DFGLARV D I WT
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT-------- 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 172 -APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ L ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ ++ +KI DFG+ + D TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y ++D W+ G + E+L G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
K+ + +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYI 142
+ ++ + IY++ E ME+ L +K + LT Q+ + +I
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWY 195
N HRDL+ NIL + KI DFGLAR+ ++ T I WT
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT-------- 170
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 -APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 81/319 (25%), Positives = 125/319 (39%), Gaps = 53/319 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+ I E G+ G + ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF-WTDYVATRWYRAPELCGS 203
+ HRD+K +NI N + + DFG A + + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNV------VHQLDLMTDLLGT-PSLDTI 255
Y PA+DIWS G + E+ T LF + Q+ L+ GT P+ I
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE----------RLLAFDPKDR 305
D Y+ +K S + P + P L E ++LAFD R
Sbjct: 316 DAQANLD--EIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367
Query: 306 PTAE--------EALADPY 316
P+AE + + DPY
Sbjct: 368 PSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKV--AIKKIHD--IFEHISDAARILREIKLLRLLRHPDI 84
+VIGKGS+G V A H E+ A+K + I + + + LL+ ++HP +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + + +Y V + + +L ++ +F+ ++ AL Y+H
Sbjct: 59 VGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ N+ +RDLKP+NIL ++ + + DFGL + TT + + T Y APE+
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F +N D
Sbjct: 171 --QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 73/301 (24%), Positives = 131/301 (43%), Gaps = 33/301 (10%)
Query: 3 QDHRKKNS-----PEMEFFSEYGDASRYKIQEVIGKGSYG-VVCSAIDTHTGEKVAIKKI 56
Q H+KK+S P+ + +Y D + +G GS+G V+ + VAIK+
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYED---FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64
Query: 57 HD--IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE-LMESDL 113
I + + E K+L + HP V L S +D +Y+V E ++ +
Sbjct: 65 EKSKIIKQ-KQVDHVFSERKILNYINHPFCVN-----LYGSFKDESYLYLVLEFVIGGEF 118
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + + +K+ DFG A
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG------ 227
+V T T T Y APE+ + + A D W++G E+L G
Sbjct: 179 KVVDTRTYT------LCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYA 230
Query: 228 -KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA 286
+PL + ++ + L + +++ +D +RY + Q V+ F N
Sbjct: 231 NEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290
Query: 287 D 287
D
Sbjct: 291 D 291
|
Length = 340 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 79/308 (25%), Positives = 129/308 (41%), Gaps = 52/308 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 83
++ V+GKG +G VC+ TG+ A K++ + + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 139
+V + + + KD + +V +M DL H N E F+ ++L L
Sbjct: 62 VVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+ +H N +RDLKP+NIL + ++I D GLA P V T Y APE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + +YT + D W +GC+ E++ G+ F G+ +V
Sbjct: 172 VLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------------------EKVK 209
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
R + RR L + +S KF S ++ LL DPK R +E +G
Sbjct: 210 REEVDRRVLETEE-----VYSAKFSEEAKSICKM---LLTKDPKQRLGCQE-------EG 254
Query: 320 LSKVEREP 327
+V+R P
Sbjct: 255 AGEVKRHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 26 KIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
K+++ +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF--FLYQLLRALKY 141
V++ ++ + IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
I N HRDL+ NIL +A+ KI DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
F +T D+WS G + E++T G+ +PG
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI++L HP IV+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVK---- 73
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVY 148
+L D K ++++ E I D LT Q Q+L AL+Y+H+ +
Sbjct: 74 LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK N+L + +K+ DFG V+ + T ++ T ++ APE+ K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 209 TP---AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
TP DIWS+G E+ +P H+L+ M LL ++ +++
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLL---------KIAKSEPPT 234
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324
QP ++S +F + L+ L P+ RP+A + L P+ ++
Sbjct: 235 L-------SQPSKWSMEFRD-------FLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G +G V KVA+K + L E ++++ LRH +V++ +
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 91 MLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYIHTANV 147
+ S IY+V E M + L +K + + Q+ + YI N
Sbjct: 70 V---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRDL+ NIL KI DFGLAR+ D T +W APE + + +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AALYGR 179
Query: 208 YTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
+T D+WS G + E++T G+ +PG N
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 40/205 (19%)
Query: 125 REHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
REH+ + ++ +++ AL ++H + +RD+K +NIL ++ + + DFGL++ +
Sbjct: 99 REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158
Query: 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239
+ + T Y APE+ + A+D WS+G + E+LTG F
Sbjct: 159 EEERAY--SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-------- 208
Query: 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLERLL 298
++D + +++ +RR L K +P FP A +++LL
Sbjct: 209 -----------TVDG-EQNSQSEISRRIL----KSKP-----PFPKTMSAEARDFIQKLL 247
Query: 299 AFDPKDR---PTAEEALADPYFKGL 320
DPK R A+E P+F+G+
Sbjct: 248 EKDPKKRLGANGADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 23/246 (9%)
Query: 7 KKNSPEMEFFSEYGD-----------ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKK 55
+KN F + Y D A Y++ +VIG+G++G V + + KV K
Sbjct: 16 RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMK 74
Query: 56 IHDIFEHI--SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDL 113
+ FE I SD+A E ++ P +V++ + +D + +Y+V E M
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGD 129
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ +N D+ + +F+ +++ AL IH+ HRD+KP N+L + + LK+ DFG
Sbjct: 130 LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLF 231
+ + V T Y +PE+ S Y D WS+G E+L G F
Sbjct: 190 MKMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 232 PGKNVV 237
++V
Sbjct: 248 YADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 30 VIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPD 83
+G G++G V A + KVA+K + H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVIKANDD--LTREHYQFFLYQLLRALK 140
IV L + I V+ E DL ++ + LT E F YQ+ + +
Sbjct: 101 IVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++ + N HRDL +N+L +KICDFGLAR ND+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +++ EV+G G+YG V TG+ AIK + D+ E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEEEIKLEINMLKKYSH 71
Query: 82 PDIVEIKHIML----PPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLY 133
+ + PP D +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++LR L ++H V HRD+K +N+L N ++K+ DFG V+ T ++ T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 185
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y DIWS+G E+ G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 50/307 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 83
++ V+GKG +G VC+ TG+ A KK+ + + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 139
+V + + + KD + +V LM DL H F+ ++ L
Sbjct: 62 VVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+ +H + +RDLKP+NIL + + ++I D GLA P V T Y APE
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + +YT + D W++GC+ E++ G+ F + + +
Sbjct: 172 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRK---------------------KKI 208
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALAD 314
+ ++ R + K+ ++S+KF P A L + LL DPK+R A E
Sbjct: 209 KREEVERLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
Query: 315 PYFKGLS 321
P FK ++
Sbjct: 262 PLFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 83/339 (24%), Positives = 140/339 (41%), Gaps = 47/339 (13%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +Y I V+G G+ G V A GE A+K + +D R E+ L
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTR---EHYQFFLY- 133
IV+ R+ +++ ++ +++ DL Q IK+ R EH L+
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ + T + T
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTP 209
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+Y APE+ Y+ D++S+G + E+LT K F G+N M ++
Sbjct: 210 YYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEV------- 253
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
M K ++ P+ P ++ LL+ DPK RP++ + L
Sbjct: 254 -----------------MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296
Query: 314 DPYFKGLSKVERE-PSCQPISKMEFEFERRRVTKEDIRE 351
P K E QP F R I++
Sbjct: 297 MPICKLFISGLLEIVQTQP----GFSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
H R +Y V E + DL I+ F+ ++ L ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ ++ +KI DFG+ + D TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 74/306 (24%), Positives = 135/306 (44%), Gaps = 46/306 (15%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLRLLRHPD 83
++I +VIG+G++G V HT E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
I L + +D +Y+V + + DL ++ K D L + +F++ +++ A+
Sbjct: 60 CQWIT--TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH + HRD+KP N+L + N +++ DFG D T+ + V T Y +PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD--GTVQSSVAVGTPDYISPEIL 175
Query: 202 GSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
+ KY P D WS+G E+L G+ F +++V
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------------------- 216
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD---- 314
Y M ++ QF + A L++RL+ ++R + + D
Sbjct: 217 --------YGKIMNHEERFQFPSHITDVSEEAKDLIQRLIC--SRERRLGQNGIEDFKKH 266
Query: 315 PYFKGL 320
+F+G+
Sbjct: 267 AFFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 80/312 (25%), Positives = 122/312 (39%), Gaps = 38/312 (12%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y + + + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKHIMLPPSRRDFKDIY-VVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+K +NI N ++ I D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLF---------PGKNV-VHQLDLMTDLLGTPS 251
KY DIWS G + E+L +F K+ H L +++ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 252 ---LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 308
D SR+VR Y + R+ + N L+ ++L FD RP+A
Sbjct: 288 EFPRDPGSRLVRG--FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345
Query: 309 EEALADPYFKGL 320
EE L P F L
Sbjct: 346 EEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 93 PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL 152
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAEVLT-GKPLFPG 233
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V T KVAIK + L+E ++++ LRH +V + +
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 91 MLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYIHTANV 147
+ + IY+V E M + L +K D + Q Q+ + YI N
Sbjct: 70 V------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRDL+ NIL N KI DFGLAR+ D T +W APE + + +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AALYGR 179
Query: 208 YTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
+T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIK 88
+G G+ GVV +G +A K IH I A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN- 146
+I + E M+ L QV+K + E +LR L Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
S + DIWS+G E+ G+ P + + + G P +D
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVD 220
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 41/213 (19%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + N +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKK 274
S G + E+ + G +PG + + +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPGVQ-----------------------INEEFCQRLKDGTRMR 297
Query: 275 QPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
P NA P R++ DPK+RPT
Sbjct: 298 AP-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
K+ + IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDD--LTREHYQFFLYQLLRALKYI 142
++ +++ + +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
N HRDL +N+L + + K+ DFGL + A ++ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW-TAPEALR 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVVHQLD 241
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 60/258 (23%)
Query: 11 PEMEFFSEYGDASRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIH-DIFEHIS 64
PE E R + + +G+G++G V A +D VA+K + D E
Sbjct: 5 PEWEL-----PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-- 57
Query: 65 DAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAN-- 120
D + ++ E+++++++ +H +I+ +L ++ +YVV E +L ++A
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRP 112
Query: 121 --------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166
+ LT++ F YQ+ R ++++ + HRDL +N+L + +K
Sbjct: 113 PGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMK 172
Query: 167 ICDFGLARVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSI 217
I DFGLAR I DY + +W APE + F + YT D+WS
Sbjct: 173 IADFGLAR--------DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSF 220
Query: 218 GCIFAEVLT--GKPLFPG 233
G + E+ T G P +PG
Sbjct: 221 GVLLWEIFTLGGSP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-12
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +++ E++G G+YG V TG+ AIK + D+ + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTG--DEEEEIKQEINMLKKYSH 61
Query: 82 PDIVEIKHIML----PPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLY 133
+ + PP D +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++LR L ++H V HRD+K +N+L N ++K+ DFG V+ T ++ T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 175
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 72/306 (23%), Positives = 132/306 (43%), Gaps = 46/306 (15%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLRLLRHPD 83
++I +VIG+G++G V + + +KV KI + +E + A RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
+ H +D ++Y+V + + DL ++ K D L + +F+L +++ A+
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H + HRD+KP NIL + N +++ DFG D T+ + V T Y +PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPDYISPEIL 175
Query: 202 GSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
+ KY P D WS+G E+L G+ F +++V
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------------------- 216
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD---- 314
Y M K+ QF + + A L+ RL+ ++ + + D
Sbjct: 217 --------YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLIC--SREHRLGQNGIEDFKQH 266
Query: 315 PYFKGL 320
P+F G+
Sbjct: 267 PFFTGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 46 HTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103
+TGE+VA+K K HI+D + +EI++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 104 VVFELMES-DLHQVIKANDDLTREHYQF-FLYQLLRALKYIHTANVYHRDLKPKNILANA 161
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
++KI DFGL + D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 222 AEVLT 226
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + D+ D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 88 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
H+ F+ +F +ME DL I+++ +F+ +++ L+++H
Sbjct: 60 -HLFC-----TFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFN-DTPTTIFWTDYVATRWYRAPELCG 202
+ +RDLK N+L + + +KI DFG+ + N + + F T Y APE+
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF----CGTPDYIAPEILK 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G++
Sbjct: 170 G--QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 118 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
+ LT E + +Q+ R ++++ + HRDL +NIL + N +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 NDTPTTIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPGKNV 236
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+++ +G+G +G V T +VAIK + +S A L+E ++++ LRH +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKP--GTMSPEA-FLQEAQVMKKLRHEKLV 64
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYI 142
++ ++ + IY+V E M + L +K Q Q+ + Y+
Sbjct: 65 QLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
N HRDL+ NIL N K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
+ + ++T D+WS G + E+ T G+ +PG
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 68/308 (22%), Positives = 133/308 (43%), Gaps = 45/308 (14%)
Query: 25 YKIQEVIGKGSYGVV--CSAIDTH-TGEKVAIK--KIHDIFEHISDAARILREIKLLRLL 79
+++ +V+G G+YG V + H +G+ A+K K I + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 139
R + H + D K ++ + +L + + + Q + +++ AL
Sbjct: 62 RQSPFLVTLHYAF---QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPD 176
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + A+D WS+G + E+LTG +P +
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG--------------------ASPFTVDGEKNS 216
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDR----PT-AEEALA 313
+ + +RR L K +P +P A +++RLL DPK R P+ A+E
Sbjct: 217 QAEISRRIL----KSEP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 314 DPYFKGLS 321
P+F+ ++
Sbjct: 268 HPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 31 IGKGSYGVVCSAI-DTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
I + + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFND-----TPTTIFWTDYVATRWYRAPELCG 202
HRDL +N+L KI DFGL++ D T W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT 226
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
K+ + +G G +G V + KVA+K + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--DLTREHYQFFLYQLLRALKYI 142
+ ++ + IY++ E M + L +K+++ + F Q+ + YI
Sbjct: 65 RLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWY 195
N HRDL+ N+L + + KI DFGLARV ++ T I WT
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT-------- 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 -APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKL 75
E D KI E +G G+ GVV +G +A K IH I A R I+RE+++
Sbjct: 1 ELKDDDFEKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQV 56
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
L P IV +I + E M+ L QV+K + +
Sbjct: 57 LHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 135 LLRALKYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+++ L Y+ + + HRD+KP NIL N+ ++K+CDFG++ + + +V TR
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTR 166
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 232
Y +PE L G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 167 SYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 17/228 (7%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRL 78
+ + +V+G G++G V + GEK VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYVMAS 65
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLL 136
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+ + Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243
A E YT D+WS G E++T G + G V DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 74/307 (24%), Positives = 123/307 (40%), Gaps = 34/307 (11%)
Query: 24 RYKIQEVIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+Y I + GS G VC+ +KV +K + + REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+ + H + R + +V + DL + + L E +LL AL Y
Sbjct: 146 RAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLMTDLLGTPSL---- 252
L Y DIWS G + E+ GK V QL + + L
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPS--ALRLLERLLAFDPKDRPTAEE 310
+ + + ++ K +Y ++ + P L+ ++L FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QY--AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371
Query: 311 ALADPYF 317
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A GE A+K + D+ D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
H+ ++ ++ V E + DL H K DL R F+ +++ L+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFLHS 114
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLK N++ + + +KI DFG+ + F D + F T Y APE+
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
KYT ++D WS G + E+L G+ F G +
Sbjct: 171 L--KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 73/306 (23%), Positives = 130/306 (42%), Gaps = 60/306 (19%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIVEI-- 87
+GKG +G VC+ +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 88 -----KHIMLPPSRRDFKDI-YVVFELMES--DLHQVIKANDDLTREHYQFFLYQLLRAL 139
H+ L S + D+ Y ++ + E ++ +VI + Q+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
++H+ ++ +RD+KP+N+L + ++ D GLA V D T T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPE 164
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ Y+ +D +++GC E++ G+ TP D +V
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGR--------------------TPFKDHKEKVA 202
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP---- 315
+ + RR L + V+F + N + + LA P+DR + E DP
Sbjct: 203 KEELKRRTL-----EDEVKFEHQ--NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHE 255
Query: 316 YFKGLS 321
+FK ++
Sbjct: 256 FFKTIN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 53/287 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IG+G++G V S VA+K + A+ L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRLI 59
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR-------ALKY 141
+ + IY+V EL++ L E + + +L++ ++Y
Sbjct: 60 GVCTQK-----QPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LKI DFG++R + + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ +Y+ D+WS G + E + LG +S N
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LGAVPYANLS----N 202
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLERLLAFDPKDRPT 307
+ R + + P P A+ RL+ER +DP RP+
Sbjct: 203 QQTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 47/286 (16%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIVEI 87
E++GKG++G V VA+K D+ + + + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
I + R + IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 --IGVCTQR---QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LKI DFG++R +D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264
+Y+ D+WS G + E + G +PG MT N +A
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPG---------MT----------------NQQA 203
Query: 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
R + K + QK P+ ++++R + P++RP E
Sbjct: 204 RE---QVEKGYRMSCPQKCPD---DVYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
LT E + +Q+ + ++++ + HRDL +NIL + N +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 233
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-11
Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 89/341 (26%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA----RILREIKLLRLL 79
RY I +IGKG G V A D +VA+KKI E +S+ R LRE K+ L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR---EDLSENPLLKKRFLREAKIAADL 59
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA---NDDLTREHYQ-----F 130
HP IV + I D +Y +E L ++K+ + L++E +
Sbjct: 60 IHPGIVPVYSIC-----SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 131 FL---YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-----------VA 176
FL +++ ++Y+H+ V HRDLKP NIL ++ I D+G A +
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 177 FNDT---------PTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLT 226
++ P I V T Y APE L G S+ T DI+++G I ++LT
Sbjct: 175 VDERNICYSSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
Query: 227 GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA 286
FP R K R+ P++ + P
Sbjct: 227 LS--FP--------------------------YRRKKGRKISYRDVILSPIEVA---PYR 255
Query: 287 D--PSALRLLERLLAFDPKDRPTAEEALAD---PYFKGLSK 322
+ P ++ + LA DP +R ++ + L P+ +G +
Sbjct: 256 EIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296
|
Length = 932 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 74/313 (23%), Positives = 126/313 (40%), Gaps = 63/313 (20%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEHISDAARILREIKLLRLLRHPDIVE 86
+I G+YG V T ++ A+KKI+ I + + R+I L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ S + + +V E +E D ++K L + + + + + AL+Y+H
Sbjct: 66 -----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGS 203
+ HRDLKP N+L + +K+ DFGL+++ TT + ++ TR + ++CG+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDKQVCGT 179
Query: 204 ---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
Y +D W++G I E L G F G TP +
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------------TPE-EL 224
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNAD----PSALRLLERLLAFDPKDR---PT 307
+V+ +D +P D A L+ RLL +P +R
Sbjct: 225 FGQVISDDIE------------------WPEGDEALPADAQDLISRLLRQNPLERLGTGG 266
Query: 308 AEEALADPYFKGL 320
A E +F GL
Sbjct: 267 AFEVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 94 PSRRDFKDIYVVFELMESDLHQVIKANDDLT--REHYQFFLYQLLRALKYIHTANVYHRD 151
P++ D + ++ D+ I D+L E F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPA 211
L +NIL KICDFGLAR ND+ + + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 212 IDIWSIGCIFAEVLT-GKPLFPGKNV 236
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 66/300 (22%)
Query: 30 VIGKGSYGVVCSA---IDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + DIF SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKHIMLPPSRRDFKDI-YVVFELME-SDLHQVIKAND------DLTREHYQFFLYQLLR 137
++ + L + I V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-------- 189
++Y+ + N HRDL +N + N N + + DFGL++ I+ DY
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASK 176
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 177 LPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG--------------- 218
Query: 249 TPSLDTISRVVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
V N + YL R KQP P+ L+ + + +PK RP+
Sbjct: 219 ----------VENSEIYNYLIKGNRLKQP-------PDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDI--FEHISDAARILREIKLLRLLRHPD 83
+ +G GS+GVV + +G K VA+K + + + D L+E ++ L H +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHEN 57
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
++ + ++L + +V EL L + + ++ + Q+
Sbjct: 58 LIRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANG 109
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYR- 196
++Y+ + HRDL +NIL ++ K+KI DFGL R + N+ D+ +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLK 161
Query: 197 ------APELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
APE ++ A D+W G E+ T
Sbjct: 162 VPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 98 DFKDIYVVFELME----SDLHQVIKANDDLTREHYQF-------FLYQLLRALKYIHTAN 146
DFK + +ME DL++ IK +EH F YQ++ AL +H+
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRK 189
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
+ HRDLK NI +K+ DFG ++ ++D+ + + + T +Y APEL
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--K 246
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266
+Y+ D+WS+G I E+LT F G + Q ++M +L
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVL------------------- 284
Query: 267 YLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYFK 318
K P FP S ++ LL+ LL+ +P RPT ++ L + K
Sbjct: 285 ----YGKYDP------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + D+ D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
H+ ++ +++ V E + DL I++ F+ +++ L+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVA-FNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ +RDLK NIL + + +KI DFG+ + D T F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
P IV + + P + F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L+++H V +RDLKP NIL + + ++I D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDT 254
APE+ + Y + D +S+GC+ ++L G F H++D MT + D+
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 255 IS 256
S
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+VIG+G++G V TG A+K + D+ E A I E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D +++Y++ E + D+ ++ D L+ E QF++ + + A+ IH
Sbjct: 66 MFY-----SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLA-------RVAF----NDTPTTIF--------- 185
HRD+KP N+L +A +K+ DFGL R F P + F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 186 ----WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
W V T Y APE+ + Y D WS+G I E+L G P F
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 73/282 (25%), Positives = 119/282 (42%), Gaps = 47/282 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + A L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 89 HIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ + KD + +V +M DL H N + F+ +L L+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
KYT + D W +GC+ E++ G+ P K V + + + R V+ D+
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-------------EEVDRRVKEDQ 221
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305
++S+KF S R+ LL +PK+R
Sbjct: 222 E-------------EYSEKFSEDAKSICRM---LLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 79/311 (25%), Positives = 123/311 (39%), Gaps = 70/311 (22%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
P IV + + P + F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L+++H V +RDLKP NIL + + ++I D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLMTDLLGTPSLDT 254
APE+ + Y + D +S+GC+ ++L G F H++D MT
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 211
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAE 309
+M + P FS P LLE LL D R A+
Sbjct: 212 --------------LTMAVELPDSFS-------PELRSLLEGLLQRDVNRRLGCLGRGAQ 250
Query: 310 EALADPYFKGL 320
E P+F+ L
Sbjct: 251 EVKEHPFFRSL 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 70 LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTR 125
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHYQFFLY--------QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
Y Q+ +KY+ + N HRDL +N L N +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 24 RY-KIQEVIGKGSYGVVC----SAIDTHTGEKVAIKKIHDIFEHISDAARILR-----EI 73
RY K V+G+G +G V + TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFF 131
+L+ L H +IV+ K S + K + ++ E + S + K +L + F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLF 112
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA----------RVAFN-DT 180
Q+ + Y+H+ + HRDL +N+L + + +KI DFGLA RV + D+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
P +FW A E K++ A D+WS G E+LT
Sbjct: 173 P--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 65/283 (22%)
Query: 51 VAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108
VA+K + SD AR L+E+K+L L P+I + L D + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 109 ME-SDLHQVIKANDDLTREH--------YQFFLY---QLLRALKYIHTANVYHRDLKPKN 156
ME DL+Q ++ + T + LY Q+ ++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 157 ILANANCKLKICDFGLARVAF-ND-------TPTTIFWTDYVATRWYRAPELCGSFF-SK 207
L N +KI DFG++R + +D P I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267
+T D+W+ G E+LT P + +TD ++ R+D + Y
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQP-------YEHLTD---QQVIENAGHFFRDDGRQIY 258
Query: 268 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
L + PN L+ D +DRPT E
Sbjct: 259 L------------PRPPNCPKDIYELMLECWRRDEEDRPTFRE 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 24 RYKIQEVIGKGSYGVV--CSAID------------THTGEKVAIKKIHDIFEHISDAAR- 68
+ +++E +G+G +G V C A VA+K + ++ AR
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR---ADVTKTARN 62
Query: 69 -ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--------- 117
L+EIK++ L++P+I+ + + + D + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCV---SDD--PLCMITEYMENGDLNQFLSQREIESTF 117
Query: 118 -KAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +KI DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
++ I + RW + K+T A D+W+ G E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 53/243 (21%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFE-----HISDAARILREIKLLRLLRH 81
+VIG+G++G V TG A+K + D+ E HI IL E L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK- 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
+ S +D ++Y++ E + D+ ++ D LT E QF++ + + A+
Sbjct: 66 ----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLA-------RVAFNDTPTTIFWTDY---- 189
IH HRD+KP N+L ++ +K+ DFGL R F +D+
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 190 ---------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIV 85
+V+G G++G V I GE V I I + + E ++ + HP +V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
+ + L P+ I +V +LM L V + D++ + + Q+ + + Y+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALECI 183
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+ K+T D+WS G E++T GKP
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 21/222 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI +L HP+IV++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALKYIHTANVY 148
+ +++++ E + + LT + Q L AL Y+H +
Sbjct: 71 FYYEN-----NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK NIL + +K+ DFG V+ +T T ++ T ++ APE+ SK
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 209 TP---AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
P D+WS+G E+ +P H+L+ M LL
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 47/294 (15%)
Query: 29 EVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 86
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKHIMLPPSRRD-FKDIYVVFELME-SDLHQVI---KANDD---LTREHYQFFLYQLLRA 138
+ + L + + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N N + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
V N + YL R KQP P+ L+ +PKDRP+ E
Sbjct: 218 -VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 75/308 (24%), Positives = 135/308 (43%), Gaps = 48/308 (15%)
Query: 25 YKIQEVIGKGSYG---VVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLL 79
+++ +V+G G+YG +V TG+ A+K + + + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 80 RH-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
R P +V + + ++ YV M + L+Q D+ + + +F+ +++ A
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILA 117
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL ++ + + DFGL++ ++ + + T Y AP
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ + A+D WS+G + E+LTG F L G R
Sbjct: 176 EIIRG-KGGHGKAVDWWSLGILIFELLTGASPF-------------TLEG-------ERN 214
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDR-----PTAEEAL 312
+++ +RR L + FP+ P A LL +LL DPK R A E
Sbjct: 215 TQSEVSRRIL---------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265
Query: 313 ADPYFKGL 320
P+FKGL
Sbjct: 266 EHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 27 IQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
I+E +G+GS+G+V + +VAIK +++ + + L E +++
Sbjct: 11 IRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNC 68
Query: 82 PDIVEIKHIML---PPSRRDFKDIYVVFELM-ESDLHQVIKA---NDDLTRE----HYQF 130
+V + ++ P VV ELM + DL +++ + Q
Sbjct: 69 HHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 131 FLY---QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
F+ ++ + Y+ HRDL +N + + +KI DFG+ R I+ T
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYET 172
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
DY + RW APE +T D+WS G + E+ T
Sbjct: 173 DYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 28/192 (14%)
Query: 51 VAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108
VA+K + D SD AR RE +LL L+H IV+ + + + + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 109 ME-SDLHQVIKAN-------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
+N L N +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 215 WSIGCIFAEVLT 226
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
F YQ+ ++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+W APE F + YT D+WS G + E+ T G P
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160
+++V E + DL ++ L EH +F+ ++ AL ++H + +RDLK N+L +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
A+ +K+ D+G+ + TT + + T Y APE+ +Y ++D W++G +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVL 185
Query: 221 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS 280
E++ G+ F D++TD P ++T YL + ++P++
Sbjct: 186 MFEMMAGRSPF---------DIITD---NPDMNT----------EDYLFQVILEKPIRIP 223
Query: 281 QKFPNADPSALRLLERLLAFDPKDR 305
+ A +L+ L DPK+R
Sbjct: 224 RFL---SVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDL R F Q+ + + ++ + N HRD+ +N+L KICDFGLAR ND+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
+ + +W APE F YT D+WS G + E+ + GK +PG
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVEI 87
VIG+GSY V T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A +K+ D+G+ + TT + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 39/243 (16%)
Query: 31 IGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D + ++ E+++++++ +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 81
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--------DLTR---EHYQF 130
+I+ +L +D +YV+ E + +L + ++A D+ R E F
Sbjct: 82 NIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 131 -----FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185
YQ+ R ++Y+ + HRDL +N+L N +KI DFGLAR N
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 186 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDL 242
+ +W APE + F + YT D+WS G + E+ T G P +PG V L
Sbjct: 197 TNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKL 251
Query: 243 MTD 245
+ +
Sbjct: 252 LKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEK-----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G+G +G V A + VA+K + + S+ +L E LL+ + HP +
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHV 65
Query: 85 VEI-----------------KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LT 124
+++ K+ L R+ + + + + + + N D LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
F +Q+ R ++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 185 FWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 186 RSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLLRHP 82
+ + +VIG+G++G V + + A+K + FE I SD+A E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV++ + +D K +Y+V E M DL ++ +N D+ + +F+ +++ AL
Sbjct: 104 WIVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFG----LARVAFNDTPTTIFWTDYVATRWYRA 197
IH+ HRD+KP N+L + + LK+ DFG + T + DY+ +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI------S 211
Query: 198 PELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
PE+ S Y D WS+G E+L G F
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 75/339 (22%), Positives = 135/339 (39%), Gaps = 57/339 (16%)
Query: 23 SRYKIQEVIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL---------- 70
+ +++ + + G++G +C A+ T E A + ++ + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 71 -----REIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLH-----QVIKAN 120
EI L L H +I++I+ I+ + + Y++ + + DL+ +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND- 179
D + + + QLL A++YIH + HRD+K +NI N + K+ + DFG A +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL----------TGKP 229
W VAT +PE+ Y DIWS G I ++L GKP
Sbjct: 322 EAFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRV--VRNDKARRYLTSMRKKQPVQFSQKFPNAD 287
++ L + + P + D A + + + + ++P
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--- 433
Query: 288 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 326
L ++L FD RP A E LA P F ++ E E
Sbjct: 434 ------LVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 70/306 (22%)
Query: 26 KIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
K+ +++G+G +G V D + KVA+K + DI + S+ L E ++ H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDH 60
Query: 82 PDIVEIKHIMLPPSRRD-FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL--- 136
P+++++ + S V+ M+ DLH + + + Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKF 118
Query: 137 -----RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-- 189
++Y+ N HRDL +N + + + + DFGL++ I+ DY
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYR 170
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 242
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 171 QGRIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG--------- 218
Query: 243 MTDLLGTPSLDTISRVVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 301
V N + YL R KQP + L+ D
Sbjct: 219 ----------------VENHEIYDYLRHGNRLKQP-------EDCLDELYDLMYSCWRAD 255
Query: 302 PKDRPT 307
PKDRPT
Sbjct: 256 PKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 41/179 (22%)
Query: 71 REIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQ----------VIKA 119
+E +L+ L+HP+IV + + + ++FE + DLH+ V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 120 NDDLTREH---YQFFL---YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ D T + FL Q+ ++Y+ + + HRDL +N L +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 174 RVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
R I+ DY + RW PE + K+T DIWS G + E+
Sbjct: 172 R--------DIYSADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLL-RLLRHPDIVEI 87
VIG+GSY V T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L ++ +K+ D+G+ + TT + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 61/308 (19%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDI-------FEHISDAARILREIKLLRLLRHPD 83
+GKG +G V + TG+ A KK++ +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-----DLHQVIKANDDLTREHYQFFLYQLLRA 138
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + ++I D GLA V D + Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
EL +Y ++D +++G E++ + F + +V
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARG--------------------EKV 204
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 313
+ +R L V + KF A S E LLA DP+ R +
Sbjct: 205 ENKELKQRIL-----NDSVTYPDKFSPASKS---FCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 314 DPYFKGLS 321
P F+ L+
Sbjct: 257 HPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 9e-10
Identities = 83/338 (24%), Positives = 132/338 (39%), Gaps = 87/338 (25%)
Query: 17 SEYGDA----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
+Y D + Y++ + IG G +G V T E K I + ++++ E
Sbjct: 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK------------A 119
+ ++R L+H +IV L + + +Y++ E ++ DL + I+ A
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 120 NDDLTREHYQFFLYQLLRALKYIHT-------ANVYHRDLKPKNILANANCK-------- 164
D+TR QLL AL Y H V HRDLKP+NI + +
Sbjct: 120 IVDITR--------QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 165 ---------LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
KI DFGL++ + V T +Y +PEL Y D+W
Sbjct: 172 ANNLNGRPIAKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ 275
++GCI E+ +GK F N Q L+++L P L
Sbjct: 228 ALGCIIYELCSGKTPFHKANNFSQ--LISELKRGPDL----------------------- 262
Query: 276 PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
P++ K N L++ LL K+RP+A + L
Sbjct: 263 PIKGKSKELNI------LIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 31 IGKGSYGVVCSAIDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 89
+G G +GVV G+ VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 90 IMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT---REHYQFF-LYQLLR-------A 138
+ + IY+V E M +N L REH + F QLL
Sbjct: 67 VCTKQ-----RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKDVCEG 112
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+ + HRDL +N L + +K+ DFGL+R +D T+ + + RW P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
E+ +SK++ D+W+ G + EV + GK
Sbjct: 171 EVL--LYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 27 IQEVIGKGSYGVV----CSAID-THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
++ +G+G++G V C + T VA+K + D ++ RE +LL L+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA----------------NDDLT 124
IV+ + D + +VFE M+ DL++ ++A +L
Sbjct: 67 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
Q+ + Y+ + + HRDL +N L AN +KI DFG++R ++ +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 182 GGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-R 77
+ + K Q+VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFE---------------LMESDLHQVI--KAN 120
L HP+I+ +++ R + +Y+ E ++E+D I
Sbjct: 64 LGHHPNII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L+ + F + R + Y+ HRDL +NIL N KI DFGL+R
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
T+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 179 KKTM---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 37/250 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKL 75
+R + + +G+G +G V A ID K VA+K + D D + ++ E+++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEM 70
Query: 76 LRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKA-------------- 119
++++ +H +I+ +L +D +YV+ E + +L + ++A
Sbjct: 71 MKMIGKHKNIIN----LLGACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 120 --NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
+ LT + YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
N + +W APE + F + YT D+WS G + E+ T G +PG
Sbjct: 186 NIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 236 VVHQLDLMTD 245
V L+ +
Sbjct: 242 VEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 47/225 (20%)
Query: 31 IGKGSYGVV----CSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND---------------DLTREHYQ 129
+ + + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
Q+ + Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 177
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T DIWS G + E+ T
Sbjct: 178 YRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
++I +VIG+G++G V V +K ++ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKHIMLPPSRR----------DFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFL 132
E + +++ RR D ++Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
+++ A+ +H HRD+KP N+L + N +++ DFG D T+ V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAVGT 166
Query: 193 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
Y +PE+ + +Y P D WS+G E+L G+ F +++V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 31 IGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D A ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--------DLTREHYQFF-- 131
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEG-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 132 ------LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185
YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 186 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 194 SNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 70 LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA--------- 119
L+E+K+L L+ P+I+ + + + D + ++ E ME+ DL+Q + +
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 120 -NDDLTREH------YQFFLY---QLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169
ND + H Y L+ Q+ +KY+ + N HRDL +N L N +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
FG++R + I + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 49/235 (20%)
Query: 31 IGKGSYGVVC--SAID---THTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V +A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL------- 136
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RALKYIHTANVYHRDLKPKNILA-----NANCKLKICDFGLARVAFNDTPTTIFWTDY-- 189
+ Y+ + HRDL +N L +A+ +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-RLLRHP 82
K ++VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFE----------LMESDLHQVIKANDDLTREH---YQ 129
+I+ +++ R + +Y+ E L +S +V++ + +EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 130 FFLYQLLR-------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182
QLL+ ++Y+ HRDL +N+L N KI DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
T+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 TM---GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 75/277 (27%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 72 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM-------ESDLHQVIKAN-DDL 123
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
QLL A+ YIH + HRD+K +N+L N + + DFG A A + +T
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWST 316
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
F T APE+ YTP++DIWS G + E VH L
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEA-----------AVHTASLF 363
Query: 244 TDLLGT---PSLDTISRVVRNDK---------ARRYLTSMRKKQPVQFSQKFPNADPSAL 291
+ G P I R++R + A L S + + + +++ P+
Sbjct: 364 SASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR-NRRPAYTRPAWT 422
Query: 292 R----------LLERLLAFDPKDRPTAEEALADPYFK 318
R L+ R L FD RP+A E L P F+
Sbjct: 423 RYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK-KIHDIFEHISDAA--RILREIKLLRLL 79
+ +K +V+G G++G V + GEKV I I ++ E S A IL E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLR 137
+P + + I L + + ++ +LM L V + D++ ++ + Q+ +
Sbjct: 67 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ YT D+WS G E++T
Sbjct: 181 ESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 68/319 (21%), Positives = 122/319 (38%), Gaps = 78/319 (24%)
Query: 23 SRYKIQE--VIGKGSYGVV----CSAIDTHTGEKVAIKKIHDIFEHISDAARIL---REI 73
R +QE +G+G +G V I+ GE + + K + D RE+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRREL 59
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD---------L 123
+ R L H ++V + + R+ + Y++ E + DL Q ++A L
Sbjct: 60 DMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
+ + Q+ + ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---- 170
Query: 184 IFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
+Y + RW APE ++ D+WS G + EV T G+ F G
Sbjct: 171 ----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-- 221
Query: 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL-RLL 294
++D L ++ + P PS L +L+
Sbjct: 222 -------LSD-------------------EEVLNRLQAG---KLELPVPEGCPSRLYKLM 252
Query: 295 ERLLAFDPKDRPTAEEALA 313
R A +PKDRP+ E ++
Sbjct: 253 TRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 24/112 (21%)
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY--- 189
YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK-KIHDIFEHISDAA--RILREIKLLRLLRHPDIVE 86
V+G G++G V I GE V I I + E+ S A IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 87 IKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ I L + + +V +LM L V + D + + + Q+ + + Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D T + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKNV 236
++T D+WS G E++T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 91 MLPPSRRDFKDIYVVFELMESD-LHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVY 148
+ + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW---YRAPELCGSFF 205
HRDL +N+L KI DFGL++ D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 206 SKYTPAIDIWSIGCIFAEVLT--GKP 229
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-RLLRHPDIV 85
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESDL-----HQVIKANDDLTREH---YQFFLYQLLR 137
+++ R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
+ Y+ HRDL +NIL N KI DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 55/250 (22%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+ +G G++G VC A T A+K + D+ + A + E +L + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVK 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D ++Y V + + D+ ++ + +F++ +L A++ +H
Sbjct: 66 LYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGL----------------ARVAFNDTPTTIFWTD- 188
HRD+KP NIL + + +K+ DFGL + + + + W D
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 189 ---------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
V T Y APE+ YT D WS+G I
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVIL 238
Query: 222 AEVLTGKPLF 231
E+L G+P F
Sbjct: 239 FEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 89/343 (25%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+ +G G++G VC A T A+K + D+ + A + E +L + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-NQVAHVKAERDILAEADNEWVVR 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D ++Y V + + D+ ++ + +F++ +L A++ +H
Sbjct: 66 LYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF-----------------WTD 188
HRD+KP NIL + + +K+ DFGL F T + + W D
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 189 ----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
V T Y APE+ + YT D WS+G I
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVI 237
Query: 221 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS 280
E+L G+P F L L+T +V+ + TS+ + S
Sbjct: 238 LYEMLVGQPPF---------------LAQTPLETQMKVI------NWQTSLHIPPQAKLS 276
Query: 281 QKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 320
P A L+ +L P+DR A+E A P+FK +
Sbjct: 277 -------PEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 37/119 (31%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDF 170
DL ++K L+ + + QL+ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
GL ++ TP+ Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEK----VAIKKIHD-----IFEHISDAARILREIKLLRLL 79
+++G G +G V I G+ VAIK I D F+ I+D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLR 137
H IV + I S + +V +L S L V + D L + + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HR+L +NIL ++ ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 59/256 (23%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLR 80
S + + IG G++G VC T A+K + D+ + AA + E +L
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEAD 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFEL-----MESDLHQVIKANDDLTREHYQFFLYQL 135
+ +V++ + S +D ++Y V + M S L ++ +DL R F++ +L
Sbjct: 60 NEWVVKLYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAEL 110
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL------------------ARVAF 177
A++ +H HRD+KP NIL + + +K+ DFGL R
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 178 NDTPTTIFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIW 215
+ D V T Y APE+ + YT D W
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWW 228
Query: 216 SIGCIFAEVLTGKPLF 231
S+G I E+L G+P F
Sbjct: 229 SVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDA--ARILREIK 74
R + +++ +G++G + I E+V +K + D H S+ +L+E
Sbjct: 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESC 60
Query: 75 LLRLLRHPDIVEIKH----------IMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDL 123
LL L H +I+ I H ++ P + + K L E++ Q +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS----- 115
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
T++ + Q+ + Y+H V H+D+ +N + + ++KI D L+R F
Sbjct: 116 TQQLVHMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ + +W L +S A D+WS G + E++T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 59/243 (24%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 24 RYKIQEV--IGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISD--AARILREIK 74
R I+ V IG+G++G V A + VA+K + E S A RE
Sbjct: 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAA 60
Query: 75 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND------------ 121
L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 61 LMAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 122 ----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171
L+ Q+ + Y+ HRDL +N L N +KI DFG
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 172 LARVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
L+R I+ DY + RW PE F+++YT D+W+ G + E
Sbjct: 176 LSR--------NIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWE 224
Query: 224 VLT 226
+ +
Sbjct: 225 IFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRL 78
D KI+ ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLL- 136
H +IV ++ ++ + + +V E M + A D R+H Q QL+
Sbjct: 63 FDHSNIVRLEGVITRGN-----TMMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 137 ------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DY 189
+KY+ H+ L +L N++ KI F + D I+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSG 168
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ + APE + ++ A D+WS G + EV++
Sbjct: 169 KSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 64/263 (24%), Positives = 107/263 (40%), Gaps = 65/263 (24%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRHP 82
+ +VIGKG++G V TG+ A+K + ++F+ A + E +L P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK-DQLAHVKAERDVLAESDSP 61
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
+V + + F+D ++ +ME DL ++ D + + +F++ + + A
Sbjct: 62 WVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLA------------------------- 173
++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 174 ----RVAFNDTPTTIFWTDYVATRW----------------YRAPELCGSFFSK-YTPAI 212
VA + T+ D +AT W Y APE+ F + Y
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQQGYGQEC 229
Query: 213 DIWSIGCIFAEVLTGKPLFPGKN 235
D WS+G I E L G P F +N
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 23 SRYKIQEVIGKGSYGVVCSA--IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 77
S + E +G+ +G V T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 78 LLRHPDIV----------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT--- 124
L+HP+IV + I S D + F +M S V +DD T
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE----FLVMRSPHSDVGSTDDDKTVKS 119
Query: 125 -REHYQFF--LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
E F + Q+ ++++ + +V H+DL +N+L +KI D GL R +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ + RW +PE + K++ DIWS G + EV +
Sbjct: 180 YKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 129 QFFLYQLLRALKYIHTANVYHRDLKPKNIL-ANANCKLKICDFGLA---RVAFNDTPTTI 184
Q + Q+L AL +H+ + HRD+KP+NI+ + + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244
+++ Y APE S TP+ + + VL L P + ++ L+
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNL-PDRFDIYSAGLIF 369
Query: 245 DLLGTPSLDTISRVV---RNDKARRY-LTSMRKKQPVQFSQKFPNA-------DPSALRL 293
+ P+L + S ++ R K Y L + RK + S + L
Sbjct: 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWEL 429
Query: 294 LERLLAFDPKDRPTAEEALADPYFKGLS 321
L+ ++ F + R +A+ ALA PYF
Sbjct: 430 LKSMMRFKGRQRISAKAALAHPYFDREG 457
|
Length = 566 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
IG G +G V + H G +V +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQ-----LLRALKY 141
+ + +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD---YVATRWYRAP 198
+H A+ H DL +N A+ +KI D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 199 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 226
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 51 VAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE- 107
VAIK + DI + + +E L+ L HP+IV + ++ + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEY 88
Query: 108 LMESDLHQVI-----------KANDDLT----REHYQFF--LYQLLRALKYIHTANVYHR 150
L + DLH+ + +++D T +H F Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
DL +NIL +KI D GL+R ++ + + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 211 AIDIWSIGCIFAEVLT 226
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 189
+++ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
I +G++G V + + A+K K I +++ + R+ L L + P IV +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKSPFIVHL 69
Query: 88 KHIMLPPSRRDFKDIYVVFELM-----ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ S + ++Y+V E + +S LH ++++ ++ ++ AL Y+
Sbjct: 70 YY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVALALDYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
H + HRDLKP N+L + +K+ DFGL++V N
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 28 QEVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-- 84
QE IG G +G V+ S I T TG + K + L++ R+L+HP+I
Sbjct: 1 QE-IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 85 -----VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLY----Q 134
VE +L VFE E DL + R L +
Sbjct: 60 CLGQCVEAIPYLL------------VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
+ + ++H N H DL +N ++ +K+ D+G+ + + V RW
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 195 YRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVL 225
APEL G F ++ T ++W++G E+
Sbjct: 168 L-APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 50/244 (20%)
Query: 30 VIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V + +VA+K + + D + L E ++ H +I
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNI 71
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLR------ 137
V + + R +++ ELM DL ++ N + LL
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 138 -ALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLARVAFNDTPTTIFWTDY-- 189
KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 240
+ +W PE L G F SK D+WS G + E+ + G +PG+ +
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 241 DLMT 244
+ +T
Sbjct: 232 EFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 59/336 (17%)
Query: 30 VIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR-EIKLLRLLRHPDIVE 86
VIG+G V A TGE V +++I ++ ++ L+ E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHPNIVP 63
Query: 87 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ---------FFLYQLLR 137
+ + + +++VV M + DL H+ + L +L+
Sbjct: 64 YRATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLK 112
Query: 138 ALKYIHTANVYHRDLKPKNILANANCK---------LKICDFGLARVAFNDTPTTIFWTD 188
AL YIH HR +K +IL + + K L + + G +D P
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY----- 167
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
V + +PE+ Y DI+S+G E+ G P K++ L+ L G
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNG 225
Query: 249 TPS--LDTI-----------SRVVRNDKARRYLTSMRKKQPVQFSQKFP---NADPSALR 292
T LDT SR N T + S P P
Sbjct: 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285
Query: 293 LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328
+E+ L +P RP+A L +FK +++R S
Sbjct: 286 FVEQCLQRNPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/101 (26%), Positives = 44/101 (43%), Gaps = 19/101 (18%)
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 189
++ + Y++ HRDL +N + + +KI DFG+ R I+ TDY
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR 68
+S + + S K + VI +G G G + +K+I+D+ I +
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-NSIPSS-- 732
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 127
EI + L+HP+IV++ + R K Y++ E +E +L +V++ +L+ E
Sbjct: 733 ---EIADMGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWER 781
Query: 128 YQFFLYQLLRALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
+ + +AL+++H + V +L P+ I+ + + + L + DT I
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
+ Y APE + T DI+ G I E+LTGK
Sbjct: 841 -------SSAYVAPETRET--KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/42 (40%), Positives = 28/42 (66%)
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ Q+L L+ +H + HRD+KP+N+L + ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 82/339 (24%), Positives = 136/339 (40%), Gaps = 73/339 (21%)
Query: 26 KIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR-EIKLLRLLRHP 82
++Q IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQL 135
+I+ + S ++V+ M + ++K ++ L L+
Sbjct: 60 NIMTSWTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGA 110
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL------------ARVAFNDTPTT 183
LR L Y+H HR++K +IL + + + + GL A+V + D P
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ- 166
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
F T + W +PEL Y DI+S+G E+ TG+ P ++++ L+
Sbjct: 167 -FSTSVLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLL 220
Query: 244 TDLLGTP---------------------SLDT-ISRVVRNDKARRYLTSMRKKQPVQ--F 279
L G P +D+ I V + +TS R + P F
Sbjct: 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280
Query: 280 SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
S F N L+E L DP+ RP+A L+ +FK
Sbjct: 281 SPAFQN-------LVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 19/96 (19%)
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY--------V 190
+ Y++ HRDL +N + + +KI DFG+ R I+ TDY +
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKGGKGLL 183
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
RW L F+ + D+WS G + E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 6/102 (5%)
Query: 129 QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
Q ++ L ++H N H DL +N L A+ +KI D+GL+ + +
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162
Query: 189 YVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAEVL 225
+V RW APEL T ++WS+G E+
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 52/221 (23%), Positives = 77/221 (34%), Gaps = 54/221 (24%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
Q I KG + I T K + DI E EIK LR + +I++I
Sbjct: 33 QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITE---------NEIKNLRRIDSNNILKI 83
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLY---QLLRALKY--- 141
Y + DL ++ + TR + + L L K
Sbjct: 84 ---------------YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMA 128
Query: 142 ----IHTANVYHRDLKP------KNILANANCKLKICDFGLARV----AFNDTPTTIFWT 187
N+Y KP + L N KLKI GL ++ F +
Sbjct: 129 IDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-------- 180
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
V Y + ++ FS+YT DI+S+G + E+ TGK
Sbjct: 181 --VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 16/39 (41%), Positives = 26/39 (66%)
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+L L+YIH + H D+KP+NI+ + N + I D+G+A
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 620 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.07 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.74 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.65 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.61 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.18 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.93 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.86 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.42 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.18 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.01 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.99 | |
| PLN02236 | 344 | choline kinase | 95.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.31 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.88 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.66 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.65 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.43 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.33 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.8 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.67 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.25 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.09 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-75 Score=590.23 Aligned_cols=342 Identities=58% Similarity=0.975 Sum_probs=322.3
Q ss_pred ccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 17 ~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
..+....+|..++.||+|+||+||+|.++.+|+.||||++.+.+.+..++++.+||+++|+.++|+||+.+++++.++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 33455677777899999999999999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+.++++|+|+|+|+.||+++|+.+..|++++++++++|||+||+|+|+.||+||||||.|+|++.+|.+||||||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ....++|+|+.|+||+|||++.+ +..|+.++||||+||||+|||+|+++|+|.+..+|+..|++++|+|+.+.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 765 56678899999999999999976 4899999999999999999999999999999999999999999999999999
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchh
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKME 336 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~ 336 (620)
.+ .+++++.|+.++....+.+|...||+.++.+.||+++||.+||.+|+|++|+|+||||..+..+++||.+++....
T Consensus 254 ~i-~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~- 331 (359)
T KOG0660|consen 254 KI-RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS- 331 (359)
T ss_pred Hh-ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc-
Confidence 98 8999999999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred hhHHhhcCCHHHHHHHHHHHHHHhCchhh
Q 007050 337 FEFERRRVTKEDIRELIFREILEYHPQLL 365 (620)
Q Consensus 337 ~~~e~~~~~~e~~~~~~~~ei~~~~~~~l 365 (620)
++.. .+.+++++++|+|+++|+|...
T Consensus 332 --~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 --FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred --cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 4444 8999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=472.28 Aligned_cols=288 Identities=37% Similarity=0.656 Sum_probs=248.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|+.+.++|+|+||+|++|+++.||+.||||++.....+..-.+-.+|||++|++|+|+|+|.++++| +-.+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999987655555556678999999999999999999999 566789
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
++|||||+.++.+.+.. ...++++.++.|++|++.|+.|||+++++||||||+||||+.+|.+||||||+|+.....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 99999999876666654 346999999999999999999999999999999999999999999999999999987542
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
...+|+|+.|+||+|||++.+. ..|+..+||||+||++.||++|.++|+|.++.+|+..|...+|....+-.+-+..+
T Consensus 155 -gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2346899999999999998874 68999999999999999999999999999999999999999999887765554333
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+.. +.-.....+.++..++|+++..+.||+++||..||.+|++.+++|.||||.++
T Consensus 233 ~~F~G-v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHG-VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred Cceee-eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 22111 11112233445667899999999999999999999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-59 Score=457.96 Aligned_cols=288 Identities=40% Similarity=0.650 Sum_probs=254.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.+|..+++||+|.||+||+|+|..||+.||||+|+.......-....+|||+.|+.++|+||+.++++| ....++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 589999999999999999999999999999999986544444455678999999999999999999999 556789
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
.||+|||+.||..+|+.+. .++..+++.|+.++++||+|||+++|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998654 799999999999999999999999999999999999999999999999999998765443
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
. .+..+.|+||+|||++.+. ..|+..+||||+|||++||+.|.|.|+|.++.+|+..|+..+|+|..+.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 3 2444899999999988774 78999999999999999999999999999999999999999999999999988655
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
..+-.+. .....+....|+..++++.||+.+||.+||.+|+|+.|+|+|+||+....+
T Consensus 233 pdY~~~~----~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 PDYVKIQ----QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred ccHHHHh----cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 5544432 223333445889999999999999999999999999999999999975443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-57 Score=480.55 Aligned_cols=338 Identities=93% Similarity=1.452 Sum_probs=306.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||+|+||.||+|+++.+++.||||++...........++.+|+.+|+.++||||+++++++......+...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555667789999999999999999999998766555667899
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 104 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
+|||||+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654443333
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
..+...+||++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+ .+..
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i-~~~~ 239 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV-RNEK 239 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh-hhhh
Confidence 445667899999999998754357899999999999999999999999999999999999999999999888877 6677
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHHhhc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRR 343 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~ 343 (620)
...++..+....+..+...++.+++.+.+||.+||..||++|||++|+|+||||+++....+.+..++++.+++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRR 319 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHh
Confidence 77888888888888888888999999999999999999999999999999999999999888899999999999999999
Q ss_pred CCHHHHHHHHHHHHHHhCc
Q 007050 344 VTKEDIRELIFREILEYHP 362 (620)
Q Consensus 344 ~~~e~~~~~~~~ei~~~~~ 362 (620)
.+++++++.+++++++|||
T Consensus 320 ~~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 320 LTKEDVRELIYREILEYHP 338 (338)
T ss_pred cCHHHHHHHHHHHHHhcCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-59 Score=489.93 Aligned_cols=288 Identities=39% Similarity=0.682 Sum_probs=253.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (620)
..+||.+++.||.|.||.||+|+.+.+|+.||||++++.+....+... +||++.|++|. |||||+|++++.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d----~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRD----ND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhc----cC
Confidence 457899999999999999999999999999999999988776555444 58999999998 9999999999943 23
Q ss_pred CeEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||+.+|+++++.++ .|++..++.|++||+.||+|+|.+|++||||||||||+.....|||+||||||....
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 4899999999999999998754 799999999999999999999999999999999999999888999999999998654
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .+|+|+.|+||+|||++... ..|+.++|||++|||++|+.+-+++|+|.++.+|+.+|++++|+|..+.|..-
T Consensus 163 kp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred CC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 43 35899999999999988763 68999999999999999999999999999999999999999999998887653
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..-+...--.+....+..+...+++++.++.+||.+||.+||++||||+|+|+||||+.-
T Consensus 238 --~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 238 --YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred --HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 122223333345556667777889999999999999999999999999999999999854
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=456.97 Aligned_cols=291 Identities=38% Similarity=0.597 Sum_probs=251.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|+.+..|++|+||+||+|+|+.|++.||+|+++........--.-+|||.+|.+++|||||.+.++....+ .+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence 46799999999999999999999999999999999876555444455679999999999999999999986543 466
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+.||..++...+ +|...+++.++.|+|.||+|||.++|+||||||+|+|++..|.+||+||||||.+.+..
T Consensus 152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99999999999999998765 89999999999999999999999999999999999999999999999999999886542
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
..+|..+.|.||+|||++.+. ..|+.++|+||+|||++||++++|+|+|.+..+|+++|+.++|+|+...|..+..
T Consensus 232 ---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 232 ---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred ---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 345788999999999999874 7899999999999999999999999999999999999999999999999988733
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNA--DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
-... .. -.+.......+...|+.. ++...+|+..+|.+||.+|.||+|+|+|+||....
T Consensus 308 lp~~-k~-~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 308 LPAV-KK-MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred cchh-hc-cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 2211 11 111222233344556554 49999999999999999999999999999999753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=476.85 Aligned_cols=287 Identities=39% Similarity=0.626 Sum_probs=249.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|+.+++||+|.||.||+|++..+|+.||+|++...........-..|||.||++|.||||++|.+++... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 4578899999999999999999999999999999986655556666778999999999999999999998654 3468
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+.||.-++...+ .|++.+++.|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+.+....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999999999999997643 79999999999999999999999999999999999999999999999999999775444
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.. .+|..+.|+||+|||++++. ..|+.++|+||+||||.||++|++.|+|.++.+|+..|++++|.|+.+.|... +
T Consensus 273 ~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~-k 348 (560)
T KOG0600|consen 273 SA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS-K 348 (560)
T ss_pred Cc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc-c
Confidence 32 36888999999999999875 78999999999999999999999999999999999999999999999998822 2
Q ss_pred chhHHHHHHhhhccC--CCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 261 NDKARRYLTSMRKKQ--PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
-..+ ..++... ...+.+.|..++..+++|+..||..||.+|.||.++|+|+||..
T Consensus 349 LP~~----~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHA----TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcc----cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 2211 1111111 12244557788999999999999999999999999999999953
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=458.07 Aligned_cols=264 Identities=34% Similarity=0.566 Sum_probs=221.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-----~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
..+.|.+.+.||+|+||.|-+|.+++||+.||||++++..... .....+.+|++||++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 3467899999999999999999999999999999997643222 1233467999999999999999999999
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC---CcEEEcccC
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFG 171 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~lKL~DFG 171 (620)
++....|+||||++ |+|++.+..++.+.+...+.+++|||.||.|||+.||+||||||+|||++.+ +.+||+|||
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 45566899999999 6999999999999999999999999999999999999999999999999876 889999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCC-CCcccchHhHHHHHHHHHhCCCCCCCCChhH-HHHHhhhccCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGT 249 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~-y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~-~l~~i~~~lg~ 249 (620)
+|+... +..++.+.|||+.|.|||++.+.... |..++||||||||||-+|+|.+||.+..... ..+.|
T Consensus 325 lAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------ 394 (475)
T KOG0615|consen 325 LAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------ 394 (475)
T ss_pred hhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence 999864 23456789999999999998753233 4458999999999999999999998754221 11111
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.+.........|..+|+++++||.+||..||+.|||++|+|+||||+...
T Consensus 395 ----------------------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 395 ----------------------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ----------------------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 11112222345778999999999999999999999999999999999653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=454.63 Aligned_cols=258 Identities=34% Similarity=0.585 Sum_probs=230.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..+|+..+.||+|+|+.||.+++..+|+.||+|++.+. ..+.....++.+||+|.+.|+|||||+++++| +|..
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~ 91 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSN 91 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCC
Confidence 37899999999999999999999999999999999653 44556778899999999999999999999999 8889
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
++|||.|+|. ++|..+++.++.++|.++++|++||+.||.|||+.+|+|||||..|||++++.+|||+|||||.....+
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999 799999999999999999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.... .+.||||.|.|||++.. .+++..+||||+|||||.||+|+|||..++..+.+.+|...
T Consensus 172 ~Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------- 233 (592)
T KOG0575|consen 172 GERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------- 233 (592)
T ss_pred cccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------
Confidence 3332 56899999999999986 78999999999999999999999999998887777666431
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+ | .....+|.+++|||.+||..||.+|||++++|.|+||+.-.
T Consensus 234 --~----Y-------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 234 --E----Y-------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred --C----c-------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 0 0 01125789999999999999999999999999999995433
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=439.15 Aligned_cols=285 Identities=38% Similarity=0.664 Sum_probs=243.3
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|.-.+++|.|+||.||.|+...+++.||||++-.... --.+|+.+|+.++|||||+++.+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 47888999999999999999999999999999853211 123799999999999999999988765433345677
Q ss_pred EEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCccccccC
Q 007050 104 VVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFN 178 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~~~~~ 178 (620)
+|||||+.+|.++++. +..++.-+++-+.+||++||.|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999984 6789999999999999999999999999999999999999987 9999999999999776
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
..+. ..|..|++|+|||++.+. ..|+.++||||.||+++||+.|+++|+|.+..+|+..|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554 468899999999999874 78999999999999999999999999999999999999999999999999877
Q ss_pred hhchhHHHHHHhhhccCCCcccC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
--+-. . .......+..+.. .+...++++.+|+.++|.++|++|.++.|+|.||||+.+...
T Consensus 254 n~~y~--~--~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYT--E--FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred Ccccc--c--ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 32211 0 0111222233333 456789999999999999999999999999999999988664
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=434.91 Aligned_cols=294 Identities=38% Similarity=0.658 Sum_probs=251.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCC-CCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPS-RRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn-Iv~l~~v~~~~~-~~~~ 99 (620)
...|+.+++||+|+||+||+|+++.+|+.||+|++......+.--....||+.+|+.|+|+| |+++++++.... ++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45678888999999999999999999999999999865443333345679999999999999 999999996543 2334
Q ss_pred CeEEEEEecCCccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 100 KDIYVVFELMESDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
..+|+||||++.||..++.... .++...++.|++||+.||+|||+.+|+||||||+||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 5799999999999999998755 588889999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..-.. ..++..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.++.+|+..|++++|+|+.+.|
T Consensus 170 ~~ip~---~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPM---RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCc---ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 53222 225678999999999998874 57999999999999999999999999999999999999999999999999
Q ss_pred hhhhhchhHHHHHHhhhccC-CCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 SRVVRNDKARRYLTSMRKKQ-PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
..+........ ...... +..+....++.++.+.+|+.+||+.||.+|.|++.+|.||||..+..
T Consensus 246 p~v~~~~~~k~---~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKA---PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccc---cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 88753333221 222222 55566677888899999999999999999999999999999997643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=424.40 Aligned_cols=260 Identities=30% Similarity=0.525 Sum_probs=228.3
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.-..+.|+++++||+|+||+||.++.+.|++.||+|++++.. ....+.+.+.+|..||..++||+||+++..| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 345678999999999999999999999999999999997642 2234677889999999999999999999988 7
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|+|+||+. |+|+..|++.+.|++..+++|+.+|+.||.|||++|||||||||+|||+|.+|+++|+||||++..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 7788999999999 599999999999999999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
......+ .++|||+.|||||++.+ ..|+.++|+||||+++|+||+|.+||.+.+.....+.|...
T Consensus 176 ~~~~~~t---~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~---------- 240 (357)
T KOG0598|consen 176 LKDGDAT---RTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG---------- 240 (357)
T ss_pred ccCCCcc---ccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----------
Confidence 5443333 45899999999999988 69999999999999999999999999998876655555321
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCC-CCHHHHHHHHHhcccCCCCCC----CHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRP----TAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rp----sa~elL~hp~f~~~ 320 (620)
+ ....+. ++.++++||+++|..||++|. .++++-+||||.++
T Consensus 241 ------------------k----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 241 ------------------K----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ------------------c----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 0 112344 789999999999999999995 78999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-53 Score=421.02 Aligned_cols=341 Identities=36% Similarity=0.657 Sum_probs=293.7
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~ 97 (620)
|....||.-+..+|.|.- .|+.|.|..+++.||||+....+.....+.+..+|+.++..+.|+||++++.+|.+.. ..
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 455679999999999999 8999999999999999999888888788899999999999999999999999998763 35
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
++.+.|+|||+|..+|.+++. -.+..+.+.+|++|++.|++|||+.||+||||||+||+++.+|.+||+|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 578899999999999999998 358899999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
. ...+++|+.|++|+|||++.+ ..|.+.+||||+|||+.||++|..+|+|.+..+|+.+|.+.+|+|....+.+
T Consensus 170 ~----~~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 T----DFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred c----ccccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 2 246789999999999999988 5699999999999999999999999999999999999999999999999888
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPN------------ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 325 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~ 325 (620)
+ ....+.|+....+.....+...||+ -+..++||+.+||..||++|.|++++|+||||+-|. ..+
T Consensus 244 L--~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~-~~~ 320 (369)
T KOG0665|consen 244 L--QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY-DPD 320 (369)
T ss_pred h--hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec-ccc
Confidence 6 4566777776666555666555543 245789999999999999999999999999999443 233
Q ss_pred CCCCCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhCchhhhhhccc
Q 007050 326 EPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNG 371 (620)
Q Consensus 326 ~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~l~~~~~~ 371 (620)
++..++....+..++.+..+.++|+++|++|+.+|.+...-+.+++
T Consensus 321 ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~~~~~I~~~ 366 (369)
T KOG0665|consen 321 EVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEFNKNNIMNG 366 (369)
T ss_pred cccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcccccchhhcC
Confidence 4443333344556677888899999999999999998655555554
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=442.33 Aligned_cols=282 Identities=37% Similarity=0.639 Sum_probs=236.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-C-----CCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H-----PDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-H-----pnIv~l~~v~~~~~ 95 (620)
+.||.|++.||+|+||.|.+|.|..|++.||||++++. .....+...|+.||..|+ | -|+|+++++|..
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-- 259 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-- 259 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--
Confidence 45899999999999999999999999999999999863 455667778999999997 4 389999999954
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC--CcEEEcccC
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFG 171 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~lKL~DFG 171 (620)
.+++|||+|+++.+|+++|+.+. .|+...++.|+.|||.||.+||+.||||+|||||||||..- +.|||+|||
T Consensus 260 ---r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 260 ---RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ---ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 46799999999999999999876 68999999999999999999999999999999999999753 579999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
.|...... . ..|+.+++|+|||++.+ ..|+.++||||||||++||++|.|+|+|.++.+|+..|++++|.|+
T Consensus 337 SSc~~~q~----v--ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 337 SSCFESQR----V--YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccCCc----c--eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99764322 2 37899999999999998 7999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhchhHHHHHHh----------------------------hhcc--CC---CcccCCCC-CCCHHHHHHHHHh
Q 007050 252 LDTISRVVRNDKARRYLTS----------------------------MRKK--QP---VQFSQKFP-NADPSALRLLERL 297 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~----------------------------~~~~--~~---~~~~~~~~-~~s~~l~dLI~~m 297 (620)
...+....+. ..|++. .... .| ..+....+ .....+.|||++|
T Consensus 409 ~~mL~~~~~~---~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 409 PKMLDTAKKA---HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred HHHHHhcccc---ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 9887755322 222222 1111 11 11111222 2345679999999
Q ss_pred cccCCCCCCCHHHHHcCCcccCCCc
Q 007050 298 LAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 298 L~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
|.+||.+|+|+.++|+||||.+...
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred hccCchhcCCHHHHhcCcccccccc
Confidence 9999999999999999999996543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=417.55 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=220.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++.+.++.||+|..|+|++|+|+.|++.+|+|+|... ......+++.+|+++++.++||+||++|++|.... ..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceE
Confidence 3667789999999999999999999999999999543 45567788999999999999999999999995431 159
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||+ |+|..+++.-+.++|..+..|+.++++||.|||. .+||||||||+|||++..|+|||||||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 6999999988999999999999999999999995 99999999999999999999999999999887544
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC-----ChhHHHHHhhhccCCCChhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-----NVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~-----~~~~~l~~i~~~lg~p~~e~i 255 (620)
...+++||..|||||.+.+ ..|+.++||||||+.+.||.+|+.||+.. +..+.+..|.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----------- 295 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----------- 295 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-----------
Confidence 3467899999999999998 79999999999999999999999999764 2222222222
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
...+..+... .+|+++++||..||++||.+|+|+.|+|+|||++....
T Consensus 296 -----------------~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 296 -----------------DEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -----------------cCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 1122222111 37999999999999999999999999999999987543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=413.05 Aligned_cols=294 Identities=38% Similarity=0.625 Sum_probs=248.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
...|++++.||+|.||.||+|+.+.++. .+|||+++.......-.....||+.++|.|+||||+.+..+|+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 3469999999999999999997665543 689999986544444455678999999999999999999999753
Q ss_pred CCCeEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC----CcEEEc
Q 007050 98 DFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKIC 168 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~lKL~ 168 (620)
+..++++|||.+.||+++|+-+ ..++...++.|++||+.|++|||++.|+||||||.|||+..+ |.|||+
T Consensus 100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 4789999999999999999743 368999999999999999999999999999999999999988 899999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---------hhHH
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---------VVHQ 239 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~---------~~~~ 239 (620)
|||+++.+.+....-......+.|.||+|||++.+. ..|++++|+|++|||++|||+-+|+|.+.. ..+|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999876554433334567899999999999874 789999999999999999999999998753 4679
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCc-----ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQ-----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+++|++++|+|+.+.|..+.........+..++...... +...+..-++.+.+|+.+||++||.+|+|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 999999999999999998866666656666665443222 223445567779999999999999999999999999
Q ss_pred CcccCC
Q 007050 315 PYFKGL 320 (620)
Q Consensus 315 p~f~~~ 320 (620)
+||..-
T Consensus 338 ~yF~~d 343 (438)
T KOG0666|consen 338 PYFTED 343 (438)
T ss_pred cccccC
Confidence 999853
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=419.49 Aligned_cols=335 Identities=56% Similarity=0.990 Sum_probs=285.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||.|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35689999999999999999999999999999999976544445566778999999999999999999988665445556
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+||||+.++|.+++..++.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 79999999999999999888899999999999999999999999999999999999999999999999999998653321
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.....+.++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+.+|.+..+.+..+ .
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (337)
T cd07858 163 ---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI-R 237 (337)
T ss_pred ---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc-C
Confidence 223456789999999987642 35889999999999999999999999999988889999999999888776544 5
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHH
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 340 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 340 (620)
......+...+.......+...++++++.+.+||++||+.||++|||++|+|+||||..+.....++..+. .++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~ 315 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFE 315 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhh
Confidence 55566666554444444444556788999999999999999999999999999999998877766666543 5678888
Q ss_pred hhcCCHHHHHHHHHHHHHHhCc
Q 007050 341 RRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 341 ~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
+...++++++++++.|++.|||
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 316 EDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhcCHHHHHHHHHHHHhhcCC
Confidence 8889999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=426.28 Aligned_cols=261 Identities=31% Similarity=0.557 Sum_probs=227.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (620)
...+|.+++.||.|+|++|++|+++.+++.||||++.+..- .......+.+|-.+|.+| .||.|++|+..| +|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 35689999999999999999999999999999999875422 222344567899999999 799999999998 77
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+|+||++ |+|.++|+.-+.|++..+++|..||+.||+|||++|||||||||+|||++.|+++||+|||.|+.+.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 788999999999 7999999999999999999999999999999999999999999999999999999999999998864
Q ss_pred CCCCc----------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 178 NDTPT----------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 178 ~~~~~----------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
..... ......+|||..|.+||++.. ...++.+|||+||||||.|+.|.+||.+.++...+++|+++-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 33221 111255899999999999987 678899999999999999999999999999888888776531
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..| -++.++.++|||+++|..||++|+|+++|-+||||.++
T Consensus 304 -----------------------------y~f---p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 304 -----------------------------YEF---PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred -----------------------------ccC---CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 111 24567899999999999999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=409.57 Aligned_cols=287 Identities=35% Similarity=0.644 Sum_probs=239.8
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
|+..++|++++.||.|+||.||+|.++.++..||+|++..... ......+.+|+.+++.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDII-----HT 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cC
Confidence 5777899999999999999999999999999999999875321 22334567899999999999999999998 44
Q ss_pred CCeEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+||||+.++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 56799999999999999987654 57999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....++++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2221 12445789999999988652 5689999999999999999999999999999999999999999999988877
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
+........+.. ......+.....+.++++++|||.+||++||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYLF--PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhcccc--CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 644443333221 1111222223446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=410.05 Aligned_cols=257 Identities=33% Similarity=0.513 Sum_probs=221.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..+|.+.+.||+|+||+||+|+++.++..||||.|.+........+.+..||++|+.++|||||+++++. +..+.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 4579999999999999999999999999999999987644566677788999999999999999999998 55568
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC------CcEEEcccCccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN------CKLKICDFGLAR 174 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~------~~lKL~DFGlA~ 174 (620)
+|+|||||+ |||.++|+..+.+++..++.|+.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999 7999999999999999999999999999999999999999999999999875 469999999999
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
..... ....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+..
T Consensus 164 ~L~~~----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k--------- 228 (429)
T KOG0595|consen 164 FLQPG----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK--------- 228 (429)
T ss_pred hCCch----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---------
Confidence 87532 34567899999999999976 7999999999999999999999999988776655443321
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.......+ ...++...+|+..+|+.+|..|.+.++-+.|+++..
T Consensus 229 ---------------------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 229 ---------------------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ---------------------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 00011111 124566779999999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=402.81 Aligned_cols=260 Identities=31% Similarity=0.470 Sum_probs=219.2
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
......|+|++.||+|+||.||++++..+|+.+|.|.|+-..-+....+.+..||.+|++|+|||||++++.-+. ++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~ 91 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---ED 91 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---cc
Confidence 345567999999999999999999999999999999998555566677788999999999999999999883322 33
Q ss_pred CCeEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeecCCCCceEeCCCCcEEEcc
Q 007050 99 FKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHT--AN--VYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs--~g--IvHrDLKP~NILl~~~~~lKL~D 169 (620)
..-++||||||+ |||.+.|+. +..++|..+|.++.|+|.||.+||+ .+ |+||||||.||+++.+|.|||+|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 345999999999 799999963 4579999999999999999999999 45 99999999999999999999999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
|||++..... +.+.+.++|||+||+||++.+ ++|+.++|||||||++|||+.-.+||.|.+..+...+|.+. .
T Consensus 172 fGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d- 244 (375)
T KOG0591|consen 172 FGLGRFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-D- 244 (375)
T ss_pred chhHhHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-C-
Confidence 9999987433 345678999999999999988 79999999999999999999999999999776655555431 0
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
+...+ .-+|..+..||..|+..||+.||+. +|++.++.+
T Consensus 245 -----------------------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 245 -----------------------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred -----------------------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 11111 1357889999999999999999997 666665543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=417.61 Aligned_cols=292 Identities=44% Similarity=0.770 Sum_probs=242.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|++++.||+|+||.||++.+..+++.||||++...........++.+|+.+|+.++||||+++++++.......+..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999976555555667889999999999999999999998655433445799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 104 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
+||||+.++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986532221
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
...+..++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+.... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~--~~ 235 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC--EG 235 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh--HH
Confidence 223456789999999988752 458999999999999999999999999999999999999999999987765542 12
Q ss_pred HHHHHHhhhccCCC--cccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 264 ARRYLTSMRKKQPV--QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 264 ~~~~~~~~~~~~~~--~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...++.......+. .........++++.+||.+||++||++|||++|+|+||||.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 22222221111111 0011234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=393.88 Aligned_cols=259 Identities=30% Similarity=0.511 Sum_probs=226.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|++.+.||+|.|++|+++.+..||+.+|+|+|+.......+.+.+.+|+.|-+.|+||||+++.+.+ .+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 3579999999999999999999999999999999975444445778899999999999999999999987 56678
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC---CcEEEcccCcccccc
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~lKL~DFGlA~~~~ 177 (620)
.|+|||+|.| +|+.-|.++.-++|..+..+++|||.+|.|+|.+||||||+||+|+|+-+. .-|||||||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999995 999888887788999999999999999999999999999999999998654 459999999998765
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
....|..++|||.|||||++.. ..|+..+|||+.|||||-||.|.+||.+.+..+.++.|+.
T Consensus 165 ----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~------------ 226 (355)
T KOG0033|consen 165 ----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA------------ 226 (355)
T ss_pred ----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc------------
Confidence 2345788999999999999987 7999999999999999999999999988776555555532
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.........|+.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 227 ----------------g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 ----------------GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 2222233478999999999999999999999999999999999985
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=410.45 Aligned_cols=326 Identities=41% Similarity=0.793 Sum_probs=261.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (620)
..++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999999999999999997654444455678899999999999999999998754322 334
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+++|++.++|.++++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred CcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 56899999999999888764 56999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.+.++||++|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+..+
T Consensus 172 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (343)
T cd07878 172 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI- 243 (343)
T ss_pred ------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc-
Confidence 2456899999999998652 46899999999999999999999999999999999999999999888877665
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 339 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 339 (620)
.......++..+.......+...+...++.+.+||.+||..||++|||+.|+|+||||..+......+...+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~~ 320 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DESP 320 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccch
Confidence 4444555555544433334444556778899999999999999999999999999999987655443333222 1122
Q ss_pred HhhcCCHHHHHHHHHHHHH
Q 007050 340 ERRRVTKEDIRELIFREIL 358 (620)
Q Consensus 340 e~~~~~~e~~~~~~~~ei~ 358 (620)
+....+.+++++..+.+..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07878 321 ENKERTIEEWKELTYEEVS 339 (343)
T ss_pred hhhhccHHHHHHHHHHHHH
Confidence 2334445666666555543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=410.82 Aligned_cols=328 Identities=35% Similarity=0.645 Sum_probs=258.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357999999999999999999999999999999999866555566778889999999999999999999886542 2344
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 67899999999999988864 4889999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+..+.
T Consensus 180 ----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 180 ----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ----CcccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 12245689999999999977 679999999999999999999999999999999999999999998877655541
Q ss_pred hchhHHHHHHhhhccCCCcccC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQ------------KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 327 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~ 327 (620)
.....+...........+.. .....+..+++||.+||+.||.+|||++|+|+||||..+......+
T Consensus 254 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 254 --PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred --HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 12223322222111111111 1122456899999999999999999999999999998776554433
Q ss_pred CCCCCcchhhhHHhhcCCHHHHHHHHHHHHHH
Q 007050 328 SCQPISKMEFEFERRRVTKEDIRELIFREILE 359 (620)
Q Consensus 328 ~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~ 359 (620)
...+.. -+...+.+..+.+++++.++.+.++
T Consensus 332 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 332 APPPKI-PDKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCCCC-CCccchhhhccHHHHHHHHHHHHHc
Confidence 222211 1112334456777888887777643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=407.50 Aligned_cols=334 Identities=51% Similarity=0.878 Sum_probs=274.2
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...++|++.+.||+|+||.||+|++..+|+.||||++... .......++.+|+.+++.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 3457899999999999999999999999999999998642 233445667899999999999999999998876655566
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+|+||+.++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 77999999999999988854 46999999999999999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..........+|++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+.+.++.|..+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI- 237 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh-
Confidence 3222233456889999999987542 46889999999999999999999999999999999999999999988877666
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 339 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 339 (620)
.....+.++..........+....+..++.+.+||.+||+.||++|||+.|+|+||||+.+.....++..++...++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFEL 317 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhcc
Confidence 34444555544444444444445567889999999999999999999999999999999988766666554444444443
Q ss_pred HhhcCCHHHHHHHHHHHHH
Q 007050 340 ERRRVTKEDIRELIFREIL 358 (620)
Q Consensus 340 e~~~~~~e~~~~~~~~ei~ 358 (620)
. ..+.++.++++|+.+|.
T Consensus 318 ~-~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 318 F-DDLPKEKLKELIFEEIM 335 (336)
T ss_pred c-cccCHHHHHHHHHHHhc
Confidence 3 45568889999988874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=416.10 Aligned_cols=264 Identities=29% Similarity=0.479 Sum_probs=223.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|+++++||+|+||.||+|+.+.||+.||+|++++.. ........+..|-.||....+|.||+++-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 4678999999999999999999999999999999998642 2334567788899999999999999999998 777
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.++||||||++ ||+..+|...+.|+++++++++.+++.||..||+.|+|||||||+|+|||..|++||+||||+.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 89999999999 59999999999999999999999999999999999999999999999999999999999999853211
Q ss_pred C-----------------------CCc--cc-------------------ccccccCCccccCcccccccCCCCCcccch
Q 007050 179 D-----------------------TPT--TI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (620)
Q Consensus 179 ~-----------------------~~~--~~-------------------~~~~~~gt~~Y~APEvl~~~~~~y~~~~DI 214 (620)
. ... .. .....+|||.|+|||++.+ .+|+..+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 000 00 0123589999999999998 789999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHH
Q 007050 215 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 294 (620)
Q Consensus 215 WSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI 294 (620)
||||||+||||.|.|||.+.+..+.+..|...- .. ..+.. -..++++++|||
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------------~~------l~fP~-~~~~s~eA~DLI 423 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------------ET------LKFPE-EVDLSDEAKDLI 423 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------------hh------ccCCC-cCcccHHHHHHH
Confidence 999999999999999999999887777665420 00 00111 124678999999
Q ss_pred HHhcccCCCCCC---CHHHHHcCCcccCC
Q 007050 295 ERLLAFDPKDRP---TAEEALADPYFKGL 320 (620)
Q Consensus 295 ~~mL~~DP~~Rp---sa~elL~hp~f~~~ 320 (620)
.+||. ||++|. +++||-+||||+++
T Consensus 424 ~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 424 TRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999 999997 59999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=416.91 Aligned_cols=258 Identities=33% Similarity=0.536 Sum_probs=218.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC--C-hHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--H-ISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 96 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--~-~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (620)
..++|++.+.||+|+||+|++|.+..++..||+|++.+... . ......+.+|+.+++.++ ||||+++++++.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---- 90 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---- 90 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe----
Confidence 45689999999999999999999999999999997765311 1 134456678999999999 999999999994
Q ss_pred CCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCccc
Q 007050 97 RDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLAR 174 (620)
Q Consensus 97 ~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~ 174 (620)
....+|+|||||.| +|++.|...+++.|.+++.+++||+.||+|||+.||+||||||+|||++.+ +.+||+|||++.
T Consensus 91 -t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 91 -TPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred -cCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 44569999999995 999999998999999999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCC-CC-cccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~-y~-~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
... .....+.+.|||+.|+|||++.+ .. |+ .++||||+|+|||.|++|..||...+....+..|..
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 763 12234578899999999999987 34 64 789999999999999999999988665444333211
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
....+...+. |+++++||.+||..||.+|+|+.+++.||||+.
T Consensus 238 ----------------------~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ----------------------GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----------------------CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1111111111 999999999999999999999999999999996
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=409.83 Aligned_cols=294 Identities=37% Similarity=0.694 Sum_probs=241.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (620)
..++|++++.||+|+||.||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457999999999999999999999999999999999765555566777889999999999999999999986543 2344
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 57899999999999888753 5899999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|..+.+....
T Consensus 177 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 177 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 1 2245688999999999977 689999999999999999999999999999999999999999999887765542
Q ss_pred hchhHHHHHHhhhccCCCcccCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKF------------PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~ 324 (620)
. ....+...........+.+.+ ...++.+++||.+||..||++|||+.|+|+||||..+....
T Consensus 251 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 251 P--TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred H--HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 1 222232222211111221111 12467899999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=369.03 Aligned_cols=286 Identities=39% Similarity=0.640 Sum_probs=244.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|.-.++||+|.||+||+|+++.+++.||+|.+.....++.-....+|||.+|+.|+|.|||+++++. ...+.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 56778899999999999999999999999999976544444556788999999999999999999998 4457799
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+|||+|..+|..+... ++.+..+.++.++.|+++||.|+|+.++.||||||+|+||+.+|++||+|||+++...-.
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9999999999999875 678999999999999999999999999999999999999999999999999999875322
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
...+...+.|.||++|.++.+. .-|+..+|+||.|||++|+.. |+++|+|.+..+|+.+|+.++|.|+.+.|..+..-
T Consensus 155 vrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 1224556889999999998874 679999999999999999986 88999999999999999999999999999887543
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..+..| ..-.....+++..|.++...+||++++|.-+|..|++++.+|+||||.+..
T Consensus 234 pdyk~y---p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 234 PDYKPY---PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCccc---CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 322211 001112234556677888899999999999999999999999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=402.91 Aligned_cols=291 Identities=34% Similarity=0.579 Sum_probs=230.1
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
||..++|++++.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+++.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDII-----HT 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEE-----ec
Confidence 6888999999999999999999999999999999999875322 22234567899999999999999999998 44
Q ss_pred CCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+|||||.++|.+.+..+ +.++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 5679999999999999888764 568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~-~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ......++|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+. +..+++..+...++.|..+.+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 221 112456789999999988652 46889999999999999999999999875 4456777777778888766655
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
......... ........+..+...+ ...++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus 231 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLPHFK--PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhccccc--cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 432110000 0000000111111111 13467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=388.34 Aligned_cols=253 Identities=28% Similarity=0.522 Sum_probs=224.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||.|+||.|.+++++.+|..||+|++++. .-.....+...+|..+|+.+.||++++++..+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 35789999999999999999999999999999999753 23445667788999999999999999999988 6778
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+||||.+ |.|+.++++.++|++.++++++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 8999999999 599999999999999999999999999999999999999999999999999999999999999987544
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. .+.||||.|+|||++.+ .+|+.++|+|||||++|||+.|.+||...+....+++|.+-
T Consensus 198 T------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------- 256 (355)
T KOG0616|consen 198 T------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------- 256 (355)
T ss_pred E------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------
Confidence 2 45799999999999988 79999999999999999999999999998887777666431
Q ss_pred hchhHHHHHHhhhccCCCcccCCC-CCCCHHHHHHHHHhcccCCCCC-----CCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~R-----psa~elL~hp~f~~~ 320 (620)
. -.| +-++++++|||+++|+.|-.+| ...+++..||||+++
T Consensus 257 -~-------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 257 -K-------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred -c-------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 0 012 2468899999999999999999 367899999999964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=415.52 Aligned_cols=256 Identities=34% Similarity=0.584 Sum_probs=230.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|-+.+.||+|+||.||+|+.+.+.+.||||.+.+......+...+.+|+.|++.|+|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 679999999999999999999999999999999998888888999999999999999999999999998 777889
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 103 YVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
|+|.|||.|+|+.++...+.++|+.++.|.++++.||.|||+.+|+|||+||.|||++.+|.+|+||||+|+.... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998643 3
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
+...+..-|||.|||||+..+ ..|+..+|+||||||+|||..|+|||...+..+....|..
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 445677889999999999987 7999999999999999999999999977665544443321
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+..+ ....+..+++||+.+|.+||.+|+|-.++|.|||.++-
T Consensus 215 ------------d~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 215 ------------DPVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ------------CCCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 11111 23678999999999999999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=392.65 Aligned_cols=289 Identities=42% Similarity=0.737 Sum_probs=248.2
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+--+.||.|+||+||.+.|..+|+.||+|++.+.+......+++.+|+++|.-++|.|++..+++..++...-+..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999999999999999999888888888999999999999999999999999887766667889999
Q ss_pred EecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 106 FELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 106 ~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
+|+|..||+.+|..-..++.++++-|++||++||+|||+.||.||||||.|+|++++|.+||||||+|+....+.. ..
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LN 213 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh--hh
Confidence 9999999999999988999999999999999999999999999999999999999999999999999998654433 34
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
++..+.|.+|+|||++.+. ..|+.++||||+|||+.|||..+.+|...+..+|++.|++++|+|+.|.+..- ..+...
T Consensus 214 MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A-CEGAk~ 291 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA-CEGAKN 291 (449)
T ss_pred hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH-hhhhHH
Confidence 5777899999999998874 78999999999999999999999999999999999999999999999977544 222212
Q ss_pred HHHHhhhccCCCcccCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFP-----NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~-----~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+... .++..+...+. ....+..+++.+||.+||.+|++.+++|.|+|+...
T Consensus 292 H~LR~~--~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAG--LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccC--CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 222111 11222222221 234578999999999999999999999999998653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=419.13 Aligned_cols=261 Identities=30% Similarity=0.489 Sum_probs=226.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..+-|++++.||.|+.|.|.+|.+..||+.+|||+|.+.. ........+.+||-||+.+.|||+++++++| ++.
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~ 84 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENK 84 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccC
Confidence 4457999999999999999999999999999999997652 3334566789999999999999999999999 677
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.++|+|.||+. |.|++++..++++++.++.+|++||+.|+.|||..+|+||||||+|+|++..+.+||+|||+|....+
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 88999999999 69999999999999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...+.+.||++.|.|||++.+. ...+.++||||+|||||.||+|+.||.+.|....+.++..
T Consensus 165 ----gklLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------------- 226 (786)
T KOG0588|consen 165 ----GKLLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------------- 226 (786)
T ss_pred ----CccccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------
Confidence 2346788999999999999883 3346799999999999999999999987665444433321
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
.. .+...++++++++||.+||.+||.+|+|.+||++|||+.+....
T Consensus 227 ---------------G~----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 227 ---------------GV----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ---------------Cc----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 11 01124789999999999999999999999999999999987543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=394.10 Aligned_cols=285 Identities=35% Similarity=0.646 Sum_probs=227.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 479999999999999999999999999999999976544444456778999999999999999999988 455679
Q ss_pred EEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+++++.+.+. ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999999976655554 345799999999999999999999999999999999999999999999999999986533221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||++.+..+.+..+....+....+.+..+..+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1245679999999999876 57899999999999999999999999998888887777777776665544433221
Q ss_pred hhHHHHHHhhhccCCCcc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
......... ....+... ......++..+.+||++||++||++|||++|+|+||||
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFP-AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccC-cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111000000 00000000 11123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=402.69 Aligned_cols=292 Identities=37% Similarity=0.681 Sum_probs=239.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||++...........++.+|+.+++.++||||+++++++.... ..+.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357999999999999999999999999999999999866555566778889999999999999999999986543 2344
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+|||||+++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 57899999999999888864 4899999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|..+.+..+
T Consensus 173 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 245 (355)
T cd07874 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 245 (355)
T ss_pred c----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-
Confidence 1 2245689999999999876 67999999999999999999999999999999999989888888887766544
Q ss_pred hchhHHHHHHhhhccCCCcc-----------c-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 260 RNDKARRYLTSMRKKQPVQF-----------S-QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~-----------~-~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
......+...........+ . ......+..+++||.+||..||++|||+.|+|+||||..+..
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 -QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred -cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 1222233222111111000 0 111234678899999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=401.19 Aligned_cols=329 Identities=53% Similarity=0.957 Sum_probs=276.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++.... .+...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 47899999999999999999999999999999999765444455667889999999999999999999875443 34567
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 102 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
+|+||||+.++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 83 VYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999976543222
Q ss_pred c-ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 182 T-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 182 ~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .......+++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|..+.+..+ .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~-~ 240 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI-G 240 (334)
T ss_pred CCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh-c
Confidence 1 1222456899999999987652 45899999999999999999999999999999999999999999998887766 4
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHH
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 340 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 340 (620)
.+....++..........+...++..++.+.+||++||+.||.+|||++++|.||||.+....+.++.+.+ ..+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDFE 318 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCC--CCCCChh
Confidence 44555555555555555555666788999999999999999999999999999999999888777766543 4566677
Q ss_pred hhcCCHHHHHHHHHH
Q 007050 341 RRRVTKEDIRELIFR 355 (620)
Q Consensus 341 ~~~~~~e~~~~~~~~ 355 (620)
....+.|.+.+.|.+
T Consensus 319 ~~~~~~~~~~~~~~~ 333 (334)
T cd07855 319 AIELSREQLKEAIVK 333 (334)
T ss_pred hhhcChhhHHHHhhc
Confidence 777777777766643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=391.26 Aligned_cols=284 Identities=34% Similarity=0.585 Sum_probs=230.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~ 98 (620)
++|++++.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 467899999875433333344566787777765 6999999999986544345
Q ss_pred CCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999998753 35899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.|..+.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1234578999999999876 678999999999999999999999999999999999999888888766554
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
....... . .........+....+.+++.+++||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPR--Q---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccc--h---hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 3311100 0 111122223334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=393.26 Aligned_cols=291 Identities=37% Similarity=0.670 Sum_probs=240.8
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
|+..++|.+++.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++.++||||+++++++ .+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIV-----HT 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEE-----ee
Confidence 6778899999999999999999999999999999999875322 22334567899999999999999999998 34
Q ss_pred CCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
....|+||||++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 5679999999999999988764 458999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12345789999999988652 4689999999999999999999999999999999999999999999888776
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+........+ ......+..+....+.+++++++||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhh--hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 5332222111 1112222233345567899999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=396.93 Aligned_cols=330 Identities=56% Similarity=0.967 Sum_probs=280.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||.|++|.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667888999999999999999999998665434456799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 104 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
+||||+.++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765433211
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
.......++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|..+.+... ....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~ 238 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI-TSEK 238 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc-cccc
Confidence 223456789999999998762 37899999999999999999999999999999999999999999988877654 4556
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHHhhc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRR 343 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~ 343 (620)
...++..........+....+.++..+.+||.+||++||.+|||++++|.||||+++.....++......++. .++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 317 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDE 317 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhh
Confidence 6666666666666666667788999999999999999999999999999999999988777666555444331 346667
Q ss_pred CCHHHHHHHHHHH
Q 007050 344 VTKEDIRELIFRE 356 (620)
Q Consensus 344 ~~~e~~~~~~~~e 356 (620)
+++++.+++|+.|
T Consensus 318 ~~~~~~~~~~~~~ 330 (330)
T cd07834 318 LTEEELKELIYEE 330 (330)
T ss_pred cCHHHHhHHhhcC
Confidence 8899999888653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=408.23 Aligned_cols=286 Identities=36% Similarity=0.625 Sum_probs=229.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---CC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---RD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~---~~ 98 (620)
..+|++++.||+|+||.||+|++..+++.||||++.... ....+|+.+|+.++||||+++++++..... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 468999999999999999999999999999999885421 223479999999999999999998754322 22
Q ss_pred CCeEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCcc
Q 007050 99 FKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLA 173 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGlA 173 (620)
...+|+|||||.++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999998887775 345799999999999999999999999999999999999999765 7999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+....... ...++||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+...+|.|..+
T Consensus 219 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred hhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 86543222 2356889999999987652 468999999999999999999999999999999999999999999887
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.+..+. .....+ .+....+..+...+| ..++++++||.+||++||.+|||+.|+|+||||..+..
T Consensus 294 ~~~~~~--~~~~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMN--PNYADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhc--hhhhcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 665431 110000 000011111112222 46789999999999999999999999999999987654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=394.33 Aligned_cols=330 Identities=44% Similarity=0.838 Sum_probs=278.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (620)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+.||||+++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999999999999999987654444456678899999999999999999988754432 334
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 56899999999999999875 46999999999999999999999999999999999999999999999999999765322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
...+.++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.|..+.+.++
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 243 (343)
T cd07851 172 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI- 243 (343)
T ss_pred ------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc-
Confidence 2445789999999987642 46789999999999999999999999999988889999998998888777766
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 339 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 339 (620)
..+....+...+.......+...+...++.+.+||.+||..||++|||+.|+|+||||..+...+.++...+ ...++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~---~~~~~ 320 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPP---YDQSF 320 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccc---cCcch
Confidence 556666776666666555566666778999999999999999999999999999999998877665554222 23456
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCc
Q 007050 340 ERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 340 e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
+...+..++++++++.++.+|.|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 321 ESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhhhcCHHHHHHHhHHHHHhccC
Confidence 77888999999999999988765
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=384.63 Aligned_cols=283 Identities=35% Similarity=0.595 Sum_probs=228.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+|++++.||+|+||.||+|.++.+++.||+|.+............+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875432222233455677776655 799999999998655444456
Q ss_pred eEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+++|||++.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999988764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. ......+|..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|..+.+...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cc----cCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 21 1234578999999999876 67999999999999999999999999999888888888888877766544322
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..... .......+.......+.++..+.+||.+||+.||++|||++|+|.||||
T Consensus 235 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR-----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc-----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11000 0011112222334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=404.37 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=222.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
...|...+.||+|+.|.||.|....+++.||||.+... .....+-+++|+.+|+.++|+|||++++.|+.. ..
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ce
Confidence 46788899999999999999999999999999999753 333455688999999999999999999998543 67
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ |+|.+++... .++|.++..|++++|.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 345 LWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999 5888888654 59999999999999999999999999999999999999999999999999998775444
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ...+.+||++|||||++.. ..|++++||||||++..||+-|++||-..+....+.+|.. -|+|.
T Consensus 424 ~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~--------- 488 (550)
T KOG0578|consen 424 S---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPK--------- 488 (550)
T ss_pred C---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCC---------
Confidence 3 3467899999999999987 7899999999999999999999999987777666666643 22222
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
......+|+.++|||.+||++|+.+|++|.|||+||||+.
T Consensus 489 -------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 489 -------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 2234568999999999999999999999999999999953
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=391.22 Aligned_cols=325 Identities=38% Similarity=0.676 Sum_probs=255.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 468899999999999999999999999999999998765555556677889999999999999999999886542 2344
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
...|+|||||.++|.+.+... +++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 678999999999999988654 899999999999999999999999999999999999999999999999999865332
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...++.|..+....+.
T Consensus 172 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 172 FM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 21 234578899999999876 679999999999999999999999999999999999999999999887655441
Q ss_pred hchhHHHHHHhhhccCCCcccCC-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQK-------------FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 326 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~ 326 (620)
.....+...........+... ....+..+++||.+||+.||++|||+.|+|.||||+.+......
T Consensus 246 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~ 323 (353)
T cd07850 246 --PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV 323 (353)
T ss_pred --hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence 111222221111111111111 11346678999999999999999999999999999987654332
Q ss_pred CCCCCCcchhhhHHhhcCCHHHHHHHHHHH
Q 007050 327 PSCQPISKMEFEFERRRVTKEDIRELIFRE 356 (620)
Q Consensus 327 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 356 (620)
....+ ...+...+.+..+.+++++.++.+
T Consensus 324 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 324 EAPPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCCC-CccccccccccccHHHHHHHHHhh
Confidence 22111 122333455667778887766654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=374.00 Aligned_cols=263 Identities=30% Similarity=0.493 Sum_probs=220.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-----CCh-HHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-----EHI-SDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-----~~~-~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (620)
...|.-.+.||+|..++|.+++++.+|..+|+|+|.... ... .-.+...+|+.||+++ .||+|+.+.++|
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--- 92 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--- 92 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec---
Confidence 356778899999999999999999999999999995321 111 1234456899999998 599999999999
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
+....+++|||+|. |.|++++...-.+++++...|++||+.|+.|||.++||||||||+|||++++.++||+|||+|
T Consensus 93 --es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 93 --ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred --cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 45556899999999 899999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCccccccc----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~----~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
...... ..+.+.||||.|+|||.+.+. ..+|+..+|+|++|+|+|.||.|.+||..+...-.+..|++
T Consensus 171 ~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime---- 242 (411)
T KOG0599|consen 171 CQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME---- 242 (411)
T ss_pred eccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh----
Confidence 876433 345788999999999987542 24699999999999999999999999966544333333322
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.....-+..|.++|..++|||.+||+.||.+|+|++|+|.||||.++.
T Consensus 243 ------------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 243 ------------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ------------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 112223456889999999999999999999999999999999997654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=398.63 Aligned_cols=281 Identities=25% Similarity=0.346 Sum_probs=221.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.+|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+.+|+.|+||||+++++++. .....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCee
Confidence 57999999999999999999999999999999753 234678999999999999999999983 44568
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 103 YVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
|+|||++.++|..++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999975332211
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC-------ChhHHHHHhhhccCCCChhhh
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~-------~~~~~l~~i~~~lg~p~~e~i 255 (620)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+. +...++..+...+|.+..+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11245689999999999976 67999999999999999999999776543 234567777777776654322
Q ss_pred hhhhhchhHHHHH-HhhhccCCCc----ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 SRVVRNDKARRYL-TSMRKKQPVQ----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 ~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
... .......+ .........+ .......++.++.+||.+||++||++|||++|+|+||||+.+..
T Consensus 315 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 315 IDA--QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred cch--hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 111 01111111 1111111000 00111245678999999999999999999999999999987644
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=385.37 Aligned_cols=282 Identities=35% Similarity=0.600 Sum_probs=219.2
Q ss_pred EEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
.++||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence 468999999999999975 467899999986532 123467899999999999999999988543 34578999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----CCCCcEEEcccCc
Q 007050 106 FELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (620)
Q Consensus 106 ~E~~~gdL~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~lKL~DFGl 172 (620)
|||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999988632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------hHHHHHh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VHQLDLM 243 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~---------~~~l~~i 243 (620)
++...............++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98754332222223456899999999988652 4689999999999999999999999976542 4678888
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccCCC--c----ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPV--Q----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
...+|.|....+..+................... . +.......+..+.+||.+||++||++|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8899999887776653222222222221111000 0 011122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=383.82 Aligned_cols=275 Identities=29% Similarity=0.426 Sum_probs=226.0
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...+.|++.++||.|..++||+|+...+++.||||++.....+ .+...+.+|+..|+.++||||++++..|.. .
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-----~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVV-----D 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEe-----c
Confidence 3567899999999999999999999999999999999754333 447889999999999999999999999954 4
Q ss_pred CeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..+|+||.||. |++.++++.. ..++|..+..|++++|+||.|||.+|.||||||+.||||+++|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 57999999999 7999999863 35999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCCccccc-ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~-~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
.......... ..++||++|||||++...-.+|+.|+||||||+...||.+|..||........+ +..+-+.|..-..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 6544333333 778999999999996544478999999999999999999999999776554432 2333344431111
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
... . .+....++..++.+|..||+.||.+||||+++|+|+||+....
T Consensus 255 ~~~-~-------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGL-D-------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccC-C-------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 100 0 0111234668999999999999999999999999999997543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=383.72 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=214.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 47999999999999999999999999999999986431 1223456678999999999999999999887 45578
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--------------- 212 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--------------- 212 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 23579999999999877 6789999999999999999999999987665443333211
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. ... .....++.+++||++||+.||.+|++ ++|+++||||+.+
T Consensus 213 -------------~-~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 213 -------------G-KLE---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred -------------C-CcC---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0 000 11245789999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=407.31 Aligned_cols=285 Identities=27% Similarity=0.436 Sum_probs=224.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC------CcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP------DIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hp------nIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++|. +|+++++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 468999999999999999999999999999999996431 2233455677777777554 57888887732
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCC-----------
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANC----------- 163 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~----------- 163 (620)
+...+|+|||++.++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 33579999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----cEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhH
Q 007050 164 -----KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238 (620)
Q Consensus 164 -----~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~ 238 (620)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754221 1245689999999999987 689999999999999999999999999999999
Q ss_pred HHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCc----cc-----CCC--CCCCHHHHHHHHHhcccCCCCCCC
Q 007050 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQ----FS-----QKF--PNADPSALRLLERLLAFDPKDRPT 307 (620)
Q Consensus 239 ~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~--~~~s~~l~dLI~~mL~~DP~~Rps 307 (620)
++..|...+|.+..+..... .....+.++.......+.. +. ..+ ...++.+.|||.+||++||++|||
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhc-cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 99999999998876654432 2222223322211111000 00 000 012567889999999999999999
Q ss_pred HHHHHcCCcccCCCc
Q 007050 308 AEEALADPYFKGLSK 322 (620)
Q Consensus 308 a~elL~hp~f~~~~~ 322 (620)
++|+|+||||..+..
T Consensus 432 a~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 432 ARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHhcCccccccCC
Confidence 999999999997654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=386.28 Aligned_cols=263 Identities=30% Similarity=0.457 Sum_probs=212.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..+|...+.||+|+||.||++.++.+|..+|||.+... +......+.+|+.+|+.|+|||||++++..... ++ ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-ee
Confidence 45688999999999999999999999999999998754 222266788999999999999999999964221 11 46
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~~~~ 178 (620)
++|+|||+. |+|.++++..+ .|++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999 69999999876 7999999999999999999999999999999999999999 79999999999987653
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~-~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
............||+.|||||++... ..-..++|||||||++.||+||++||... .....+-.|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i-------------- 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI-------------- 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--------------
Confidence 11221223457899999999999841 22335999999999999999999999763 111111111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.... . .......+++++++||.+||.+||++||||+++|+|||.+..
T Consensus 236 -------------g~~~-~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 236 -------------GRED-S--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------hccC-C--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0011 0 112334589999999999999999999999999999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=389.73 Aligned_cols=266 Identities=27% Similarity=0.449 Sum_probs=217.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc------------CChHHHHHHHHHHHHHHhcCCCCcceee
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF------------EHISDAARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~------------~~~~~~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
.-++|++++.||+|.||+|.+|++..+++.||||++.+.. ......+++.+||.||++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999999999999999996421 1122346789999999999999999999
Q ss_pred eEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEE
Q 007050 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lK 166 (620)
++.-++ ....+|||+|||. |.+. +....++ +++.+++.|+++++.||.|||.+||+||||||+|+||+++|+||
T Consensus 175 EvLDDP---~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCc---ccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 998544 4578999999999 4443 3333344 99999999999999999999999999999999999999999999
Q ss_pred EcccCccccccCC--CCcccccccccCCccccCcccccccC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007050 167 ICDFGLARVAFND--TPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (620)
Q Consensus 167 L~DFGlA~~~~~~--~~~~~~~~~~~gt~~Y~APEvl~~~~--~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~ 242 (620)
|+|||.+...... ......+...+|||.|+|||+|.+.. ...+.+.|||||||+||.|+.|+.||-+....+..++
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998754221 12222344579999999999987621 2356789999999999999999999988887777776
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
|.+. +..| ...+.+.+.++|||.+||.+||++|++..++..|||...-
T Consensus 331 Ivn~-----------------------------pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 IVND-----------------------------PLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HhcC-----------------------------cccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 6541 1111 2235678899999999999999999999999999998754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=381.14 Aligned_cols=291 Identities=36% Similarity=0.661 Sum_probs=236.5
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
|+..++|++++.||.|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++ .+
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~ 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDII-----HT 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEE-----ec
Confidence 56678999999999999999999999999999999998643221 2234567899999999999999999998 44
Q ss_pred CCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 5679999999999999988753 468999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2221 12344678999999987652 4688899999999999999999999999998889999999899888777665
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+........+. .............+.+++.+++||.+||+.||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKSYN--YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccccc--cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 53322211110 000011111223356788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=394.15 Aligned_cols=261 Identities=33% Similarity=0.533 Sum_probs=225.8
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~ 97 (620)
.....|++.+.||+|.||+||+|+++.+|+.+|+|++.+.... ..+...+.+|+.+|+.+. |||||.++++| +
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----E 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 3456899999999999999999999999999999999765332 224567889999999998 99999999999 5
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC----CcEEEcccCc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKICDFGL 172 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~lKL~DFGl 172 (620)
+...+|+|||+|. |+|++.|... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 6678999999999 6999999876 49999999999999999999999999999999999998643 4799999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+..... .......|||+.|+|||++.. ..|+..+||||+|||+|.|++|.+||.+.+.......|..
T Consensus 186 a~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~------- 252 (382)
T KOG0032|consen 186 AKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR------- 252 (382)
T ss_pred ceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------
Confidence 987654 223567899999999999986 6899999999999999999999999998876554443321
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.........|++++..+++||.+||.+||.+|+|+.++|+|||++..
T Consensus 253 ---------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 253 ---------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ---------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 11222345789999999999999999999999999999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=387.06 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=215.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..+.|++.+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence 3468999999999999999999999999999999986431 2223456788999999999999999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 67999999998 59999999888899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 171 ~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~------------- 229 (329)
T PTZ00263 171 RT------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA------------- 229 (329)
T ss_pred Cc------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 21 23579999999999887 6789999999999999999999999987665433332211
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKG 319 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~ 319 (620)
.. .. ....++..+++||++||+.||.+|++ ++++++||||++
T Consensus 230 ---------------~~-~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 ---------------GR-LK---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ---------------CC-cC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 00 00 11236788999999999999999997 799999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=382.17 Aligned_cols=330 Identities=41% Similarity=0.767 Sum_probs=270.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (620)
..++|++++.||+|+||.||++.+..++..||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999999999999999987544444445678899999999999999999999864422 223
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 46799999998899888864 57999999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.....+++.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+....+.+..+....+
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (343)
T cd07880 172 ------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL- 243 (343)
T ss_pred ------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh-
Confidence 1345678999999988652 35889999999999999999999999998888888888777777766655544
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 339 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 339 (620)
.......+...+....+..+...++.+++.+.+||.+||+.||++|||+.++|.||||+.+...+.++...+ +..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~ 320 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDDSF 320 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---ccccH
Confidence 445555666555544444444556788999999999999999999999999999999998876655544333 44456
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCc
Q 007050 340 ERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 340 e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
+....+.|+++.+.+.||+.++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 321 DEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred HhhccchHHHHHHHHHHHHhcCC
Confidence 77777889999999999998775
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=401.73 Aligned_cols=256 Identities=26% Similarity=0.477 Sum_probs=221.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (620)
.+.|.++++||+|+||+|+++..+.+++.||||++++. .....+......|-.|++... ||.++.++..| ++.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTK 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccC
Confidence 35799999999999999999999999999999999864 334456777888999998885 99999999998 667
Q ss_pred CeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.++|+||||+.| |+. .+...+.|++..+.+|...|+.||.|||++|||+||||.+|||+|.+|++||+|||+++....
T Consensus 442 ~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 789999999995 744 444557899999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
....+ .++||||.|+|||++.+ ..|+.++|+|||||+|||||.|.+||+|.++.+..+.|..
T Consensus 521 ~g~~T---sTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------- 582 (694)
T KOG0694|consen 521 QGDRT---STFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------- 582 (694)
T ss_pred CCCcc---ccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 43333 67999999999999998 7999999999999999999999999999998888777743
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
+. + ...-.+|.++.+++++||..||++|.. +++|..||||+.+
T Consensus 583 ---d~------------~----~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 583 ---DE------------V----RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ---CC------------C----CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 00 0 011246889999999999999999974 5889999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=386.81 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=210.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 47999999999999999999999999997532 2233456778999999999999999999988 45567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
|+. ++|.+.+..++.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 59999998888999999999999999999999999999999999999999999999999999875332211 12
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+....+..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45689999999999976 6799999999999999999999999987654433322211
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. .. .....+++.+.+||++||..||++|| ++.++|+||||..+
T Consensus 210 -------~-~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -------E-EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -------C-CC---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=377.76 Aligned_cols=252 Identities=30% Similarity=0.565 Sum_probs=221.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
-||++.+.||+|.||+|-+|.+...|+.||||.|++. .....+.-.|.|||+||..|+||||+.++++| ++...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence 5899999999999999999999999999999999754 44556778899999999999999999999999 77788
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+.|||||.. |+|+++|..++.|++.++..|++||..|+.|||.++++|||||.+|||+|.+|.+||+||||+..+..
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 999999998 79999999999999999999999999999999999999999999999999999999999999976543
Q ss_pred CcccccccccCCccccCcccccccCCCC-CcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y-~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..+++++||++.|.+||++.+ ..| ++.+|.||||++||.|+.|..||.|.+.-..+..|..
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~-------------- 267 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR-------------- 267 (668)
T ss_pred --ccHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--------------
Confidence 346789999999999999988 454 6789999999999999999999999875443333311
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
+. | .-|..+..+.-||+.||-+||++|.|++++-+|=|++
T Consensus 268 --Ga---Y--------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 268 --GA---Y--------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --cc---c--------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11 0 1134456789999999999999999999999998876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=380.50 Aligned_cols=326 Identities=49% Similarity=0.831 Sum_probs=263.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~t--g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+|++.+.||+|+||.||++.+..+ +..||||++............+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999988 89999999876544444456778999999999 5999999998754321 3345
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+++|+++++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999998654322
Q ss_pred Cc-ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .......+||..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.|..+.+..+
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI- 237 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-
Confidence 11 1112346799999999987642 46899999999999999999999999999999999999999999988877666
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 339 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 339 (620)
.......+...........+...++..+..+.+||.+||+.||++|||+.++|.||||..+......+.|.......|+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES 317 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc
Confidence 33444444444444444455555677899999999999999999999999999999999888777777776443333332
Q ss_pred HhhcCCHHHHHHHHHH
Q 007050 340 ERRRVTKEDIRELIFR 355 (620)
Q Consensus 340 e~~~~~~e~~~~~~~~ 355 (620)
| -+.++++..|..
T Consensus 318 ~---~~~~~~~~~~~~ 330 (332)
T cd07857 318 E---DSMEELRDMIIE 330 (332)
T ss_pred c---ccHHHHHHHHhh
Confidence 2 345566665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=380.34 Aligned_cols=330 Identities=41% Similarity=0.800 Sum_probs=269.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (620)
..++|.+++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999999999999999999999999999765444445667889999999999999999999885432 1334
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|++++++.++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred ccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 56899999998899888765 46999999999999999999999999999999999999999999999999998754221
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.....++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.+..+
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 245 (345)
T cd07877 174 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI- 245 (345)
T ss_pred ------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc-
Confidence 2345789999999987652 46889999999999999999999999998888888888888888887776665
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 339 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 339 (620)
.....+.++..+.......+...+...++.+++||.+||+.||.+|+|+.++|.||||+++..++.++... .++..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~~ 322 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSF 322 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCcc
Confidence 34445556555544444445555556789999999999999999999999999999999887766666433 244455
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCc
Q 007050 340 ERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 340 e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
+.+.+..+++....|++...|.|
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 323 ESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred hhcccCHHHHHHHHHHHHHhcCC
Confidence 55566668888888888766543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=383.68 Aligned_cols=261 Identities=26% Similarity=0.477 Sum_probs=218.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 479999999999999999999999999999999975422 223456688999999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 59999998888899999999999999999999999999999999999999999999999999976533
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 217 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------- 217 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence 1245679999999999887 589999999999999999999999998876655444332210000
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+ ........+++++.+||.+||..+|.+||+++++++||||..+
T Consensus 218 -------------~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 218 -------------QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -------------cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 0111113578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=368.53 Aligned_cols=276 Identities=32% Similarity=0.504 Sum_probs=226.2
Q ss_pred ccccccCCCCCCeEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeE
Q 007050 13 MEFFSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHI 90 (620)
Q Consensus 13 ~~~~~~~g~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v 90 (620)
|.| .++...++|.+- ++||-|-.|+|..|.++.||+++|+|++.+ ..+..||+++.-.. .|||||.++++
T Consensus 52 m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidV 123 (400)
T KOG0604|consen 52 MDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDV 123 (400)
T ss_pred cch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehh
Confidence 455 677778888875 589999999999999999999999998853 34566888886555 69999999999
Q ss_pred ecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCc
Q 007050 91 MLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCK 164 (620)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~ 164 (620)
|.. ++.+..++.+|||.|+ |+|+..|+.++. |+|.++..|++||..|+.|||+.+|.||||||+|+|... |+.
T Consensus 124 yeN-s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 124 YEN-SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred hhh-hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcc
Confidence 854 4566788999999999 599999998775 999999999999999999999999999999999999864 577
Q ss_pred EEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 007050 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~ 244 (620)
+||+|||+|+.... ...+.+.|-|++|.|||+++. .+|+..+|+||||||+|-||+|.|||....-.
T Consensus 203 lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~------- 269 (400)
T KOG0604|consen 203 LKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------- 269 (400)
T ss_pred eEecccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCc-------
Confidence 99999999986432 233567799999999999987 68999999999999999999999999775421
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~ 324 (620)
+-...+.. .++..+.......|..+|+.++|||++||..+|.+|.|+++++.|||+.+...+.
T Consensus 270 -----aispgMk~------------rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 270 -----AISPGMKR------------RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred -----cCChhHHh------------HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 11111111 1112222333457888999999999999999999999999999999999876654
Q ss_pred CCC
Q 007050 325 REP 327 (620)
Q Consensus 325 ~~~ 327 (620)
..+
T Consensus 333 ~tp 335 (400)
T KOG0604|consen 333 QTP 335 (400)
T ss_pred CCC
Confidence 433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=387.21 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=213.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||+||+|.++.+++.||||++..... .......+.+|+.++..++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 479999999999999999999999999999999975321 223345678899999999999999999998 45578
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999987543211
Q ss_pred Cc--------------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC
Q 007050 181 PT--------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (620)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~ 228 (620)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134689999999999876 67999999999999999999999
Q ss_pred CCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC---C
Q 007050 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD---R 305 (620)
Q Consensus 229 ~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~---R 305 (620)
.||.+.+..+.+..+.... ....+. ....+++++++||.+|+. +|.+ |
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~---------------------------~~~~~p-~~~~~s~~~~~li~~l~~-~~~~r~~r 284 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK---------------------------ETLIFP-PEVPISEKAKDLILRFCC-EWEHRIGA 284 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc---------------------------CcccCC-CcCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence 9998876655444443210 001111 112478899999999886 5554 5
Q ss_pred CCHHHHHcCCcccCC
Q 007050 306 PTAEEALADPYFKGL 320 (620)
Q Consensus 306 psa~elL~hp~f~~~ 320 (620)
|+++|+++||||+++
T Consensus 285 ~~~~ei~~hp~f~~~ 299 (363)
T cd05628 285 PGVEEIKTNPFFEGV 299 (363)
T ss_pred CCHHHHhCCCCCCCC
Confidence 899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=387.95 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=214.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|+++.+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999999999999999997531 1223445677899999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++..++.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred Ccc-----------------------------------cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHH
Q 007050 181 PTT-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (620)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLl 225 (620)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 01123479999999999876 68999999999999999999
Q ss_pred hCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCC
Q 007050 226 TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305 (620)
Q Consensus 226 tG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R 305 (620)
+|.+||.+.+..+.+..+... .....+. ....+++.+++||.+||. ||.+|
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW---------------------------KETLQFP-DEVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC---------------------------CCccCCC-CCCCCCHHHHHHHHHHcc-CHhhc
Confidence 999999887655443333211 0001111 112568899999999997 99999
Q ss_pred CC---HHHHHcCCcccCC
Q 007050 306 PT---AEEALADPYFKGL 320 (620)
Q Consensus 306 ps---a~elL~hp~f~~~ 320 (620)
++ ++|+|+||||++.
T Consensus 285 ~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 285 LGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 98 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=389.66 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=213.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|+++.+++.||+|++.... ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence 46999999999999999999999999999999987532 1223456788999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------cccccccccCCccccCcccccccCCCCCcccchHh
Q 007050 181 P--------------------------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (620)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWS 216 (620)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999976 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHH
Q 007050 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 296 (620)
Q Consensus 217 LG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~ 296 (620)
|||++|||++|++||.+.+..+....+.... ... .......+++++.+||.+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------------------~~~-~~p~~~~~s~~~~~li~~ 285 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ---------------------------TSL-HIPPQAKLSPEASDLIIK 285 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccC---------------------------CCc-CCCCcccCCHHHHHHHHH
Confidence 9999999999999998876544333222100 000 011224578999999999
Q ss_pred hcccCCCCCCC---HHHHHcCCcccCC
Q 007050 297 LLAFDPKDRPT---AEEALADPYFKGL 320 (620)
Q Consensus 297 mL~~DP~~Rps---a~elL~hp~f~~~ 320 (620)
|+. ||.+|++ ++|+++||||+.+
T Consensus 286 l~~-~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 286 LCR-GPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred Hcc-CHhHcCCCCCHHHHhcCCCcCCc
Confidence 874 9999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=369.59 Aligned_cols=299 Identities=33% Similarity=0.535 Sum_probs=244.2
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC---CC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP---SR 96 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~---~~ 96 (620)
.+.+.|+-+..||+|.||.||+|+.+.+|+.||+|++....++...-...++|+++|..|+|+|++.+++++... ..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 456789889999999999999999999999999998754334444455678999999999999999999987543 22
Q ss_pred CCCCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+...+|+||++|+.||.-++... ..++..+++.++.+++.||.|||+..|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 445669999999999999999765 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
+..... ....++..+.|.||++||++.+. ..|++++|||..|||++||++|.+.|.|.++.+++..|..++|.-+.|.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 543322 22335778899999999998874 7899999999999999999999999999999999999999999999999
Q ss_pred hhhhhhchhHHHHH-HhhhccCCCcccCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 255 ISRVVRNDKARRYL-TSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 255 i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
|..+..-+-....- +.+.+.....+..... .-++++.||+.+||..||.+|+.++++|+|.||..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 98773222211110 0011111111111111 23678999999999999999999999999999974
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=368.58 Aligned_cols=282 Identities=38% Similarity=0.626 Sum_probs=228.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|++++.||.|++|.||+|.++.++..||||++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 48999999999999999999999999999999875433333445678899999999999999999998 3456799
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELMESDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888642 468999999999999999999999999999999999999999999999999997543221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112334678999999987652 4578899999999999999999999999888888877777777776665544321
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .+..................+++++.+||++||..||.+|||+.++|+||||
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LP---DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hH---HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 11 1211111111122223345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=388.54 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=212.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.|++++.||+|+||+||+|+++.+++.||||++... .........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCE
Confidence 3699999999999999999999999999999999653 22334456788999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975421100
Q ss_pred Cc--------------------------------------------ccccccccCCccccCcccccccCCCCCcccchHh
Q 007050 181 PT--------------------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (620)
Q Consensus 181 ~~--------------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWS 216 (620)
.. .......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 00 000124589999999999876 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHH
Q 007050 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 296 (620)
Q Consensus 217 LG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~ 296 (620)
||||+|||++|..||.+.+..+....+..... .. .......+++++++||.+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~~-~~~~~~~~s~~~~dli~~ 285 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------------------TL-HIPPQVKLSPEAVDLITK 285 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------------------cc-CCCCCCCCCHHHHHHHHH
Confidence 99999999999999987665433332221100 00 011223578999999999
Q ss_pred hccc--CCCCCCCHHHHHcCCcccCC
Q 007050 297 LLAF--DPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 297 mL~~--DP~~Rpsa~elL~hp~f~~~ 320 (620)
||.. ++..|++++|+++||||.++
T Consensus 286 ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 286 LCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HccCcccccCCCCHHHHhcCcccCCC
Confidence 7655 44459999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=378.20 Aligned_cols=326 Identities=40% Similarity=0.756 Sum_probs=258.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 100 (620)
..+|.+.+.||+|+||.||+|+++.+|+.||||++............+.+|+.+++.++||||+++++++.... ..+..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999999999999999998764433334456789999999999999999999885432 12345
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|+||+..+|..++ ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred eEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 68999999998887765 346899999999999999999999999999999999999999999999999998754221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
...+.++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.+..+.+..+ .
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 243 (342)
T cd07879 171 -----MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL-E 243 (342)
T ss_pred -----CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh-c
Confidence 2345788999999988652 45889999999999999999999999999888888888888888877665554 3
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHH
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 340 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 340 (620)
......+...........+...++..++.+.+||.+||+.||++||+++++|.||||+.+...+.+....+ +....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~ 320 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLE 320 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhh
Confidence 33333443333333333444456778999999999999999999999999999999998876544443222 222334
Q ss_pred hhcCCHHHHHHHHHHHHHHh
Q 007050 341 RRRVTKEDIRELIFREILEY 360 (620)
Q Consensus 341 ~~~~~~e~~~~~~~~ei~~~ 360 (620)
......+++...+|+|...+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~ 340 (342)
T cd07879 321 NEKLSVDEWKKHIYKEVKSF 340 (342)
T ss_pred hhhCCHHHHHHHhhhhhhcc
Confidence 44556677777777776443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=371.10 Aligned_cols=282 Identities=37% Similarity=0.611 Sum_probs=227.2
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||+|+||.||+|.++.+|+.||+|.+............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 69999999999999999999999999999999875322222334577899999999999999999988 4456799
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+|+||++++|.+.+.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999988865 56799999999999999999999999999999999999999999999999999976432211
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p-F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
......++..|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+....+..+...++.+..+.+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345678999999988652 4578999999999999999998765 6777778888888888888877665544221
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.....+ .. ......+.+..+.+++.+++||.+||+.||.+|||++++|.||||
T Consensus 232 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPY-PM--YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccc-CC--CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111000 00 000111223446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=379.88 Aligned_cols=328 Identities=43% Similarity=0.769 Sum_probs=261.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++.+.||.|+||.||+|.+..+++.+|+|++............+.+|+.+++.+ +||||+++++++.. .+..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence 4679999999999999999999999999999999876544445566778899999999 99999999998743 2335
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+||||+.++|.+++..+ .+++...+.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred eEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 68999999999999999776 78999999999999999999999999999999999999999999999999998654332
Q ss_pred Cc--ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 181 PT--TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 181 ~~--~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. ......++++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+....+.+..+....+.+..+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 11 1223456899999999987542 46788999999999999999999999999988999999888888887766655
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhh
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 338 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 338 (620)
........+..+.......+...++.++..+.+||.+||+.||.+|||+.++|+||||+++.....++......+..+.
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 241 -KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred -HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 3333444444444444444555667789999999999999999999999999999999988665555443322222222
Q ss_pred HHhhcCCHHHHHHHHHHH
Q 007050 339 FERRRVTKEDIRELIFRE 356 (620)
Q Consensus 339 ~e~~~~~~e~~~~~~~~e 356 (620)
..+++...+.+..+|+|
T Consensus 320 -~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 -DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred -ccceeeHHHHHhhhhhc
Confidence 23344445555555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=388.32 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=212.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|.+++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47999999999999999999999999999999986431 1223456678899999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999996422110
Q ss_pred Cc------------c--------------------------------cccccccCCccccCcccccccCCCCCcccchHh
Q 007050 181 PT------------T--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (620)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWS 216 (620)
.. . ......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00013579999999999876 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHH
Q 007050 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 296 (620)
Q Consensus 217 LG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~ 296 (620)
|||++|||++|.+||.+.+..+.+..+.... ....+ .....++.++.+||.+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------------------~~~~~-p~~~~~s~~~~dli~~ 285 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR---------------------------ETLYF-PDDIHLSVEAEDLIRR 285 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------------------CccCC-CCCCCCCHHHHHHHHH
Confidence 9999999999999998776554443332210 00011 1122468899999999
Q ss_pred hcccCCCCC---CCHHHHHcCCcccCC
Q 007050 297 LLAFDPKDR---PTAEEALADPYFKGL 320 (620)
Q Consensus 297 mL~~DP~~R---psa~elL~hp~f~~~ 320 (620)
||. +|.+| +++.|+|.||||++.
T Consensus 286 lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 286 LIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred Hhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 998 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=382.25 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=214.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCC-cEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
..++|++++.||+|+||.||+|.++.++ ..||+|++.... ........+.+|+.+++.++||||+++++++ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 4568999999999999999999977665 689999986432 2233456788999999999999999999998 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+|||||. |+|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 567999999997 6999999988899999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~----------- 243 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG----------- 243 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 22 134579999999999876 67899999999999999999999999876654333333210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.. ...+.+++.+.+||++||+.||++|+ +++++++||||.++
T Consensus 244 ------------------~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 244 ------------------II---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ------------------CC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 01234678999999999999999995 89999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=371.23 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=210.6
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+|+.++|+||+++++++ .+...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 38899999999999999999999999999999864322 222334577999999999999999999988 445679
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+|||||. |+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 589887754 336899999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. .....+||..|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-------------- 215 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-------------- 215 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH--------------
Confidence 1 1234579999999999986 6899999999999999999999999987653221111110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~~ 321 (620)
.+.. ........+++.+.+||++||+.||++||+ ++++++||||.++.
T Consensus 216 ----------~~~~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 216 ----------RVKE----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------Hhhc----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0000 001123457889999999999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=377.33 Aligned_cols=248 Identities=32% Similarity=0.500 Sum_probs=208.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999986432 2234456778999999999999999999988 4556799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccccc
Q 007050 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (620)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~ 188 (620)
. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 59999998888899999999999999999999999999999999999999999999999999975432221 1245
Q ss_pred ccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHH
Q 007050 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYL 268 (620)
Q Consensus 189 ~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~ 268 (620)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 689999999999987 6799999999999999999999999987654333222211
Q ss_pred HhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccCC
Q 007050 269 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 320 (620)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp---sa~elL~hp~f~~~ 320 (620)
.+. .....+++.+.+||.+||..||++|| ++.|+|+||||...
T Consensus 208 ------~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ------EPL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ------CCC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 011 11235788999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=387.98 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=213.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.|++++.||+|+||.||+|+++.+++.||||++.... ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986431 1223345677999999999999999999998 45568
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------cccccccccCCccccCcccccccCCCCCcccchHhHHHH
Q 007050 181 P----------------------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (620)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~I 220 (620)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999976 679999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhccc
Q 007050 221 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300 (620)
Q Consensus 221 lyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~ 300 (620)
+|+|++|+.||.+.+..+....+... ...........+++.+.+||.+|+ .
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~----------------------------~~~~~~~~~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINW----------------------------ETTLHIPSQAKLSREASDLILRLC-C 284 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhcc----------------------------CccccCCCCCCCCHHHHHHHHHHh-c
Confidence 99999999999887654433322110 000001123457899999999987 4
Q ss_pred CCCCCC---CHHHHHcCCcccCC
Q 007050 301 DPKDRP---TAEEALADPYFKGL 320 (620)
Q Consensus 301 DP~~Rp---sa~elL~hp~f~~~ 320 (620)
||.+|+ +++|+++||||+++
T Consensus 285 ~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 285 GAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=382.39 Aligned_cols=262 Identities=30% Similarity=0.490 Sum_probs=217.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|.+++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 479999999999999999999999999999999975322 223456678899999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999997654332
Q ss_pred C--------------------------cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 007050 181 P--------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (620)
Q Consensus 181 ~--------------------------~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~ 234 (620)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234679999999999987 58999999999999999999999999887
Q ss_pred ChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHc
Q 007050 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALA 313 (620)
Q Consensus 235 ~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-a~elL~ 313 (620)
+.......+..... ... ......+++.+.+||.+||. ||.+|++ ++++|+
T Consensus 234 ~~~~~~~~i~~~~~---------------------------~~~-~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 TLQETYNKIINWKE---------------------------SLR-FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CHHHHHHHHhccCC---------------------------ccc-CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 65444433322100 000 01122378999999999998 9999999 999999
Q ss_pred CCcccCC
Q 007050 314 DPYFKGL 320 (620)
Q Consensus 314 hp~f~~~ 320 (620)
||||+++
T Consensus 285 hp~~~~~ 291 (350)
T cd05573 285 HPFFKGI 291 (350)
T ss_pred CCCcCCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=371.93 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=221.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..+.|++++.||.|.-|+||+|..+.++..+|+|++.+.. .......++..|-+||..++||.+..||..| +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 3467889999999999999999999999999999997642 2344566778899999999999999999998 667
Q ss_pred CeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..+|+|||||. |||+.+.+.. +.|++..+++|+.+++.||+|||-.|||+|||||+||||-++|+|.|.||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 78999999999 5999988764 47999999999999999999999999999999999999999999999999997432
Q ss_pred cC---------------------------------C-C-------------------CcccccccccCCccccCcccccc
Q 007050 177 FN---------------------------------D-T-------------------PTTIFWTDYVATRWYRAPELCGS 203 (620)
Q Consensus 177 ~~---------------------------------~-~-------------------~~~~~~~~~~gt~~Y~APEvl~~ 203 (620)
.. . . +.......+|||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 0 00011234789999999999998
Q ss_pred cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCC
Q 007050 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF 283 (620)
Q Consensus 204 ~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (620)
.+.+.++|+|+||+++||||.|..||.|.+..+.+..|.. ++..|.. .
T Consensus 310 --~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------------------~~l~Fp~-~ 357 (459)
T KOG0610|consen 310 --EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------------------QPLKFPE-E 357 (459)
T ss_pred --CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------------------CCCcCCC-C
Confidence 7899999999999999999999999999987666554432 1222222 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC----HHHHHcCCcccCC
Q 007050 284 PNADPSALRLLERLLAFDPKDRPT----AEEALADPYFKGL 320 (620)
Q Consensus 284 ~~~s~~l~dLI~~mL~~DP~~Rps----a~elL~hp~f~~~ 320 (620)
+.++..++|||+++|.+||.+|.. |.||-+||||+++
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 367789999999999999999998 9999999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=377.55 Aligned_cols=250 Identities=25% Similarity=0.460 Sum_probs=209.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
+.||+|+||.||++.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997532 2234456788999999999999999999988 45567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
|++ ++|...+.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 59999998888899999999999999999999999999999999999999999999999999875332211 12
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 44679999999999876 6789999999999999999999999977654433222210
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
... .....+++.+.+||++||..||++|+ +++|+++||||.+.
T Consensus 210 --------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 --------EDI---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred --------CCc---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 11235688999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=375.82 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=209.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
+.||+|+||.||++.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 479999999999999999999999999975322 223456677899999999999999999988 44567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
||+ ++|..++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 59999998888899999999999999999999999999999999999999999999999999875332221 12
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34679999999999876 6789999999999999999999999977655433322211
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
... .....+++.+.+||.+||..||++|+ ++.++++||||.+.
T Consensus 210 --------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 --------EEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 01135688999999999999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.84 Aligned_cols=294 Identities=40% Similarity=0.633 Sum_probs=234.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 35689999999999999999999999999999999864433322233456899999999999999999998532 235
Q ss_pred eEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+||||++++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 6899999999999988875 357999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ..+...++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|....+..+.
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 12334568899999988652 468899999999999999999999999999999999999999988776655442
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
.......+. ........+...+...++.+.+||.+||++||++|||++|+|.||||++..-+
T Consensus 238 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred ccccccccc--ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 111111110 00001111222344568899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.71 Aligned_cols=282 Identities=35% Similarity=0.590 Sum_probs=216.4
Q ss_pred EEEeeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
...||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++... +...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 3689999999999999654 66889999986531 223567899999999999999999988543 34578999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----CCCCcEEEcccCc
Q 007050 106 FELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (620)
Q Consensus 106 ~E~~~gdL~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~lKL~DFGl 172 (620)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999999888532 248899999999999999999999999999999999999 5567899999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------hHHHHHh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VHQLDLM 243 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~---------~~~l~~i 243 (620)
++...............++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98754333222223456789999999988652 4689999999999999999999999976432 3567778
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccC--CCc----ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ--PVQ----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
...+|.|..+.+..+................. ... ........+..+++||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88888888777765532222111111111000 000 011112356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=377.09 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=215.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||+|+||.||+|.++.+++.||||+++.... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 479999999999999999999999999999999975422 223445677899999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999998 6999999876 67999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCccccccc----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~----~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
... .....+||+.|+|||++... ...++.++||||||||+|+|++|..||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 22345799999999998631 146789999999999999999999999876654443333221
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.....+ ...+.+++.+.+||++||. ||.+|||++++++||||..+
T Consensus 225 ------------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 ------------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ------------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 000011 1234678999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=373.63 Aligned_cols=261 Identities=24% Similarity=0.406 Sum_probs=209.5
Q ss_pred CeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (620)
.|++++.||+|+||.||++.+. .+++.||+|++.+.. ........+.+|+.+|+.+ +||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 578999999986431 1223455678899999999 599999999988 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|+|||||. ++|.+++..+..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 5567999999998 599999988888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..........
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--------------- 217 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--------------- 217 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---------------
Confidence 332221 12346899999999998752 357889999999999999999999996543211100
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.+...+....+ ...+.+++.+.+||.+||+.||++|| +++++++||||++.
T Consensus 218 ---------~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 218 ---------EVSRRILKCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred ---------HHHHHHhcCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00011111111 11235788999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=372.42 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=212.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCe
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~ 101 (620)
.|++++.||+|+||.||+|.++.+++.||||++..... .......+..|+.++..+.|+ +|+.+++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 48999999999999999999999999999999975321 234456778899999999765 577888887 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234679999999999986 67899999999999999999999999887655444333210
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~elL~hp~f~~~ 320 (620)
. . .....+++.+.+||.+||..||.+|++. +++++||||...
T Consensus 217 --------------~-~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 --------------N-V---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred --------------C-C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 1123568899999999999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=370.02 Aligned_cols=280 Identities=24% Similarity=0.390 Sum_probs=218.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+++++.++..+|+|.+.... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 468999999999999999999999999999999987532 234456788999999999999999999998 34467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999 59999998888899999999999999999999986 5999999999999999999999999998765322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh---
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS--- 256 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~--- 256 (620)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+..+...
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999887 6799999999999999999999999987665432221 1211110000
Q ss_pred -hh------------------hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 257 -RV------------------VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 257 -~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .........+..+........ ....+++++++||.+||.+||++|||++|+|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00 000001111111111111111 112468899999999999999999999999999999
Q ss_pred cCC
Q 007050 318 KGL 320 (620)
Q Consensus 318 ~~~ 320 (620)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=369.53 Aligned_cols=321 Identities=47% Similarity=0.858 Sum_probs=261.8
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+...++|++++.||.|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++.+++.. .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~ 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----P 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----C
Confidence 345678999999999999999999999999999999987544444455677899999999999999999998843 2
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
....|+||||+.++|.++++. ..+++..+..++.||+.||.|||+.+|+||||+|+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 346899999999999888864 4689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||++.+.......+.+.+|.|..+.+..+
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345678899999987542 46899999999999999999999999999888888888889999988777665
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhh
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 338 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 338 (620)
. ......++.......+.+....++.+++.+.+||++||+.||++|||++++|.||||..+..+..++... .++++.
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~--~~~~~~ 310 (328)
T cd07856 234 C-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAE--EKFDWS 310 (328)
T ss_pred c-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCch--hhcCCc
Confidence 3 3334445555555555555666678899999999999999999999999999999998776654444322 256666
Q ss_pred HHhhcCCHHHHHHHHH
Q 007050 339 FERRRVTKEDIRELIF 354 (620)
Q Consensus 339 ~e~~~~~~e~~~~~~~ 354 (620)
+....+..+.|+-.+|
T Consensus 311 ~~~~~~~~~~~~~~~~ 326 (328)
T cd07856 311 FNDADLPVDTWKVMMY 326 (328)
T ss_pred hhcccCCHHHHHHHhc
Confidence 6666666666664443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.61 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=208.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999987532 1223455677899988876 699999999998 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875422211 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234679999999999876 6789999999999999999999999988765544433321
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~elL~hp~f~~~ 320 (620)
... .....+++++.+||++||+.||++|+++ +++++||||+.+
T Consensus 211 --------~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 211 --------DEV----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred --------CCC----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 000 0112467899999999999999999998 999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.45 Aligned_cols=257 Identities=30% Similarity=0.459 Sum_probs=221.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
....|..++.||+|+||.||+|+|..+++.||||++... ....+...+..|+.+|.+++++||.++|+.|+.. .
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~ 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----T 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----c
Confidence 345788889999999999999999999999999999754 3345677888999999999999999999999655 4
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.++++||||. |++.++++.++.+.+.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||++......
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 5899999999 599999999888899999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ....+++||++|||||++.+ ..|+.++||||||++.+||++|.|||........+..|
T Consensus 165 ~---~rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------------- 223 (467)
T KOG0201|consen 165 V---KRRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------------- 223 (467)
T ss_pred h---hccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------
Confidence 2 23368899999999999986 79999999999999999999999999776543222222
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.+..|..+.. .+|+.+++||..||..||+.||||.++|+|+|++.
T Consensus 224 ------------pk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 ------------PKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------------cCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 2222322222 67889999999999999999999999999999986
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.44 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=226.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|..++++|+|+||.+++++++..++.|++|+|...............|+.++++++|||||.+++.|. .+...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 46899999999999999999999999999999999866555556667889999999999999999999983 33344
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+||||+||+ |+|.+.|+.. .-|+++.++.|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999 5999999754 3689999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .+...++||+.|+.||+|.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|...+..|-
T Consensus 159 ~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------- 226 (426)
T KOG0589|consen 159 ED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------- 226 (426)
T ss_pred ch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence 43 23467899999999999998 7999999999999999999999999999988777777765433332
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
-..++.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 227 ------------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 227 ------------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ------------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 2356889999999999999999999999999988763
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=361.57 Aligned_cols=282 Identities=39% Similarity=0.642 Sum_probs=229.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|++++.||.|++|.||+|.++.+++.||||++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 48999999999999999999999999999999875433333445788999999999999999999987 4556799
Q ss_pred EEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 104 VVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
+||||+.++|..++.. ...+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 35689999999999999999999999999999999999999999999999999876432211
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|....+..+..
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 12334678899999987652 4468899999999999999999999999988888888888888887655543311
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
...+...........+....+.+++.+++||.+||+.||.+|||++++|+||||
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 --LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred --HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111212222222222333345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=360.88 Aligned_cols=285 Identities=41% Similarity=0.711 Sum_probs=234.0
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 59999999999999999999999999999999876433334456788999999999999999999998 3456799
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 45799999999999999999999999999999999999999999999999999986543322
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+....+..+...++.|....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999988652 457899999999999999999999999998888888888888888776665432111
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
..... .........+...+++.+..+.+||++||..||++|||++++|+||||.
T Consensus 233 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKI--TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcc--cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11000 0111122223344567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.62 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=208.1
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHH---HhcCCCCcceeeeEecCCCCCCCC
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLL---RLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL---~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
|++++.||+|+||.||+|.++.+++.||||+++... ........+.+|+.++ +.++||||+++++++ .+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 789999999999999999999999999999997532 1223445666776665 466799999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+ ++|...+.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999999 588887754 56999999999999999999999999999999999999999999999999998753322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------- 215 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------------- 215 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 21 1245689999999999877 6789999999999999999999999988765444333321
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
... .....+++.+.+||.+||+.||.+|| +++++++||||+++
T Consensus 216 --------------~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 --------------DEV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred --------------CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 000 01134688999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=374.87 Aligned_cols=250 Identities=27% Similarity=0.474 Sum_probs=208.5
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
+.||+|+||.||++.++.+|+.||+|++.... ........+.+|+.+++.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997532 2223456678899999999999999999988 45567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|++ ++|...+.....+++..++.|+.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5899999888889999999999999999999997 7999999999999999999999999999875432221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234679999999999876 6789999999999999999999999987664433322211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.... ....+++.+.+||++||+.||++|+ ++.++|+||||.+.
T Consensus 211 ---------~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 ---------EEIR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ---------CCCC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 0000 1134688999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=379.21 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=214.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..++||||+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46999999999999999999999999999999996432 1223456678899999999999999999988 45678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred Cc--------------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC
Q 007050 181 PT--------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (620)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~ 228 (620)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999877 68999999999999999999999
Q ss_pred CCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC--
Q 007050 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-- 306 (620)
Q Consensus 229 ~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-- 306 (620)
+||.+.+....+..+... .....+. ....+++.+++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~p-~~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 234 PPFCSETPQETYRKVMNW---------------------------KETLVFP-PEVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCCCHHHHHHHHHcC---------------------------CCceecC-CCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 999887655444333210 0001111 112468899999999875 999998
Q ss_pred -CHHHHHcCCcccCC
Q 007050 307 -TAEEALADPYFKGL 320 (620)
Q Consensus 307 -sa~elL~hp~f~~~ 320 (620)
+++|+++||||+++
T Consensus 285 ~~~~ei~~hp~f~~~ 299 (360)
T cd05627 285 NGVEEIKSHPFFEGV 299 (360)
T ss_pred CCHHHHhcCCCCCCC
Confidence 58999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=362.63 Aligned_cols=287 Identities=37% Similarity=0.655 Sum_probs=229.0
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
||..++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDII-----HT 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEE-----ec
Confidence 57778999999999999999999999999999999998653222 1223467899999999999999999998 45
Q ss_pred CCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
....|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 5679999999999999988754 468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... ......++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+.+ ..+++..+.+.++.|..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11234578889999987642 458899999999999999999999998766 667777888888888777665
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+........+.. ....+......++.++ ..+.+||.+||+.||++|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPYSF--PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccccccc--cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 5532222111110 0011112222334445 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=379.23 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=214.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 3468999999999999999999999999999999996431 2223445577899999999999999999988 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 67999999998 6999988654 689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCccccCccccccc--CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~--~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------- 262 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH---------- 262 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----------
Confidence 211 112356799999999988642 124889999999999999999999999887654443333210
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~ 319 (620)
.....+ .....++.++++||.+||..+|.+ |+|++|+++||||++
T Consensus 263 -----------------~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 263 -----------------KNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred -----------------CCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 000111 123357899999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.64 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=222.2
Q ss_pred cCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 18 ~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.....++|++.+.||+|.||.||+|+.++++..||+|++.+. .........+.||++|...|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f----- 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF----- 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----
Confidence 345667899999999999999999999999999999999754 22233456688999999999999999999999
Q ss_pred CCCCeEEEEEecCC-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~--~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.+...+||++||.. |+|+..+. ....+++...+.+++|++.||.|+|.++|+||||||+|+|++.++.+||+|||.+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 45677999999998 79999998 5668999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
...... ...+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+.+.+|..+
T Consensus 172 V~~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------- 237 (281)
T KOG0580|consen 172 VHAPSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------- 237 (281)
T ss_pred eecCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------
Confidence 764321 2356799999999999988 78999999999999999999999999887655555544321
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
. . .....++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 238 ---------------------~-~---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 238 ---------------------D-L---KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------------------c-c---cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 0 0 011467899999999999999999999999999999864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=375.90 Aligned_cols=259 Identities=28% Similarity=0.497 Sum_probs=226.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++-|.+.+.||+|-|.+|-+|++..||+.||||+|.+...+.-....+..|+..|+.++|||||++|++. ....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 46779999999999999999999999999999999987655555567788999999999999999999998 5567
Q ss_pred eEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe-CCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA-NANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-~~~~~lKL~DFGlA~~~~ 177 (620)
.+|||+|+-+ |||+++|.++. .++|+.++.|+.||+.|+.|||+..+|||||||+|+++ ..-|-|||.|||++..+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 7999999998 59999997654 69999999999999999999999999999999999975 556899999999997654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCC-cccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~-~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.. ..+++.||+..|-|||++.+ ..|+ +++||||||||||.|++|++||...++.+.+..|++.--+
T Consensus 171 PG----~kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt------- 237 (864)
T KOG4717|consen 171 PG----KKLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT------- 237 (864)
T ss_pred Cc----chhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-------
Confidence 33 23578899999999999988 5665 5799999999999999999999999998888888763111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
....++.+.+|||.+||..||++|.|.+||..|+|++....
T Consensus 238 -------------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 238 -------------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred -------------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 11246789999999999999999999999999999997643
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=370.82 Aligned_cols=251 Identities=29% Similarity=0.493 Sum_probs=207.9
Q ss_pred EEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 28 QEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++.||+|+||.||++.+. .+++.||+|+++... ........+.+|+.+|+.++||||+++++++ .+...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 468999999999999864 578899999987531 1223345677899999999999999999998 445679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999 59999998888899999999999999999999999999999999999999999999999999875432221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234679999999999876 5789999999999999999999999987665443333221
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.. ....+.+++.+.+||.+||+.||++|| +++++++||||...
T Consensus 215 -----------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 -----------GK-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred -----------CC-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 011245688999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.63 Aligned_cols=258 Identities=36% Similarity=0.607 Sum_probs=211.8
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.+++.++||||+++++++. +...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 89999999999999999999999999999999865433334444567999999999999999999984 4577999
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
|||++.+ +|.+++.....+++..++.++.||+.||.+||+.||+|+||||+|||++.++.++|+|||.+...... .
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---N 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c
Confidence 9999997 99999987788999999999999999999999999999999999999999999999999999764111 1
Q ss_pred cccccccCCccccCccccc-ccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 184 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~-~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
.......++..|+|||++. + ..++.++|||||||++|+|++|..||...+..+....+......+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~------------ 218 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP------------ 218 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH------------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccc------------
Confidence 2235678999999999987 4 678999999999999999999999998764444333332211100
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..... ......+..+.+||.+||+.||++|||+.++++||||
T Consensus 219 ----~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 219 ----LPSSS---------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----HHHHT---------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----ccccc---------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00000 0011123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=371.76 Aligned_cols=250 Identities=28% Similarity=0.477 Sum_probs=206.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||+||+|.++.+|+.||||++.... ........+.+|.. +++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999986432 12233455666655 46789999999999988 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999875332221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999876 6799999999999999999999999987765443332211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~elL~hp~f~~~ 320 (620)
.+ ....+.+++.+.+||++||+.||.+||++ .++++||||..+
T Consensus 211 ---------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 ---------KP---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred ---------CC---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 11234678899999999999999999988 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=370.79 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=209.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+++.||||++.... ........+..|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999987532 1233455677899998866 799999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||+ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999876432221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999876 67999999999999999999999999887765544433210
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-------TAEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-------sa~elL~hp~f~~~ 320 (620)
.. .....++.++.+||.+||+.||++|+ +++++++||||..+
T Consensus 212 ---------~~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 ---------DV----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ---------CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 00 01123678999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=369.55 Aligned_cols=264 Identities=25% Similarity=0.433 Sum_probs=213.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||++.++.+++.||+|++.+. .........+.+|+.++..++|+||+.+++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4799999999999999999999999999999998642 12223445677899999999999999999998 45568
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999998 699999976 457999999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11235799999999998631 145788999999999999999999999877655444333211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~~ 320 (620)
.....+....+.+++.+++||++||..++++ |++++++|+||||.++
T Consensus 224 -----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 -----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred -----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0111122234457899999999999765554 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=361.06 Aligned_cols=288 Identities=36% Similarity=0.627 Sum_probs=230.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998754333334456788999999995 699999999886544333445
Q ss_pred EEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCcccc
Q 007050 102 IYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~ 175 (620)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999888642 35899999999999999999999999999999999999998 88999999999876
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
....... .+...++++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.|..+.+
T Consensus 161 ~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 4322111 1234678899999987542 46789999999999999999999999999888888888888888877655
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
........... .....+.......+.+++.+.+||.+||..||.+||+++|+|.||||+
T Consensus 237 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHE----FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhh----cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 43321111100 111112222333467889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=378.14 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=213.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||++.++.+++.||+|++.+. .........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 346899999999999999999999999999999998642 12223445677899999999999999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 67999999998 6999988654 689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~--~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|..||.+.+....+..|.+..
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 263 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK--------- 263 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 211 1224568999999999986521 237899999999999999999999998876554444332210
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~ 319 (620)
....+ .....++..+++||.+||..++.+ |++++|+|+||||+.
T Consensus 264 ------------------~~~~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 264 ------------------NSLNF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ------------------cccCC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 00111 112356889999999999866544 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=368.23 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=212.3
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCe
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.|.+++.||+|+||.||+|.++.+++.||||++.+... .......+..|..++..+ .|++|+.+++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48899999999999999999999999999999875422 223345567788888877 588999999888 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||+. |+|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1245679999999999987 67999999999999999999999999887655444433220
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. . .....++.++.+||.+||+.||.+|++ ..++++||||+.+
T Consensus 217 --------------~-~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 --------------N-V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred --------------C-C---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 011357889999999999999999997 4899999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=358.17 Aligned_cols=282 Identities=38% Similarity=0.678 Sum_probs=218.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 479999999999999999999999999999999865432222334577899999999999999999998 445679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 5555555666799999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
......++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.-...........
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999987652 45889999999999999999999999988877666555544333222111100000
Q ss_pred hhHHHHHHhhhcc---CCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKK---QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~---~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+...+... ........+++++..+.+||.+||..||++|||+.|+|.||||
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ----QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ----cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000000000 0011122346778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.75 Aligned_cols=286 Identities=40% Similarity=0.637 Sum_probs=233.3
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+|++.+.||.|+||.||+|.++.+++.||||++...... ......+.+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 589999999999999999999999999999999754322 22345567899999999999999999998 3456
Q ss_pred eEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+||||+.++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998766 7999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334578899999987542 467899999999999999999999999988888888888878877766554432
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
...... ......+......+...+..+.+||.+||.+||++|||+.|+|.||||.+...
T Consensus 232 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLPDYV----EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccc----cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 111110 01111222233445677899999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=367.96 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=205.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+|+.||+|+++.... .......+..|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975321 123345567788888754 899999999998 4556899999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|.+.+..++.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987532111 12
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 345689999999999986 6799999999999999999999999987665433322211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-~elL~hp~f~~~ 320 (620)
..+ .....++.++++||++||..||++|+++ +++++||||+..
T Consensus 211 --------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 --------DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred --------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 000 0112367899999999999999999998 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.12 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=206.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
++||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 479999999999999999999999999975422 223455678899999988 699999999998 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||+ ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .|.. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~----------~~~ 210 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQ----------NTE 210 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccc----------cch
Confidence 245689999999999987 678999999999999999999999996422100 0000 000
Q ss_pred HH-HHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCCcccCC
Q 007050 266 RY-LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 320 (620)
Q Consensus 266 ~~-~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps------a~elL~hp~f~~~ 320 (620)
.+ ...+... ... ....++..+.+||.+||+.||.+|+| ++++++||||..+
T Consensus 211 ~~~~~~~~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 211 DYLFQVILEK-QIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 01 1111111 111 12357889999999999999999987 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.64 Aligned_cols=295 Identities=34% Similarity=0.540 Sum_probs=227.4
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~--- 96 (620)
.+.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 45568999999999999999999999999999999986543333334456789999999999999999998865432
Q ss_pred CCCCeEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
......|+||||+.++|.+.+.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 2345679999999999988887643 689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCc-ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... ........++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+..+.|....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 5432211 1112345678899999987652 4578899999999999999999999999988888888888777766654
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQ--KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
+.....-+... .+. ........... .....++.+.+||.+||..||.+|||++|+|+||||
T Consensus 248 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFK-KME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhh-hcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 44331111100 000 00000000000 011246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.01 Aligned_cols=251 Identities=28% Similarity=0.459 Sum_probs=209.3
Q ss_pred EEEeeecCceEEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 28 QEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d---~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
++.||+|+||.||++.+ +.+|+.||+|++............+.+|+.+|+.++||||+++++++ .+...+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence 36899999999999876 46789999999976433334456677899999999999999999998 44567999
Q ss_pred EEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 105 VFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 105 V~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
|||||+ ++|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999876433221
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 1234679999999999876 67899999999999999999999999877654443333210
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. ......+++.+.+||++||+.||++||+ +++++.||||..+
T Consensus 214 ----------~-----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 ----------K-----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ----------C-----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0 0111346889999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=368.21 Aligned_cols=280 Identities=32% Similarity=0.575 Sum_probs=224.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CC----cceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PD----IVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H--pn----Iv~l~~v~~~~~ 95 (620)
..||.++..+|+|.||.|..+.|..++..||||+++.. ....++ .+-||.+|.++.+ |+ ++.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreA--a~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREA--ALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhH--HHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 58999999999999999999999999999999999754 333333 3459999999943 32 56666666
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC------------
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA------------ 161 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~------------ 161 (620)
+..+.+|||||.++.++++++++|+ +++..+++.|.+||+.+++|||+.+++|.||||+|||+.+
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 5567899999999999999999876 6899999999999999999999999999999999999743
Q ss_pred --------CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 007050 162 --------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (620)
Q Consensus 162 --------~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g 233 (620)
+..|+|+|||.|+...... +..+.|+.|+|||++.+ -+|+.++||||+||||+||.+|..+|++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 2348999999998654332 45689999999999998 6899999999999999999999999999
Q ss_pred CChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccC---------------CCcccCCCCCC---CHHHHHHHH
Q 007050 234 KNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ---------------PVQFSQKFPNA---DPSALRLLE 295 (620)
Q Consensus 234 ~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~---s~~l~dLI~ 295 (620)
.++.+.+..|...+|..+...+.+.. ...|+..-+-.+ +.++....... ...+.|||+
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~----~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTR----KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhh----hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 99999999999999977766665441 333332221111 11111111112 235889999
Q ss_pred HhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 296 RLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 296 ~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+||.+||.+|+|+.|+|.||||+.+.
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcCC
Confidence 99999999999999999999998753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=366.06 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=205.3
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~-L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.+..+++.||||+++.... .......+..|..++.. ++||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 479999999999999999999999999975321 22334456677777765 4899999999988 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
||+. ++|.+++...+.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999997643222 12
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999876 6789999999999999999999999988765443333211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-~elL~hp~f~~~ 320 (620)
..+ .....++.++.+||.+||..||.+||++ .+++.||||..+
T Consensus 211 --------~~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 --------DRP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred --------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 000 0112467899999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.19 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=213.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47999999999999999999999999999999986421 1223344577899999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.. ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------- 223 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----------
Confidence 21 112345799999999988521 146889999999999999999999999887655544443221
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~~ 320 (620)
.....+......+++.+++||++||..++++ |++++|+++||||.++
T Consensus 224 -----------------~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 224 -----------------KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred -----------------CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 0111122334567899999999999776555 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=358.58 Aligned_cols=287 Identities=38% Similarity=0.661 Sum_probs=230.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||+|++|.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 579999999999999999999999999999999865433333345677899999999999999999998 445679
Q ss_pred EEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCccccccCC
Q 007050 103 YVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~~~~~ 179 (620)
|+||||++++|.+.+..... +++..++.++.||+.||+|||+++|+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999988876543 578888999999999999999999999999999999985 567999999999754322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ..+...+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345678999999987652 468899999999999999999999999988888888888888888776655332
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.. ..+................+.+++.+.+||.+||+.||++||+++++|+||||.++.
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 SL---PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cc---hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11 111111111111222223467889999999999999999999999999999998754
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=366.37 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=207.9
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||+||+|.++.+++.||||++.+.. ........+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999997532 2223455677899999888 699999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999977 6799999999999999999999999987664433322211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~elL~hp~f~~~ 320 (620)
... .....++..+.+||++||..||++|||+ .++++||||+.+
T Consensus 211 --------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 --------DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred --------CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 0112467899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=360.66 Aligned_cols=287 Identities=40% Similarity=0.662 Sum_probs=231.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|++.+.||.|+||.||+|.++.+++.+++|.++...........+.+|+.+++.++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 3579999999999999999999999999999999975433333344567899999999999999999988543 2367
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||+.++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887644 58999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|..+.+..+..
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12345678899999988652 3468899999999999999999999999998888888888888888776654421
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNA--DPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
-..... ..........+...++.. ++.+.+||++||+.||++|||++|+|.||||
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK--KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc--cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 111100 000111112223345554 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.26 Aligned_cols=280 Identities=24% Similarity=0.312 Sum_probs=217.4
Q ss_pred CCeEEEEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++ ....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~ 159 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAY-----RWKS 159 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeE-----eeCC
Confidence 47999999999999999999764 45678999988642 1245799999999999999999988 4456
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|||++.++|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 79999999999999999877889999999999999999999999999999999999999999999999999997654332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---hhHHHHHhhhccCCCChhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---VVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~---~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..+...++....+....
T Consensus 240 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 240 DT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 21 12235679999999999876 679999999999999999999999997754 3455666666555544332111
Q ss_pred hhhchhHHHHHHhhhc--cCCCcccCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 258 VVRNDKARRYLTSMRK--KQPVQFSQK--FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
. .......+..... +.+...... ....+.++.+||.+||.+||++|||+.|+|.||||..
T Consensus 317 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 G--STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred c--chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0 0011111111110 111111111 1245678999999999999999999999999999975
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=355.51 Aligned_cols=287 Identities=37% Similarity=0.602 Sum_probs=222.9
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
||..+.|++++.||+|+||.||+|.++.++..||+|.+..... ......+.+|+.+++.++|+||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~ 74 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDII-----HT 74 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ec
Confidence 4667899999999999999999999999999999999864321 22233567899999999999999999998 34
Q ss_pred CCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
....|+||||+.++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 467999999999888887754 3468889999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... .....+++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+ ..+++..+...+|.|..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2211 12334678999999988642 457889999999999999999999997654 445666677777777766554
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+.........+.. ...+..+...+. ..++.+.+||.+||..||++|||++|+|.||||
T Consensus 231 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKLPNYKPEWFL--PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhcccccchhcc--ccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 43221111111100 011111111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.68 Aligned_cols=281 Identities=38% Similarity=0.673 Sum_probs=229.4
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++++.||.|++|.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++.+ .+....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEE
Confidence 58999999999999999999999999999999875422 22345677899999999999999999998 4446789
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELMESDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+||||++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||++++++.+||+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988754 358999999999999999999999999999999999999999999999999997543221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......++..|++||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|..+.+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678899999987652 4578899999999999999999999999998888888888888888777665531
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .+................+..+..+.++|.+||+.||.+||+++++++||||
T Consensus 231 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LP---EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred Cc---hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1111111111111222345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=371.70 Aligned_cols=258 Identities=26% Similarity=0.334 Sum_probs=203.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|++++.||+|+||.||+|.++.+++.||||++.... .......+.+|+.+|+.++|+||+++++++ .+...
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 357889999999999999999999999999999986432 233456788999999999999999999998 45567
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||.+ +|... ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999995 66542 346788889999999999999999999999999999999999999999999998653222
Q ss_pred CcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+...
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---------------- 283 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS---------------- 283 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH----------------
Confidence 1 12346799999999987431 1234568999999999999999999996432111100
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
......... .......++..+++||.+||..||++|||+.|+|+||||.+-
T Consensus 284 ---------~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 284 ---------LMCAICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ---------HHHHHhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000000000 111234678899999999999999999999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.45 Aligned_cols=294 Identities=37% Similarity=0.619 Sum_probs=231.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---C
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---R 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~---~ 97 (620)
..++|++++.||.|+||.||+|.++.+++.+|||++............+.+|+++++.++||||+++++++..... .
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 4579999999999999999999999999999999986433222223456789999999999999999998754432 2
Q ss_pred CCCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
....+|+||||+.++|...+.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3456899999999988888765 347999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCc--------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccC
Q 007050 177 FNDTPT--------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 177 ~~~~~~--------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg 248 (620)
...... ....+...+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 432211 1122345678999999987652 4588999999999999999999999999999888888888877
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+....+........... .......+..+...+...++.+.+||.+||..||.+|||+.|+|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEG--VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccc--cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 776654433211000000 0001111222233455677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=368.54 Aligned_cols=259 Identities=23% Similarity=0.409 Sum_probs=205.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+++.||+|++++.. ........+.+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997542 2234455677899988776 799999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|...+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9999 59999988888899999999999999999999999999999999999999999999999999875332221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..+... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------~~~~~~---------~~~ 211 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS----------DNPDQN---------TED 211 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCc----------CCcccc---------cHH
Confidence 234679999999999987 67899999999999999999999999532110 000000 000
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps------a~elL~hp~f~~~ 320 (620)
.....+... .. .....++..+.+||++||+.||++|++ ++++++||||+.+
T Consensus 212 ~~~~~i~~~-~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 212 YLFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcC-CC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 011111111 11 122357889999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=372.56 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=212.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3579999999999999999999999999999999986421 2223445677899999999999999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 67999999998 6999988654 589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccC--CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~--~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|..||.+.+....+..|....
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 263 (371)
T cd05622 195 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--------- 263 (371)
T ss_pred CCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 221 1123568999999999986521 238899999999999999999999998876544443332210
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~ 319 (620)
....+ ...+.++..+++||.+||..++.+ |++++|+++||||++
T Consensus 264 ------------------~~~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 264 ------------------NSLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred ------------------CcccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 00111 123468899999999999844433 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=363.72 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=210.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCe
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+|++++.||+|+||.||+|.++.+|+.||||++.+... .......+..|+.++..+. |++|+++++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 47889999999999999999999999999999875321 2234456778999998886 56778888887 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ ++|.+++...+.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234579999999999876 67899999999999999999999999887654443333210
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. ......++..+.+|+.+||+.||.+|++ .+++++||||..+
T Consensus 217 --------------~----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 --------------N----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred --------------C----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 0112356789999999999999999997 5899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=354.51 Aligned_cols=281 Identities=41% Similarity=0.677 Sum_probs=230.2
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|++++.||.|++|.||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++ .+....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 6789999999999999999999999999999875433333345678899999999999999999998 34467999
Q ss_pred EEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 105 VFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 105 V~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
||||++++|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999997765 789999999999999999999999999999999999999999999999999975432211
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+.+++|..+.+..+....
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 11234568899999987652 357889999999999999999999999998888888888888888877655442221
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+................+.++..+.+||.+||+.||.+|||++|++.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 ---DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ---hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1222222222222333456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=367.09 Aligned_cols=250 Identities=29% Similarity=0.501 Sum_probs=205.5
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|.. +++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 469999999999999999999999999865321 2233445566665 46789999999999988 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|...+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245689999999999876 6789999999999999999999999987664433322211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~elL~hp~f~~~ 320 (620)
. . ....+..+..+.+||++||..||.+||++ .++++||||+..
T Consensus 211 --------~-~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 --------K-P---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred --------C-C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 0 11234678899999999999999999976 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=364.83 Aligned_cols=298 Identities=40% Similarity=0.656 Sum_probs=228.0
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~--- 96 (620)
+...+|.+.+.||.|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 44689999999999999999999999999999999986532 2345667899999999999999999988754321
Q ss_pred ------CCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcc
Q 007050 97 ------RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICD 169 (620)
Q Consensus 97 ------~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~D 169 (620)
.+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 12246899999999999988864 46999999999999999999999999999999999999974 56789999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
||+++................++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997653322211122334688999999986542 56889999999999999999999999988877777666655444
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
+..+....... .. .............++....+.++.++++||.+||+.||++|||++|+|.||||+.+..+
T Consensus 238 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 238 VREEDRNELLN-VI-PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CChHHhhhhhh-hh-hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 44433222211 00 01111000111112223345788999999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.77 Aligned_cols=290 Identities=37% Similarity=0.614 Sum_probs=222.8
Q ss_pred CeEEEEEeeecCceEEEEEEECC--CCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+|++.+.||+|+||.||+|.++. ++..||+|.+.... ........+.+|+.+++.++||||+++++++... +..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999997532 1122345677899999999999999999998543 236
Q ss_pred eEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC----CCcEEEcccC
Q 007050 101 DIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----NCKLKICDFG 171 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----~~~lKL~DFG 171 (620)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChh---------HHHHH
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---------HQLDL 242 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~---------~~l~~ 242 (620)
++................+++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+.. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654332222223445789999999987652 46889999999999999999999999876532 35566
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCC-----cccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPV-----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
+...++.+....+...................... .....+...+..+.+||.+||+.||++|||+.|++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 66777777665554432222222211111000000 0011112577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.68 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=202.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||+|+||+||++.++.+++.||+|++..... .......+.+|+.+|+.++||||+++.+++ .+...+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 7999999999999999999999999864321 222345677899999999999999999988 4456799999999
Q ss_pred C-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccc
Q 007050 110 E-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 110 ~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
+ ++|.+.+.. +..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 588877742 346999999999999999999999999999999999999999999999999999765432221
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhH
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~ 264 (620)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------- 210 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------------- 210 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--------------------
Confidence 234679999999999987 678999999999999999999999997653211100000
Q ss_pred HHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
..+. ..+ ....+.+++.+.+|+.+||+.||++|| +++++++||||+++
T Consensus 211 ----~~~~-~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 211 ----QRIL-NDS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ----Hhhc-ccC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 0000 001 112245788999999999999999999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.08 Aligned_cols=250 Identities=24% Similarity=0.421 Sum_probs=205.3
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~-L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+++.||||+++.... ..........|..++.. ++||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975421 12334556678888876 4899999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
||+. |+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--------------------- 209 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--------------------- 209 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------
Confidence 234679999999999876 679999999999999999999999998766443332221
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-elL~hp~f~~~ 320 (620)
...+. ....++..+.+||.+||+.||++|+++. ++++||||+.+
T Consensus 210 -------~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 210 -------MDNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -------hCCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 00000 1123678899999999999999999996 89999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.14 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=204.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|+++.+++.||+|++..... .......+.+|.. +++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 479999999999999999999999999864321 1223334555554 57889999999999988 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999887 6799999999999999999999999987665443332211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHH----HHHcCCcccC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE----EALADPYFKG 319 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~----elL~hp~f~~ 319 (620)
.+ ....+.+++.+.+||++||+.||.+|+++. ++++|+||..
T Consensus 211 ---------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 211 ---------KP---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ---------CC---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 00 112356789999999999999999999876 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.24 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=204.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
++||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+. +++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999986432 12233445556654 67889999999999988 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||+ ++|...+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999876 6799999999999999999999999988764433322211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~elL~hp~f~~~ 320 (620)
.+. ...+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 ---------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 ---------KPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred ---------CCC---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 011 1124567899999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=347.06 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=211.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+.|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 5699999999999999999999999999999998643222 12345678999999999999999999998 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 68999999998 59999998888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2222111134568899999999987 5689999999999999999999999976543222111110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
... .......++..+.+||.+||..||++|||+.++|+||||
T Consensus 222 --------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 --------------QPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------cCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 000 011223578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.26 Aligned_cols=277 Identities=27% Similarity=0.434 Sum_probs=228.0
Q ss_pred eEE-EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeE
Q 007050 25 YKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 25 Y~i-~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (620)
|++ .+.||+|+|+.|-.|+...+|..||||+|.+... -...+++||++++.+++ |+||++++++| +++..+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 544 4689999999999999999999999999987532 35678999999999995 99999999998 788899
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEcccCccccccC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVAFN 178 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DFGlA~~~~~ 178 (620)
|||||-|. |.|...|.++.-|++.++..++++|+.||.|||.+||.||||||+|||....+. ||||||.|+.-...
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999 599999999999999999999999999999999999999999999999876544 89999999865332
Q ss_pred CC----CcccccccccCCccccCccccc---ccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 179 DT----PTTIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 179 ~~----~~~~~~~~~~gt~~Y~APEvl~---~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
.. ..+..+.+.||+..|||||+.. +....|+.++|.||||||+|-||.|.+||.|....+ .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--------C---- 299 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--------C---- 299 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--------C----
Confidence 21 1223345678999999999753 333579999999999999999999999998864211 0
Q ss_pred hhhhhh-hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 252 LDTISR-VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 252 ~e~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.|.+ -........+++.+.....-.....|..+|.+++|||..+|..|+..|.++.++|+|||++....
T Consensus 300 --GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 300 --GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred --CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 1110 00223344566777766665566778899999999999999999999999999999999997654
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=369.19 Aligned_cols=279 Identities=25% Similarity=0.330 Sum_probs=208.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
...|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+|+.++||||+++++++. +...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence 34699999999999999999999999999999975432 2346999999999999999999984 4456
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 899999999999998865 4579999999999999999999999999999999999999999999999999997532221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CCCCCCC---------hhHHHHHhhhccCCC
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKN---------VVHQLDLMTDLLGTP 250 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~pF~g~~---------~~~~l~~i~~~lg~p 250 (620)
......||..|+|||++.+ ..|+.++|||||||++|||+++. ++|.... ...++..+...++..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234579999999999877 67999999999999999999855 4554321 112233333333332
Q ss_pred ChhhhhhhhhchhHHHHHHhhhc-cCCCccc--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRK-KQPVQFS--QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+..... .......++..... +.+.... ....+++..+.+||.+||++||++|||++|+|+||||+++
T Consensus 286 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDP-GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCC-ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 22111000 11111111111000 0110000 0123567788999999999999999999999999999863
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=363.61 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=212.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.+++.++|+||+++++++ .+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986421 2223345577899999999999999999998 45578
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+|||||. |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05624 156 GT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred Cc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC----------
Confidence 21 112335799999999988642 135788999999999999999999999876654443333210
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~ 319 (620)
.....+...+..+++.+++||.+||..++.+ |++++++++||||+.
T Consensus 224 -----------------~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 224 -----------------EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred -----------------CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 0111223334567899999999999976655 569999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=354.95 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=209.6
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+ .+...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4899999999999999999999999999999986432 2222334577899999999999999999988 344579
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+|||||. ++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5898887543 46899999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-------------- 215 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-------------- 215 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--------------
Confidence 11 134578999999999876 6789999999999999999999999987654322211111
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.+... . ......+++.+.+||.+||..||++|| +++++++||||...
T Consensus 216 ----------~~~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 216 ----------RVKED-Q---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------Hhhhc-c---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 01100 0 112235788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=353.43 Aligned_cols=285 Identities=35% Similarity=0.638 Sum_probs=221.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++ .+....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 479999999999999999999999999999999865433333455677899999999999999999988 455679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 666666666679999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
...+.+.++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.......... ..
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 230 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF-QK 230 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh-cc
Confidence 123456789999999988652 45788999999999999999999999988777766666655544322111111 00
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.....................+++++..+.+|+.+||..||++||++.++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00000000000000111222356789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=361.90 Aligned_cols=284 Identities=23% Similarity=0.364 Sum_probs=216.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||.|+||.||++.++.++..+|+|.+.... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCE
Confidence 368999999999999999999999999999999887542 3344567889999999999999999999983 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 59999998888899999999999999999999985 7999999999999999999999999998754322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhh-ccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~-~lg~p~~e~i~~~ 258 (620)
. ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.. ..+.+........
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134578999999999876 5789999999999999999999999987654332221110 1111111100000
Q ss_pred hhc---------------hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 VRN---------------DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+. .........+....+..+. ....+.++++||.+||++||++|||++|+|.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 0000111111111111110 12357889999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=350.71 Aligned_cols=280 Identities=39% Similarity=0.736 Sum_probs=222.1
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
|++++.||+|+||.||+|.++.+++.||+|+++...... ......+|+.+++.+. |+||+++++++... ....+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 788999999999999999999999999999987643332 2234457999999885 99999999998542 225789
Q ss_pred EEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+||||++++|.+.+... ..+++..+..++.||+.||.|||+.|++||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999888763 57899999999999999999999999999999999999999 9999999999986543222
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
.....++..|+|||++... ..++.++|||||||++|+|++|.+||++.+..+.+..+.+.++.+..+..... ...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 229 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF-RKS 229 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh-ccc
Confidence 2345688999999976432 45788999999999999999999999999988888888888888776543222 111
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
....+ .........+....+.++..+.+||.+||..||++|||++++|+||||
T Consensus 230 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 230 RHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 10000 000000111111234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=381.29 Aligned_cols=266 Identities=27% Similarity=0.389 Sum_probs=218.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---C
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---R 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~---~ 97 (620)
..++|.+.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+..... .
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3479999999999999999999999999999999997654455666778899999999999999999887643321 1
Q ss_pred CCCeEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
....+++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 1224789999999 699998865 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
++........ ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 190 s~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~------- 259 (496)
T PTZ00283 190 SKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA------- 259 (496)
T ss_pred Ceeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-------
Confidence 9865432211 11235689999999999987 6799999999999999999999999987664433322211
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.. .....+.+++.+.+||.+||..||.+||++.++|+|||++.+
T Consensus 260 ---------------------~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 260 ---------------------GR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ---------------------CC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 00 011234678899999999999999999999999999998754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=364.47 Aligned_cols=253 Identities=30% Similarity=0.401 Sum_probs=207.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcE-EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~-vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.....+.+.||.|+||+||++... |.. ||||++............+.+|+.+|+.|+|||||++++++..+. .
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~ 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----G 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----C
Confidence 445566777999999999999764 566 999999865544455778999999999999999999999995432 1
Q ss_pred eEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCceEeCCCC-cEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTAN-VYHRDLKPKNILANANC-KLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILl~~~~-~lKL~DFGlA~~ 175 (620)
.++||||||. |+|.+++.. ...++...+..|+.||++||.|||+++ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 6899999999 799999977 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..... ...+...||+.|||||++.+....|+.++||||+|+++|||+||+.||.+.........+....-+|.
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 54321 22344789999999999984115899999999999999999999999988776443333322111111
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.....++.+..|+++||..||.+||+..+++.
T Consensus 267 --------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 --------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 01126789999999999999999999999865
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=376.99 Aligned_cols=281 Identities=26% Similarity=0.324 Sum_probs=210.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.|+||||+++++++. ....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 457999999999999999999999999999999643 123568999999999999999999873 3456
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.|+|||++.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999998653322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCC-CCCCCC------hhHHHHHhhhccCCCChh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKN------VVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~-pF~g~~------~~~~l~~i~~~lg~p~~e 253 (620)
.. ......+||+.|+|||++.+ ..++.++||||||||||||++|.. +|.... ...++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 21 11234579999999999977 679999999999999999999875 444321 123334443332221111
Q ss_pred hhhhhhhchhHHHHHHhhhc----cCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 254 TISRVVRNDKARRYLTSMRK----KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.. ..........+...... .........+..++..+.+||.+||++||.+|||++|+|+||||+.
T Consensus 392 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FP-QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CC-CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 10 00000111111111111 1111111223356788999999999999999999999999999974
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=366.42 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=202.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
||+|+||+||+|.++.+++.||||++.... ..........+|..++..+ .||||+++++++ .+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999999999999999986421 1223344556777777665 699999999998 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
||+. ++|.+.+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432221 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456899999999988652 4589999999999999999999999987654433322211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP----TAEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp----sa~elL~hp~f~~~ 320 (620)
.. ..+. ...+++.+.+||++||..||.+|| +++++++||||...
T Consensus 212 --------~~-~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 --------GK-VRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred --------CC-CCCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 00 0000 123688999999999999999998 79999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=352.54 Aligned_cols=286 Identities=39% Similarity=0.681 Sum_probs=223.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||+|+||.||+|.++.+++.||+|+++...........+.+|+.+++.++|+||+++++++. +...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 4799999999999999999999999999999998754344444567889999999999999999999983 35679
Q ss_pred EEEEecCCccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQ-VIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~-~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+++++.+ ++.....+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999999975544 444556799999999999999999999999999999999999999999999999999987544332
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....++++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++............+
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998762 37889999999999999999999999988877776666665555444332222111
Q ss_pred hhHHHHHHhhhccCCCcccCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..... ........+..+...++. ++..+++||++||..||++|||++++++||||
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAG-VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccc-cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 10000 000000011111122333 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=361.79 Aligned_cols=257 Identities=22% Similarity=0.393 Sum_probs=205.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++..+ +||||+.+++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975422 223456678899999888 699999999988 4556799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|||. ++|...+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---------~~~~------------ 209 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------NTED------------ 209 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---------ccHH------------
Confidence 245689999999999876 68899999999999999999999999643211000 0000
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps------a~elL~hp~f~~~ 320 (620)
.....+ ...+.. ....++..+.+||.+||..||++|++ .+++++||||+.+
T Consensus 210 ~~~~~~-~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 210 YLFQVI-LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHH-HhCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 000111 111111 12346889999999999999999998 5799999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=349.50 Aligned_cols=282 Identities=46% Similarity=0.758 Sum_probs=233.8
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+|+.++|+||+++++++. +...+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 67889999999999999999999999999998765444345667889999999999999999999883 4467999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 105 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 105 V~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
||||++++|.+.+... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999999888763 579999999999999999999999999999999999999999999999999997664332
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
.......++.+|+|||.+.+. ..++.++|+|||||++|+|++|+.||++.+..+++..+.+.++.+..+.+..+...
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-- 229 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh--
Confidence 112345688899999998762 37899999999999999999999999999998888888888888877666554221
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
...................++.++..+++||.+||..||.+||+++++|.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111111222222223333456788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.35 Aligned_cols=293 Identities=39% Similarity=0.592 Sum_probs=233.4
Q ss_pred CCCCCCeEE-EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH------------HHHHHHHHHHHHhcCCCCcc
Q 007050 19 YGDASRYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD------------AARILREIKLLRLLRHPDIV 85 (620)
Q Consensus 19 ~g~~~rY~i-~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~------------~~~i~rEi~iL~~L~HpnIv 85 (620)
+...++|.. .+.||.|+||+||+|.++.+++.||||++......... ...+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 455678875 57799999999999999999999999998643221100 12467899999999999999
Q ss_pred eeeeEecCCCCCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcE
Q 007050 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (620)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~l 165 (620)
++++++. ....+|+||||+.++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+
T Consensus 84 ~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYV-----EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEe-----cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 9999983 44579999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEcccCccccccCCC-----------CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 007050 166 KICDFGLARVAFNDT-----------PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (620)
Q Consensus 166 KL~DFGlA~~~~~~~-----------~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~ 234 (620)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011112334678899999988652 45789999999999999999999999999
Q ss_pred ChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 235 ~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+..+.+..+...++.|....|.......... ......+..+...++..+..+.+||.+||..||++|||++|+|.|
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYT----EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhccccc----ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 9999998898888888765544321110000 011112222333456678899999999999999999999999999
Q ss_pred CcccCCC
Q 007050 315 PYFKGLS 321 (620)
Q Consensus 315 p~f~~~~ 321 (620)
|||+...
T Consensus 314 ~~~~~~~ 320 (335)
T PTZ00024 314 EYFKSDP 320 (335)
T ss_pred cccCCCC
Confidence 9998654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=338.53 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=210.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|++++.||+|++|.||++.++.+++.||+|++............+.+|+.+++.++|+|++++++.+. .+...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 499999999999999999999999999999999754444455667889999999999999999988763 2234689
Q ss_pred EEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+||||+. ++|.+++.. ...+++..++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 589998876 3468999999999999999999999999999999999999999999999999998653322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 2244578999999999876 6788999999999999999999999977553322211110
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .......+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 217 -------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -------------GK---LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------------cC---CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 001123577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.21 Aligned_cols=281 Identities=42% Similarity=0.713 Sum_probs=233.0
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|++.+.||+|.||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++. +...+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 67889999999999999999999999999999865433344566778999999999999999999883 4467999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 105 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 105 V~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
......++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+...++.+..+.+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999988652 478999999999999999999999999999988999998888888877665542211
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+...............++..+..+.+||.+||..||++||++++++.||||
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 --DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred --cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111222222334566778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=373.58 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=211.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~t-g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..|.+.+.||+|++|.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCE
Confidence 3499999999999999999999888 78899997753 2334556677899999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+|||||||. |+|.+.+.. ..++++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 699887753 446899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----------- 285 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----------- 285 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 43221 112345689999999999877 6799999999999999999999999987655433332211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
... ......+++.+.+||.+||..||++||+++++|.|+|++.
T Consensus 286 -----------------~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 286 -----------------GKY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------------CCC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 000 0112356789999999999999999999999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.88 Aligned_cols=287 Identities=23% Similarity=0.309 Sum_probs=207.4
Q ss_pred EEEEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 27 IQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 27 i~~~LG~G--~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
++++||+| +|++||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++. +...+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 57889999 6789999999999999999999765444445566778999999999999999999984 4467999
Q ss_pred EEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 105 VFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 105 V~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|||||+ ++|.+++..+ ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 6999998653 4589999999999999999999999999999999999999999999999987654321111
Q ss_pred cc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC-C------
Q 007050 182 TT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT-P------ 250 (620)
Q Consensus 182 ~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~-p------ 250 (620)
.. ......+++..|+|||++.+....|+.++|||||||++|+|++|..||........+..... +. |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccccccc
Confidence 00 01112356788999999875334689999999999999999999999986554332222211 11 0
Q ss_pred ---ChhhhhhhhhchhHHHHHHh-----hhc-cCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 251 ---SLDTISRVVRNDKARRYLTS-----MRK-KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 251 ---~~e~i~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+.............+... ... ............+++.+.+||++||+.||++|||++|+|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00000000000000000000 000 00000011122467899999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.92 Aligned_cols=285 Identities=39% Similarity=0.660 Sum_probs=228.3
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|++++.||.|+||.||+|.+..+++.+|+|++............+.+|+.+++.++|||++++++++... ....+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 7899999999999999999999999999999986543334456678999999999999999999998432 1367999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 105 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 105 V~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
||||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999987644321
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+.+..+.|..+.+..+.....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 112344678899999977642 4688999999999999999999999999998888888888888877665544321111
Q ss_pred HHHHHHhhhccCCCcccCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
...+.. ....+..+...+.. .++.+.++|++||..||.+||++++++.||||
T Consensus 235 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKP--KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccc--cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000000 00001111122333 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=388.81 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=213.9
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...++|++++.||.|+||.||+|.++.++..||+|++............+.+|+.+|+.|+||||++++++|... ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence 345789999999999999999999999999999999976545556677889999999999999999999988543 33
Q ss_pred CeEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeecCCCCceEeCC------
Q 007050 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-------NVYHRDLKPKNILANA------ 161 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~-------gIvHrDLKP~NILl~~------ 161 (620)
..+|||||||. ++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 57999999999 599998865 35799999999999999999999985 4999999999999964
Q ss_pred -----------CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC
Q 007050 162 -----------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (620)
Q Consensus 162 -----------~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p 230 (620)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|++|..|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2458999999997653221 1234579999999999865335689999999999999999999999
Q ss_pred CCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007050 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310 (620)
Q Consensus 231 F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 310 (620)
|...+...++... +.... ....+..+..+.+||.+||.+||.+||++.|
T Consensus 243 F~~~~~~~qli~~---------------------------lk~~p----~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 243 FHKANNFSQLISE---------------------------LKRGP----DLPIKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred CCcCCcHHHHHHH---------------------------HhcCC----CCCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 9765443322111 10100 1112456789999999999999999999999
Q ss_pred HHcCCcccCC
Q 007050 311 ALADPYFKGL 320 (620)
Q Consensus 311 lL~hp~f~~~ 320 (620)
+|.||||+.+
T Consensus 292 lL~h~~ik~i 301 (1021)
T PTZ00266 292 CLGYQIIKNV 301 (1021)
T ss_pred HhccHHHhhc
Confidence 9999999754
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.59 Aligned_cols=284 Identities=24% Similarity=0.371 Sum_probs=216.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||++.+..++..+|+|.+.... ......++.+|+++++.++||||+++++++ .+...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEE
Confidence 36999999999999999999999999999999987532 234456788999999999999999999998 445679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999997 599999999999999999999999999987543221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh-----
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI----- 255 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i----- 255 (620)
....++++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 234678999999999876 57899999999999999999999999876543322222111000000000
Q ss_pred ---hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 256 ---SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 256 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...............+....+. ......+++++.+||.+||..||++|||++++|+||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0000000001111111111111 111123688999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=347.77 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=207.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+.+++.+ .+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 47889999999999999999999999999999864322 222345577899999999999999999988 344679
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 5898888643 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~------------------ 211 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE------------------ 211 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH------------------
Confidence 11 123478999999999976 678999999999999999999999997643211000
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
.......... ......+++.+.+||.+||+.||++||| ++|+++||||+.+
T Consensus 212 ---~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 212 ---EVERLVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ---HHHhhhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0000111000 0112356889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=335.41 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=211.6
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|.+.+.||+|++|.||+|.++.+++.|++|.+............+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 48899999999999999999999999999999875444456677888999999999999999999988 3446799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999998 5999999764 578999999999999999999999999999999999999999999999999988654322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......++.+|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234578899999999876 5789999999999999999999999977654332222211
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. +......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 216 -------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 -------------GV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------------CC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 001111467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.70 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=214.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+++|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47999999999999999999999999999999986432 2234456788999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||+++.....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999996 799999988889999999999999999999999999999999999999999999999999999875433
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134578999999998876 5788999999999999999999999977653322222210
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~~ 321 (620)
.... .....++.+.+||++||..||.+|+ +++|+++||||+.+.
T Consensus 213 --------------~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 --------------GKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred --------------CCcc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 0001 1124578999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=343.49 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=209.5
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++.+ .+.
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~ 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRR 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeC
Confidence 3456899999999999999999999999999999998653 223445677899999999999999999988 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 67999999998 59999998888999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCccccCcccccc-cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... ......|+..|+|||++.. ....++.++|+|||||++|+|++|..||........+..+..
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------ 223 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------------
Confidence 221 1234578999999998741 114588999999999999999999999865432221111100
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
....+..+ .....++..+.+||.+||..||++|||++++|+|||
T Consensus 224 --------------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 --------------SNFQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------cCCCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001111 111246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.55 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=221.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+.|.++++||+|.||+|-+|+.+.+++.||||++++.. -...+....+.|-.+|...+||.+..+.-.| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 467888999999999999999999999999999998653 2335566778899999999999999988777 5667
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+||||.. |+|+-.+.....|++...+++...|+.||.|||+.+||.||||.+|+|+|.||++||.||||++.....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 7999999999 599999988888999999999999999999999999999999999999999999999999999865443
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..+ ..++||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+....+..|.-.
T Consensus 322 g~t---~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------- 383 (516)
T KOG0690|consen 322 GDT---TKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------- 383 (516)
T ss_pred cce---eccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------
Confidence 333 367999999999999987 78999999999999999999999999988765555444210
Q ss_pred hchhHHHHHHhhhccCCCcccCCCC-CCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.-.|| .++++++.|+..+|..||++|. .+.|+.+|+||..+
T Consensus 384 --------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 384 --------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred --------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 01223 5799999999999999999996 57899999999865
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.75 Aligned_cols=282 Identities=38% Similarity=0.632 Sum_probs=224.2
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCCe
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
|++++.||.|+||.||+|.++.+++.||+|++............+.+|+.+++.+ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975433333344566788877766 5999999999986554334445
Q ss_pred EEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|++|||+.++|.+++.... .+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5899999999999999999999999999999999999999999999999999775432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 133467889999999876 578999999999999999999999999998888888887766665443322110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
. ... ..........+....+.+++.+.+||.+||+.||.+||+++|+|.||||
T Consensus 235 ~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 S-LPR----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred c-cch----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 000 0011112222233345677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=354.74 Aligned_cols=253 Identities=26% Similarity=0.456 Sum_probs=198.9
Q ss_pred CCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (620)
++|++.+.||+|+||.||+|.+ ..+++.||+|++... ........+.+|+.+|..+ +||||+++++++..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 5899999999999999999975 244568999998753 2334556788999999999 89999999998742
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC-------------------------------------------------------
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~------------------------------------------------------- 120 (620)
....+|+|||||+ |+|.+++...
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2346899999999 6999988653
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCc
Q 007050 121 -------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193 (620)
Q Consensus 121 -------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~ 193 (620)
..+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCc
Confidence 24778889999999999999999999999999999999999999999999999865322211 1112334567
Q ss_pred cccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhh
Q 007050 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMR 272 (620)
Q Consensus 194 ~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (620)
.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+... +.
T Consensus 241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~---------------------------~~ 291 (338)
T cd05102 241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR---------------------------LK 291 (338)
T ss_pred cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---------------------------Hh
Confidence 8999999876 679999999999999999997 99999875432211110 00
Q ss_pred ccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 273 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 273 ~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ......+++.+.+||.+||..||++|||+.|+++
T Consensus 292 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 0112356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=347.73 Aligned_cols=289 Identities=38% Similarity=0.643 Sum_probs=228.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-----C
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-----R 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-----~ 96 (620)
.++|++.+.||.|+||.||+|.++.+|+.||+|+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46899999999999999999999999999999999754333333456678999999999999999999885432 1
Q ss_pred CCCCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+...+|+||||++++|...+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888888754 3689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
....... ......++..|+|||.+.+. ..++.++|||||||++|+|++|++||...+....+..+....+.+....+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 12234567889999987642 45788999999999999999999999988888888888887777766554
Q ss_pred hhhhhchhHHHHHHhhhc--cCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 256 SRVVRNDKARRYLTSMRK--KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..+..... ...... .........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 243 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPY----FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccc----ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 43311100 000000 00011223345678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=344.59 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=200.2
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||+|+||.||++.++.+|+.||+|++...... ......+..|+.+|+.++||||+++.+++ .+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 79999999999999999999999998643221 12233456799999999999999999988 4556799999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 110 E-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 110 ~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 58988886543 58899999999999999999999999999999999999999999999999987653321 12
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~----------------------- 206 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL----------------------- 206 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-----------------------
Confidence 34578999999999876 56999999999999999999999999764321000000
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCcccCC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 320 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~elL~hp~f~~~ 320 (620)
....... ........+++++++||.+||+.||++||++ ++++.||||+.+
T Consensus 207 -~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 207 -KRRTLED---EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred -HHHhhcc---ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 0000000 0111123578899999999999999999999 778899999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.48 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=207.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..|++.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 468999999999999999999999999999999864322 223455688999999999999999999987432 23
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+. ++|.+++...+.+++...+.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 57899999998 59999998878899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~--------- 224 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---Q--------- 224 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---C---------
Confidence 2111111233568889999999876 5789999999999999999999999976433222111100 0
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
+. .......+++.+.+|| +||..||++||+++|+|+||||+
T Consensus 225 -----------------~~-~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 225 -----------------PT-NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -----------------CC-CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00 0011123577889999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.14 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.|++.+.||+|+||+||++.+..+++.||+|.+.... ........+.+|+.+|+.++|+||+.+.+.+ .+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 4788999999999999999999999999999986532 2222345577899999999999999999888 345679
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999 5888877543 36999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-------------- 215 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-------------- 215 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--------------
Confidence 1 1234578999999999876 6799999999999999999999999987654332222211
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
...... ....+.+++.+.+|+.+||+.||++||+ +++++.|+||+..
T Consensus 216 ----------~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 216 ----------RVLETE----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ----------hhhccc----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 000000 0122456789999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.11 Aligned_cols=264 Identities=23% Similarity=0.386 Sum_probs=211.9
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
....+.|++++.||.|+||.||+|.+..+++.+++|.+... .......+.+|+.+++.++||||+++++.+. .
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 80 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFY-----W 80 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----e
Confidence 34457899999999999999999999999999999998752 3445677889999999999999999999883 4
Q ss_pred CCeEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||+.+ +|..++.+ ...+++..+..++.||+.+|.|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 4579999999995 77777654 457899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
..... ......++..|+|||++.+. ...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------- 229 (292)
T cd06644 161 VKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 229 (292)
T ss_pred ccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--------
Confidence 32211 12345688899999987521 14578899999999999999999999976543222211110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
... +.......++..+.+||.+||..||++||+++++|+||||..+.
T Consensus 230 --------------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 230 --------------------SEP-PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred --------------------CCC-ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 00111235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.91 Aligned_cols=280 Identities=41% Similarity=0.742 Sum_probs=227.3
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
|++.+.||.|++|.||+|.+..+++.|+||++...... .+.....+|+..++.++ ||||+++++++ .+....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEE
Confidence 78899999999999999999999999999998754332 23334567999999999 99999999988 3456799
Q ss_pred EEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 104 VVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 104 lV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
+||||+.++|.+.+.... .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999998764 789999999999999999999999999999999999999999999999999976543221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....++..|+|||++.+. ..++.++|+|||||++++|++|++||++.+..+.+..+...++.|..+.+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2346789999999987542 46889999999999999999999999999998899889888888876654433211
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.....+ .+....+......++..+..+.+||++||+.||++|||++|++.||||
T Consensus 230 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGF--RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccc--cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 111100 111111112223344557899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=375.03 Aligned_cols=287 Identities=24% Similarity=0.293 Sum_probs=205.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc-EEEEEEe--------------cC-ccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE-KVAIKKI--------------HD-IFEHISDAARILREIKLLRLLRHPDIV 85 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~-~vAIK~i--------------~~-~~~~~~~~~~i~rEi~iL~~L~HpnIv 85 (620)
.++|++++.||+|+||.||+|..+.... ..++|.+ .+ ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3689999999999999999987653322 2222211 11 111223345678999999999999999
Q ss_pred eeeeEecCCCCCCCCeEEEEEecCCccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~-----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
++++++ .+....|+|+|++.++|.+++.... ......+..|+.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999998 4456789999999999988875432 244677888999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC-CCC--CChh
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPG--KNVV 237 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p-F~g--~~~~ 237 (620)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..+ |.+ .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 12234689999999999987 6799999999999999999998754 432 2344
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhc-cCCCcccCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRK-KQPVQFSQK--FPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.++..+...++.+..+.... ......++..... ..+..+... ...++..+.+||.+||++||++|||+.|+|.|
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDP---PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCc---HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 55555555555443321110 0111222211110 000111111 12356788999999999999999999999999
Q ss_pred CcccCC
Q 007050 315 PYFKGL 320 (620)
Q Consensus 315 p~f~~~ 320 (620)
|||...
T Consensus 455 p~f~~~ 460 (501)
T PHA03210 455 PLFSAE 460 (501)
T ss_pred hhhhcC
Confidence 999753
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.46 Aligned_cols=261 Identities=27% Similarity=0.448 Sum_probs=213.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+++++.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4799999999999999999999999999999999754222 23556788999999999999999999988 45567
Q ss_pred EEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999984 999998754 5799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCc--------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 007050 179 DTPT--------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (620)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~ 232 (620)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 2110 011124578999999999876 578999999999999999999999998
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC----H
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT----A 308 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps----a 308 (620)
+.+....+..+.. ....+ .....+++.+.+||++||..||++||| +
T Consensus 234 ~~~~~~~~~~~~~-----------------------------~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 234 GSNRDETFSNILK-----------------------------KEVTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred CCchHHHHHHHhc-----------------------------CCccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 7765433322211 00011 111236889999999999999999999 9
Q ss_pred HHHHcCCcccCC
Q 007050 309 EEALADPYFKGL 320 (620)
Q Consensus 309 ~elL~hp~f~~~ 320 (620)
+|+|.||||++.
T Consensus 284 ~~ll~~~~~~~~ 295 (316)
T cd05574 284 AEIKQHPFFRGV 295 (316)
T ss_pred HHHHcCchhhcC
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.25 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=204.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEE
Confidence 46889999999999999999999999999999986532 2334567889999999999999999999983 44678
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
++||||+++ +|... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999995 55433 357899999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
....++|..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+. .+..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---------~~~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG---------SLMP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccc---------ccch---------
Confidence 234579999999999876 6789999999999999999999999965321100 0000
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
......+....+. .......++++.+||.+||+.||.+||+++|++.||||...
T Consensus 206 ---~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 ---LQLLQCIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ---HHHHHHHhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0000000000110 11123467899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.38 Aligned_cols=260 Identities=29% Similarity=0.465 Sum_probs=212.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
...+|++++.||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+ .+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSY-----LVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 3489999999999999999999999999999999986432 23445678999999999999999999998 3456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 7999999998 589998865 46899999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.|
T Consensus 169 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~--------- 233 (297)
T cd06656 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP--------- 233 (297)
T ss_pred cc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC---------
Confidence 21 1234578899999999876 6788999999999999999999999977554322211110 0111
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.......++..+.+||.+||..||++||+++++|+||||+....
T Consensus 234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 234 -------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred -------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 01112346788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=329.33 Aligned_cols=291 Identities=31% Similarity=0.604 Sum_probs=233.9
Q ss_pred cccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007050 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (620)
Q Consensus 16 ~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~ 94 (620)
..+.|.-+.|++++.+|+|.|+.||.|++..+.+.++||+++. -..+.+.||++||+.|+ ||||++++++..++
T Consensus 31 ~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 31 VIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3456778899999999999999999999999999999999874 35677899999999997 99999999998765
Q ss_pred CCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCc
Q 007050 95 SRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGL 172 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGl 172 (620)
. .....+||||++. |..++.. .|+.-++.+++++||.||.|||+.||.|||+||.|++|+.. ..++|+||||
T Consensus 106 ~---SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 106 E---SKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred c---ccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 3 3556899999995 7666653 58999999999999999999999999999999999999965 5699999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChhHHHHHhhhccCCCC
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
|..+..... ..-.+.+++|--||++... ..|+.+-|+|||||+|+.|+..+ |.|.|.++.+|+.+|..++|+-.
T Consensus 180 AEFYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 180 AEFYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred HhhcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 987654322 2345889999999998763 78999999999999999999987 55689999999999999999866
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKF-----PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
....-.-..-+-.++|-.-+.......+.... .-+++++.|||.++|..|-.+|+||.|++.||||..+.+
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 54332221222222222222222222222211 125799999999999999999999999999999986543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.62 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=208.2
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+..++|++++.||+|+||.||+|.++.+++.||+|++... .......+.+|+.+++.++||||+++++.+. +.
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SR 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eC
Confidence 3446799999999999999999999999999999998643 2234456778999999999999999999883 44
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||++ ++|.+++..++.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 67899999999 59999998888899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccc-cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....++..|+|||.+.. ....++.++|+||+||++|+|++|..||...+.......+...
T Consensus 159 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06646 159 TIAK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------- 224 (267)
T ss_pred cccc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-----------
Confidence 2111 134568899999998742 1245788999999999999999999998654322211111000
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
...+. .......++..+.+||++||..||++|||++++|+|+|
T Consensus 225 ---------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ---------------NFQPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---------------CCCCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000 00112346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.41 Aligned_cols=266 Identities=29% Similarity=0.444 Sum_probs=208.6
Q ss_pred cccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEec
Q 007050 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIML 92 (620)
Q Consensus 14 ~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~ 92 (620)
+++.--| ..|++++.||+|+.+.||++.... ...||+|++.....+.....-+.+||.+|.+|+ |.+||+|+++-+
T Consensus 354 ~~i~Vkg--~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKG--REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECc--chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 4444333 679999999999999999997543 356777877766667778888999999999995 999999999874
Q ss_pred CCCCCCCCeEEEEEecCCccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccC
Q 007050 93 PPSRRDFKDIYVVFELMESDLHQVIKANDDL-TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 93 ~~~~~~~~~lylV~E~~~gdL~~~i~~~~~l-se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
. ++.+|+|||+-+.||.+++++.... ..-.+++|.+|||.|++++|..||||.||||.|+|+- .|.|||+|||
T Consensus 431 ~-----d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 431 T-----DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred c-----CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeec
Confidence 3 5679999999999999999876543 3358899999999999999999999999999999885 4589999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccC---------CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~---------~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~ 242 (620)
.|.....+. +.+.....+||..||+||.+.... -+.+.++||||||||||+|+.|++||..-. .++++
T Consensus 505 IA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aK 581 (677)
T KOG0596|consen 505 IANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAK 581 (677)
T ss_pred hhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHH
Confidence 998876544 345556789999999999874311 126688999999999999999999994421 11221
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
+.. +..|.. .-.||.++ .++.++++.||.+||++|||+.|+|+|||+..
T Consensus 582 l~a-I~~P~~---------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 LHA-ITDPNH---------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHh-hcCCCc---------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 111 112211 11233333 24999999999999999999999999999975
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.18 Aligned_cols=261 Identities=24% Similarity=0.424 Sum_probs=209.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. ....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeE
Confidence 47899999999999999999999999999999987532 3344567889999999999999999999873 45679
Q ss_pred EEEEecCCc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 103 YVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
|+|||||.+ +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999995 888888763 379999999999999999999997 599999999999999999999999999987643
Q ss_pred CCCCcccccccccCCccccCccccccc----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~----~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
... ....+++..|+|||++.+. ...++.++|||||||++|+|++|..||...+.......+
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---------- 219 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---------- 219 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----------
Confidence 221 1234688899999987542 124688999999999999999999999654322211111
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
..+.... .....+.+++++.+||.+||..||.+||++++++.||||.....
T Consensus 220 ---------------~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 220 ---------------SAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ---------------HHHhhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 0111111 11223457889999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=342.47 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=214.4
Q ss_pred ccccCC-CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007050 15 FFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (620)
Q Consensus 15 ~~~~~g-~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~ 93 (620)
.+..+| ...+|++++.||.|+||.||++++..++..|++|.+.... ......+.+|+.+++.+.||||+++++.+.
T Consensus 11 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~- 87 (296)
T cd06654 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYL- 87 (296)
T ss_pred hccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence 344455 4579999999999999999999999999999999987532 234566889999999999999999999884
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
+....|+||||+. ++|.+++.. ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 88 ----~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~ 162 (296)
T cd06654 88 ----VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (296)
T ss_pred ----eCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECcccc
Confidence 3457999999998 589998865 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 163 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~------- 230 (296)
T cd06654 163 CAQITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT------- 230 (296)
T ss_pred chhcccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-------
Confidence 876432211 1234578899999999876 5788999999999999999999999976554322211110
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...........++..+.+||.+||..||++|||++|+|+||||...
T Consensus 231 ----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 ----------------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------------------CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0000111123567889999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=334.11 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=212.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||.|+||.||+|.+..++..+++|++...... .....+.+|+.+|+.++|+||+++++.+ .+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-TSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-hHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEE
Confidence 4799999999999999999999999999999998754322 2567788999999999999999999988 445679
Q ss_pred EEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 103 YVVFELME-SDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
|+|||++. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5899998764 4589999999999999999999999999999999999999999999999999977654
Q ss_pred CCCcc-cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... ......+++..|+|||.+... ..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~------------ 221 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ------------ 221 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc------------
Confidence 32221 112345789999999988762 3688999999999999999999999976544322222111
Q ss_pred hhhchhHHHHHHhhhccCCCccc--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFS--QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..+..+. ..+..+++.+.+||.+||..||++|||++++|+||||
T Consensus 222 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 222 ----------------NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----------------CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0011111 1234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=338.60 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=209.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|.+.+.||+|+||.||++.++.+++.+|+|.+... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57899999999999999999999999999999998643 12335567899999998 799999999998655433446
Q ss_pred eEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 7999999998 589888753 45789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCcccccccccCCccccCcccccccC---CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~---~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
....... .....++..|+|||++.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 5322211 12356889999999875421 2368899999999999999999999976554332222111
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
..+..+ ......+..+.+||.+||+.||++||++.|+|+||||+
T Consensus 248 ---------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 ---------------------NPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------CCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000000 11124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=331.05 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=213.2
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++++.||.|+||.|+.+.+..+++.+++|.+............+.+|+.+|+.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 69999999999999999999999999999999875544455667788999999999999999999998 4456799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|||||. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999764 468999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2244678999999999876 5688899999999999999999999977654433322211
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. +......++..+.+||.+||..||.+|||++++|+|||+
T Consensus 216 -------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 -------------GN---YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------CC---CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00 111124568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=335.11 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=208.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-------SDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-------~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 5888999999999999999999999999999886432211 1235677899999999999999999987
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+....++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||+++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 34567899999998 49999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcc---cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 176 AFNDTPTT---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 176 ~~~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 64221111 11123468889999999876 5788999999999999999999999977543322211110
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
. ........++..+.+||++||+.||++||++.|+++||||
T Consensus 227 ---------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 ---------------------N---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------------------c---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 0011123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=341.76 Aligned_cols=264 Identities=28% Similarity=0.483 Sum_probs=216.0
Q ss_pred cccCC-CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007050 16 FSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (620)
Q Consensus 16 ~~~~g-~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (620)
..++| ...+|++++.||.|+||.||++++..+++.|++|.+... .......+.+|+.+++.++||||+++++.+
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--- 85 (296)
T cd06655 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSF--- 85 (296)
T ss_pred HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeE---
Confidence 34565 456899999999999999999999999999999998643 223456678999999999999999999988
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.+...+|+||||+. ++|..++... .+++.++..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++
T Consensus 86 --~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 86 --LVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred --ecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 34467999999998 5888888654 6899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
......... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 163 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-------- 229 (296)
T cd06655 163 AQITPEQSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------- 229 (296)
T ss_pred hhccccccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence 764332211 133568899999999876 5788999999999999999999999977654333222210
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...........+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 230 ---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 230 ---------------------NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ---------------------cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 00011112345788999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=333.10 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=209.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++.+ .+...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEE
Confidence 6899999999999999999999999999999998753 223567788999999999999999999988 445679
Q ss_pred EEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999995 899888776 789999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ....+++..|+|||++.+. ...++.++|+|||||++|+|++|.+||.+.+.......+...
T Consensus 156 ~~---~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~------------- 219 (262)
T cd06613 156 AK---RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS------------- 219 (262)
T ss_pred hc---cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Confidence 11 1345788899999998651 126888999999999999999999999876543332222110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
...+. .......++..+.+||++||..||..|||+.++|.|+|
T Consensus 220 -------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 -------------NFPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -------------cCCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00000 00111235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=339.02 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=207.9
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|++++.||.|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++++. +....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEE
Confidence 78899999999999999999999999999998642 3345667889999999999999999999884 3457899
Q ss_pred EEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 105 VFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 105 V~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
||||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999998 578777654 45799999999999999999999999999999999999999999999999999876432211
Q ss_pred ccccccccCCccccCcccccc---cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 183 TIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~---~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
......++..|+|||++.. ....++.++|||||||++|+|++|.+||...+.......+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 222 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------------- 222 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh--------------
Confidence 1234578999999998742 114578899999999999999999999977554333222211
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. .+. .......++..+.+||.+||..||.+||+++++++||||...
T Consensus 223 -------------~-~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 223 -------------S-EPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------c-CCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0 000 001123467899999999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.55 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=211.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||.|+||.||++.+..++..+|+|.+.. ........+.+|+.+++.++||||+++++.+. +...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCe
Confidence 4679999999999999999999999999999999864 23455667889999999999999999999984 4467
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999995 898888764 46999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... .....++..|+|||++... ...++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 211 1345688999999987521 13578899999999999999999999977654332221110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
... +.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 223 -----------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 -----------------SEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------------CCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0011123467899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.58 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=207.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC-CC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR-DF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~-~~ 99 (620)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 357999999999999999999999999999999986532 2345677899999998 699999999998654221 13
Q ss_pred CeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 5999988763 36899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
..... ......|+..|+|||++.+. ...|+.++|||||||++|+|++|..||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32211 12346789999999988531 1358889999999999999999999996543221111110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.... .......++..+.+||.+||..||.+|||+.|++.||||
T Consensus 230 -------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 -------------------RNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------cCCC--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000 001123467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=347.12 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=214.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
-|.++++||+|+||.|++|+++.+|..+|||++.- ..+.+.+..||.||.+++.|++|++|+.|+- ..++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceE
Confidence 47789999999999999999999999999999863 3678899999999999999999999998843 45799
Q ss_pred EEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 104 VVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
||||||+ |+..++++. +++|++.++..+++..|.||.|||-..-+|||||..|||++.+|..||+|||.|-.+...
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-- 182 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-- 182 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--
Confidence 9999999 899999975 568999999999999999999999999999999999999999999999999999764322
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
-....+.+||++|||||++.. -+|+.++||||||+...||..|++||..-..... |+- .
T Consensus 183 -MAKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFM---I------------ 241 (502)
T KOG0574|consen 183 -MAKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFM---I------------ 241 (502)
T ss_pred -HHhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccce---eEe---c------------
Confidence 222356789999999999987 6899999999999999999999999965332211 111 1
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...|.+-..+...+|.++.|||++||...|++|-||-++++|||++..
T Consensus 242 -----------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 -----------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred -----------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 111222222223467899999999999999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=333.41 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=208.0
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC----ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE----HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~----~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+..... .......+.+|+.+|+.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 588999999999999999986 4788999998864321 122345688999999999999999999998 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 78999999998 59999998878899999999999999999999999999999999999999999999999999876432
Q ss_pred CC---CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 179 DT---PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 179 ~~---~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
.. ..........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------- 222 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------- 222 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----------
Confidence 11 11112234578999999999876 6789999999999999999999999976543222111100
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
. ..........++..+.+||++||..||.+||++.++|+||||
T Consensus 223 -----------------~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 -----------------H--RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----------------c--cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 000111223578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.18 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=208.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..|++.+.||+|+||.||++.+..++..||||++.... ........+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 57999999999999999999999999999999885321 1223456788999999999999999999987332 23
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 56899999998 59999998877899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 2111111234568899999999876 578999999999999999999999996543322211110 000
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
......+.++..+.++|.+||. +|++||+++|+++|||+.
T Consensus 226 -------------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 -------------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -------------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0011123467789999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=360.07 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=215.6
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...+.|.|+..||.|+||+||+|.++.++-..|.|+|.. ....+...++-||.||..++||+||++++.|+. .
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~-----e 101 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-----E 101 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-----c
Confidence 334568899999999999999999999998999999864 344667788899999999999999999999843 3
Q ss_pred CeEEEEEecCCccHHH-HHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELMESDLHQ-VIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~-~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
+.++|+.|+|.|...+ ++.. ...|++.+++.+++|+|.||+|||+++|||||||..|||++-+|.++|+|||.+-...
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch
Confidence 6799999999975444 4433 4579999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
. +......++|||+|||||+..+. ...|+.++||||||+.|.||.-+.||-...+....+-.|..
T Consensus 182 ~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK--------- 249 (1187)
T KOG0579|consen 182 S---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------- 249 (1187)
T ss_pred h---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---------
Confidence 2 22223568999999999986432 25799999999999999999999999988777665544432
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..|..+. ....++..+.|||++||..||..||++.++|+||||....
T Consensus 250 -------------------SePPTLl-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 250 -------------------SEPPTLL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -------------------cCCCccc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 1111111 1124577899999999999999999999999999998653
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=333.49 Aligned_cols=261 Identities=27% Similarity=0.447 Sum_probs=209.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-CCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-RDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~-~~~ 99 (620)
.++|++.+.||.|+||.||+|.++.+++.+++|++.... .....+.+|+.+++.+ .|+||+++++++..... .+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999999999999987432 2345688999999999 69999999999865543 345
Q ss_pred CeEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 100 KDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 100 ~~lylV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
..+|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 678999999994 88888764 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
....... ......++..|+|||++... ...++.++||||||||+|+|++|.+||...+....+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 6432221 12345689999999987531 13578899999999999999999999976543322222111
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..... ......++..+.+||.+||..||++|||++++++|||+
T Consensus 233 ----------------------~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ----------------------NPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------------cCCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00000 01112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=334.58 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=209.2
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 488899999999999999999999999999998643211 12356788999999999999999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGlA~~~~ 177 (620)
..+++||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 67999999999 59999998888899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCcc-cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
...... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---------- 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----------
Confidence 331111 11123468889999999876 57889999999999999999999999654432221111110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
... .......+.+++.+.++|.+||..||.+|||+.++|+||||+
T Consensus 224 ---------------~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 224 ---------------ASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------hcc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000 000112234678999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=385.82 Aligned_cols=263 Identities=26% Similarity=0.423 Sum_probs=225.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+++|.|+++||+|+||.|.+++++.|++.||+|++++. ..+..+..-|..|-.+|-.-..+=|+.+.-.| +|..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 57899999999999999999999999999999999763 22344566788888999888888899998887 7889
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
++|+|||||. |||..++..-+.++++-+++|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999998 699999998888999999999999999999999999999999999999999999999999999776533
Q ss_pred CCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
. .......+|||.|.+||++... ...|+..+|+|||||++|||+.|..||...+..+.+-+|++-
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 3 3445677999999999998432 256999999999999999999999999998888777777642
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps---a~elL~hp~f~~~ 320 (620)
+....|. .-..+|+++++||+++|. +|+.|.. ++++-.||||.++
T Consensus 297 -----------------k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 297 -----------------KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred -----------------hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 1112222 123589999999999998 8889988 9999999999875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.31 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=211.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.|++++.||+|+||.||++.++.+++.|++|.+..... .......+.+|+.+++.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 369999999999999999999999999999999875322 223456778999999999999999999988 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987421111
Q ss_pred Cc------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccC
Q 007050 181 PT------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 181 ~~------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg 248 (620)
.. ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 00 001123467889999999876 5789999999999999999999999987654332222111
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccCC
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 320 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps---a~elL~hp~f~~~ 320 (620)
. ........+.++..+.+||.+||+.||++||+ +.++|+||||...
T Consensus 231 -------------------------~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 -------------------------D-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -------------------------c-ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 0 00011111257889999999999999999997 7999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.98 Aligned_cols=255 Identities=32% Similarity=0.525 Sum_probs=212.0
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++++.||.|+||.||++.+..++..||+|.+...........++.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999876544555667888999999999999999999977532 345689
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 104 VVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIH-----TANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLH-----s~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
++|||+. ++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 599998865 457999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
........ ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 223 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------- 223 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh---------
Confidence 87543321 1234578999999999876 568899999999999999999999997765332221111
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
... +.......+..+.+|+.+||..||++||+++++|+|||+
T Consensus 224 -------------------~~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 224 -------------------EGK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------cCC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 110 111123567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.04 Aligned_cols=261 Identities=30% Similarity=0.456 Sum_probs=212.4
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
||++.+.||+|+||.||++.+..+++.|++|.+............+.+|+.+++.++|+||++++++. .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 69999999999999999999999999999999976544445677889999999999999999999987 4456799
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+|+||+. ++|.+++.....+++..++.|+.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 599999988778999999999999999999999999999999999999999999999999999875433322
Q ss_pred ccc-cccccCCccccCcccccccC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 183 TIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 183 ~~~-~~~~~gt~~Y~APEvl~~~~-~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
... .....++..|+|||++.+.. ..++.++|||||||++|+|++|..||.+.+.........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~---------------- 219 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV---------------- 219 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH----------------
Confidence 111 22456788999999987631 238899999999999999999999996543211110000
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. ........+..+++.+.+||.+||+.||.+|||++|++.|||+
T Consensus 220 -----------~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 220 -----------GA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------hc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0011111233458899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.35 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=209.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++++.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++++ .+....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 69999999999999999999999999999999875433444556788999999999999999999988 4556799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+||||+. ++|.+.+.... .+++..+..|+.||+.||.|||+++++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 59999887643 57899999999999999999999999999999999999999999999999997653322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.. .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+..
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 11 123468889999999876 5788999999999999999999999976544333222210
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. ........+..+.+||.+||+.||.+||++.++|+||||
T Consensus 216 -------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -------------GS---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -------------CC---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 001123567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=333.96 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=210.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 58999999999999999999999999999999975422 224567788999999999999999999887 456779
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+|+||+. ++|.+.+.....+++..+..|+.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999887789999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~-------------------- 208 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RD-------------------- 208 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HH--------------------
Confidence 1234568889999999876 568999999999999999999999997654310 00
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHHcCCcc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA--EEALADPYF 317 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa--~elL~hp~f 317 (620)
.+...... ......+.++..+.+||.+||..||.+||++ +|+++||||
T Consensus 209 ----~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 209 ----QIRAKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----HHHHHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00000000 0011223467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=336.43 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=211.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeE
Confidence 47999999999999999999999999999999986532 2344566789999999999999999999883 44679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+|+||+. ++|.+++..+ .+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5899998765 799999999999999999999999999999999999999999999999999987643321
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.
T Consensus 154 ~---~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----------------- 211 (274)
T cd06609 154 K---RNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP----------------- 211 (274)
T ss_pred c---cccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-----------------
Confidence 1 234578889999999887 569999999999999999999999997654322211111
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+..+. ...+++.+.+||.+||..||++|||++++++||||...
T Consensus 212 -----------~~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 212 -----------KNNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------hcCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 11111111 11267889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.18 Aligned_cols=258 Identities=29% Similarity=0.551 Sum_probs=218.1
Q ss_pred CCeEE--EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i--~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.-|+| -++||+|.||+||-|+++++|+.||||+|.+..........+.+|+.||..+.||.||.+...| +...
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~e 636 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPE 636 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCc
Confidence 34555 4799999999999999999999999999987644445567788999999999999999998887 5667
Q ss_pred eEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC---CcEEEcccCcccc
Q 007050 101 DIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~lKL~DFGlA~~ 175 (620)
.+++|||-+.||+.+.|.. .+.|++...++++.|||.||.|||-+||+|+||||+|||+.+. -++||||||+|+.
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 7999999999999888854 5689999999999999999999999999999999999999765 4699999999998
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..+. .+....+||+.|+|||++.+ .+|+..-|+||+|||+|--|.|..||....+.+ +.|
T Consensus 717 IgEk----sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQI------------ 776 (888)
T KOG4236|consen 717 IGEK----SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQI------------ 776 (888)
T ss_pred cchh----hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchh--HHh------------
Confidence 7543 34467899999999999988 799999999999999999999999996543321 111
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.| -.-......|..+++.+.|||..+|+..-.+|.|.+..|.|||++++.
T Consensus 777 ----QN------------AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 777 ----QN------------AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ----hc------------cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 11 001112345778999999999999999999999999999999999754
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.27 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=203.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~i-L~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+++++.+|+.||||.+....... ....+..|+.+ ++.+.||||+++++.+. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCc
Confidence 46999999999999999999999999999999987643332 33455667665 67779999999999983 4456
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 102 IYVVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999998887754 34689999999999999999999997 9999999999999999999999999998765
Q ss_pred cCCCCcccccccccCCccccCccccccc--CCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~--~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e 253 (620)
..... .+...++..|+|||++.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+.
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 32211 1234688899999987541 1357889999999999999999999995421 111111110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. .....+ ....++..+.+||.+||..||.+||+++++++||||...
T Consensus 222 ---------------~----~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 ---------------E----EPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ---------------h----cCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 000000 112467899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.58 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=210.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||.|+||.||++.++.+++.+|+|.+..... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEE
Confidence 368889999999999999999999999999999876432 345567889999999999999999999883 34679
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998765322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------------------- 205 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDP---------------------- 205 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccc----------------------
Confidence 11 12568889999999877 57899999999999999999999999654210
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.......+..+......... ...+++.+++||.+||..||++|||+.+++.||||+.+
T Consensus 206 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 206 -PDGIFELLQYIVNEPPPRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -cccHHHHHHHHhcCCCCCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00000011111111110010 01168899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.89 Aligned_cols=267 Identities=24% Similarity=0.407 Sum_probs=210.4
Q ss_pred cccCC-CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007050 16 FSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (620)
Q Consensus 16 ~~~~g-~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (620)
+..+. ..++|++++.||+|+||.||+|.++.+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44454 4689999999999999999999999999999999876421 2234577899999999 69999999998865
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
....+...+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44445567999999998 589887753 3468899999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhh
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~ 245 (620)
|||+++....... ......|++.|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 9999876532211 12345689999999987531 14588999999999999999999999976543222211100
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..... ......++..+.+||.+||+.||++|||+.|+|+|+||
T Consensus 244 ----------------------------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 ----------------------------NPPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------------------------cCCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00000 00111246789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.51 Aligned_cols=252 Identities=28% Similarity=0.471 Sum_probs=208.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++++.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+|+.++||||+++++.+ .+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 69999999999999999999999999999999875443445567788999999999999999999987 3456799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCccccccCC
Q 007050 104 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFND 179 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~~~~~~ 179 (620)
+||||+. ++|.+++... ..+++..+..++.||+.+|+|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999763 358999999999999999999999999999999999999865 46899999999865433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 21 123568889999999876 5788999999999999999999999977654332222211
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .......+++.+.+||.+||..||.+|||+.|+|+||||
T Consensus 216 --------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 --------------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred --------------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 011123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=330.24 Aligned_cols=252 Identities=30% Similarity=0.508 Sum_probs=208.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||.|+||.||+|++..++..+++|.+... .....+.+|+.+++.++||||+++++.+. +...+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcE
Confidence 5799999999999999999999999999999998643 22667889999999999999999999884 44679
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
|+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999 599999865 4578999999999999999999999999999999999999999999999999988654332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......++..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.......+..
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 213 (256)
T cd06612 154 A---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------------- 213 (256)
T ss_pred c---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---------------
Confidence 1 1133457889999999876 5789999999999999999999999976543322111100
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
...........++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 214 --------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 214 --------------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=339.22 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=205.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.|+.++.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++. +...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCc
Confidence 4677788999999999999999999999999998754222 45567889999999996 999999999873 3456
Q ss_pred EEEEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 102 IYVVFELMESDLHQVIK-----ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~-----~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+++|||+..+|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999976555432 235799999999999999999999974 999999999999999999999999999976
Q ss_pred ccCCCCcccccccccCCccccCcccccccC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~-~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... ....++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...+. ....+....
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~------- 224 (288)
T cd06616 158 LVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV------- 224 (288)
T ss_pred hccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc-------
Confidence 5432211 2346888999999987521 2689999999999999999999999965431 111111100
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
....+.........++..+.+||.+||+.||++|||+++++.||||...
T Consensus 225 -----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 225 -----------------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -----------------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 0000111111224578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.65 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=208.9
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+|+..+.||+|+||+||+|.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 58888999999999999999999999999999864321 123456788999999999999999999987 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|+||++ ++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 7999999998 499999988878999999999999999999999999999999999999999999999999998765433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ......++..|++||.+... ..++.++|+|||||++|+|++|..||...........+..
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------------- 216 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-------------- 216 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--------------
Confidence 2 12345688999999988652 2388999999999999999999999966542222111100
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
........+.+++.+.+||.+||..||.+||+++++|.|||+
T Consensus 217 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 217 ----------------SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------------cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 000111234578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.55 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=207.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-CC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-RD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~-~~ 98 (620)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +||||+++++++..... ..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 446899999999999999999999999999999998642 23445677899999988 69999999998864321 23
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 467899999998 5999988753 3588889999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
...... .....+++..|+|||++... ...++.++|+|||||++|+|++|..||........+..+.
T Consensus 171 ~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------- 239 (282)
T cd06636 171 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------- 239 (282)
T ss_pred hhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--------
Confidence 432211 12345789999999987521 2468889999999999999999999996644322111110
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .........++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 240 --------------------~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 --------------------RN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------hC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 00111123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.06 Aligned_cols=262 Identities=26% Similarity=0.470 Sum_probs=208.6
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--------ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--------~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 588999999999999999999999999999988532111 11234577899999999999999999987
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+...+++||||+. ++|.+++...+.+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||+++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 34467999999998 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... ........++..|+|||++......++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 6432211 111234568889999999876323488999999999999999999999965433221111100
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
............+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 -----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0001111112335678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=336.52 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=198.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH----------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~----------------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv 85 (620)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3589999999999999999998532 34479999987532 234456788999999999999999
Q ss_pred eeeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 007050 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-------------------DLTREHYQFFLYQLLRALKYIHTA 145 (620)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~-------------------~lse~~~~~i~~QIl~aL~yLHs~ 145 (620)
++++++. +...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999984 3456899999998 59999886532 367788899999999999999999
Q ss_pred CcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHH
Q 007050 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (620)
Q Consensus 146 gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLl 225 (620)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999765332211 11123456788999999876 57999999999999999998
Q ss_pred h--CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCC
Q 007050 226 T--GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 303 (620)
Q Consensus 226 t--G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~ 303 (620)
+ +..||.+.+..+.+..+.. ++. ......+....+.++..+.+||.+||..||+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~---------------------~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGE---------------------FFR---DQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHH---------------------Hhh---hccccccccCCCCCCHHHHHHHHHHccCCch
Confidence 7 5577776554333222211 000 0000011112345678999999999999999
Q ss_pred CCCCHHHHHc
Q 007050 304 DRPTAEEALA 313 (620)
Q Consensus 304 ~Rpsa~elL~ 313 (620)
+|||++++.+
T Consensus 291 ~RPs~~~i~~ 300 (304)
T cd05096 291 ERPSFSDIHA 300 (304)
T ss_pred hCcCHHHHHH
Confidence 9999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=339.96 Aligned_cols=259 Identities=27% Similarity=0.501 Sum_probs=210.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++.+. ....
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~ 93 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDE 93 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCe
Confidence 35667778899999999999999999999999998642 2344566889999999999999999999873 4467
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 8999999985 78887754 569999999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.. ....+++..|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+....+..+..
T Consensus 173 ~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------------- 232 (292)
T cd06658 173 PK---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD--------------- 232 (292)
T ss_pred cc---CceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 11 234578999999999876 5789999999999999999999999977654332222111
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
..+. ........+..+.+||.+||..||.+|||++|+|+||||.....
T Consensus 233 -------------~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 233 -------------NLPP-RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred -------------cCCC-ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0000 01112346788999999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=335.77 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=200.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~-~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
..||+|++|.||+|.. +|+.||||.+......... ...+.+|+.+|+.++||||+++++++.... .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5789999999999976 6899999999764332222 466779999999999999999999885411 22456899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
||. |+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 5999999988889999999999999999999998 499999999999999999999999999998653221
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
...+++..|+|||++.+....|+.++|||||||++|||++|..||.+.+..+.+..+...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 237 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK------------------- 237 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 234688999999998754457999999999999999999999999876644433322210
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..... .....++.+.+||.+||+.||++|||++|+|+
T Consensus 238 --------~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 238 --------NNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00000 11256889999999999999999999999986
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.24 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=213.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+.|++.+.||.|++|.||+|.+..+++.|++|++...... .....+.+|+.++..++|+||+++++++. +...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeE
Confidence 3689999999999999999999999999999998764322 45677889999999999999999999984 44679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
|+||||+. ++|.+++.....+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999998754332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.....+
T Consensus 155 ~~~---~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~------------------- 210 (264)
T cd06623 155 DQC---NTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE------------------- 210 (264)
T ss_pred Ccc---cceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH-------------------
Confidence 221 34568889999999876 578899999999999999999999997653200000
Q ss_pred chhHHHHHHhhhccCCCcccCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
....+...... ..... ++..+.+||.+||..+|++|||+.++|+||||+..
T Consensus 211 ------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 211 ------LMQAICDGPPP---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ------HHHHHhcCCCC---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 00111111111 11123 67899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=366.98 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=204.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeee-EecCCCCCC-C
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKH-IMLPPSRRD-F 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~-v~~~~~~~~-~ 99 (620)
-+++|.++|.+|||+.||+|.+...|..||+|++... +......+.+||.+|++|+ |+|||.+++ ......... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4678999999999999999999988899999998653 5566777889999999997 999999999 433332223 3
Q ss_pred CeEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
..++|+||||+ |.|.+++.. ...|++.++..|++|+++||.+||... |||||||-|||||+.+|..||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 56889999999 699999974 345999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCcc---ccc---ccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 175 VAFNDTPTT---IFW---TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 175 ~~~~~~~~~---~~~---~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
-........ ... -....|+.|||||+|.-. ....++|+|||+|||+||.|+....||.+.-... |.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Il--- 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----IL--- 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EE---
Confidence 533222111 000 113578999999987310 1468999999999999999999999997652211 10
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+.+ .. ...++.++..+++||..||+.||++||++.+++.+
T Consensus 268 -------------ng~-------------Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 -------------NGN-------------YS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -------------ecc-------------cc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 100 00 12347789999999999999999999999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=328.93 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=201.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+|+.++||||+++++++. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----R 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----c
Confidence 467999999999999999999765 455689999987542 2344567889999999999999999999984 3
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 456899999999 5899888764 57899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+.
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 224 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG--------- 224 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------
Confidence 221110 0112235678999999876 689999999999999999775 99999876654433333211
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... .....++..+.+|+.+||+.||.+||+++++++
T Consensus 225 -------------------~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 -------------------FRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------CCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 000 112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.26 Aligned_cols=264 Identities=28% Similarity=0.478 Sum_probs=219.7
Q ss_pred ccccCCCCCCe-EEEEEeeecCceEEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007050 15 FFSEYGDASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEIKHIM 91 (620)
Q Consensus 15 ~~~~~g~~~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~--~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~ 91 (620)
.+.+-...+|| ++.++||+|+|-+||+|.|..+|..||+-.++ +........+++..|+.+|+.|+||||++++..|
T Consensus 31 ~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 31 EFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred cccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 34444555566 56789999999999999999999999986553 3445566779999999999999999999999999
Q ss_pred cCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCC-CcEEE
Q 007050 92 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANAN-CKLKI 167 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~-~~lKL 167 (620)
.+.. ...+-+|+|+|. |+|.+++++.+.++.+.++.|++|||+||.|||+.. |+|||||.+||||+.+ |.|||
T Consensus 111 ~d~~---n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 111 VDTD---NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred ecCC---CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence 7653 267899999998 899999999999999999999999999999999986 9999999999999976 89999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
+|+|||........ ...+|||.|||||+... .|++.+||||||+++.||+|+..||.......|+.+-.
T Consensus 188 GDLGLAtl~r~s~a-----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV--- 256 (632)
T KOG0584|consen 188 GDLGLATLLRKSHA-----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV--- 256 (632)
T ss_pred cchhHHHHhhcccc-----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---
Confidence 99999987643332 34689999999999874 89999999999999999999999998765544432221
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.....|..|.. --++++++||.+||.. .+.|+|+.|+|.||||..
T Consensus 257 -----------------------~SGiKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 257 -----------------------TSGIKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -----------------------HcCCCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11122222222 1278999999999999 899999999999999985
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.34 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=223.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..-|.+.+.||+|.|++|.++++..++..||||.|.+...+......+.+|+++|..|.|||||+++.++ +....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecce
Confidence 4579999999999999999999999999999999998877777777899999999999999999999998 55578
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+||||+. |++++++.+++.+.+..+..++.|++.|++|||+++|||||||++|||++.+..+||+|||++..+...
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 999999998 699999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
....++||++.|.|||++.+. ...++.+|+||||++||.|+.|..||.|.+....-...
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv----------------- 267 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV----------------- 267 (596)
T ss_pred ---ccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh-----------------
Confidence 335678999999999999885 45678999999999999999999999987642211100
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
++.+..++ --++.+..+||++||..+|.+|++.+++..|.|......
T Consensus 268 ----------l~gk~rIp-----~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 268 ----------LRGKYRIP-----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred ----------eeeeeccc-----ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 01111111 135668899999999999999999999999999986544
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=328.43 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=205.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 6999999999999999999999999975422 223456788999999999999999999987 4456799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccccc
Q 007050 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (620)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~ 188 (620)
+ ++|.+++.....+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888789999999999999999999999999999999999999999999999999998764332 1133
Q ss_pred ccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC--hhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 189 ~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~--~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+ ....+..+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578899999999876 578999999999999999999999997654 2111111110
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
...... .....++.+.+||.+||..||.+|++ ++|+++||||+++
T Consensus 209 ------~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 209 ------GNGKLE---FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ------cCCCCC---CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 000111 11234789999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=355.73 Aligned_cols=272 Identities=26% Similarity=0.389 Sum_probs=222.1
Q ss_pred ccCCCCCccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCc
Q 007050 6 RKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDI 84 (620)
Q Consensus 6 ~~~~~~~~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnI 84 (620)
.-|++..-+.|..-+.-..|.-++.||.|+||-||-|+|..+.+.||||++..... .......|+.|+.+|++|+|||+
T Consensus 9 slKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnt 88 (948)
T KOG0577|consen 9 SLKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNT 88 (948)
T ss_pred CCCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCc
Confidence 33455455556555555678889999999999999999999999999999976533 33456789999999999999999
Q ss_pred ceeeeEecCCCCCCCCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC
Q 007050 85 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (620)
Q Consensus 85 v~l~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (620)
|.+.++|+-. ...|||||||-|+-.+++.- .+++.+.++..|..+.|.||.|||+.+.||||||..|||+++.|
T Consensus 89 ieYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g 163 (948)
T KOG0577|consen 89 IEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG 163 (948)
T ss_pred ccccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC
Confidence 9999999643 35799999999876666653 35799999999999999999999999999999999999999999
Q ss_pred cEEEcccCccccccCCCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007050 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (620)
Q Consensus 164 ~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~ 242 (620)
.|||+|||.|..... ...++|||+|||||+|... .+.|+-++||||||+...||.-.+||+-..+....+.-
T Consensus 164 ~VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH 236 (948)
T KOG0577|consen 164 LVKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 236 (948)
T ss_pred eeeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH
Confidence 999999999976532 2467999999999988531 25799999999999999999999998766554444433
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
|.. ...|.-- -+.+|..+++||..||+.-|.+|||.+++|.|+|...
T Consensus 237 IAQ---------------------------NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 237 IAQ---------------------------NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHh---------------------------cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 321 1111111 2456889999999999999999999999999999864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=331.42 Aligned_cols=258 Identities=28% Similarity=0.518 Sum_probs=210.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
..|...+.||.|++|.||++.++.+++.+++|++... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeE
Confidence 4566678999999999999999999999999998642 2234556889999999999999999999884 34568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+|+||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998 599998877 6799999999999999999999999999999999999999999999999998875433222
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~---------------- 229 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---------------- 229 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh----------------
Confidence 1 133568999999999876 5789999999999999999999999977554333222211
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.. .........++..+.+||.+||..||++|||+.++|+||||+....
T Consensus 230 ------------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 230 ------------NL-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------cC-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00 0111112346789999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=325.08 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=205.6
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||.|+||.||++.++.+++.+|+|.+.... .......+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 5899999999999999999999999999999986432 234566788999999999999999999998 4557899
Q ss_pred EEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 599998865 3458999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234678999999999876 5789999999999999999999999977654332222211
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ......++..+.+||.+||..||++|||+.++|+-
T Consensus 215 -------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 -------------GSY---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------CCC---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 01123467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=324.42 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=207.9
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|.+.+.||+|+||.||++.++.+|..+|+|.+............+.+|+.+++.++|+||+++++.+ .+...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 58999999999999999999999999999999865323334456778999999999999999999988 4456799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc-EEEcccCccccccCC
Q 007050 104 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-LKICDFGLARVAFND 179 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-lKL~DFGlA~~~~~~ 179 (620)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+++|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 59999887643 4799999999999999999999999999999999999998864 699999999765432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
... .....|++.|+|||++.+ ..++.++|+|||||++++|++|..||...+.......+..
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred ccc---ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 211 123468899999998876 5788999999999999999999999976553322211110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
..+....+.++..+.++|.+||..+|++|||+.|+++||||
T Consensus 217 -----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 -----------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 01112234577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.01 Aligned_cols=256 Identities=32% Similarity=0.551 Sum_probs=212.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 100 (620)
++|.+.+.||.|+||.||++.++.+++.||+|++.... ........+.+|+.+++.+. ||||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 47999999999999999999999999999999987532 23344567789999999998 99999999987 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||++. ++|.+++...+.+++..++.|+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 7999999996 699999998888999999999999999999999999999999999999999999999999999865433
Q ss_pred CCc-----------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007050 180 TPT-----------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (620)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~ 242 (620)
... ........++..|+|||++.+ ..++.++|||||||++++|++|..||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 221 011233467889999998876 5688999999999999999999999987653322222
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCcc
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYF 317 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~elL~hp~f 317 (620)
+.. .. ......+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 234 ~~~---------------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK---------------------------LE-----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh---------------------------cC-----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 210 00 01123457899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.32 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=207.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||.|++|.||+|.+..+++.+|+|.+... .......++.+|+++++.++||||+++++++... +...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 4799999999999999999999999999999998753 2224566788999999999999999999988532 33568
Q ss_pred EEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 103 YVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||....... ..+ .+.
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~-~~~--- 216 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---------LGP-IEL--- 216 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---------CCh-HHH---
Confidence 2211 23467889999999876 678999999999999999999999997652100 000 000
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKF---PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..++. ......+.... ...++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 217 -------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 217 -------LSYIV---NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -------HHHHh---cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 00000 00000011100 1246789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=332.99 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=211.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||++.+..+++.||+|++... ........+.+|+.+++.++||||+++++.+. +...
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCE
Confidence 35799999999999999999999999999999988643 22344567889999999999999999999983 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||++ ++|.+++...+.+++..+..++.+|+.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999 5899999887889999999999999999999997 58999999999999999999999999998654222
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ...+++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .
T Consensus 158 ~~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--------~--------- 213 (284)
T cd06620 158 IA-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--------D--------- 213 (284)
T ss_pred cc-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--------h---------
Confidence 11 23578999999999876 578899999999999999999999997654321100 0
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........+..+....+..+. ...++..+.+||.+||..||.+|||++|+++|+||..-
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 214 DPMGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hhhHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000011111111111111111 11367789999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=330.26 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=203.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
++|++++.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~----- 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT----- 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----
Confidence 47899999999999999999876655 68999998743 22344566889999999999999999999883
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
+....|++|||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 4456899999998 6999999764 4578899999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~ 239 (620)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999764322211 11234467888999998876 578999999999999999998 9999987654332
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
...+. ..... .....+++++.+|+.+||+.||.+||++.|++++
T Consensus 236 ~~~i~----------------------------~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIR----------------------------SRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHH----------------------------cCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22221 11111 1123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=323.41 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=209.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..|++.+.||+|+||.||+|.++.+++.||+|.+.... ........+.+|+.+++.++||||+++++.+... +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 57999999999999999999999999999999875321 1223456788999999999999999999987432 23
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+++||||+. ++|.+.+...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 56899999998 58999998877899999999999999999999999999999999999999999999999999986533
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
........+...++..|+|||++.+ ..++.++|+|||||++|+|++|++||........+..+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP-------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC--------
Confidence 2211112234578999999999876 57889999999999999999999999764432221111 0000
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
........+++.+.++|.+||. +|.+||++.++|.|||.
T Consensus 226 -------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 -------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0011234578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.55 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=202.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++ .....+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 6999999999999999999999999864322 222345667899999999999999999988 4456799999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 110 E-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 110 ~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
+ ++|.+++.... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----I 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----c
Confidence 9 59999987655 799999999999999999999999999999999999999999999999999876432211 2
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 33567889999999876 5689999999999999999999999976543111111100
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
... .. .....+.+++.+.+||.+||+.||.+|| ++.++++||||..+
T Consensus 209 ---~~~-~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 209 ---RTL-EM---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ---ccc-cc---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 000 00 1112235688999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=318.23 Aligned_cols=264 Identities=26% Similarity=0.416 Sum_probs=209.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.+||+|.+.||.|+|+.|+++.+..++..||+|+|... ...+.+..++|+...++++|||++++++..+........
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 468999999999999999999999999999999999764 356778899999999999999999999877665444566
Q ss_pred eEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 101 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
..||+++|.. |+|.+.|.. +..+++.++..|+.+|++||++||+.. ++||||||.|||+.+++..+|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999998 899998864 236999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCC------cccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc
Q 007050 174 RVAFNDTP------TTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 174 ~~~~~~~~------~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~ 246 (620)
....-... ....|.....|..|+|||++.-. ....++++|||||||+||.|+.|..||.- +.+-
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhhc
Confidence 75321111 11224455678899999987531 14578999999999999999999999932 1110
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.|.-.... .+ ....+... ..+|..+.+||+.||+.||.+||++.++|.+
T Consensus 248 GgSlaLAv-----~n-------------~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAV-----QN-------------AQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEee-----ec-------------cccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11000000 00 01111111 2378899999999999999999999999874
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=333.38 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=210.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++. +...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCc
Confidence 47899999999999999999999999999999998642 2334567889999999999999999999883 4456
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.|+|+||++ ++|.+++... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 899999998 5999988654 58899999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ......+++.|++||.+.+ ..++.++|+|||||++|+|++|..||...+...++..+..
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--------------- 229 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------- 229 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---------------
Confidence 1 1234568899999999876 5789999999999999999999999977554322211100
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...+.......++..+.+||++||..||.+||++++++.|+||+...
T Consensus 230 --------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 --------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred --------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 00000111234677899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.16 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=210.5
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.....+|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++.+++.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~----- 85 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL----- 85 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----
Confidence 344578999999999999999999999999999999986432 23344567889999999999999999999984
Q ss_pred CCCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+....|+||||+.|+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 4456899999999998888764 457999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
... ....++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 166 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---------- 228 (307)
T cd06607 166 SPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------- 228 (307)
T ss_pred CCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----------
Confidence 221 234688899999987421 24688999999999999999999999976654332221110
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
..+..+ ....++..+.+||.+||..||++||++.+++.||||..
T Consensus 229 ------------------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 ------------------NDSPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ------------------CCCCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000000 01235678999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.33 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=214.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+.|..-++||+|+||.||-++-+.||+.||+|++.+... ...-....++|-.||.+++.+.||.+--.| +...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 3567788999999999999999999999999999864322 222334567899999999999999998877 6667
Q ss_pred eEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
.+|+|+..|+ |||+-.|.+.+ .|++..+.++..+|+.||.+||..+||.|||||+|||+|+.|+++|+|+|||..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 8999999999 59999887765 79999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
...+ ....+||..|||||++.+ ..|+...|+|||||++|||+.|+.||.....-.
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------------- 393 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------------- 393 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhh-------------------
Confidence 4433 245699999999999988 569999999999999999999999996543211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.++ -++.+....+..++ ...|+++++|.+.+|+.||++|. .++++-+||||+++
T Consensus 394 --k~e----Evdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 394 --KRE----EVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred --hHH----HHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 110 11111122222233 35689999999999999999996 67899999999976
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.31 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=210.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
...|.....||.|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+.||||+++++.+ .....
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~ 92 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEE 92 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCe
Confidence 345566678999999999999999999999999986432 23345678999999999999999999988 34467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 93 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 999999999 588887754 568999999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 172 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------------- 231 (297)
T cd06659 172 P---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD--------------- 231 (297)
T ss_pred c---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234678999999999876 5789999999999999999999999976654433322210
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...........++..+.+||.+||+.||++||+++++++||||....
T Consensus 232 --------------~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 --------------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --------------cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 01111122346788999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.27 Aligned_cols=253 Identities=31% Similarity=0.511 Sum_probs=211.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|.+.+.||.|+||.||++.+..+++.|++|++............+.+|+.+++.++|||++++.+.+. +...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 589999999999999999999999999999999765444466777889999999999999999999884 336799
Q ss_pred EEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 104 VVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 104 lV~E~~~g-dL~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+|++++ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 999998763 6799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 32 11234578899999998876 5688999999999999999999999976553322211110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
... .......+..+.++|.+||..||.+|||+.|+|+||||
T Consensus 218 ---------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 ---------------GQY---PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011 11112567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=330.17 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=209.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
..|+.++.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.||||+++++++ .+....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEE
Confidence 4688899999999999999999999999999998743 2234567788999999999999999999998 445679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998 489998865 5699999999999999999999999999999999999999999999999999976543221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------- 214 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------
Confidence 1133468889999999876 578999999999999999999999997654332211110
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+ ......++..+.+||.+||..||++||+++++|+||||...
T Consensus 215 -----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 -----------KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -----------cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0000 11123456789999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=327.98 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=208.9
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 100 (620)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++ .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCC
Confidence 5888999999999999999999999999999986532 2344567889999999996 99999999988 3446
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 7899999998 489988865 47999999999999999999999999999999999999999999999999999876433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 21 12345789999999987642 457889999999999999999999997654332211110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...+..+. ...++..+.+||.+||..||++||++.|++.|+||+...
T Consensus 216 -------------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 -------------KSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -------------cCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00010110 112678999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=325.64 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=200.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~i-L~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||.|+||.||+|.+..+++.||+|.+..... .......+..|..+ ...+.|+||+++++++ .+...+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 579999999999999999999999999864321 11222334455544 4456899999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468889999999876 4589999999999999999999999977654332222211
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccCC
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 320 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp---sa~elL~hp~f~~~ 320 (620)
............+++.+.+||.+||+.||++|| +++|+|.||||+.+
T Consensus 208 --------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 --------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred --------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000001112235788999999999999999999 55899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=329.67 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=197.2
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHH---hcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILREIKLLR---LLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-~~~~~i~rEi~iL~---~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
.||+|+||.||++.+..+++.+|+|.+....... .......+|..+++ ...||||+.+++.+. ..+.+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999999999999986542221 22223345554444 347999999999883 34578999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccc
Q 007050 106 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
|||+. ++|.+++..++.+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999 5999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhH
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~ 264 (620)
.....|+..|+|||.+.+. ..++.++||||+||++|+|++|..||.+...... +.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------------~~~~~------- 209 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------HEIDR------- 209 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-------------HHHHH-------
Confidence 1234789999999988631 4688999999999999999999999975432110 00000
Q ss_pred HHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCCC
Q 007050 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 321 (620)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~~ 321 (620)
...... ....+.+++.+.+||++||..||.+|+ |+.|+++||||+++.
T Consensus 210 ------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 210 ------MTLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ------HhhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 000000 112345788999999999999999999 699999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=345.78 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=198.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|++..+| ..||+|+++... .......+.+|+.+|+.+ +|+||+++++.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGAC---- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence 457999999999999999999865444 579999997542 334456788999999999 899999999988
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~------------------------------------------------------ 120 (620)
.+...+|+|||||. |+|.+++...
T Consensus 112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 34467899999999 6999988542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccc
Q 007050 121 ----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 121 ----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24788899999999999999999999999999999999999999999999999765432211 1
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122335667999999876 679999999999999999997 9999976432211111100
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...... .....++++.+||.+||+.||.+|||++++++
T Consensus 330 ---------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 ---------RGYQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ---------cccCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000 11235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=317.58 Aligned_cols=253 Identities=32% Similarity=0.534 Sum_probs=212.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+++++.++|||++++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 58999999999999999999999999999999986544445667889999999999999999999988 3446799
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+|||++++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 99999988888999999999999999999999999999999999999999999999999999876443321
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234568889999999876 458899999999999999999999997654322111110
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. ......+.++..+.+||.+||..||++|||+.++|.||||
T Consensus 213 ----------~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ----------QD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----------cc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 0111223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=352.58 Aligned_cols=252 Identities=32% Similarity=0.523 Sum_probs=209.5
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
+||+|.||+||-|+|..|..++|||.|.. ....+.+.+..||.+.++|+|.|||++++.+ .+.+.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 78999999999999999999999999964 2345667788999999999999999999987 5556788999999
Q ss_pred C-ccHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCccccccCCCCccc
Q 007050 110 E-SDLHQVIKA-NDDL--TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 110 ~-gdL~~~i~~-~~~l--se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
. |+|..+++. -+++ .|..+.++.+||++||+|||.+.|||||||-+|+||+. .|.+||.|||-++....-.+-+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T- 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT- 733 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc-
Confidence 8 599999975 4677 88899999999999999999999999999999999975 6899999999999876554443
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhH
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~ 264 (620)
.++.||..|||||++.....+|+.++|||||||.+.||.||+|||... |.|....+.
T Consensus 734 --ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-------------gspqAAMFk-------- 790 (1226)
T KOG4279|consen 734 --ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-------------GSPQAAMFK-------- 790 (1226)
T ss_pred --cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-------------CChhHhhhh--------
Confidence 567899999999999766689999999999999999999999999553 333322111
Q ss_pred HHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
-.+-+.-| .....++.+++.||.+|+.+||.+||+|.++|.+||++.-
T Consensus 791 ----VGmyKvHP----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 ----VGMYKVHP----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----hcceecCC----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 00000000 1112467789999999999999999999999999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.27 Aligned_cols=249 Identities=23% Similarity=0.449 Sum_probs=202.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
...|.+.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCC
Confidence 34689999999999999999999999999999998743 23456788999999999999999999988 34456
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999998 6999998754 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+..
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 220 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 220 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------------
Confidence 22111 112234567999998876 678999999999999999998 9999987654333222211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .....+++.+.+||.+||..||++|||+.++++
T Consensus 221 ----------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 ----------------GYRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------------CCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 112356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=339.11 Aligned_cols=287 Identities=21% Similarity=0.282 Sum_probs=205.6
Q ss_pred EEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G--~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+| +||+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++ .....+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456766 999999999999999999999875444445567788999999999999999999998 3446789999
Q ss_pred ecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 107 ELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 107 E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999 5999988764 358999999999999999999999999999999999999999999999998654332211110
Q ss_pred --cc--cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh--h--
Q 007050 184 --IF--WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT--I-- 255 (620)
Q Consensus 184 --~~--~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~--i-- 255 (620)
.. .....++..|+|||++.+....++.++|||||||++|+|++|.+||.+......+..+.........+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00 011234567999999876334588999999999999999999999987765444333322111100000 0
Q ss_pred --hhhhhchhHHHHH----Hhhhc-----cCC-Ccc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 --SRVVRNDKARRYL----TSMRK-----KQP-VQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 --~~~~~~~~~~~~~----~~~~~-----~~~-~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
..+ .+. ...+. ..... ... ... ......+++.+++||.+||+.||++|||++|+|+||||+.+..
T Consensus 239 ~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRM-KNS-QSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhh-ccc-hhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000 000 00000 00000 000 000 0012245778999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=316.12 Aligned_cols=259 Identities=28% Similarity=0.450 Sum_probs=212.4
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|.+.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999999765444456778889999999999999999999884321 26799
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+|+||+. ++|.+++.....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988778999999999999999999999999999999999999999999999999999876544321
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
.......++..|++||.+.+ ..++.++|||||||++|+|++|..||...+.. ...+...
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---------------- 216 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKI---------------- 216 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhc----------------
Confidence 01133568889999999876 46899999999999999999999999775411 1111100
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. ...........+..+.+||.+||..||.+||++.|+|.||||
T Consensus 217 ---------~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 217 ---------GS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------cc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00 001111223457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.86 Aligned_cols=255 Identities=28% Similarity=0.406 Sum_probs=207.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+.|++++.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. +...+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCce
Confidence 45778899999999999999999999999999987442 2344567889999999999999999999883 44578
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 588888764 5689999999999999999999999999999999999999999999999999876533211
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1223468889999999876 578999999999999999999999996543322111110
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+ ......++..+.+||.+||..||++||++.++|+||||..+
T Consensus 215 -----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 -----------KNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred -----------cCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0000 01112457789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=321.47 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=199.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
...||+|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++ .+...+|+|||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEe
Confidence 35899999999999999999999999988653 334566788999999999999999999988 34467999999
Q ss_pred cCC-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCccccccCCCCc
Q 007050 108 LME-SDLHQVIKAN-DDL--TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 108 ~~~-gdL~~~i~~~-~~l--se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~~~~~~~~ 182 (620)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5999998764 445 88889999999999999999999999999999999976 67899999999876533221
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
......++..|+|||++.+....++.++|+|||||++|+|++|.+||..........
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--------------------- 221 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--------------------- 221 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---------------------
Confidence 123346888999999986532458899999999999999999999996532111000
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
+....... .......+++.+++|+++||..+|.+|||+.|++.||||
T Consensus 222 ----~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 222 ----FKVGMFKI----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ----hhhhhhcc----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000000 011123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.36 Aligned_cols=282 Identities=33% Similarity=0.545 Sum_probs=224.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC------CCcceeeeEecCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH------PDIVEIKHIMLPPSR 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H------pnIv~l~~v~~~~~~ 96 (620)
++|.+....|+|-||.|+.|.|...|..||||+|.+. ..-.+.=++|+.||+.|.. -++++++..|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F----- 503 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF----- 503 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----
Confidence 6899999999999999999999999999999999753 1222334689999999953 3688888877
Q ss_pred CCCCeEEEEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGL 172 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGl 172 (620)
...+++|||||-+.-+|.++++.-+ .|....+..|..||+.||..|..+||+|.||||+|||++.. ..+||||||.
T Consensus 504 ~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 4557899999999999999998743 68899999999999999999999999999999999999875 5699999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
|.....+. .+.|..+++|+|||++.+ -.|+...|+||+||+||||.||+.+|+|.++-+.|...+++-|..+.
T Consensus 584 A~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 584 ASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 98654332 367889999999999998 68999999999999999999999999999999999999999998877
Q ss_pred hhhhhhh-hchhH---HHHH-------------HhhhccCC-Cccc------CCCC----CCCHHHHHHHHHhcccCCCC
Q 007050 253 DTISRVV-RNDKA---RRYL-------------TSMRKKQP-VQFS------QKFP----NADPSALRLLERLLAFDPKD 304 (620)
Q Consensus 253 e~i~~~~-~~~~~---~~~~-------------~~~~~~~~-~~~~------~~~~----~~s~~l~dLI~~mL~~DP~~ 304 (620)
..+.+-. ...-+ ..|+ .-+....| ..+. +.++ .+-..+++||.+||..||.+
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 6654310 00000 0000 00000011 0000 0111 12245899999999999999
Q ss_pred CCCHHHHHcCCcccC
Q 007050 305 RPTAEEALADPYFKG 319 (620)
Q Consensus 305 Rpsa~elL~hp~f~~ 319 (620)
|.|+.++|.||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.87 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=198.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~---- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGAC---- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeee----
Confidence 34799999999999999999964 3566789999987432 234556788999999999 899999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~----------------------------------------------------- 121 (620)
.+....|+|||||. |+|.+++....
T Consensus 109 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 -TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred -ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 44456899999999 69998886432
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 122 ----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 122 ----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 4678889999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 268 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~-------------- 330 (375)
T cd05104 268 SNYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI-------------- 330 (375)
T ss_pred cccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH--------------
Confidence 2111 1122345667999999876 679999999999999999998 889997654322111110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. ..... ......+.++.+||.+||+.||++|||+.|+++.
T Consensus 331 -~------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 331 -K------------EGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -H------------hCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 00000 0112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.67 Aligned_cols=259 Identities=21% Similarity=0.362 Sum_probs=203.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4689999999999999999997652 34589999886542 2344556789999999999999999999883
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~l 165 (620)
+....|+||||+. |+|.+++... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 4456899999998 6999999753 234667888999999999999999999999999999999999999
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~ 244 (620)
||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999998643322111 1122345677999999876 578999999999999999998 788997755433222221
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------CCccc
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA------DPYFK 318 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~------hp~f~ 318 (620)
+ .. ........++.+.+||.+||+.||++|||+.++++ ||||.
T Consensus 236 ~----------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 236 D----------------------------GG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred c----------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 1 00 00111245688999999999999999999999987 99998
Q ss_pred CC
Q 007050 319 GL 320 (620)
Q Consensus 319 ~~ 320 (620)
++
T Consensus 285 ~~ 286 (288)
T cd05061 285 EV 286 (288)
T ss_pred CC
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.74 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=202.6
Q ss_pred eEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 100 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 100 (620)
|++++.||+|+||.||+|.+.. ++..||+|+++...........+.+|+.+++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998765 34789999997654444556778999999999999999999998865432 3345
Q ss_pred eEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 101 DIYVVFELME-SDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
..++||||+. ++|..++... ..+++..+..++.||+.||.|||+.+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5899999999 6998888432 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654332111 1112234667999999876 678999999999999999999 8899977654333222211
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ......++..+.+||.+||+.||++|||+.|++++
T Consensus 231 ---------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 ---------------------GNR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------------------CCC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 11223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.12 Aligned_cols=262 Identities=22% Similarity=0.380 Sum_probs=208.4
Q ss_pred CeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (620)
.|++.+.||.|+||.||+|.+. .+|+.||+|.+.... ........+.+|+.+|+.+ +|+||+.+++.+ +
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4889999999999999999875 478999999986431 1223456678899999999 599999999887 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
....+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 4567899999999 599999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... .......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~------------- 220 (290)
T cd05613 156 HEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI------------- 220 (290)
T ss_pred ccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH-------------
Confidence 33221 112346789999999998753345788999999999999999999999643221111111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
...+....+ + ....+++.+.+||++||..||++|+ ++++++.||||+.+
T Consensus 221 -----------~~~~~~~~~-~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 221 -----------SRRILKSEP-P---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred -----------HHHhhccCC-C---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 111111111 1 1234678999999999999999997 89999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.26 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=196.7
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHH---HHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILRE---IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-~~~~~i~rE---i~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
.||+|+||.||+|.+..+++.||||.+....... ........| +.+++...||+|+.+++.+ .+...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999999999999999986532211 111223333 3445556899999999988 445679999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccc
Q 007050 106 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
|||+. ++|.+++...+.+++..+..|+.||+.||.|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhH
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~ 264 (620)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|..||.+........ +.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-------------~~-------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-------------ID-------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-------------HH--------
Confidence 1235789999999998642 468899999999999999999999997653211000 00
Q ss_pred HHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.. ...... ......+..+.+||.+||..||.+|+ +++++++||||+..
T Consensus 209 ----~~-~~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 209 ----RM-TLTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ----HH-hhccCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 00 000011 11234688999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.06 Aligned_cols=254 Identities=20% Similarity=0.357 Sum_probs=200.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
..++|++.+.||+|+||.||+|.++ .++..||+|++... ........+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~---- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence 3468999999999999999999865 24568999998643 2334556788999999999999999999988
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 164 (620)
.+....|+||||+. ++|.+++.... .++...+..++.||+.||.|||+.|++||||||+|||++.++.
T Consensus 79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 44467899999998 69999987532 3577888999999999999999999999999999999999999
Q ss_pred EEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHh
Q 007050 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i 243 (620)
+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987643222111 1122345778999999876 578999999999999999999 78999776544333222
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+ ... .......++.+.+||.+||+.||++|||+.|++++
T Consensus 235 ~~----------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 ME----------------------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred Hc----------------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 000 01112456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.70 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=202.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|.+++.||+|+||.||+|.+.. ++..||||.++... .......+.+|+++|+.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCT---- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEe----
Confidence 3578999999999999999998753 45789999987542 2234567889999999999999999999984
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND--------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~--------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (620)
+....|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 79 -EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred -cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 3467999999998 59999997643 4788999999999999999999999999999999999999
Q ss_pred CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007050 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 240 (620)
Q Consensus 162 ~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l 240 (620)
++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.....
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999764322211 11123456788999999876 679999999999999999998 99999776544332
Q ss_pred HHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 241 ~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..+.. .. .......++..+.+||.+||..||++||++.|+++
T Consensus 235 ~~~~~----------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQ----------------------------GR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHc----------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22211 00 01112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=318.24 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=209.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|++.+.||.|+||.||++.++.+++.+++|++............+.+|+.+++.++|+||+++.+++. +....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 589999999999999999999999999999999765444455667889999999999999999999883 346799
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 104 VVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999998 589988865 45789999999999999999999999999999999999999999999999999987644
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 123568889999999876 6788999999999999999999999977654322111110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. +.......+.+++++|.+||..||++|||+.++|+||++
T Consensus 216 ---------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 ---------------GK---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ---------------CC---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 011112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.82 Aligned_cols=253 Identities=31% Similarity=0.519 Sum_probs=205.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||.|+||.||++.+..+|+.+++|.+..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999999999999999865321 224456788999999999999999999887 4556799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc-----c
Q 007050 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-----T 183 (620)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~-----~ 183 (620)
. ++|.+++...+.+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998764432110 1
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
.......++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999876 5688999999999999999999999976654333222211
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHHcCCcccCC
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYFKGL 320 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa---~elL~hp~f~~~ 320 (620)
....+.. ...+++.+.+||.+||+.||.+|||+ .++|+||||+++
T Consensus 216 -----------~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 -----------GKIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -----------CCcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0001111 11247899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.35 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=196.0
Q ss_pred CCeEEEEEe--eecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVI--GKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~L--G~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
+.|.+.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.+...+ +||||+++++.+. ..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~-----~~ 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT-----TL 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe-----cC
Confidence 456666665 99999999999999999999999986432111 123333323 6999999999984 34
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGlA~~~~ 177 (620)
..+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 57999999998 69999998888899999999999999999999999999999999999999998 99999999987643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ..+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-----------~~~---- 217 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-----------DLE---- 217 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-----------hHH----
Confidence 22 22468889999999976 6789999999999999999999999975432110 000
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCCccc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALADPYFK 318 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-a~elL~hp~f~ 318 (620)
.+.... .......+..++.+.+||.+||+.||.+|++ ++++|+||||+
T Consensus 218 --------~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 218 --------SLLKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred --------HHHHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 000000 0111223468899999999999999999996 59999999997
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.66 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=201.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||+|+||.||+|.++.+++.||||++... .........+.+|+.+++.++||||+++++++. +...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 5799999999999999999999999999999988642 223344567889999999999999999999883 4467
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 589888753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChh-HHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~-~~l~~i~~~lg~p~~e~i 255 (620)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ..+.
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-------------- 217 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-------------- 217 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH--------------
Confidence 33221 1234568889999999876 57889999999999999999999998653211 0000
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..+......+ ......+..+.+||.+||..||.+||++.++|+
T Consensus 218 -------------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 218 -------------QKIEQCDYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -------------HHHhcCCCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 0010000000 011245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.07 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=208.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+-|++++.||.|+||.||+|.+..+++.||||.+... ........+.+|+.+++.++||||+++++.+ .+....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeE
Confidence 3478899999999999999999999999999988643 2234456788999999999999999999998 445679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||++ ++|.+++.. ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999 488888864 468999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.......++.+|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP----------------- 214 (277)
T ss_pred --hhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-----------------
Confidence 11234568889999999876 578889999999999999999999997654322221110
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.... ......++..+.++|.+||..||.+||++.++++||||...
T Consensus 215 -----------~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 215 -----------KNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -----------cCCC---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0000 11123467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=313.22 Aligned_cols=251 Identities=30% Similarity=0.515 Sum_probs=207.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++++. .....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence 48899999999999999999999999999999975422 45677889999999999999999999883 346789
Q ss_pred EEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 104 VVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
+|+||+. ++|.+++... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998775 5799999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 134568889999999876 4688999999999999999999999976543322221110
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
... ........++..+.+||.+||..||++|||+.|+|+|||
T Consensus 212 ------------~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ------------NGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------cCC-CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 000011124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.52 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=200.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||.|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +|+||+++++.+..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK-- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec--
Confidence 358999999999999999999754 345789999987542 234456778999999999 79999999998743
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~------------------------------------------------------ 120 (620)
+...+|+||||+. ++|.+++...
T Consensus 83 --~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 83 --PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred --CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3356899999999 5999888542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCc
Q 007050 121 -------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193 (620)
Q Consensus 121 -------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~ 193 (620)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence 25788999999999999999999999999999999999999999999999999875432211 1122345667
Q ss_pred cccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhh
Q 007050 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMR 272 (620)
Q Consensus 194 ~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (620)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.... .
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~---------------------------~ 290 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL---------------------------K 290 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH---------------------------h
Confidence 8999999876 689999999999999999998 999997643222111110 0
Q ss_pred ccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 273 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 273 ~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..... ......++.+.+|+.+||+.+|++||+++|+++|
T Consensus 291 ~~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 291 EGTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 0112457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.07 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=196.8
Q ss_pred EeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 30 VIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
.||+|+||.||+|.+ +.++..+|+|+++...........+.+|+.+++.+.||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999964 467789999998755444455677889999999999999999999862 235799999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
|+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887789999999999999999999999999999999999999999999999999998654332211111
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~--------------------- 212 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE--------------------- 212 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------------
Confidence 22334578999998865 578899999999999999998 999997755433322221
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ....+.+++.+.+||.+||+.||.+||+++++..
T Consensus 213 -------~~~~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 213 -------SGER---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCC---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 1110 0112357889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.95 Aligned_cols=245 Identities=28% Similarity=0.421 Sum_probs=201.2
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.+++++.||+|-||.||.|.... ...||+|.++.. ......+++|+++|++|+|+|||++++++. ....+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceE
Confidence 45567899999999999997642 238999999753 233456779999999999999999999993 334699
Q ss_pred EEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
||||||. |+|.++++. +..+.......|+.||++|++||+++++|||||-..||||++++.+||+|||||+...++.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999 899999987 4578999999999999999999999999999999999999999999999999999544333
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.... ...--..-|.|||.+.. ..++.++||||+|++|+||+| |+.||++.+..+.+..+..-.-
T Consensus 358 Y~~~--~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR----------- 422 (468)
T KOG0197|consen 358 YTAS--EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR----------- 422 (468)
T ss_pred eeec--CCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-----------
Confidence 2211 11222345899999976 789999999999999999999 8899999888777666643110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
....+++++.+.+|+..||..+|++|||++.+.
T Consensus 423 --------------------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 423 --------------------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 012246889999999999999999999999664
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.57 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=212.9
Q ss_pred ccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007050 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIM 91 (620)
Q Consensus 13 ~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~ 91 (620)
.+++....-.+.|...+.||+|+||.||+|.+..+++.|+||++..... .......+.+|+.+++.++|||++++++++
T Consensus 11 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 90 (313)
T cd06633 11 ADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY 90 (313)
T ss_pred HHHhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3344444445668888999999999999999999999999999864322 233446788999999999999999999998
Q ss_pred cCCCCCCCCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 92 LPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
.+....|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+||
T Consensus 91 -----~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 91 -----LKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred -----EeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeec
Confidence 44567899999999998888865 457899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
|++..... .....++..|+|||++... ...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 166 g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---- 234 (313)
T cd06633 166 GSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---- 234 (313)
T ss_pred CCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----
Confidence 99864221 1245688999999987421 14588899999999999999999999977654333222211
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
...+ ....+.++..+++||.+||+.||.+||++.++|.||||..
T Consensus 235 -----------------------~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 -----------------------NDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred -----------------------cCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 0000 0112345678999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.53 Aligned_cols=275 Identities=24% Similarity=0.290 Sum_probs=201.3
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC-ccH
Q 007050 35 SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDL 113 (620)
Q Consensus 35 ~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-gdL 113 (620)
++|.||+++++.+++.||+|++............+.+|+.+++.++||||+++++++. +....|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence 4566777777889999999999765344556778999999999999999999999883 4466899999999 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc----ccccc
Q 007050 114 HQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT----TIFWT 187 (620)
Q Consensus 114 ~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~----~~~~~ 187 (620)
.+++... ..+++..+..+++||+.||+|||+.+|+||||||+|||++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9988753 46899999999999999999999999999999999999999999999999998765322211 11123
Q ss_pred cccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHH
Q 007050 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267 (620)
Q Consensus 188 ~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~ 267 (620)
...++..|+|||++.+....|+.++||||+||++|+|++|..||........+... ..+..... + ........
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~-~----~~~~~~~~ 239 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCL-L----DKSTYPLY 239 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCccc-c----ccCchhhh
Confidence 34678889999998653346889999999999999999999999876543322111 11111000 0 00000000
Q ss_pred HHhhhc--------cCCCcc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 268 LTSMRK--------KQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 268 ~~~~~~--------~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...+.. ...... ......++..+.+||.+||..||++|||++++|+||||+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000 000000 001123467899999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=320.27 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=201.6
Q ss_pred eEEEEEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCe
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 101 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~--~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 101 (620)
|.+.+.||+|+||.||+|.+..++. .+|+|.++...........+.+|+.+++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3577899999999999999887775 69999987654555667788899999999999999999998754321 22346
Q ss_pred EEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 102 IYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.++|||||. ++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 699888742 2348899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 228 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--------- 228 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------
Confidence 754322111 1122345678999999876 678999999999999999999 889997755432222111
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..... ...+.++..+.+||.+||+.||.+|||+++++++
T Consensus 229 -------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 229 -------------------QGNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------cCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11110 1124567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=362.56 Aligned_cols=148 Identities=24% Similarity=0.434 Sum_probs=133.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|.+++.||.|+||.||+|.+..+++.||||++... .........+.+|+.++..++||||++++.++ .+..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 46899999999999999999999999999999999743 22334456788999999999999999999887 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+|||||||. ++|.+++...+.+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999887889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.89 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=199.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||++..+ .+..+|+|.+.... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCC
Confidence 357999999999999999999875 45689999876431 2245678899999999999999999988 34466
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 899999998 6999998753 46899999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+...
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~------------ 217 (256)
T cd05114 154 EYTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG------------ 217 (256)
T ss_pred ceec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC------------
Confidence 2111 122345567999999876 578999999999999999999 89999877655444433220
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .....+..+.+|+.+||..||++|||++++++
T Consensus 218 ----------------~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 218 ----------------FRLY---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----------------CCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 01124678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.15 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=193.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEec
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 108 (620)
+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+.+++.++||||+++++++ .+...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEee
Confidence 46999999999999999999999999886532 234456788999999999999999999998 344578999999
Q ss_pred CC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 109 ME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 109 ~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 59999987644 68999999999999999999999999999999999999999999999999987543221110 01
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+.
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~--------------------- 210 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--------------------- 210 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---------------------
Confidence 11123456999999876 578999999999999999997 888886544322111111
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..... ......+..+.+|+.+||+.||++|||+.++++
T Consensus 211 -------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 211 -------QGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------cCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011 112245789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.23 Aligned_cols=259 Identities=32% Similarity=0.515 Sum_probs=213.8
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+..+.|++.+.||.|+||.||++.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+. ..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYL-----VG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----EC
Confidence 456779999999999999999999999999999999875322 4567889999999999999999999984 34
Q ss_pred CeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 67999999999 69999998876 89999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......++..|++||++.+ ..++.++|+||||||+|+|++|..||...+.......+..
T Consensus 168 ~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~------------ 230 (286)
T cd06614 168 KEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------------ 230 (286)
T ss_pred cchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 2221 1123457889999999876 5789999999999999999999999976554322221110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
... ........++..+.+||.+||+.||.+|||+.++|+|+||+..
T Consensus 231 ----------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ----------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0111123467899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=327.02 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=208.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...+|...+.||+|+||.||+|+++.+++.+|+|.+.... .......++.+|+.+++.++|+|++++++++. +.
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----RE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cC
Confidence 3456888999999999999999999999999999986431 22344567889999999999999999999984 34
Q ss_pred CeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
...|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 56899999999988887754 45689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
. ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------ 228 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------ 228 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh------------
Confidence 1 234688899999987421 14578899999999999999999999866443222111100
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+ ......++..+.+||++||..+|++||+++++++|||+...
T Consensus 229 ---------------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 ---------------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 01123567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.19 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=200.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++++ .+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCC
Confidence 467999999999999999999864 5677999987642 23456788999999999999999999987 34466
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999998 699999865 34688999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 219 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR------------ 219 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc------------
Confidence 2211 1123345678999999876 578899999999999999998 9999987654333322211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......++..+.+||.+||..||++|||++++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 220 ----------------GYR---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 0122356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=315.99 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=202.6
Q ss_pred EEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++. +...+|+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEE
Confidence 4799999999999999866 8899999997643332 4677889999999999999999999984 35679999
Q ss_pred EecCC-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 106 FELME-SDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
|||+. ++|.+++... ..+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+.+
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 644321 111234567889999999876 578999999999999999999 6999987654333322211
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. .......+++++.++|.+||..||.+|||++|++++
T Consensus 223 -------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 -------------------GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 011223558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=329.15 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=209.0
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+....|...+.||+|+||.||++.+..++..+|+|++.... ........+.+|+.+++.++|||++++++++. +
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 96 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----R 96 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 33456899999999999999999999999999999986432 23344567889999999999999999999983 4
Q ss_pred CCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
....|+||||+.|+|.+.+.. ...+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++....
T Consensus 97 ~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 97 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 456899999999988887754 4578999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.. ....++..|+|||++... ...++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---------- 239 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------- 239 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc----------
Confidence 21 234688899999987421 146889999999999999999999999765433322222110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
..+ ......+++.+++||.+||+.||.+||++.++++|+|+..
T Consensus 240 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -----------------ESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------------cCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0112246778999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=319.18 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=202.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
..+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+.+|+.+++.++||||+++++++ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 4689999999999999999999875554 79999886532 234456788999999999999999999988 34
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
....|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 456899999998 5999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..............++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------
Confidence 433221111122233567999999876 578999999999999999886 999997765443333332110
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. .....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 227 --------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 --------------------RL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --------------------cC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=328.42 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=200.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~----vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..+|++.+.||+|+||.||+|.+..+++. ||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----
Confidence 45799999999999999999998766664 899998643 233456678899999999999999999998843
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...++|+||+. |+|.+++..+. .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred --CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 24689999998 69999998743 688999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.. .+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~--------- 225 (316)
T cd05108 159 LGADEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE--------- 225 (316)
T ss_pred ccCCCcc-eeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHh---------
Confidence 5432221 11122334667999999876 678999999999999999997 99999765432211 1110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..... ...+.++..+.+|+.+||..||.+||++.+++.+
T Consensus 226 ------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 ------------------KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 1123467789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=321.53 Aligned_cols=252 Identities=21% Similarity=0.374 Sum_probs=200.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+.|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 569999999999999999999987 7789999988643 22334456889999999999999999999873
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cEE
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLK 166 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~lK 166 (620)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 3456799999997 59999997653 488999999999999999999999999999999999998765 599
Q ss_pred EcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhh
Q 007050 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTD 245 (620)
Q Consensus 167 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~ 245 (620)
|+|||+++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 160 l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCcccee-cCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999998653221111 0112233567999999876 579999999999999999997 9999987665433222211
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. .. ......++..+.+|+.+||+.||++|||+.++|+|
T Consensus 237 ~----------------------------~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G----------------------------GR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C----------------------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 01123467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=365.78 Aligned_cols=264 Identities=33% Similarity=0.486 Sum_probs=202.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 95 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~------- 95 (620)
..|+.++.||+|+||.|++++++-+|..||||+|.... ......++.+|+++|.+|+|||||+++..|....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 34567889999999999999999999999999998665 5567788999999999999999999877652100
Q ss_pred ----------------------------------------------C--------------------CC-----------
Q 007050 96 ----------------------------------------------R--------------------RD----------- 98 (620)
Q Consensus 96 ----------------------------------------------~--------------------~~----------- 98 (620)
. ++
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 00
Q ss_pred ----------------------C--------CeEEEEEecCCcc-HHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 007050 99 ----------------------F--------KDIYVVFELMESD-LHQVIKANDDL-TREHYQFFLYQLLRALKYIHTAN 146 (620)
Q Consensus 99 ----------------------~--------~~lylV~E~~~gd-L~~~i~~~~~l-se~~~~~i~~QIl~aL~yLHs~g 146 (620)
. ..+||=||||+.+ |.++|..+... ....+|.++++|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 3479999999965 55555555433 47889999999999999999999
Q ss_pred cEeecCCCCceEeCCCCcEEEcccCcccccc--------------C-CCCcccccccccCCccccCcccccccC-CCCCc
Q 007050 147 VYHRDLKPKNILANANCKLKICDFGLARVAF--------------N-DTPTTIFWTDYVATRWYRAPELCGSFF-SKYTP 210 (620)
Q Consensus 147 IvHrDLKP~NILl~~~~~lKL~DFGlA~~~~--------------~-~~~~~~~~~~~~gt~~Y~APEvl~~~~-~~y~~ 210 (620)
||||||||.||++++++.|||+|||+|.... . ........|..+||..|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 011122457789999999999997642 26999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhcc-CCCcccCCCCCCCHH
Q 007050 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKK-QPVQFSQKFPNADPS 289 (620)
Q Consensus 211 ~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~ 289 (620)
|+||||||+||+||+. ||... .+... .+..++.. .|.+ ...+.+--+.
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts--MERa~-------------------------iL~~LR~g~iP~~-~~f~~~~~~~ 846 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS--MERAS-------------------------ILTNLRKGSIPEP-ADFFDPEHPE 846 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch--HHHHH-------------------------HHHhcccCCCCCC-cccccccchH
Confidence 9999999999999985 46432 11111 12222211 1111 2223344456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 290 ALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 290 l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
-..+|+.||+.||.+||||.|+|++.||-
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 78999999999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=324.78 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=206.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (620)
+.+.|++.+.||+|+||.||+|.+..+++.||||.++.... ......+.+|+.++..+. ||||+++++++ .+.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 34679999999999999999999999999999999975422 234456677887776664 99999999998 445
Q ss_pred CeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
..+|+||||+.+.|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 67999999999888887765 4578999999999999999999997 599999999999999999999999999987653
Q ss_pred CCCCcccccccccCCccccCcccccccC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCh-hHHHHHhhhccCCCChhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~--~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~-~~~l~~i~~~lg~p~~e~ 254 (620)
..... ....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 233 (296)
T cd06618 167 DSKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ--------- 233 (296)
T ss_pred CCCcc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---------
Confidence 22211 2335778899999986521 3478899999999999999999999965321 111111110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..... ......++..+.+||.+||..||.+||++++++.||||..+.
T Consensus 234 -------------------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 234 -------------------EEPPS-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred -------------------CCCCC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00000 011124678999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=322.02 Aligned_cols=252 Identities=21% Similarity=0.380 Sum_probs=200.9
Q ss_pred CCeEEEEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+.|++.+.||+|+||.||+|.+. .++..|++|.+... ........+.+|+.+++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ec
Confidence 57899999999999999999853 45678999998753 2334456788999999999999999999988 34
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
....|+||||+. ++|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 456899999998 5999988532 2478888999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~ 239 (620)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999998654322111 1233445678999999876 578999999999999999998 9999977654332
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
...+.. ... ......+++.+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~----------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK----------------------------RQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc----------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222211 110 11223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.24 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=208.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
..|.....||+|+||.||++.++.+++.||||++... .......+.+|+.+++.++|+||+++++.+ .+....
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEE
Confidence 3455557899999999999999999999999998642 233456688999999999999999999988 345679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+.+ +|.+++. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999985 7887764 45689999999999999999999999999999999999999999999999999875533221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+..
T Consensus 172 ~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---------------- 230 (292)
T cd06657 172 R---RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---------------- 230 (292)
T ss_pred c---ccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Confidence 1 134568899999998876 5788999999999999999999999987654433222211
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..+.. ......+++.+.+||.+||..||.+||++.++|+||||....
T Consensus 231 ------------~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 231 ------------NLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------------hCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00111 112245688999999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.42 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=202.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++.+.||+|+||.||+|.++.+ ...||||.+.... .......+.+|+.+++.++||||+++++.+ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ec
Confidence 46799999999999999999998654 4579999887532 334456788999999999999999999987 34
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||+. ++|.+++... +.+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 456899999998 5999998764 47899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.+
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---------- 223 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---------- 223 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc----------
Confidence 4222111 1112345678999999876 678999999999999999998 9999966544332222211
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
....+ .....++.+.+|+.+||+.||++||+++|++++
T Consensus 224 ------------------~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 ------------------GYRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 113467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.34 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=201.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
++|...+.||+|+||.||+|.++.++. .+|+|++.... .......+.+|+.+++.++||||+++.+++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 478899999999999999999887665 79999886532 234566788999999999999999999998 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 67899999999 5999988764 578999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--------- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--------- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---------
Confidence 33222111111223457999999876 578999999999999999997 999997765443333332110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..+ .....+..+.+|+.+||..||++||++.++++
T Consensus 228 -------------------~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -------------------RLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 11245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.65 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=202.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|+||+++++.+. +...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 5799999999999999999999999999999988642 223334667889999999999999999999984 3457
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
.++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999999 599988864 345899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... +..
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-------------- 215 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYS-------------- 215 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHH--------------
Confidence 332211 234568889999998876 67899999999999999999999999654310 000
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....+......+ .....++..+.++|.+||..||++|||+.++++
T Consensus 216 ----------~~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 216 ----------LCKKIEKCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------HHhhhhcCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000000000000 011256778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.04 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=200.5
Q ss_pred CCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 77 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 77 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 46899999999999999999853 34567999988653 2344567889999999999999999999983
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (620)
+...+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||+.|++||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 4467899999998 69999997543 489999999999999999999999999999999999999999
Q ss_pred cEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007050 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 242 (620)
Q Consensus 164 ~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~ 242 (620)
.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999976533221 111233456778999999876 578999999999999999998 8999977654333322
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+.. .... ......+..+.+|+.+||+.||.+|||+.+++.
T Consensus 235 i~~----------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQ----------------------------GRVL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHc----------------------------CCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 211 1100 111246788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.14 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=198.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~--~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
++|++.+.||+|+||.||+|.++.++. .+++|.++.. ........+.+|+.+++++ +||||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccC
Confidence 579999999999999999999887775 4688887632 3334556788999999999 799999999988 444
Q ss_pred CeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC
Q 007050 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 162 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (620)
..+|+||||+. ++|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 56899999998 69999997542 47889999999999999999999999999999999999999
Q ss_pred CcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHH
Q 007050 163 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLD 241 (620)
Q Consensus 163 ~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~ 241 (620)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864321111 111223456999999876 678999999999999999997 999997765433322
Q ss_pred HhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 242 ~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+.. ... ......++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~~----------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ----------------------------GYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc----------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2110 000 01123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.98 Aligned_cols=245 Identities=21% Similarity=0.323 Sum_probs=195.9
Q ss_pred EEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.+.||||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEE
Confidence 47999999999999876555 78999998754332 45667889999999999999999999762 2357999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccc
Q 007050 106 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
|||+. ++|.+++..+..+++..+..++.||+.||.|||..+++|+||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchh
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~ 263 (620)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999998876 679999999999999999998 9999976554332222211
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......++..+.+||.+||..||++||++.++++
T Consensus 214 ----------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ----------GER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 1122356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.44 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=219.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
+..|.++.+||+|+||+|.+|..+.+.+.||||++++.. -...+.+-.+.|-.+|... +-|.++++..+| +..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence 457889999999999999999999999999999997642 2334455556777888776 467888888887 566
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+. |||...|++-+.+.|..+.+++..|+-||-|||++||+.||||.+|||++.+|++||+|||+++....
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 77999999999 59999999999999999999999999999999999999999999999999999999999999986443
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...++ .++|||+.|+|||++.= ..|+.++|+||+||+|||||.|++||.|.++.+.+..|++-
T Consensus 503 ~~~TT---kTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------ 565 (683)
T KOG0696|consen 503 DGVTT---KTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------ 565 (683)
T ss_pred CCcce---eeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------------
Confidence 33332 57899999999999874 79999999999999999999999999999988888777651
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~elL~hp~f~~~ 320 (620)
+ ......+|.++.++.+.+|...|.+|... .++-.||||+.+
T Consensus 566 --n------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 566 --N------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred --c------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 1 11224578999999999999999999744 678899999854
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.42 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=199.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.+. +++.||+|.++... .....+.+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCC
Confidence 357999999999999999999875 45689999987532 2345678999999999999999999987 34466
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999996 69999997654 689999999999999999999999999999999999999999999999999987642
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... ......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----------- 220 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21111 111223457999999876 678999999999999999999 99999876544333322110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+..+.+|+.+||+.||.+||+++++++
T Consensus 221 -----------------~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 -----------------YRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----------------CCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000 112346789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.74 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=201.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|.+.+.||+|+||.||++.++..+ ..||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc----
Confidence 468999999999999999999887544 78999998643 23344567889999999999999999999983
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~l 165 (620)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 80 -~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 80 -TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred -CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 4466899999998 69999986532 36788899999999999999999999999999999999999999
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~ 244 (620)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999765432211 11123456788999998876 578999999999999999998 999997765433222221
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .......+..+.+||.+||+.||++|||+.++++
T Consensus 236 ----------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ----------------------------DGGH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ----------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 0112235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.44 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=201.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++.+.||+|+||.||++.++..+ ..+|+|.+.... .......+.+|+.+++.+ +|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 468999999999999999999876443 689999987542 234556788999999999 799999999988
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 158 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (620)
.+...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 34456899999998 6999998642 35889999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChh
Q 007050 159 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVV 237 (620)
Q Consensus 159 l~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~ 237 (620)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122234567999998876 678999999999999999997 99999876543
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+....+.. ... .......+..+.+|+.+||..||++|||+.|+|++
T Consensus 242 ~~~~~~~~----------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE----------------------------GYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc----------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 33222211 000 01123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.06 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=199.1
Q ss_pred CCe-EEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRY-KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY-~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSE---Q 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 456 999999999999998864 34578899999987542 22345667899999999999999999998743 2
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 3356899999999 5899988764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc-cCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL-LGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~-lg~p~~e~i 255 (620)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~----- 228 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQM----- 228 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccccccc-----
Confidence 432221111123345677999998876 57899999999999999999999998543211 1111100 0000
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....+...+...... .....++..+.+|+.+||..||++|||++++++
T Consensus 229 -------~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 229 -------TVVRLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -------chhhhhhhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000011101011100 112356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.25 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=198.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCC
Confidence 3579999999999999999997653 4469999887432 22356789999999999999999999983 3456
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 5899998764 36899999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 2111 112235567999999876 578999999999999999998 99999765543322222110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.... .....+..+.+|+.+||..||.+||++.+++.+
T Consensus 218 ----------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ----------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.69 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=202.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC----------------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG----------------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 86 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg----------------~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~ 86 (620)
++|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 58999999999999999999876544 458999987542 2345667889999999999999999
Q ss_pred eeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~-----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (620)
+++++. +....++|||++. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999883 3467899999998 59999997765 689999999999999999999999999999999
Q ss_pred CceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh--CCCCCC
Q 007050 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (620)
Q Consensus 155 ~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt--G~~pF~ 232 (620)
+||+++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999764332211 11223456778999999876 578999999999999999998 677886
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
..+..+.+..+..... ...........+.++.++.+||.+||+.||++|||+.|++
T Consensus 236 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 236 HLTDQQVIENAGHFFR------------------------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CcChHHHHHHHHhccc------------------------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 6554333322211100 0000011112235678999999999999999999999996
Q ss_pred c
Q 007050 313 A 313 (620)
Q Consensus 313 ~ 313 (620)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=346.82 Aligned_cols=243 Identities=32% Similarity=0.490 Sum_probs=201.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~-L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+.|.+...+|.|+|+.|..+.++.+++.+++|++.+.. ....+|+.++.. -+||||+++.+++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 467888889999999999999999999999999997641 223357765544 4799999999998 6778
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe-CCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA-NANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-~~~~~lKL~DFGlA~~~~~ 178 (620)
++|+|||++.| .|.+.|.....+. .++..|+++|+.|+.|||++|||||||||+|||+ ++.++++|||||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999995 6777776665555 7888899999999999999999999999999999 6899999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. +...|-|..|.|||++.. ..|++++||||||++||+||+|+.||....... .|...++.|
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~-------- 529 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMP-------- 529 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCC--------
Confidence 3 234577899999999985 799999999999999999999999996654321 111111111
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
+++ ..+|+.++|||+.||++||.+|+++.+++.||||
T Consensus 530 -------------------~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 -------------------KFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------------------ccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 4689999999999999999999999999999999
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.28 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=197.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~--vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
+.|++.+.||+|+||.||+|.++.++.. +++|.+... ........+.+|+.++..+ +||||+++++++ .+.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 5799999999999999999999888764 577776542 2234456788999999999 899999999998 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC
Q 007050 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 162 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (620)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 67999999998 69999997542 47899999999999999999999999999999999999999
Q ss_pred CcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHH
Q 007050 163 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLD 241 (620)
Q Consensus 163 ~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~ 241 (620)
+.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 9999999999864211111 011223567999998876 568999999999999999998 999997665433222
Q ss_pred HhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 242 ~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+. .... .......++.+.+||.+||+.||++||+++++|.+
T Consensus 235 ~~~----------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLP----------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHh----------------------------cCCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 0000 01112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.68 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=198.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..+|++.+.||+|+||.||++.++ ++..+|+|++..... ....+.+|+.+++.++||||+++++++ .+...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCc
Confidence 356889999999999999999876 567899999864322 234577899999999999999999987 34456
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.|+||||++ ++|.+++..+ ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999998 5899998764 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA------------- 216 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 111223457999999876 678999999999999999999 8999976554332222211
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... .......+..+.+|+.+||..+|++|||++|+++.
T Consensus 217 ---------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 ---------------GYR---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 000 01123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=322.32 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=200.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.+|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----T 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----c
Confidence 4688899999999999999987543 5789999997542 223456688999999999999999999998 3
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
+...+++++||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 4456899999998 5899888532 2478888999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~ 239 (620)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998865332211 11233456778999999876 578999999999999999998 8889987665444
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+..+.+. ... ....+++..+.+|+.+||+.||.+||++.+++..
T Consensus 236 ~~~i~~~----------------------------~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNR----------------------------QVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcC----------------------------CcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 3333221 000 1123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.18 Aligned_cols=269 Identities=23% Similarity=0.391 Sum_probs=201.0
Q ss_pred CCeEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.+|++++.||+|+||.||++. +..++..||+|++... .......+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---C
Confidence 479999999999999999997 4567889999998753 334566788999999999999999999987543 2
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 346899999998 6999999764 46899999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..............++..|+|||++.+ ..++.++|||||||++|||++|..++...... ....+ +....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~----~~~~~---- 227 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMM----GNDKQ---- 227 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhc----ccccc----
Confidence 432221111112234456999999876 57899999999999999999998776443211 11111 11000
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...........+...... .....++..+.+||.+||..||++|||+.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 228 ---GQMIVYHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---cccchHHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000000111111111111 123457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.48 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=202.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++.+.||+|+||.||++.++.+++.+|||.+.... ........+.+|+.+++.+.||||+++++.+. +...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 47899999999999999999999999999999886432 23344567889999999999999999999883 4467
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 999999998 489888863 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... .
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-------------- 215 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--S-------------- 215 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH--H--------------
Confidence 33221 1234578899999999876 5788999999999999999999999965432100 0
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....+...... .......++.+.+||.+||..||++|||+.++++
T Consensus 216 ----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 216 ----------LCKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------HhhhhhcCCCC--CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00000000000 0112346789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.62 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=197.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+. ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCC
Confidence 46799999999999999999988765 4699999875322 2346788999999999999999998762 234
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 5999999753 3588999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------ 218 (262)
T cd05071 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 218 (262)
T ss_pred ccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------
Confidence 22111 122346678999998876 578999999999999999999 8889977654333322211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .....++..+.+||.+||+.||.+||++.++++
T Consensus 219 ----------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 ----------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------------CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 012346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=317.27 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=202.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
..|++++.||.|+||.||+|.++. +..+++|++... .......+.+|+.+++.++||||+++++++ .+...+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 468999999999999999999987 889999998753 223456688999999999999999999988 344568
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 5999999753 46899999999999999999999999999999999999999999999999999765332
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 220 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG------------ 220 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC------------
Confidence 111 123345678999999876 578999999999999999998 89999876644333322210
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. .......++.+.++|.+||+.||.+|||+.++++
T Consensus 221 ----------------~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 221 ----------------YR---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------------Cc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 0112456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.57 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=197.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCC
Confidence 357999999999999999999765 566799999875322 2345789999999999999999998762 234
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5999999753 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----------- 219 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 122345667999998876 578999999999999999999 89999876554433332110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+..+.+||.+||..||.+|||+.++++
T Consensus 220 -----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 -----------------YRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------------CCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 112356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.89 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=199.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||.|+||+||+|.+..++. .||+|.+... ........+.+|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence 4679999999999999999999877776 4899988653 233445678899999999999999999998843
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...+++|||+. |+|.+++..+ +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 --STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 23689999998 6999999764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----------- 224 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL----------- 224 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----------
Confidence 5432211 11122234677999999876 578999999999999999998 89999664432211111
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. .... ....+..+..+.+||.+||..||++||++.+++.
T Consensus 225 --------------~---~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 225 --------------E---KGER---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------H---CCCc---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 1111 1112456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.00 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=198.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|.+... +..||||++... ........+.+|+.+|+.+. ||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 46889999999999999999987533 347999999753 23345567899999999996 99999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~------------------------------------------------------ 120 (620)
.+...+|+|||||. |+|.+++..+
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 44567999999998 6998887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 007050 121 ------------------------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 158 (620)
Q Consensus 121 ------------------------------------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (620)
..+++..+..++.||+.||+|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 23778888999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChh
Q 007050 159 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVV 237 (620)
Q Consensus 159 l~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~ 237 (620)
++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999865432211 11123456778999999876 678999999999999999997 88999764322
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+.+... +...... .....++..+.+||.+||+.||++|||+.++.+
T Consensus 347 ~~~~~~---------------------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNK---------------------------IKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHH---------------------------HhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 111000 0000000 112356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.00 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=199.7
Q ss_pred CCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~ 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVC-----G 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----c
Confidence 46999999999999999999854 34557899988642 234456688999999999999999999998 3
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
+....++||||+. ++|.+++..++ .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 4456899999998 69999997543 378999999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~ 239 (620)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999976533221 111234457888999999876 678999999999999999998 9999976554332
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+..+.. .. ........+..+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~----------------------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ----------------------------GR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC----------------------------CC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 222111 00 01112345778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=314.04 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=201.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.+.|++.+.||+|+||.||+|.++.+++ .||||.+.... .......+.+|+.+++.++||||+++++++ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CC
Confidence 4579999999999999999999887765 59999987532 344567788999999999999999999988 44
Q ss_pred CCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||++ ++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 566899999998 589998875 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCcccccccc--cCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 177 FNDTPTTIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 177 ~~~~~~~~~~~~~--~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
............. ..+..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 4322211111111 12457999999876 678999999999999999886 99999776543333222110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ...+.++..+.+|+.+||..||.+||++++++.
T Consensus 228 ---------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 ---------------------YRL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ---------------------CcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011 112356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=357.35 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=202.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++ .+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 589999999999999999999999999999999975432 233456788999999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcc
Q 007050 102 IYVVFELME-SDLHQVIKAN-----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~D 169 (620)
.|+|||||+ ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 999999998 5999988641 2355667888999999999999999999999999999999999999999
Q ss_pred cCccccccCCCC---------------cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 007050 170 FGLARVAFNDTP---------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (620)
Q Consensus 170 FGlA~~~~~~~~---------------~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~ 234 (620)
||+++....... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999986521110 0001123579999999999877 67899999999999999999999999764
Q ss_pred ChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 235 ~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+....... ..+ ..+... ..+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i--------------------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVI--------------------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhc--------------------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211100 000 000000 1134678899999999999999999887776654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.32 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=198.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC--------------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG--------------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg--------------~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+|+.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 358999987542 234456788999999999999999999
Q ss_pred eEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 007050 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (620)
+++. .....|+|||||. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 9983 4456899999998 59999886532 3688889999999999999999999999999999
Q ss_pred ceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh--CCCCCCC
Q 007050 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 233 (620)
Q Consensus 156 NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt--G~~pF~g 233 (620)
|||++.++.+||+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322211 11122345678999998876 578999999999999999988 5678876
Q ss_pred CChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 234 KNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 234 ~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.+..+.+..+.. ++. ......+....+..++.+.+||.+||..||++|||++++++
T Consensus 236 ~~~~~~~~~~~~---------------------~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGE---------------------FFR---NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHH---------------------hhh---hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 554333222211 000 00000111223456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.70 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=200.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|.+.+.||.|+||.||+|.+. .+..+|||.+.... .....+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCc
Confidence 468999999999999999999975 45789999987432 2345688999999999999999999987 34456
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 59999997643 689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+.....
T Consensus 156 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05034 156 DEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR--------- 222 (261)
T ss_pred hhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21111 112234567999999876 678999999999999999998 9999987665444443322110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.......+..+.+++.+||..||.+||+++++++
T Consensus 223 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ----------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0111245778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.87 Aligned_cols=270 Identities=24% Similarity=0.362 Sum_probs=203.3
Q ss_pred CCeEEEEEeeecCceEEEEEEE----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAID----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.-|++++.||+|+||.||+|.. +.++..||+|.++.. ........+.+|+.+++.++||||+++.+++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 4579999999999999999974 467889999998754 2334456788999999999999999999987432 2
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999998 59999986643 5899999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..............++..|+|||++.+ ..++.++|||||||++|+|+++..|+.... . ......+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~--~---~~~~~~~~~~~~~-- 230 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM--T---LFLKMIGPTHGQM-- 230 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc--c---hhhhhcccccccc--
Confidence 433221112234567778999999876 578999999999999999999876653321 1 1111111111110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
........+.... .......++..+.+||.+||+.||++|||+++++++
T Consensus 231 ------~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 ------TVTRLVRVLEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ------cHHHHHHHHHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0011111111111 112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.12 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=198.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|+++++||+|+||.||+|.++ +++.||+|.+.... .....+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCC
Confidence 357999999999999999999864 56789999987532 23456889999999999999999998762 235
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 899999998 6999988653 3689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+...
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG----------- 219 (260)
T ss_pred CCccc--ccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-----------
Confidence 21111 122345678999999876 578999999999999999999 99999876644333222110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+..+.+||.+||..||++|||++++++
T Consensus 220 -----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 220 -----------------YRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 112345778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=373.10 Aligned_cols=261 Identities=30% Similarity=0.412 Sum_probs=213.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
|++-...||.|.||.||.|++..+|+..|+|.|+-..........+.+|.++|..|+|||+|+++++=.+ ...+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Rekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----REKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HHHHH
Confidence 5666779999999999999999999999999987543344455667899999999999999999998643 35689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
|.||||+ |+|.+++...+-.++...+.+..|++.||+|||+.|||||||||.|||++.+|.+|++|||.|....+...+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999 699999987777777778889999999999999999999999999999999999999999999987665321
Q ss_pred -ccccccccCCccccCcccccccC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 183 -TIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 183 -~~~~~~~~gt~~Y~APEvl~~~~-~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
......+.||+.|||||++.+.. .+...+.|||||||++.||+||+.||...+..-++ |..+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~V-------------- 1454 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYHV-------------- 1454 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhHH--------------
Confidence 22345789999999999997642 45677999999999999999999999765433221 1110
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.+ ...| +....+|.+.+|||.+||..||++|+++.|+|+|-|-+.
T Consensus 1455 ---------~~-gh~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 ---------AA-GHKP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ---------hc-cCCC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 00 0111 111237899999999999999999999999999998764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.61 Aligned_cols=245 Identities=30% Similarity=0.500 Sum_probs=203.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (620)
||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999999999999999875422 223556788999999999999999999887 4567799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccccc
Q 007050 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (620)
Q Consensus 110 ~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~ 188 (620)
. ++|.+++.....+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998887899999999999999999999999999999999999999999999999999977543321 1234
Q ss_pred ccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHH
Q 007050 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYL 268 (620)
Q Consensus 189 ~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~ 268 (620)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 568889999999876 5688899999999999999999999976553222211110
Q ss_pred HhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHHcCCcc
Q 007050 269 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYF 317 (620)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa---~elL~hp~f 317 (620)
... ......+..+.+||++||..||++||++ +++++||||
T Consensus 208 ------~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 ------DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 000 1112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.07 Aligned_cols=262 Identities=23% Similarity=0.393 Sum_probs=205.2
Q ss_pred CeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (620)
.|++.+.||+|+||.||++.+. .+++.||||.+++.. ........+.+|+.+++.+ +||||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4899999999999999999864 467899999986431 1223445678999999999 599999999887 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
....+|+||||+. ++|.+.+..+..+++..++.++.||+.+|.|||+.+++||||||+||+++.++.++|+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 4467999999998 599999987778999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
....... .....++..|+|||.+.+.....+.++|+|||||++|+|++|..||...........+
T Consensus 156 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------- 220 (288)
T cd05583 156 LAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI------------- 220 (288)
T ss_pred ccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH-------------
Confidence 4332111 1234688999999998653234788999999999999999999999643221111000
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps---a~elL~hp~f~~~ 320 (620)
...+....+ .....++..+.+||.+||+.||++||| +.++|+||||+.+
T Consensus 221 -----------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 221 -----------SRRILKSKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred -----------HHHHHccCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 000000100 112346789999999999999999998 5778999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.32 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=199.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (620)
.++|.+.+.||+|+||.||++.+.. +...+|+|.+... ........+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 3689999999999999999998643 2357999998753 2334556788999999999 799999999998
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+||||+. ++|.+++.... .++...+..++.||+.||+|||+.|++||||||+|
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 94 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 34457899999998 69999997642 47889999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998765321111 01112234567999998876 578999999999999999998 889997654
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+....+. .... .......+.++.+||.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~----------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLK----------------------------EGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHH----------------------------cCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 322221110 0100 11223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.70 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=208.9
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEEE
Q 007050 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
+++..||.|++|+||+++.+.+|...|||.+.+. .+..+.++|+..+.++.... +|+||+.+++|+.. .+++|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~I 168 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVFI 168 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHHH
Confidence 4677899999999999999999999999999875 44567788999998876664 89999999999654 35789
Q ss_pred EEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 105 VFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 105 V~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
.||.|..-+..+++. .++++|..+-.+...++.||.||..+ +|+|||+||+|||+|..|.+||||||.+-.+.....
T Consensus 169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 999998655555543 35799999999999999999999865 799999999999999999999999999976543322
Q ss_pred ccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChhhhhhhhh
Q 007050 183 TIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.+...|-+.|||||.+.-. ..+|+..+|+||||+.++||.||..||.+.+ +.+.+..|.+
T Consensus 248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--------------- 309 (391)
T KOG0983|consen 248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--------------- 309 (391)
T ss_pred ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---------------
Confidence 2445788999999988643 4679999999999999999999999999854 3333333322
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..|. ....-.++|+.+.+|+..||+.|+.+||...++|+|||+..+.
T Consensus 310 -------------~ePP-~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 310 -------------EEPP-LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred -------------cCCC-CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 1221 1112234799999999999999999999999999999998654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=313.15 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=201.3
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
||.+.+.||+|+||.||++.+..++..+++|.++... ........+.+|+.+++.++||||+++++.+. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 6999999999999999999998888777777765321 12234456778999999999999999999873 345
Q ss_pred eEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 6899999998 488887753 457999999999999999999999999999999999999975 5699999999876
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 5432221 234568889999998865 5788899999999999999999999976543322221110
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .......++.++.+||.+||..||.+||++.|+|+||||
T Consensus 220 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 ------------------GP---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ------------------CC---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00 001123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.13 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=199.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|.+.+.||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCT---- 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEe----
Confidence 357889999999999999999743 35678999988753 3345567889999999999999999999883
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND---------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~---------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 78 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred -cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 4456899999998 69999987643 478899999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~ 239 (620)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322211 11122345678999998876 578999999999999999998 8999976554333
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+..+.. .... .....+++.+.+||.+||+.||.+||+++|++.
T Consensus 234 ~~~~~~----------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQ----------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHc----------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222211 0000 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=309.97 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=196.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..+|++.+.||+|+||.||++... |..+|+|.+... .....+.+|+.+++.++|+||+++++++. .+...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCc
Confidence 457999999999999999999654 788999998642 23456889999999999999999998763 23456
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+||||+. ++|.+++..+. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 59999997654 478999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~------------- 213 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------------- 213 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------------
Confidence 21 12234567999999876 578999999999999999997 999997654322221111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ....+.+++.+.+||.+||..||++|||+.++++
T Consensus 214 ---------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 214 ---------------KGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------cCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1100 0122456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=319.76 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=199.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (620)
++|.+++.||+|+||.||+|.+.. ....+|+|.++... .......+.+|+.+++.+ .||||+++++++.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 589999999999999999998642 34579999887542 334566788999999999 6999999999883
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (620)
+...+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 4456899999998 6999999753 3488899999999999999999999999999999999
Q ss_pred EeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCh
Q 007050 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (620)
Q Consensus 158 Ll~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~ 236 (620)
|++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998653222111 0112234467999999876 678999999999999999999 8899977654
Q ss_pred hHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 237 ~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.+.+..+.. ... ......++..+.+||.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLRE----------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHc----------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 333322211 000 0112456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=319.10 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred CCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (620)
++|.+.+.||+|+||.||++.+ ..++..||+|+++... .......+.+|+.+++.+ +||||+++++.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 108 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC----- 108 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence 4799999999999999999975 3345689999987542 234456788999999999 799999999988
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.....+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 34456899999998 69999997643 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+....
T Consensus 189 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~-------- 257 (302)
T cd05055 189 RDIMNDSNYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI-------- 257 (302)
T ss_pred ccccCCCcee-ecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH--------
Confidence 8654332111 1122346778999998876 578999999999999999998 999997654322111110
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ..... ......++.+.+|+.+||..||++|||+.|+++
T Consensus 258 ----------------~---~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 258 ----------------K---EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------------H---cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 00000 112345789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=309.93 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=197.1
Q ss_pred EEeeecCceEEEEEEECC-CCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTH-TGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~-tg~--~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+.||+|+||.||+|.+.. .++ .||||.+...... .....+.+|+.+++.++||||+++++++. + ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEE
Confidence 468999999999999865 333 6999999764333 55678889999999999999999999883 3 678999
Q ss_pred EecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 106 FELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
|||+. ++|.+.+..+. .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99998 69999997754 6899999999999999999999999999999999999999999999999999876432221
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.+..+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123456778999998876 578999999999999999998 99999766544333222110
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... .......+..+.+|+.+||..+|++|||+.++++
T Consensus 217 ------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 ------------GER---LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCc---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000 0011245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=318.32 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=201.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-------~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (620)
..+|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 468999999999999999999753 234579999887532 234556788999999999 899999999988
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+||||+. ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 34467899999998 6999999753 246788899999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999865432211 11223345678999999876 578999999999999999998 788997765
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+....+.. ... ......++..+.+||.+||..+|.+|||+.|+|+.
T Consensus 245 ~~~~~~~~~~----------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE----------------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc----------------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4433322211 000 01123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=308.90 Aligned_cols=243 Identities=26% Similarity=0.433 Sum_probs=199.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|++.+.||.|+||.||+|.+. |+.||+|.+.... ....++.+|+.+++.++|+||+++++++. +...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCC
Confidence 467999999999999999999764 7899999997542 25677889999999999999999999984 3466
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999999 59999998765 699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... ....+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 155 ~~~------~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------- 213 (256)
T cd05039 155 GQD------SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE------------- 213 (256)
T ss_pred ccc------cCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------------
Confidence 211 2234567999998876 578899999999999999997 999997654332211111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .......++.+.+||.+||..+|++|||++|+++
T Consensus 214 ---------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 214 ---------------KGYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------cCCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 0112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.54 Aligned_cols=247 Identities=28% Similarity=0.382 Sum_probs=196.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.+..++ .+|+|.+.... .....+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCC
Confidence 357999999999999999999876554 68999876432 22356788999999999999999998762 234
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 799999998 59999997643 478999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+..+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05069 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER------------ 218 (260)
T ss_pred Ccccc--cCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 22111 122345677999998876 578999999999999999999 8999987654433322211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ......+..+.+|+++||..||++||+++++++
T Consensus 219 ----------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 ----------------GYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------CCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.68 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=197.3
Q ss_pred CeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ec
Confidence 48899999999999999998753 23568888886532 234556788999999999999999999987 34
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~------------------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (620)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 456899999999 6999988642 247888999999999999999999999999999
Q ss_pred CCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 007050 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (620)
Q Consensus 154 P~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~ 232 (620)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999765332211 11122345678999998876 678999999999999999998 999998
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
+.......+.+.. .. .. .....++..+.+|+.+||+.||++||++.|++
T Consensus 232 ~~~~~~~~~~~~~----------------------------~~--~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 232 GIAPERLFNLLKT----------------------------GY--RM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CCCHHHHHHHHhC----------------------------CC--CC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 7654332221110 00 00 01134678999999999999999999999997
Q ss_pred c
Q 007050 313 A 313 (620)
Q Consensus 313 ~ 313 (620)
+
T Consensus 281 ~ 281 (290)
T cd05045 281 K 281 (290)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.89 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=197.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||+|+||+||+|.+..++. .+++|.+... ........+..|+.+++.+.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~----- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP----- 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----
Confidence 3578999999999999999999887776 4777776532 22234456778899999999999999999862
Q ss_pred CCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
....++|+||+. |+|.+++.. .+.+++..+..|+.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 234789999998 799999976 45789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+.
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05111 159 LYPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---------- 225 (279)
T ss_pred ccCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 543221 112234456778999999876 579999999999999999998 999997765332211110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...... .....+..+.+++.+||..||++|||+.|+++
T Consensus 226 ------------------~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 226 ------------------KGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000 11234568899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.09 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=197.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 45899999999999999999985 3567899999997532 234456788999999999 68999999998742
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~------------------------------------------------------ 120 (620)
....+|+|||||+ |+|.+++..+
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 3356899999999 6999988643
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccc
Q 007050 121 -------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187 (620)
Q Consensus 121 -------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~ 187 (620)
..++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677888899999999999999999999999999999999999999999999765322211 1112
Q ss_pred cccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 188 ~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+...
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------------- 294 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------- 294 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-----------------------
Confidence 2345677999999876 678999999999999999997 89999764321111100
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+....... .....++.+.+++.+||+.||++|||+.|+++|
T Consensus 295 ----~~~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 ----LKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----HhccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000000 011356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.01 Aligned_cols=248 Identities=28% Similarity=0.456 Sum_probs=194.6
Q ss_pred EEEEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 26 KIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++.+.||.|.||.||+|... ..+..|+||.++.. ........+.+|+++++.++||||+++++++. +...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccc-----cccc
Confidence 57899999999999999887 44568999999652 44455788999999999999999999999995 3344
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+++|||||. |+|.+++... ..+++..+..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6999999887 6799999999999999999999999999999999999999999999999999987632
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ...........|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+....+.+
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~------------ 220 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ------------ 220 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT------------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc------------
Confidence 2211 11233456778999999876 568999999999999999999 6799877654433332211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......++..+.+||.+||..||++|||+.++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 221 ----------------GQR---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------------TEE---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------------ccc---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 1112346889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.48 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=196.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTH----------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 86 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~----------------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~ 86 (620)
++|++.+.||+|+||.||++.+.. ++..+|+|++... ........+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 3457999998753 23344567889999999999999999
Q ss_pred eeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~-----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (620)
+++++. +....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 999883 3456899999998 69999987642 366788999999999999999999999999999
Q ss_pred CceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh--CCCCCC
Q 007050 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (620)
Q Consensus 155 ~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt--G~~pF~ 232 (620)
+|||++.++.+||+|||+++......... ......++..|++||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997653322111 1122344678999998765 578999999999999999998 678886
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
..+..+.+.... .++... .........+.+++.+.+|+.+||+.||++||++.|++
T Consensus 236 ~~~~~~~~~~~~---------------------~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 236 QLSDEQVIENTG---------------------EFFRDQ---GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred ccChHHHHHHHH---------------------HHHhhc---cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 654433221110 011000 00001112234678999999999999999999999986
Q ss_pred c
Q 007050 313 A 313 (620)
Q Consensus 313 ~ 313 (620)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.02 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=213.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+-+-|..++.||-|+||.|+++....|...||+|.+.+. .........+..|-.||..-..+-||+||-.| +|.
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDk 701 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDK 701 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccC
Confidence 456688899999999999999999999999999998643 22334455677899999999999999999888 788
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.++|+||||+. ||+..++...+-|.|+.+++++.+|..|+++.|..|+|||||||+|||||.+|++||.||||+.-+..
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee
Confidence 89999999999 59999999999999999999999999999999999999999999999999999999999999853211
Q ss_pred CCCc---------------------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHH
Q 007050 179 DTPT---------------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (620)
Q Consensus 179 ~~~~---------------------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~ 219 (620)
.... .+.....+||+.|+|||++.. .+|+..+|+||.||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGV 859 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhH
Confidence 0000 001123589999999999987 78999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcc
Q 007050 220 IFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 299 (620)
Q Consensus 220 IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~ 299 (620)
|||||+.|++||...+..+...++.+ .+.++. .....++|+++.+||.++..
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~n------------------w~~~l~----------~~~~~~ls~e~~~li~kLc~ 911 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVIN------------------WRNFLH----------IPYQGNLSKEALDLIQKLCC 911 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeee------------------hhhccc----------cccccccCHHHHHHHHHHhc
Confidence 99999999999977654332222211 111111 11234789999999998765
Q ss_pred cCCCCCC---CHHHHHcCCcccCC
Q 007050 300 FDPKDRP---TAEEALADPYFKGL 320 (620)
Q Consensus 300 ~DP~~Rp---sa~elL~hp~f~~~ 320 (620)
++++|. .++|+-.||||+++
T Consensus 912 -sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 912 -SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred -ChhhhhcccchhhhhcCcccccc
Confidence 888886 56789999999976
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.28 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=191.8
Q ss_pred EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 30 VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++. ....|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEE
Confidence 3899999999999775 44567999998754 22344567889999999999999999999872 235899999
Q ss_pred cCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccc
Q 007050 108 LME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (620)
Q Consensus 108 ~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~ 185 (620)
|++ ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 599998875 457899999999999999999999999999999999999999999999999999764332221111
Q ss_pred cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhH
Q 007050 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264 (620)
Q Consensus 186 ~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~ 264 (620)
.+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 112233567999998875 578999999999999999996 9999976554332221111
Q ss_pred HHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ...+..++++.+||.+||..||++||++.++++
T Consensus 214 ---------~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 ---------GKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 112356889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.75 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=202.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35689999999999999999999876 3578999988643 3445567788999999999999999999987432
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN--------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 167 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~--------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL 167 (620)
....++++||+. ++|.+++... ..+++..++.++.||+.||.|||+.+++||||||+|||++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 346799999998 6999988653 35899999999999999999999999999999999999999999999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~ 246 (620)
+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 9999998654322111 1122345677999999876 578999999999999999998 9999976544322111110
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .....+++.+.+++.+||..||++|||+.++++
T Consensus 235 ---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 ---------------------------GYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.87 Aligned_cols=265 Identities=17% Similarity=0.190 Sum_probs=194.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHH---------HHHHHHHHHHHhcCCCCcceeee
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDA---------ARILREIKLLRLLRHPDIVEIKH 89 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~---------~~i~rEi~iL~~L~HpnIv~l~~ 89 (620)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+........... .....++..+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999998877 6677777643221111000 11223444566778999999998
Q ss_pred EecCCCCCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcc
Q 007050 90 IMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~D 169 (620)
+..... ......|+++|++..++.+.+.....+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 753321 1122457889988888888887666678999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhh
Q 007050 170 FGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (620)
Q Consensus 170 FGlA~~~~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~ 245 (620)
||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~- 246 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA- 246 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh-
Confidence 99998654222111 11123479999999999887 679999999999999999999999998763221111100
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...++..+.... ...++.++.+.++++.|+..+|++||+.+++++
T Consensus 247 ------------------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 ------------------KCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------------------HHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 011111111110 123456789999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.33 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=200.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|.+.+.||+|+||.||+|.+... ...|+||.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987644 346899988643 223456678899999999999999999998732
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 34689999998 69999997644 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..... ...+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---------- 223 (270)
T cd05056 158 EDESY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN---------- 223 (270)
T ss_pred ccccc--eecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 43311 11122334567999998876 578999999999999999986 9999987665433322211
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.... ...+.++..+.+||.+||..+|.+|||+.+++..
T Consensus 224 ------------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 224 ------------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ------------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001 1234568899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.53 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=199.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHT-------GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~t-------g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (620)
.+|++++.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 4799999999999999999986432 236899988743 2334567788999999999 7999999999983
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (620)
+...+|+||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 4456899999998 59999987532 367788899999999999999999999999999999
Q ss_pred EeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCh
Q 007050 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (620)
Q Consensus 158 Ll~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~ 236 (620)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999765432211 11122334567999999876 678999999999999999998 8899987654
Q ss_pred hHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 237 ~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+....+.. ... .......+..+.+||.+||+.+|++|||+.|+|++
T Consensus 243 ~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE----------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc----------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 433322211 000 01123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.50 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=200.7
Q ss_pred eEEEEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+++.+.||.|+||.||++.+..++ ..||+|++... ........+.+|+.+++.++|+||+++++++. +..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCC
Confidence 357889999999999999998776 89999999654 22235678889999999999999999999983 446
Q ss_pred eEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
..|+||||+. ++|.+++..... +++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 7999999998 599999976554 9999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 155 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 219 (258)
T smart00219 155 DDDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------- 219 (258)
T ss_pred cccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 331111 112236788999998865 678999999999999999998 7899977554333322211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... .......+..+.+++.+||..||++|||+.|+++
T Consensus 220 -----------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 -----------------GYR---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------------CCC---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 000 0112336889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.48 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++++.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.+.||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~----- 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVC----- 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEE-----
Confidence 3579999999999999999998753 67899999987532 233456688999999999999999999988
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (620)
.+...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 34456899999999 59999997432 36788899999999999999999999999999
Q ss_pred CCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 007050 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (620)
Q Consensus 154 P~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~ 232 (620)
|+|||++.++.+||+|||+++......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987643222111 0122334567999999876 679999999999999999997 888887
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
+.+..+.+..+.+ ... .......+..+.+||.+||+.||.+|||++|++
T Consensus 235 ~~~~~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 235 GMAHEEVIYYVRD----------------------------GNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CCCHHHHHHHHhc----------------------------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 6554332221110 000 011234678999999999999999999999987
Q ss_pred c
Q 007050 313 A 313 (620)
Q Consensus 313 ~ 313 (620)
+
T Consensus 284 ~ 284 (288)
T cd05050 284 R 284 (288)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.98 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=197.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++. + ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CC
Confidence 468999999999999999999754 4567999988642 234567889999999999999999999873 2 45
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.|+||||+. ++|.+++... ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 899999998 6999999763 3578889999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....++..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05073 155 NEYTA--REGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER------------ 218 (260)
T ss_pred CCccc--ccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC------------
Confidence 21111 122345667999999876 578999999999999999998 8999987654433322211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... .......+..+.+|+.+||+.||++||++.++++
T Consensus 219 ----------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ----------------GYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------CCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 0122456789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.71 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=198.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
..+|++.+.||.|+||.||++.+. .+..+|+|.+..... ....+.+|+.+++.+.||||+++++++ .+...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCc
Confidence 468999999999999999999875 467899998874322 234578899999999999999999988 44457
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.|+||||+. ++|.+++... +.++++.++.++.||+.||.|||+.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5899888764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+....+..+..
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 2111 112234568999999876 578999999999999999998 9999976554333222211
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.... + .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 217 ---------------~~~~-~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 ---------------GFRL-Y--KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------CCCC-C--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0000 0 011246889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=319.14 Aligned_cols=286 Identities=28% Similarity=0.458 Sum_probs=217.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----C---CCcceeeeEecCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----H---PDIVEIKHIMLPP 94 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-----H---pnIv~l~~v~~~~ 94 (620)
.||-++++||-|-|++||+|.|..+.+.||+|+.+.. .-..+..+.||++|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7999999999999999999999999999999998743 233455678999999884 3 3599999988654
Q ss_pred CCCCCCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCC---------
Q 007050 95 SRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANAN--------- 162 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~--------- 162 (620)
..+..++|+|||+++.+|..+|+.. ..++...++.|++|||.||.|||. +||||-||||+|||+..+
T Consensus 155 -GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 -GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred -CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 3678899999999999999999864 369999999999999999999996 699999999999997321
Q ss_pred --C-----------------------------------------------------------------------------
Q 007050 163 --C----------------------------------------------------------------------------- 163 (620)
Q Consensus 163 --~----------------------------------------------------------------------------- 163 (620)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------cE
Q 007050 164 ------------------------------------------------------------------------------KL 165 (620)
Q Consensus 164 ------------------------------------------------------------------------------~l 165 (620)
+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 01
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC------ChhHH
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------NVVHQ 239 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~------~~~~~ 239 (620)
||+|||-|.-. ...+|+-+.|+.|+||||+.+ .+|+..+||||++|+++||+||..+|.-. .+.+.
T Consensus 394 KIaDlGNACW~------~khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 394 KIADLGNACWV------HKHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred EEeeccchhhh------hhhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 11111111100 011244577999999999998 79999999999999999999999999532 36778
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCC---------CC----CHHHHHHHHHhcccCCCCCC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP---------NA----DPSALRLLERLLAFDPKDRP 306 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----s~~l~dLI~~mL~~DP~~Rp 306 (620)
++.|++++|.-+..... .....+.|+...-.-+.+.-...|+ .+ ..++-|||.-||+++|++|+
T Consensus 466 iA~i~ELLG~iPr~ia~---~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIAL---GGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHhhccHHHHh---cCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 99999999987655432 2333445544322111111111222 12 24578999999999999999
Q ss_pred CHHHHHcCCcccCCCcC
Q 007050 307 TAEEALADPYFKGLSKV 323 (620)
Q Consensus 307 sa~elL~hp~f~~~~~~ 323 (620)
||.++|+|||++.....
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999977654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.71 Aligned_cols=234 Identities=26% Similarity=0.437 Sum_probs=194.2
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
++.||.|+.|-||+|+ -.++.||||+++... ..+|+-||+|+||||+.+++++. ....+|||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCt-----qsPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCT-----QSPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeec-----CCceeEEeee
Confidence 5789999999999995 458899999986421 13788899999999999999994 3457999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
||. |-|.+++++...++......|..+|+.|++|||...|||||||.-||||+.+..|||+|||-++..... .+.
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk--- 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK--- 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh---
Confidence 999 899999999999999999999999999999999999999999999999999999999999999865433 221
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
-.++||-.|||||+|.. ...++|+||||+||+|||||||..||..-+ +-..|+.+ |.-
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd---ssAIIwGV-GsN---------------- 326 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD---SSAIIWGV-GSN---------------- 326 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccc---hheeEEec-cCC----------------
Confidence 35799999999999997 789999999999999999999999995532 22222211 000
Q ss_pred HHHhhhccCCCcccCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 267 YLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+.-..| .+++-++-||+.||.-.|..||++.++|.|
T Consensus 327 -----------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 327 -----------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -----------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0011112 345678889999999999999999999998
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.38 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=190.8
Q ss_pred EEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~--~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+.||+|+||.||+|.++.++. .+++|.++.. ........+.+|+.++..+ +||||+++++++ .....+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEE
Confidence 368999999999999988876 4688887642 2234456788999999999 799999999998 344568999
Q ss_pred EecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEc
Q 007050 106 FELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
|||+. ++|.+++..+. .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999997543 47889999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhcc
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~l 247 (620)
|||+++....... ......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 9999864221111 111233567999999876 678999999999999999997 999997655432222111
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .......+..+.+|+.+||..||.+|||+++++.
T Consensus 226 -------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 -------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------------------CCCC---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0000 0112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.08 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=200.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..+|++++.||+|+||.||+|.++.+|+ .+|+|.+.... .......+.+|+.++..++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4689999999999999999999877765 58999886542 23455678899999999999999999998843
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...++||||+. ++|.+++..+ ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 46899999998 6999998764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
........ ......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54322211 1112223567999998865 578999999999999999998 9999977543322221111
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ......+..+.+++.+||..||++||++.++++
T Consensus 227 -------------------~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 -------------------GERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 112345678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.66 Aligned_cols=252 Identities=22% Similarity=0.379 Sum_probs=200.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
++|++++.||.|+||.||+|+++.+ .+.+++|.+... ........+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----R 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----C
Confidence 5799999999999999999997643 457999987643 2223456788999999999999999999987 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEE
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND---------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 167 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~---------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL 167 (620)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 4456899999998 69999998665 6899999999999999999999999999999999999999999999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~ 246 (620)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+.
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-- 232 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-- 232 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--
Confidence 99999875432211 12233456778999998876 568899999999999999998 788996544322221110
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. ...+ .....++..+.++|.+||..||.+|||+.|++.+
T Consensus 233 --------------------------~~-~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 --------------------------AG-KLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --------------------------cC-CcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0001 1123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.27 Aligned_cols=244 Identities=26% Similarity=0.413 Sum_probs=194.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEec
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 108 (620)
+.||.|+||.||++.+.. ++.||+|++...... .....+.+|+.+++.++||||+++++++ .+....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEc
Confidence 479999999999999887 999999998754332 4556788999999999999999999988 444678999999
Q ss_pred CC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 109 ME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 109 ~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
+. ++|.+++.. ...+++..+..++.+++.+|.|||+++++||||||+|||++.++.+||+|||+++......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 589999865 3468999999999999999999999999999999999999999999999999997643211110 00
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------------------- 210 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------------------- 210 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc--------------------
Confidence 11233566999998876 578999999999999999999 8899977654322221110
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ......+..+.+|+.+||..+|.+|||++|+|+
T Consensus 211 --------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 --------GYRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 011245779999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=339.05 Aligned_cols=279 Identities=20% Similarity=0.288 Sum_probs=187.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCC----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHT----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS- 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~t----g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~- 95 (620)
..++|++.+.||+|+||.||+|.+..+ +..||+|++..... .....+| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999988 99999999864211 1111111 122223333433333322211
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDD--------------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~--------------------lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (620)
..+...+++||||+. ++|.+++..... ..+..+..|+.||+.||.|||+.+|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 145567999999999 589998875421 12345678999999999999999999999999
Q ss_pred CceEeCC-CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccC--------------------CCCCcccc
Q 007050 155 KNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (620)
Q Consensus 155 ~NILl~~-~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~--------------------~~y~~~~D 213 (620)
+|||++. ++.+||+|||+|+....... .....+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57999999999976432211 1234678999999999653210 13455679
Q ss_pred hHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCccc---CCCCCCCHHH
Q 007050 214 IWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS---QKFPNADPSA 290 (620)
Q Consensus 214 IWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~l 290 (620)
|||||||||||+++. |+..+...++..+....+.... .|... .......... ..+...+..+
T Consensus 362 VwSlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~~d~~~~~~ 426 (566)
T PLN03225 362 IYSAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLV-AWRKL------------VEPRASPDLRRGFEVLDLDGGAG 426 (566)
T ss_pred cHHHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHH-HHHHh------------hccccchhhhhhhhhccccchHH
Confidence 999999999999855 4444444444444433332211 11111 1111000101 1112234567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 291 LRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 291 ~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.+||.+||++||++|||++|+|+||||++...
T Consensus 427 ~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 427 WELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 89999999999999999999999999987543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=302.10 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=192.9
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEec
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 108 (620)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++ .+....|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEEC
Confidence 47899999999999864 68899999987543 233445688999999999999999999988 344568999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccc
Q 007050 109 ME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (620)
Q Consensus 109 ~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~ 186 (620)
+. ++|.+++... ..+++..+..++.||+.+|.|||+.|++||||||+||+++.++.+||+|||+++......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999988653 468999999999999999999999999999999999999999999999999987543221111 0
Q ss_pred ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHH
Q 007050 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265 (620)
Q Consensus 187 ~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~ 265 (620)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 11234567999999876 578999999999999999998 9999987654332221110
Q ss_pred HHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......++..+.+|+.+||..||++||++.|+++
T Consensus 210 --------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 --------GYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred --------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000 1122356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.55 Aligned_cols=228 Identities=25% Similarity=0.358 Sum_probs=185.4
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC-cc
Q 007050 34 GSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SD 112 (620)
Q Consensus 34 G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-gd 112 (620)
|.||.||+++++.+++.||+|++.... ...+|...+....||||+++++++ .+....|+||||++ ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence 899999999999999999999997531 122344555556799999999987 44567999999999 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCC
Q 007050 113 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192 (620)
Q Consensus 113 L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt 192 (620)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 234567
Q ss_pred ccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhh
Q 007050 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMR 272 (620)
Q Consensus 193 ~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (620)
..|+|||.+.+ ..++.++|+||+||++|+|++|..||...... + .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~----~------------ 190 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------I----N------------ 190 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------c----c------------
Confidence 78999999876 57889999999999999999999887432100 0 0
Q ss_pred ccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCcc
Q 007050 273 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYF 317 (620)
Q Consensus 273 ~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~elL~hp~f 317 (620)
..... ...+.+++.+.+||.+||+.||++|+++ +++++||||
T Consensus 191 ~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 THTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00000 0112467899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.11 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=187.2
Q ss_pred EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 30 VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
.||+|+||.||+|... .....+++|.+... ........+.+|+.+++.++||||+++++.+. +...+|+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 6899999999999643 24457888887643 23344556789999999999999999999883 4456899999
Q ss_pred cCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 108 LME-SDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 108 ~~~-gdL~~~i~~~~-----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 998 69999997643 246778889999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCCccccCccccccc-----CCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 182 TTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
.. ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+.....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------- 227 (269)
T cd05042 156 YI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD------- 227 (269)
T ss_pred ee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-------
Confidence 11 01223456779999987431 1357889999999999999999 7889977654433322211000
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...........+++...+++..|+ .||++|||++++++
T Consensus 228 -------------------~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 228 -------------------IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------------ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000011122356788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.99 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=199.9
Q ss_pred eEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC-CC
Q 007050 25 YKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD-FK 100 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~-~~ 100 (620)
|.+.+.||+|+||.||+|.++ .++..||||++............+.+|+.+|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 45789999999765555566778889999999999999999999886543222 12
Q ss_pred eEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 101 DIYVVFELME-SDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
..++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6888877432 14788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+........ .......++..|++||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYY-RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCcce-ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 865322211 11123345677999998876 578899999999999999999 8899976654322221111
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ....+..++.+.+|+.+||..+|++|||+.+++.+
T Consensus 231 ---------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 ---------------------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01113567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=304.57 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=190.0
Q ss_pred EEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+.||+|+||.||+|.+.. .+..+|||.+... ........+.+|+.+++.++||||+++++++... ....|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence 468999999999998653 3457999988642 2334567788999999999999999999977432 2457899
Q ss_pred EecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 106 FELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 106 ~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999999764 356788888999999999999999999999999999999999999999999997643221111
Q ss_pred -cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 184 -~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 11123345678999998876 578999999999999999999 567786654332221110
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
....... ...+++.+.+|+.+||..||++||++.|++..
T Consensus 217 -----------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 217 -----------QGRRLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -----------cCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0011111 12356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.74 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=198.5
Q ss_pred CCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (620)
++|.+.+.||+|+||.||+|++. .+++.||+|+++... .......+.+|+.+|..+. ||||+++++++.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 56888999999999999999853 455789999997642 2334557889999999997 999999999983
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC------------------------------------------------------
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~------------------------------------------------------ 121 (620)
....+|+|||||. |+|.+++..++
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 3456899999999 69999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 007050 122 --------------------------------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (620)
Q Consensus 122 --------------------------------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (620)
.+++..+..|+.||+.||.|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677888999999999999999999999999999
Q ss_pred EeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCh
Q 007050 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (620)
Q Consensus 158 Ll~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~ 236 (620)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999865322211 11123456788999999876 578999999999999999998 8899976443
Q ss_pred hHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 237 ~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+.+..... .... ......++..+.+||.+||..||.+||+++|+++.
T Consensus 348 ~~~~~~~~~---------------------------~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIK---------------------------RGYR---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHH---------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222111100 0000 01123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=304.79 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=188.2
Q ss_pred EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEE
Confidence 36899999999999754 4566899999875432 23445688999999999999999999987 3445689999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 107 ELME-SDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 107 E~~~-gdL~~~i~~~~-----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
||+. ++|.+++.... .+++..+..++.||+.||.|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999 69999986532 35677888999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCCccccCcccccccC-----CCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~-----~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
. ........++..|+|||++.+.. ..++.++|||||||++|+|++ |..||...+..+.+.....
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11112345778899999886421 136789999999999999996 9999976544322211100
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ..............++.+.+|+++|+ .||++|||++|++.
T Consensus 225 ---------------~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 ---------------E--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------------c--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 00000001111245778999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.36 Aligned_cols=238 Identities=18% Similarity=0.284 Sum_probs=186.2
Q ss_pred EEeeecCceEEEEEEECCCCc-------EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 29 EVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~-------~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.||.|+||.||+|.++.++. .+++|.+... .......+.+|+.+++.+.||||+++++++. +...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCC
Confidence 469999999999999876554 3888877542 2334556788999999999999999999984 3356
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc--------EEEcccC
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--------LKICDFG 171 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--------lKL~DFG 171 (620)
.++|||||. |+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999998 58999997654 5899999999999999999999999999999999999987765 6999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChhHHHHHhhhccCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~pF~g~~~~~~l~~i~~~lg~p 250 (620)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++|. +||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 98654321 234678889999998752 45789999999999999999984 666544332111100
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. ... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 ------------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 ------------------E---DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ------------------H---ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 000 0112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.50 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=222.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+..+++..||-|+||.|=++.-......+|+|++++. .-+......+..|-.||..++.|.||++|..| ++.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 35678888999999999999876655556999998753 23344566788999999999999999999988 7888
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
++|++||-|- |+|+.++..++.|.+...++++..+++|+.|||++|||+|||||+|++++.+|-+||.|||+|+.....
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999987 699999999999999999999999999999999999999999999999999999999999999987655
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..+ .++|||+.|.|||++.+ .+.+.++|.||||+++||||+|.|||.+.+....++.|..-+ ..+
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi--------d~i- 638 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI--------DKI- 638 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh--------hhh-
Confidence 433 46899999999999987 789999999999999999999999999999888877775411 111
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
.....++..+.+||+++-..+|.+|.. +.||-+|.||.++
T Consensus 639 ---------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 639 ---------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred ---------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 011235678999999999999999975 8999999999875
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.16 Aligned_cols=240 Identities=25% Similarity=0.452 Sum_probs=194.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence 579999999999999999985 57889999998643 234567899999999999999999998732 236
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 59999997643 5889999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------------- 211 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------------- 211 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh--------------
Confidence 1 12234567999998876 578999999999999999997 999997765433222111
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..... .....+++.+.+||.+||..+|++||++++++.
T Consensus 212 --------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 212 --------------KGYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=310.55 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=198.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++.+.||+|+||.||+|.+..+|. .+|+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----
Confidence 3578999999999999999999987776 4688887643 223334567899999999999999999998843
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...++|+||+. |+|.+++..+. .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 --PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred --CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 23579999998 69999987654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---------- 225 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------
Confidence 5432221 11223445778999999876 678999999999999999997 889997654322111110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..... ...+..+..+.+|+.+||..||++||+++++++.
T Consensus 226 ------------------~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 226 ------------------KGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 1123467789999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=305.98 Aligned_cols=269 Identities=24% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCeEEEEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+.|++.+.||+|+||.||+|... .+++.+|+|++...... .....+.+|+.+++.++||||+++++++... +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---G 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---C
Confidence 56889999999999999999854 45789999999754332 3566788999999999999999999987432 2
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++|+||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 456899999998 59999997654 6899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..............++..|++||.+.+ ..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~--- 229 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQ--- 229 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccc---
Confidence 432221111122345667999998876 578899999999999999999999886532110 0111110000
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.........+...... .....++..+.+|+.+||..||.+|||+.|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 -----MIVTRLLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred -----ccHHHHHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001111111111111 112345678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=305.01 Aligned_cols=238 Identities=21% Similarity=0.296 Sum_probs=184.2
Q ss_pred EEeeecCceEEEEEEECC------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 29 EVIGKGSYGVVCSAIDTH------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~------------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
+.||+|+||.||+|.... ....+++|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~---- 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCV---- 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe----
Confidence 468999999999997432 2336888887643 2334556788999999999999999999984
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc-------EEE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-------LKI 167 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------lKL 167 (620)
+....++||||++ ++|..++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++. +|+
T Consensus 75 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 -RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred -cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 3345799999999 577777764 356899999999999999999999999999999999999987664 899
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHH-hCCCCCCCCChhHHHHHhhhc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLl-tG~~pF~g~~~~~~l~~i~~~ 246 (620)
+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ +|..||.+....+...
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----- 220 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----- 220 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----
Confidence 999998654321 234678889999987632 57899999999999999998 5888886643221110
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+... . .......++++.+||.+||+.||++||++.+||++
T Consensus 221 --------------------~~~~----~----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 221 --------------------FYEG----Q----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------HHhc----C----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0000 0 00112235688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.06 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=219.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
....|+|.++||.|.||.||++.++++++..|+|+....... ...+..|+++|+.+ .|||++.++++|........
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 456799999999999999999999999999999988754332 33456789999888 59999999999987766677
Q ss_pred CeEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+.+|||||||. |+..++++. ...+.|+.+.+|++.+|.||.+||.+.++|||||-.|||++.++.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 88999999999 688888865 457999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
.. +.....+.+||++|||||+|.+. ...|+..+|+||||++..||.-|.+|+-..-....+-.|
T Consensus 174 ds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---------- 240 (953)
T KOG0587|consen 174 DS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---------- 240 (953)
T ss_pred ec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC----------
Confidence 43 22334678999999999998653 135888999999999999999999999654433222111
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
.+.|.+-...+...+..+.+||..||..|-.+||+..++|.|||++
T Consensus 241 -------------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 241 -------------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred -------------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 2233333445567788999999999999999999999999999998
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=304.67 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=192.6
Q ss_pred EEeeecCceEEEEEEECCCC------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 29 EVIGKGSYGVVCSAIDTHTG------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg------~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+.||+|+||.||+|.++... +.+|||.+.... .......+.+|+.+++.++||||+++++++. +....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCe
Confidence 36899999999999876443 689999886432 2234567889999999999999999999884 34568
Q ss_pred EEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-----cEEEcc
Q 007050 103 YVVFELME-SDLHQVIKAN-------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-----KLKICD 169 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~-------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-----~lKL~D 169 (620)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccC
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg 248 (620)
||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997653322111 1122345678999999876 578999999999999999998 9999977654433222210
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......++..+.+||.+||..+|.+||+++++++
T Consensus 229 -------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 -------------------------GGR---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------------------CCc---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 0112356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.52 Aligned_cols=236 Identities=19% Similarity=0.274 Sum_probs=186.1
Q ss_pred EEeeecCceEEEEEEECCCC----------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 29 EVIGKGSYGVVCSAIDTHTG----------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg----------~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+.||+|+||.||+|.++.++ ..+++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765321 225678899999999999999999998743
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-------cEEEcc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-------KLKICD 169 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-------~lKL~D 169 (620)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 34699999999 69999998765 789999999999999999999999999999999999999887 799999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccC
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg 248 (620)
||++...... ....++..|+|||++.+....++.++|||||||++|+|++ |..||...+.......
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~------ 218 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF------ 218 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH------
Confidence 9999865331 2235677899999987622378999999999999999999 5777755432111100
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. ..... .......+.+||.+||..||.+|||+.++++
T Consensus 219 -------------------~~---~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 219 -------------------YQ---DQHRL-----PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------Hh---cCCCC-----CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00000 0112268899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.49 Aligned_cols=237 Identities=19% Similarity=0.259 Sum_probs=183.4
Q ss_pred EeeecCceEEEEEEECCC------------------------CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007050 30 VIGKGSYGVVCSAIDTHT------------------------GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~t------------------------g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv 85 (620)
.||+|+||.||+|....+ ...|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999974321 235888888642 233455678899999999999999
Q ss_pred eeeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC
Q 007050 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (620)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (620)
++++++. +....|+|||||+ ++|..++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 80 ~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCV-----RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEE-----eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 9999984 3456899999999 588888865 45789999999999999999999999999999999999997643
Q ss_pred -------cEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHH-hCCCCCCCCC
Q 007050 164 -------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKN 235 (620)
Q Consensus 164 -------~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLl-tG~~pF~g~~ 235 (620)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643221 223577889999988653 56899999999999999995 6899997654
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+... ++.. ... .....++.+.+||.+||+.||++|||+.++|++
T Consensus 227 ~~~~~~-------------------------~~~~---~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKER-------------------------FYEK---KHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHH-------------------------HHHh---ccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 322110 0000 000 011245689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.82 Aligned_cols=274 Identities=27% Similarity=0.437 Sum_probs=214.6
Q ss_pred ccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-----hHHHHHHHHHHHHHHhcCCCCcceeee
Q 007050 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-----ISDAARILREIKLLRLLRHPDIVEIKH 89 (620)
Q Consensus 15 ~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-----~~~~~~i~rEi~iL~~L~HpnIv~l~~ 89 (620)
|...-.-.+||-++.+||+|+|+.||+|.|....+.||+|+-...... ....+...||..|.+.|.||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 333334568999999999999999999999999999999976422111 112345679999999999999999999
Q ss_pred EecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCC---CC
Q 007050 90 IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA---NC 163 (620)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~---~~ 163 (620)
+|.- +...+|-|+|||+| ||.-+++.+..+++.+++.|+.||+.||.||.... |||-||||.|||+.. -|
T Consensus 535 yfsl----DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSL----DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeee----ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 9843 34568999999997 89999999999999999999999999999999875 999999999999854 37
Q ss_pred cEEEcccCccccccCCCCccc----ccccccCCccccCccccc--ccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChh
Q 007050 164 KLKICDFGLARVAFNDTPTTI----FWTDYVATRWYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237 (620)
Q Consensus 164 ~lKL~DFGlA~~~~~~~~~~~----~~~~~~gt~~Y~APEvl~--~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~ 237 (620)
.+||.||||++++..+..... ......||.||++||.+. ....+.+.++||||+|||||..+.|+.||...-..
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 899999999999876554421 123468999999999653 22356899999999999999999999999553221
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. .+.+ ..+.+.....|.. -|-+++++++||++||++.-++|....++-.||||
T Consensus 691 Qd--ILqe-----------------------NTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 691 QD--ILQE-----------------------NTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred HH--HHhh-----------------------hchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 11 0000 0011111122222 25689999999999999999999999999999999
Q ss_pred c
Q 007050 318 K 318 (620)
Q Consensus 318 ~ 318 (620)
.
T Consensus 745 l 745 (775)
T KOG1151|consen 745 L 745 (775)
T ss_pred c
Confidence 6
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.14 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=199.1
Q ss_pred CeEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCcc--------CChHHHHHHHHHHHHHHh-cCCCCcceeeeEecC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIF--------EHISDAARILREIKLLRL-LRHPDIVEIKHIMLP 93 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~--------~~~~~~~~i~rEi~iL~~-L~HpnIv~l~~v~~~ 93 (620)
.|++.+.||+|+||.||++.++. +++.+|+|.+.... .......++.+|+.+++. ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 38889999999999999999987 77899999885321 222344567789998865 7999999999988
Q ss_pred CCCCCCCeEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEE
Q 007050 94 PSRRDFKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKI 167 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL 167 (620)
.+....|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ .+++|+||+|+|||++.++.+||
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 445679999999984 88877632 3468999999999999999999996 78999999999999999999999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
+|||++....... ......++..|++||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+.+.
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~- 228 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA- 228 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc-
Confidence 9999998654332 2245678899999999876 56899999999999999999999999765443322222110
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
...+. ....+++.+.+||.+||+.||++||++.|+..+
T Consensus 229 ---------------------------~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 229 ---------------------------VYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ---------------------------cCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00000 112457899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.08 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=202.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+...+.+.||+|+||+||+|.+- -.||||+++...-.....+.|.+|+.+|++-+|.||+=+.+++..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 356678999999999999999763 37999999877667778889999999999999999999999985443
Q ss_pred EEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+.||+-+|+| +|+.+|.. ..+|.......|+.||++|+.|||.++|||||||..|||+.++++|||+||||+.....-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 4999999997 89998864 346888899999999999999999999999999999999999999999999999753211
Q ss_pred CCcccccccccCCccccCcccccc-cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~-~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.....+....|...|||||++.. ....|++.+||||+||++|||++|..||... ..+|+--+. |.-.
T Consensus 542 -~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmV---GrG~------- 609 (678)
T KOG0193|consen 542 -SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMV---GRGY------- 609 (678)
T ss_pred -ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEe---cccc-------
Confidence 11112233457788999999853 2367999999999999999999999999843 333321111 1100
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.-........+...++++|+..||.+++++||...+||.
T Consensus 610 ----------------l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 610 ----------------LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ----------------cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 001112223456679999999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=298.82 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=186.2
Q ss_pred EeeecCceEEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEe
Q 007050 30 VIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~t--g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (620)
.||+|+||.||++..... ...+++|.+... ........+.+|+.+++.++||||+++++.+. +...+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 599999999999975433 335677776543 22345667889999999999999999999884 3456899999
Q ss_pred cCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 108 LME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 108 ~~~-gdL~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
||. ++|.+++... ..+++..++.++.||+.||.|||+.+++||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 999 6999999754 2456777889999999999999999999999999999999999999999999864322111
Q ss_pred ccccccccCCccccCccccccc-----CCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 183 TIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.......+++..|+|||++... ...++.++|||||||++|||++ |.+||...+..+.+..+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----------- 223 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----------- 223 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------
Confidence 1111345688899999987531 1246789999999999999997 5678876554433332211
Q ss_pred hhhhchhHHHHHHhhhccCCCcc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
......+ ......+++.+.+|+..|| .||++||+++++++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 224 ----------------DQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------------hcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000001 1112346788999999999 68999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=299.62 Aligned_cols=265 Identities=23% Similarity=0.416 Sum_probs=214.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
.+.|.++++||+|+|.+|.+++.++|.+.||+|++++..- ...+..-...|-.+..+- +||.+|.+..+| +..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence 4689999999999999999999999999999999987543 334455566777777766 699999999988 556
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+++|.||+. |+|.-.++...++++++++++...|+.||+|||+.||+.||||.+|+|++..|++||.|+|.++....
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 67999999999 59988888888999999999999999999999999999999999999999999999999999987555
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...++ .++||||.|.|||++.+ ..|+..+|+|+||++++||+.|+.||.- .|..+.
T Consensus 404 ~gd~t---stfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi-------------vgm~n~------ 459 (593)
T KOG0695|consen 404 PGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI-------------VGMDNP------ 459 (593)
T ss_pred CCccc---ccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce-------------ecCCCc------
Confidence 44443 57899999999999998 7999999999999999999999999941 111111
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC------CHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP------TAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp------sa~elL~hp~f~~~ 320 (620)
..+.+.|+-.+.-.+.+.+ ...+|..+-.+++..|.+||++|. ...++-.|+||..+
T Consensus 460 --d~ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 460 --DMNTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred --ccchhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 1112223222221111111 124566778899999999999996 46899999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.14 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=205.8
Q ss_pred CeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
..++.+.||+|+||+||+|.-. .....||||.++.. ........|.||+.+|..|+|||||++++++ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~ 560 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC-----RE 560 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence 4567889999999999999743 33458999999864 3334567899999999999999999999999 56
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND----------D----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~----------~----lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (620)
.+-+|+|||||. |||++++..+. + |+..+...|+.||+.|+.||-+..+|||||-..|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 677999999999 89999997542 3 88999999999999999999999999999999999999999
Q ss_pred cEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007050 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 242 (620)
Q Consensus 164 ~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~ 242 (620)
.|||+||||++.....+.-... ....-...||+||-|.- ++|+.++||||+||+|||+++ |+.||.|.++.+.++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 9999999999875433322211 11123457999998875 799999999999999999998 8899999988887777
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~el 311 (620)
|.+ .. ......+++.++.+|+..||+.+|++||++.||
T Consensus 718 i~~----------------g~---------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRA----------------GQ---------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHc----------------CC---------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 743 11 112224678899999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.75 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=193.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC-e
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK-D 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~-~ 101 (620)
+.|.-...||+|+||.||+|.-.. |..||||++....... ...|.+|+.+|..++|||+|+++++|. +.. .
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~-----e~~~~ 146 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCL-----EGGEH 146 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEe-----cCCce
Confidence 456666899999999999998654 4899999887543221 445999999999999999999999994 334 5
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN---VYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+||+|||. |+|.+.+.... .++|.....|+.++++||+|||... |+|||||++|||+|.+...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999999 89999997654 8999999999999999999999864 99999999999999999999999999965
Q ss_pred ccCCCCcccccccc-cCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~-~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
.... ... .... .||..|+|||.+.. ...+.++||||+|++|.||++|+.+........... +. ++
T Consensus 227 ~~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~-l~--------~w 292 (361)
T KOG1187|consen 227 GPEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS-LV--------EW 292 (361)
T ss_pred CCcc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCccccc-HH--------HH
Confidence 4321 111 1122 79999999999876 578999999999999999999998876432111100 00 00
Q ss_pred hhhhhhchhHHHHHHhhhccCCCccc-CCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFS-QKFP--NADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....+.......+++. .+. ..++ ..-..+..+..+|++.+|++||+..|++.
T Consensus 293 ~~~~~~~~~~~eiiD~-------~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDP-------RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHCcchhheeCC-------CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0011111111111111 000 1111 11123667888999999999999999744
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.23 Aligned_cols=207 Identities=31% Similarity=0.491 Sum_probs=175.2
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 98 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~ 98 (620)
+...-+..-+.||+|+||.||+++++.+|+.||||.++... .....++..+|+++|++|+|||||+++++-.+.. .--
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 45566788899999999999999999999999999998653 5567788899999999999999999988742211 000
Q ss_pred CCeEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC--CCCc--EEEccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANCK--LKICDF 170 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~---~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~--lKL~DF 170 (620)
...-.+|||||. |||..++.. ...|++.++..++..+..||.|||.+||+||||||.||++- .+|+ -|||||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 234579999999 699999964 34699999999999999999999999999999999999963 3444 699999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~ 232 (620)
|.|+....+. ..+..+||+.|.+||+... ...|+..+|.|||||++|+..||..||-
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9999875544 4578899999999999874 2689999999999999999999999994
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.23 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=207.7
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~i-L~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
+-+..||.|+||+|++-.++.+|+..|||.|..... ..+..+++.|+.. ++.-..||||+++++.+ .+++.||
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWi 140 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWI 140 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceee
Confidence 335689999999999999999999999999986432 4667788889876 45557999999999984 3467899
Q ss_pred EEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 105 VFELMESDLHQVIK-----ANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 105 V~E~~~gdL~~~i~-----~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.||+|.-+|..+.+ .+..++|+.+-.|....+.||.||.. .+|+|||+||+|||++..|.|||||||.+-.+.+
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999976655443 34578999999999999999999985 5899999999999999999999999999876543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... -+.-.|-+.|||||.+.....+|+-++|+||||+.|||+.||..|+.+-+ ..+|+..+. .|.|..-
T Consensus 221 SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l---- 290 (361)
T KOG1006|consen 221 SIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPIL---- 290 (361)
T ss_pred HHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCee----
Confidence 322 23457889999999997655679999999999999999999999986643 333333332 3333211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.+....-.++..++.+|.-||.+|-++||...+++++||++.+.
T Consensus 291 --------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 291 --------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred --------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 11222345788999999999999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.77 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=201.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCc---E-EEEEEecC-ccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE---K-VAIKKIHD-IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~---~-vAIK~i~~-~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
++-.+.+.||+|+||.||+|.-+..+. . ||+|..+. ..........+++|..+|++++|||||+++++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~----- 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV----- 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----
Confidence 344566899999999999998765432 3 89999875 2345567788999999999999999999999984
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...-+|||||+|. |+|.++++.++ .++..+...++++.+.||+|||+++++||||-..|+|++.++.+||+|||+++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 4456999999999 59999999887 499999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... ....-....|+|||.+.. ..|+.++||||+||++||+++ |..||++....+....|...
T Consensus 312 ~~~~~~~---~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------- 378 (474)
T KOG0194|consen 312 GSQYVMK---KFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------- 378 (474)
T ss_pred Ccceeec---cccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence 4211100 001124567999999987 589999999999999999999 78899998876555544210
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..... .....+.++..++.+|+..||++|||+.++.+
T Consensus 379 -------------------~~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 -------------------GYRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------------------CccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 00000 11244567889999999999999999999855
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=280.09 Aligned_cols=242 Identities=40% Similarity=0.646 Sum_probs=197.5
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCCc-cH
Q 007050 35 SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DL 113 (620)
Q Consensus 35 ~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL 113 (620)
+||.||+|.+..+++.+|+|++....... ....+.+|+.+++.++|+||+++++.+. .....++|||++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-KRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCH
Confidence 58999999999999999999987542221 1577889999999999999999999884 33678999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCc
Q 007050 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193 (620)
Q Consensus 114 ~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~ 193 (620)
.+++.....++...++.++.+|+.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999998764432 123456888
Q ss_pred cccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhH-HHHHhhhccCCCChhhhhhhhhchhHHHHHHhhh
Q 007050 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMR 272 (620)
Q Consensus 194 ~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~-~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (620)
.|++||.+.+ ..++.++||||||+++++|++|..||......+ .+..+.
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---------------------------- 200 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---------------------------- 200 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----------------------------
Confidence 9999998875 578889999999999999999999997632211 111110
Q ss_pred ccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 273 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 273 ~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
............++..+.+++.+||..||++||++.++++||||
T Consensus 201 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 201 -KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -ccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 01111111112267899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=328.23 Aligned_cols=251 Identities=22% Similarity=0.398 Sum_probs=205.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..-.+.+.||+|+||.||.|.-.... ..||||.+.+. ....+...|++|..+|+.++|||||+++++++.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 45678899999999999999754322 35999999764 556778899999999999999999999999965
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~D 169 (620)
....+|++|||+ |||..+|++. ..++..+...|..||++|++||+++++|||||-..|+|++....|||+|
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 345799999999 6999999875 3589999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccC
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg 248 (620)
||+|+........... ....-...|||||.+.. ..++.++|||||||++||+++ |..||++.++.+.+.....-
T Consensus 846 FGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-- 920 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-- 920 (1025)
T ss_pred cchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--
Confidence 9999954332221111 11122346999999986 689999999999999999999 78999998876655433210
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. -....+.+++.+.+|+..||+.+|++||++..|++
T Consensus 921 -------------------------g----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 -------------------------G----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------------------C----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0 01122456778999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.08 Aligned_cols=278 Identities=17% Similarity=0.249 Sum_probs=187.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEEC----------------CCCcEEEEEEecCccCChH------------HHHHHHHH
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDT----------------HTGEKVAIKKIHDIFEHIS------------DAARILRE 72 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~----------------~tg~~vAIK~i~~~~~~~~------------~~~~i~rE 72 (620)
..++|++.++||+|+||+||+|.+. ..++.||||++........ .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 3456899999864311100 01123346
Q ss_pred HHHHHhcCCCCc-----ceeeeEecCCC---CCCCCeEEEEEecCC-ccHHHHHHhC-----------------------
Q 007050 73 IKLLRLLRHPDI-----VEIKHIMLPPS---RRDFKDIYVVFELME-SDLHQVIKAN----------------------- 120 (620)
Q Consensus 73 i~iL~~L~HpnI-----v~l~~v~~~~~---~~~~~~lylV~E~~~-gdL~~~i~~~----------------------- 120 (620)
+.++..++|.++ +++++++.... ..+....|+||||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 55666553321 112356899999999 5888887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcc
Q 007050 121 -DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199 (620)
Q Consensus 121 -~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE 199 (620)
..+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 123566788999999999999999999999999999999999999999999997543221111 11223578999999
Q ss_pred cccccCC------------------CCC--cccchHhHHHHHHHHHhCCC-CCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 200 vl~~~~~------------------~y~--~~~DIWSLG~IlyeLltG~~-pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
++..... .|+ .++||||+|||+|+|++|.. ||.+........ .
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~--------------~-- 444 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL--------------R-- 444 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH--------------h--
Confidence 8753110 122 34799999999999999874 775432111100 0
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHcCCcccC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP---KDRPTAEEALADPYFKG 319 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP---~~Rpsa~elL~hp~f~~ 319 (620)
..+.....+... ......+. .+...++.++|||.+||..+| .+|+|++|+|+||||..
T Consensus 445 -~~~~~~~~~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 445 -QYDNDLNRWRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred -hccchHHHHHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000000001111 11112222 356788999999999999876 68999999999999963
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.90 Aligned_cols=247 Identities=32% Similarity=0.480 Sum_probs=191.4
Q ss_pred EEEeeecCce-EEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 28 QEVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 28 ~~~LG~G~~G-~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
.+++|.|+-| .||+|. -.|+.||||.+-. .....+.|||.+|+.- .|||||++++.- .+.+.+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 3578999887 579995 4588999998753 3344567999999988 599999998865 667889999
Q ss_pred EecCCccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---C--CcEEEcccCccccc
Q 007050 106 FELMESDLHQVIKAN-DD---LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---N--CKLKICDFGLARVA 176 (620)
Q Consensus 106 ~E~~~gdL~~~i~~~-~~---lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~--~~lKL~DFGlA~~~ 176 (620)
.|+|..+|.++++.. .. ......+..+.|++.||++||+.+||||||||.||||+. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999874 11 112445788999999999999999999999999999976 3 46899999999998
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..+...-....+..||..|+|||++.. ..-+.++|||||||++|+.++| ..||...- ..+.+.+. |.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~~NIl~---~~------ 729 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQANILT---GN------ 729 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-Hhhhhhhc---Cc------
Confidence 766555444567789999999999987 4556799999999999999987 79994432 11111110 00
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
..+...-+..+.++.|||.+||.+||..||+|.++|.||+|=.
T Consensus 730 ---------------------~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 730 ---------------------YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ---------------------cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 0111111222238999999999999999999999999999943
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.87 Aligned_cols=244 Identities=27% Similarity=0.472 Sum_probs=196.8
Q ss_pred EEEeeecCceEEEEEEEC--CCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 28 QEVIGKGSYGVVCSAIDT--HTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~--~tg~--~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.+.||.|-||.||+|+.. +.|+ .||||..+.. ....+.+.|+.|..+|+.++||||+++++++.. .-+|
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~W 466 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPMW 466 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec------ccee
Confidence 458999999999999753 2333 5899988764 344567889999999999999999999999943 4589
Q ss_pred EEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 104 VVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
||||++. |.|..+++.+. .|+......+++||+.||.|||++++|||||-..|||+.+...|||+||||++....+..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999 89999998765 688889999999999999999999999999999999999999999999999998654432
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
-. .+...-..-|||||-+.- ..++.++|+|.|||++||++. |..||.|-.+.+.+-.|.+
T Consensus 547 Yk--aS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------------- 607 (974)
T KOG4257|consen 547 YK--ASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------------- 607 (974)
T ss_pred hh--ccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC---------------
Confidence 21 111122346999998864 789999999999999999876 8899988654433322211
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+ .-....+++++.+..|+.+||.+||.+||++.|+..
T Consensus 608 -G---------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 -G---------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred -C---------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 0 011234688999999999999999999999988743
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=294.26 Aligned_cols=286 Identities=28% Similarity=0.445 Sum_probs=213.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~ 97 (620)
.+.|.++++||.|+|++||++.+.. ..+.||+|.|... +...++.+|+++|..+. +.||+++.+++ +
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r 105 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF-----R 105 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence 4678999999999999999999887 7889999998643 34567899999999995 89999999988 5
Q ss_pred CCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCcccc
Q 007050 98 DFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~~ 175 (620)
..+...+|+||++. +..+++. .++..+++.+++.++.||.++|++|||||||||.|+|.+.. +.-.|+|||||..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 66789999999996 5666654 37789999999999999999999999999999999999864 6678999999972
Q ss_pred ccCCC--------------C-----------------c----------ccccccccCCccccCcccccccCCCCCcccch
Q 007050 176 AFNDT--------------P-----------------T----------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (620)
Q Consensus 176 ~~~~~--------------~-----------------~----------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DI 214 (620)
..... . . ........||+.|+|||++... ...+.++||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDi 261 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDI 261 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccce
Confidence 11000 0 0 0001224799999999998764 678899999
Q ss_pred HhHHHHHHHHHhCCCCC-CCCChhHHHHHhhhccCCCChhhhhhhhhc------h---hHHHH---H-----HhhhccCC
Q 007050 215 WSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLGTPSLDTISRVVRN------D---KARRY---L-----TSMRKKQP 276 (620)
Q Consensus 215 WSLG~IlyeLltG~~pF-~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~------~---~~~~~---~-----~~~~~~~~ 276 (620)
||.|+|+..++++..|| ...++.+.+..|..++|.-........... . ..... + ..+.+...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999998765 566777777777776665443322111100 0 00111 1 11111111
Q ss_pred C-cccCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 277 V-QFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 277 ~-~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. .....+.+ .+..+.||+.+||..||.+|+||+|+|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0 11112222 45589999999999999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.95 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=207.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCC-Cc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHT-GE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~t-g~--~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
++.++.+.||+|+||+||+|.++.. |+ .||||.+....... ....|++|+.+|..|+|||+++||++.+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~------ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD------ 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc------
Confidence 3456678999999999999988743 33 58999997643332 66789999999999999999999999964
Q ss_pred CeEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
.-+.+|||++. |+|.+.+.+ ...|-......|+.||+.|+.||.++++|||||-..|||+-....||||||||.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 34689999999 799999976 346888889999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
........+....-....|+|||.+.. ..++.++|+|++||.+|||++ |+.||.|.+..+.|..|-+-
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 655443332222334456999999987 789999999999999999999 67999999887776665320
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
......+.++.++.+++++||.++|.+|||+..|.+.-+
T Consensus 332 ----------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 ----------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ----------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 011223467889999999999999999999998865433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=296.45 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=202.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++..++++||+|-||.|.+|.- ..+.+||+|+++.. ........|.+||++|.+|+||||++++++++.. +-+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 4567889999999999999964 33689999999854 3333457899999999999999999999999543 458
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
++|+|||+ |||.+++.++. .+..+....|+.||+.|++||.+.++|||||.+.|+|++.+.++||+|||.++.+...
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 89999999874 3345566779999999999999999999999999999999999999999999965443
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh--CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt--G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... -...+-...|||+|.+.- .+++.++|+|++|+.+||+++ ...||...++.+..+....++..+...
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~---- 763 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ---- 763 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----
Confidence 33221 123456678999997765 689999999999999999754 678997766655444333333222211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
......+-++..+.+|+.+|+..|.++|||.+++-.
T Consensus 764 --------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 --------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 111223446678899999999999999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.81 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=220.3
Q ss_pred CCCccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce
Q 007050 10 SPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 86 (620)
Q Consensus 10 ~~~~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~ 86 (620)
++..||-.|. +++..+|.++||.|.||.||+|+.+..|+ .||||.++.- ...+....|+.|..||-+++||||++
T Consensus 617 qAvreFakEI-d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 617 QAVREFAKEI-DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred HHHHHhhhhc-ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEE
Confidence 3445555554 45677899999999999999999987775 6999999753 44566778999999999999999999
Q ss_pred eeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 164 (620)
|.++. ...+-+.||+|||+ |+|..+++.+ +.|+..++..+++.|+.|++||-..|+|||||-..|||++.+-.
T Consensus 695 LEGVV-----Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv 769 (996)
T KOG0196|consen 695 LEGVV-----TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV 769 (996)
T ss_pred EEEEE-----ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE
Confidence 99998 34466899999999 8999999875 47999999999999999999999999999999999999999999
Q ss_pred EEEcccCccccccCCCCcccccccccC--CccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHH
Q 007050 165 LKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLD 241 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~~~~~~~~g--t~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~ 241 (620)
+|++||||+|...++.+.. .++.-| ...|.|||.|.- .+++.++|+||+|++|||.++ |..||...++.+.+.
T Consensus 770 CKVsDFGLSRvledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk 845 (996)
T KOG0196|consen 770 CKVSDFGLSRVLEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK 845 (996)
T ss_pred EEeccccceeecccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHH
Confidence 9999999999775554322 222222 357999999976 799999999999999999776 899999999988888
Q ss_pred HhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 242 ~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.|.+-...|. ..+++..+..|+..||++|-..||.+.+|+.+
T Consensus 846 aIe~gyRLPp-------------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 846 AIEQGYRLPP-------------------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHhccCCCC-------------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 8866433332 13677889999999999999999999999873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=290.34 Aligned_cols=246 Identities=24% Similarity=0.438 Sum_probs=204.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
......+||.|.||.||.+++++-.-.||||.++ ++......|+.|..+|+.++|||+|+++++|.. ..-+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFY 339 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFY 339 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeE
Confidence 3445679999999999999999999999999987 455678899999999999999999999999943 34589
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 104 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
||+|||. |+|.++++..+ .++.-.+.++.-||..|+.||..+++|||||-..|+|+.++..||++||||++.+..+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999998 89999998754 47777888999999999999999999999999999999999999999999999887665
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.+.. ...--..-|.|||-+.- +.++.++|+|+|||+|||+.| |..||+|-+..+.+.++.+-
T Consensus 420 YTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg------------- 482 (1157)
T KOG4278|consen 420 YTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG------------- 482 (1157)
T ss_pred eecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-------------
Confidence 4432 11112345999997753 689999999999999999988 78999997655444433210
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
.+. ....++++.+.+|+..||+++|.+||++.|+-
T Consensus 483 -----------yRM-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 483 -----------YRM-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -----------ccc-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 011 11246888999999999999999999999983
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=318.39 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=184.3
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|...+.||+|+||.||+|.++.++..||+|++...... ..+|+.+++.++||||+++++++. +....|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCR-----SEKGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEE-----cCCCCE
Confidence 456677999999999999999999999999998643211 124688999999999999999984 345689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLH---s~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|||||+ |+|.++++ .+++.....|+.||+.||.||| +.+|+||||||+||+++.++..+++ ||........
T Consensus 760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999998 69999996 3889999999999999999999 6799999999999999999888775 6655432211
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
....+|+.|+|||++.+ ..|+.++||||+||++|||++|+.||...... ......+.+..
T Consensus 836 -------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-----------~~~~~~~~~~~ 895 (968)
T PLN00113 836 -------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGV-----------HGSIVEWARYC 895 (968)
T ss_pred -------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCC-----------CCcHHHHHHHh
Confidence 23468899999999876 67999999999999999999999999432110 00000000000
Q ss_pred -hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 260 -RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 260 -~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.......+.+.. ..... ........++.+|+.+||+.||++|||++|+++.
T Consensus 896 ~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 896 YSDCHLDMWIDPS---IRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCccchhheeCcc---ccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000000000 00000 0001112357789999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=289.89 Aligned_cols=200 Identities=25% Similarity=0.405 Sum_probs=173.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcC---CCCcceeeeEec
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLR---HPDIVEIKHIML 92 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~ 92 (620)
-..|..+..+|.|+||.||+|+++.+...|+||.|.+..- .....-.+--||.||..|+ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 3568999999999999999999999999999999975411 0111223456999999997 99999999999
Q ss_pred CCCCCCCCeEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 93 PPSRRDFKDIYVVFELME-S-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 93 ~~~~~~~~~lylV~E~~~-g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
++.+++||+||--+ | ||+++|..+..++|.+++.|++|+..|+++||+.||||||||-+|+.++.+|.+||+||
T Consensus 639 ----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 ----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 78889999999887 5 99999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~ 232 (620)
|.|....+.. +..++||..|.|||++++. ...+..-|||+||++||.++....||.
T Consensus 715 gsaa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987654332 3457999999999999983 334677999999999999999988885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=254.27 Aligned_cols=209 Identities=25% Similarity=0.438 Sum_probs=173.7
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCCCeEEEE
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~-~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
-+..||+|+||+|-+.++..+|...|+|.+..... ....++.++|+.+.. ...+|.+|.+++.+ ..+.+++|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvwIc 123 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVWIC 123 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEEEe
Confidence 35689999999999999999999999999976533 456677889998754 45799999999987 456789999
Q ss_pred EecCCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 106 FELMESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 106 ~E~~~gdL~~~i----~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
||.|..+|..+. +.++.++|..+-.|+..++.||.|||++ .++|||+||+||||+.+|+||+||||.+-.+.+..
T Consensus 124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 999998776544 5577899999999999999999999985 89999999999999999999999999987654433
Q ss_pred CcccccccccCCccccCccccccc--CCCCCcccchHhHHHHHHHHHhCCCCCC-CCChhHHHHHhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFP-GKNVVHQLDLMTD 245 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~--~~~y~~~~DIWSLG~IlyeLltG~~pF~-g~~~~~~l~~i~~ 245 (620)
.. +-..|-..|||||.+... ...|+-++||||||+.+.||.+++.||. +.+..+|+..+.+
T Consensus 204 Ak----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 204 AK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred HH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 22 224577789999987532 2479999999999999999999999985 4567777766654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=296.16 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=214.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
-..+|+++.++|.|.||.||+++|+.+++..|+|+++. ....+..-+..||-+++.++||||+-+++.|+.. .
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----D 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhh-----c
Confidence 45689999999999999999999999999999999985 3345566677899999999999999999988543 4
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+++.||||+ |+|.+...-.+++++.++.+..+..++||+|||+.|-+|||||-.|||+++.|.+||.|||.+-.+.
T Consensus 86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit-- 163 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT-- 163 (829)
T ss_pred CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh--
Confidence 5899999999 5888888888899999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccccccCCccccCccccc-ccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~-~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.+......++||++|||||+.. +....|...+|||++|+.-.||---++|.-..-....+..+..-.-
T Consensus 164 -ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~---------- 232 (829)
T KOG0576|consen 164 -ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGF---------- 232 (829)
T ss_pred -hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCC----------
Confidence 2233346789999999999742 2236799999999999999999887877544444444444433111
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
++..+. .-...++.+.+|++.+|..+|++|||++.+|.|||..+
T Consensus 233 ----------------qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 233 ----------------QPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ----------------CCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 111111 12345778999999999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=277.24 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=203.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~--L~HpnIv~l~~v~~~~~~~~~ 99 (620)
....+++++||+|.||.||+|. -+++.||||++.. .+.+.+.+|-.|.+. ++|+||++++..-...+. +.
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cc
Confidence 3456788999999999999995 5679999999863 556677777777765 589999999886543332 25
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeecCCCCceEeCCCCcEEEcc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------NVYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILl~~~~~lKL~D 169 (620)
..++||+||.+ |+|.++++.+ .+++.+..+|+..|++||+|||+- .|+|||||.+||||.+|++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 57999999998 8999999876 599999999999999999999963 599999999999999999999999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCC-----cccchHhHHHHHHHHHhCCCCCC-CCChhHHHHHh
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKNVVHQLDLM 243 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~-----~~~DIWSLG~IlyeLltG~~pF~-g~~~~~~l~~i 243 (620)
||||.++....+.. .....+||..|||||++.+. .+.. ..+||||+|.+||||++....+. +....-++.--
T Consensus 360 FGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 99999876443332 23457999999999998763 2222 36999999999999999876654 43333333333
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHH
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTAEEA 311 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~l~dLI~~mL~~DP~~Rpsa~el 311 (620)
.++-.+|+.+.+...+-.++. ...+...|.. .-..+++.++.||..|++-|.|+.=+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~-----------RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQ-----------RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhcc-----------CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 345667887776665432222 2222222222 23468999999999999999998654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=265.62 Aligned_cols=267 Identities=26% Similarity=0.384 Sum_probs=200.2
Q ss_pred ccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH--hcCCCCcceeeeE
Q 007050 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR--LLRHPDIVEIKHI 90 (620)
Q Consensus 13 ~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~--~L~HpnIv~l~~v 90 (620)
+.++.+-..+.+..+++.||+|.||.||+|. ..|+.||||++.. .+.....||-+|.+ .|+|+||+.++..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 3445555567889999999999999999995 5699999999864 23444566777665 5699999999876
Q ss_pred ecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCceEeCC
Q 007050 91 MLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANA 161 (620)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~ 161 (620)
-.... ..-..+|||++|-+ |+|++++.. ..++.+....++..++.||+|||.. .|.|||||..|||+..
T Consensus 274 D~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 274 DNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred cccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 43332 34467999999999 899999987 5799999999999999999999953 4999999999999999
Q ss_pred CCcEEEcccCccccccCCC-CcccccccccCCccccCccccccc-----CCCCCcccchHhHHHHHHHHHhC--------
Q 007050 162 NCKLKICDFGLARVAFNDT-PTTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTG-------- 227 (620)
Q Consensus 162 ~~~lKL~DFGlA~~~~~~~-~~~~~~~~~~gt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~IlyeLltG-------- 227 (620)
++.+-|+|+|||....... .-.+..+..+||-.|||||++... +..| ..+||||||.|+||++..
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 9999999999998766553 233445678999999999998642 1112 358999999999999763
Q ss_pred --CCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCC--HHHHHHHHHhcccCCC
Q 007050 228 --KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPK 303 (620)
Q Consensus 228 --~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~ 303 (620)
++||.+- +-..|+.|.+.+++.-++ +++ .+...|.+.+ ..+-.|++.||..||.
T Consensus 431 ey~~Pyyd~-----------Vp~DPs~eeMrkVVCv~~-------~RP----~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 431 EYQLPYYDV-----------VPSDPSFEEMRKVVCVQK-------LRP----NIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred hhcCCcccC-----------CCCCCCHHHHhcceeecc-------cCC----CCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 3555432 234566666655543222 111 1222333322 2356789999999999
Q ss_pred CCCCHHHH
Q 007050 304 DRPTAEEA 311 (620)
Q Consensus 304 ~Rpsa~el 311 (620)
-|.||-.+
T Consensus 489 aRltALri 496 (513)
T KOG2052|consen 489 ARLTALRI 496 (513)
T ss_pred hhhHHHHH
Confidence 99998766
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=259.98 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=198.7
Q ss_pred CccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeE
Q 007050 12 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHI 90 (620)
Q Consensus 12 ~~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v 90 (620)
.++.+...+..+.|.|.+.||+|.||.+-+|.|+.+..++++|-+... ......+.+|...--.| .|.||+..|++
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v 89 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEV 89 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHH
Confidence 455566667788999999999999999999999999999999999865 34566788898775555 58999999998
Q ss_pred ecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC-C-CCcEEE
Q 007050 91 MLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-A-NCKLKI 167 (620)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~-~~~lKL 167 (620)
.+ +..+.+.+++||+. |||..-+..++ +-|...+.++.|++.||.|+|++++||||||.+||||- . .-+|||
T Consensus 90 aF----qt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 90 AF----QTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred Hh----hcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEe
Confidence 74 44457889999999 89999887754 88999999999999999999999999999999999974 3 347999
Q ss_pred cccCccccccCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~ 244 (620)
||||+.+......... --+..|.+||++... .-...+..|||.||+|+|.+|||++||.....
T Consensus 165 cDFG~t~k~g~tV~~~------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-------- 230 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVKYL------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-------- 230 (378)
T ss_pred eecccccccCceehhh------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--------
Confidence 9999987643221111 123458999987532 12357789999999999999999999963221
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCC
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R 305 (620)
....+.+|..-... ........|..+++.+..+.++-|..++++|
T Consensus 231 ---------------~d~~Y~~~~~w~~r-k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 231 ---------------MDKPYWEWEQWLKR-KNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ---------------cCchHHHHHHHhcc-cCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 12222233222222 2224455677889999999999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-29 Score=238.93 Aligned_cols=212 Identities=38% Similarity=0.637 Sum_probs=181.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC
Q 007050 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME 110 (620)
Q Consensus 31 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~ 110 (620)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++++. .....++|||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCC
Confidence 689999999999998889999999987542221 3567889999999999999999999984 3367899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCccccccCCCCcccccc
Q 007050 111 -SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWT 187 (620)
Q Consensus 111 -gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~~~~~~~~~~~~~ 187 (620)
++|.+++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999999875 47899999999999999999999999999999999999999 89999999999986543321 123
Q ss_pred cccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHH
Q 007050 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267 (620)
Q Consensus 188 ~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~ 267 (620)
...+...|++||.+... ..++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 35678889999998762 2788999999999999998
Q ss_pred HHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 007050 268 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315 (620)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp 315 (620)
..+.+++.+||..||++||+++++++|+
T Consensus 188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2457899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-29 Score=284.15 Aligned_cols=247 Identities=27% Similarity=0.467 Sum_probs=195.3
Q ss_pred EEEEEeeecCceEEEEEEEC----C---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007050 26 KIQEVIGKGSYGVVCSAIDT----H---TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~----~---tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (620)
.+.+.||.|.||.||+|.-. . ....||+|.++..... .+...+..|+++|+.+ +||||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 56779999999999999632 1 1457999999876444 7788899999999998 59999999999843
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
...+++|+|||+ |+|.++++.+. .++..+...|.+||+.|+.||++..++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 567999999999 89999998765 389999999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccC--CccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC-h
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN-V 236 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~g--t~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~-~ 236 (620)
.+..+||+|||+|+.......... ..-.+ ...|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986443322211 11122 334999999887 689999999999999999998 678997732 1
Q ss_pred hHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 237 ~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.+.+..+ + .... ......+++++.+|++.||+.+|++||+..++..
T Consensus 529 ~~l~~~l----------------~------------~G~r---~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFL----------------K------------EGNR---MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHH----------------h------------cCCC---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 1111111 1 1000 1112345889999999999999999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=300.34 Aligned_cols=208 Identities=15% Similarity=0.179 Sum_probs=148.0
Q ss_pred hcCC-CCcceeeeEecCCC--CCCCCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 007050 78 LLRH-PDIVEIKHIMLPPS--RRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (620)
Q Consensus 78 ~L~H-pnIv~l~~v~~~~~--~~~~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (620)
.++| +||.++++.|.... ..+...++++||+++++|+++|.. ...+++.+++.|++||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 57777777652221 112245788999999999999975 3469999999999999999999999999999999
Q ss_pred CCceEeCCC-------------------CcEEEcccCccccccCCCC-------------cccccccccCCccccCcccc
Q 007050 154 PKNILANAN-------------------CKLKICDFGLARVAFNDTP-------------TTIFWTDYVATRWYRAPELC 201 (620)
Q Consensus 154 P~NILl~~~-------------------~~lKL~DFGlA~~~~~~~~-------------~~~~~~~~~gt~~Y~APEvl 201 (620)
|+||||+.. +.+||+|||+++....... ........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4456666666653211000 00011225789999999998
Q ss_pred cccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccC
Q 007050 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQ 281 (620)
Q Consensus 202 ~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (620)
.+ ..|+.++||||||||||||++|.+||..... .+..+.. . ..+ .
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~------------------------~---~~~----~ 232 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH------------------------R---VLP----P 232 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH------------------------h---hcC----h
Confidence 87 6799999999999999999999888743211 0000000 0 000 0
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 282 KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 282 ~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+....+...+++.+||+.||.+||++.|+|+||||...
T Consensus 233 ~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 233 QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 011123466789999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=238.02 Aligned_cols=200 Identities=38% Similarity=0.652 Sum_probs=172.5
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+. .....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEE
Confidence 67889999999999999999998999999999754222 25677889999999999999999999873 3456899
Q ss_pred EEecCCc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 105 VFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
++|++.+ +|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999987766 899999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g 233 (620)
......++..|++||.+.+ ...++.++|+|+|||++++|++|+.||.+
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234567889999999831 26788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=281.41 Aligned_cols=268 Identities=27% Similarity=0.353 Sum_probs=203.0
Q ss_pred CCe-EEEEEeeecCceEEEEEEECCCCcEEEEEEecC---ccCChHHH-HHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEHISDA-ARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~---~~~~~~~~-~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+.| ...+++|.|++|.|+.+......+.++.|.... ........ ..+..|+.+-..|+|||++..+.++..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~---- 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE---- 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh----
Confidence 345 346789999999888888877777777776541 11222222 236778888899999999888777633
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...++-+||||.+||+.++...+.++..++..++.||+.||+|||+.||.||||||+|++++.+|.+||+|||.+....
T Consensus 393 -~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 393 -IDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred -cccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 3334455999999999999998889999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCc-ccccccccCCccccCcccccccCCCCCc-ccchHhHHHHHHHHHhCCCCCCCCChhHHHH-HhhhccCCCChhh
Q 007050 178 NDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD-LMTDLLGTPSLDT 254 (620)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~-~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~-~i~~~lg~p~~e~ 254 (620)
-.... .....+.+|+..|+|||++.+ ..|++ .+||||.|+|++.|++|+.||.-....++.. .+....
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~------- 542 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD------- 542 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc-------
Confidence 33322 244567899999999999987 56766 5899999999999999999996543222110 000000
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...........+..++...+.+|.+||++||.+|.|+++||+++||+.+.
T Consensus 543 -----------------~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 543 -----------------QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred -----------------ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 00000011112234566789999999999999999999999999999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=264.38 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=195.8
Q ss_pred EEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
..++||.|+||+||+|++--.|+ .||||++... ...+....+++|.-+|..|+|||+++|+++++... +
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~ 772 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------L 772 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------H
Confidence 35699999999999999876565 6888887643 44455678899999999999999999999986543 6
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
-||++||. |.|.++++.+ +.+-.+....|.+||++|+.|||.++++||||-..|+|+..-..+||.|||+++....+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 79999999 7999999864 578999999999999999999999999999999999999999999999999999865544
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.... ...---.+-|||=|.+.. ..|+.++||||+||.+|||+| |..|+.+....+. ..++
T Consensus 853 ~ey~-~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dll 913 (1177)
T KOG1025|consen 853 KEYS-APGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLL 913 (1177)
T ss_pred cccc-ccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHH
Confidence 3221 111122345888887765 789999999999999999998 7888877543221 1111
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+. +.. ....|..+-++.-++.+||-.|+..||+++++..
T Consensus 914 e~--------------geR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 914 EK--------------GER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred hc--------------ccc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 10 001 1233567888999999999999999999998854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=224.50 Aligned_cols=165 Identities=22% Similarity=0.279 Sum_probs=126.8
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccc
Q 007050 111 SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189 (620)
Q Consensus 111 gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~ 189 (620)
|+|.+++..+ ..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 46999999999999999999999998 999999999999999 9998765322 12
Q ss_pred cCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhH-HHHHhhhccCCCChhhhhhhhhchhHHHHH
Q 007050 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRVVRNDKARRYL 268 (620)
Q Consensus 190 ~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~-~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~ 268 (620)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .+..+.
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~------------------------ 118 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL------------------------ 118 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH------------------------
Confidence 68999999999987 689999999999999999999999996543221 111111
Q ss_pred HhhhccCCCcccCCCCCCCH--HHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 269 TSMRKKQPVQFSQKFPNADP--SALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~s~--~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
..+....+.. ......++. .+.+||.+||..||.+||++.|+++|+|+.
T Consensus 119 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 119 NGMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0010000000 000111222 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-25 Score=223.29 Aligned_cols=265 Identities=34% Similarity=0.518 Sum_probs=204.8
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH-HHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCeE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS-DAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~-~~~~i~rEi~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~l 102 (620)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 889999999999999999887 8899999976654443 567788999999999988 7999999983 33348
Q ss_pred EEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCcccccc
Q 007050 103 YVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGlA~~~~ 177 (620)
+++++++. +++.+++.... .+++.....++.|++.++.|+|+.+++||||||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999 48887777664 799999999999999999999999999999999999999998 79999999998554
Q ss_pred CCCCcc---cccccccCCccccCcccccccC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCh---hHHHHHhhhccCCC
Q 007050 178 NDTPTT---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLMTDLLGTP 250 (620)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~Y~APEvl~~~~-~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~---~~~l~~i~~~lg~p 250 (620)
...... ......+||.+|++||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 333221 1346779999999999987521 3688899999999999999999999877653 12211111111111
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.......... ......+.+++.+|+..+|..|.+..+...++|....
T Consensus 234 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 -----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred -----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1123578999999999999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=231.68 Aligned_cols=179 Identities=21% Similarity=0.208 Sum_probs=134.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~---~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..+|.+.+.||+|+||+||+|+++. +++.+|||++..... .......+.+|+.+|+.|+|+||+..+..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 4679999999999999999999886 677889998753211 223456688999999999999998533221
Q ss_pred CCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL-KPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...|+|||||+| +|.. +.. .. ...++.|++.+|.|||+.||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 246999999996 6752 211 11 1467899999999999999999999 99999999999999999999987
Q ss_pred ccCCCCccc-----ccccccCCccccCcccccccCCC----CCcccchH
Q 007050 176 AFNDTPTTI-----FWTDYVATRWYRAPELCGSFFSK----YTPAIDIW 215 (620)
Q Consensus 176 ~~~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~----y~~~~DIW 215 (620)
......... ..+..+++..|+|||.+...... .+...|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 643321111 12456788899999988642222 23346666
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=223.22 Aligned_cols=252 Identities=19% Similarity=0.336 Sum_probs=197.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.|+++.-.+-+|.||.||.|+++... +.|.+|.++.. ...-....++.|-.+|..+.|||+..+.++.. +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i----e 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI----E 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe----e
Confidence 46777888999999999999765332 34666666543 23345667889999999999999999999985 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN--------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~--------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
+...-++++.+++ |+|..++... ..++..+...+..||..|+.|||+.||||.||-..|++|++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 5566789999999 8999999732 247778888899999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhcc
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~l 247 (620)
|=.++|..+..+..... .......-||+||.+.. ..|+.++|+||||+++|||+| |+.|+-.-++.+....+.+
T Consensus 439 DsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-- 513 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-- 513 (563)
T ss_pred cchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc--
Confidence 99999988766554322 12234556999999987 789999999999999999998 7788855444333222211
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...+.+ .-++++++..++--||..+|++||+.+++..
T Consensus 514 ----------------------------GyRlaQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 ----------------------------GYRLAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------------------------cceecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111122 2378899999999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-23 Score=216.39 Aligned_cols=204 Identities=23% Similarity=0.282 Sum_probs=164.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhcCC----CCcceeeeEecCCCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLRH----PDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H----pnIv~l~~v~~~~~~~~ 98 (620)
+|++.+.||+|+||.||+|.+..++ +.+|+|.......... . .+..|+.+|..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-c-cchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999998775 6788887764322111 1 56678888888863 57888877762 23
Q ss_pred CCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-----CcEEEcccC
Q 007050 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-----CKLKICDFG 171 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-----~~lKL~DFG 171 (620)
...-|+||++++.+|.++.+.. +.++...+..+..|++.+|.+||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4567999999999999988654 479999999999999999999999999999999999999765 469999999
Q ss_pred ccc--cccCCCCcc---c-c-cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 007050 172 LAR--VAFNDTPTT---I-F-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235 (620)
Q Consensus 172 lA~--~~~~~~~~~---~-~-~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~ 235 (620)
+++ ......... . . ...+.||..|.++.+..+ ...+.+.|+||++.++.+|+.|..||.+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 999 432222110 0 1 134569999999999887 688999999999999999999999997654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=241.26 Aligned_cols=265 Identities=28% Similarity=0.405 Sum_probs=191.6
Q ss_pred CCCCccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcce
Q 007050 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVE 86 (620)
Q Consensus 9 ~~~~~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L~HpnIv~ 86 (620)
.++.-.+|.+..- .|...+.||++.|=+|++|.|. .| .|+||++-+.. .......+.++|++ ...++|||.+.
T Consensus 11 i~~~e~yfsd~~~--e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lP 85 (1431)
T KOG1240|consen 11 ISPVEVYFSDLSV--ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLP 85 (1431)
T ss_pred cchHHHHhhcCcc--ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccc
Confidence 3444444544332 7889999999999999999764 34 48999986432 23344555567777 67789999998
Q ss_pred eeeEecCCCCCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEE
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lK 166 (620)
+..+. ...+.-|+|-+|...+|++.+..+.-+..-+.+.|+.||+.||.-+|..||+|+|||.+||||++=+-+.
T Consensus 86 fqk~~-----~t~kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~ 160 (1431)
T KOG1240|consen 86 FQKVL-----VTDKAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLY 160 (1431)
T ss_pred hHHHH-----HhhHHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhh
Confidence 87764 3445678999999999999999888899999999999999999999999999999999999999998999
Q ss_pred EcccCcccccc--CC--CCcccccccccCCccccCccccccc--------CCC-CCcccchHhHHHHHHHHHh-CCCCCC
Q 007050 167 ICDFGLARVAF--ND--TPTTIFWTDYVATRWYRAPELCGSF--------FSK-YTPAIDIWSIGCIFAEVLT-GKPLFP 232 (620)
Q Consensus 167 L~DFGlA~~~~--~~--~~~~~~~~~~~gt~~Y~APEvl~~~--------~~~-y~~~~DIWSLG~IlyeLlt-G~~pF~ 232 (620)
|.||..-+... .+ .....++.+...-..|.|||.+... ... .+++.||||+||+++||++ |+|||.
T Consensus 161 LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 161 LTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred hhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 99998765421 11 1222233333444579999976431 012 6788999999999999988 689993
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
-. |+-.... | ........++.+ -+..+++||..|++.||.+|.+|++.|
T Consensus 241 LS----QL~aYr~--~-----------~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 241 LS----QLLAYRS--G-----------NADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred HH----HHHhHhc--c-----------CccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHH
Confidence 21 1111100 0 001111112111 134689999999999999999999999
Q ss_pred cC
Q 007050 313 AD 314 (620)
Q Consensus 313 ~h 314 (620)
+.
T Consensus 290 ~~ 291 (1431)
T KOG1240|consen 290 QK 291 (1431)
T ss_pred Hh
Confidence 85
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=197.55 Aligned_cols=209 Identities=26% Similarity=0.366 Sum_probs=167.0
Q ss_pred cccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCC
Q 007050 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPP 94 (620)
Q Consensus 16 ~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H-pnIv~l~~v~~~~ 94 (620)
..++-..+.|++++.||.|+||.+|+|....+|+.||||+-.....+ ..+..|.++.+.|++ ..|..+..+.
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~--- 80 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG--- 80 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc---
Confidence 34455667999999999999999999999999999999987643322 245678999999975 4555555554
Q ss_pred CCCCCCeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC---CcEEEccc
Q 007050 95 SRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDF 170 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~lKL~DF 170 (620)
.+...-.+|||+++.+|.+++.- ...|+-..+.-++-|++.-|+|+|..+++||||||+|+|..-+ ..+.|+||
T Consensus 81 --~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 81 --TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred --cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 44456689999999888888764 3469999999999999999999999999999999999997543 45999999
Q ss_pred CccccccCCCCcc-cc---cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 007050 171 GLARVAFNDTPTT-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235 (620)
Q Consensus 171 GlA~~~~~~~~~~-~~---~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~ 235 (620)
|||+.+.+..... +. -....||..|.+-....+ ...+...|+-|+|.+|.++..|..||.|-.
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 9999865432221 11 134579999998876665 466788999999999999999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=237.11 Aligned_cols=225 Identities=28% Similarity=0.452 Sum_probs=170.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|..++.|..|+||-||.++|+.+.+++|+ +|++. + -|||. |..+-+ +
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq--~-----------lilRn-----ilt~a~-----------n 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ--N-----------LILRN-----ILTFAG-----------N 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-ccccc--c-----------hhhhc-----cccccC-----------C
Confidence 45789999999999999999999999999999 45431 1 11221 222211 1
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 102 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
.++| ||-...++..+.++... +.+++|||+.||+|||+||+|.||+.-|++|+.|||+.+.......
T Consensus 132 pfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 132 PFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2344 66666777666666543 7899999999999999999999999999999999999976433222
Q ss_pred ccc-----------c-cccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 182 TTI-----------F-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 182 ~~~-----------~-~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
+.. + -...|||+.|+|||++.. .+|+..+|+|++|+|+||.+.|..||-|.+..+.+...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis---- 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh----
Confidence 111 1 123599999999999987 7899999999999999999999999988876655443321
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCcccCC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 320 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp---sa~elL~hp~f~~~ 320 (620)
..+.|.+......+++++||.++|+.+|..|. .+-++-+|+||+.+
T Consensus 273 -------------------------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 273 -------------------------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred -------------------------hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 11223333456788999999999999999994 67788899999876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=203.72 Aligned_cols=213 Identities=21% Similarity=0.328 Sum_probs=171.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (620)
-.|++.++||+|+||+.+.|.+.-+++.||||.-... +++-.+..|....+.|. .+.|..++-+- ++..+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~ 98 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKY 98 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeec-----cccch
Confidence 4699999999999999999999999999999975432 44556677888888774 67787765443 44455
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-----CcEEEcccCcccc
Q 007050 102 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-----CKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-----~~lKL~DFGlA~~ 175 (620)
-.||+|+++.+|.+++.-+ ..|+.+.+..++.||+.-++|+|++++|.|||||+|+||..- ..|.|+|||+|+.
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 6799999998888888644 479999999999999999999999999999999999999754 3489999999998
Q ss_pred ccCCCCc-cccc---ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC---ChhHHHHHhhhc
Q 007050 176 AFNDTPT-TIFW---TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---NVVHQLDLMTDL 246 (620)
Q Consensus 176 ~~~~~~~-~~~~---~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~---~~~~~l~~i~~~ 246 (620)
+...... .+.+ ....||..||+=....+ ..-+...|+-|||-+|.+.|.|..||.|. +.-+.+++|-+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 7543222 2221 34579999999988877 67889999999999999999999999885 444555555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=234.78 Aligned_cols=239 Identities=25% Similarity=0.411 Sum_probs=194.9
Q ss_pred EeeecCceEEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEEEE
Q 007050 30 VIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d---~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV 105 (620)
++|.|+||.|++++. ...|..+|+|+.++.............|-.++...+ ||.++++...+ +....+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 479999999988753 345678999998765444343335556778888886 99999998888 566789999
Q ss_pred EecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccc
Q 007050 106 FELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (620)
Q Consensus 106 ~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~ 184 (620)
+++..| +|+..+.....+++...+.+...++.++.++|+.+|+|||+|++||+++.+|++|+.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999985 999999888889999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhh-ccCCCChhhhhhhhhchh
Q 007050 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISRVVRNDK 263 (620)
Q Consensus 185 ~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~-~lg~p~~e~i~~~~~~~~ 263 (620)
..|||..|||||++. ....++|+||+|+++++|++|..||.+ +....|.. .++-
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~-------------- 206 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM-------------- 206 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC--------------
Confidence 228999999999986 467899999999999999999999976 22222221 0111
Q ss_pred HHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCCC
Q 007050 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGLS 321 (620)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~~ 321 (620)
....+..+++++..|+..+|..|.- +.|+++|++|..+.
T Consensus 207 -------------------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 207 -------------------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred -------------------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 1235678999999999999999974 48999999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=195.14 Aligned_cols=176 Identities=13% Similarity=0.126 Sum_probs=133.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HHH------HHHHHHHHHhcCCCCcceeeeEecCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AAR------ILREIKLLRLLRHPDIVEIKHIMLPP 94 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~-~~~------i~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (620)
.++|+++++||.|+||.||++.+ ++..+|||++......... ..+ +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46999999999999999999644 4678999999754333222 222 46899999999999999998886543
Q ss_pred CCCC---CCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 95 SRRD---FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 95 ~~~~---~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
.... ....+|||||++| +|.++. .+++ ....+|+.+|..||..|++||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2211 2458999999997 787763 2333 2466999999999999999999999999999998 999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHH
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLl 225 (620)
|..+....+.... .+... ..|+.++||||||+.+..+.
T Consensus 179 g~~~~~~e~~a~d---------------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD---------------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH---------------HHHHH--hHhcccccccceeEeehHHH
Confidence 9886542211110 02222 45778999999999987664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=197.21 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=150.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCC----------CCcceeeeEec
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRH----------PDIVEIKHIML 92 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~H----------pnIv~l~~v~~ 92 (620)
.+...+.||.|+++.||.+.|..||+.+|+|++.... ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567789999999999999999999999999885332 222345556666544444322 11222222221
Q ss_pred CCCC-------CCCC-----eEEEEEecCCccHHHHHHh---CCCC--CH--HHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 007050 93 PPSR-------RDFK-----DIYVVFELMESDLHQVIKA---NDDL--TR--EHYQFFLYQLLRALKYIHTANVYHRDLK 153 (620)
Q Consensus 93 ~~~~-------~~~~-----~lylV~E~~~gdL~~~i~~---~~~l--se--~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (620)
.... .+.. +.+++|+.+.+||.+++.. .... .. .....+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1100 1111 3478999999998888753 2222 12 2224455899999999999999999999
Q ss_pred CCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCccccccc------CCCCCcccchHhHHHHHHHHHhC
Q 007050 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTG 227 (620)
Q Consensus 154 P~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~------~~~y~~~~DIWSLG~IlyeLltG 227 (620)
|+|+|++.+|.++|+||+......... .....+..|.+||+.... .-.++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999877543211 112345679999976431 13578899999999999999999
Q ss_pred CCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCC
Q 007050 228 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305 (620)
Q Consensus 228 ~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R 305 (620)
..||........ .. ..|.. +.++++.+++||.+||++||.+|
T Consensus 247 ~lPf~~~~~~~~----------------~~-------------------~~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------PE-------------------WDFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------SG-------------------GGGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------cc-------------------ccchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 999966432100 00 01222 23778899999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-22 Score=192.37 Aligned_cols=140 Identities=21% Similarity=0.255 Sum_probs=109.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD------------------------AARILREIKLLRLLRHPD 83 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~------------------------~~~i~rEi~iL~~L~Hpn 83 (620)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999653211100 112345999999998877
Q ss_pred cceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCceEeCC
Q 007050 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILANA 161 (620)
Q Consensus 84 Iv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILl~~ 161 (620)
+.....+.. ...+|||||++| ++...+.....++++.+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 644332221 123899999996 5554444556799999999999999999999 799999999999999998
Q ss_pred CCcEEEcccCccccc
Q 007050 162 NCKLKICDFGLARVA 176 (620)
Q Consensus 162 ~~~lKL~DFGlA~~~ 176 (620)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=184.83 Aligned_cols=142 Identities=23% Similarity=0.202 Sum_probs=111.6
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH----------------------H--HHHHHHHHHHHHhcCCC
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS----------------------D--AARILREIKLLRLLRHP 82 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~----------------------~--~~~i~rEi~iL~~L~Hp 82 (620)
+.+.||+|++|.||+|.+. +|+.||||+++....... . ...+.+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999875421100 0 12235799999999999
Q ss_pred CcceeeeEecCCCCCCCCeEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeC
Q 007050 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILAN 160 (620)
Q Consensus 83 nIv~l~~v~~~~~~~~~~~lylV~E~~~gd-L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~ 160 (620)
+|.....+... ..||||||++|. +...+.....+++..+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 88554444311 138999999963 43333344568899999999999999999999 9999999999999999
Q ss_pred CCCcEEEcccCcccccc
Q 007050 161 ANCKLKICDFGLARVAF 177 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~ 177 (620)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=190.22 Aligned_cols=257 Identities=28% Similarity=0.371 Sum_probs=174.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-----------------------------------cEEEEEEecCccCChHHH
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----------------------------------EKVAIKKIHDIFEHISDA 66 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----------------------------------~~vAIK~i~~~~~~~~~~ 66 (620)
-++|+|.+.||+|.-..||.|.-+..| -..|||.+.+- ++.+..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~-~~~s~~ 234 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF-EHDSGD 234 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc-ccCCch
Confidence 357999999999999999998643311 13566665432 222322
Q ss_pred HHHH----HHHH-------H-------HHh--------cCCCCcceeeeEecCC----------------------CCCC
Q 007050 67 ARIL----REIK-------L-------LRL--------LRHPDIVEIKHIMLPP----------------------SRRD 98 (620)
Q Consensus 67 ~~i~----rEi~-------i-------L~~--------L~HpnIv~l~~v~~~~----------------------~~~~ 98 (620)
..++ +|+- . .+. -+|||||++...|.+. ...+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 2222 2211 1 111 2599999998877431 1234
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC--CCC--cEEEcccCccc
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANC--KLKICDFGLAR 174 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~--~lKL~DFGlA~ 174 (620)
...+|+||..+..+|++++-.+. .+.....-++.|+++|+.|||..||.|||||.+|||+. +|+ .+.|+|||.+-
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 46799999999999999997654 67777888999999999999999999999999999974 443 48999999875
Q ss_pred cccCCCCccc---ccccccCCccccCcccccccCCC----CCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 175 VAFNDTPTTI---FWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 175 ~~~~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~----y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
......-... ..-+.-|.-.-||||+......+ .-.++|.|+.|.+-||+++...||.+.-...
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--------- 464 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--------- 464 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---------
Confidence 3222111111 11234577788999987532111 1247999999999999999999998743211
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 310 (620)
. ..+.|-+ ..+......+++.+++|+..+|+.||++|+++.=
T Consensus 465 ----L----------~~r~Yqe-------~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 465 ----L----------DTRTYQE-------SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred ----e----------chhhhhh-------hhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 0 0011111 1111222357789999999999999999998743
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=177.13 Aligned_cols=189 Identities=16% Similarity=0.060 Sum_probs=137.4
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--HHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEE
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--DAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~--~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+...|++|+||+|+.+.. .+.+++.+.+........ ....+.+|+++|++|. |++|.+++++ ...|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGRH 74 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCEE
Confidence 578999999999998754 677888777764322111 2235779999999995 5789988775 2369
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 104 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL-KPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
++|||+.| +|.+.+.. . ...++.|++.+|.+||+.||+|||| ||+|||++.++.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999997 66554321 1 1357889999999999999999999 79999999999999999999985433221
Q ss_pred c----c--------cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 007050 182 T----T--------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235 (620)
Q Consensus 182 ~----~--------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~ 235 (620)
. . .++ ...++.|++|+...-....--...++++.|+-+|.++|+..++.+.+
T Consensus 148 ~~r~L~~rDl~~llk~~--~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHK--RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHH--HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 011 12567788888533211222256789999999999999998875543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=201.17 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=165.0
Q ss_pred CeEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeee-------EecC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH-------IMLP 93 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~-------v~~~ 93 (620)
.+.+.+..+..+++.+....-... .+.+.-+.... .+........+++-.+....|.+..-+.+ .+..
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence 344555666666666554432222 22222222111 12123344556666666555544433333 1111
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~D 169 (620)
.......++||.|++|+ .+|.++|..+. ..+....+.++.||..|+.| +|.+|||+||.||++..++.+||+|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhh
Confidence 11222346899999999 69999997543 46777889999999999999 9999999999999999999999999
Q ss_pred cCccccccCCC---CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc
Q 007050 170 FGLARVAFNDT---PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 170 FGlA~~~~~~~---~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~ 246 (620)
||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+||+||+. +|.. ..+...
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~---~f~T--~~er~~----- 467 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLI---QFST--QFERIA----- 467 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHH---Hhcc--HHHHHH-----
Confidence 99987755443 11123467799999999999998 789999999999999999997 1211 000000
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.+..++.. .+...+..-.+.-.+|+..||...|.+||++.+.--|+|.
T Consensus 468 --------------------t~~d~r~g---~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 --------------------TLTDIRDG---IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --------------------hhhhhhcC---CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11111111 1111111223466799999999999999988777677764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=176.63 Aligned_cols=136 Identities=21% Similarity=0.256 Sum_probs=106.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-----CCCCcceeeeEecCCCCCCCCeE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-----RHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-----~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+++.| .||||+++++++.+.. +.+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 46899999999995 7777776 69988642 123456789999999999 5799999999995432 12344
Q ss_pred E-EEEecCC---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeecCCCCceEeCC----CCcEEEcccCcc
Q 007050 103 Y-VVFELME---SDLHQVIKANDDLTREHYQFFLYQLLRAL-KYIHTANVYHRDLKPKNILANA----NCKLKICDFGLA 173 (620)
Q Consensus 103 y-lV~E~~~---gdL~~~i~~~~~lse~~~~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILl~~----~~~lKL~DFGlA 173 (620)
+ +||||++ ++|.++++.. .+++. ..++.|++.++ +|||+.+|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 46665 46688888888 8999999999999999999974 347999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-19 Score=178.52 Aligned_cols=145 Identities=18% Similarity=0.135 Sum_probs=112.1
Q ss_pred CCeEEEEEeeecCceEEEEEE-ECCCCcEEEEEEecCccCCh--------------------H--HHHHHHHHHHHHHhc
Q 007050 23 SRYKIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHI--------------------S--DAARILREIKLLRLL 79 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~-d~~tg~~vAIK~i~~~~~~~--------------------~--~~~~i~rEi~iL~~L 79 (620)
.-|.+.+.||+|+||.||+|. +..+|+.||||++....... . ....+.+|+.++..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 458899999999999999999 77899999999986432100 0 112356899999999
Q ss_pred CCCCcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCce
Q 007050 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN-VYHRDLKPKNI 157 (620)
Q Consensus 80 ~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g-IvHrDLKP~NI 157 (620)
.+. ++.+..++.. ...|+||||++| +|......+..+....+..++.||+.+|.+||+.| |+||||||+||
T Consensus 108 ~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred Hhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 753 3333333311 124899999997 56555444556777778899999999999999999 99999999999
Q ss_pred EeCCCCcEEEcccCcccc
Q 007050 158 LANANCKLKICDFGLARV 175 (620)
Q Consensus 158 Ll~~~~~lKL~DFGlA~~ 175 (620)
+++ ++.++|+|||.+..
T Consensus 181 li~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEE-CCCEEEEEChhhhc
Confidence 999 88999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.5e-19 Score=202.67 Aligned_cols=194 Identities=24% Similarity=0.317 Sum_probs=152.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~ 98 (620)
+..|.|.+.||+|+||+||+|.+.. |+.||+|+-+..... .++==.+++.+|+ -+.|..+...++..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccC----
Confidence 4689999999999999999999877 999999986643221 1221234444554 23444444444322
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-------CCcEEEccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------NCKLKICDF 170 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------~~~lKL~DF 170 (620)
+..+||+||.+ |+|.+++..++.+++..+.+|+.|||..|.+||..+|||+||||+|+||.. .--|+|+||
T Consensus 767 -~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 -NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred -CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 23589999999 899999998889999999999999999999999999999999999999843 234999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~ 229 (620)
|.+..+.--... ..+...++|-.+-.+|+..+ ..|+..+|.|.|..+++-||.|+.
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHHH
Confidence 999764332222 23456788888999999988 799999999999999999999873
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-18 Score=166.88 Aligned_cols=136 Identities=22% Similarity=0.273 Sum_probs=110.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH------HHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS------DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~------~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++.||+|++|.||+|.+ .|..+++|+......... ...++.+|+.++..+.|++|.....++. +...
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPEN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCC
Confidence 36799999999999976 678899998653322111 2345778999999999998876665553 2345
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.++||||++| +|.+++..... ....++.+|+.+|.+||+.+++|+||+|.|||++ ++.++|+|||++..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7899999986 89888865432 7788999999999999999999999999999999 78999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-20 Score=206.34 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=206.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t-g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (620)
...|.+.+.||+|+|+.|-++....+ ...+|.|.+............+..|..+-..+. |+|++.+++.. .+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 55789999999999999998876443 346777777654333344556667888888887 99999999887 455
Q ss_pred CeEEEEEecCC-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCceEeCCCC-cEEEcccCccc
Q 007050 100 KDIYVVFELME-SDLHQVI-KAND-DLTREHYQFFLYQLLRALKYIH-TANVYHRDLKPKNILANANC-KLKICDFGLAR 174 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i-~~~~-~lse~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~-~lKL~DFGlA~ 174 (620)
...++++++.. ++++..+ .... ..+......++.|+..+|.|+| ..++.||||||+|.+++..+ .+|+.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 66899999977 4899888 5544 6788889999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCcccccccccC-CccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 175 VAFNDTPTTIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-t~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
.+.............+| ++.|.|||...+. ....+..|+||+|+++.-|++|..||......+
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--------------- 237 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--------------- 237 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc---------------
Confidence 87652233334566788 9999999998763 356778999999999999999999985543211
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.....+. ......-...|..++..+.+++.++|..+|..|.+.+++-.+||+..
T Consensus 238 --------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 238 --------GRYSSWK----SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred --------ccceeec----ccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000010 00001112346778899999999999999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-18 Score=168.59 Aligned_cols=240 Identities=16% Similarity=0.238 Sum_probs=177.9
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
..++.+|.....|..|+++. .|..++.|+++-..........|..|.-.|+-+.||||+.+++.+-.+ .++.+
T Consensus 192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceE
Confidence 34566788999999999965 566777887764333334455678899999999999999999998443 56899
Q ss_pred EEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEc--ccCcccccc
Q 007050 105 VFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKIC--DFGLARVAF 177 (620)
Q Consensus 105 V~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~--DFGlA~~~~ 177 (620)
+..||. |+|+.++.... -++..++..|..+|++|++|||+.. |.---|....++||++-+.+|. |--++ +
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---f 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---F 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---e
Confidence 999999 89999997654 3577788999999999999999975 4444688889999998776553 32222 1
Q ss_pred CCCCcccccccccCCccccCcccccccC-CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~-~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.. ....-.+.||+||.+.... ...-.++|+||+.+++|||.|...||...+..+---+|
T Consensus 342 qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------- 401 (448)
T KOG0195|consen 342 QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------- 401 (448)
T ss_pred ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------------
Confidence 11 1234567899999886521 12345799999999999999999999776554322111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~el 311 (620)
-++.++. ...|+++..+..|+.-|+.-||.+||..+.+
T Consensus 402 ----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 402 ----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 1122221 2347899999999999999999999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=174.15 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=151.0
Q ss_pred HHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-EeecC
Q 007050 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANV-YHRDL 152 (620)
Q Consensus 76 L~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gI-vHrDL 152 (620)
|+.+.|.|+.++++..+.+ ..+++|.+||. |+|.+.+.. .-.++......++++|+.||.|||..-| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999654 66899999999 899999987 3468888888999999999999999877 99999
Q ss_pred CCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCccccccc--CC---CCCcccchHhHHHHHHHHHhC
Q 007050 153 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEVLTG 227 (620)
Q Consensus 153 KP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~--~~---~y~~~~DIWSLG~IlyeLltG 227 (620)
+..|++++....+||.|||+........ .........-...|.|||++... .. ..+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999987653210 00111112234568999998752 11 146779999999999999999
Q ss_pred CCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCccc---CCCCCCCHHHHHHHHHhcccCCCC
Q 007050 228 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS---QKFPNADPSALRLLERLLAFDPKD 304 (620)
Q Consensus 228 ~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~l~dLI~~mL~~DP~~ 304 (620)
..||........-. +.+..+ .......+. .......+.+..++..||.-+|.+
T Consensus 155 ~~~~~~~~~~~~~~-----------eii~~~-------------~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPD-----------EIILRV-------------KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred cCccccccccCChH-----------HHHHHH-------------HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhh
Confidence 99997643211101 111111 110000010 111134557999999999999999
Q ss_pred CCCHHHHH
Q 007050 305 RPTAEEAL 312 (620)
Q Consensus 305 Rpsa~elL 312 (620)
||+++++-
T Consensus 211 rPs~~~i~ 218 (484)
T KOG1023|consen 211 RPSIEQIR 218 (484)
T ss_pred CccHHHHH
Confidence 99999884
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.9e-17 Score=159.08 Aligned_cols=137 Identities=22% Similarity=0.213 Sum_probs=105.7
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--------------------HHHHHHHHHHHHHhcCCCC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--------------------DAARILREIKLLRLLRHPD 83 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~--------------------~~~~i~rEi~iL~~L~Hpn 83 (620)
.|.+.+.||.|+||.||++.+. +|+.||||++........ ......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 799999998754211000 1123567899999998774
Q ss_pred --cceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 84 --IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 84 --Iv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
+...++ ....++||||++| +|..+.. ......++.+|+.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 333322 1235899999996 6655432 134567889999999999999999999999999999
Q ss_pred CCCcEEEcccCccccc
Q 007050 161 ANCKLKICDFGLARVA 176 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~ 176 (620)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.3e-17 Score=158.98 Aligned_cols=131 Identities=27% Similarity=0.380 Sum_probs=101.8
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCc-cCCh-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHI-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~-----~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.||+|+||.||++. .+|..+++|+.... .... ....++.+|+.+++.+.|+++....-++. +....+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 48999999999997 46788999986432 1111 12356778999999999876544333332 123468
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 104 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 104 lV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+||||++| +|.+++..... .++.+|+.+|.+||+.|++|+||+|.||+++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=178.57 Aligned_cols=139 Identities=22% Similarity=0.292 Sum_probs=107.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEe-cCccCC-----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEH-----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i-~~~~~~-----~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
...|...+.||+|+||.||++.+. +..+++|+. .+.... .....++.+|+.+++.++|++|+....+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 344566889999999999999764 334444443 221111 1224567899999999999999876655532
Q ss_pred CCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 96 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 96 ~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
....++||||++| +|.+++. ....++.+|+.+|.+||+.||+||||||+|||+ .++.++|+|||+++
T Consensus 408 ---~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 408 ---PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred ---CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 2346899999985 8888875 346789999999999999999999999999999 67789999999998
Q ss_pred cc
Q 007050 175 VA 176 (620)
Q Consensus 175 ~~ 176 (620)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-16 Score=150.22 Aligned_cols=137 Identities=24% Similarity=0.253 Sum_probs=97.4
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR----------------------ILREIKLLRLLRHPD-- 83 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~----------------------i~rEi~iL~~L~Hpn-- 83 (620)
.+.||+|+||.||+|.+. +++.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999886 8999999998653221111111 135666666664432
Q ss_pred cceeeeEecCCCCCCCCeEEEEEecCCc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeC
Q 007050 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLH-QVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILAN 160 (620)
Q Consensus 84 Iv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~-~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~ 160 (620)
+.+.+.. ...++||||+++ .+. ..+.... . ...++.++.+++.++.++|. .+|+||||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333332 235899999996 211 1121111 1 16778899999999999999 9999999999999999
Q ss_pred CCCcEEEcccCcccccc
Q 007050 161 ANCKLKICDFGLARVAF 177 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~ 177 (620)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.2e-16 Score=168.58 Aligned_cols=257 Identities=25% Similarity=0.249 Sum_probs=200.9
Q ss_pred CCeEEEEEeee--cCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGK--GSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~--G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~ 97 (620)
.++.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..+.......+-++|+.-.+.++ |+|.++.+..+ +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 35667889999 99999999988 889999999986655554445555567887777774 99999866666 6
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccC
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLR----ALKYIHTANVYHRDLKPKNILANAN-CKLKICDFG 171 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~-lse~~~~~i~~QIl~----aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFG 171 (620)
+.+.+|+-+|+|+.+|..+...... +++..++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 6678999999999988888876544 889999999999999 9999999999999999999999999 889999999
Q ss_pred ccccccCCCCccccc--ccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC--ChhHHHHHhhhcc
Q 007050 172 LARVAFNDTPTTIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLMTDLL 247 (620)
Q Consensus 172 lA~~~~~~~~~~~~~--~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~--~~~~~l~~i~~~l 247 (620)
+............+. ...-|..-|++||+..+ -++...||++||.++.+-.++..++... +.+.++..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 998765444222111 12245667999999875 6889999999999999999988776554 3222221110
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+.+...+..+...+..|+..||..|++++.+++|+++...
T Consensus 343 ------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0112233456667779999999999999999999999998743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-14 Score=146.54 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=103.4
Q ss_pred EEee-ecCceEEEEEEECCCCcEEEEEEecCcc------C-----ChHHHHHHHHHHHHHHhcCCCCc--ceeeeEecCC
Q 007050 29 EVIG-KGSYGVVCSAIDTHTGEKVAIKKIHDIF------E-----HISDAARILREIKLLRLLRHPDI--VEIKHIMLPP 94 (620)
Q Consensus 29 ~~LG-~G~~G~V~~a~d~~tg~~vAIK~i~~~~------~-----~~~~~~~i~rEi~iL~~L~HpnI--v~l~~v~~~~ 94 (620)
..|| .|+.|+||.+.. .+..+++|.+.... . ......++.+|+.++..|.|++| +..+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 788888888855 37889999874310 0 11234567899999999998775 5566553221
Q ss_pred CCCCCCeEEEEEecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 95 SRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~g--dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111223599999995 88888765 4566543 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 007050 173 ARV 175 (620)
Q Consensus 173 A~~ 175 (620)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=131.87 Aligned_cols=131 Identities=24% Similarity=0.228 Sum_probs=106.6
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCeEEE
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lyl 104 (620)
+++.||.|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.++| .++.+++... ...+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEE
Confidence 46789999999999998754 7899999865422 4567889999999976 5888887766 23356899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---NVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+|||+.| .+..+ +......++.+++.+|.+||.. +++|+||+|.||+++.++.++++|||++..
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34332 5566677899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-13 Score=150.30 Aligned_cols=184 Identities=23% Similarity=0.352 Sum_probs=138.4
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
|.+ +..+-++.+..-.|..+.++..|.|.+++.... .....+.+-++.|+.|+||||+++++.+ +....+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 555 444445555333566778899999998875422 4455677889999999999999999987 56678999
Q ss_pred EEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc
Q 007050 105 VFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH-TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (620)
Q Consensus 105 V~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~ 183 (620)
|+|.+. .|..++++ ++...+...++||+.||.||| .++++|++|.-+.|+|+..|..||++|.++.........
T Consensus 87 vTErV~-Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~- 161 (690)
T KOG1243|consen 87 VTERVR-PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP- 161 (690)
T ss_pred Eeeccc-cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-
Confidence 999887 34455554 447888889999999999997 788999999999999999999999999998764433210
Q ss_pred cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC
Q 007050 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (620)
Q Consensus 184 ~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG 227 (620)
.....---.|..|+.+.. .. -..|.|-|||++++++.|
T Consensus 162 --~~~~~~~~s~~~P~~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 --AKSLYLIESFDDPEEIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cccchhhhcccChhhcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 111122223677876654 22 358999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-14 Score=165.01 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=193.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+.+.+.+.+-+|+++.++.+.-..+|...++|+...... ...+...+.++-.++-...+|-+++..--+ .-..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 3456788899999999999998888887777776543211 111233334444444445566666543332 2234
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.++||++|+. ++|...+.+-+..+++-...++..+..++++||+..+.|||++|.|+|+..++..++.|||......--
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 5899999998 599999988888888889999999999999999999999999999999999999999999844322110
Q ss_pred CCc----------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCC
Q 007050 180 TPT----------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (620)
Q Consensus 180 ~~~----------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF 231 (620)
... ...-...++|+.|.+||...+ ...+..+|+|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 000 001123578999999999887 67888999999999999999999999
Q ss_pred CCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHH--
Q 007050 232 PGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-- 309 (620)
Q Consensus 232 ~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-- 309 (620)
...........|.. ...++..-....+..+++++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~-----------------------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN-----------------------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCcchhhhhhcccc-----------------------------CCCCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence 77665443322211 11122222234678899999999999999999887
Q ss_pred -HHHcCCcccCC
Q 007050 310 -EALADPYFKGL 320 (620)
Q Consensus 310 -elL~hp~f~~~ 320 (620)
+.-.|+||+..
T Consensus 1087 ~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDV 1098 (1205)
T ss_pred cccccCCccCCC
Confidence 88899999865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-13 Score=140.64 Aligned_cols=246 Identities=20% Similarity=0.231 Sum_probs=160.2
Q ss_pred EEEEEECCCCcEEEEEEecCccCChHHHHHHHHH--HHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC-ccHHH
Q 007050 39 VCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE--IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQ 115 (620)
Q Consensus 39 V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rE--i~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~ 115 (620)
||++.+...|..|+.-.+.....+.-..+.-.++ ..-|-++-|.|||++..+|.+...++...+.++.|||+ |+|.+
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~ 161 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ 161 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence 4566666666666554442111111111111112 23344567999999999987776667778999999999 79999
Q ss_pred HHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEcccCccc--cccCCCCcccccc
Q 007050 116 VIKA----NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWT 187 (620)
Q Consensus 116 ~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~DFGlA~--~~~~~~~~~~~~~ 187 (620)
+++. ...+......+|+-||+.||.|||+.. |+|+++..+-|++..+|-+|++----.. .......+. ...
T Consensus 162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~-Ek~ 240 (458)
T KOG1266|consen 162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA-EKS 240 (458)
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh-hhh
Confidence 8864 346889999999999999999999986 9999999999999999988876422111 100000000 001
Q ss_pred cccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHH
Q 007050 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARR 266 (620)
Q Consensus 188 ~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p-F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~ 266 (620)
-..+-+.|.+||.-.. .+.+-++|||++|+...+|..+..- =.+.+.... .+.+...
T Consensus 241 ~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~------------ee~ia~~-------- 298 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEV------------EENIANV-------- 298 (458)
T ss_pred ccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeeh------------hhhhhhh--------
Confidence 1245678999996433 4567789999999999999877632 111111000 0001100
Q ss_pred HHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 267 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.+..-.+.-+++|.+||+-.|+.||++.++|.||.+-.+..
T Consensus 299 ---------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 299 ---------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred ---------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 01111234467999999999999999999999998765543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.6e-13 Score=148.09 Aligned_cols=141 Identities=18% Similarity=0.277 Sum_probs=95.8
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh--------------------------------HHHHHHHH
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--------------------------------SDAARILR 71 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~--------------------------------~~~~~i~r 71 (620)
.|.. +.||.|++|.||+|+.+.+|+.||||++....... .....+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3444 78999999999999998889999999996431100 01122233
Q ss_pred ------HHHHHHhc----CCCCcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHH--HHhCC----CCCHHHHHHHHHH
Q 007050 72 ------EIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV--IKAND----DLTREHYQFFLYQ 134 (620)
Q Consensus 72 ------Ei~iL~~L----~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~--i~~~~----~lse~~~~~i~~Q 134 (620)
|...+.++ .+.+.+.+-.+|.. -...-+||||||.| .+.++ +.+.+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 33333333 24444444444421 23446899999996 77653 33333 3555556666666
Q ss_pred HHHHHHHHHhCCcEeecCCCCceEeCCCC----cEEEcccCccccc
Q 007050 135 LLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVA 176 (620)
Q Consensus 135 Il~aL~yLHs~gIvHrDLKP~NILl~~~~----~lKL~DFGlA~~~ 176 (620)
|+ ..|++|+|++|.||+++.+| +++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 65 48999999999999999988 9999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=1e-11 Score=136.56 Aligned_cols=140 Identities=21% Similarity=0.257 Sum_probs=93.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--H------------------------------------HHHHH
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--D------------------------------------AARIL 70 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~--~------------------------------------~~~i~ 70 (620)
+.||.|++|.||+|+. .+|+.||||+.+......- + .-.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 4799999999854211000 0 00133
Q ss_pred HHHHHHHhc----CCCCcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 007050 71 REIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLR-ALKYIH 143 (620)
Q Consensus 71 rEi~iL~~L----~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~QIl~-aL~yLH 143 (620)
+|...+..+ +|.+-+.+-.++.. ....-+|||||++| +|.++.... ..+. ...+...++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 444444444 34444444444422 12345899999996 676665421 1222 2345555555 467899
Q ss_pred hCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 144 TANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 144 s~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..|++|+|++|.||+++.+++++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.8e-12 Score=118.06 Aligned_cols=126 Identities=18% Similarity=0.164 Sum_probs=92.3
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc-eeeeEecCCCCCCCCeEEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV-EIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv-~l~~v~~~~~~~~~~~lylV~ 106 (620)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEE
Confidence 468899999999999764 78899998764321 122356799999988655543 444432 1 1237999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeecCCCCceEeCCCCcEEEcccCccc
Q 007050 107 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV-----YHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gI-----vHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
|+++| ++.+. .. ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 01 123457899999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.8e-12 Score=139.17 Aligned_cols=249 Identities=21% Similarity=0.217 Sum_probs=179.3
Q ss_pred CCeEEEEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~-~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+|.++..||.|.|+.|+.+... .++..|++|.+.+......+...-+.|+.+...+ .|.++++.+..| ....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~r 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQLR 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----cccc
Confidence 45678999999999999987654 6788999998877655544444455777777666 599999988777 3445
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCccccccC
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~~~~~ 178 (620)
..|+=-|||++ ++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.......
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 67899999984 444333333458888999999999999999999999999999999999886 7789999999864211
Q ss_pred CCCcccccccccCCcccc-CcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~-APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
. .......-++. ..|++... ..+..+.|++|||.-+.+.+++.++-...+.... |
T Consensus 420 ~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i-------------- 475 (524)
T KOG0601|consen 420 S------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---I-------------- 475 (524)
T ss_pred e------cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccccee---e--------------
Confidence 1 11122333444 35555442 5788999999999999999998865332221100 0
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
+.+ .....++....+..+.+.|+..|+..|+++.++..|.=|.
T Consensus 476 --~~~----------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 --RSG----------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --ecc----------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 000 0011233446788899999999999999999998876554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.7e-11 Score=118.51 Aligned_cols=139 Identities=21% Similarity=0.260 Sum_probs=99.5
Q ss_pred EEEeeecCceEEEEEEECC------CCcEEEEEEecCc---cC-----------------ChHHHHHH----HHHHHHHH
Q 007050 28 QEVIGKGSYGVVCSAIDTH------TGEKVAIKKIHDI---FE-----------------HISDAARI----LREIKLLR 77 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~------tg~~vAIK~i~~~---~~-----------------~~~~~~~i----~rEi~iL~ 77 (620)
...||.|.-+.||.|.... .+..+|||+.+-. +. +......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 3579999987421 00 01112222 37999999
Q ss_pred hcCC--CCcceeeeEecCCCCCCCCeEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCC
Q 007050 78 LLRH--PDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLK 153 (620)
Q Consensus 78 ~L~H--pnIv~l~~v~~~~~~~~~~~lylV~E~~~gd-L~~~i~~~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLK 153 (620)
++.. -++.+++.+. .-+|||||++++ +..-......++++....++.+++.+|..| |..||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 8853 4556665542 248999999863 322112223466677788889999999998 89999999999
Q ss_pred CCceEeCCCCcEEEcccCccccc
Q 007050 154 PKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 154 P~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-09 Score=117.51 Aligned_cols=214 Identities=17% Similarity=0.215 Sum_probs=157.5
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC--ccH
Q 007050 36 YGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDL 113 (620)
Q Consensus 36 ~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~--gdL 113 (620)
-.+.|++....+|..|++|.++... .........-+++++++.|+|||.+.++|.... .+...+++|++|.. ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchH
Confidence 3578999999999999999994211 111112233467889999999999999998544 35567999999998 478
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 114 HQVIKA---------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 114 ~~~i~~---------------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.++.-. +...+|+.+|.|+.||..||.+||+.|+.-+-|.|.+||++.+.+++|...|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 876632 23578899999999999999999999999999999999999999999999888766544
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChhHH-HHHhhhccCCCChhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQ-LDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p-F~g~~~~~~-l~~i~~~lg~p~~e~i~ 256 (620)
+.. |.+.+ -.+-|.=.||.++..|.||..- +........ +.
T Consensus 446 d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------------- 488 (655)
T KOG3741|consen 446 DPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------------- 488 (655)
T ss_pred CCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------------
Confidence 331 11211 2357999999999999998632 111111000 11
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
...+.++.+++++|.-+...++++ -++.++|.|
T Consensus 489 ------------------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 489 ------------------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 112356788899999999988887 789999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-09 Score=107.42 Aligned_cols=142 Identities=17% Similarity=0.245 Sum_probs=100.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.|+.|..+.||++... +|+.+++|........ .....+.+|..+++.+.+ .++.+++.+.... ......|+||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence 67899999999999764 3688999987643211 134467789999999975 3456666654211 1123568999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 007050 107 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT----------------------------------------- 144 (620)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs----------------------------------------- 144 (620)
|+++| ++.+.+.. ..++++....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99996 45443321 346666667777777777777773
Q ss_pred ---------------CCcEeecCCCCceEeCC--CCcEEEcccCcccc
Q 007050 145 ---------------ANVYHRDLKPKNILANA--NCKLKICDFGLARV 175 (620)
Q Consensus 145 ---------------~gIvHrDLKP~NILl~~--~~~lKL~DFGlA~~ 175 (620)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.3e-09 Score=99.54 Aligned_cols=143 Identities=22% Similarity=0.291 Sum_probs=102.6
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEe-cCccCChH-----HHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHIS-----DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i-~~~~~~~~-----~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+..|-+|+-+.|+++. ..|+.++||.= .+...++. ...+..+|+.+|.++.--.|.--.-++.+ ..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TY 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cC
Confidence 57889999999999994 56888888853 22223322 34567889999988753332221112211 12
Q ss_pred eEEEEEecCCc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEcccCcc
Q 007050 101 DIYVVFELMES--DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLA 173 (620)
Q Consensus 101 ~lylV~E~~~g--dL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DFGlA 173 (620)
.-.|+|||++| .+.+++.... ....+-...++.+|-..|.-||.++|+|+||..+||++.+++. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 8888886532 2333344788999999999999999999999999999977653 589999998
Q ss_pred ccc
Q 007050 174 RVA 176 (620)
Q Consensus 174 ~~~ 176 (620)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.5e-09 Score=99.32 Aligned_cols=130 Identities=22% Similarity=0.320 Sum_probs=93.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEE-ecCccCChH-----HHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCC
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKK-IHDIFEHIS-----DAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~-i~~~~~~~~-----~~~~i~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~ 100 (620)
..+++|+-+.++.+.. -|..+++|. +.+...+.. ...+..+|..+|+.++- -+..-++++. ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CC
Confidence 4578899999998844 344566664 333333332 23456789999988853 3344444543 12
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...|+|||.+| .|.+.+... ...++..+=.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 35799999998 566677654 145667777778889999999999999999998886 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.3e-08 Score=102.93 Aligned_cols=143 Identities=13% Similarity=0.077 Sum_probs=95.4
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh--H-------HHHHHHHHHHHHHhcCCCCc--ceeeeEecCCCCCC
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--S-------DAARILREIKLLRLLRHPDI--VEIKHIMLPPSRRD 98 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~--~-------~~~~i~rEi~iL~~L~HpnI--v~l~~v~~~~~~~~ 98 (620)
.+-......|.++. ..|+.|.||......... . -...+.+|...+..|..-+| ..++.+........
T Consensus 29 ~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333334455553 357789999764321110 0 01136688888877743333 22333321111111
Q ss_pred CCeEEEEEecCCc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-------CCcEEE
Q 007050 99 FKDIYVVFELMES--DLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------NCKLKI 167 (620)
Q Consensus 99 ~~~lylV~E~~~g--dL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------~~~lKL 167 (620)
...-+||||++++ +|.+++.. ....+......++.+|...+.-||..||+|+||++.|||++. +..+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 3457899999996 78888864 345667778899999999999999999999999999999975 467999
Q ss_pred cccCccc
Q 007050 168 CDFGLAR 174 (620)
Q Consensus 168 ~DFGlA~ 174 (620)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6e-10 Score=123.74 Aligned_cols=151 Identities=25% Similarity=0.358 Sum_probs=111.1
Q ss_pred HHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccccc--------ccCCccccCcccccccCCC
Q 007050 137 RALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--------YVATRWYRAPELCGSFFSK 207 (620)
Q Consensus 137 ~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~--------~~gt~~Y~APEvl~~~~~~ 207 (620)
.||.|+|. .++||++|.|++|.++.++.+||+.|+.+....+... ..... ......|.|||++.+ ..
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc--cc
Confidence 89999995 6899999999999999999999999999876544222 11111 134557999999987 67
Q ss_pred CCcccchHhHHHHHHHHH-hCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCC
Q 007050 208 YTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA 286 (620)
Q Consensus 208 y~~~~DIWSLG~IlyeLl-tG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (620)
.+.++|++||||++|.+. .|+..|.+.+.......-... .. ......-.++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---------------~~-------------~~~~~~s~~~ 237 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---------------LN-------------AGAFGYSNNL 237 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---------------cc-------------cccccccccC
Confidence 889999999999999998 677777554321111000000 00 0000111467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 287 DPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 287 s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
++++++=|.++|..|+..||++.+++..|||.+
T Consensus 238 p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 238 PSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred cHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 889999999999999999999999999999975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.7e-08 Score=97.56 Aligned_cols=129 Identities=22% Similarity=0.310 Sum_probs=92.7
Q ss_pred CCCcEEEEEEecCccCC-----hHHHHHHHHHHHHHHhcCCC--CcceeeeEecCCCCCCCCeEEEEEecCCc--cHHHH
Q 007050 46 HTGEKVAIKKIHDIFEH-----ISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQV 116 (620)
Q Consensus 46 ~tg~~vAIK~i~~~~~~-----~~~~~~i~rEi~iL~~L~Hp--nIv~l~~v~~~~~~~~~~~lylV~E~~~g--dL~~~ 116 (620)
..++.+-+|........ .....+..+|...+..|..- .+.+.+.+..... ......++|+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHH
Confidence 34556666654322111 12345677888887777432 2333444332221 112456899999996 79999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cEEEcccCcccc
Q 007050 117 IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARV 175 (620)
Q Consensus 117 i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~lKL~DFGlA~~ 175 (620)
+.....++......++.++...+.-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 98755577888899999999999999999999999999999999987 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.7e-08 Score=96.03 Aligned_cols=126 Identities=29% Similarity=0.336 Sum_probs=81.6
Q ss_pred EEEEEEECCCCcEEEEEEecCc----------------cC------Ch--HHHHHHHHHHHHHHhcCCC--CcceeeeEe
Q 007050 38 VVCSAIDTHTGEKVAIKKIHDI----------------FE------HI--SDAARILREIKLLRLLRHP--DIVEIKHIM 91 (620)
Q Consensus 38 ~V~~a~d~~tg~~vAIK~i~~~----------------~~------~~--~~~~~i~rEi~iL~~L~Hp--nIv~l~~v~ 91 (620)
.||.|.. ..|..+|+|+.+.. +. .. .......+|...|..+..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3788876 56779999987421 00 00 0123466899999999754 566666543
Q ss_pred cCCCCCCCCeEEEEEecCC--c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeecCCCCceEeCCCCcEEE
Q 007050 92 LPPSRRDFKDIYVVFELME--S-DLHQVIKANDDLTREHYQFFLYQLLRALKY-IHTANVYHRDLKPKNILANANCKLKI 167 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~--g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~y-LHs~gIvHrDLKP~NILl~~~~~lKL 167 (620)
.-+|||||++ | .+.. +... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|
T Consensus 80 ---------~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred ---------CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence 1279999999 6 3333 3221 12345667788888885555 689999999999999999988 8999
Q ss_pred cccCccccc
Q 007050 168 CDFGLARVA 176 (620)
Q Consensus 168 ~DFGlA~~~ 176 (620)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.3e-07 Score=89.57 Aligned_cols=141 Identities=17% Similarity=0.159 Sum_probs=100.6
Q ss_pred eecCceEEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCeEEEE
Q 007050 32 GKGSYGVVCSAIDTHTGEKVAIKKIHDIF----EHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 32 G~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV 105 (620)
|+|+.|.|+.... .|+.+-+|.-.+-. ....-...+.+|+..|+.|..-+ +.++. ++-.........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888888743 34478888764211 11223456889999998885332 33333 1111111123446899
Q ss_pred EecCCc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc--EEEcccCcccc
Q 007050 106 FELMES--DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFGLARV 175 (620)
Q Consensus 106 ~E~~~g--dL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--lKL~DFGlA~~ 175 (620)
+|-++| +|.+++... .+.++.....++.+|...|.-||..|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 999988653 34577778899999999999999999999999999999987777 99999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.3e-07 Score=95.42 Aligned_cols=136 Identities=27% Similarity=0.283 Sum_probs=100.9
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEec-------Ccc---------CChH----HHHHHHHHHHHHHhcCCC--
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DIF---------EHIS----DAARILREIKLLRLLRHP-- 82 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~-------~~~---------~~~~----~~~~i~rEi~iL~~L~Hp-- 82 (620)
+.+...||-|.-|.||.|.+. .|..+|||.=+ +.. .+.+ ......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999875 78899999532 000 1111 123456899999998654
Q ss_pred CcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC
Q 007050 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (620)
Q Consensus 83 nIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (620)
.+.+.++. +.-.+|||+.+| .|... +++.+....++..|+.-+.-+-..||||+|+.+=|||++.
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 55554443 345899999998 44332 2346666777888888888888999999999999999999
Q ss_pred CCcEEEcccCcccc
Q 007050 162 NCKLKICDFGLARV 175 (620)
Q Consensus 162 ~~~lKL~DFGlA~~ 175 (620)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1e-06 Score=93.17 Aligned_cols=263 Identities=16% Similarity=0.156 Sum_probs=159.1
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeE---ecCCCCCCCCe
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI---MLPPSRRDFKD 101 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v---~~~~~~~~~~~ 101 (620)
....+.||+|+-+.+|-.-. -...+.|++...-- ....+.. ..+...-.||.+-.-+.+ .+.+. +...-
T Consensus 13 i~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Ppp--a~~aqk~--a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPP--AAQAQKV--AELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred cCCCccccCCccceeeecch---hhchhheeecCCCc--hHHHHHH--HHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 44567899999999986522 12335577765321 1111111 112222346654331110 01121 22233
Q ss_pred EEEEEecCCc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 102 IYVVFELMES--DLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 102 lylV~E~~~g--dL~~~i~~------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
+-++|..+.| ..+.++.. ...+.+..+.+..+.|+.+.+-||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7889998885 55555532 224677888889999999999999999999999999999999999999985433
Q ss_pred ccccCCCCcccccccccCCccccCccccc-ccC--CCCCcccchHhHHHHHHHHHhC-CCCCCCCChhHHHHHhhhccCC
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~-~~~--~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
....+ .....-.+|...|.+||+-. +.+ -.-+...|.|.||+++++||.| +.||.|-- .+.+ -+.
T Consensus 165 qi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~------~~~~-ap~ 233 (637)
T COG4248 165 QINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP------LISD-APN 233 (637)
T ss_pred eeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc------ccCC-CCC
Confidence 22211 12233458999999999753 111 2345679999999999999997 89998732 1111 011
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccC--CCCCCCHHH
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD--PKDRPTAEE 310 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D--P~~Rpsa~e 310 (620)
|-+..|.. ..+..--+.-+...+.+..-.|.-+.+.+..|+.+|+..- +.-|||++-
T Consensus 234 p~E~~Ia~----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 234 PLETDIAH----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cchhhhhc----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11111111 0000000111233444444556678899999999999853 568999853
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=86.71 Aligned_cols=143 Identities=20% Similarity=0.263 Sum_probs=88.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HH------HHHHHHHHHHhcCC---CCcceeeeEe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AA------RILREIKLLRLLRH---PDIVEIKHIM 91 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~-~~------~i~rEi~iL~~L~H---pnIv~l~~v~ 91 (620)
.++|++++++-......|.+. ...|+.+++|........... .. ...+++..+..+.. -.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 367899999988888777766 456789999987643211111 01 11233343333322 2222222222
Q ss_pred cCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 92 LPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
.-....-....++||||++| .|.+.. .+++. +...|..+|.-||..|++|+|..|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 11111122345689999998 555442 13332 345677789999999999999999999999665 999999
Q ss_pred Ccccc
Q 007050 171 GLARV 175 (620)
Q Consensus 171 GlA~~ 175 (620)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5e-06 Score=97.57 Aligned_cols=205 Identities=17% Similarity=0.222 Sum_probs=141.4
Q ss_pred HHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 007050 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146 (620)
Q Consensus 68 ~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g 146 (620)
...-|+..+..+.|+|+++++.+-+..-... ..+.+..|+|.. ++...+..-+..+.+..+.+..+++.||.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3345666778889999999988765432111 133455677874 88888888888999999999999999999999997
Q ss_pred cEeecCCCC---ceEeCCCCcEEEc--ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHH
Q 007050 147 VYHRDLKPK---NILANANCKLKIC--DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (620)
Q Consensus 147 IvHrDLKP~---NILl~~~~~lKL~--DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il 221 (620)
..|.-|... +-..+.++.+.+. ||+..+........ .......-+.++|.............|+|.+|..+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 766666555 4445666777777 88887765432221 22334555778887765222233347999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCH-HHHHHHHHhccc
Q 007050 222 AEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADP-SALRLLERLLAF 300 (620)
Q Consensus 222 yeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~l~dLI~~mL~~ 300 (620)
..+..|..+-.-.. .. ....+..+. ...+++.+|+.-
T Consensus 383 ~~~~~~~~i~~~~~---------------------------~~---------------~~~l~~~~~~~~~d~~~~~~~~ 420 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---------------------------VP---------------VSLLDVLSTSELLDALPKCLDE 420 (1351)
T ss_pred hhhhhcCccccccc---------------------------ch---------------hhhhccccchhhhhhhhhhcch
Confidence 99988764321000 00 000111111 678899999999
Q ss_pred CCCCCCCHHHHHcCCcccC
Q 007050 301 DPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 301 DP~~Rpsa~elL~hp~f~~ 319 (620)
|+++|+++.++|.|+|.+-
T Consensus 421 ~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 421 DSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhccchhhhhhchhccc
Confidence 9999999999999999863
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.1e-05 Score=76.67 Aligned_cols=139 Identities=19% Similarity=0.224 Sum_probs=80.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC--CcceeeeEecCCCCCCCCeEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hp--nIv~l~~v~~~~~~~~~~~lylV 105 (620)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|... .+.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 48999987542 4556777899999888533 244555433111 223347999
Q ss_pred EecCCc-cHHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 007050 106 FELMES-DLHQ----------------VIK---AN----DDLTREH------YQFF---------------LYQLLR-AL 139 (620)
Q Consensus 106 ~E~~~g-dL~~----------------~i~---~~----~~lse~~------~~~i---------------~~QIl~-aL 139 (620)
|++++| .+.. .+. .. ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999986 4444 111 11 0111000 0000 011111 23
Q ss_pred HHHH-------hCCcEeecCCCCceEeC-CCCcEEEcccCccc
Q 007050 140 KYIH-------TANVYHRDLKPKNILAN-ANCKLKICDFGLAR 174 (620)
Q Consensus 140 ~yLH-------s~gIvHrDLKP~NILl~-~~~~lKL~DFGlA~ 174 (620)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 24599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=79.36 Aligned_cols=132 Identities=19% Similarity=0.214 Sum_probs=79.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV~ 106 (620)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+++.+. ++....++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence 57899999999984 25567888876422 2344688999998885332 45555554 3334568899
Q ss_pred ecCCcc--HHHHHH---------------------hC--CCCCHHH-HHHHHHHH----------HH-HHHHHH----hC
Q 007050 107 ELMESD--LHQVIK---------------------AN--DDLTREH-YQFFLYQL----------LR-ALKYIH----TA 145 (620)
Q Consensus 107 E~~~gd--L~~~i~---------------------~~--~~lse~~-~~~i~~QI----------l~-aL~yLH----s~ 145 (620)
|+++|. +...+. .. ....... ...+..+| .. ...+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 111110 00 0011000 01111111 11 111222 12
Q ss_pred CcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 146 NVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 146 gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.7e-07 Score=103.57 Aligned_cols=244 Identities=16% Similarity=0.109 Sum_probs=161.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~~l 102 (620)
-|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++ +.+.+...
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~ 309 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYL 309 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCccccc
Confidence 4556677899999999999887766555 6666532 22334789999999999 443333 23556778
Q ss_pred EEEEecCCcc--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 103 YVVFELMESD--LHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 103 ylV~E~~~gd--L~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+++++++.+. ....+ ...-.+.+-+...+.+.-+++|+++|+.-=+|+| ||+..+ +..|+.||+....+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999842 11111 0111234444555667777899999998778998 777665 57999999988765433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ......+|+.++|||+... +.+....|.|++|.--.+|.-|-+|-.. ....+..+-.-.+.|..+.
T Consensus 385 ~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~----- 451 (829)
T KOG0576|consen 385 M----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTD----- 451 (829)
T ss_pred c----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccch-----
Confidence 2 2355789999999999887 6899999999999877777777776533 1111111100000000000
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
+ ..|.... -.++...|+..-|..|+...+++.|.+|++.
T Consensus 452 --~------------------~aw~~~~--~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 452 --K------------------SAWSPVF--HRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred --h------------------hhcCccc--ccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0 0111111 1157788999999999999999999999865
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.6e-05 Score=77.30 Aligned_cols=137 Identities=20% Similarity=0.160 Sum_probs=92.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChH-----------------HHH-----HHHHHHHHHHhcC--CCCc
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS-----------------DAA-----RILREIKLLRLLR--HPDI 84 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~-----------------~~~-----~i~rEi~iL~~L~--HpnI 84 (620)
..|+.|.-+.||+|.. .++..+|+|+++.....-. +.. -..+|+.-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666777788999864 5688999999853211100 001 1236777777764 3344
Q ss_pred ceeeeEecCCCCCCCCeEEEEEecCCcc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCC
Q 007050 85 VEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANA 161 (620)
Q Consensus 85 v~l~~v~~~~~~~~~~~lylV~E~~~gd--L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~ 161 (620)
.+-+.+. .-.||||+++.+ -.-.++. -++..+++..+..++++.+.-|-. .++||+||..=|||+.
T Consensus 133 P~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFR---------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeec---------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 4444443 237999999843 1111111 134455788888999999998877 9999999999999999
Q ss_pred CCcEEEcccCcccccc
Q 007050 162 NCKLKICDFGLARVAF 177 (620)
Q Consensus 162 ~~~lKL~DFGlA~~~~ 177 (620)
++.+.|+|||-|....
T Consensus 202 ~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 DGEPYIIDVSQAVTID 217 (268)
T ss_pred CCeEEEEECccccccC
Confidence 8899999999887543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.1e-05 Score=87.84 Aligned_cols=150 Identities=21% Similarity=0.299 Sum_probs=93.6
Q ss_pred CccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------------------------H
Q 007050 12 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---------------------------S 64 (620)
Q Consensus 12 ~~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---------------------------~ 64 (620)
..+.|.+|.. +.|+.++-|.||+|+-+ +|+.||||+........ .
T Consensus 121 iee~F~eF~~-------~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~ 192 (517)
T COG0661 121 IEELFSEFEP-------EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLV 192 (517)
T ss_pred HHHHHHHcCC-------CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChH
Confidence 3455666652 78999999999999865 49999999875321100 0
Q ss_pred -H----HH------HHHHHHHHHHhc----CCCCcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHH--HHhCCCCCHH
Q 007050 65 -D----AA------RILREIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV--IKANDDLTRE 126 (620)
Q Consensus 65 -~----~~------~i~rEi~iL~~L----~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~--i~~~~~lse~ 126 (620)
. .+ .+.+|...+..+ ++..-+++=.+|..- ...-.|+|||++| .+.+. ++. ..++.+
T Consensus 193 ~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k 267 (517)
T COG0661 193 EVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKS-AGIDRK 267 (517)
T ss_pred HHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHh-cCCCHH
Confidence 0 01 123444444443 333334444555321 2335899999998 55554 444 335544
Q ss_pred HHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 127 ~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
.+...+.++. +..+-..|++|.|..|.||+++.+|++-+.|||.....
T Consensus 268 ~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 268 ELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 4333222222 12233379999999999999999999999999998654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.2e-05 Score=74.38 Aligned_cols=132 Identities=26% Similarity=0.328 Sum_probs=91.4
Q ss_pred CCeEEEEEeeecCc-eEEEEEEECCCCcEEEEEEecC---c--------cC-Ch-------HHHHHHHHHHHHHHhc---
Q 007050 23 SRYKIQEVIGKGSY-GVVCSAIDTHTGEKVAIKKIHD---I--------FE-HI-------SDAARILREIKLLRLL--- 79 (620)
Q Consensus 23 ~rY~i~~~LG~G~~-G~V~~a~d~~tg~~vAIK~i~~---~--------~~-~~-------~~~~~i~rEi~iL~~L--- 79 (620)
..++.++.||.|.- |.||++. -.|+.||+|.+.. . +. .. .....+..|....-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 9999995 4688999999321 0 00 00 1223466777766555
Q ss_pred CCCCc--ceeeeEecCCC-------------CCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007050 80 RHPDI--VEIKHIMLPPS-------------RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144 (620)
Q Consensus 80 ~HpnI--v~l~~v~~~~~-------------~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs 144 (620)
.+.++ |++++++.-.. ........||.||....- .++.++ +.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHH
Confidence 45566 88888774331 011223468888877532 233333 5678888889999
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.||+-+|+++.|.. + =||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999985 3 389999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=73.85 Aligned_cols=71 Identities=15% Similarity=0.091 Sum_probs=45.9
Q ss_pred EEeeecCc-eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~-G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.|..|.. ..||++.. .+..+++|...... ...+.+|+.+++.+. +--+.+++.... ....-++||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEE
Confidence 34556655 78899854 34678888765421 334667999988884 334555666542 223468999
Q ss_pred ecCCc
Q 007050 107 ELMES 111 (620)
Q Consensus 107 E~~~g 111 (620)
|+++|
T Consensus 72 e~i~G 76 (244)
T cd05150 72 SAVPG 76 (244)
T ss_pred EeeCC
Confidence 99987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=6.4e-06 Score=98.36 Aligned_cols=155 Identities=19% Similarity=0.146 Sum_probs=115.3
Q ss_pred HHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHH
Q 007050 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIH 143 (620)
Q Consensus 69 i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~----~lse~~~~~i~~QIl~aL~yLH 143 (620)
.+.|...++...|+++.....-..+ .+....|.+++||. |+++++|.++- ++.+.-+.....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3445556667789998876655433 33456799999999 79999986532 3333333333344477777777
Q ss_pred hCC-----cEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHH
Q 007050 144 TAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218 (620)
Q Consensus 144 s~g-----IvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG 218 (620)
+.. .+|++||+-|.+|..+-.+|++++|+.+... +...+....++++.|++|++... -.++.++|||+.|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn---p~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN---PVLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccC---chHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 642 6999999999999999999999999998432 22233455678899999998876 5788889999999
Q ss_pred HHHHHHHhCCCCC
Q 007050 219 CIFAEVLTGKPLF 231 (620)
Q Consensus 219 ~IlyeLltG~~pF 231 (620)
|-+|++..|.++|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999999988887
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00028 Score=84.07 Aligned_cols=83 Identities=17% Similarity=0.222 Sum_probs=55.3
Q ss_pred EEEEeeecCceEEEEEEECCCC--cEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCc--ceeeeEecCCCCCCCCe
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTG--EKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDI--VEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg--~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnI--v~l~~v~~~~~~~~~~~ 101 (620)
-++.|+.|.++.+|+......+ ..+++|+..... .......+.+|+.+|+.|. |.++ .+++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3678899999999998765432 467888764321 1123446779999999995 6654 6666655322 12245
Q ss_pred EEEEEecCCcc
Q 007050 102 IYVVFELMESD 112 (620)
Q Consensus 102 lylV~E~~~gd 112 (620)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 78999999873
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0002 Score=68.50 Aligned_cols=130 Identities=20% Similarity=0.281 Sum_probs=90.1
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEE
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (620)
-++.+.|++|..|.||++.. .|..+|+|+-.. ++....+..|.++|..+.--++..=+-.| +..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhhh
Confidence 45677899999999999965 466899997643 24455677899999998866654422222 22356
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC-CCceEeCCCCcEEEcccCcccc
Q 007050 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLK-PKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK-P~NILl~~~~~lKL~DFGlA~~ 175 (620)
.|||+.| .|.+..... +.++ +..+++.---|-..||-|..|. |..+++-.++.+.|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6999998 666654321 3333 3445555555778899999985 5655565666899999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00072 Score=66.61 Aligned_cols=128 Identities=20% Similarity=0.263 Sum_probs=89.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc--------------CChHHHHHHHHHHHHHHhcC------CCCcceee
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--------------EHISDAARILREIKLLRLLR------HPDIVEIK 88 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~--------------~~~~~~~~i~rEi~iL~~L~------HpnIv~l~ 88 (620)
..||+|+.-.||.- . ......||+..... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999888865 3 33455789886543 11122455667777666665 78899999
Q ss_pred eEecCCCCCCCCeEEEEEecCC---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC
Q 007050 89 HIMLPPSRRDFKDIYVVFELME---S----DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~---g----dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (620)
++. ++...+-+|+|.+. | +|.++++.. .+++ .+ ...+-.-..||-..+|+.+||+|.||++..
T Consensus 84 G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 998 55566889999864 2 688888554 4766 33 333445556788899999999999999854
Q ss_pred C---C-cEEEcc
Q 007050 162 N---C-KLKICD 169 (620)
Q Consensus 162 ~---~-~lKL~D 169 (620)
+ . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 3 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00055 Score=76.55 Aligned_cols=141 Identities=23% Similarity=0.278 Sum_probs=87.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--H---------------------------HHH------HHHH
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--D---------------------------AAR------ILRE 72 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~--~---------------------------~~~------i~rE 72 (620)
-+.||.-+.|.|++|+-+. |+.||||+-+....+.. + .+. +.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4689999999999998765 99999998653322110 0 011 2333
Q ss_pred HHHH----HhcCCCC---cceeeeEecCCCCCCCCeEEEEEecCCc----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 007050 73 IKLL----RLLRHPD---IVEIKHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALKY 141 (620)
Q Consensus 73 i~iL----~~L~Hpn---Iv~l~~v~~~~~~~~~~~lylV~E~~~g----dL~~~i~~~~~lse~~~~~i~~QIl~aL~y 141 (620)
.+-. +.+.|-+ -|.+=.+|..- ...-.|+||||+| || +.|.+.+ ++...+..-+.+... .-
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~~l~~~~~--~q 316 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILNKLVEAYL--EQ 316 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHHHHHHHHH--HH
Confidence 3332 2334555 12233344221 1235899999996 55 4555544 666544433333322 22
Q ss_pred HHhCCcEeecCCCCceEeCC----CCcEEEcccCcccccc
Q 007050 142 IHTANVYHRDLKPKNILANA----NCKLKICDFGLARVAF 177 (620)
Q Consensus 142 LHs~gIvHrDLKP~NILl~~----~~~lKL~DFGlA~~~~ 177 (620)
|=..|++|+|=.|.||++.. ++.+.|-|||+.....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 33467999999999999984 6789999999987643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00045 Score=69.59 Aligned_cols=31 Identities=32% Similarity=0.486 Sum_probs=26.1
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
..++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0015 Score=65.40 Aligned_cols=72 Identities=11% Similarity=0.189 Sum_probs=45.0
Q ss_pred EEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCCCCeEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~~lylV 105 (620)
++.|..|-...+|++.... .++.|++|+....... .....+|+.+++.+.... ..+++... .+ .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence 4678888889999986443 3578889976532111 112246888888885333 34444332 11 379
Q ss_pred EecCCc
Q 007050 106 FELMES 111 (620)
Q Consensus 106 ~E~~~g 111 (620)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00077 Score=73.81 Aligned_cols=177 Identities=24% Similarity=0.346 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 007050 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143 (620)
Q Consensus 64 ~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLH 143 (620)
.....++-...+++.+.|+|....+++-.. ......+|||+++.+|.+..+.+. +-.....
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~~~Sled~~~~~~-l~~~s~~-------------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHYTMSLEDILKTGN-LKDESLL-------------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecC----ccceEEEEehhhccchHHHHHhcc-cchhhhc--------------
Confidence 345567778899999999999998887532 223488999999999999987654 3221111
Q ss_pred hCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHH
Q 007050 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (620)
Q Consensus 144 s~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~Ilye 223 (620)
..++.| .|| ++++| .++ +. | |- ...+++||||+|.|+.+
T Consensus 85 ~~~~~~-----~~~-------~~~td-~~~-------------t~------~--~~-------~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHGVLH-----LNI-------IYITD-HFL-------------TK------Y--PS-------PIGPKSDVWSLGFIILE 123 (725)
T ss_pred ccccce-----ehh-------hhccc-ccc-------------cc------C--CC-------CCCcchhhhhHHHHHHH
Confidence 122222 222 23333 110 00 1 11 12258999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCC
Q 007050 224 VLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 303 (620)
Q Consensus 224 LltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~ 303 (620)
+..|..+|......+++..|......+.....-.. +... .-.++....+++.+|+...|.
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~---e~~~-----------------~~~~d~~~~~~~~~c~~~~~~ 183 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTAM---EHLI-----------------QLLADKKRLPLLKKCLWLEPI 183 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH---HHHH-----------------HHhhhHhHHHHhccCCccccc
Confidence 99999999888888888777665544433222111 0000 113456778999999999999
Q ss_pred CCCCHHHHHcCCcccCC
Q 007050 304 DRPTAEEALADPYFKGL 320 (620)
Q Consensus 304 ~Rpsa~elL~hp~f~~~ 320 (620)
.||...++.+++-|...
T Consensus 184 ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 184 IRPLPMELSKRCSFTEV 200 (725)
T ss_pred cccchhHHhcCccHHHH
Confidence 99999999999999765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0035 Score=65.82 Aligned_cols=153 Identities=15% Similarity=0.108 Sum_probs=84.9
Q ss_pred ccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEec
Q 007050 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIML 92 (620)
Q Consensus 15 ~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~ 92 (620)
++..|+. +....++.++.|....+|++.. ++..+++|+..... ....+..|+.+++.|.... +.+++...-
T Consensus 15 ~l~~y~~-~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 15 FLDGYDL-GELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHhcCC-CCceeccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 4445543 3455577888888889998853 24467888765421 1234556778887774322 333332110
Q ss_pred CC-CCCCCCeEEEEEecCCcc-H-----H------HHH----HhCCCCCH-------HHHHH----------------HH
Q 007050 93 PP-SRRDFKDIYVVFELMESD-L-----H------QVI----KANDDLTR-------EHYQF----------------FL 132 (620)
Q Consensus 93 ~~-~~~~~~~lylV~E~~~gd-L-----~------~~i----~~~~~lse-------~~~~~----------------i~ 132 (620)
.. .....+..++||||++|. + . ..+ .....++. ...+. ..
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 00 001234578999998761 1 1 111 00011100 00000 01
Q ss_pred HHHHHHHHHHHh-------CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 133 YQLLRALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 133 ~QIl~aL~yLHs-------~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
..+...+.++.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112334555532 579999999999999998877899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0011 Score=64.70 Aligned_cols=97 Identities=23% Similarity=0.236 Sum_probs=77.0
Q ss_pred HHHHHHHhcCC-CCcceeeeEecCCCCCCCCeEEEEEecCC-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 007050 71 REIKLLRLLRH-PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQV---IKANDDLTREHYQFFLYQLLRALKYIHT- 144 (620)
Q Consensus 71 rEi~iL~~L~H-pnIv~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~---i~~~~~lse~~~~~i~~QIl~aL~yLHs- 144 (620)
.|.-+|+.+.+ +++.++++.+ + -++|.||.. +++... +..--..+++....|+.+++..+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 58889999976 6999999987 1 257889988 444321 1111246889999999999999999997
Q ss_pred --CCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 145 --ANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 145 --~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..+.-.|++|+|+-+++++++|++|...+...
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0014 Score=66.95 Aligned_cols=132 Identities=16% Similarity=0.236 Sum_probs=74.4
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCeEEEEEec
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVFEL 108 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~E~ 108 (620)
.+..|-.+.+|+.. .+++.+++|......... .....+|..+++.+..-.+ .+++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 35667788899885 457788898764321111 0123578889988864333 2333322 1 2689999
Q ss_pred CCc-cHH--------------HHHHh---C----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcE
Q 007050 109 MES-DLH--------------QVIKA---N----DDLTR-EHYQFFLYQL---------LRALKYIHT--------ANVY 148 (620)
Q Consensus 109 ~~g-dL~--------------~~i~~---~----~~lse-~~~~~i~~QI---------l~aL~yLHs--------~gIv 148 (620)
++| .+. +.+.+ . .+++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 986 221 11111 0 11121 2222322222 111222211 2489
Q ss_pred eecCCCCceEeCCCCcEEEcccCcccc
Q 007050 149 HRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 149 HrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
|+|+.|.||+++.++ +.|+||+.|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999887 88999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0098 Score=64.77 Aligned_cols=77 Identities=21% Similarity=0.201 Sum_probs=52.4
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCC
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----E-HISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~-~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~ 99 (620)
.+.||.|.+..||++.+...++.++||.-.... . ..-...+...|...|+.+. ...+.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence 468999999999999986444689999753110 1 1124556777888888763 24566666652 2
Q ss_pred CeEEEEEecCCc
Q 007050 100 KDIYVVFELMES 111 (620)
Q Consensus 100 ~~lylV~E~~~g 111 (620)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 346899999874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0067 Score=63.87 Aligned_cols=30 Identities=30% Similarity=0.306 Sum_probs=26.0
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999977656899999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.014 Score=61.12 Aligned_cols=78 Identities=13% Similarity=0.103 Sum_probs=51.8
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC---CCcceeeeEecCCCCCCCCeE
Q 007050 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH---PDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H---pnIv~l~~v~~~~~~~~~~~l 102 (620)
.-.+.||.|..+.||...+. +..+++|..+. ......+.+|...|+.|.. ..+.++++++... ...+.-
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~ 88 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPD 88 (297)
T ss_pred heeeecCCccceeEEEEEcC--CCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCe
Confidence 34678999999999998532 23566776432 1123467789999988853 3567777665332 123457
Q ss_pred EEEEecCCc
Q 007050 103 YVVFELMES 111 (620)
Q Consensus 103 ylV~E~~~g 111 (620)
+||||+++|
T Consensus 89 ~LVmE~i~G 97 (297)
T PRK10593 89 VLLLERLRG 97 (297)
T ss_pred EEEEeccCC
Confidence 999999885
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.004 Score=64.79 Aligned_cols=139 Identities=16% Similarity=0.065 Sum_probs=79.9
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCC--CCCCCeEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPS--RRDFKDIY 103 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~~~~--~~~~~~ly 103 (620)
++.|..|....+|++.. .+..+++|+... .....+..|+.+++.|.+-. +.+++... .+. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceE
Confidence 56788888889998853 345788998753 12345667888888885332 33433211 000 01224568
Q ss_pred EEEecCCcc-H--------HHHHH-------hCCCCCH--------H----HHH--------HHHHHHHHHHHHHHh---
Q 007050 104 VVFELMESD-L--------HQVIK-------ANDDLTR--------E----HYQ--------FFLYQLLRALKYIHT--- 144 (620)
Q Consensus 104 lV~E~~~gd-L--------~~~i~-------~~~~lse--------~----~~~--------~i~~QIl~aL~yLHs--- 144 (620)
+|+++++|. + .++.+ ....+.. . ... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 999999862 1 11110 0000000 0 000 011112234444443
Q ss_pred ----CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ----ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ----~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999998778899999774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.014 Score=61.00 Aligned_cols=72 Identities=15% Similarity=0.105 Sum_probs=43.9
Q ss_pred EEEeeecCceEEEEEEECC------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCC
Q 007050 28 QEVIGKGSYGVVCSAIDTH------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFK 100 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~ 100 (620)
++.|..|-...||++.... .++.+++|+..... .......+|+.+++.+....+ .+++..+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~-- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIF-----PN-- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEe-----CC--
Confidence 4567777778899886433 35789999875432 122345678888888853333 3444433 11
Q ss_pred eEEEEEecCCc
Q 007050 101 DIYVVFELMES 111 (620)
Q Consensus 101 ~lylV~E~~~g 111 (620)
.+|+||++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 257888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.025 Score=59.67 Aligned_cols=147 Identities=17% Similarity=0.198 Sum_probs=83.2
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC--CcceeeeEecCCCCCCCCe
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hp--nIv~l~~v~~~~~~~~~~~ 101 (620)
.-.+++.+..|-...+|...+. ++.+++. ...............+|+.+|+.+.-- -+...+.++.... -..
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~ 99 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGT 99 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCC
Confidence 3445556645544556666544 7888888 322223345566677899988887532 2233333332211 246
Q ss_pred EEEEEecCCcc-------------------HHHHHHhC--------------CCCCHHHHHHHHHHH-------------
Q 007050 102 IYVVFELMESD-------------------LHQVIKAN--------------DDLTREHYQFFLYQL------------- 135 (620)
Q Consensus 102 lylV~E~~~gd-------------------L~~~i~~~--------------~~lse~~~~~i~~QI------------- 135 (620)
.|.||++++|. |.+++..- +.+...++..+..+.
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 79999999872 11111100 001112222222222
Q ss_pred -HHHHHHHHhC--------CcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 136 -LRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 136 -l~aL~yLHs~--------gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..-..+|+.. .++|+|+.+.||+++.++-+=+.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1223334332 4899999999999999988999999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0036 Score=65.30 Aligned_cols=136 Identities=19% Similarity=0.231 Sum_probs=93.6
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecC---ccCC---------------hHH--HHHHHHHHHHHHhcC-CC
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEH---------------ISD--AARILREIKLLRLLR-HP 82 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~---~~~~---------------~~~--~~~i~rEi~iL~~L~-Hp 82 (620)
-|.+++.||-|.-+-||.+.+ ..|...++|.-.. .|.+ .-. .-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 356788999999999999976 4577888884310 0000 001 122457888888885 32
Q ss_pred -CcceeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 83 -DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 83 -nIv~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
.+.+.+ +...-++|||++.| .|.++-.- .....+...|+.-+.-|...|+||+|..-=||++.
T Consensus 172 fpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPI---------DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcc---------cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 222322 33456999999996 66654321 12344556677777789999999999999999999
Q ss_pred CCCcEEEcccCcccc
Q 007050 161 ANCKLKICDFGLARV 175 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~ 175 (620)
+++.++++||--...
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999986543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.047 Score=57.05 Aligned_cols=29 Identities=24% Similarity=0.381 Sum_probs=25.4
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.043 Score=58.82 Aligned_cols=83 Identities=17% Similarity=0.101 Sum_probs=53.3
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCc-----cCChHHHHHHHHHHHHHHhcC--CC-CcceeeeEecCCCCCCCCe
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-----FEHISDAARILREIKLLRLLR--HP-DIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-----~~~~~~~~~i~rEi~iL~~L~--Hp-nIv~l~~v~~~~~~~~~~~ 101 (620)
.||.|....||++.+...++.|+||.-..- ....-...+..-|...|+... -| .+.+++.+ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 579999999999998644468999964311 122344556667888887763 34 45555543 3344
Q ss_pred EEEEEecCCc--cHHHHHHh
Q 007050 102 IYVVFELMES--DLHQVIKA 119 (620)
Q Consensus 102 lylV~E~~~g--dL~~~i~~ 119 (620)
..+|||+++. .|.+.+.+
T Consensus 75 ~~~vMEdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLIE 94 (370)
T ss_pred ceehHhhCccchHHHHHHHc
Confidence 5799999863 55555543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.036 Score=60.10 Aligned_cols=93 Identities=22% Similarity=0.208 Sum_probs=60.0
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecC----ccCChHHHHHHHHHHHHHHhcC--CC-CcceeeeEe
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD----IFEHISDAARILREIKLLRLLR--HP-DIVEIKHIM 91 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~----~~~~~~~~~~i~rEi~iL~~L~--Hp-nIv~l~~v~ 91 (620)
|...+.+. ++.||.|.-.-||++.+...++.|+||.-.. ..+..-...|..-|..+|+.+. .| .+.+++.+
T Consensus 26 ~~~~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 26 FEHAKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred CCCcccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 44444555 6789999999999998854467899996421 1122345667777888888763 34 45555543
Q ss_pred cCCCCCCCCeEEEEEecCCc--cHHHHHHh
Q 007050 92 LPPSRRDFKDIYVVFELMES--DLHQVIKA 119 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~g--dL~~~i~~ 119 (620)
+.....+|||+++. .|.+.+.+
T Consensus 104 ------D~e~~~~vMEdL~~~~ilR~~Li~ 127 (409)
T PRK12396 104 ------DSVMNCCVMEDLSDHTILRTALIN 127 (409)
T ss_pred ------CcHHhhHHHHhCcccHHHHHHHHc
Confidence 33456789999863 45555543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.057 Score=56.77 Aligned_cols=30 Identities=17% Similarity=0.128 Sum_probs=27.6
Q ss_pred CcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 146 NVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 146 gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
++||+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.056 Score=56.09 Aligned_cols=30 Identities=30% Similarity=0.529 Sum_probs=25.3
Q ss_pred CcEeecCCCCceEeCCCCc-EEEcccCcccc
Q 007050 146 NVYHRDLKPKNILANANCK-LKICDFGLARV 175 (620)
Q Consensus 146 gIvHrDLKP~NILl~~~~~-lKL~DFGlA~~ 175 (620)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.094 Score=56.18 Aligned_cols=139 Identities=16% Similarity=0.149 Sum_probs=76.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI-v~l~~v~~~~~~~ 97 (620)
+... +..|..|-...+|++.... .++.|++|+...... ....+ .+|+.+++.+..-++ .++++.+ .
T Consensus 37 ~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~idR-~~E~~~~~~l~~~gl~P~~~~~~-----~ 107 (344)
T PLN02236 37 EALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFDR-DDEIRTFECMSRHGQGPRLLGRF-----P 107 (344)
T ss_pred CcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeech-HHHHHHHHHHHHcCCCCceEEEE-----C
Confidence 3444 4466668888999986432 347899998754321 11122 468888888854333 2444443 1
Q ss_pred CCCeEEEEEecCCc-cHH-----------HHH---H---hCC------CCCHHHHHHHHHHHH-----------------
Q 007050 98 DFKDIYVVFELMES-DLH-----------QVI---K---AND------DLTREHYQFFLYQLL----------------- 136 (620)
Q Consensus 98 ~~~~lylV~E~~~g-dL~-----------~~i---~---~~~------~lse~~~~~i~~QIl----------------- 136 (620)
+ ..|.||+++ .|. .+. . ... ....+.+..++.++.
T Consensus 108 ~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 108 N----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred C----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 1 147788764 221 111 1 000 011223333332221
Q ss_pred HHHHHH----H----hCCcEeecCCCCceEeCC-CCcEEEcccCccc
Q 007050 137 RALKYI----H----TANVYHRDLKPKNILANA-NCKLKICDFGLAR 174 (620)
Q Consensus 137 ~aL~yL----H----s~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~ 174 (620)
..+..| . ...++|+||++.|||++. ++.+.|+||..|.
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111111 1 235899999999999986 4789999998774
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.088 Score=56.04 Aligned_cols=28 Identities=32% Similarity=0.444 Sum_probs=24.8
Q ss_pred cEeecCCCCceEeCC-CCcEEEcccCccc
Q 007050 147 VYHRDLKPKNILANA-NCKLKICDFGLAR 174 (620)
Q Consensus 147 IvHrDLKP~NILl~~-~~~lKL~DFGlA~ 174 (620)
++|.||.+.|||++. ++.++|+||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.076 Score=56.61 Aligned_cols=138 Identities=22% Similarity=0.305 Sum_probs=87.7
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCcc----------------------CChHHHHH--HHHHHHHHHhcCCC
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----------------------EHISDAAR--ILREIKLLRLLRHP 82 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----------------------~~~~~~~~--i~rEi~iL~~L~Hp 82 (620)
|-..|.-|.-+.||-|.. .+|..+|||+++... .+....-+ ...|+.-|.+|..-
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344677788888999864 678889999875321 01111111 23466667666544
Q ss_pred CcceeeeEecCCCCCCCCeEEEEEecCCcc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCceEe
Q 007050 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILA 159 (620)
Q Consensus 83 nIv~l~~v~~~~~~~~~~~lylV~E~~~gd--L~~~i~~~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILl 159 (620)
.|.-..-+++ ..-.|||++++.+ -.-.+ ..-.++...+..+-.|++.-+.-| |.+++||.||.-=|+|+
T Consensus 227 GIP~PePIlL-------k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILL-------KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceee-------ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 3322211221 2236999999842 11112 223577777777777777777766 56899999999999988
Q ss_pred CCCCcEEEcccCccc
Q 007050 160 NANCKLKICDFGLAR 174 (620)
Q Consensus 160 ~~~~~lKL~DFGlA~ 174 (620)
-. |.|.|+|-+-+.
T Consensus 299 hd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSV 312 (520)
T ss_pred EC-CEEEEEEccccc
Confidence 64 579999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.27 Score=53.70 Aligned_cols=76 Identities=16% Similarity=0.165 Sum_probs=49.6
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-----ChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCC
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-----HISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-----~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~ 98 (620)
-.+.||.|....||+..+. +..++||.-..-.. ..-...+...|...|+.+. ..++.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 3678999999999998763 45688997541111 0113445556777777664 246777777652
Q ss_pred CCeEEEEEecCCc
Q 007050 99 FKDIYVVFELMES 111 (620)
Q Consensus 99 ~~~lylV~E~~~g 111 (620)
..-++|||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 335789999975
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.52 Score=51.30 Aligned_cols=29 Identities=31% Similarity=0.326 Sum_probs=24.2
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
...+|.||-+.|||.+.+ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 457999999999997654 59999998763
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.16 Score=53.61 Aligned_cols=73 Identities=26% Similarity=0.334 Sum_probs=45.7
Q ss_pred EEEEecCCcc-----HHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcEeecCCCCceEeCCCC---------
Q 007050 103 YVVFELMESD-----LHQVIKAND-DLTREHYQFFLYQLLRALKYIH----TANVYHRDLKPKNILANANC--------- 163 (620)
Q Consensus 103 ylV~E~~~gd-----L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLH----s~gIvHrDLKP~NILl~~~~--------- 163 (620)
.+||.+..++ +.... +.| ..-.+-+++++.||+.-.--+- -.+.+|-||||+|||+-+..
T Consensus 247 IIIfPLA~~Sadkv~~~~~~-e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAA-ELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred EEEEehhhcchhhcCHHHHH-hcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 5888887642 22222 222 2234556778888876442232 24689999999999974321
Q ss_pred ---------cEEEcccCccccc
Q 007050 164 ---------KLKICDFGLARVA 176 (620)
Q Consensus 164 ---------~lKL~DFGlA~~~ 176 (620)
.++|.||.++++.
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 2678888888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.66 E-value=0.49 Score=47.33 Aligned_cols=100 Identities=20% Similarity=0.239 Sum_probs=63.6
Q ss_pred EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEEEEEecCCc--cHHHHHHhCCCCCHHH
Q 007050 50 KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREH 127 (620)
Q Consensus 50 ~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g--dL~~~i~~~~~lse~~ 127 (620)
...+|++....... ...-+.++..++.++. .|+++.. .+.-.+-++.|+|-. .+..
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~~------------ 144 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINFS------------ 144 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccchh------------
Confidence 34556665322221 2233467788877764 3666652 244567899999973 1111
Q ss_pred HHHHHHHHHHHHHHHHh--CCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 128 YQFFLYQLLRALKYIHT--ANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 128 ~~~i~~QIl~aL~yLHs--~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.++.-=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|-+..
T Consensus 145 --N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 --NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred --HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111112456667784 46999999999999999999999998753
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.26 Score=52.65 Aligned_cols=73 Identities=23% Similarity=0.365 Sum_probs=55.8
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+..+.|++|++-.+.|.- ++ .-..+++..|+++-+..+.-+..+ ..-||||...||||+ +|.|-|+||-++|.
T Consensus 297 e~~y~yl~~kdhgt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 445688999988765432 22 234567777888877776666654 579999999999999 99999999999984
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.43 E-value=0.96 Score=50.18 Aligned_cols=28 Identities=32% Similarity=0.672 Sum_probs=23.9
Q ss_pred CcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 146 NVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 146 gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.++|.|+-+.|||.+.++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 479999999999987654 9999998763
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.33 E-value=0.26 Score=50.99 Aligned_cols=43 Identities=33% Similarity=0.414 Sum_probs=32.7
Q ss_pred HHHHHHHHHHHHhC--CcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 132 LYQLLRALKYIHTA--NVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 132 ~~QIl~aL~yLHs~--gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
+..+-.++.-++.. -++|+|+.|+|+|.++.+.++|+||..|.
T Consensus 138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33344444444433 48999999999999999999999998875
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.80 E-value=0.82 Score=48.29 Aligned_cols=61 Identities=25% Similarity=0.248 Sum_probs=38.7
Q ss_pred eEEEEEecCCcc-----HHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHh----CCcEeecCCCCceEeCCC
Q 007050 101 DIYVVFELMESD-----LHQVIKANDDL-TREHYQFFLYQLLRALKYIHT----ANVYHRDLKPKNILANAN 162 (620)
Q Consensus 101 ~lylV~E~~~gd-----L~~~i~~~~~l-se~~~~~i~~QIl~aL~yLHs----~gIvHrDLKP~NILl~~~ 162 (620)
.-.|||.+..++ +.... +.+-. -.+-+++++.||+.-.-.+-. .+.+|-||||+|||+-+.
T Consensus 249 GnIIIfPLArcSadkv~~~~~~-e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAA-ELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred CcEEEEehhhcccccCCHHHHH-HcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 346888876632 22222 33322 345578888999876644432 368999999999997443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.67 E-value=0.17 Score=49.39 Aligned_cols=28 Identities=25% Similarity=0.394 Sum_probs=25.2
Q ss_pred cEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 147 VYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 147 IvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998887 99999998853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.25 E-value=2.9 Score=43.64 Aligned_cols=74 Identities=15% Similarity=0.098 Sum_probs=42.3
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCCe
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+-.+.|+.|....+|+.. .+++.+.+|+-.. .....+..|..-|+.|. --.+.+++.+... ...
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-----~~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-----DDD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE------SSC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-----cCC
Confidence 4456789999999999985 7788999998652 22234556777777773 2335556555422 123
Q ss_pred EEEEEecCC
Q 007050 102 IYVVFELME 110 (620)
Q Consensus 102 lylV~E~~~ 110 (620)
-||||||++
T Consensus 87 ~fLlle~l~ 95 (288)
T PF03881_consen 87 AFLLLEFLE 95 (288)
T ss_dssp CEEEEE---
T ss_pred ceEEEEeec
Confidence 499999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.09 E-value=0.17 Score=49.85 Aligned_cols=30 Identities=40% Similarity=0.594 Sum_probs=21.3
Q ss_pred CcEeecCCCCceEe-CCCCcEEEcccCcccc
Q 007050 146 NVYHRDLKPKNILA-NANCKLKICDFGLARV 175 (620)
Q Consensus 146 gIvHrDLKP~NILl-~~~~~lKL~DFGlA~~ 175 (620)
-++|+||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 620 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-82 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-82 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-79 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-78 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-78 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-78 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-78 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-78 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-78 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-78 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-78 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-78 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-78 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-78 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-78 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-78 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-77 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-77 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-77 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-77 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-77 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-77 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-77 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-76 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-76 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-75 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-73 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-72 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-72 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-67 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-67 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-67 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-67 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-67 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-67 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-67 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-67 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-67 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-67 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-67 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-67 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-67 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-67 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-67 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-67 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-67 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-67 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-67 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-67 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-67 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-67 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-67 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-67 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-67 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-67 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-67 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-67 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-67 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-67 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-67 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-67 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-67 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-67 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-67 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-67 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-67 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-67 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-67 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-67 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-67 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-66 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-66 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-66 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-66 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-66 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-66 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-66 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-66 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-66 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-66 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-66 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-66 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-66 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-66 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-66 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-66 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-66 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-65 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-65 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-63 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-63 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-62 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-62 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-62 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-60 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-58 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-53 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-51 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-51 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-50 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-50 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-50 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-50 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-50 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-50 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-50 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-50 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-50 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-50 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-50 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-50 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-50 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-50 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-50 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-50 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-50 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-50 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-50 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-49 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-49 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-49 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-49 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-49 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-49 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-49 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-48 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-48 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-48 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-48 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-48 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-46 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-46 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-45 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-44 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-41 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-41 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-41 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-40 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-40 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-40 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-40 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-40 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-40 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-40 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-40 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-40 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-40 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-40 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-40 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-40 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-40 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-40 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-40 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-40 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-40 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-40 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-40 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-40 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-40 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-40 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-40 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-40 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-40 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-40 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-40 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-40 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-40 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-40 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-39 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-39 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-39 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-39 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-39 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-38 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-37 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-37 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-37 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-37 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-37 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-36 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-36 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-36 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-36 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-36 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-36 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-36 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-36 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-36 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-36 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-36 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-35 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-35 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-35 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-35 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-35 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-35 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-35 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-35 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-34 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-33 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-32 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-32 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-32 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-32 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-32 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-31 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-31 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-31 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-31 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-30 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-27 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-24 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-23 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-23 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-23 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-23 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-23 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-23 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-23 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-23 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-23 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-23 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-23 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-23 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-22 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-22 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-19 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-19 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-19 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 620 | |||
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 0.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 0.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 0.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 0.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 0.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 0.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 0.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 0.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 0.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 0.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 0.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-179 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-162 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-150 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-148 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-142 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-134 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-119 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-112 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-102 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-102 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-102 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-102 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-101 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-101 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-101 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-100 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-100 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-99 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-85 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-79 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-67 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-66 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 9e-64 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-63 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-62 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-62 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-62 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-61 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-60 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-59 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-58 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-57 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-57 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-56 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-56 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-56 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-56 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-56 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-54 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-54 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-54 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-53 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-53 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-52 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-52 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-52 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-52 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-52 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-51 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-51 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-51 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-50 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-50 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-50 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-50 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-50 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-49 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-49 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-49 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-49 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 7e-49 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-48 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-48 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-47 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-47 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-47 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-47 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-47 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 7e-47 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-47 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-46 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-46 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-46 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-46 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-45 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-45 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-45 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-45 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-45 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-45 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-45 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-44 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-44 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-44 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-44 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-44 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-43 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-43 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-43 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-43 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-43 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-42 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-42 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-42 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-42 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-42 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-41 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-41 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-41 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-41 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-40 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-40 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-39 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-38 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-38 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-38 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-38 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-38 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-37 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-37 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-37 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-37 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-37 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-37 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-37 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-37 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-37 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-37 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-36 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-36 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-36 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-36 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-36 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-35 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-34 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-34 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-34 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-33 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-32 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-30 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-29 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-29 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-29 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-29 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 7e-29 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-29 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-28 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-28 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-28 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-28 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-27 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-27 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-27 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-27 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-26 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-26 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-26 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-26 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-26 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-26 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-26 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 9e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-25 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-25 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-25 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-25 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-25 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-25 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-24 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-24 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-24 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-24 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-23 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-23 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-23 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-23 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-22 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-22 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-22 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-22 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 7e-22 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-21 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-21 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-21 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-21 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-20 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-20 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-19 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-19 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-19 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-18 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-17 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-17 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-17 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-17 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-16 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-15 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-15 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-15 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-14 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-12 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-11 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-09 |
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 576 bits (1486), Expect = 0.0
Identities = 137/427 (32%), Positives = 214/427 (50%), Gaps = 53/427 (12%)
Query: 1 MQQDHRKKNSPEMEFFSEYGD---ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH 57
M H + E +F + Y I+ +IG+GSYG V A D +T + VAIKK++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI 117
+FE + D RILREI +L L+ I+ + +++P F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
K LT EH + LY LL +IH + + HRDLKP N L N +C +K+CDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 NDTPTTI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
++ T I T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAEVLTG-----------KPLFPG-----------------KNVVHQLDLMTDLLGTP 250
CIFAE+L PLFPG K+ QL+++ +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
+ D + + + +Y+ ++P+ QK+P+ + LLE +L F+P R T ++
Sbjct: 300 TEDDLKN-INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQ 358
Query: 311 ALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMN 370
AL PY K + K + E + F+ + +++ +R + +E+ +HP+L+ +
Sbjct: 359 ALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVF 417
Query: 371 GTERTNF 377
NF
Sbjct: 418 TIHENNF 424
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 570 bits (1471), Expect = 0.0
Identities = 164/363 (45%), Positives = 225/363 (61%), Gaps = 6/363 (1%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
PEM + RY IG+G+YG+VCSA D +VAIKKI FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND 121
H + R LREIK+L RH +I+ I I+ P+ KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
L+ +H +FLYQ+LR LKYIH+ANV HRDLKP N+L N C LKICDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
T F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 301
+ +LG+PS + ++ + N KAR YL S+ K V +++ FPNAD AL LL+++L F+
Sbjct: 243 HILGILGSPSQEDLNC-IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 301
Query: 302 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 361
P R E+ALA PY + EP + +F+ E + KE ++ELIF E +
Sbjct: 302 PHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQ 359
Query: 362 PQL 364
P
Sbjct: 360 PGY 362
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 569 bits (1470), Expect = 0.0
Identities = 149/355 (41%), Positives = 221/355 (62%), Gaps = 12/355 (3%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M Y +S ++++ ++G+G+YGVVCSA TGE VAIKKI + F+ A R LRE
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLRE 59
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IK+L+ +H +I+ I +I P S +F ++Y++ ELM++DLH+VI L+ +H Q+F+
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFI 118
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------TPTTIF 185
YQ LRA+K +H +NV HRDLKP N+L N+NC LK+CDFGLAR+ T
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
++VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG++ HQL L+
Sbjct: 179 MVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305
++GTP D R + + +AR Y+ S+ + FP +P + LL+R+L FDP R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 306 PTAEEALADPYFKGLSKVEREPSCQPISKMEFEF--ERRRVTKEDIRELIFREIL 358
TA+EAL PY + EP +PI FEF + +T +D+++LI+ EI
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 544 bits (1403), Expect = 0.0
Identities = 136/387 (35%), Positives = 217/387 (56%), Gaps = 44/387 (11%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 81
+Y++ + +GKG+YG+V +ID TGE VA+KKI D F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+IV + +++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARV------------------AFNDTPTT 183
+H+ + HRD+KP NIL NA C +K+ DFGL+R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF----------------PNA 286
+ ++ PS + + +++ A+ + S+++K ++ S K +
Sbjct: 243 IIGVIDFPSNEDVES-IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 287 DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTK 346
+ AL LL++LL F+P R +A +AL P+ EP+C I + + + +
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSI 360
Query: 347 EDIRELIFREILEYHPQLLKDYMNGTE 373
+D R L++ EI +L+ + +
Sbjct: 361 DDYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 541 bits (1396), Expect = 0.0
Identities = 122/368 (33%), Positives = 184/368 (50%), Gaps = 22/368 (5%)
Query: 6 RKKNSPEMEFFSE-YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD------ 58
K + + +E + S Y +Q I GSYG VC+ +D+ G VAIK++ +
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGR 62
Query: 59 ---IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQ 115
I R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL Q
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 116 VIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174
VI ++ +H Q+F+Y +L L +H A V HRDL P NIL N + ICDF LAR
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 183 EDTADA----NKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRL 293
+QL+ + +++GTP ++ + + AR YL S+ ++ P ADP AL L
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVM-FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 294 LERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELI 353
+ ++L F+P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIF 353
Query: 354 FREILEYH 361
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 539 bits (1391), Expect = 0.0
Identities = 134/342 (39%), Positives = 208/342 (60%), Gaps = 13/342 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ Y+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 83 DIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P + DF D Y+V M +DL +++K L + QF +YQ+L+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N +C+LKI DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP + + R +++
Sbjct: 198 LN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR-LQS 255
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
D+A+ Y+ + + + F+ NA P A+ LLE++L D + R TA EALA PYF+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 363
E EP Q + F+ T ++ + + ++E+L + P
Sbjct: 316 DTEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 133/341 (39%), Positives = 199/341 (58%), Gaps = 13/341 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y +G G+YG VCSAID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 83 DIVEIKHIMLPPSR-RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P S R+F D Y+V M++DL +++ + E Q+ +YQ+L+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH+A V HRDLKP N+ N +C+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
S + Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P + + + + +
Sbjct: 196 LS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK-LND 253
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
A+ Y+ S+ + F+Q FP A P A LLE++L D R TA +AL P+F+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
E E Q + E ++T ++ ++ I++EI+ + P
Sbjct: 314 DPEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 542 bits (1398), Expect = 0.0
Identities = 142/418 (33%), Positives = 208/418 (49%), Gaps = 58/418 (13%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
Q K + S++ RY+I+ +IG GSYG VC A D VAIKKI +FE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND 121
+ D RILREI +L L H +V++ I++P F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA----- 176
LT H + LY LL +KY+H+A + HRDLKP N L N +C +K+CDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAEVLT-----------GKPLFPGKNVV--------------------HQLDLMTDL 246
GCIFAE+L PLFPG + QL+++ ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 306
LGTPS + I + + A+RY+ K++ +++FP + A+ LL+R+L F+P R
Sbjct: 331 LGTPSEEDIEA-LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI 389
Query: 307 TAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 364
T E LA P+FK + E E + ++ F + + + +R +EI YHP++
Sbjct: 390 TINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 537 bits (1386), Expect = 0.0
Identities = 141/378 (37%), Positives = 217/378 (57%), Gaps = 20/378 (5%)
Query: 1 MQQDHRKKNSPEMEFFS------EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK 54
M H + F+ + RY+ +G G+YG VC+A DT TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDL 113
K+ F+ I A R RE++LL+ ++H +++ + + P S +F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ ++K LT +H QF +YQ+LR LKYIH+A++ HRDLKP N+ N +C+LKI DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R + T YVATRWYRAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 293
+ + QL L+ L+GTP + + + + ++ AR Y+ S+ + + F+ F A+P A+ L
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKK-ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 291
Query: 294 LERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELI 353
LE++L D R TA +ALA YF + EP P + E R + ++ + L
Sbjct: 292 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLT 348
Query: 354 FREILEYHPQLLK-DYMN 370
+ E++ + P L + M
Sbjct: 349 YDEVISFVPPPLDQEEME 366
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 133/452 (29%), Positives = 221/452 (48%), Gaps = 57/452 (12%)
Query: 1 MQQDHRKKNSPEMEFFS-EYGDA-----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK 54
+ + K+ + +F+S E GD+ RY+ + IG G+ G+VC+A D VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDL 113
K+ F++ + A R RE+ L++ + H +I+ + ++ P + +F+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
QVI+ +L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA------- 286
++ + Q + + + LGTP + + ++ R Y+ + K + F + FP++
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL--QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 323
Query: 287 -----DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFER 341
A LL ++L DP R + ++AL PY P + + +
Sbjct: 324 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDE 382
Query: 342 RRVTKEDIRELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSG 401
R T E+ +ELI++E++ + + G
Sbjct: 383 REHTIEEWKELIYKEVMNSEEKTKNGVVKGQPS--------------------------- 415
Query: 402 PVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 433
P SLP S+ V+ + +Q S
Sbjct: 416 PSGAAVNSSESLPPSSSVNDISSMSTDQTLAS 447
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 521 bits (1345), Expect = 0.0
Identities = 124/375 (33%), Positives = 201/375 (53%), Gaps = 30/375 (8%)
Query: 8 KNSPEMEFFS-EYGDA-----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
++ + F+S E GD+ RY+ + IG G+ G+VC+A D VAIKK+ F+
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKAN 120
+ + A R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+
Sbjct: 64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM- 122
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A
Sbjct: 123 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 177
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DP 288
+ + + LGTP + + ++ R Y+ + K F + FP+
Sbjct: 236 NKVIEQLGTPCPEFMKKL--QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 289 SALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKED 348
A LL ++L D R + +EAL PY + P + + + R T E+
Sbjct: 294 QARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEE 352
Query: 349 IRELIFREILEYHPQ 363
+ELI++E+++
Sbjct: 353 WKELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 510 bits (1315), Expect = e-179
Identities = 120/316 (37%), Positives = 171/316 (54%), Gaps = 16/316 (5%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
SRY + +G G G+V SA+D ++VAIKKI + LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKHIMLPPSRR---------DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
+IV++ I+ P + + +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
YQLLR LKYIH+ANV HRDLKP N+ N + LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
+ + Y+ + + +Q P A+ LE++L F P DR TAEEA
Sbjct: 246 EEDRQEL--LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 312 LADPYFKGLSKVEREP 327
L+ PY S EP
Sbjct: 304 LSHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-162
Identities = 111/366 (30%), Positives = 177/366 (48%), Gaps = 28/366 (7%)
Query: 7 KKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 66
N+ + R++++ + G+G++G V + TG VAIKK+ +
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFR 63
Query: 67 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY--VVFELMESDLHQVIK----AN 120
R L+ ++ L +L HP+IV+++ RD +DIY VV E + LH+ +
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 121 DDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILAN-ANCKLKICDFGLARVAF 177
+ FL+QL+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
P Y+ +R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G N
Sbjct: 184 PSEPNV----AYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF----PNADPSALRL 293
QL + +LG PS + + + + L + + +S F A L
Sbjct: 239 GQLHEIVRVLGCPSREVLRK-LNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDL 294
Query: 294 LERLLAFDPKDRPTAEEALADPYFKGL-SKVEREPSCQPISKMEFEFERR--RVTKEDIR 350
L LL + P++R EAL PYF L + P+ + + + F F V E +
Sbjct: 295 LSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQK 354
Query: 351 ELIFRE 356
+ R+
Sbjct: 355 AKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 439 bits (1130), Expect = e-150
Identities = 116/377 (30%), Positives = 193/377 (51%), Gaps = 32/377 (8%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 83 DIVEIKHIMLPPS-RRDFKDIYVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLR 137
++V++K ++D + +V E + +++ K + + ++YQLLR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 138 ALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+L YIH+ + HRD+KP+N+L + LK+ DFG A++ P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG++ + QL + +LGTPS + I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALAD 314
+ + +P FS+ F P P A+ L+ RLL + P R TA EAL
Sbjct: 267 KTM----NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 315 PYFKGLSKVE-REPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 373
P+F L E R P+ + + + F + + + +R + ++ H + + G +
Sbjct: 323 PFFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGID 377
Query: 374 RTNFLYPSAVDQFRKQF 390
NF P ++ +
Sbjct: 378 VHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-148
Identities = 99/384 (25%), Positives = 178/384 (46%), Gaps = 68/384 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 82 PDIVEIKHIM---------------------------------LPPSRRDFKDIYVVFEL 108
+I+++ + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 109 MESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-C 163
+ LH+V+ ++ + ++YQL RA+ +IH+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 222
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 223 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQK 282
E++ GKPLF G+ + QL + ++GTP+ + + R + + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR-MNPHYTEVRF---PTLKAKDWRKI 289
Query: 283 FPNADPS-ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKME----- 336
P PS A+ LLE++L ++P R EA+A P+F L +
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQN 349
Query: 337 ----FEF---ERRRVTKEDIRELI 353
F F E + + ++
Sbjct: 350 IPQLFNFSPYELSIIPGNVLNRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 419 bits (1078), Expect = e-142
Identities = 106/340 (31%), Positives = 172/340 (50%), Gaps = 26/340 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKHIMLPPS-RRDFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRA 138
IV +++ ++D + +V + + +++V + A L + + ++YQL R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ + I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADP 315
+ + + +++ F P P A+ L RLL + P R T EA A
Sbjct: 283 EM----NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 316 YFKGLSKVE-REPSCQPISKM-EFEFERRRVTKEDIRELI 353
+F L + P+ + + F + LI
Sbjct: 339 FFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-134
Identities = 89/315 (28%), Positives = 156/315 (49%), Gaps = 23/315 (7%)
Query: 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
E+G+ Y++ +G+G Y V AI+ EKV +K + + +I REIK+L
Sbjct: 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILE 85
Query: 78 LLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 136
LR P+I+ + I+ P V + +D Q+ + LT +F++Y++L
Sbjct: 86 NLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEIL 140
Query: 137 RALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
+AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R++
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYF 196
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLDT 254
+ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT L
Sbjct: 197 KGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPN-----ADPSALRLLERLLAFDPKDRPTAE 309
+ R+ + + ++ + + P AL L++LL +D + R TA
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 310 EALADPYFKGLSKVE 324
EA+ PYF + K +
Sbjct: 316 EAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-119
Identities = 105/307 (34%), Positives = 164/307 (53%), Gaps = 13/307 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYI 142
+V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LC 201
H N HRD+KP+NIL + +K+CDFG AR P+ + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
G ++Y P +D+W+IGC+FAE+L+G PL+PGK+ V QL L+ LG +V
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI-PRHQQVFST 232
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
++ + + KFPN AL LL+ L DP +R T E+ L PYF+ +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 322 KVEREPS 328
++E
Sbjct: 293 EIEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-112
Identities = 96/319 (30%), Positives = 157/319 (49%), Gaps = 13/319 (4%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
H + +Y+ ++G+GSYG+V + TG VAIKK + +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD 63
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-N 120
+REIKLL+ LRH ++V + + + K Y+VFE ++ + ++
Sbjct: 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFP 118
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+ L + Q +L+Q++ + + H+ N+ HRD+KP+NIL + + +K+CDFG AR
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA- 176
Query: 181 PTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239
P ++ D VATRWYRAPEL G KY A+D+W+IGC+ E+ G+PLFPG + + Q
Sbjct: 177 PGEVY-DDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233
Query: 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 299
L + LG +N + K+ +++P + L ++ L
Sbjct: 234 LYHIMMCLGNLIPRHQELFNKN-PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292
Query: 300 FDPKDRPTAEEALADPYFK 318
DP RP E L +F+
Sbjct: 293 IDPDKRPFCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-102
Identities = 101/307 (32%), Positives = 144/307 (46%), Gaps = 25/307 (8%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI-----LREIKLLR 77
SRY+ IG G+YG V A D H+G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 78 LLR---HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA--NDDLTREHYQFFL 132
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
Q LR L ++H + HRDLKP+NIL + +K+ DFGLAR ++ T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
WYRAPE L S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
D R V + + + P P + S +LL +L F+P R +A A
Sbjct: 240 EDDWPRDVSLPRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 312 LADPYFK 318
L Y
Sbjct: 295 LQHSYLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-102
Identities = 120/323 (37%), Positives = 173/323 (53%), Gaps = 19/323 (5%)
Query: 4 DHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
H +S E G +Y+ E +G+G+YGVV A D+ G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAE 58
Query: 64 SDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-N 120
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L + +LYQLLR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 299
L + +LGTP+ +V ++ + + + +S P + LL +L
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLC 286
Query: 300 FDPKDRPTAEEALADPYFKGLSK 322
FDP R +A +A+ PYFK L
Sbjct: 287 FDPNKRISARDAMNHPYFKDLDP 309
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-102
Identities = 114/302 (37%), Positives = 164/302 (54%), Gaps = 20/302 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 81
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 140
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL +
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
Y H V HRDLKP+N+L N +LKI DFGLAR AF P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
L GS KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ V
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
+ +Y + +P+ + D S + LL ++L DP R TA++AL YFK
Sbjct: 230 ---ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
Query: 320 LS 321
+
Sbjct: 287 NN 288
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-101
Identities = 110/327 (33%), Positives = 173/327 (52%), Gaps = 21/327 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y + +G+G+Y V T VA+K+I + E A +RE+ LL+ L+H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHA 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKY 141
+IV + I+ + +VFE ++ DL Q + + + + + FL+QLLR L Y
Sbjct: 61 NIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
H V HRDLKP+N+L N +LK+ DFGLAR A + PT + + V T WYR P+ L
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDIL 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ +T ++
Sbjct: 173 LGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320
N++ + Y + K + P D LL +LL F+ ++R +AE+A+ P+F L
Sbjct: 231 NEEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288
Query: 321 ----SKVEREPSCQPISKMEFEFERRR 343
K+ S + +++ + E
Sbjct: 289 GERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-101
Identities = 109/331 (32%), Positives = 159/331 (48%), Gaps = 20/331 (6%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARI--LREIKLLRL 78
A RY+ + +G+G + V A D +T + VAIKKI D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLR 137
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE L G+ Y +D+W++GCI AE+L P PG + + QL + + LGTP+ +
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ + + + F A L L++ L F+P R TA +AL Y
Sbjct: 239 DMCSLPDYV----TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 317 FKGLSKVEREPSCQPISKMEFEFERRRVTKE 347
F P E + +
Sbjct: 295 FSNRPG-PTPGCQLPRPNCPVETLKEQSNPA 324
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-101
Identities = 112/304 (36%), Positives = 163/304 (53%), Gaps = 20/304 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 140
+IV + ++ + + +VFE + DL + + N DL E + FL+QLL+ L
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ + +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
K Y P + + LL+ LL +P R +AEEAL PYF
Sbjct: 231 T---KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 319 GLSK 322
Sbjct: 288 DFCP 291
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-100
Identities = 111/338 (32%), Positives = 163/338 (48%), Gaps = 23/338 (6%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRL 78
+ S+Y+ IG+G++G V A TG+KVA+KK+ E+ + I LREIK+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 79 LRHPDIVEIKHIM---LPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQ 134
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---VA 191
LL L YIH + HRD+K N+L + LK+ DFGLAR AF+ Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTA 308
+ + V + + + K Q + + DP AL L+++LL DP R +
Sbjct: 249 TPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 309 EEALADPYFKGL---SKVEREPSCQPISKMEFEFERRR 343
++AL +F S ++ S S E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-100
Identities = 100/324 (30%), Positives = 157/324 (48%), Gaps = 29/324 (8%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLL 79
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
LLR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR ++ T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
YRAPE L S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P +
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
R V + + K + + D LL + L F+P R +A AL+
Sbjct: 242 DWPRDVALPRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296
Query: 314 DPYFKGLSKVEREPSCQPISKMEF 337
PYF+ L C+
Sbjct: 297 HPYFQDL------ERCKENLDSHL 314
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = 1e-99
Identities = 113/307 (36%), Positives = 163/307 (53%), Gaps = 24/307 (7%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLR 80
RY+ +G+G+YG V AIDT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YIHTANVYHRDLKPKNILANANCK-----LKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
+ H+ HRDLKP+N+L + + LKI DFGLAR AF P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + + QL + ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALA 313
V + S K + + D L LL +L DP R +A+ AL
Sbjct: 262 WPGVTAL---PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318
Query: 314 DPYFKGL 320
PYF
Sbjct: 319 HPYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 3e-98
Identities = 110/312 (35%), Positives = 170/312 (54%), Gaps = 28/312 (8%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 80
+S++K E +G G+Y V ++ TG VA+K++ D E A +REI L++ L+
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELK 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN------DDLTREHYQFFLYQ 134
H +IV + ++ ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
LL+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
YRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA-----DPSALRLLERLLAFDPKDRPTA 308
V K +Y +++++ P Q D + + L LL +P R +A
Sbjct: 232 LWPSV---TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 309 EEALADPYFKGL 320
++AL P+F
Sbjct: 289 KQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-85
Identities = 109/359 (30%), Positives = 167/359 (46%), Gaps = 48/359 (13%)
Query: 26 KIQEVIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+G+G+YG V A D + A+K+I IS +A REI LLR L+HP+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRELKHPN 79
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---------LTREHYQFFLYQ 134
++ ++ + L + + ++++F+ E DL +IK + L R + LYQ
Sbjct: 80 VISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 135 LLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIF-WTDY 189
+L + Y+H V HRDLKP NIL ++KI D G AR FN +
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPV 195
Query: 190 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---------VVHQ 239
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F + Q
Sbjct: 196 VVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS------QKFPNADPSALRL 293
LD + +++G P+ + + + + R+ S + D A L
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 294 LERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQP-ISKMEFEFERRRVTKEDIRE 351
L++LL DP R T+E+A+ DPYF E + + + +R E+ +
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-79
Identities = 92/401 (22%), Positives = 151/401 (37%), Gaps = 68/401 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHP 82
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRALKY 141
+++ + +D + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 IHTANVYHRDLKPKNIL-----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K I DFGL + + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE L T +DI+S GC+F V++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------------- 230
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
+R + + + D A L+E+++A DP+ RP+A+ L
Sbjct: 231 ------GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284
Query: 315 PYFKGLSK-----------VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILE---- 359
P+F L K +E+E PI K + E R V K D RE I +
Sbjct: 285 PFFWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRK 343
Query: 360 ---YHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENV 397
Y ++D + Y + R+ L ++
Sbjct: 344 FRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 7e-67
Identities = 97/331 (29%), Positives = 155/331 (46%), Gaps = 45/331 (13%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A RY++ +VIGKGS+G V A D + VA+K + + + A EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 82 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 138
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 139 LKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L +H + H DLKP+NIL +K+ DFG + + T Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-HQRVYT-----YIQSRFYR 266
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE + G+ +Y ID+WS+GCI AE+LTG PL PG++ QL M +LLG PS +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 256 SR---------------------------VVRNDKARRYLTSMRKKQPVQFSQKFPNADP 288
V+ ++RR + + DP
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 289 SALRLLERLLAFDPKDRPTAEEALADPYFKG 319
L L++ L +DP R T +AL P+ +
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-66
Identities = 54/347 (15%), Positives = 91/347 (26%), Gaps = 62/347 (17%)
Query: 12 EMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARI 69
E S R K+ E + G VV D E A+K S+ R+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 70 LREIKLLRLLRHPDIVEI-------------------KHIMLPPSRRDFK--DIYVVFEL 108
L E L P + D+ + ++
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 109 MESDLHQVIKANDDLTREHY-------QFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161
DL + D + QL+R + + + H P N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP 229
Query: 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ +L + D P + Y E + + +T A++ W +G
Sbjct: 230 DGRLMLGDVSALWKVGTRGPAS------SVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 222 AEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQ 281
V F + L P D+++
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA-----------------------FG 320
Query: 282 KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328
L+ R L FD + R EA+ P F +++ E S
Sbjct: 321 SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-64
Identities = 73/328 (22%), Positives = 114/328 (34%), Gaps = 48/328 (14%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
+ + F S Y I + IG G V ++ + AIK ++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 62 HISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
+ + + +L A+ IH + H DLKP N L + LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T T++ V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 T-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 290
F + + ++ ++F +
Sbjct: 239 FQQI--------------INQISKLHAII------------DPNHEIEFP---DIPEKDL 269
Query: 291 LRLLERLLAFDPKDRPTAEEALADPYFK 318
+L+ L DPK R + E LA PY +
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-63
Identities = 91/336 (27%), Positives = 150/336 (44%), Gaps = 50/336 (14%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY+I +IGKGS+G V A D E VAIK I + + + A+I E++LL L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQI--EVRLLELMNK 109
Query: 82 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 138
D +I+ F++ + +VFE++ +L+ +++ + ++ + F Q+ A
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 139 LKYIHT--ANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L ++ T ++ H DLKP+NIL +KI DFG + Y+ +R+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ-----YIQSRF 223
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
YR+PE+ Y AID+WS+GCI E+ TG+PLF G N V Q++ + ++LG P
Sbjct: 224 YRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 255 I-------------------------SRVVRNDKARRYLTSMRKKQ---PVQFSQKFPNA 286
+ + R L ++ + P
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 287 DPSALR----LLERLLAFDPKDRPTAEEALADPYFK 318
+ L+ R+L +DPK R AL +FK
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-62
Identities = 93/344 (27%), Positives = 144/344 (41%), Gaps = 50/344 (14%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
RY+I +G+G++G V +D G +VA+K I ++ +AAR+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 81 HPDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 137
D +L +F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 138 ALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVAF- 177
AL+++H + H DLKP+NIL + N +++ DFG A F
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFD 192
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
++ TT VATR YR PE + + D+WSIGCI E G LF
Sbjct: 193 HEHHTT-----IVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 237 VHQLDLMTDLLGTPSLDTISRVVR-----NDKARRYLTSMRKKQPVQFSQKFPNA----- 286
L +M +LG I R + S + + + +
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 287 --DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328
L+ R+L FDP R T EAL P+F GL+ ER
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-62
Identities = 69/341 (20%), Positives = 140/341 (41%), Gaps = 58/341 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+ + + +G G++G V + A+K + +I + + +A+I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 82 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 138
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+A
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 139 LKYIHTANVYHRDLKPKNIL-------------------------ANANCKLKICDFGLA 173
L Y+ ++ H DLKP+NIL + +K+ DFG A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 174 RVAF-NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
F +D + + TR YRAPE + + + D+WS GC+ AE+ TG LF
Sbjct: 210 --TFKSDYHGS-----IINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGSLLF 259
Query: 232 PGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR------------RYLTSMRKKQPVQF 279
+ L +M ++ + + + + ++ +S+ + V+
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319
Query: 280 SQKFPNA--DPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
L +L DP RP+ E L + +
Sbjct: 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-62
Identities = 89/342 (26%), Positives = 147/342 (42%), Gaps = 58/342 (16%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
++RY+I + +G+G++G V ID G VA+K + ++ + +AAR EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 137
D + + I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 ALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVAF- 177
++ ++H+ + H DLKP+NIL N +K+ DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
++ +T V+TR YRAPE + ++ D+WSIGCI E G +FP +
Sbjct: 188 DEHHST-----LVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQK---FPNADP----- 288
L +M +LG +++ + R+Y R S P
Sbjct: 240 KEHLAMMERILGPLP----KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295
Query: 289 --------SALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
L++++L +DP R T EAL P+F L K
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-61
Identities = 72/331 (21%), Positives = 118/331 (35%), Gaps = 48/331 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP- 82
Y I + IG G V ++ + AIK ++ EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 83 -DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+ + + IY+V E DL+ +K + + + +L A+
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 200
IH + H DLKP N L + LK+ DFG+A DT T++ V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAI 181
Query: 201 --------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
G SK +P D+WS+GCI + GK F +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQI 227
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ ++ ++F + +L+ L DPK R + E L
Sbjct: 228 SKLHAII------------DPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRR 343
A PY + + + + +M++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 5e-60
Identities = 87/399 (21%), Positives = 135/399 (33%), Gaps = 60/399 (15%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
D K +S E S G Y I + IG G V ++ + AIK ++
Sbjct: 37 TDDDDKASSSANECISVKG--RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 93
Query: 62 HISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + IY+V E DL+ +K
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKK 148
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
+ + + +L A+ IH + H DLKP N L + LK+ DFG+A D
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207
Query: 180 TPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T T++ V Y PE G SK +P D+WS+GCI + GK
Sbjct: 208 T-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 290
F + IS++ + ++F +
Sbjct: 267 FQQII-----------------NQISKLHAI---------IDPNHEIEFP---DIPEKDL 297
Query: 291 LRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIR 350
+L+ L DPK R + E LA PY +++ P Q E K +
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKGTTEEM------KYVLG 347
Query: 351 ELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQ 389
+L+ + K S+ F K+
Sbjct: 348 QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 386
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 1e-59
Identities = 75/335 (22%), Positives = 125/335 (37%), Gaps = 48/335 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+RY + +G G + V A D VA+K + + ++AA EIKLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 81 HPDIVEIKHIMLPPSRR-----DFKDIYV-----VFELMESDLHQVIKANDD--LTREHY 128
D + + + + K VFE++ +L +IK + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 129 QFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCK------LKICDFGLARVAFNDTP 181
+ QLL L Y+H + H D+KP+N+L +KI D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY- 192
Query: 182 TTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---- 236
T+ + TR YR+PE L G+ + DIWS C+ E++TG LF
Sbjct: 193 -----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 237 --VHQLDLMTDLLGTPSLDTISRVVR---------NDKARRYLTSMRKKQPVQFSQKFPN 285
+ + +LLG + + L + + KF
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 286 ADPSALR-LLERLLAFDPKDRPTAEEALADPYFKG 319
+ + L +L DP+ R A + P+ K
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-58
Identities = 78/319 (24%), Positives = 124/319 (38%), Gaps = 57/319 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
AS ++ V+G+G++G V A + AIKKI E + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTE--EKLSTILSEVMLLASLNH 61
Query: 82 PDIVEIKH--------IMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFF 131
+V + + + +++ E E L+ +I + N + R+ Y
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW----- 186
Q+L AL YIH+ + HRDLKP NI + + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
T + T Y A E+ Y ID++S+G IF E++ P G V+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN-- 236
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLA 299
++ L + ++F F N +++ L+
Sbjct: 237 -ILKKL--------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLID 269
Query: 300 FDPKDRPTAEEALADPYFK 318
DP RP A L +
Sbjct: 270 HDPNKRPGARTLLNSGWLP 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 77/357 (21%), Positives = 142/357 (39%), Gaps = 49/357 (13%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDA-SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 59
M H + ++ + Y + +Y + IG+GS+G T G + IK+I+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-- 58
Query: 60 FEHISDAAR--ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV 116
+S R RE+ +L ++HP+IV+ + S + +Y+V + E DL +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKR 113
Query: 117 IK-ANDDLTREHY-QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174
I L +E + Q+ ALK++H + HRD+K +NI + +++ DFG+AR
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
V T + T +Y +PE+C + Y DIW++GC+ E+ T K F
Sbjct: 174 VL---NSTVELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 294
+ M +L + +++ + +S + L+
Sbjct: 229 S-------MKNL--------VLKIISGS---------FPPVSLHYSYDLRS-------LV 257
Query: 295 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRE 351
+L +P+DRP+ L + + P F + +
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 90/308 (29%), Positives = 136/308 (44%), Gaps = 50/308 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARILREIKLLR 77
Y + + +G G+ G V A + T +KVAI+ I A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
L HP I++IK+ D +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
D I + +Y F + + AL L+++LL DPK R T EEA
Sbjct: 355 DQI-------TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
Query: 312 LADPYFKG 319
L P+ +
Sbjct: 398 LRHPWLQD 405
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 75/320 (23%), Positives = 113/320 (35%), Gaps = 64/320 (20%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+K E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVEIKH-----------IMLPPSRRDFKDIYVVFELMES-DLHQVIKA--NDDLTREH 127
+IV SR K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
Q+ + + YIH+ + +RDLKP NI ++KI DFGL ND T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 306
F +K LL++LL+ P+DRP
Sbjct: 232 ------------------------RDGIISDIFDKKEKT-------LLQKLLSKKPEDRP 260
Query: 307 TAEEALADPYFKGLSKVERE 326
E L S + E
Sbjct: 261 NTSEILRTLTVWKKSPEKNE 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-56
Identities = 71/298 (23%), Positives = 105/298 (35%), Gaps = 47/298 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRH 81
++ +G GSYG V G A+K+ F D AR L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRALK 140
P V ++ + + +Y+ EL L Q +A E +L L AL
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
Y A D++S+G EV L G QL
Sbjct: 228 LQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ P +F+ +L +L DPK R TAE LA P +
Sbjct: 265 ----------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 25/314 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + +++G+G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRAL 139
IV++ I + + ++ E L+ V++ L + L ++ +
Sbjct: 69 IVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249
P++ KY +D+WSIG F TG F + + + T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 309
V+ + S S +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 310 EALADPYFKGLSKV 323
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-56
Identities = 68/325 (20%), Positives = 118/325 (36%), Gaps = 56/325 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIVEIKH-------IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF---F 131
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT---------PT 182
Q+ A++++H+ + HRDLKP NI + +K+ DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242
T V T+ Y +PE + Y+ +DI+S+G I E+L P V L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL-- 237
Query: 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 302
R +F F P +++ +L+ P
Sbjct: 238 -------------------TDVRNL----------KFPPLFTQKYPCEYVMVQDMLSPSP 268
Query: 303 KDRPTAEEALADPYFKGLSKVEREP 327
+RP A + + F+ L +
Sbjct: 269 MERPEAINIIENAVFEDLDFPGKTV 293
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-56
Identities = 79/307 (25%), Positives = 126/307 (41%), Gaps = 53/307 (17%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 81
Y++ IG GSYG G+ + K++ + +++A + ++ E+ LLR L+H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 64
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK----ANDDLTREHYQFFLYQLL 136
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 65 PNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 137 RALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
ALK H + V HRDLKP N+ + +K+ DFGLAR+ T F +V
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVG 178
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F + +L
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKEL----- 224
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
++ ++ P ++S + ++ R+L RP+ EE
Sbjct: 225 ---AGKIREGK---------FRRIPYRYSDELNE-------IITRMLNLKDYHRPSVEEI 265
Query: 312 LADPYFK 318
L +P
Sbjct: 266 LENPLIL 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 7e-56
Identities = 90/308 (29%), Positives = 133/308 (43%), Gaps = 50/308 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARILREIKLLR 77
Y + + +G G+ G V A + T +KVAIK I A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
L HP I++IK+ D +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 229
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
D I F + + AL L+++LL DPK R T EEA
Sbjct: 230 DQI-----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
Query: 312 LADPYFKG 319
L P+ +
Sbjct: 273 LRHPWLQD 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 85/340 (25%), Positives = 130/340 (38%), Gaps = 62/340 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+V D ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 192
+H V HRDLK N+ N + ++KI DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------------- 247
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+T R+ +N+ Y P + P A L++++L DP RPT E L
Sbjct: 248 ETYLRIKKNE----Y------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELL 290
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 352
D +F R P F + + + L
Sbjct: 291 NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-54
Identities = 83/318 (26%), Positives = 126/318 (39%), Gaps = 63/318 (19%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+V D ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 192
+H V HRDLK N+ N + ++KI DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------------- 221
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+T R+ +N+ Y P + P A L++++L DP RPT E L
Sbjct: 222 ETYLRIKKNE----Y------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELL 264
Query: 313 ADPYF-KGLSKVEREPSC 329
D +F G +C
Sbjct: 265 NDEFFTSGYIPARLPITC 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 7e-54
Identities = 64/357 (17%), Positives = 124/357 (34%), Gaps = 27/357 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + +++G+G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRAL 139
IV++ I + + ++ E L+ V++ L + L ++ +
Sbjct: 69 IVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249
P++ KY +D+WSIG F TG F + + + T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 309
V+ + S S +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 310 EALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI-LEYHPQLL 365
+ A+ V S Q ++ + T EL++++ + Q L
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSNQEL 354
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 96/337 (28%), Positives = 141/337 (41%), Gaps = 49/337 (14%)
Query: 5 HRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
H +S E G A RY I ++GKGS+G V D T ++ A+K I+
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD 122
D + ILRE++LL+ L HP+I+++ I+ D Y+V EL +L I
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFND 179
+ + Q+ + Y+H N+ HRDLKP+NIL +C +KI DFGL+ F
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQ 176
Query: 180 TPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
D + T +Y APE L G Y D+WS G I +L+G P F GKN
Sbjct: 177 NTK---MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN--- 226
Query: 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERL 297
I + V + F ++ A L+ ++
Sbjct: 227 -------------EYDILKRV-------------ETGKYAFDLPQWRTISDDAKDLIRKM 260
Query: 298 LAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 334
L F P R TA + L P+ + S S P +
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-53
Identities = 98/376 (26%), Positives = 159/376 (42%), Gaps = 67/376 (17%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 66
+ +P M S+ G + Y+ + +G G+YG V D T + AIK I S
Sbjct: 21 QATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN 80
Query: 67 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTR 125
+++L E+ +L+LL HP+I+++ D ++ Y+V E + +L I
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE 135
Query: 126 EHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPT 182
+ Q+L + Y+H N+ HRDLKP+N+L + +KI DFGL+ V F +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKK 194
Query: 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242
+ + T +Y APE+ KY D+WSIG I +L G P F G+
Sbjct: 195 ---MKERLGTAYYIAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT------- 241
Query: 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFD 301
I R V K F S ++ N A L++++L FD
Sbjct: 242 ---------DQEILRKVEKGK-------------YTFDSPEWKNVSEGAKDLIKQMLQFD 279
Query: 302 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE----FERRR-------------- 343
+ R +A++AL P+ K + + P E F+ +
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKL 339
Query: 344 VTKEDIREL--IFREI 357
++E+ +EL IFR I
Sbjct: 340 TSQEETKELTDIFRHI 355
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-52
Identities = 85/334 (25%), Positives = 141/334 (42%), Gaps = 48/334 (14%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISD 65
+P M + RYK Q V+GKGS+G V D TG++ A+K I + +D
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLT 124
+LRE++LL+ L HP+I+++ D Y+V E+ +L I + +
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 181
+ Q+L + Y+H + HRDLKP+N+L + + ++I DFGL+ F +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASK 183
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
D + T +Y APE+ Y D+WS G I +L+G P F G N
Sbjct: 184 K---MKDKIGTAYYIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN------ 231
Query: 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAF 300
I + V +K F ++ SA L+ ++L +
Sbjct: 232 ----------EYDILKKV-------------EKGKYTFELPQWKKVSESAKDLIRKMLTY 268
Query: 301 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 334
P R +A +AL + + +K + +
Sbjct: 269 VPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 74/305 (24%), Positives = 129/305 (42%), Gaps = 54/305 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 80
+ ++I++ IG+G + V A G VA+KK+ IF+ + AR ++EI LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFF-------- 131
HP++++ S + ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
QL AL+++H+ V HRD+KP N+ A +K+ D GL R + T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVG 198
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T +Y +PE + Y DIWS+GC+ E+ + F G D + S
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG-----------DKMNLYS 245
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
L ++ + D +S++ L+ + DP+ RP
Sbjct: 246 L--CKKIEQCD--------YPPLPSDHYSEELRQ-------LVNMCINPDPEKRPDVTYV 288
Query: 312 LADPY 316
Sbjct: 289 YDVAK 293
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 95/327 (29%), Positives = 142/327 (43%), Gaps = 49/327 (14%)
Query: 5 HRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
H +S E G A RY I ++GKGS+G V D T ++ A+K I+
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD 122
D + ILRE++LL+ L HP+I+++ I+ D Y+V EL +L I
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFND 179
+ + Q+ + Y+H N+ HRDLKP+NIL +C +KI DFGL+ +
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 180 TPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
T D + T +Y APE L G Y D+WS G I +L+G P F GKN
Sbjct: 178 T----KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN--- 226
Query: 239 QLDLMTD-LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 297
+ D++ G + D ++ A L+ ++
Sbjct: 227 EYDILKRVETGKYAFD--------------------------LPQWRTISDDAKDLIRKM 260
Query: 298 LAFDPKDRPTAEEALADPYFKGLSKVE 324
L F P R TA + L P+ + S E
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-52
Identities = 84/348 (24%), Positives = 129/348 (37%), Gaps = 82/348 (23%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLL 79
+Y ++ IG+GSYGVV AI+ T AIK + + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF-------- 130
HP+I + + D + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQLLRALKYIHTANVYHRDLKPKNIL 158
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N + ++K+ DFGL++ + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ 275
S G + +L G FPG N DTIS+V +
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN---------------DADTISQV--------------LNK 291
Query: 276 PVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
+ F + + P A LL LL + +R A AL P+ S
Sbjct: 292 KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-52
Identities = 81/358 (22%), Positives = 136/358 (37%), Gaps = 69/358 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRH 81
+ ++++G GS G V + G VA+K++ F I L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF-------FLYQ 134
P+++ + +Y+ EL +L ++++ + L Q
Sbjct: 69 PNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 135 LLRALKYIHTANVYHRDLKPKNIL-------------ANANCKLKICDFGLAR-VAFNDT 180
+ + ++H+ + HRDLKP+NIL N ++ I DFGL + + +
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 181 PTTIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ T +RAPEL + T +IDI+S+GC+F +L+ GK F K
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 294
S ++R + L M+ A L+
Sbjct: 244 Y-----------------SRESNIIRGIFS---LDEMKCLHDRSLI-------AEATDLI 276
Query: 295 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 352
+++ DP RPTA + L P F SK + +S E E R + +
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-51
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 49/316 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+I+ + D +Y++ E +++ ++ + ++ +L AL
Sbjct: 69 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DYVATRWYRAPE 199
Y H+ V HRD+KP+N+L + +LKI DFG + A + T + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + +D+WS+G + E L GKP F +T R+
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETYKRIS 220
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF-K 318
R + F A L+ RLL +P RP E L P+
Sbjct: 221 RVE--------------FTFPDFVT---EGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
Query: 319 GLSKVEREPSCQPISK 334
SK + + SK
Sbjct: 264 NSSKPSNCQNKESASK 279
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-51
Identities = 83/303 (27%), Positives = 125/303 (41%), Gaps = 50/303 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y ++ IG+GS+G V A+ T + A KKI + D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ + D DIY+V EL +L + + + +L A+ Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 142 IHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
H NV HRDLKP+N L + + LK+ DFGLA V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL-GTPSLDTIS 256
+ L G Y P D WS G + +L G P F ++M + GT +
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP--- 227
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
+ + N P A L+ RLL PK R T+ +AL +
Sbjct: 228 -----------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264
Query: 317 FKG 319
F+
Sbjct: 265 FEK 267
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 8e-51
Identities = 89/338 (26%), Positives = 130/338 (38%), Gaps = 60/338 (17%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---------- 56
+P M + G Y +G G+YG V + + + AIK I
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 57 -HDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLH 114
D I EI LL+ L HP+I+++ + D K Y+V E E +L
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELF 134
Query: 115 QVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFG 171
+ I + Q+L + Y+H N+ HRD+KP+NIL N+ +KI DFG
Sbjct: 135 EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 172 LARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
L+ F+ D + T +Y APE L KY D+WS G I +L G P
Sbjct: 195 LSSF-FSKDYK---LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPS 289
F G+N I + V K F + N
Sbjct: 247 FGGQN----------------DQDIIKKVEKGK-------------YYFDFNDWKNISDE 277
Query: 290 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 327
A L++ +L +D R TAEEAL + K + +
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-50
Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 55/303 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
+K+ ++GKGS+ V A HTG +VAIK I R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALK 140
I+E+ + D +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 72 SILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVATRWY 195
Y+H+ + HRDL N+L N +KI DFGLA P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+PE+ S + D+WS+GC+F +L G+P F V +T+
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---------------NTL 221
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
++VV D Y + P S A L+ +LL +P DR + L P
Sbjct: 222 NKVVLAD----Y------EMPSFLS-------IEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 316 YFK 318
+
Sbjct: 265 FMS 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-50
Identities = 72/325 (22%), Positives = 129/325 (39%), Gaps = 47/325 (14%)
Query: 3 QDHRKKNSPEME----FFSEYGDASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH 57
Q+ R + ++E + R+ K IG+GS+ V +DT T +VA ++
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 58 DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV 116
D S+ R E ++L+ L+HP+IV + K I +V ELM S L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTY 119
Query: 117 IKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA-NCKLKICDFGLA 173
+K + + + + Q+L+ L+++HT + HRDLK NI +KI D GLA
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ + T + APE+ KY ++D+++ G E+ T + +
Sbjct: 180 TLKRASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSE 231
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 293
Q+ Y +P F + A P +
Sbjct: 232 CQNAAQI--------------------------YRRVTSGVKPASFDK---VAIPEVKEI 262
Query: 294 LERLLAFDPKDRPTAEEALADPYFK 318
+E + + +R + ++ L +F+
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 1e-50
Identities = 99/473 (20%), Positives = 168/473 (35%), Gaps = 57/473 (12%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++++E +G G +G V I TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DLHQVIKANDD---LTREHYQFFLYQLLRA 138
+V + + + D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ + KI D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH-------------- 233
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL---------RLLERLLAFDPKDRP 306
VR + V+FS P P+ L R L+ +L + + R
Sbjct: 234 -GKVREKSNEHIVVYDDLTGAVKFSSVLP--TPNHLSGILAGKLERWLQCMLMWHQRQRG 290
Query: 307 TAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI-----LEYH 361
T + F+ L + ++ + VT+ + + + + +
Sbjct: 291 TDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEE 350
Query: 362 PQLLKDYMNGTER-----TNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRS 416
Q L T ++ V R+ L V P+ + P S
Sbjct: 351 EQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPES 410
Query: 417 TIVHSNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL 469
V PK + R+ +++ + + +R L Q+ +
Sbjct: 411 --VSIVLQDPKRPLTYTHLRRVWGQIWQ----TIRALKEDCARLLQGQRTSMV 457
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-50
Identities = 81/326 (24%), Positives = 137/326 (42%), Gaps = 55/326 (16%)
Query: 4 DHRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 62
H +S E G + + +G G++G V + +G + IK I +
Sbjct: 2 HHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRS 60
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND 121
+I EI++L+ L HP+I++I + D+ ++Y+V E E +L + I +
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQ 115
Query: 122 DLTREHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLA 173
+ + Q++ AL Y H+ +V H+DLKP+NIL + + +KI DFGLA
Sbjct: 116 A-RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ +D T+ T Y APE T DIWS G + +LTG F
Sbjct: 175 ELFKSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFT 226
Query: 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR 292
G ++ V + + ++ + P A+
Sbjct: 227 G-------------------TSLEEVQQKATYKEP----------NYAVECRPLTPQAVD 257
Query: 293 LLERLLAFDPKDRPTAEEALADPYFK 318
LL+++L DP+ RP+A + L +FK
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-50
Identities = 84/319 (26%), Positives = 137/319 (42%), Gaps = 57/319 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y ++E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQ-----FFLYQLL 136
+IV + + ++ Y+VF+L+ +L + I A RE Y + Q+L
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQIL 115
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTP 171
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 251
Y +PE L Y+ +DIW+ G I +L G P F ++ Q L G
Sbjct: 172 GYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYD 225
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
S ++ P A L++ +L +PK R TA++A
Sbjct: 226 YP--------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
Query: 312 LADPYFKGLSKVEREPSCQ 330
L P+ +V Q
Sbjct: 260 LKVPWICNRERVASAIHRQ 278
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 66/304 (21%), Positives = 107/304 (35%), Gaps = 44/304 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y + +G+G + V H G A+K+I + D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPN 87
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRA 138
I+ + L R + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT------IFWTDYVAT 192
L+ IH HRDLKP NIL + + D G A + W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 193 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QK 252
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
D+++ V+N + Q + S LL ++ DP RP
Sbjct: 253 GDSVALAVQN--------QLSIPQSPRHSSALWQ-------LLNSMMTVDPHQRPHIPLL 297
Query: 312 LADP 315
L+
Sbjct: 298 LSQL 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
+ I +GKG +G V A + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+I+ + + D K IY++ E +L++ ++ + + F+ +L AL
Sbjct: 74 PNILRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DYVATRWYRAPE 199
Y H V HRD+KP+N+L +LKI DFG + A + T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + +D+W G + E L G P F + +T R+V
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---------------ETHRRIV 225
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
D KFP + L+ +LL + P R + + P+ K
Sbjct: 226 NVD------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267
Query: 319 GLSKVEREPSCQPI 332
S+ P Q
Sbjct: 268 ANSRRVLPPVYQST 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 77/319 (24%), Positives = 130/319 (40%), Gaps = 52/319 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------HDIFEHISDAARILREIKL 75
Y+ +E++G+G VV I T ++ A+K I E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
LL + +H N+ HRDLKP+NIL + + +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLG 248
Y APE + S Y +D+WS G I +L G P F + Q+ ++ + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 244
Query: 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 308
S ++ + + L+ R L P+ R TA
Sbjct: 245 NYQFG--------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278
Query: 309 EEALADPYFKGLSKVEREP 327
EEALA P+F+ E
Sbjct: 279 EEALAHPFFQQYVVEEVRH 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-49
Identities = 96/405 (23%), Positives = 162/405 (40%), Gaps = 67/405 (16%)
Query: 6 RKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS 64
++ + + Y ++E +GKG++ VV + TG + A K I+
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDL 123
D ++ RE ++ R L+HP+IV + + ++ Y+VF+L+ +L + I A
Sbjct: 71 DFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA---- 121
Query: 124 TREHYQ-----FFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARV 175
RE Y + Q+L ++ Y H+ + HR+LKP+N+L +K+ DFGLA
Sbjct: 122 -REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 176 AFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
ND+ W + T Y +PE L Y+ +DIW+ G I +L G P F +
Sbjct: 181 -VNDSE---AWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 235 NVVHQLDLMTD-LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 293
+ Q L G S ++ P A L
Sbjct: 234 D---QHRLYAQIKAGAYDYP--------------------------SPEWDTVTPEAKSL 264
Query: 294 LERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELI 353
++ +L +PK R TA++AL P+ +V Q +F RR K I +
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTM 324
Query: 354 F--REILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN 396
R + LL G PS + + + +++N
Sbjct: 325 IATRNLSNLGRNLLNKKEQGP-------PSTIKESSESSQTIDDN 362
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-48
Identities = 84/332 (25%), Positives = 135/332 (40%), Gaps = 56/332 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQLL 136
+IV + + + Y++F+L+ +L + I A RE+Y + Q+L
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQIL 120
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A+ + H V HR+LKP+N+L +K+ DFGLA + W + T
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTP 177
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 251
Y +PE L Y +D+W+ G I +L G P F ++ Q L G
Sbjct: 178 GYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD 231
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
S ++ P A L+ ++L +P R TA EA
Sbjct: 232 FP--------------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
Query: 312 LADPYFKGLSKVEREPSCQPISKMEFEFERRR 343
L P+ S V Q +F RR
Sbjct: 266 LKHPWISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-48
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 50/316 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
Y++ E +G G + +V TG++ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
+RHP+I+ + I + D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 138 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTP 175
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+ APE+ + D+WSIG I +L+G F G+ + + +
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL---------T 221
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
IS V F + F N A + RLL DPK R T ++L
Sbjct: 222 NISAVN-----------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264
Query: 313 ADPYFKGLSKVEREPS 328
+ K + +
Sbjct: 265 EHSWIKAIRRRNVRGE 280
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 77/324 (23%), Positives = 128/324 (39%), Gaps = 50/324 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
++HP+++ + + + D+ ++ EL+ +L + + LT E FL Q+L
Sbjct: 71 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 138 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + + T
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTP 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+ APE+ + D+WSIG I +L+G F G +
Sbjct: 182 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---------------KQE 224
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
T++ V + +F + F N A + RLL DPK R T +++L
Sbjct: 225 TLANVSAVN--------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 313 ADPYFKGLSKVEREPSCQPISKME 336
P+ K + ME
Sbjct: 271 QHPWIKPKDTQQALSRKASAVNME 294
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 82/339 (24%), Positives = 130/339 (38%), Gaps = 64/339 (18%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLL 79
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFF------- 131
+HP IVE+ +Y+VFE M+ +DL I R F
Sbjct: 84 KHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVK-----RADAGFVYSEAVAS 133
Query: 132 --LYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFW 186
+ Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
V T + APE + Y +D+W G I +L+G F G
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK---------- 237
Query: 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKD 304
R+ +Y + +++ + SA L+ R+L DP +
Sbjct: 238 ----------ERLFEGIIKGKY----------KMNPRQWSHISESAKDLVRRMLMLDPAE 277
Query: 305 RPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRR 343
R T EAL P+ K + + + +F RR
Sbjct: 278 RITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 74/314 (23%), Positives = 125/314 (39%), Gaps = 61/314 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLL 76
+Y ++VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQ----- 129
R + HP I+ + +++VF+LM +L + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETR 203
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
+ LL A+ ++H N+ HRDLKP+NIL + N ++++ DFG + +
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLREL 259
Query: 190 VATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
T Y APE L S Y +D+W+ G I +L G P F + Q+ ++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316
Query: 246 -LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 304
+ G S ++ + + L+ RLL DP+
Sbjct: 317 IMEGQYQFS--------------------------SPEWDDRSSTVKDLISRLLQVDPEA 350
Query: 305 RPTAEEALADPYFK 318
R TAE+AL P+F+
Sbjct: 351 RLTAEQALQHPFFE 364
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 56/340 (16%), Positives = 120/340 (35%), Gaps = 57/340 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---------------DIFEHISDAAR 68
Y+I + +G + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREH 127
E++++ +++ + + I+ ++ ++Y+++E ME+ + + + L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 128 YQ--------FFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
+ +L + YIH N+ HRD+KP NIL + N ++K+ DFG + +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 179 DTPTTIFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
T +++ PE + S +DIWS+G + F K
Sbjct: 205 KKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK--- 255
Query: 238 HQLDLMTDLLGTPSLDTISRVVRNDKAR---RYLTSMRKKQPVQFSQKFPNADPSALRLL 294
SL + +R + + + + L
Sbjct: 256 ------------ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 295 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 334
+ L +P +R T+E+AL + + + + + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 72/334 (21%), Positives = 130/334 (38%), Gaps = 50/334 (14%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAAR 68
ME F + Y I E +G G + +V + TG + A K I
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 127
I RE+ +LR + H +++ + + + D+ ++ EL+ +L + + L+ E
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE 116
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTT 183
F+ Q+L + Y+HT + H DLKP+NI+ +K+ DFGLA +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-- 174
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
+ + T + APE+ + D+WSIG I +L+G F G
Sbjct: 175 --FKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ 224
Query: 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDP 302
+T++ + F + F + A + +LL +
Sbjct: 225 ---------ETLANITSVS--------------YDFDEEFFSHTSELAKDFIRKLLVKET 261
Query: 303 KDRPTAEEALADPYFKGLSKVEREPSCQPISKME 336
+ R T +EAL P+ + + + + +E
Sbjct: 262 RKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-47
Identities = 79/363 (21%), Positives = 139/363 (38%), Gaps = 65/363 (17%)
Query: 5 HRKKNSPEMEFFSEYGDASRYKI-------QEVIGKGSYGVVCSAIDTHTGEKVAIKKIH 57
H +S +E + + +Y + ++V+G G G V TG+K A+K +
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL- 62
Query: 58 DIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQ 115
D+ + +E+ + P IV I + + + ++ E ME +L
Sbjct: 63 ------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFS 115
Query: 116 VIKANDDLTREHYQF-------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKL 165
I+ R F + + A++++H+ N+ HRD+KP+N+L + L
Sbjct: 116 RIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
K+ DFG A+ + T T +Y APE+ G KY + D+WS+G I +L
Sbjct: 171 KLTDFGFAKETTQNALQTP-----CYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILL 223
Query: 226 TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFP 284
G P F G + R +R + F + ++
Sbjct: 224 CGFPPFYSNT------------GQAISPGMKRRIRLGQ-------------YGFPNPEWS 258
Query: 285 NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRV 344
A +L+ LL DP +R T + + P+ V + P E + V
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEV 318
Query: 345 TKE 347
+E
Sbjct: 319 KEE 321
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 71/308 (23%), Positives = 126/308 (40%), Gaps = 43/308 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + + +G+G+YG V A++ T E VA+K I D+ + I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ + Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
++ +D+WS G + +L G+ +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPW------------------------------ 208
Query: 262 DKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF-KG 319
D+ + + + D + L LL ++L +P R T + D ++ K
Sbjct: 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 320 LSKVEREP 327
L K + P
Sbjct: 269 LKKGAKRP 276
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 71/324 (21%), Positives = 126/324 (38%), Gaps = 50/324 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
+ HP+I+ + + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+ APE+ + D+WSIG I +L+G F G +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------------E 225
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
T++ + F + F A + +LL + + R T +EAL
Sbjct: 226 TLANITAVS--------------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 313 ADPYFKGLSKVEREPSCQPISKME 336
P+ + + + + +E
Sbjct: 272 RHPWITPVDTQQAMVRRESVVNLE 295
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 67/327 (20%), Positives = 131/327 (40%), Gaps = 75/327 (22%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------------------------HDI 59
+Y +++ IGKGSYGVV A + + A+K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 60 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK 118
+ ++ +EI +L+ L HP++V++ ++ P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPT 130
Query: 119 A---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175
++D R ++Q L++ ++Y+H + HRD+KP N+L + +KI DFG++
Sbjct: 131 LKPLSEDQARFYFQ----DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS-- 184
Query: 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGK 234
+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKK---QPVQFSQKFPNADPSAL 291
++ + K Q ++F P+
Sbjct: 244 RIM--------------------------------CLHSKIKSQALEFP-DQPDIAEDLK 270
Query: 292 RLLERLLAFDPKDRPTAEEALADPYFK 318
L+ R+L +P+ R E P+
Sbjct: 271 DLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 72/369 (19%), Positives = 126/369 (34%), Gaps = 107/369 (28%)
Query: 22 ASR----YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
ASR ++ + +G+G +GVV A + AIK+I + +++RE+K L
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALA 59
Query: 78 LLRHPDIV-------------------------------------------------EIK 88
L HP IV
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 89 HIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQ---FFLYQLLRALKY 141
+ ++ M+ +L + L + Q+ A+++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 192
+H+ + HRDLKP NI + +K+ DFGL D P T V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
+ Y +PE + Y+ +DI+S+G I E+L V
Sbjct: 240 KLYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVR-------------- 281
Query: 253 DTISRVVRNDKARRYLTSMRKKQ-PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
+T +R + P+ F+QK+P +++ +L+ P +RP A +
Sbjct: 282 --------------IITDVRNLKFPLLFTQKYPQ----EHMMVQDMLSPSPTERPEATDI 323
Query: 312 LADPYFKGL 320
+ + F+ L
Sbjct: 324 IENAIFENL 332
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-46
Identities = 81/340 (23%), Positives = 149/340 (43%), Gaps = 55/340 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y++ + IGKG++ V A TG +VAIK I + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +A+ +KI DFG + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
F KY P +D+WS+G I +++G F G+N+ L
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------------KEL------- 222
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK- 318
R + + + P S LL+R L +P R T E+ + D +
Sbjct: 223 -----RERVLRGKYRIPFYMS-------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270
Query: 319 GLSKVEREPSCQPISKMEFEF-----ERRRVTKEDIRELI 353
G + E +P +P + + ++E+I+E +
Sbjct: 271 GHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-46
Identities = 75/349 (21%), Positives = 135/349 (38%), Gaps = 47/349 (13%)
Query: 3 QDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 62
+D KK P+ + Y I E +G G++GVV ++ TG K I+ +
Sbjct: 31 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PY 88
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKAN 120
D + EI ++ L HP ++ + D ++ ++ E + +L ++ +
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAED 143
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFN 178
++ ++ Q LK++H ++ H D+KP+NI+ +KI DFGLA
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-- 201
Query: 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
P I AT + APE+ D+W+IG + +L+G F G++ +
Sbjct: 202 -NPDEIVKVT-TATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL- 256
Query: 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERL 297
+T+ V R D +F F + P A ++ L
Sbjct: 257 --------------ETLQNVKRCD--------------WEFDEDAFSSVSPEAKDFIKNL 288
Query: 298 LAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTK 346
L +P+ R T +AL P+ KG + + +
Sbjct: 289 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 72/319 (22%), Positives = 127/319 (39%), Gaps = 47/319 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + + +G+G+YG V A++ T E VA+K I D+ + I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ + Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
++ +D+WS G + +L G+ +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPW---------------------------- 208
Query: 260 RNDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF- 317
D+ + + + D + L LL ++L +P R T + D ++
Sbjct: 209 --DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
Query: 318 KGLSKVEREPSCQPISKME 336
K L K + P E
Sbjct: 267 KPLKKGAKRPRVTSGGVSE 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 60/308 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
++++ +G+G+ +V T + A+K + + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHP 108
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-----QFFLYQLL 136
+I+++K I +I +V EL+ +L I + +Y + Q+L
Sbjct: 109 NIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQIL 158
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A+ Y+H + HRDLKP+N+L + LKI DFGL+++ + T
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTP 214
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE L G Y P +D+WS+G I +L G F + +
Sbjct: 215 GYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-----------F 260
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
I F S + +A L+ +L+ DPK R T +A
Sbjct: 261 RRI-----------------LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
Query: 312 LADPYFKG 319
L P+ G
Sbjct: 304 LQHPWVTG 311
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 3e-45
Identities = 50/349 (14%), Positives = 98/349 (28%), Gaps = 83/349 (23%)
Query: 12 EMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---------------- 54
SE G+ R V+G+ A D TGE +
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 55 -------KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107
++ ++ A LR I L++ P ++ + L + ++
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 108 LMESDLHQVIKANDDLTREHYQF-------FLYQLLRALKYIHTANVYHRDLKPKNILAN 160
M+S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240
Query: 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPA 211
+ + F V + +R + PEL + T +
Sbjct: 241 QRGGVFLTGFEHL-VRDGARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 212 IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSM 271
D W++G + + + + R+
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAAL---------------GGSEWIFRS---------- 328
Query: 272 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320
LLE L + +DR +A+ P ++ L
Sbjct: 329 ----CKNIP-------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 66/319 (20%), Positives = 123/319 (38%), Gaps = 53/319 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRH 81
+Y + +++G+GSYG V +D+ T + A+K + + + A + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRAL 139
+++++ ++ + + +Y+V E + +++ + QL+ L
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVATRW 194
+Y+H+ + H+D+KP N+L LKI G+A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
PE+ + ++ +DIWS G + TG F G N
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------------------ 217
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
I ++ N Y P P LL+ +L ++P R + +
Sbjct: 218 -IYKLFENIGKGSY------AIPGDCG-------PPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 314 DPYF-KGLSKVEREPSCQP 331
+F K E P
Sbjct: 264 HSWFRKKHPPAEAPVPIPP 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 73/315 (23%), Positives = 128/315 (40%), Gaps = 45/315 (14%)
Query: 24 RYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 81
Y++Q +V+G+G++ V + I+ T ++ A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQL 135
+++E+ + Y+VFE M + I R H+ + +
Sbjct: 71 RNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDV 120
Query: 136 LRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARV----AFNDTPTTIFWTD 188
AL ++H + HRDLKP+NIL N +KICDF L +T
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKD 304
+ +F + + + +A L+ +LL D K
Sbjct: 241 ACPACQNMLFESIQEGK--------------YEFPDKDWAHISCAAKDLISKLLVRDAKQ 286
Query: 305 RPTAEEALADPYFKG 319
R +A + L P+ +G
Sbjct: 287 RLSAAQVLQHPWVQG 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-45
Identities = 79/352 (22%), Positives = 139/352 (39%), Gaps = 61/352 (17%)
Query: 8 KNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
K+SP F+ Y + +G+GS+ + + + + A+K I A
Sbjct: 2 KDSP---FYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEA 50
Query: 68 RILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR 125
+EI L+L HP+IV++ + D ++V EL+ +L + IK +
Sbjct: 51 NTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKK-----K 100
Query: 126 EHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAF 177
+H+ + + +L+ A+ ++H V HRDLKP+N+L N N ++KI DFG AR+
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
D T Y APE L + Y + D+WS+G I +L+G+ F +
Sbjct: 161 PDNQP---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214
Query: 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLE 295
+++ ++ + D F + + N A L++
Sbjct: 215 SLTCTSAVEIM--------KKIKKGD--------------FSFEGEAWKNVSQEAKDLIQ 252
Query: 296 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 347
LL DP R + + + S++ P P K
Sbjct: 253 GLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-45
Identities = 57/326 (17%), Positives = 101/326 (30%), Gaps = 72/326 (22%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLR 80
+ + E IG G +G V + G AIK+ D LRE+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR----EHYQFFLYQL 135
H +V + + + + E L I N + + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 136 LRALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVA 176
R L+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR- 183
Query: 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 296
H++ R+ + + Q LL+
Sbjct: 237 WHEI-------------------------------RQGRLPRIPQVLS---QEFTELLKV 262
Query: 297 LLAFDPKDRPTAEEALADPYFKGLSK 322
++ DP+ RP+A + S+
Sbjct: 263 MIHPDPERRPSAMALVKHSVLLSASR 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 81/367 (22%), Positives = 134/367 (36%), Gaps = 64/367 (17%)
Query: 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 73
+Y +V+G G G V + T EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREV 105
Query: 74 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF- 130
+L R + P IV I + K + +V E ++ +L I+ R F
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RGDQAFT 159
Query: 131 ------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 181
+ + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ +
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
T T +Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 220 ----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
Query: 242 LMTD--LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 299
M +G + ++ L+ LL
Sbjct: 274 GMKTRIRMGQYEFP--------------------------NPEWSEVSEEVKMLIRNLLK 307
Query: 300 FDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILE 359
+P R T E + P+ +KV + P E + V +E L +
Sbjct: 308 TEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDY 367
Query: 360 YHPQLLK 366
++ K
Sbjct: 368 EQIKIKK 374
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 46/330 (13%), Positives = 88/330 (26%), Gaps = 71/330 (21%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR-- 80
V+G+ A D TGE + + + ++ E+ LRLLR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 81 --------------------HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
P ++ + L + ++ M+S+L +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 121 DDLTREHYQ-------FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ H Q++R L +H + H L+P +I+ + + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
A A + + T A D W++G +
Sbjct: 259 VRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 290
+ + R+ N
Sbjct: 317 NTDDAAL---------------GGSEWIFRSC---------------------KNIPQPV 340
Query: 291 LRLLERLLAFDPKDRPTAEEALADPYFKGL 320
LLE L + +DR +A+ P ++ L
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 62/306 (20%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+++ ++ P+ D ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATR 193
H V HRDLKP+N+L +A+ KI DFGL+ + + +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 175
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE+ Y P +DIWS G I +L G F ++V P+L
Sbjct: 176 -YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------------PTL 219
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ + P + S LL +L DP R T ++
Sbjct: 220 ------------FKKIRGGVFYIPEYLN-------RSVATLLMHMLQVDPLKRATIKDIR 260
Query: 313 ADPYFK 318
+FK
Sbjct: 261 EHEWFK 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-44
Identities = 71/326 (21%), Positives = 124/326 (38%), Gaps = 47/326 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDL-HQVIKANDDLTREHYQFFLYQLLRALK 140
+V + D ++ +++E M +L +V ++ ++ + ++ Q+ + L
Sbjct: 215 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 141 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++H N H DLKP+NI+ + +LK+ DFGL T + AP
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAP 325
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ D+WS+G + +L+G F G+N +T+ V
Sbjct: 326 EVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETLRNV 368
Query: 259 VRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
D F + +LL DP R T +AL P+
Sbjct: 369 KSCD--------------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414
Query: 318 KGLSKVEREPSCQPISKMEFEFERRR 343
+ R+ + +
Sbjct: 415 TPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 95/417 (22%), Positives = 153/417 (36%), Gaps = 68/417 (16%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
M + +M + RY + IG G++GV D T E VA+K I
Sbjct: 1 MDRAPVTTGPLDMPIMHDSD---RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER-- 55
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA 119
D + REI R LRHP+IV K ++L P+ + ++ E +L++ I
Sbjct: 56 GAAID-ENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIIMEYASGGELYERICN 109
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAF 177
+ + +FF QLL + Y H+ + HRDLK +N L + +LKICDFG ++ +
Sbjct: 110 AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 178 NDT-PTTIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPG 233
+ P + V T Y APE+ +Y D+WS G +L G F
Sbjct: 170 LHSQPKS-----TVGTPAYIAPEV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNAD---PSA 290
TI R++ V++ P+ P
Sbjct: 221 PEEPRDYR-----------KTIQRILS----------------VKY--SIPDDIRISPEC 251
Query: 291 LRLLERLLAFDPKDRPTAEEALADPYF-KGLSKVEREPSCQPISKMEFEFERRRVTKEDI 349
L+ R+ DP R + E +F K L S E E + + + I
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSL--DTI 309
Query: 350 RELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPP 406
++I P + ++ N D + E ++ SG ++
Sbjct: 310 MQIISEAT---IPAVRNRCLDDFMTDNLD---LDDDMDDFDSESEIDIDSSGEIVYA 360
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 64/306 (20%), Positives = 128/306 (41%), Gaps = 50/306 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+Y I E +G+G +G+V ++T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRALK 140
+I+ + +++ ++FE + D+ ++ + +L +++Q+ AL+
Sbjct: 62 NILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 141 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++H+ N+ H D++P+NI+ + +KI +FG AR + Y AP
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYAP 172
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + A D+WS+G + +L+G F + + I
Sbjct: 173 EVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---------------NQQIIEN 214
Query: 258 VVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
++ + F + F A+ ++RLL + K R TA EAL P+
Sbjct: 215 IMNAE--------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 317 FKGLSK 322
K +
Sbjct: 261 LKQKIE 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 80/324 (24%), Positives = 126/324 (38%), Gaps = 61/324 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHP 82
Y+++E IG GSY V I T + A+K I EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-----QFFLYQLL 136
+I+ +K + D K +YVV ELM+ +L I ++ + L+ +
Sbjct: 77 NIITLKDVY-----DDGKYVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTIT 126
Query: 137 RALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
+ ++Y+H V HRDLKP NIL + ++ICDFG A+ T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYT 183
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTP 250
+ APE L Y A DIWS+G + +LTG F +++ G
Sbjct: 184 ANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
SL + + +A L+ ++L DP R TA
Sbjct: 241 SLS--------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 311 ALADPYFKGLSKVEREPSCQPISK 334
L P+ ++ + + +
Sbjct: 275 VLRHPWIVHWDQLPQYQLNRQDAP 298
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 70/316 (22%), Positives = 119/316 (37%), Gaps = 50/316 (15%)
Query: 17 SEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL 75
EY + Q +G+GS+G V D TG + A+KK+ E E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVA 103
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLY 133
L P IV + + R+ + + EL+E S L Q+IK L + ++L
Sbjct: 104 CAGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLG 157
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLA-RVAFNDTPTTIFWTDYVA 191
Q L L+Y+HT + H D+K N+L +++ + +CDFG A + + ++ DY+
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 192 -TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T + APE+ +DIWS C+ +L G + Q L
Sbjct: 218 GTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPW------TQYFRGPLCL--- 266
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
++ R + P + P + ++ L +P R +A E
Sbjct: 267 ------KIASEPPPIR-------EIPPSCA-------PLTAQAIQEGLRKEPVHRASAME 306
Query: 311 ALADPYFKGLSKVERE 326
+
Sbjct: 307 LRRKVGKALQEVGGLK 322
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 85/305 (27%), Positives = 134/305 (43%), Gaps = 61/305 (20%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y I+E +G+GS+G V A T +KVA+K I + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATRW 194
H + HRDLKP+N+L + N +KI DFGL+ + + +P
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------------ 172
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
Y APE+ Y P +D+WS G + +L G+ F + + P+L
Sbjct: 173 YAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-------------PNL- 216
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
+ + S P S P A L+ R++ DP R T +E
Sbjct: 217 -----------FKKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRR 258
Query: 314 DPYFK 318
DP+F
Sbjct: 259 DPWFN 263
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 71/329 (21%), Positives = 119/329 (36%), Gaps = 63/329 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
+ Y++ ++GKG +G V + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 79 LR----HPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFL 132
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPY-TDFDG 200
Query: 192 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
TR Y PE +Y +WS+G + +++ G F
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPF------------------- 239
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
+ ++ P S P L+ R LA P RP+ EE
Sbjct: 240 --ERDQEILE----AEL------HFPAHVS-------PDCCALIRRCLAPKPSSRPSLEE 280
Query: 311 ALADPYFK-GLSKVEREPSCQPISKMEFE 338
L DP+ + V PS + + +
Sbjct: 281 ILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 74/348 (21%), Positives = 120/348 (34%), Gaps = 85/348 (24%)
Query: 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 73
+Y +V+G G G V + T EK A+K + D + RE+
Sbjct: 14 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREV 61
Query: 74 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF- 130
+L R + P IV I + K + +V E ++ +L I+ R F
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RGDQAFT 115
Query: 131 ------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 181
+ + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------- 166
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
A E G KY + D+WS+G I +L G P F + +
Sbjct: 167 ---------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 242 LMTD--LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 299
M +G + ++ L+ LL
Sbjct: 209 GMKTRIRMGQYEFP--------------------------NPEWSEVSEEVKMLIRNLLK 242
Query: 300 FDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 347
+P R T E + P+ +KV + P E + V +E
Sbjct: 243 TEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 60/306 (19%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 79
+Y++ ++G G +G V S I VAIK + + + + R+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQL 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L A+++ H V HRD+K +NIL + N +LK+ DFG T++ TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVY-TDFDGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPF---------------------E 250
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
++R + + S L+ LA P DRPT EE
Sbjct: 251 HDEEIIR----GQV------FFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQN 293
Query: 314 DPYFKG 319
P+ +
Sbjct: 294 HPWMQD 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 68/357 (19%), Positives = 121/357 (33%), Gaps = 51/357 (14%)
Query: 5 HRKKNSPEMEFFSEYGD-ASRYKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKI---HD 58
H + + S + Y++ VIGKG V A TGE V +++I
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 59 IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQV 116
E ++ + E+ + +L HP+IV + + + +++VV M S +
Sbjct: 66 SNEMVTF---LQGELHVSKLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDL 116
Query: 117 IKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG--- 171
I D + + L +L+AL YIH HR +K +IL + + K+ +
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 172 -LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP- 229
+ F V + +PE+ Y DI+S+G E+ G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
Query: 230 --------------------LFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLT 269
L + + M+ + + +
Sbjct: 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
Query: 270 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 326
S FS F + +E+ L +P RP+A L +FK + + E
Sbjct: 297 SPSHPYHRTFSPHFHH-------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 78/317 (24%), Positives = 122/317 (38%), Gaps = 58/317 (18%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + V+GKG+YG+V + D ++AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLL 136
H +IV+ S + I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPT------TIFWTDY 189
LKY+H + HRD+K N+L N + LKI DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249
APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM------ 235
Query: 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTA 308
+ M K P + P + A + + DP R A
Sbjct: 236 -----------------FKVGMFKVHP-----EIPESMSAEAKAFILKCFEPDPDKRACA 273
Query: 309 EEALADPYFKGLSKVER 325
+ L D + K SK ++
Sbjct: 274 NDLLVDEFLKVSSKKKK 290
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 72/355 (20%), Positives = 130/355 (36%), Gaps = 73/355 (20%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLLR 77
+Y +G G++G V +A+D ++V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQL 135
+ H +I+++ I + +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 196 RAPELCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ Y P +++WS+G L T +
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVT---------------------LYTLVFEENPF 230
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ V P S + L+ LL P+ R T E+ +
Sbjct: 231 CELEETVE----AAI------HPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLV 273
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 367
DP+ QP++ ++ +E + ++ LE + L D
Sbjct: 274 TDPWVT-----------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD 317
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 74/315 (23%), Positives = 128/315 (40%), Gaps = 53/315 (16%)
Query: 23 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
S Y + E++G G +G V +T TG K+A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRA 138
H +++++ DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 139 LKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTP-TTIFWTDYVATRWY 195
++++H + H DLKP+NIL ++KI DFGLAR F T +
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE-----F 254
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE + F + D+WS+G I +L+G F G N +T
Sbjct: 255 LAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---------------ET 296
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
++ ++ ++F + A + +LL + R +A EAL
Sbjct: 297 LNNILACR--------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 314 DPYFKGLSKVEREPS 328
P+ R +
Sbjct: 343 HPWLSDHKLHSRLSA 357
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 69/308 (22%), Positives = 124/308 (40%), Gaps = 55/308 (17%)
Query: 23 SRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+ Y + + +G+G + VV I TG++ A K + A IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQ 134
P ++ + + + +I ++ E ++ + E + Q
Sbjct: 88 CPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQ 139
Query: 135 LLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
+L + Y+H N+ H DLKP+NIL +KI DFG++R + + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIMG 195
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T Y APE+ + T A D+W+IG I +LT F G++
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------------- 239
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
+T + + + V + + F + A ++ LL +P+ RPTAE
Sbjct: 240 -ETYLNISQVN--------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284
Query: 311 ALADPYFK 318
L+ + +
Sbjct: 285 CLSHSWLQ 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 60/309 (19%), Positives = 114/309 (36%), Gaps = 57/309 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HP 82
R +++ V+ +G + V A D +G + A+K++ + I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME---SDLHQVI---KANDDLTREHYQFFLYQLL 136
+IV+ L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 137 RALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA--- 191
RA++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 192 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
T YR PE+ +S DIW++GCI + + F +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 303
R+V +Y F + L+ +L +P+
Sbjct: 260 -------------RIVN----GKY----SIPPHDTQYTVFHS-------LIRAMLQVNPE 291
Query: 304 DRPTAEEAL 312
+R + E +
Sbjct: 292 ERLSIAEVV 300
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-40
Identities = 95/451 (21%), Positives = 162/451 (35%), Gaps = 84/451 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+++ ++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATR 193
H V HRDLKP+N+L +A+ KI DFGL+ + + +P
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 180
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE+ Y P +DIWS G I +L G F +V P+L
Sbjct: 181 -YAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------------PTL 224
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ + P + PS + LL+ +L DP R T ++
Sbjct: 225 ------------FKKICDGIFYTPQYLN-------PSVISLLKHMLQVDPMKRATIKDIR 265
Query: 313 ADPYFKGLSKVEREPSCQPISKMEFEFERRR-------VTKEDIRELIFREILEYHPQ-- 363
+FK P S + E + ++E++ ++ +
Sbjct: 266 EHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNR--NHQDPLA 323
Query: 364 ----LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIV 419
L+ D + A D + PER + +
Sbjct: 324 VAYHLIIDN-------RRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRA 376
Query: 420 HSNTVPPKEQQNLSRDRQAAEEVFNKNSKES 450
Q++ + + A+ S+
Sbjct: 377 RHTLDELNPQKSKHQGVRKAKWHLGIRSQSR 407
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 61/313 (19%), Positives = 118/313 (37%), Gaps = 46/313 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIK-LLRL 78
+ + + +G G+ G V TG +A+K++ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKS 80
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLR 137
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 138 ALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
AL Y+ V HRD+KP NIL + ++K+CDFG++ + Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 197 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
APE Y D+WS+G E+ TG+ + +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--------------TDFE 237
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
+++V++ + + FS F + ++ L D + RP + L
Sbjct: 238 VLTKVLQEE-------PPLLPGHMGFSGDFQS-------FVKDCLTKDHRKRPKYNKLLE 283
Query: 314 DPYFKGLSKVERE 326
+ K +E +
Sbjct: 284 HSFIKRYETLEVD 296
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 72/313 (23%), Positives = 125/313 (39%), Gaps = 45/313 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLL 79
A K IG+G+YG V + +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM----ESDLHQVIKANDDLTREHY-QFFLYQ 134
P IV+ + D ++ ELM + V DD+ E
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 135 LLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++AL ++ + HRD+KP NIL + + +K+CDFG++ + +I T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCR 189
Query: 194 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
Y APE + Y D+WS+G E+ TG+ +P N
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN--------------SV 235
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
D +++VV+ D + + + +FS F N + L D RP +E
Sbjct: 236 FDQLTQVVKGDPPQ-----LSNSEEREFSPSFIN-------FVNLCLTKDESKRPKYKEL 283
Query: 312 LADPYFKGLSKVE 324
L P+ +
Sbjct: 284 LKHPFILMYEERA 296
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+IV S +++VV E + L V+ + + L+AL++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ V HRD+K NIL + +K+ DFG TP + V T ++ APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 202 GSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
Y P +DIWS+G I A E++ G+P + +N + L L+ GTP L
Sbjct: 189 TR--KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL-------- 236
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ P + S F + L R L D + R +A+E L + K
Sbjct: 237 -------------QNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 81/320 (25%), Positives = 133/320 (41%), Gaps = 50/320 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ Y++QEVIG G+ VV +A EKVAIK+I ++ + + +L+EI+ +
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD-----LTREHYQFF 131
HP+IV + ++++V +L+ D+ + I A + L
Sbjct: 72 HPNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDY 189
L ++L L+Y+H HRD+K NIL + ++I DFG++ D +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL-- 247
V T + APE+ Y DIWS G E+ TG + H+ M L+
Sbjct: 187 VGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLT 239
Query: 248 ---GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 304
PSL+T + K ++ + F ++ L DP+
Sbjct: 240 LQNDPPSLETGVQDKEMLK--------------KYGKSFRK-------MISLCLQKDPEK 278
Query: 305 RPTAEEALADPYFKGLSKVE 324
RPTA E L +F+ E
Sbjct: 279 RPTAAELLRHKFFQKAKNKE 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 69/319 (21%), Positives = 122/319 (38%), Gaps = 29/319 (9%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
++ +G G+ GVV +G +A K IH + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 89
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRAL 139
P IV +I + E M+ L QV+K + + +++ L
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 140 KYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
Y+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +P
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSP 199
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E L G + Y+ DIWS+G E+ G+ P + + + + +T R
Sbjct: 200 ERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 258 VVRNDKARRYLTSMRKKQPVQFS--QKFPNADPSALRLLERLLAF----------DPKDR 305
+ + F N P L L F +P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 306 PTAEEALADPYFKGLSKVE 324
++ + + K E
Sbjct: 317 ADLKQLMVHAFIKRSDAEE 335
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 78/343 (22%), Positives = 136/343 (39%), Gaps = 66/343 (19%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
M D ++ E++ + A +++ E++G G+YG V TG+ AIK +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 61 EHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFKD-IYVVFELME----SDLH 114
+ + I +EI +L+ H +I + + D +++V E +DL
Sbjct: 62 DEEEE---IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 115 QVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA- 173
+ K N L E + ++LR L ++H V HRD+K +N+L N ++K+ DFG++
Sbjct: 119 KNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 174 --------RVAFNDTPTTIFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA 222
R F TP +W APE C + Y D+WS+G I A
Sbjct: 178 QLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-ITA 224
Query: 223 -EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQ 281
E+ G P + + L L+ P L + ++S+
Sbjct: 225 IEMAEGAPPLCDMHPMRALFLIPR-NPAPRL----------------------KSKKWSK 261
Query: 282 KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324
KF + +E L + RP E+ + P+ +
Sbjct: 262 KFQS-------FIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 45/298 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
IG+GS G+VC A + H+G +VA+K + + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
++VE+ S ++++V+ E ++ L ++ L E +L+AL Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H V HRD+K +IL + ++K+ DFG + V T ++ APE+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 202 GSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
S Y +DIWS+G I E++ G+P + + V + + D P L
Sbjct: 214 SR--SLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKL-------- 261
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
K + S + LER+L DP++R TA+E L P+
Sbjct: 262 -------------KNSHKVSPVLRD-------FLERMLVRDPQERATAQELLDHPFLL 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 87/357 (24%), Positives = 136/357 (38%), Gaps = 69/357 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D +++EV+G+G++GVVC A + VAIK+I S+ + E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVN 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREHYQFFLYQLL 136
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 137 RALKYIHTAN---VYHRDLKPKNILANANCK-LKICDFGLARVAFNDTPTTIFWTDYVAT 192
+ + Y+H+ + HRDLKP N+L A LKICDFG A T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGS 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
+ APE+ S Y+ D++S G I EV+T + F
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------------- 211
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEA 311
I V N +P P + L+ R + DP RP+ EE
Sbjct: 212 -RIMWAVHNG-----------TRP-----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254
Query: 312 LA-----DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 363
+ YF G + + P + E RV +R H +
Sbjct: 255 VKIMTHLMRYFPGADEPLQYPCQHSLPPG----EDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 64/302 (21%), Positives = 107/302 (35%), Gaps = 61/302 (20%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-----DIFEHISDAARILREIKLLRLLR 80
+ ++ IGKG +G+V VAIK + E I RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI-KANDDLTREHYQFFLYQLLRA 138
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYIHTAN--VYHRDLKPKNIL-----ANANCKLKICDFGLARVAFNDTPT---TIFWTD 188
++Y+ N + HRDL+ NI NA K+ DFGL++ + + W
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWM- 193
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
APE G+ YT D +S I +LTG+ F +
Sbjct: 194 --------APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---------- 235
Query: 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 308
+ I+ + +R P + P ++E + DPK RP
Sbjct: 236 ---IKFINMIREEG--------LRPTIP-------EDCPPRLRNVIELCWSGDPKKRPHF 277
Query: 309 EE 310
Sbjct: 278 SY 279
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-37
Identities = 82/375 (21%), Positives = 136/375 (36%), Gaps = 92/375 (24%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY + +G G + V + D + VA+K + EH ++ A EI+LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 82 PDIVEIKHIMLPPSRRDFKD-------IYVVFELMESDLHQVIKANDD--LTREHYQFFL 132
D + M+ DFK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 133 YQLLRALKYIHT-ANVYHRDLKPKNILANAN----------------------------- 162
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 163 --------------------CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
K+KI D G A + T + TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWV-HKHFTED-----IQTRQYRSLEVL- 265
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQLDLMTDLLGTPSLDTIS 256
S Y DIWS C+ E+ TG LF + + L+ +LLG I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 257 RVVRNDKARRYLTS---MRKKQPVQFSQ---------KFPNAD-PSALRLLERLLAFDPK 303
++ + T ++ ++ ++ + L +L P+
Sbjct: 325 ---AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 304 DRPTAEEALADPYFK 318
R TA E L P+
Sbjct: 382 KRATAAECLRHPWLN 396
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 78/329 (23%), Positives = 139/329 (42%), Gaps = 52/329 (15%)
Query: 2 QQDHRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
++ ++ +++ S + + E +G+GSYG V AI TG+ VAIK++ +
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVE 65
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQV 116
+ + I++EI +++ P +V+ + D+++V E SD+ ++
Sbjct: 66 SDLQE---IIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRL 117
Query: 117 IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176
N LT + L L+ L+Y+H HRD+K NIL N K+ DFG VA
Sbjct: 118 R--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VA 172
Query: 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKN 235
T T + T ++ APE+ Y DIWS+G I A E+ GKP + +
Sbjct: 173 GQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLG-ITAIEMAEGKPPYADIH 229
Query: 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 295
+ + ++ P+ ++P +S F + ++
Sbjct: 230 PMRAIFMIPT-NPPPTF---------------------RKPELWSDNFTD-------FVK 260
Query: 296 RLLAFDPKDRPTAEEALADPYFKGLSKVE 324
+ L P+ R TA + L P+ + V
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 67/306 (21%), Positives = 124/306 (40%), Gaps = 47/306 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLL 79
A + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM----ESDLHQVIKANDDLTREHYQFFLYQL 135
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 136 LRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ + + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKP 174
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE Y+ DIWS+G E+ + FP + + ++ PS
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ +FS +F + + L + K+RPT E +
Sbjct: 233 --------------------QLPADKFSAEFVD-------FTSQCLKKNSKERPTYPELM 265
Query: 313 ADPYFK 318
P+F
Sbjct: 266 QHPFFT 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 69/340 (20%), Positives = 126/340 (37%), Gaps = 55/340 (16%)
Query: 2 QQDHRKKNSPEMEFFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
+ +K S F E+ + +I E+IGKG +G V GE VAI+ I
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIER 67
Query: 61 EHISDAARILREIKLLRLLRHPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVI- 117
++ RE+ R RH ++V + M PP + ++ L + L+ V+
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP------HLAIITSLCKGRTLYSVVR 121
Query: 118 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
A L + ++++ + Y+H + H+DLK KN+ + N K+ I DFGL ++
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 178 NDTPTTIFWTDYVATRWYR--APEL-------CGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
+ W APE+ ++ D++++G I+ E+ +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADP 288
F + P+ I ++ M+
Sbjct: 241 WPFKTQ---------------PAEAIIWQMGTG---------MKPNLSQ------IGMGK 270
Query: 289 SALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328
+L AF+ ++RPT + + + L K R S
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 63/314 (20%), Positives = 119/314 (37%), Gaps = 40/314 (12%)
Query: 1 MQQDHRKKNSPEMEFFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 59
M++ H + + ++ + + + IG GS+G V G+ VA+K ++
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVT 57
Query: 60 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIK 118
E+ +LR RH +I+ P + +V + E S L+ +
Sbjct: 58 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAIVTQWCEGSSLYHHLH 111
Query: 119 ANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
A++ + Q R + Y+H ++ HRDLK NI + + +KI DFGLA
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-K 170
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
+ + + + + APE + + Y+ D+++ G + E++TG+ + N
Sbjct: 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN- 229
Query: 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 296
+ D I +V L+ +R N RL+
Sbjct: 230 --------------NRDQIIEMVGRGSLSPDLSKVR-----------SNCPKRMKRLMAE 264
Query: 297 LLAFDPKDRPTAEE 310
L +RP+
Sbjct: 265 CLKKKRDERPSFPR 278
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-37
Identities = 71/340 (20%), Positives = 122/340 (35%), Gaps = 56/340 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
S EV+GKG +G TGE + +K++ E L+E+K++R L
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLE 65
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 137
HP++++ I + + + E ++ L +IK+ D F +
Sbjct: 66 HPNVLKFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT-----------PTTIFW 186
+ Y+H+ N+ HRDL N L N + + DFGLAR+ ++ P
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
V ++ APE+ Y +D++S G + E++ P
Sbjct: 180 YTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPD------------- 224
Query: 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 306
P VR + + P PN PS + R DP+ RP
Sbjct: 225 -YLPRTMDFGLNVRGF--------LDRYCP-------PNCPPSFFPITVRCCDLDPEKRP 268
Query: 307 TAEE---ALADPYFKGLSKVEREPSCQPISKMEFEFERRR 343
+ + L + P + + + +E RR
Sbjct: 269 SFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 65/288 (22%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
I+E IG GS+G V A G VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD---LTREHYQFFLYQLLRALKY 141
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 142 IHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H N + HR+LK N+L + +K+CDFGL+R+ + ++ T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ D++S G I E+ T + + N ++ V
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAAVG 252
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
R + P N +P ++E +P RP+
Sbjct: 253 FKC--------KRLEIP-------RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 85/342 (24%), Positives = 131/342 (38%), Gaps = 83/342 (24%)
Query: 1 MQQDHRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 59
M + P M+ + D + E IGKGS+G V ID T + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQ--NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DL 57
Query: 60 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQ 115
E + I +EI +L P + + L + ++++ E + DL +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE 112
Query: 116 VIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA-- 173
L L ++L+ L Y+H+ HRD+K N+L + + ++K+ DFG+A
Sbjct: 113 ----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 174 -------RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVL 225
R F TP FW APE+ S Y DIWS+G I A E+
Sbjct: 169 LTDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELA 213
Query: 226 TGKPLFPGKNVVHQLDLMTDLL-----GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS 280
G+P +L M L P+L+ +S
Sbjct: 214 RGEPPH------SELHPMKVLFLIPKNNPPTLEG-----------------------NYS 244
Query: 281 QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322
+ +E L +P RPTA+E L + +K
Sbjct: 245 KPLKE-------FVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 58/323 (17%)
Query: 6 RKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHI 63
P++ D + IG GS+G V A D E VAIKK+ +
Sbjct: 36 GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDL 123
I++E++ L+ LRHP+ ++ + L ++V E +++ +
Sbjct: 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKP 150
Query: 124 TREHY-QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA-----RVAF 177
+E + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +F
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 210
Query: 178 NDTPTTIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKN 235
TP +W APE+ +Y +D+WS+G I E+ KP N
Sbjct: 211 VGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMN 257
Query: 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 295
+ L + +P+L Q +S+ F N ++
Sbjct: 258 AMSALYHIAQ-NESPAL----------------------QSGHWSEYFRN-------FVD 287
Query: 296 RLLAFDPKDRPTAEEALADPYFK 318
L P+DRPT+E L +
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVL 310
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 48/367 (13%), Positives = 101/367 (27%), Gaps = 76/367 (20%)
Query: 3 QDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIH 57
Q P+ EF + + ++G+G++ V A D +K +K
Sbjct: 48 QCKLPAIKPKTEF---QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 58 DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQV 116
+ + + ++ L+ ++ L +V EL L
Sbjct: 105 P--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNA 157
Query: 117 IK-----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL-----------AN 160
I + + F ++L ++ +H + H D+KP N + +
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGC 219
+ L + D G + TIF T ++ E L + ID + +
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAA 273
Query: 220 IFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF 279
+L G + + +P
Sbjct: 274 TVYCMLFGTYMK-----------------------------------VKNEGGECKPEGL 298
Query: 280 SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA---DPYFKGLSKVEREPSCQPISKME 336
++ P+ D +L + + L F+ + + +
Sbjct: 299 FRRLPHLDMWN-EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLL 357
Query: 337 FEFERRR 343
E +R R
Sbjct: 358 LECKRSR 364
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 78/340 (22%), Positives = 135/340 (39%), Gaps = 79/340 (23%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 66
+ S E E D ++I +G G++G V A + TG A K I + + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ET-KSEEEL 60
Query: 67 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD 122
+ EI++L HP IV++ ++++ E + +++ +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRG 113
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA--------- 173
LT Q Q+L AL ++H+ + HRDLK N+L +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGKP 229
R +F TP +W APE+ K Y DIWS+G I E+ +P
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 230 LFPGKNVVHQLDLMTDLL-----GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP 284
P H+L+ M LL P+L P ++S +F
Sbjct: 221 --P----HHELNPMRVLLKIAKSDPPTL---------------------LTPSKWSVEFR 253
Query: 285 NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324
+ L+ L +P+ RP+A + L P+ ++ +
Sbjct: 254 D-------FLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 61/300 (20%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPD 83
++E+IG G +G V A G++VA+K + + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKHI-MLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+ ++ + + P ++ +V E L++V+ + + + Q+ R + Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 142 IHTANVY---HRDLKPKNIL--------ANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
+H + HRDLK NIL +N LKI DFGLAR T +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
W APE+ + S ++ D+WS G + E+LTG+ F G +
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
L V N + P +L+E DP RP+
Sbjct: 219 GLAVAYGVAMNK--------LALPIP-------STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 80/325 (24%), Positives = 119/325 (36%), Gaps = 38/325 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
A + ++ + IGKG YG V GEKVA+K E S EI L+R
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMR 89
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 138
H +I+ I + +Y++ + E+ L+ +K+ L + Y +
Sbjct: 90 HENILGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSG 146
Query: 139 LKYIHTANVY--------HRDLKPKNILANANCKLKICDFGLARVAFNDT-PTTIFWTDY 189
L ++HT HRDLK KNIL N I D GLA +DT I
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 190 VATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
V T+ Y PE L S + + D++S G I EV G +QL
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDL 265
Query: 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305
+ PS + + +V K R + +L+ A +P R
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC---------LRQMGKLMTECWAHNPASR 316
Query: 306 PTAEEALADPYFKGLSKVEREPSCQ 330
TA K L+K+ +
Sbjct: 317 LTALRVK-----KTLAKMSESQDIK 336
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 40/289 (13%), Positives = 88/289 (30%), Gaps = 51/289 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+ + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--KANDDLTREHYQFFLYQLLRALKYI 142
+ P ++ M L+ V+ N + + F + R + ++
Sbjct: 71 PVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 143 HTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPE 199
HT + L ++++ + + +I + + W APE
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------APE 178
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L + D+WS + E++T + F + +++ +V
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMKV 223
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
+R P P P +L++ + DP RP
Sbjct: 224 ALEG--------LRPTIP-------PGISPHVSKLMKICMNEDPAKRPK 257
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 72/309 (23%), Positives = 131/309 (42%), Gaps = 58/309 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + I + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 137
V++ + +D + +Y + + ++ ++ TR F+ +++
Sbjct: 91 FFVKLYF-----TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR----FYTAEIVS 141
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL+Y+H + HRDLKP+NIL N + ++I DFG A+V ++ + +V T Y +
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVS 200
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PEL + D+W++GCI +++ G P F N +
Sbjct: 201 PELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------YLIFQK 243
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEA 311
++ K F +KF P A L+E+LL D R
Sbjct: 244 II--------------KLEYDFPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYGPL 286
Query: 312 LADPYFKGL 320
A P+F+ +
Sbjct: 287 KAHPFFESV 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 77/329 (23%), Positives = 123/329 (37%), Gaps = 46/329 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
A +QE IGKG +G V GE+VA+K R EI +LR
Sbjct: 40 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLR 94
Query: 81 HPDIV-----EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
H +I+ + K +++V + E L + +T E
Sbjct: 95 HENILGFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALS 147
Query: 135 LLRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-TIF 185
L ++H + HRDLK KNIL N I D GLA + T T I
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 186 WTDYVATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
V T+ Y APE L S K+ + DI+++G +F E+ + G + +QL
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLP 266
Query: 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 301
+ PS++ + +VV K R + + + A +++ +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE---------ALRVMAKIMRECWYAN 317
Query: 302 PKDRPTAEEALADPYFKGLSKVEREPSCQ 330
R TA K LS++ ++ +
Sbjct: 318 GAARLTALRIK-----KTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 66/307 (21%), Positives = 112/307 (36%), Gaps = 43/307 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+ E +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRAL 139
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYIHTANVY--------HRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYV 190
++H HRDLK KNIL N + I D GLA + + + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDR 305
PS + + +VV D+ R P ++ F + ++L L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR----------PNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287
Query: 306 PTAEEAL 312
TA
Sbjct: 288 LTALRIK 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 78/300 (26%), Positives = 121/300 (40%), Gaps = 53/300 (17%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLR 80
Y+++ ++G+G G V A DT VA+K + + SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 81 HPDIVEIKHIMLPPSRRDFKDI----YVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 135
P +V I DF +I YV L+ DL +++ L + Q+
Sbjct: 93 EPHVVPI---------HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
AL H A HRD+KP+NIL +A+ + DFG+A A D T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE S T DI+++ C+ E LTG P + G D +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALAD 314
S ++ + S P + ++ R +A +P+DR T + A
Sbjct: 241 S------VMGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 69/296 (23%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 87
IGKGS+G VC T + A+K ++ E ++ + +E+++++ L HP +V +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
+ S +D +D+++V +L+ DL ++ N E + F+ +L+ AL Y+
Sbjct: 81 WY-----SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL + + + I DF +A + +T T T+ Y APE
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMFSSRKG 191
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
+ Y+ A+D WS+G E+L G+ + R+ +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHI--------------------------RSSTSS 225
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALADPYFKGL 320
+ + + V + + + LL++LL +P R + PY +
Sbjct: 226 KEIVHTFETTVVTYPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 68/305 (22%), Positives = 113/305 (37%), Gaps = 33/305 (10%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ ++ EV +G +G V A E VA+K + + E+ L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 138
H +I++ I S D++++ E L +KAN ++ + R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 139 LKYIHTANVY----------HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
L Y+H HRD+K KN+L N I DFGLA F +
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305
+ PSL+ + VV + K R L +K +E D + R
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG---------MAMLCETIEECWDHDAEAR 303
Query: 306 PTAEE 310
+A
Sbjct: 304 LSAGC 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 82/308 (26%), Positives = 123/308 (39%), Gaps = 63/308 (20%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRL 78
RYKI + +G G V A DT KVAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 79 LRHPDIVEIKHIMLPPSRRDF----KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLY 133
L H +IV + D Y+V E +E L + I+++ L+ + F
Sbjct: 68 LSHQNIVSM---------IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV-AT 192
Q+L +K+ H + HRD+KP+NIL ++N LKI DFG+A+ A ++T T T++V T
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLGT 175
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLMTDLL 247
Y +PE DI+SIG + E+L G+P F G+ V H
Sbjct: 176 VQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--------- 224
Query: 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP- 306
++ P + + S ++ R D +R
Sbjct: 225 -----------------------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261
Query: 307 TAEEALAD 314
T +E D
Sbjct: 262 TIQEMKDD 269
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 73/313 (23%), Positives = 116/313 (37%), Gaps = 60/313 (19%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
A +Y+++ I G G + A+D + G V +K + + A + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 139
HP IV+I + + R Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ +LK+ D G N T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + T A DI+++G A + P G+ V + L S
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG------ 298
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALADPYFK 318
RLL R + DP+ R TAEE A
Sbjct: 299 --------------------------------RLLRRAIDPDPRQRFTTAEEMSAQ---- 322
Query: 319 GLSKVEREPSCQP 331
L+ V RE Q
Sbjct: 323 -LTGVLREVVAQD 334
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 80/312 (25%), Positives = 125/312 (40%), Gaps = 66/312 (21%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRL 78
+ RY++ E++G G V A D VA+K + + D R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 79 LRHPDIVEI--------KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQ 129
L HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
+ +AL + H + HRD+KP NI+ +A +K+ DFG+AR A D+ ++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 190 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLM 243
V T Y +PE D++S+GC+ EVLTG+P F G + V H
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----- 231
Query: 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 303
VR D P+ S + ++ + LA +P+
Sbjct: 232 ---------------VRED-------------PIPPSARHEGLSADLDAVVLKALAKNPE 263
Query: 304 DRP-TAEEALAD 314
+R TA E AD
Sbjct: 264 NRYQTAAEMRAD 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ K + +GKG++G V + +TGE VA+KK+ REI++L
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 65
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
+ L+H +IV+ K + RR+ + ++ E + L ++ + + + + Q
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + ++Y+ T HRDL +NIL ++KI DFGL +V D +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEP 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 177 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 78/342 (22%), Positives = 132/342 (38%), Gaps = 61/342 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE--IKLLRLLRHPD 83
K+ E+IG+G YG V + VA+K ++ + E I + L+ H +
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSF-----ANRQNFINEKNIYRVPLMEHDN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
I + + +V E + L + + + + + R L Y+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYL 127
Query: 143 HTANVY---------HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 189
HT HRDL +N+L + I DFGL+ + D
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 190 -VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVV-HQLD 241
V T Y APE L G+ +D++++G I+ E+ LFPG++V +Q+
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNA---DPSALRLLERLL 298
T++ P+ + + +V +K R P KFP A + A+R L+ +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQR----------P-----KFPEAWKENSLAVRSLKETI 292
Query: 299 ----AFDPKDRPTA---EEALADPYFKGLSKVEREPSCQPIS 333
D + R TA EE +A + + ER S P +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA----ELMMIWERNKSVSPTA 330
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ K + +GKG++G V + +TGE VA+KK+ REI++L
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 96
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
+ L+H +IV+ K + RR+ + ++ E + L ++ + + + + Q
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + ++Y+ T HRDL +NIL ++KI DFGL +V D Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKEP 207
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 208 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 64/304 (21%), Positives = 119/304 (39%), Gaps = 50/304 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 87
VIG+G++ V TG+ A+K ++ D+ + + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DL-HQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ +D +Y+V E DL + K + + E +F+L +++ A+ +H
Sbjct: 127 HF-----AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL---- 200
HRD+KP NIL + +++ DFG ++ + T + V T Y +PE+
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LV-AVGTPDYLSPEILQAV 238
Query: 201 -CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
G Y P D W++G E+ G+ F + +T ++
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---------------ETYGKI- 282
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPY 316
+ K+ + A ++RLL P+ R A + P+
Sbjct: 283 -----------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
Query: 317 FKGL 320
F GL
Sbjct: 331 FFGL 334
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 66/321 (20%), Positives = 125/321 (38%), Gaps = 60/321 (18%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRHPDIVEI 87
V+G+G +G V + TG+ A KK+ + + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSL 250
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DL----HQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ + + +V +M D+ + V + N F+ Q++ L+++
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPEL 200
H N+ +RDLKP+N+L + + ++I D GLA A Y T + APEL
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPEL 360
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
+Y ++D +++G E++ + F + + + +
Sbjct: 361 LLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV------------- 405
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADP 315
+Q V + KF P++ E LL DP+ R + + P
Sbjct: 406 ------------LEQAVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
Query: 316 YFKGLS--KVER---EPSCQP 331
F+ +S ++E P P
Sbjct: 451 LFRDISWRQLEAGMLTPPFVP 471
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-29
Identities = 70/336 (20%), Positives = 140/336 (41%), Gaps = 53/336 (15%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIKK 55
++ + + + F+ R ++ VIG+G++G V + + A+K
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 56 IH--DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-D 112
++ ++ + ++ A E +L I + + + +D ++Y+V + D
Sbjct: 107 LNKWEMLKR-AETACFREERDVLVNGDSKWITTLHY-----AFQDDNNLYLVMDYYVGGD 160
Query: 113 L-HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171
L + K D L E +F+L +++ A+ +H + HRD+KP NIL + N +++ DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220
Query: 172 LA-RVAFNDTPTTIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTG 227
++ + T + V T Y +PE+ +Y P D WS+G E+L G
Sbjct: 221 SCLKLMEDGTVQS--SV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 228 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNAD 287
+ F +++V +T ++ M K+ QF + +
Sbjct: 278 ETPFYAESLV---------------ETYGKI------------MNHKERFQFPTQVTDVS 310
Query: 288 PSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 320
+A L+ RL+ + R E+ P+F G+
Sbjct: 311 ENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGI 345
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 53/316 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + A L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + +V LM DL H F+ ++ L+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
+ +RDLKP+NIL + + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
+YT + D W++GC+ E++ G+ F + + + +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------------- 399
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 320
+ K+ P ++S++F P A L +LL DP +R +A E P FK L
Sbjct: 400 -----LVKEVPEEYSERFS---PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
Query: 321 S--KVER---EPSCQP 331
+ ++ EP +P
Sbjct: 452 NFKRLGAGMLEPPFKP 467
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAAR--ILREIK 74
+ K +G+G +G V +TGE+VA+K + + +EI+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIE 75
Query: 75 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
+LR L H +IV+ K I I ++ E + S L + + N + + + +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
Q+ + + Y+ + HRDL +N+L + ++KI DFGL + D Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVK 186
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK+ A D+WS G E+LT
Sbjct: 187 DDRDSPVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-28
Identities = 74/344 (21%), Positives = 122/344 (35%), Gaps = 64/344 (18%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DIFEHISDAARILREIKLLRLLRHP 82
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV + + P + + + +LM DLH + + + +F+ +++ L++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H V +RDLKP NIL + + ++I D GLA P V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
Y + D +S+GC+ ++L G F
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQ--------------------------HK 395
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPY 316
K + + M V+ F P LLE LL D R A+E P+
Sbjct: 396 TKDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
Query: 317 FKGL--SKVER---EPSCQPISKM---EFEFERRRVTKEDIREL 352
F+ L V P P F+ +ED + +
Sbjct: 453 FRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI 496
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D S + IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRA 138
HP +V++ + L + I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 192
+ Y+ A V HRDL +N L N +K+ DFG+ R +D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W +PE FS+Y+ D+WS G + EV + GK + ++ VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 81 HPDIVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQL 135
HP++V++ + PP Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTD 188
A++Y+ N HRDL +N L N +K+ DFGL+R+ DT T I WT
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 179
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 180 --------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ K +GKG++G V +TG VA+K++ REI++L
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQIL 78
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
+ L IV+ + + P R + + +V E + S L ++ + L + Q
Sbjct: 79 KALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + ++Y+ + HRDL +NIL + +KI DFGLA++ D YV
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YVVREP 189
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE + ++ D+WS G + E+ T
Sbjct: 190 GQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHIS 64
N + E + +K +V+G G++G V + GEK VAIK++ +
Sbjct: 5 NQALLRILKE----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-K 59
Query: 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD- 122
IL E ++ + +P + + I L + + ++ +LM L ++ + D
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDN 113
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182
+ ++ + Q+ + + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 183 TIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
Y A +W A E YT D+WS G E++T G + G
Sbjct: 174 ------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 236 ---VVHQLD 241
+ L+
Sbjct: 225 ASEISSILE 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 79/334 (23%), Positives = 132/334 (39%), Gaps = 59/334 (17%)
Query: 7 KKNSPEMEFFSEYGDAS------RYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIKK 55
+KN F S Y D R K ++ VIG+G++G V T + A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 56 IH--DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SD 112
+ ++ + SD+A E ++ P +V++ + + +D + +Y+V E M D
Sbjct: 102 LSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQLFY-----AFQDDRYLYMVMEYMPGGD 155
Query: 113 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172
L ++ N D+ + +F+ +++ AL IH+ HRD+KP N+L + + LK+ DFG
Sbjct: 156 LVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 173 A-RVAFNDTPTTIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ T V T Y +PE Y D WS+G E+L G
Sbjct: 215 CMKMNKEGMVRC--DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPS 289
F ++V T S++ M K + F +
Sbjct: 272 PFYADSLV---------------GTYSKI------------MNHKNSLTFP-DDNDISKE 303
Query: 290 ALRLLERLLAFDPKDR---PTAEEALADPYFKGL 320
A L+ L D + R EE +FK
Sbjct: 304 AKNLICAFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRA 138
HP +V+ + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 192
+ ++ + HRDL +N L + + +K+ DFG+ R +D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE + KY+ D+W+ G + EV + GK + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ K+ + IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 137
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF---WTDYVATRW 194
A++Y+ N HRDL +N+L + + K+ DFGL + A + T WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 33/238 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 75
DA+ I +V+G G +G VCS +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 133
+ HP+I+ ++ ++ K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 192
+ +KY+ HRDL +NIL N+N K+ DFGL RV +D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
RW +PE + K+T A D+WS G + EV++ G+ + + V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 34/239 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLL 76
++ E +G GS+GVV + VA+K + D+ +RE+ +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
L H +++ + ++L P + +V EL L ++ + + Q
Sbjct: 76 HSLDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEH 183
Query: 193 -----RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G N ++H++D
Sbjct: 184 RKVPFAWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
+ASR I+++IG G G VC G+ VAIK + ++ R L E +
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASI 103
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 133
+ HP+I+ ++ ++ + +V E ME+ L ++ +D T L
Sbjct: 104 MGQFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 192
+ ++Y+ HRDL +N+L ++N K+ DFGL+RV +D Y T
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTG 213
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
RW APE F ++ A D+WS G + EVL G+ + V+ ++
Sbjct: 214 GKIPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
R ++ IG+G +G V I VAIK SD+ R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 76 LRLLRHPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQL AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 34/238 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLL 76
+ + +V+G G +G V + GE V IK I D S A + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAI 69
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + + Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 25/227 (11%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPD 83
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRAL 139
IV + + P IY+V EL++ D ++ L + + +
Sbjct: 174 IVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+Y+ + HRDL +N L LKI DFG++R + V +W APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285
Query: 200 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+ + +Y+ D+WS G + E + G +P + ++
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+ +G G++G V VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ I S +V E+ E L++ ++ N + ++ ++Q+ +KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWYRA 197
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------YKAQTHGKWPVKWY-A 188
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 137
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
A++Y+ N HR+L +N L N +K+ DFGL+R+ DT T I WT
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 386
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 55/252 (21%), Positives = 97/252 (38%), Gaps = 38/252 (15%)
Query: 7 KKNSPEMEFFSEYG---DASRYKIQEVIGKGSYGVVCSAIDTHTGE-KVAIKKIHDIFEH 62
KN+P D + +G G +GVV G+ VAIK I E
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIK---EG 59
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND 121
+ E K++ L H +V++ + + I+++ E M + L ++
Sbjct: 60 SMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMR 114
Query: 122 D-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+ + A++Y+ + HRDL +N L N +K+ DFGL+R +D
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD- 173
Query: 181 PTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+Y ++ RW PE +SK++ DIW+ G + E+ + GK +
Sbjct: 174 -------EYTSSVGSKFPVRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
Query: 233 GKN---VVHQLD 241
+
Sbjct: 224 RFTNSETAEHIA 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 54/240 (22%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 133
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 192
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARI--LREIK 74
S Q+VIG G +G V + + K VAIK + ++ R+ L E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAG 98
Query: 75 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
++ H +I+ ++ ++ +K + ++ E ME+ L + ++ D + L
Sbjct: 99 IMGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
+ +KY+ N HRDL +NIL N+N K+ DFGL+RV +D Y +
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTS 208
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
RW APE + + K+T A D+WS G + EV+T G+ + + V+ ++
Sbjct: 209 GGKIPIRWT-APE---AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLR 237
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 137
H +V++ ++ + IY+V E M L +K L Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T I WT
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 348
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 349 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 30/215 (13%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLL 79
K +G+G +G V + TGE VA+K + R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTL 90
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 138
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 192
+ Y+H + HRDL +N+L + + +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE K+ A D+WS G E+LT
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHIS 64
N + E + +K +V+G G++G V + GEK VAIK++ +
Sbjct: 5 NQALLRILKE----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-K 59
Query: 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD- 122
IL E ++ + +P + + I L + + ++ +LM L ++ + D
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDN 113
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182
+ ++ + Q+ + + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 183 TIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
Y A +W A E YT D+WS G E++T G + G
Sbjct: 174 ------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 236 ---VVHQLD 241
+ L+
Sbjct: 225 ASEISSILE 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 57/288 (19%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 82
+ + +G GS+G V +G A+K + + L E ++L+ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFP 101
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 137
+V+++ S +D ++Y+V E + S L ++ + ++ R F+ Q++
Sbjct: 102 FLVKLEF-----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR----FYAAQIVL 152
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T WT T A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LCGTPEALA 206
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ S Y A+D W++G + E+ G P F + +
Sbjct: 207 PEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQIYEK 249
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 305
+V V+F F LL LL D R
Sbjct: 250 IV--------------SGKVRFPSHF---SSDLKDLLRNLLQVDLTKR 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/313 (23%), Positives = 126/313 (40%), Gaps = 72/313 (23%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 82
++I +G GS+G V H G A+K K + E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 137
I+ + + +D + I+++ + +E S L + + + + + F+ ++
Sbjct: 67 FIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAEVCL 117
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVAT 192
AL+Y+H+ ++ +RDLKP+NIL + N +KI DFG A+ + T +T DY+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYI-- 170
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ + Y +ID WS G + E+L G F N + +L
Sbjct: 171 ----APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKIL----- 216
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PT 307
++F F + LL RL+ D R
Sbjct: 217 ---------------------NAELRFPPFF---NEDVKDLLSRLITRDLSQRLGNLQNG 252
Query: 308 AEEALADPYFKGL 320
E+ P+FK +
Sbjct: 253 TEDVKNHPWFKEV 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 27 IQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V + + VAIK + E ++RE +++ L +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYI 72
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 73 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWY 195
N HRDL +N+L KI DFGL++ D Y A +WY
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 180
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 181 -APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLR 320
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 137
H +V++ ++ + IY+V E M L +K L Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T I WT
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 431
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 432 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ K+ + IGKG +G V + G KVA+K I + A L E ++ LR
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK---NDATAQA-FLAEASVMTQLR 244
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 137
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + K+ DFGL + A + T +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 77
+ EVIG+G +G V K A+K ++ I + I + ++ L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQL 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT--- 192
+ +KY+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
K+ E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLL 136
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT---- 192
+ +I N HRDL+ NIL + KI DFGLAR+ ++ +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 35/244 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLR 77
D + + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------DDLTREHYQF 130
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-Y 189
F+ + ++Y+ N HRDL +N + + + + DFGL++ I+ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 190 VAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 237
+W A E S YT D+W+ G E+ T G +PG +
Sbjct: 204 RQGRIAKMPVKWI-AIE---SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 238 HQLD 241
L
Sbjct: 260 DYLL 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
K+++ +G G +G V A KVA+K + L E +++ L+
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQ 241
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 137
H +V++ ++ + IY++ E M L +K+++ F Q+
Sbjct: 242 HDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
+ +I N HRDL+ NIL +A+ KI DFGLARV ++ T I WT
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT--- 352
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 ------APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 65/308 (21%)
Query: 30 VIGKGSYG---VVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 84
V+GKG YG V +TG+ A+K K I + D A E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 85 VEIKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
V++ + + +Y++ EL + ++ + F+L ++ A
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L ++H + +RDLKP+NI+ N +K+ DFGL + + +D T + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E L S + A+D WS+G + ++LTG P F G+N
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGEN---------------------- 225
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEAL 312
R+ K + A LL++LL + R P A E
Sbjct: 226 -------RKKTIDKILKCKLNLPPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275
Query: 313 ADPYFKGL 320
A P+F+ +
Sbjct: 276 AHPFFRHI 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 77
+ EVIG+G +G V K A+K ++ I + I + ++ L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQL 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT--- 192
+ +K++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 44/258 (17%)
Query: 9 NSPEMEFFSEY---GDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEH 62
+S + + + VIGKG +GVV + + AIK + I E
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE- 62
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIML---PPSRRDFKDIYVVFELMES-DLHQVIK 118
+ LRE L+R L HP+++ + IML +V+ M DL Q I+
Sbjct: 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIR 115
Query: 119 AND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
+ + T + F Q+ R ++Y+ HRDL +N + + + +K+ DFGLAR
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-- 173
Query: 178 NDTPTTIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
I +Y + +W A E ++T D+WS G + E+LT
Sbjct: 174 ------ILDREYYSVQQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 227 GKPLFPGKN---VVHQLD 241
G P + + + H L
Sbjct: 225 GAPPYRHIDPFDLTHFLA 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 27 IQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V + + VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWY 195
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 75
R ++ IG+G +G V I VAIK SD+ R L+E
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALT 444
Query: 76 LRLLRHPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 445 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQL AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + Y
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 549
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 550 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLR 77
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 78 LLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMES-DLHQVIKAN------DDLTREHYQ 129
HP + ++ + L ++ V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
F+ + ++Y+ + N HRDL +N + + + + DFGL+R I+ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 237
+ +W A E + YT D+W+ G E++T G+ + G +
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 238 HQLD 241
+ L
Sbjct: 250 NYLI 253
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 71/300 (23%), Positives = 128/300 (42%), Gaps = 53/300 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K + I + A + E ++L+ RHP + +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTAL 70
Query: 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
K+ R + V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 71 KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
V +RD+K +N++ + + +KI DFGL + +D T + T Y APE L
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--- 179
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
+ Y A+D W +G + E++ G+ F ++ + + ++ ++ R
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------ERLFELILMEEIR 223
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 320
P S P A LL LL DPK R A+E + +F +
Sbjct: 224 F---------PRTLS-------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 52/298 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRL-LRHPDIVE 86
++GKGS+G V A T + AIK K + D + E ++L L HP +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTH 82
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ ++ V E + DL I++ F+ +++ L+++H+
Sbjct: 83 MFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLK NIL + + +KI DFG+ + + + T + T Y APE+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FCGTPDYIAPEILLG 192
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
KY ++D WS G + E+L G+ F G++ + + +R D
Sbjct: 193 --QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----------------EELFHSIRMDN 234
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALADPYFKGL 320
P A LL +L +P+ R + P F+ +
Sbjct: 235 PFY---------PRWLE-------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 36/292 (12%), Positives = 70/292 (23%), Gaps = 66/292 (22%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 80
RY++ G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 139
P + + ++ VV E + L +V + + + L A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
P DI IG +L + P V ++
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGV---------------RSGLAPAE 215
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
R+ + P++ + + + R + D R +
Sbjct: 216 RDTAGQ----------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 38/244 (15%), Positives = 77/244 (31%), Gaps = 40/244 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREI 73
E +G+G++ + + G+ +V +K + H + +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAA 63
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFF 131
++ L H +V + + + +V E ++ L +K N + +
Sbjct: 64 SMMSKLSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNIL--------ANANCKLKICDFGLARVAFNDTPTT 183
QL A+ ++ + H ++ KNIL +K+ D G++
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---- 174
Query: 184 IFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 237
D W PE C A D WS G E+ + G + +
Sbjct: 175 ----DILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 238 HQLD 241
+
Sbjct: 229 QFYE 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 70/308 (22%), Positives = 123/308 (39%), Gaps = 67/308 (21%)
Query: 30 VIGKGSYG---VVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 84
V+G+GS+G +V + + A+K K + D R E +L + HP I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFI 88
Query: 85 VEIKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
V++ + + +Y++ +L + L + + ++ + F+L +L A
Sbjct: 89 VKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAELALA 138
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L ++H+ + +RDLKP+NIL + +K+ DFGL++ + + + T Y AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAP 195
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + +T + D WS G + E+LTG F GK+
Sbjct: 196 EVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD---------------------- 230
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEAL 312
R+ +M K + Q P A LL L +P +R EE
Sbjct: 231 -------RKETMTMILKAKLGMPQFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280
Query: 313 ADPYFKGL 320
+F +
Sbjct: 281 RHSFFSTI 288
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 52/300 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K K I + A L E ++L+ RHP + +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTAL 213
Query: 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 145
K+ R + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 214 KYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + + +KI DFGL + D T + T Y APE+
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 323
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR 265
+ Y A+D W +G + E++ G+ F ++
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------------------------H 354
Query: 266 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADPYFKGL 320
L + + ++F + P A LL LL DPK R A+E + +F G+
Sbjct: 355 EKLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 70/319 (21%), Positives = 124/319 (38%), Gaps = 55/319 (17%)
Query: 20 GDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILRE 72
G +Q+ VIG+GSY V T A+K K + + D + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTE 59
Query: 73 IK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF 130
+ HP +V + SR ++ V E + DL ++ L EH +F
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTD 188
+ ++ AL Y+H + +RDLK N+L ++ +K+ D+G+ + + DT +T
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----- 169
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
+ T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 170 FCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------ 220
Query: 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-- 305
YL + ++ ++ + A +L+ L DPK+R
Sbjct: 221 --------------QNTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLG 263
Query: 306 ----PTAEEALADPYFKGL 320
+ P+F+ +
Sbjct: 264 CHPQTGFADIQGHPFFRNV 282
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 63/338 (18%), Positives = 125/338 (36%), Gaps = 67/338 (19%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK-- 54
+ +K + + F G+ R K+ + V+GKGS+G V + T E A+K
Sbjct: 315 TKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL 374
Query: 55 KIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-D 112
K + + D + E + L + P + ++ R +Y V E + D
Sbjct: 375 KKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGD 428
Query: 113 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172
L I+ H F+ ++ L ++ + + +RDLK N++ ++ +KI DFG+
Sbjct: 429 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 173 AR--VAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ + T T + T Y APE + Y ++D W+ G + E+L G+
Sbjct: 489 CKENIWDGVTTKT-----FCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKAR--RYLTSMRKKQPVQFSQKFPNAD 287
F G++ D + + + + ++
Sbjct: 541 PFEGEDE----------------DELFQSIMEHNVAYPKSMS------------------ 566
Query: 288 PSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 320
A+ + + L+ P R + +F+ +
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 61/308 (19%), Positives = 114/308 (37%), Gaps = 68/308 (22%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 86
V+GKGS+G V + T E A+K K + + D + E + L + P + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQ 85
Query: 87 IKHIMLPPSRRDFKDIYVVFE------LMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
+ R +Y V E LM H I+ H F+ ++ L
Sbjct: 86 LHSCFQTMDR-----LYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
++ + + +RDLK N++ ++ +KI DFG+ + D TT + T Y APE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEI 192
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ Y ++D W+ G + E+L G+ F G++ D + + +
Sbjct: 193 IAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSI 233
Query: 260 RNDKAR--RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEAL 312
+ ++ A+ + + L+ P R P +
Sbjct: 234 MEHNVAYPKSMS------------------KEAVAICKGLMTKHPGKRLGCGPEGERDIK 275
Query: 313 ADPYFKGL 320
+F+ +
Sbjct: 276 EHAFFRYI 283
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 50/304 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 86
VIG+GSY V T A++ K + + D + E + HP +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ SR ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 118 LHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPE-LCG 202
+ +RDLK N+L ++ +K+ D+G+ + + DT +T + T Y APE L G
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-----FCGTPNYIAPEILRG 227
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y ++D W++G + E++ G+ F D
Sbjct: 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------------------Q 264
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR------PTAEEALADPY 316
YL + ++ ++ + A +L+ L DPK+R + P+
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
Query: 317 FKGL 320
F+ +
Sbjct: 322 FRNV 325
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/303 (21%), Positives = 127/303 (41%), Gaps = 47/303 (15%)
Query: 30 VIGKGSYG---VVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH-PD 83
V+G G+YG +V TG+ A+K + I + E ++L +R P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V + + ++ ++++ + + +L + + T Q ++ +++ AL+++
Sbjct: 121 LVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP++
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPDIVR 233
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
S + A+D WS+G + E+LTG F
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-------------------------EK 268
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADPYF 317
++ ++ K + Q+ A L++RLL DPK R P A+E +F
Sbjct: 269 NSQAEISRRILKSEPPYPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
Query: 318 KGL 320
+ +
Sbjct: 326 QKI 328
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 61/305 (20%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 86
V+GKGS+G V A TG+ A+K K I + D + E + L HP + +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQ 88
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ P R ++ V E + DL I+ + +F+ +++ AL ++H
Sbjct: 89 LFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFWT-DYVATRWYRAPE-LC 201
+ +RDLK N+L + K+ DFG+ + T T T DY+ APE L
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI------APEILQ 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
Y PA+D W++G + E+L G F +N
Sbjct: 198 E---MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-------------------------- 228
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR------PTAEEALADP 315
L V + A +L+ + +P R L P
Sbjct: 229 ---EDDLFEAILNDEVVYPTWLH---EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282
Query: 316 YFKGL 320
+FK +
Sbjct: 283 FFKEI 287
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 78/340 (22%), Positives = 125/340 (36%), Gaps = 70/340 (20%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK- 54
M + +P + K + VIGKGS+G V A A+K
Sbjct: 11 MNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 55 -KIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF------ 106
+ I + + I+ E LL+ ++HP +V + + +Y V
Sbjct: 71 LQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-----LYFVLDYINGG 124
Query: 107 ELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166
EL H ++ +F+ ++ AL Y+H+ N+ +RDLKP+NIL ++ +
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179
Query: 167 ICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
+ DFGL + + N T +T + T Y APE+ Y +D W +G + E+
Sbjct: 180 LTDFGLCKENIEHNSTTST-----FCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEM 232
Query: 225 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP 284
L G P F +N M D +P+Q
Sbjct: 233 LYGLPPFYSRNT----AEMYD-------------------------NILNKPLQLKPNIT 263
Query: 285 NADPSALRLLERLLAFDPKDR----PTAEEALADPYFKGL 320
SA LLE LL D R E + +F +
Sbjct: 264 ---NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 55/256 (21%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
++ +G+G++G V A VA+K + + S++AR RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREA 94
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD---------- 122
+LL +L+H IV + + + + +VFE M DL++ ++++
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 123 -----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
L Q+ + Y+ + HRDL +N L +KI DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 178 NDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 229 PLFPGKN---VVHQLD 241
+ + + +
Sbjct: 259 QPWYQLSNTEAIDCIT 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 61/271 (22%)
Query: 7 KKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFE 61
++ +G+G++G V A T VA+K + D
Sbjct: 4 HSGIHVQHI-----KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-- 56
Query: 62 HISDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK 118
+ AAR RE +LL L+H IV+ + D + +VFE M+ DL++ ++
Sbjct: 57 --TLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLR 109
Query: 119 AN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 162
A+ +L Q+ + Y+ + + HRDL +N L AN
Sbjct: 110 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 169
Query: 163 CKLKICDFGLARVAFNDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDI 214
+KI DFG++R ++ TDY RW PE + K+T D+
Sbjct: 170 LLVKIGDFGMSRD--------VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 218
Query: 215 WSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
WS G I E+ T GK + + V+ +
Sbjct: 219 WSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 90.7 bits (224), Expect = 5e-20
Identities = 51/347 (14%), Positives = 89/347 (25%), Gaps = 70/347 (20%)
Query: 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARI 69
FS + + E IG+G +G V I HT VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 70 LREIKLLRLL---------RHPDIVEIKHIML-------------------------PPS 95
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKP 154
+++V E + + + L+QL +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 215 WSIGCIFAEVLTGKPLFPGKN----VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTS 270
+F +V + LF G +++L + S V+ +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292
Query: 271 MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ + +L F +A + L
Sbjct: 293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 50/238 (21%), Positives = 88/238 (36%), Gaps = 51/238 (21%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
S + E +G+ +G V + VAIK + + R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------ 120
L L+HP++V + ++ + + ++F DLH+ +
Sbjct: 64 MLRARLQHPNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 121 ----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176
L + + Q+ ++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 177 FNDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
++ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 56/242 (23%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREIKLLRL 78
+ +G+GS+G+V + + +VAIK ++ E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKE 84
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN----------DDLTREH 127
+V + ++ + V+ ELM DL +++ +
Sbjct: 85 FNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
++ + Y++ HRDL +N + + +KI DFG+ R I+ T
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------IYET 191
Query: 188 DYVATRWYR------------APELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
DY YR +PE S +T D+WS G + E+ T + + G
Sbjct: 192 DY-----YRKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243
Query: 234 KN 235
+
Sbjct: 244 LS 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 63/260 (24%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDI 59
H KN+P+ + D + K Q+VIG+G++G V A G + AIK++
Sbjct: 5 HHHHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-- 61
Query: 60 FEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME 110
E+ S E+++L +L HP+I+ +L +Y+ E
Sbjct: 62 -EYASKDDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAP 109
Query: 111 S-DLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153
+L ++ + L+ + F + R + Y+ HRDL
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFS 206
+NIL N KI DFGL+R + YV RW A E +S
Sbjct: 170 ARNILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYS 216
Query: 207 KYTPAIDIWSIGCIFAEVLT 226
YT D+WS G + E+++
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 49/251 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
+ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFL 132
++ H +IV + L +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 133 YQLL-------RALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAFNDTPT 182
LL +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 183 TIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
I+ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 234 KN---VVHQLD 241
K+ V+ +
Sbjct: 249 KSNQEVLEFVT 259
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 32/168 (19%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
+++ + IG G++G + + +T E VAIK E + A L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-------- 131
I ++ + K +V EL+ L +DL + F
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSL-------EDLFDLCDRTFSLKTVLMI 110
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNIL-----ANANCKLKICDFGLAR 174
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 49/251 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
+ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFL 132
++ H +IV + L +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 133 YQLL-------RALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAFNDTPT 182
LL +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 183 TIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
I+ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 234 KN---VVHQLD 241
K+ V+ +
Sbjct: 290 KSNQEVLEFVT 300
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 52/252 (20%)
Query: 23 SRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKL 75
R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
D LT EH + +Q+ + ++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 178 NDTPTTIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 229 PLFPGKNVVHQL 240
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
+RY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRA 138
I I+ + +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 139 LKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLAR 174
++YIH+ N HRD+KP N L N + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 33/168 (19%), Positives = 66/168 (39%), Gaps = 21/168 (12%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++ + + IG G +G++ A T+ EK A + E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 84 IVEIKHIMLPPSRRDFKDIY--------------VVFELMESDLHQVIKANDDLTREHYQ 129
++ Y +V E + DL ++ N +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
++L L+YIH H D+K N+L N + ++ + D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 73/251 (29%)
Query: 23 SRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIHDIFEHISDAARI--LREIKL 75
+ + IG+G++G V A + + VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKANDD---------- 122
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 123 --------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168
L+ Q+ + Y+ HRDL +N L N +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 169 DFGLARVAFNDTPTTIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 215
DFGL+R I+ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 216 SIGCIFAEVLT 226
+ G + E+ +
Sbjct: 261 AYGVVLWEIFS 271
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
YK+ IG+GS+GV+ + ++VAIK FE A L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL------- 132
I + + ++ +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQLLRALKYIHTANVYHRDLKPKNIL------ANANCKLKICDFGLAR 174
Q+L ++ IH ++ +RD+KP N L NAN + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 61/255 (23%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREIKL 75
+ + + +G G++G V A G+ KVA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 76 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME---------------SDL 113
+ L +H +IV +L P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
AN + F Q+ + + ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 174 RVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 227 -GKPLFPGKNVVHQL 240
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 79/270 (29%)
Query: 23 SRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIHDIFEHISDAARI--LREIKL 75
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN-------- 120
L+ + HP +++ + P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 121 ----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164
LT F +Q+ + ++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 165 LKICDFGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 215
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 216 SIGCIFAEVLT--GKPLFPG---KNVVHQL 240
S G + E++T G P +PG + + + L
Sbjct: 237 SFGVLLWEIVTLGGNP-YPGIPPERLFNLL 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 81/295 (27%)
Query: 1 MQQDHRKKNSPEMEFFSEYG---------DASRYKIQEVIGKGSYGVVCSA----IDTHT 47
H P + SEY + + + +G+G++G V A ID
Sbjct: 4 SHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63
Query: 48 GE---KVAIKKIHDIFEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPS 95
+ VA+K + + ++ + E++++ + +H +I+ +L P
Sbjct: 64 PKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIIN----LLGACTQDGP- 115
Query: 96 RRDFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHYQFFLYQLLRA 138
+YV+ E +L + ++A + +T + YQL R
Sbjct: 116 ------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVAT----- 192
++Y+ + HRDL +N+L N +KI DFGLAR I D Y T
Sbjct: 170 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--------INNIDYYKKTTNGRL 221
Query: 193 --RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVVHQL 240
+W APE + F YT D+WS G + E+ T G P P + + L
Sbjct: 222 PVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 81/294 (27%)
Query: 2 QQDHRKKNSPEMEFFSEYG---------DASRYKIQEVIGKGSYGVVCSA----IDTHTG 48
+ ++P + SEY + + + +G+G +G V A ID
Sbjct: 51 TRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKP 110
Query: 49 E---KVAIKKIHDIFEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPSR 96
+ VA+K + + ++ + E++++ + +H +I+ +L P
Sbjct: 111 KEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIIN----LLGACTQDGP-- 161
Query: 97 RDFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHYQFFLYQLLRAL 139
+YV+ E +L + ++A + +T + YQL R +
Sbjct: 162 -----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVAT------ 192
+Y+ + HRDL +N+L N +KI DFGLAR I D Y T
Sbjct: 217 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--------INNIDYYKKTTNGRLP 268
Query: 193 -RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQL 240
+W APE + F YT D+WS G + E+ T G +PG + + L
Sbjct: 269 VKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 64/260 (24%), Positives = 94/260 (36%), Gaps = 67/260 (25%)
Query: 23 SRYKIQEVIGKGSYGVV--CSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
+R + +G G++G V +A + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN------- 120
L L H +IV +L P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 121 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169
L E F YQ+ + + ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 170 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 222 AEVLT-GKPLFPGKNVVHQL 240
E+ + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 61/264 (23%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 23 SRYKIQEVIGKGSYGVV--CSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREI 73
R + + +G+G++G V AI + KVA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 74 KLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 121 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 170 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 220
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 221 FAEVLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 38/166 (22%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
+++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-------- 131
I ++ + +V +L+ L +DL +
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSL-------EDLFNFCSRKLSLKTVLML 108
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
Q++ ++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 74/266 (27%)
Query: 23 SRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKL 75
+ +V+G G++G V +A T +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 76 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME------------------ 110
+ +L H +IV +L P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 111 ------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164
+ + + LT E F YQ+ + ++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 165 LKICDFGLAR-VAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIW 215
+KICDFGLAR + + YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 216 SIGCIFAEVLT-GKPLFPGKNVVHQL 240
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 35/175 (20%), Positives = 67/175 (38%), Gaps = 32/175 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+K+ IG+G +G + A D ++ E V + SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 84 IVEIKHIMLPPSRRDFKDIY--------------VVFELMESDLHQVIKANDDLTREHYQ 129
++ + ++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 130 FFL-------YQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
F ++L L+YIH H D+K N+L N + ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 58/240 (24%), Positives = 89/240 (37%), Gaps = 86/240 (35%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKI-------HDIFEHISDAARILREIKLLRLLRHP 82
+IG G +G V + G KVA+K+ + F EI+ L RHP
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF---------ETEIETLSFCRHP 95
Query: 83 DIV-------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 135
+V E ++L +++ ME N +L + H LY
Sbjct: 96 HLVSLIGFCDERNEMIL------------IYKYME---------NGNL-KRH----LYGS 129
Query: 136 L-------------------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176
R L Y+HT + HRD+K NIL + N KI DFG+++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 177 FNDTPTTIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKP 229
T +++T Y PE +F + T D++S G + EVL +
Sbjct: 190 TELDQT------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 1e-13
Identities = 94/660 (14%), Positives = 179/660 (27%), Gaps = 229/660 (34%)
Query: 43 IDTHTGE-KVAIKKIHDIFE----------HISDAAR-ILREIKLLRLLRHPDIVEIKHI 90
+D TGE + K I +FE + D + IL + EI HI
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHI 54
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQL--------LRALKY 141
++ +F + S ++++ +++ R +Y+F + + + Y
Sbjct: 55 IMSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 142 IHTANVYHRD-----------LKPKNILANANCKLK----ICDFG--------LARVAFN 178
I + + D L+P L A +L+ + G +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 179 DTPTT------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
IFW ++ + + L
Sbjct: 173 SYKVQCKMDFKIFWL----------------------------NLKNCNSPETVLEML-- 202
Query: 233 GKNVVHQLDLMTDLLGTPSLDTISRVVR-NDKARRYLTSMRKKQPVQFSQKFPNA----- 286
+ +++Q+D S + R+ + RR L S+ + N
Sbjct: 203 -QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL----------KSKPYENCLLVLL 251
Query: 287 ---DPSALRLLERLLAFDPKDR---PTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 340
+ A AF+ + T + + D + S S E
Sbjct: 252 NVQNAKAWN------AFNLSCKILLTTRFKQVTD---FLSAATTTHISLDHHSMTLTPDE 302
Query: 341 RR----RVTKEDIRELIFREILEYHPQL-------LKDYMNGTERT-------------- 375
+ + ++L RE+L +P+ ++D + +
Sbjct: 303 VKSLLLKYLDCRPQDLP-REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 376 --NFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIV----HSNTVPPKEQ 429
N L P ++RK F L + P +P +
Sbjct: 362 SLNVLEP---AEYRKMFDRL---------SVFPP--SAHIPTILLSLIWFDVIKSDVMVV 407
Query: 430 QNLSRDRQAAEEVFNKNSKESE-GIP-------------ANLSRTLPAQQRFPLAKPGKV 475
N E K KES IP L R++ P
Sbjct: 408 VNKLHKYSLVE----KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463
Query: 476 VGPVV-----------------PYENASVRRDAY-DPRTF----IRSTVLPQAIPAAYC- 512
+ P E ++ R + D R F IR +
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-FLEQKIRHDSTAWNASGSILN 522
Query: 513 -------YRKSSTGKQEMDSEREMPSQVKHVPQCG---MAAKFATDI---AINMDSNPFF 559
Y+ + ER + + + +P+ + +K+ TD+ A+ + F
Sbjct: 523 TLQQLKFYKPYIC-DNDPKYERLVNAILDFLPKIEENLICSKY-TDLLRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 5e-05
Identities = 53/396 (13%), Positives = 108/396 (27%), Gaps = 96/396 (24%)
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-- 292
+ D+ +L +D I L + + QKF LR
Sbjct: 34 DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE---EVLRIN 90
Query: 293 ---LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDI 349
L+ + K + Y + ++ + Q +K R +
Sbjct: 91 YKFLMSPI-----KTEQRQPSMMTRMYIEQRDRLYNDN--QVFAKY---NVSRLQPYLKL 140
Query: 350 RELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEE----NVGKSGPVIP 405
R+ + L +L D + G+ +T ++ ++ Q + N+
Sbjct: 141 RQALLE--LRPAKNVLIDGVLGSGKT-WVALDVCLSYKVQCKMDFKIFWLNLKN------ 191
Query: 406 PERKHVSLPRSTIVHSNTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQ 465
+ P + + + Q L + + S S I + +
Sbjct: 192 -----CNSPETVL--------EMLQKLLYQ---IDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 466 RFPLAKPGKVVGPVVPYENA-SVRRDAYDPRTF----IRSTVL--------PQAIPAAYC 512
R +K PYEN V + + + + + +L + AA
Sbjct: 236 RLLKSK---------PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 513 YRKSSTGKQEMDSERE---------------MPSQVKHV-PQ-CGMAAKFATDIAINMDS 555
S + E +P +V P+ + A+ D D
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD- 345
Query: 556 NPFFMTRAGVNKVEHIEDQISIDTNLLQT---KSQY 588
+K+ I I N+L+ + +
Sbjct: 346 ---NWKHVNCDKLTTI---IESSLNVLEPAEYRKMF 375
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 25/180 (13%), Positives = 60/180 (33%), Gaps = 42/180 (23%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTG--------EKVAIKKIHDIFEHISDAARILREIKL 75
++K++ + + G++ A T T +K ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 76 L-RLLRHPDIVEIKHIMLPPS----------RRDFKDIYVVFELMESDLHQVIKANDDLT 124
R + + + K + P K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 125 REHYQFFL-------YQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
+LL AL+++H H ++ +NI + + ++ + +G A
Sbjct: 156 -----LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-QVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AEVLT-GKPLFPGKNVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 73/234 (31%)
Query: 30 VIGKGSYGVV-CSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIV- 85
+G+G +GVV ++ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL--- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGTP 128
Query: 137 ---------------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
+ ++H + HRD+K NIL + KI DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 182 TTIFWTDYVATRW-----YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + +R Y APE L G + TP DI+S G + E++TG P
Sbjct: 189 T------VMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 51/223 (22%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV---- 85
++G+G +G V G VA+K++ + + E++++ + H +++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 94
Query: 86 ---EIKHIMLPPSRRDFKDIYVVFELM-----ESDLHQVIKANDDL---TREHYQFFLYQ 134
+L V+ M S L + ++ L R +
Sbjct: 95 FCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKR-------QR 135
Query: 135 LL----RALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
+ R L Y+H + HRD+K NIL + + + DFGLA++ + T + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-T 193
Query: 188 DYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
T + APE G K + D++ G + E++TG+
Sbjct: 194 AVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 620 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.06 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.09 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-67 Score=564.45 Aligned_cols=340 Identities=49% Similarity=0.878 Sum_probs=296.9
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRR 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~-~~~ 97 (620)
+...++|++++.||+|+||+||+|+++.+|+.||||++++.........++.+|+.+|+.|+|||||++++++... .+.
T Consensus 50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 3445789999999999999999999999999999999987766777788899999999999999999999998654 345
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
+...+|||||||+|+|.++|..++.+++.+++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred cCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 66789999999999999999998999999999999999999999999999999999999999999999999999998754
Q ss_pred CCC-CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDT-PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~-~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ......++++||++|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|....|.|+.+.+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 322 222334678999999999998763 468999999999999999999999999999999999999999999988877
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchh
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKME 336 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~ 336 (620)
.+ .......++..+....+.++...+++++++++|||.+||++||++|||++|+|+||||+.+..++.++.+.+ .++
T Consensus 289 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~ 365 (398)
T 4b99_A 289 AV-GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFD 365 (398)
T ss_dssp ------CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCC
T ss_pred hh-hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCC
Confidence 66 556667777777777888888888999999999999999999999999999999999999988777777654 345
Q ss_pred hhHHhhcCCHHHHHHHHHHHHHHhCc
Q 007050 337 FEFERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 337 ~~~e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
+.++...++.+++++.+++|+.++|.
T Consensus 366 ~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 366 FAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp CHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred CccchhhcCHHHHHHHHHHHHHHHHH
Confidence 66777888999999999999998875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=501.39 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=222.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+.|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.|+|||||+++++| .+...+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 579999999999999999999999999999999965322 2345678999999999999999999999 455789
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|||||||+ |+|.+++.. +.+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999 599999876 4699999999999999999999999999999999999999999999999999987643322
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.+..
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 286 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 286 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2356899999999999987 689999999999999999999999999887766665553311
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
......+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus 287 ---------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 ---------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ---------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 011123456899999999999999999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-60 Score=501.83 Aligned_cols=260 Identities=25% Similarity=0.447 Sum_probs=220.8
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
|...++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.|+|||||++++++ ++
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~ 94 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EE 94 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EE
Confidence 3456799999999999999999999999999999999987655666778899999999999999999999999 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...+|||||||+ |+|.++|... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 678999999998 6999999754 3579999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
.... ....+..+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|...
T Consensus 175 ~~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------- 240 (350)
T 4b9d_A 175 LNST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--------- 240 (350)
T ss_dssp CCHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------
T ss_pred ecCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------
Confidence 5321 122356789999999999987 68999999999999999999999999998876665555321
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
. +......+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 241 -------------------~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 -------------------S---FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -------------------C---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0 11223567899999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=495.76 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=224.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.|+|||||+++++| ++..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 356999999999999999999999999999999997432 1223356788999999999999999999999 5667
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|||||||+ |+|.++|+..+.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 8999999999 599999999889999999999999999999999999999999999999999999999999999876433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....+.|||+.|||||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..|...
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------- 249 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------------- 249 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22 223457899999999999987 68999999999999999999999999988776655555321
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE------ALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e------lL~hp~f~~~ 320 (620)
... ....+|+++++||.+||+.||++|||++| +++||||+++
T Consensus 250 ----------------~~~---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 250 ----------------EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp ----------------CCC---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ----------------CCC---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 011 12357899999999999999999999987 5899999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=482.99 Aligned_cols=255 Identities=31% Similarity=0.540 Sum_probs=206.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+.+|+.++|||||++++++ .+..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 35899999999999999999999999999999999754322 23356788999999999999999999998 5567
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|||||+|+|.+++..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccCCccccCcccccccCCCC-CcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y-~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..++.+||+.|||||++.+ ..| +.++|||||||++|+|++|++||.+.+....+..|.+
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~-------------- 226 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------------- 226 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------------
Confidence 2346799999999999987 454 6899999999999999999999988765544433321
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.. . .....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 227 --------------~~-~---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 227 --------------GV-Y---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------TC-C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------CC-C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 00 1 112357899999999999999999999999999999973
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=509.17 Aligned_cols=347 Identities=40% Similarity=0.738 Sum_probs=285.7
Q ss_pred ccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 17 ~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
..+...++|++++.||+|+||+||+|+++.+++.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34556789999999999999999999999999999999998777777788899999999999999999999999977766
Q ss_pred CCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
++...+|+|||||+++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 67788999999999999999998889999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCc------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh------
Q 007050 177 FNDTPT------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------ 226 (620)
Q Consensus 177 ~~~~~~------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt------ 226 (620)
...... ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 422211 1134667999999999986432 579999999999999999999
Q ss_pred -----CCCCCCCCC--------------------hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccC
Q 007050 227 -----GKPLFPGKN--------------------VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQ 281 (620)
Q Consensus 227 -----G~~pF~g~~--------------------~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (620)
|.++|+|.+ ..+++..|.+++|.|..+.+..+ .......++..+.......+..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL-EKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTS-SCHHHHHHHTTSCCCCCCCGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhc-CCHHHHHHHHhcCCCCCCCHHH
Confidence 889998865 36899999999999999998887 6777888888888888888888
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhC
Q 007050 282 KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 361 (620)
Q Consensus 282 ~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 361 (620)
.++.+++++++||++||.+||++|||++|+|+||||+++.....++.+.......|+ +...++.+++++.+++|+..|+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~ 443 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYH 443 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhC
Confidence 899999999999999999999999999999999999998776666554332222222 2346789999999999999999
Q ss_pred chhhh
Q 007050 362 PQLLK 366 (620)
Q Consensus 362 ~~~l~ 366 (620)
|....
T Consensus 444 ~~~~~ 448 (458)
T 3rp9_A 444 PEIQL 448 (458)
T ss_dssp TTCCC
T ss_pred ccccC
Confidence 87544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-58 Score=500.57 Aligned_cols=347 Identities=37% Similarity=0.699 Sum_probs=295.2
Q ss_pred cccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 16 ~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
+..+...++|++++.||+|+||.||+|+++.+++.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 34456778999999999999999999999999999999999887777778889999999999999999999999997765
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
......+|+|||||+++|.+++..+..+++.+++.|++||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 55667899999999999999999888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcc-------------------cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh----------
Q 007050 176 AFNDTPTT-------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT---------- 226 (620)
Q Consensus 176 ~~~~~~~~-------------------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt---------- 226 (620)
........ ...+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence 64332210 124678999999999986442 579999999999999999998
Q ss_pred -CCCCCCCCC-----------------hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCH
Q 007050 227 -GKPLFPGKN-----------------VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADP 288 (620)
Q Consensus 227 -G~~pF~g~~-----------------~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 288 (620)
|.++|++.+ ..+++..|.+++|.|..+.+..+ .......++..+....+..+...++.+++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI-NKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTC-CCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhc-cCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 677787765 47899999999999999998887 67778888888887778788888899999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhCchhh
Q 007050 289 SALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLL 365 (620)
Q Consensus 289 ~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~l 365 (620)
.+++||++||++||++|||++|+|+||||+++.....++.+.......|+ +...++.+++++.+++|+..++|+..
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCcccc
Confidence 99999999999999999999999999999998877666544322222222 22467899999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=503.24 Aligned_cols=258 Identities=28% Similarity=0.488 Sum_probs=223.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.|+|||||+++++| .+...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCE
Confidence 357999999999999999999999999999999997532 23345688999999999999999999999 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|||||||+ |+|.++++.. .+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.|||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999 5999998764 69999999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. ..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.+..
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 363 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 363 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356899999999999987 689999999999999999999999999887766665553210
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
......+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus 364 ----------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 364 ----------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ----------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 111233567899999999999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=477.63 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=217.8
Q ss_pred CCCe-EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++| ++.+.||+|+||+||+|.++.++..||+|++...........++.+|+.+|+.|+|||||++++++.... .+..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCc
Confidence 3455 7888999999999999999999999999999866556667788999999999999999999999985421 2345
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCC-CCcEEEcccCccccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA-NCKLKICDFGLARVA 176 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~-~~~lKL~DFGlA~~~ 176 (620)
.+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 6999999999 699999999889999999999999999999999999 999999999999985 799999999999854
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+....+......
T Consensus 183 ~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~---------- 244 (290)
T 3fpq_A 183 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---------- 244 (290)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT----------
T ss_pred CCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc----------
Confidence 322 2356799999999999864 6999999999999999999999999876544333222110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
...+. ......++++++||.+||+.||++|||++|+|+||||++
T Consensus 245 ----------------~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 ----------------GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00111 112346789999999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=488.12 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=215.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+.++|++++.||+|+||+||+|++. .+++.||||++++......+..++.+|+.+|+.|+|||||++++++ +
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~ 96 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----Q 96 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----E
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----E
Confidence 4578999999999999999999984 4688999999975433333344678899999999999999999999 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|||||||+ |+|.++|...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 5678999999999 699999999889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 177 ~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 241 (304)
T 3ubd_A 177 IDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------- 241 (304)
T ss_dssp ----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred cCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence 33222 2356799999999999987 68999999999999999999999999998876665555321
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. . .....+|+++++||.+||+.||++||| ++|+|+||||+++
T Consensus 242 ------------------~-~---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 ------------------K-L---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ------------------C-C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------------C-C---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 0 0 112357899999999999999999998 5899999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=480.43 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=216.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++ .+...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~-----~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAV-----REGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEE-----EETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 4579999999999999999999999999999999975322 24799999999999999999998 45578
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGlA~~~~~~ 179 (620)
+|||||||+ |+|.++|+..+.+++.+++.|+.||+.||.|||++||+||||||+||||+.+| ++||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999 59999999988999999999999999999999999999999999999999987 6999999999876543
Q ss_pred CCcc--cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 180 TPTT--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 180 ~~~~--~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234689999999999987 6899999999999999999999999988665443333321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------HcCCcccCCCc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA-------------LADPYFKGLSK 322 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~el-------------L~hp~f~~~~~ 322 (620)
.+.++...++.+++.+.+||.+||+.||++|||+.|+ |+|||+..+.+
T Consensus 271 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 -----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp -----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred -----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1122334457889999999999999999999999997 57999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=476.33 Aligned_cols=334 Identities=40% Similarity=0.756 Sum_probs=282.5
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~ 97 (620)
+...++|++++.||+|+||.||+|.++.+|+.||||++...........++.+|+.+|+.++||||+++++++.... ..
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 44568999999999999999999999999999999999876666677788999999999999999999999996542 23
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
+...+|+|||||+++|.+++.. ..+++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 4567899999998899999987 569999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. .+.+++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+..
T Consensus 180 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 180 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 22 3457899999999988752 5799999999999999999999999999999999999999999999998887
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhh
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 337 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 337 (620)
+ .......++..+.......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+...+.++...+ +++
T Consensus 253 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~~ 328 (367)
T 1cm8_A 253 L-QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDD 328 (367)
T ss_dssp C-SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCC
T ss_pred h-hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CCC
Confidence 7 677888888888777777788888999999999999999999999999999999999999988777776653 455
Q ss_pred hHHhhcCCHHHHHHHHHHHHHHhCchh
Q 007050 338 EFERRRVTKEDIRELIFREILEYHPQL 364 (620)
Q Consensus 338 ~~e~~~~~~e~~~~~~~~ei~~~~~~~ 364 (620)
.++....+.+++++.++++++.++++.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC--
T ss_pred ChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 667778899999999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=479.81 Aligned_cols=338 Identities=39% Similarity=0.745 Sum_probs=270.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|.++.+|+.||||++...........++.+|+.+|+.+. ||||+++++++... +...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence 6899999999999999999999999999999999877777788889999999999997 99999999998542 3457
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC-
Q 007050 102 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT- 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~- 180 (620)
+|+|||||+++|.+++.. +.+++.+++.+++||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 999999999999999987 479999999999999999999999999999999999999999999999999998653211
Q ss_pred -----------------CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 007050 181 -----------------PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243 (620)
Q Consensus 181 -----------------~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i 243 (620)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||++.+..+++..|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111234567999999999998752 57999999999999999999999999999999999999
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccC---CCcccCCC-------------CCCCHHHHHHHHHhcccCCCCCCC
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ---PVQFSQKF-------------PNADPSALRLLERLLAFDPKDRPT 307 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~s~~l~dLI~~mL~~DP~~Rps 307 (620)
...++.|..+.+..+ .......++..+.... ...+...+ ..+++.+++||.+||++||++|||
T Consensus 244 ~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 244 IGVIDFPSNEDVESI-QSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHCCCCHHHHHTS-CCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhcCCCCHHHHHhc-cCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 999999999888766 4555555555544332 12222222 277899999999999999999999
Q ss_pred HHHHHcCCcccCCCcCcCCCCCCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhCchhhhh
Q 007050 308 AEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 367 (620)
Q Consensus 308 a~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~l~~ 367 (620)
++|+|+||||+.+.....++.+.......+. +....+.+++++.+++++.++++++..+
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhh
Confidence 9999999999999888777776654333332 2345688999999999999988876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-57 Score=480.86 Aligned_cols=287 Identities=27% Similarity=0.454 Sum_probs=225.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+.+|+.+ .||||++++++| +
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 368999999999999999999885 46789999998653 2345678999999998 699999999998 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~~ 175 (620)
+...+|+|||||+ |+|.++++ .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 5678999999998 69999983 59999999999999999999999999999999999999877 7999999999986
Q ss_pred ccCCCCc-------------------------ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC
Q 007050 176 AFNDTPT-------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (620)
Q Consensus 176 ~~~~~~~-------------------------~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p 230 (620)
....... ....+..+||++|||||++.+. ..|+.++||||+|||+|||++|+.|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCC
Confidence 4332111 1123457899999999998762 4699999999999999999999988
Q ss_pred C-CCCChhHHHHHhhhccCCCChhhhhhhhh----------chhHHHHHHhhhccC------------CCcccCCCCCCC
Q 007050 231 F-PGKNVVHQLDLMTDLLGTPSLDTISRVVR----------NDKARRYLTSMRKKQ------------PVQFSQKFPNAD 287 (620)
Q Consensus 231 F-~g~~~~~~l~~i~~~lg~p~~e~i~~~~~----------~~~~~~~~~~~~~~~------------~~~~~~~~~~~s 287 (620)
| .+.+..+++..|..++|.+.......... ....+...+.+.... .......|+.+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 7 67788999999999888765443322210 011112221111100 011123467899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 288 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 288 ~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
++++|||++||++||++|+|++|+|+||||+++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-56 Score=473.91 Aligned_cols=334 Identities=41% Similarity=0.799 Sum_probs=278.4
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRR 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~-~~~ 97 (620)
+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++... ...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 3445899999999999999999999999999999999987666667788899999999999999999999998654 223
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
+...+|+|||+++++|.+++.. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 4567899999999999998876 579999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. .+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+..
T Consensus 184 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 184 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp -------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 3457899999999998752 5789999999999999999999999999999999999999999999998887
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhh
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 337 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 337 (620)
+ .......++..+.......+...++..++.+++||.+||++||++|||++|+|+||||+.+.....++...+ +++
T Consensus 257 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~ 332 (367)
T 2fst_X 257 I-SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 332 (367)
T ss_dssp C-CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCG
T ss_pred h-hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCc
Confidence 7 677788888887776677777778899999999999999999999999999999999999888777766554 456
Q ss_pred hHHhhcCCHHHHHHHHHHHHHHhCchh
Q 007050 338 EFERRRVTKEDIRELIFREILEYHPQL 364 (620)
Q Consensus 338 ~~e~~~~~~e~~~~~~~~ei~~~~~~~ 364 (620)
.++......+++++++++|+..++|..
T Consensus 333 ~~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 333 SLESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred chhhccCCHHHHHHHHHHHHHHhccCc
Confidence 667778899999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=481.93 Aligned_cols=330 Identities=35% Similarity=0.674 Sum_probs=264.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 100 (620)
.++|++++.||+|+||+||+|.+..+++.||||++...........++.+|+.+|+.++||||+++++++..... ++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999998776677778889999999999999999999999976532 4567
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|||||+++|.+.+.. .+++.+++.|++||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-
T ss_pred eEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-
Confidence 8999999999999988854 4999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
...+.++||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+..+
T Consensus 218 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~-- 290 (464)
T 3ttj_A 218 ---FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-- 290 (464)
T ss_dssp ---CCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS--
T ss_pred ---cccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc--
Confidence 22356799999999999987 68999999999999999999999999999999999999999999999887765
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCC------------CHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~ 328 (620)
......++..........+...++.. ++.+++||.+||++||++|||++|+|+||||+.+........
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~ 370 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 370 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC
Confidence 24455555544333333333333332 578999999999999999999999999999998765433222
Q ss_pred CCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhCc
Q 007050 329 CQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 329 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
. +....++.++....+.+++++++++++..++.
T Consensus 371 ~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 371 P-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp C-C-----------CCCHHHHHHHHHHHHHC---
T ss_pred C-CCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 1 12234555677778899999999999876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=455.33 Aligned_cols=340 Identities=47% Similarity=0.834 Sum_probs=287.5
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+...++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++||||+++++++......+
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 55668999999999999999999999999999999999753 34455678899999999999999999999997665556
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
...+|+||||++++|.++++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 102 MKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 6789999999999999999764 699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...........+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.|..+.+..+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 43333334567899999999987542 46899999999999999999999999999999999999999999999988776
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhh
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 338 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 338 (620)
.+.....+...+.......+...++.+++.+.+||.+||++||++|||++|+|+||||+.+.....++.... .+.++
T Consensus 260 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~ 336 (364)
T 3qyz_A 260 -INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 336 (364)
T ss_dssp -CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC
T ss_pred -hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcc
Confidence 555666676666666666666777889999999999999999999999999999999998866555444332 23344
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCchh
Q 007050 339 FERRRVTKEDIRELIFREILEYHPQL 364 (620)
Q Consensus 339 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 364 (620)
.+...+.++++++++++++..++|..
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC--
T ss_pred cccccCCHHHHHHHHHHHHHHhhhhc
Confidence 55667889999999999998888753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=455.32 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=199.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-------
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR------- 96 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~------- 96 (620)
+|++++.||+|+||+||+|+++.+|+.||||+++.. .......++.+|+.+|+.|+|||||+++++|.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 589999999999999999999999999999999753 234456778999999999999999999999864321
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDDL---TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~l---se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
.+...+|||||||. |+|.+++.....+ .+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12345899999998 6999999876543 4566889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc---------cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 007050 173 ARVAFNDTPTT---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243 (620)
Q Consensus 173 A~~~~~~~~~~---------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i 243 (620)
|+......... ...+..+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+.. +....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 98764432211 12345789999999999987 689999999999999999996 775422 222212
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...... .+...++..++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 238 ~~~~~~----------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNL----------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTT----------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcC----------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 111000 01111223467789999999999999999999999999998763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=481.22 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=226.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||+||+|+++.+|+.||||++.. ....+...+.+|+.+|+.|+|||||+++++| ++...+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~ 229 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 229 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence 689999999999999999999999999999999975 3445667788999999999999999999999 566789
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC--CcEEEcccCccccccC
Q 007050 103 YVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFGLARVAFN 178 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~lKL~DFGlA~~~~~ 178 (620)
|||||||. |+|+++|.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999998 599999964 4679999999999999999999999999999999999999865 8999999999987643
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .....+||++|||||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......+
T Consensus 310 ~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 375 (573)
T 3uto_A 310 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------- 375 (573)
T ss_dssp TS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--------
T ss_pred CC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 32 2356799999999999987 689999999999999999999999999988777766664321111
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
....++.+|+++++||.+||+.||++|||++|+|+||||+....
T Consensus 376 --------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 376 --------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp --------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred --------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 12235678999999999999999999999999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=437.89 Aligned_cols=338 Identities=43% Similarity=0.796 Sum_probs=279.0
Q ss_pred cCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 18 ~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.+...++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 345678999999999999999999999999999999999643 3445567788999999999999999999998765555
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
+...+|+||||+.++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 6678999999999999999976 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcc-------cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 178 NDTPTT-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 178 ~~~~~~-------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..+...+|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112346899999999987542 578999999999999999999999999999999999999999988
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQ 330 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~ 330 (620)
................+...+.......+...++.+++.+.+||.+||..||++|||++|+|+||||+.+.....++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 322 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE 322 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence 75544444345555666665544444445556678999999999999999999999999999999999887666555555
Q ss_pred CCcc--hhhhHHhhcCCHHHHHHHHHHHHH
Q 007050 331 PISK--MEFEFERRRVTKEDIRELIFREIL 358 (620)
Q Consensus 331 ~~~~--~~~~~e~~~~~~e~~~~~~~~ei~ 358 (620)
++.. +++.......+.+++++++++|+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 5543 444555667899999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=477.59 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=213.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ..........+++.+++.++|||||+++++| +
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 467999999999999999999999999999999996431 1112222333456777788999999999999 5
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|||||||. |+|.++|...+.+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 6678999999999 699999999899999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... ....|||+.|||||++.+. ..|+.++||||||||+|||++|.+||.+.+..+....+
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~------------- 403 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------- 403 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-------------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------
Confidence 4332 2457999999999998641 57999999999999999999999999765322111100
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
..+.. ... ..+..+|+++++||.+||+.||++|++ ++||++||||+++
T Consensus 404 ------------~~i~~-~~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 404 ------------RMTLT-MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp ------------HHHHH-CCC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred ------------HhhcC-CCC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 00000 111 123468999999999999999999998 7999999999976
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=436.29 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=207.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.+++++.+.||+|+||+||+|+++ ..||||+++.........+.+.+|+.+|+.|+|||||++++++.. .
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 3568899999999999999999754 369999998655566677889999999999999999999998732 3
Q ss_pred eEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 5799999999 6999999764 5799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... ....+..+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+...
T Consensus 185 ~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~----------- 252 (307)
T 3omv_A 185 WSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR----------- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-----------
T ss_pred CCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence 222 1223557899999999998642 246999999999999999999999999887654443332210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
......+...++++++.+.+||.+||+.||++|||+.|++++
T Consensus 253 ---------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 ---------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ---------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ---------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011112233456788999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=436.06 Aligned_cols=265 Identities=23% Similarity=0.345 Sum_probs=215.2
Q ss_pred ccccccCCCCCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCccee
Q 007050 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87 (620)
Q Consensus 13 ~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l 87 (620)
++.+.+.-..++|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|++|+|||||++
T Consensus 3 ~d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l 80 (299)
T 4asz_A 3 MDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKF 80 (299)
T ss_dssp GGGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred chhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccE
Confidence 344444444578999999999999999999875 46789999999753 44556789999999999999999999
Q ss_pred eeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 007050 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (620)
Q Consensus 88 ~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~-------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (620)
++++ .+...+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++|+|||||
T Consensus 81 ~g~~-----~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK 155 (299)
T 4asz_A 81 YGVC-----VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155 (299)
T ss_dssp EEEE-----CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEE-----eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence 9999 44567999999999 6999999764 369999999999999999999999999999999
Q ss_pred CCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 007050 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (620)
Q Consensus 154 P~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~ 232 (620)
|+|||++.++.+||+|||+|+......... .....+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.
T Consensus 156 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCEE-ETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred HhhEEECCCCcEEECCcccceecCCCCcee-ecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999998654332211 1234579999999999987 689999999999999999998 899999
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
+.+..+.+..+.. ... ......+++++.+||.+||+.||++|||++|+
T Consensus 233 ~~~~~~~~~~i~~----------------------------~~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i- 280 (299)
T 4asz_A 233 QLSNNEVIECITQ----------------------------GRV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI- 280 (299)
T ss_dssp TSCHHHHHHHHHH----------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH-
T ss_pred CCCHHHHHHHHHc----------------------------CCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH-
Confidence 8776554444322 000 11224578899999999999999999999999
Q ss_pred cCCcccCC
Q 007050 313 ADPYFKGL 320 (620)
Q Consensus 313 ~hp~f~~~ 320 (620)
|+||+.+
T Consensus 281 -~~~L~~~ 287 (299)
T 4asz_A 281 -HTLLQNL 287 (299)
T ss_dssp -HHHHHHH
T ss_pred -HHHHHHH
Confidence 4577654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=439.42 Aligned_cols=329 Identities=41% Similarity=0.763 Sum_probs=275.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (620)
..++|.+++.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++..... ...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3579999999999999999999999999999999998766666667888999999999999999999999965432 223
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+|||||.++|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 3459999999999998874 35999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..+.+..+
T Consensus 198 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 269 (371)
T 4exu_A 198 ------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL- 269 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC-
T ss_pred ------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh-
Confidence 2456899999999988752 57899999999999999999999999999999999999999999998877766
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCC-CCcchhhh
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQ-PISKMEFE 338 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~-~~~~~~~~ 338 (620)
.......+...+.......+...++.+++.+.+||.+||+.||++|||++|+|+||||+.+.....+...+ ++. ..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~---~~ 346 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD---DS 346 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC---CT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcC---cc
Confidence 45555666666655555556666788999999999999999999999999999999999886654443322 222 22
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCc
Q 007050 339 FERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 339 ~e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
.+....+.+++++.+++++.+|+|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 347 LEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred hhhcccchHHHHHHHHHHHHhccc
Confidence 345567889999999999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=429.85 Aligned_cols=300 Identities=38% Similarity=0.631 Sum_probs=239.1
Q ss_pred CCCCccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007050 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 9 ~~~~~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
.+...+....-+..++|++++.||+|+||.||+|.+. +|+.||+|++............+.+|+.+|+.++||||++++
T Consensus 7 ~~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 85 (311)
T 3niz_A 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85 (311)
T ss_dssp --------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeee
Confidence 3344444455567789999999999999999999985 589999999976544444557788999999999999999999
Q ss_pred eEecCCCCCCCCeEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEE
Q 007050 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 167 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL 167 (620)
+++ .+...+|+|||||+++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 86 ~~~-----~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 86 DVI-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp EEE-----CCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEE-----ccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEE
Confidence 998 4556799999999999999887654 5999999999999999999999999999999999999999999999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
+|||+++....... .....++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+...+
T Consensus 161 ~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 236 (311)
T 3niz_A 161 ADFGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236 (311)
T ss_dssp CCCTTCEETTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred ccCcCceecCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence 99999987543222 22456899999999988652 468999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhchhHHHHHHh-hhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+.|....+....... .+... ........+....+.+++++++||.+||++||++|||++|+|+||||+++.
T Consensus 237 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 237 GTPNPREWPQVQELP---LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCTTTSGGGTTSH---HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred CCCChHHhhhhhccc---hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 998887666542211 11110 011111222334567899999999999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=439.49 Aligned_cols=329 Identities=36% Similarity=0.663 Sum_probs=255.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47999999999999999999999999999999999876556667788899999999999999999999986543 23456
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|||||+++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred ceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 899999999999999986 359999999999999999999999999999999999999999999999999998653221
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+++..+...++.|..+.+..+
T Consensus 182 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 253 (371)
T 2xrw_A 182 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-- 253 (371)
T ss_dssp ------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS--
T ss_pred ----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh--
Confidence 2345689999999999987 67999999999999999999999999999999999999999999988776654
Q ss_pred chhHHHHHHhhhccCCCcccCCCC-----C-------CCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFP-----N-------ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-----~-------~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~ 328 (620)
......+...........+...++ . .++.+++||.+||++||++|||++|+|+||||+.+........
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~ 333 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 333 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence 222333333222211111111111 1 1568999999999999999999999999999997654322111
Q ss_pred CCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhC
Q 007050 329 CQPISKMEFEFERRRVTKEDIRELIFREILEYH 361 (620)
Q Consensus 329 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 361 (620)
..+ .......++...+.+++++++++++..+.
T Consensus 334 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 334 PPP-KIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CCC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CCC-CCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 111 11123344556788999999999997754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=432.43 Aligned_cols=329 Identities=40% Similarity=0.758 Sum_probs=275.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 100 (620)
.++|.+.+.||+|+||.||+|.++.+|+.||||++...........++.+|+.+|+.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999999999999999998765566667788999999999999999999999865421 1234
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+||||+.++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred eEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 569999999999988774 35999999999999999999999999999999999999999999999999999764322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
....++|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+++..+....|.|..+.+..+ .
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~ 252 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL-N 252 (353)
T ss_dssp ---------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC-S
T ss_pred -----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH-h
Confidence 2356899999999988652 57899999999999999999999999999999999999999999998877766 4
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhhHH
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 340 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 340 (620)
......++..+.......+...++.+++.+.+||.+||..||++|||++|+|+||||+.+...+.+..... .+....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~~~ 330 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLE 330 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccchh
Confidence 55556666666555555666677889999999999999999999999999999999998866554443321 2333445
Q ss_pred hhcCCHHHHHHHHHHHHHHhCc
Q 007050 341 RRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 341 ~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
....+.+++++.+++++.++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 331 HEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TCCCCHHHHHHHHHHHHHTCCC
T ss_pred hccCCHHHHHHHHHHHHHhhcc
Confidence 5678899999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=433.44 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=203.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|.+.+.||+|+||+||+|.++ .+++.||||+++. ......+.+.+|+.+|+.|+|||||++++++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~----- 112 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVC----- 112 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 357899999999999999999865 4688999999975 3445667899999999999999999999999
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN---------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~---------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
.+...+|||||||+ |+|.+++... +++++.++..|+.||+.||.|||+++|+||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 44567999999999 6999999753 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~ 239 (620)
.++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999865433221 12245689999999999987 689999999999999999999 8999988776555
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+..+..- ... .....+++++.+||.+||+.||++|||++|++++
T Consensus 270 ~~~i~~g----------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQG----------------------------REL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHT----------------------------CCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcC----------------------------CCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4443220 000 1124578999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=429.72 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=208.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.+.+++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|++|+|||||++++++.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~---- 99 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT---- 99 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE----
Confidence 35789999999999999999985 3567899999997543 2234567899999999999999999999994
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl 159 (620)
+...+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++|+||||||+||||
T Consensus 100 -~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 100 -KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp -SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred -ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 4456899999999 6999999653 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhH
Q 007050 160 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 238 (620)
Q Consensus 160 ~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~ 238 (620)
++++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |..||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999875433221 12345689999999999987 689999999999999999998 899999887665
Q ss_pred HHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 239 ~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.+..+.+ .... ...+++++.+.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~~i~~----------------------------~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRN----------------------------RQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHT----------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHc----------------------------CCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5444422 1101 1224678899999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=420.12 Aligned_cols=287 Identities=36% Similarity=0.598 Sum_probs=238.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 589999999999999999999999999999999976555555667888999999999999999999998 445679
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+|||||+++|.+.+.. ++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 56899999999999999999999999999999999999999999999999999986543222
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCC-CCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~-pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|.. +|.+.+..+.+..+...++.|..+.+..+..
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456899999999998762 458999999999999999998765 5888888899999999999998877665422
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...... ..............+.+++.+++||.+||+.||++|||++|+|+||||+++.
T Consensus 233 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPDYKP---YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCC---CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccc---cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 111000 0000011122334567899999999999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=419.75 Aligned_cols=259 Identities=27% Similarity=0.481 Sum_probs=224.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++ .+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 34689999999999999999999999999999999987666667788899999999999999999999998 4557
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+ ++|.+++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 8999999997 699999988889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCcccccccCCCC-CcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y-~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 168 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 229 (328)
T 3fe3_A 168 G----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------ 229 (328)
T ss_dssp C----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred C----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 2 2356789999999999876 454 58999999999999999999999987765544433220
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.. .....+++.+.+||++||.+||.+|||++|+|+||||+....
T Consensus 230 ---------------~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 ---------------KY-----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ---------------CC-----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 00 011246889999999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=418.05 Aligned_cols=284 Identities=38% Similarity=0.640 Sum_probs=232.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5899999999999999999998 6899999999975433333346678999999999999999999998 344679
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+.++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 6799999999999999999999999999999999999999999999999999986542221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....++|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+..+...
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12456789999999998652 46899999999999999999999999999999999999988888876655443211
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.. +........+.++......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 PK---YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TT---CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cc---cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 11 11111122233344455678999999999999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=424.90 Aligned_cols=288 Identities=35% Similarity=0.646 Sum_probs=234.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEE
Confidence 589999999999999999999999999999999964321 11222455799999999999999999998 445679
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+|||||+++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999998754 599999999999999999999999999999999999999999999999999976432221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+...++.|..+.+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 23456789999999988652 56899999999999999999999999999999999999999999998888776554
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.....+ .............++.+++.+.+||.+||++||++|||++|+|+||||..+..
T Consensus 232 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT--CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc--ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 433222 11111222223345678999999999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=430.42 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=209.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H-pnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||+||+|.+..++ +.||||+++.. ........+.+|+.+|+.+.| ||||++++++..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-- 139 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 139 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe--
Confidence 468999999999999999999976543 68999999754 334556779999999999965 899999999843
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 158 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (620)
+...+|||||||+ |+|.++|+.. ..+++.++..|+.||+.||+|||+++||||||||+|||
T Consensus 140 --~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 140 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred --cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 2356899999999 6999999753 34899999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChh
Q 007050 159 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVV 237 (620)
Q Consensus 159 l~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~ 237 (620)
++.++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |..||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876443322 22345689999999999987 689999999999999999998 89999886543
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+.+..+.. ..... .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 295 ~~~~~~i~---------------------------~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLK---------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHH---------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH---------------------------cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 32221111 00000 1123578999999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=422.15 Aligned_cols=331 Identities=36% Similarity=0.663 Sum_probs=259.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---------ChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---------HISDAARILREIKLLRLLRHPDIVEIKHIM 91 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---------~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~ 91 (620)
..++|++++.||+|+||.||+|.+.. |+.||||++..... .......+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999999865 99999999864322 223347789999999999999999999998
Q ss_pred cCCCCCCCCeEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 92 LPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
..........+|+|||||.++|.+.+.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 765545566899999999999999987654 6999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
|+++....... ....++|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|
T Consensus 179 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 179 NLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp TC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred Ccccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99975433221 2456899999999988653 568999999999999999999999999999999999999999999
Q ss_pred ChhhhhhhhhchhHHHHHHhhhcc-CCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKK-QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 329 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~ 329 (620)
..+.+... .......++...... ....+....+..++.+.+||.+||+.||.+|||++|+|+||||+.+.........
T Consensus 254 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 254 KIEDVVMF-SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CHHHHHHT-SCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred ChHHhhhc-cchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 98776655 334444443322221 2222333456789999999999999999999999999999999987654322211
Q ss_pred CCCcchhhhHHhhcCCHHHHHHHHHHHHHHhC
Q 007050 330 QPISKMEFEFERRRVTKEDIRELIFREILEYH 361 (620)
Q Consensus 330 ~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 361 (620)
. ...+.++....+..++++.++.|+.+++
T Consensus 333 ~---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 L---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp C---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred c---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1 1123344456678899999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=417.66 Aligned_cols=288 Identities=35% Similarity=0.571 Sum_probs=233.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLL---RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|+++.+++.||||++...... ......+.+|+.+++.+ .||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 46999999999999999999999999999999998643211 11123455677777666 4999999999986554
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
......+|+||||+.++|.+++..... +++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 333446899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+..+
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86543222 245689999999999876 679999999999999999999999999999999999999999888877
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+........ .......+..+....+.+++.+.+||.+||++||++|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPR-----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCG-----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhccc-----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 6544321111 0111222233334557889999999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=421.24 Aligned_cols=289 Identities=34% Similarity=0.603 Sum_probs=222.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence 468999999999999999999999999999999997532 223345678999999999999999999998 45567
Q ss_pred EEEEEecCCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 102 IYVVFELMESDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+|+|||||+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9999999999999998753 3589999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+.+.+|.|....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 543222 12456899999999998652 46899999999999999999999999999999999999999998887766
Q ss_pred hhhhhchhHHHHHHhhhccCCCcc-----cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQF-----SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
..+...... ...+....+..+ ......+++.+.+||.+||+.||++|||++|+|+||||+++...
T Consensus 234 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKLPKY---NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGCTTC---CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhhhc---ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 554221110 000000000000 01123578899999999999999999999999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=422.78 Aligned_cols=268 Identities=27% Similarity=0.438 Sum_probs=226.9
Q ss_pred cccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeee
Q 007050 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKH 89 (620)
Q Consensus 14 ~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~rEi~iL~~L~HpnIv~l~~ 89 (620)
+.+..-...++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 82 (361)
T 2yab_A 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82 (361)
T ss_dssp -CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence 34444455678999999999999999999999999999999997543221 13467889999999999999999999
Q ss_pred EecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC----c
Q 007050 90 IMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----K 164 (620)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~ 164 (620)
++ .+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .
T Consensus 83 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 83 VY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EE-----ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCC
T ss_pred EE-----EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccC
Confidence 98 45578999999997 69999998888999999999999999999999999999999999999998877 7
Q ss_pred EEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 007050 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~ 244 (620)
+||+|||+++...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|.
T Consensus 158 vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp EEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred EEEEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322 1245689999999999986 689999999999999999999999999887766665554
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
....... ...++.+++.+++||.+||..||++|||++|+|+||||+..
T Consensus 232 ~~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 232 AVSYDFD----------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTCCCCC----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred hcCCCCC----------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 3211111 11245678999999999999999999999999999999854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=420.26 Aligned_cols=290 Identities=36% Similarity=0.569 Sum_probs=226.5
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
-...++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++ .+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence 3445789999999999999999999999999999999976544444456678999999999999999999998 45
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC-----CCCcEEEcccCcc
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-----ANCKLKICDFGLA 173 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-----~~~~lKL~DFGlA 173 (620)
...+|+|||||+++|.+++..+..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 105 NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 56799999999999999999988999999999999999999999999999999999999994 4556999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+....... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|...
T Consensus 185 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 87543221 22456789999999998752 458999999999999999999999999999999999999988888876
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+.......... ..........+... ...+++++++||.+||++||++|||++|+|+||||++.
T Consensus 261 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 261 TWPGVTALPDWK---QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TSTTGGGSTTCC---TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhh---hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 655432111100 00000000000000 01268899999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=410.02 Aligned_cols=289 Identities=36% Similarity=0.644 Sum_probs=230.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++ .+...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCe
Confidence 3689999999999999999999999999999999976555555567788999999999999999999998 44567
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999995 777888777889999999999999999999999999999999999999999999999999998754322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.........+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 22456899999999988652 5689999999999999999999999999999999888888777766544332211
Q ss_pred chhHHHHHHhhhccC---CCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 261 NDKARRYLTSMRKKQ---PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
... +....... .......++++++.+.+||.+||+.||.+|||++|+|+||||+++...
T Consensus 233 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 NQY----FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CGG----GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccc----cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 110 00000000 111122356889999999999999999999999999999999987544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=430.66 Aligned_cols=261 Identities=27% Similarity=0.474 Sum_probs=223.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+|+.||+|++........+...+.+|+.+|+.++||||+++++++ .+...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 3579999999999999999999999999999999976544455667889999999999999999999998 55678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC---CCCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999998 59999999999999999999999999999999999999999999999998 46789999999997654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+..
T Consensus 165 ~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------------ 227 (444)
T 3soa_A 165 GEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------ 227 (444)
T ss_dssp TTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred CCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh------------
Confidence 3322 2356789999999999987 6899999999999999999999999988776554444422
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.........|+.+++.+++||.+||+.||++|||++|+|+||||+..
T Consensus 228 ----------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 228 ----------------GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ----------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ----------------CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 11112233467889999999999999999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=438.14 Aligned_cols=262 Identities=33% Similarity=0.532 Sum_probs=221.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++ .+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence 45789999999999999999999999999999999965433333456788999999999999999999998 4567
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC---CCCcEEEcccCccccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVA 176 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~lKL~DFGlA~~~ 176 (620)
.+|+|||||. ++|.+.+...+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 8999999998 59999998888999999999999999999999999999999999999995 4567999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 175 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 238 (486)
T 3mwu_A 175 QQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK--------- 238 (486)
T ss_dssp CCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred CCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 4332 2345689999999999875 59999999999999999999999999887766555443211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.......|..+++.+++||.+||+.||.+|||+.|+|+||||+....
T Consensus 239 -------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 239 -------------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -------------------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -------------------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11111234567899999999999999999999999999999987643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=425.72 Aligned_cols=287 Identities=35% Similarity=0.623 Sum_probs=232.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 101 (620)
.+|++++.||+|+||.||+|.++.+|+.||||++..... ...+|+.+|+.|+||||+++++++..... .+...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 369999999999999999999999999999999864321 13479999999999999999998854321 23445
Q ss_pred EEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCccccc
Q 007050 102 IYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGlA~~~ 176 (620)
+++|||||.++|.+++. ....+++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877764 35679999999999999999999999999999999999999965 67899999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|...+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456899999999998652 479999999999999999999999999999999999999999999988776
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~ 324 (620)
.+..+ ...+ .+.......+... .+.+++++++||.+||.+||.+|||++|+|+||||+.+....
T Consensus 283 ~~~~~--~~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 283 EMNPN--YTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp HHCSC--CCCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhChh--hhhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 54110 0000 0000011111111 245789999999999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=423.31 Aligned_cols=286 Identities=37% Similarity=0.662 Sum_probs=232.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 101 (620)
.+|++++.||+|+||+||+|.+..+++ +|+|++...... ..+|+.+|+.++||||+++++++..... .+...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 479999999999999999999987776 888887542111 2369999999999999999999865432 34455
Q ss_pred EEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC-CCCcEEEcccCccccc
Q 007050 102 IYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~lKL~DFGlA~~~ 176 (620)
+|+|||||.+++.+.+. ....+++..++.|++||+.||.|||+.||+||||||+|||++ .++.+||+|||+++..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999987766654 356899999999999999999999999999999999999999 7999999999999876
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ...+++|++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|...+|.|..+.+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43332 2456899999999998652 469999999999999999999999999999999999999999999988776
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~ 324 (620)
....+-. . ..+....+..+...+ +.+++++.+||.+||++||.+|||+.|+|+||||+.+....
T Consensus 268 ~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 268 TMNPNYM--E--HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp HHCGGGS--S--SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred hhChhhh--h--hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 5421100 0 001111222222222 35889999999999999999999999999999999876544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=435.43 Aligned_cols=317 Identities=26% Similarity=0.447 Sum_probs=240.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|+++.++..||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 479999999999999999999999999999999976543334456788999999999999999999998 455779
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC---CcEEEcccCccccccC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAFN 178 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~lKL~DFGlA~~~~~ 178 (620)
|+|||||. |+|.+.+.....+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5999999888889999999999999999999999999999999999999764 5599999999987543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .....+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------ 252 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG------------ 252 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 32 2345689999999999864 6999999999999999999999999988766555444321
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc-CCCCCCCCcchhh
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE-REPSCQPISKMEF 337 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~-~~~~~~~~~~~~~ 337 (620)
........|+.+++.+++||.+||+.||.+|||++|+|+||||+...... .............
T Consensus 253 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 316 (494)
T 3lij_A 253 ----------------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIE 316 (494)
T ss_dssp ----------------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHH
T ss_pred ----------------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHH
Confidence 11111234567899999999999999999999999999999998653211 1111111111111
Q ss_pred hHHhhcCCHHHHHHHHHHHHHHhCchhhhhhccccccccccChhHHHHHHHHHHHHHhh
Q 007050 338 EFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN 396 (620)
Q Consensus 338 ~~e~~~~~~e~~~~~~~~ei~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~f~~l~~~ 396 (620)
.+ +.......+++.+...+ ...+..+..++++++.|..+|.+
T Consensus 317 ~~-~~~~~~~~l~qa~l~~i----------------a~~~~~~~~~~~l~~~F~~~D~d 358 (494)
T 3lij_A 317 NM-RKFQNSQKLAQAALLYM----------------ASKLTSQEETKELTDIFRHIDKN 358 (494)
T ss_dssp HH-HTTTTCCHHHHHHHHHH----------------HHHSCCHHHHHHHHHHHHHHCTT
T ss_pred HH-HHHHHhHHHHHHHHHHH----------------HHhcccHHHHHHHHHHHHHhCcC
Confidence 11 11111122222222211 12344677889999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=418.57 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=215.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence 468999999999999999999999999999999997531 1223455678999999988 699999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 67999999998 59999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 177 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 239 (353)
T 3txo_A 177 NGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------ 239 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 221 2346789999999999876 57999999999999999999999999988776655555321
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~elL~hp~f~~~ 320 (620)
. .. ....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 240 ----------------~-~~---~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 ----------------E-VV---YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp ----------------C-CC---CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred ----------------C-CC---CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 0 00 112478899999999999999999999 999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=411.88 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=218.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 3589999999999999999999999999999999975311 122355678999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+..
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------------- 219 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------- 219 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2346789999999999987 6899999999999999999999999988765444333321
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. ... ....+++++.+||.+||+.||++|| +++|+++||||+++
T Consensus 220 --------------~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 220 --------------E-EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp --------------C-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------C-CCC---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 0 001 1135789999999999999999999 99999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=417.08 Aligned_cols=285 Identities=32% Similarity=0.673 Sum_probs=230.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-----
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR----- 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~----- 96 (620)
.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 46899999999999999999999999999999998643221 2379999999999999999999865422
Q ss_pred ----------------------------CCCCeEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007050 97 ----------------------------RDFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHT 144 (620)
Q Consensus 97 ----------------------------~~~~~lylV~E~~~gdL~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs 144 (620)
.+...+|+|||||+++|.+.+. .+..+++..++.|+.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3345689999999998777765 35689999999999999999999999
Q ss_pred CCcEeecCCCCceEeC-CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHH
Q 007050 145 ANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~-~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~Ilye 223 (620)
.||+||||||+|||++ .++.+||+|||+++....... ....++|+.|+|||++.+. ..|+.++|||||||++|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 9999999999999997 688999999999987543322 2456889999999988752 469999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCC-CCCCHHHHHHHHHhcccCC
Q 007050 224 VLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDP 302 (620)
Q Consensus 224 LltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP 302 (620)
|++|++||.+.+..+++..+...+|.|..+.+...... ...+ .........+...+ ...++.+.+||.+||++||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH--YTEV--RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT--C--C--CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc--cccc--cCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999999999999999999998877654211 0000 00000111111112 3478899999999999999
Q ss_pred CCCCCHHHHHcCCcccCCC
Q 007050 303 KDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 303 ~~Rpsa~elL~hp~f~~~~ 321 (620)
++|||++|+|+||||+.+.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 9999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=416.04 Aligned_cols=299 Identities=33% Similarity=0.534 Sum_probs=235.9
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~--- 96 (620)
+..++|++++.||+|+||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45679999999999999999999999999999999997554444445567899999999999999999999865321
Q ss_pred CCCCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.....+|+|||||+++|.+.+... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 114578999999999998888764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...... ........+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+....+.+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 542221 12223556899999999988652 4689999999999999999999999999999999999999888887776
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+..+........+ ... ......+...+ ...++.+++||.+||+.||++|||++|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKL-ELV-KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSS-CCC-SSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhccc-ccc-cccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 5544211110000 000 00000000000 01367899999999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=412.25 Aligned_cols=289 Identities=35% Similarity=0.576 Sum_probs=231.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..++|++++.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.++||||+++++++ .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence 3578999999999999999999999999999999997432211 1124678999999999999999999998 4
Q ss_pred CCCeEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|+|||||+++|.+++..+. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 456789999999999999987653 6899999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... .....+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+...++.|..+.|.
T Consensus 163 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 43222 23456899999999998652 468999999999999999999999999999999999999988888877665
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
........ . ........++...+..+++.+++||.+||..||++|||++|+|+||||+....
T Consensus 239 ~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 239 DMCSLPDY---V-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp STTSSTTC---C-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCccc---c-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 44211100 0 00011111222335678899999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=414.98 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=222.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+|+.|+||||+++++++ .+...+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 579999999999999999999999999999999976555556677899999999999999999999998 455779
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cEEEcccCccccccC
Q 007050 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARVAFN 178 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~lKL~DFGlA~~~~~ 178 (620)
|+|||||. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999998 59999998888899999999999999999999999999999999999998654 599999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+...
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 245 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 245 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 2345789999999999987 67999999999999999999999999887655444433221
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........|..+++.+++||.+||..||++|||++|+|+||||...
T Consensus 246 ----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 246 ----------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ----------------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ----------------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1111122345678999999999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=402.83 Aligned_cols=300 Identities=39% Similarity=0.631 Sum_probs=234.7
Q ss_pred cCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC--
Q 007050 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-- 95 (620)
Q Consensus 18 ~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-- 95 (620)
.+...++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 34456899999999999999999999999999999999864 34456678899999999999999999999885432
Q ss_pred -------CCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC-CCCcEEE
Q 007050 96 -------RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKI 167 (620)
Q Consensus 96 -------~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~lKL 167 (620)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 134567999999999999999864 5799999999999999999999999999999999999997 5679999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
+|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998754332222223456789999999987642 578999999999999999999999999999988888888877
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
..+..+....+... ...++..........+...++.+++.+.+||.+||+.||++|||++|+|+||||+.+.-.
T Consensus 242 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 242 PVVHEEDRQELLSV--IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCCHHHHHHHHTT--SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCCchhhhhhhhhc--CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 77766655443221 111222211222223334456789999999999999999999999999999999976543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=411.53 Aligned_cols=273 Identities=23% Similarity=0.241 Sum_probs=195.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+++|.+.+.||+|+||+||+|.+ +|+.||||+++.. ........+|+.++..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 45799999999999999999986 5899999999643 122222335666677899999999999985432 12346
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
+|||||||+ |+|.++++.. .++++.+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 6999999765 599999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCcc-cccccccCCccccCcccccccC----CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 173 ARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 173 A~~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~----~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
|+......... ......+||++|||||++.+.. ..|+.++|||||||+||||+||.+||...+....- ......
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhccc
Confidence 98765433321 1223568999999999986521 13678999999999999999999888654321100 000001
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhc-cCCCcccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRK-KQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+..+.+... +.. .....+...+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~------------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKV------------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHH------------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHH------------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11111111111 111 0001111111 1233568899999999999999999999763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=414.86 Aligned_cols=298 Identities=21% Similarity=0.289 Sum_probs=222.2
Q ss_pred CCCCCeEEEEEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 20 GDASRYKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 20 g~~~rY~i~~~LG~G--~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+..++|++++.||+| +||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----- 96 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI----- 96 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence 566799999999999 9999999999999999999999876555666778889999999999999999999984
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
+...+|+|||||. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 4567999999998 6999999875 679999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCc----ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc---
Q 007050 175 VAFNDTPT----TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL--- 247 (620)
Q Consensus 175 ~~~~~~~~----~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l--- 247 (620)
........ .......+||+.|+|||++.+....|+.++||||||||+|+|++|+.||.+.+....+..+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 54322111 11123348999999999987633579999999999999999999999999877665554443210
Q ss_pred -----CCCChhhhhhhhhchhHHHHHHhhh------ccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 248 -----GTPSLDTISRVVRNDKARRYLTSMR------KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 248 -----g~p~~e~i~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
..+..+.............+...+. .............+++.+++||.+||+.||++|||++|+|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0000000000000000000000000 00001111234567899999999999999999999999999999
Q ss_pred ccCCCc
Q 007050 317 FKGLSK 322 (620)
Q Consensus 317 f~~~~~ 322 (620)
|+.+..
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 997653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=401.96 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=217.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++. +..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYL-----VGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECC
Confidence 45689999999999999999999999999999999864322 23456789999999999999999999984 446
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 7999999997 6999999775 6999999999999999999999999999999999999999999999999999875433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+... +.
T Consensus 170 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~---------- 233 (297)
T 3fxz_A 170 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT---------- 233 (297)
T ss_dssp TCC---BCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CS----------
T ss_pred ccc---cCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CC----------
Confidence 222 245689999999999887 68999999999999999999999999887655444333210 00
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 234 ------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 234 ------------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ------------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------------------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0011123578899999999999999999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=419.56 Aligned_cols=280 Identities=32% Similarity=0.552 Sum_probs=230.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc------CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL------RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L------~HpnIv~l~~v~~~~~ 95 (620)
..+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ .|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~---- 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF---- 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec----
Confidence 46899999999999999999999999999999999742 34455677888888877 567999999998
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc--EEEcccC
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFG 171 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--lKL~DFG 171 (620)
.....+|+|||||.++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 169 -~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 -TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp -EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred -ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 3446799999999999999998764 4999999999999999999999999999999999999999987 9999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
+++..... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+++..+.+.+|.|.
T Consensus 248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 248 SSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99764322 235689999999999987 6799999999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhchhHHHHHHhhhccC-----------------------------CCcccCC-CCCCCHHHHHHHHHhcccC
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQ-----------------------------PVQFSQK-FPNADPSALRLLERLLAFD 301 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~-~~~~s~~l~dLI~~mL~~D 301 (620)
.+.+.... ....++..-.... ...+... ....++.+++||++||++|
T Consensus 320 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 320 QKLLDASK---RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp HHHHHTBT---THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred HHHHHhhh---hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 88765431 2222221100000 0000000 1234788999999999999
Q ss_pred CCCCCCHHHHHcCCcccCC
Q 007050 302 PKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 302 P~~Rpsa~elL~hp~f~~~ 320 (620)
|++|||++|+|+||||+..
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=428.27 Aligned_cols=318 Identities=26% Similarity=0.368 Sum_probs=244.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------HHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----------SDAARILREIKLLRLLRHPDIVEIKHI 90 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-----------~~~~~i~rEi~iL~~L~HpnIv~l~~v 90 (620)
.++|++++.||+|+||.||+|.++.+++.||||++....... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999999999999999997542211 224568899999999999999999999
Q ss_pred ecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cEE
Q 007050 91 MLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLK 166 (620)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~lK 166 (620)
+ .+...+|+|||||. ++|.+.+...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 8 45678999999998 59999998888999999999999999999999999999999999999999876 699
Q ss_pred EcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc
Q 007050 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 167 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~ 246 (620)
|+|||+++...... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+...
T Consensus 190 l~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp ECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999998754332 2345689999999999874 6899999999999999999999999998776665555431
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCC
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 326 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~ 326 (620)
.... ....|+.+++.+++||.+||++||.+|||++|+|+||||+.......
T Consensus 263 ~~~~----------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~- 313 (504)
T 3q5i_A 263 KYYF----------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN- 313 (504)
T ss_dssp CCCC----------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCC-
T ss_pred CCCC----------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhccc-
Confidence 1111 11224578899999999999999999999999999999987543210
Q ss_pred CCCCCCcchhhhHHhhcCCHHHHHHHHHHHHHHhCch-hhhhhccccccccccChhHHHHHHHHHHHHHhhc
Q 007050 327 PSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ-LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENV 397 (620)
Q Consensus 327 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~f~~l~~~~ 397 (620)
... ...+ ......+..+... .++.........+++.+..++++++.|..+|.++
T Consensus 314 -------~~~---------~~~~-~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~ 368 (504)
T 3q5i_A 314 -------KSD---------QKTL-CGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNG 368 (504)
T ss_dssp -------GGG---------HHHH-HHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTC
T ss_pred -------ccc---------hhhH-HHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCC
Confidence 000 0001 1112223333322 1111111111234457788999999999999983
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=405.78 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=220.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+++.||+|++... ..+...+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCE
Confidence 47899999999999999999999999999999998742 34556688999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC--CCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999998 59999997654 7999999999999999999999999999999999999987 7899999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 156 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 223 (321)
T 1tki_A 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD------ 223 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC------
Confidence 322 2245679999999999986 5689999999999999999999999998877665555543211111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...++.+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 224 ----------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 224 ----------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 12245788999999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=403.96 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=218.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 3579999999999999999999999999999999975311 112345677899999999999999999998 4557
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 8999999998 599999999889999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..|...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 134689999999999987 68999999999999999999999999887765544444220
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. . ...+.+++++.+||.+||..||.+|+ +++|+++||||+++
T Consensus 219 ---------------~-~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 219 ---------------E-L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp ---------------C-C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ---------------C-C---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 0 0 11135788999999999999999999 99999999999865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=403.28 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=220.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++++ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 357999999999999999999999999999999997542221 1356788999999999999999999998 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC----cEEEcccCc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGL 172 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~lKL~DFGl 172 (620)
+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 5567999999997 59999998888899999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 165 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 236 (326)
T 2y0a_A 165 AHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF-- 236 (326)
T ss_dssp CEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC--
T ss_pred CeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc--
Confidence 987543221 245689999999999876 679999999999999999999999998877665554443211111
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
....++.+++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 237 --------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 237 --------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 111235678899999999999999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=427.61 Aligned_cols=261 Identities=31% Similarity=0.495 Sum_probs=222.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 3689999999999999999999999999999999965322 233466788999999999999999999998 4567
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---CCCCcEEEcccCccccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 176 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~lKL~DFGlA~~~ 176 (620)
.+|+|||||. ++|.+.+...+.+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 8999999998 5999999988899999999999999999999999999999999999999 56789999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......
T Consensus 180 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------- 245 (484)
T 3nyv_A 180 EASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT------- 245 (484)
T ss_dssp CCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred cccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 4332 1245689999999999875 6899999999999999999999999988776655554331111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.....|..+++.+++||.+||+.||++|||++|+|+||||+....
T Consensus 246 ---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 246 ---------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ---------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ---------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 111234567899999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=409.04 Aligned_cols=291 Identities=32% Similarity=0.569 Sum_probs=232.2
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
|...++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++ .+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KK 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ec
Confidence 4566799999999999999999999999999999999976555555566788999999999999999999998 45
Q ss_pred CCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+||||+++ +|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 5679999999996 666666667789999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+.......
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 22456799999999998752 4789999999999999999999999999999998888888777766544332
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
+......... ..............++.+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGV-RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTC-CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccc-cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2111110000 000000111122345678999999999999999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=410.37 Aligned_cols=256 Identities=31% Similarity=0.509 Sum_probs=214.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||||++...... .....++.+|+.+|+.++||||+++++++ .+..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 36899999999999999999999999999999998643211 11234678999999999999999999998 4456
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 79999999999999999888899999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccCCccccCcccccccCCCC-CcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y-~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+.
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------------- 221 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--------------- 221 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC---------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH---------------
Confidence 2345689999999999876 344 789999999999999999999997754322111110
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.........+++.+.+||++||..||.+|||++|+|+||||+..
T Consensus 222 -----------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 222 -----------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00111223478999999999999999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=416.65 Aligned_cols=292 Identities=34% Similarity=0.577 Sum_probs=220.5
Q ss_pred CCeEE-EEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKI-QEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i-~~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+.|++ .++||+|+||.||+|.++ .+++.||||++..... ...+.+|+.+|+.|+||||+++++++... +.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH---AD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEET---TT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecC---CC
Confidence 45776 458999999999999976 5788999999975422 23577899999999999999999998542 34
Q ss_pred CeEEEEEecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----CCCCcEE
Q 007050 100 KDIYVVFELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLK 166 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~lK 166 (620)
..+|+|||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 679999999999999988632 249999999999999999999999999999999999999 6778999
Q ss_pred EcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------h
Q 007050 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------V 237 (620)
Q Consensus 167 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~---------~ 237 (620)
|+|||+++...............+||++|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+. .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999998765433222334567899999999998762 4589999999999999999999999987654 4
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCc------ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQ------FSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~el 311 (620)
+++..|.+.+|.|....|..+............+....... +.......++.+.+||.+||++||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 78999999999999888877654444444433332211100 011123447889999999999999999999999
Q ss_pred HcCCcccCCCc
Q 007050 312 LADPYFKGLSK 322 (620)
Q Consensus 312 L~hp~f~~~~~ 322 (620)
|+||||.+...
T Consensus 332 L~hp~f~~~~~ 342 (405)
T 3rgf_A 332 MQDPYFLEDPL 342 (405)
T ss_dssp HTSGGGTSSSC
T ss_pred hcChhhccCCC
Confidence 99999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=404.99 Aligned_cols=281 Identities=22% Similarity=0.420 Sum_probs=228.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----CCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----HPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-----HpnIv~l~~v~~~~~ 95 (620)
..++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+. ||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~--- 106 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM--- 106 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE---
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee---
Confidence 35799999999999999999999999999999999974 2345566778999999997 999999999984
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC------------
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA------------ 161 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~------------ 161 (620)
+...+|+|||||.++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 107 --~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 107 --YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp --ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred --ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 446799999999889999998754 5999999999999999999999999999999999999975
Q ss_pred -------------CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC
Q 007050 162 -------------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (620)
Q Consensus 162 -------------~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~ 228 (620)
++.+||+|||+++...... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCC
Confidence 7889999999998643221 34679999999999987 67999999999999999999999
Q ss_pred CCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhh--hccCCCc-------------ccCCCCCCCHHHHHH
Q 007050 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSM--RKKQPVQ-------------FSQKFPNADPSALRL 293 (620)
Q Consensus 229 ~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~--~~~~~~~-------------~~~~~~~~s~~l~dL 293 (620)
.||.+.+..+.+..+....+.+....+......... .++... ....+.. ........++.+.+|
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGG-GGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCc-cccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 999999999999999988888777665544221110 000000 0000000 000001235788899
Q ss_pred HHHhcccCCCCCCCHHHHHcCCccc
Q 007050 294 LERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 294 I~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
|.+||+.||.+|||++|+|+||||+
T Consensus 336 i~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=415.65 Aligned_cols=267 Identities=21% Similarity=0.395 Sum_probs=214.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (620)
..++|+++++||+|+||.||+|+++.+++.||||++++... .......+.+|..+|+.+ +||||+++++++ .+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 34689999999999999999999999999999999976432 223345677899999887 899999999998 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 578999999998 5999999988899999999999999999999999999999999999999999999999999998633
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+....+.. .
T Consensus 205 ~~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~----------~------ 263 (396)
T 4dc2_A 205 RPGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP----------D------ 263 (396)
T ss_dssp CTTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------------
T ss_pred cCCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccccccc----------c------
Confidence 2222 2356799999999999987 68999999999999999999999999654221100 0
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~elL~hp~f~~~ 320 (620)
..........+... .. .....+++.+++||++||+.||++||++ +|+++||||+++
T Consensus 264 ---~~~~~~~~~~i~~~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 264 ---QNTEDYLFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ----CCHHHHHHHHHHC-CC---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---hhhHHHHHHHHhcc-cc---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 00000011111111 11 1123578999999999999999999985 899999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=404.53 Aligned_cols=266 Identities=22% Similarity=0.410 Sum_probs=216.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|+++.+++.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 457999999999999999999999999999999997543 3345567788999999988 899999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 78999999998 59999998888899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||........ +..
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------~~~------ 221 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQ------ 221 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc----------ccc------
Confidence 221 2346789999999999987 6899999999999999999999999965321100 000
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~elL~hp~f~~~ 320 (620)
.........+... ... ....+++.+.+||.+||+.||++||++ +|+++||||+++
T Consensus 222 ---~~~~~~~~~i~~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 222 ---NTEDYLFQVILEK-QIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ----CHHHHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ---ccHHHHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 0000011111111 111 123578999999999999999999995 899999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=410.15 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=218.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (620)
..++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 45789999999999999999999999999999999975311 112345677899999876 899999999998 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 567999999998 5999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|..
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------ 232 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------------ 232 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------------
Confidence 2221 1356789999999999987 6799999999999999999999999988776554444321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-elL~hp~f~~~ 320 (620)
..+ . ....+++.+++||.+||..||++||++. ++++||||+++
T Consensus 233 ----------------~~~-~---~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 233 ----------------DNP-F---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp ----------------CCC-C---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ----------------CCC-C---CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 000 0 1134789999999999999999999998 99999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=387.62 Aligned_cols=264 Identities=28% Similarity=0.495 Sum_probs=225.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 4789999999999999999999999999999999976655666778889999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DFGlA~~~~ 177 (620)
.|+||||+. ++|.+.+..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 899999998 599999988888999999999999999999999999999999999999987655 9999999997654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------- 222 (284)
T 3kk8_A 160 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222 (284)
T ss_dssp SSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------
T ss_pred cCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-----------
Confidence 322 1245689999999999887 67899999999999999999999999887655444333221
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~ 324 (620)
........+..+++.+.+||.+||+.||++|||++|+|+||||+......
T Consensus 223 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 223 -----------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred -----------------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 11111223457889999999999999999999999999999998765443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=408.39 Aligned_cols=292 Identities=33% Similarity=0.580 Sum_probs=224.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--CCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--RDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~--~~~ 99 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ....+..+|+..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 358999999999999999999999999999999986432 222345678888899999999999999865322 223
Q ss_pred CeEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCceEeCC-CCcEEEcccCc
Q 007050 100 KDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILANA-NCKLKICDFGL 172 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~----~~~~lse~~~~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILl~~-~~~lKL~DFGl 172 (620)
..+|+|||||.++|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3488999999998776654 4567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+...++.|..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986543322 2356799999999998652 45899999999999999999999999999999999999999999988
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCccc----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFS----QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 325 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~ 325 (620)
+.+..+........+ .......+. ......++.+.+||.+||+.||.+|||+.|+|+||||+++.....
T Consensus 254 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDL----YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCGGG----GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhccc----cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 877655211110000 011111111 122346789999999999999999999999999999998765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=407.40 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=218.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|.++.+++.||||++++... .......+.+|..+|..+ +||||+++++++ .+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence 4689999999999999999999999999999999975311 112345678899999887 799999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 78999999998 59999999888899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 236 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 236 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 222 2346789999999999987 68999999999999999999999999887765554444320
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. . .....+++.+.+||.+||..||.+|| +++|+++||||+.+
T Consensus 237 ----------------~-~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 237 ----------------N-V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp ----------------C-C---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred ----------------C-C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 0 0 11235789999999999999999999 47999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=396.43 Aligned_cols=290 Identities=34% Similarity=0.585 Sum_probs=235.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||+|+||.||+|.+. .+|+.||+|++............+.+|+.+++.+ .||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999995 6789999999865432222223455777777666 899999999998533323
Q ss_pred CCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
....+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 557799999999999999998754 499999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|..+.+
T Consensus 170 ~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 170 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ccCC----CCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 4321 12345679999999999876 57999999999999999999999999999999999999988888877665
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
........ ...............+.+++.+.+||.+||..||.+|||++|+|+||||+++..
T Consensus 244 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 244 PRDVALPR-----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CTTCSSCG-----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccch-----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 43311110 001111222334456778999999999999999999999999999999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=398.93 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=209.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~--~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
..++|++++.||+|+||.||+|.+. .+++.||+|++++... .......+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 90 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF---- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE----
Confidence 3568999999999999999999985 6899999999976421 223455678999999999999999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 91 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 91 -QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp -ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred -EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 44567999999998 5999999988889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------- 236 (327)
T 3a62_A 170 ESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------- 236 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--------
T ss_pred ccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--------
Confidence 6432221 1245689999999999876 67899999999999999999999999887765544443221
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. ....+.+++.+.+||.+||..||.+|| +++|+|+||||+++
T Consensus 237 -------------------~-----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 237 -------------------K-----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -------------------C-----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -------------------C-----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0 011235788999999999999999999 89999999999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=405.76 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=219.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3468999999999999999999999999999999986431 1112346788999999999999999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 78999999997 69999999888899999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 253 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------ 253 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------------
Confidence 2 134689999999999987 68999999999999999999999999887765544444220
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. . .....+++.+.+||.+||+.||.+||+ ++|+++||||+++
T Consensus 254 ----------------~-~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 ----------------K-V---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ----------------C-C---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ----------------C-C---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 0 0 112357899999999999999999998 9999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=422.37 Aligned_cols=265 Identities=24% Similarity=0.406 Sum_probs=221.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|+++++||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+|..++||||+++++++ .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 4689999999999999999999999999999999964210 111122377899999999999999999998 5567
Q ss_pred eEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||. |+|.+++.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 8999999997 699999987 56899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccCCccccCcccccc---cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
... ...+..+||++|+|||++.. ....|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 297 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------- 297 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--------
Confidence 322 22345689999999999862 11568999999999999999999999999988776665553210
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccCC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 320 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~~ 320 (620)
....+...++.+++++++||++||..+|++ |++++|+++||||+++
T Consensus 298 -------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 298 -------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp -------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred -------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 001223334668999999999999999988 9999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=400.55 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=214.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|+++.+++.||||++.... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 3578999999999999999999999999999999986432 122345678999999999999999999998 4557
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+ ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+........
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---------------- 220 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------------- 220 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH----------------
T ss_pred Cc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----------------
Confidence 21 1223457899999999998762 23478999999999999999999999775432111000
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+. . .......+..+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 221 -------~~----~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 221 -------WK----E--KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -------HH----T--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -------Hh----c--ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 0 0011122356789999999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=404.11 Aligned_cols=260 Identities=29% Similarity=0.454 Sum_probs=212.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++...... ..+|+.+|..+ +||||+++++++ .+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVY-----DDGK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEE-----ECSS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEE-----EcCC
Confidence 35799999999999999999999999999999999754322 34688888887 799999999998 5567
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC----CcEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~lKL~DFGlA~~ 175 (620)
.+|+|||||. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 8999999998 5999999988899999999999999999999999999999999999998543 3599999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.....
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------- 227 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----------------- 227 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----------------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----------------
Confidence 543322 1245689999999999876 568999999999999999999999997632110
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
....+..+...........++.+++.+++||++||..||++|||++|+|+||||.++..
T Consensus 228 --------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 228 --------PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp --------HHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred --------HHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 00111111111222222346778999999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=402.90 Aligned_cols=262 Identities=28% Similarity=0.415 Sum_probs=203.7
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
....++|++++.||+|+||.||+|+++.+++.||||++...... ...+.+|+.+++.++||||+++++++. +
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 87 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVIL-----T 87 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEe-----e
Confidence 34568999999999999999999999999999999999753222 245779999999999999999999984 4
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc--EEEcccCcccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFGLARV 175 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--lKL~DFGlA~~ 175 (620)
...+|+|||||. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 567999999997 599999988888999999999999999999999999999999999999987765 99999999975
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~-~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
..... .....+||++|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+....+..+.
T Consensus 168 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---------- 231 (361)
T 3uc3_A 168 SVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---------- 231 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH----------
T ss_pred ccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH----------
Confidence 32221 1234679999999999876 455544 999999999999999999998754322211111
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+.... .. ......+++.+.+||.+||+.||++|||++|+|+||||...
T Consensus 232 --------------~~~~~~~-~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 232 --------------QRILSVK-YS-IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp --------------HHHHTTC-CC-CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred --------------HHHhcCC-CC-CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 1110000 00 11123578999999999999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=397.18 Aligned_cols=291 Identities=31% Similarity=0.586 Sum_probs=225.7
Q ss_pred cccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007050 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (620)
Q Consensus 16 ~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~ 94 (620)
..+++..++|++++.||+|+||.||+|++..+++.||||++... ....+.+|+.+|+.++ ||||+++++++...
T Consensus 29 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 29 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp CCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred hhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 34456678999999999999999999999999999999998742 2456789999999997 99999999998542
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCc
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGL 172 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGl 172 (620)
.....|+||||+. ++|.+++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 104 ---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 104 ---VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ---TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ---CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 2467899999999 58888874 499999999999999999999999999999999999999777 899999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCC-CCCChhHHHHHhhhccCCCC
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF-~g~~~~~~l~~i~~~lg~p~ 251 (620)
++....... ....++|+.|+|||++.+. ..++.++|||||||++|+|++|..|| .+.+..+++..+...++.+.
T Consensus 178 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 178 AEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp CEECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ceEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 986543322 2446899999999998652 56899999999999999999999888 55667777777776665543
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQK-----FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
...+...........+...........+... ...+++.+.+||.+||++||++|||++|+|+||||+++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 3221111010001111111111111111111 1237899999999999999999999999999999997653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=407.95 Aligned_cols=260 Identities=29% Similarity=0.449 Sum_probs=212.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 357999999999999999999999999999999986321 1111356688999999999999999999998 44
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDF 170 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DF 170 (620)
...+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 567999999999 6998877542 35899999999999999999999999999999999999987654 999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
|+++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+. ..+..+..
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~----- 246 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIK----- 246 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHH-----
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHc-----
Confidence 99987643321 2345689999999999987 6799999999999999999999999987532 22222211
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.........++.+++.+++||.+||..||++|||+.|+|+||||+..
T Consensus 247 -----------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 247 -----------------------GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -----------------------TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -----------------------CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 01111112245678999999999999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=394.86 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=221.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
..++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 84 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY----- 84 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence 3467999999999999999999999999999999997542221 1356788999999999999999999998
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC----cEEEcccC
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFG 171 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~lKL~DFG 171 (620)
.+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 45567999999997 69999999888899999999999999999999999999999999999999988 79999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 165 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 165 LAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp TCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred cceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 9987543321 245679999999999876 6799999999999999999999999988876665555443211111
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. ..++.+++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 239 ~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 239 E----------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp H----------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred h----------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 1 1124678899999999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=407.48 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=211.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~i-L~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
..++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++||||+++++++ .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 34689999999999999999999999999999999975432 23344566777776 5778999999999998 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 578999999998 5999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 254 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------- 254 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------
Confidence 3222 1246789999999999987 68999999999999999999999999887765554444220
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~elL~hp~f~~~ 320 (620)
+. ...+.+++.+++||++||+.||.+||++ +++++||||+++
T Consensus 255 ------------------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 255 ------------------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ------------------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ------------------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 01 1124678999999999999999999986 799999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=400.60 Aligned_cols=264 Identities=26% Similarity=0.463 Sum_probs=195.1
Q ss_pred CCeEEE---EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQ---EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~---~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~ 98 (620)
++|++. +.||+|+||.||+|.++.+++.||||++... ....+.+|+.+|+.+. ||||+++++++ .+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~ 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF-----HD 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----Ec
Confidence 356665 7899999999999999999999999998642 3456678999999997 99999999998 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cEEEcccCccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLAR 174 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~lKL~DFGlA~ 174 (620)
...+|+|||||+ ++|.+++..++.+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 577999999998 59999999988999999999999999999999999999999999999998766 89999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------------- 217 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--------------- 217 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----------------------
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccc---------------
Confidence 6543221 2345688999999999977 6899999999999999999999999977543110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.......+..+...........++.+++.+++||.+||..||.+|||++|+|+||||++...
T Consensus 218 ------~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 218 ------CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------cccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 00011111112111111112234568899999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=416.00 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=218.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+|+.++||||+++++++ .+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 45689999999999999999999999999999999864210 111123467899999999999999999998 456
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+|||||. |+|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 78999999997 6999998764 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCC--CCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~--~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.. .......+||+.|+|||++.+... .|+.++|||||||++|||++|.+||.+.+....+..|....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 289 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--------- 289 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc---------
Confidence 22 112346789999999999875211 18899999999999999999999999888766655553210
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~elL~hp~f~~~ 320 (620)
.... ...++.+++++++||.+||..+|.+ |++++|+++||||+++
T Consensus 290 ------------------~~~~-~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 290 ------------------NSLT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ------------------HHCC-CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ------------------cccc-CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0000 1123468999999999999999988 9999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=407.99 Aligned_cols=261 Identities=26% Similarity=0.450 Sum_probs=216.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 468999999999999999999999999999999986431 1122346788999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||. |+|.+++..+..+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 8999999998 599999999889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+......
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----------------- 227 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----------------- 227 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-----------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-----------------
Confidence 2 23567899999999998642 1458999999999999999999999997653211110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-a~elL~hp~f~~~ 320 (620)
....+... . ......+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 228 --------~~~~~~~~-~---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 228 --------IVHTFETT-V---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp --------HHHHHHHC-C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred --------HHHHHhhc-c---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 00011010 0 1122457899999999999999999998 9999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=393.07 Aligned_cols=252 Identities=28% Similarity=0.336 Sum_probs=208.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||+||+|.++.+|+.||||++..............+|+..+..+ +||||+++++++ .+...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 579999999999999999999999999999999877656666666677777766655 899999999998 45577
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..+|.+.+....+ .. +.
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~--~~----------- 268 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQ--GY----------- 268 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TT--TC-----------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hc--cC-----------
Confidence 2 234579999999999875 6899999999999999999998777554322211 10 00
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.+ ......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 269 --------------~~---~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 --------------LP---PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------------CC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------------CC---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 00 0112457889999999999999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=416.50 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=210.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence 467999999999999999999999999999999997532 2233456678999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||+ ++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 7999999998 5999999888899999999999999999999998 9999999999999999999999999999986432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 302 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2356789999999999977 68999999999999999999999999887765544443210
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
.. .....+++.+.+||.+||+.||.+|| |++|+|+||||+++
T Consensus 365 -----------------~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 -----------------EI---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------------CC---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 00 11235789999999999999999999 99999999999976
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=390.99 Aligned_cols=260 Identities=25% Similarity=0.471 Sum_probs=207.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------------------------hHHHHHHHHHHHHHH
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH------------------------ISDAARILREIKLLR 77 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~------------------------~~~~~~i~rEi~iL~ 77 (620)
.++|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998643211 112356889999999
Q ss_pred hcCCCCcceeeeEecCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 78 ~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.++||||+++++++... ....+|+|||||+ ++|.+++ ....+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999998542 2467999999998 5777654 34579999999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCC-CCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~-~y~~~~DIWSLG~IlyeLltG~~pF~g~~ 235 (620)
||++.++.+||+|||+++....... .....+||+.|+|||++.+... .++.++|||||||++|+|++|..||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999987543321 2345689999999999876211 14788999999999999999999998765
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp 315 (620)
.......+.. . ...+ ...+.+++.+.+||.+||+.||++|||++|+|+||
T Consensus 245 ~~~~~~~~~~----------------------------~-~~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 245 IMCLHSKIKS----------------------------Q-ALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HHHHHHHHHH----------------------------C-CCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HHHHHHHHhc----------------------------c-cCCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 4332222211 0 0011 12356889999999999999999999999999999
Q ss_pred ccc
Q 007050 316 YFK 318 (620)
Q Consensus 316 ~f~ 318 (620)
||+
T Consensus 295 ~~~ 297 (298)
T 2zv2_A 295 WVT 297 (298)
T ss_dssp HHH
T ss_pred ccc
Confidence 996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=405.57 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=219.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+|+.||+|++... ...+...+.+|+.+|+.++||||+++++++ .+...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCE
Confidence 35899999999999999999999999999999999753 234556788999999999999999999998 45577
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC--CCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999998 59999997654 7999999999999999999999999999999999999974 4779999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 203 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------- 265 (387)
T 1kob_A 203 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------- 265 (387)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 3321 234579999999999987 67999999999999999999999999887765554444321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........+..+++.+++||.+||..||++|||++|+|+||||++.
T Consensus 266 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 266 -----------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -----------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1111123456789999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=383.43 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=218.0
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.....|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .+.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 4456799999999999999999999999999999999866556677788999999999999999999999875432 345
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeC-CCCcEEEcccCcccc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN-ANCKLKICDFGLARV 175 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~-~~~~lKL~DFGlA~~ 175 (620)
..+|+|||||+ ++|.+++...+.+++..++.|+.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 67999999998 599999998888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+......
T Consensus 182 ~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (290)
T 1t4h_A 182 KRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp CCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred ccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc---------
Confidence 43221 234679999999998864 6899999999999999999999999875443322211110
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
...+ .......++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 245 -----------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 -----------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------cCCc---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0001 1112345688999999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=388.78 Aligned_cols=283 Identities=30% Similarity=0.537 Sum_probs=228.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEE-CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC------cceeeeEecCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAID-THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD------IVEIKHIMLPP 94 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d-~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn------Iv~l~~v~~~~ 94 (620)
.++|++++.||+|+||.||+|.+ +.+++.||||++... ......+.+|+.+++.++|++ |+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~--- 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF--- 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE---
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc---
Confidence 47999999999999999999999 568899999999742 345567889999999887654 89999988
Q ss_pred CCCCCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-----------
Q 007050 95 SRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----------- 161 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----------- 161 (620)
.+...+|+|||||+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 --~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 87 --EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp --EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred --ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 4456899999999989999998765 6899999999999999999999999999999999999987
Q ss_pred --------CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 007050 162 --------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (620)
Q Consensus 162 --------~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g 233 (620)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999999864322 134579999999999987 6799999999999999999999999999
Q ss_pred CChhHHHHHhhhccCCCChhhhhhhhhc-------------hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhccc
Q 007050 234 KNVVHQLDLMTDLLGTPSLDTISRVVRN-------------DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300 (620)
Q Consensus 234 ~~~~~~l~~i~~~lg~p~~e~i~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~ 300 (620)
.+..+.+..+...++.+....+...... .....+...... ....+.......++.+.+||.+||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCc
Confidence 9988888888888887776655433110 111111111110 01111112223467899999999999
Q ss_pred CCCCCCCHHHHHcCCcccCCC
Q 007050 301 DPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 301 DP~~Rpsa~elL~hp~f~~~~ 321 (620)
||.+|||++|+|+||||+.+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHHh
Confidence 999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=411.70 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=217.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++ .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 3578999999999999999999999999999999996421 1112233477899999999999999999998 456
Q ss_pred CeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
..+|+|||||. |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 78999999997 6999999874 479999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCccccCccccccc-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 286 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----- 286 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence 3322 112356899999999998621 1468999999999999999999999999887766555553210
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R---psa~elL~hp~f~~~ 320 (620)
....+......+++++++||++||. ||.+| ++++|+++||||+++
T Consensus 287 ----------------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 287 ----------------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ----------------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ----------------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 0001111224689999999999999 99998 599999999999876
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=384.87 Aligned_cols=256 Identities=30% Similarity=0.496 Sum_probs=209.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.++.++..+|+|++..... ......+.+|+.+|+.++||||+++++++ .+...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 94 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN 94 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence 3689999999999999999999999999999999975432 23456788999999999999999999998 45577
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---CCCCcEEEcccCcc
Q 007050 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLA 173 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~lKL~DFGlA 173 (620)
+|+|||||+ ++|.+.+.. ...+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999998 499988854 3679999999999999999999999999999999999999 45688999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 175 ~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-------- 239 (285)
T 3is5_A 175 ELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-------- 239 (285)
T ss_dssp CC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------
T ss_pred eecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc--------
Confidence 76543221 245679999999999864 689999999999999999999999988765433222211
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
....+......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 240 ---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 240 ---------------------KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------------------CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------------------CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011112223457899999999999999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=403.50 Aligned_cols=283 Identities=27% Similarity=0.400 Sum_probs=224.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--------CCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--------HPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~--------HpnIv~l~~v~~~ 93 (620)
.++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999999999999999999742 345667889999999986 7889999998843
Q ss_pred CCCCCCCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCC-------
Q 007050 94 PSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANC------- 163 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~------- 163 (620)
.. .+...+|+|||||+++|.+.+... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 244679999999999888888764 4699999999999999999999998 999999999999999875
Q ss_pred ------------------------------------------cEEEcccCccccccCCCCcccccccccCCccccCcccc
Q 007050 164 ------------------------------------------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201 (620)
Q Consensus 164 ------------------------------------------~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl 201 (620)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865432 2445899999999999
Q ss_pred cccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC------hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccC
Q 007050 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQ 275 (620)
Q Consensus 202 ~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~------~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~ 275 (620)
.+ ..|+.++|||||||++|+|++|..||.+.+ ..+++..+.+.+|.+..+.+...... ..++.......
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~ 340 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS---KEFFTKKGDLK 340 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG---GGTBCTTSSBS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc---ccccCCccccc
Confidence 87 679999999999999999999999998765 56678888888888876654322110 00000000000
Q ss_pred CCcc-------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 276 PVQF-------------SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 276 ~~~~-------------~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.... .......++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 0001123567899999999999999999999999999973
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=381.08 Aligned_cols=257 Identities=31% Similarity=0.483 Sum_probs=219.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+++.++||||+++++++ .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 80 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTD 80 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCe
Confidence 3579999999999999999999999999999999975432 2356788999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---CCCCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||+ ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998 5999999888889999999999999999999999999999999999999 788999999999998654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 226 (277)
T 3f3z_A 161 PGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF------- 226 (277)
T ss_dssp TTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred Ccc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 332 1245679999999999875 58999999999999999999999998877655554443321111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
....+..+++.+.+||.+||+.||++|||+.++|+||||++.
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 227 ---------------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---------------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 111234678899999999999999999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=399.15 Aligned_cols=280 Identities=32% Similarity=0.531 Sum_probs=226.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCC-----cceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD-----IVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-Hpn-----Iv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|.++.+++.||||++... ......+.+|+.+++.++ |++ |+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--- 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence 47899999999999999999999999999999999742 344566778999998885 553 889988883
Q ss_pred CCCCCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCceEeC--CCCcEEEcc
Q 007050 96 RRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILAN--ANCKLKICD 169 (620)
Q Consensus 96 ~~~~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILl~--~~~~lKL~D 169 (620)
....+|+|||||+++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 127 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 --FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp --ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred --cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 44679999999999999999875 46999999999999999999999 57999999999999995 478899999
Q ss_pred cCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 170 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999875322 235689999999999987 57999999999999999999999999999999999999999999
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCC---------CcccC-C------------------CCC-------CCHHHHHHH
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQP---------VQFSQ-K------------------FPN-------ADPSALRLL 294 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~-~------------------~~~-------~s~~l~dLI 294 (620)
|..+.+... ...+.++..+....- ..+.. . ..+ .++.+++||
T Consensus 277 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 277 PPAHILDQA---PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp CCHHHHTTC---TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred CCHHHHHhh---HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 887765432 223333322211000 00000 0 000 114789999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 295 ERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 295 ~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+||++||++|||++|+|+||||++.
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=397.88 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=202.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.++.+++.||||++... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCe
Confidence 35799999999999999999999999999999999753 2345677899999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999998 599999988888999999999999999999999999999999999999975 8899999999998653
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhH-HHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~-~l~~i~~~lg~p~~e~i~ 256 (620)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~------------ 264 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------------ 264 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH------------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH------------
Confidence 321 1245689999999999987 679999999999999999999999997654322 111111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..........++.++..+.+||.+||..||++|||++|+|+||||.+..
T Consensus 265 ----------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 265 ----------------NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ----------------TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ----------------hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1111122234567899999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=407.26 Aligned_cols=262 Identities=28% Similarity=0.440 Sum_probs=204.6
Q ss_pred CCCeEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL-~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|.+. +.||+|+||+||+|.++.+++.||||++... ..+.+|+.++ +.++||||+++++++... ..+.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL-YAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCC
Confidence 4578887 7999999999999999999999999998632 3456788887 556899999999987431 1235
Q ss_pred CeEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCcEEEcccCcc
Q 007050 100 KDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLA 173 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~lKL~DFGlA 173 (620)
..+|||||||. |+|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67999999998 59999998754 5999999999999999999999999999999999999998 789999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+..... ..
T Consensus 212 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------~~ 274 (400)
T 1nxk_A 212 KETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PG 274 (400)
T ss_dssp EECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-----------CS
T ss_pred cccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-----------HH
Confidence 8653222 2345789999999999976 68999999999999999999999999775432100 00
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
... .+...........|..+++++++||++||+.||++|||++|+|+||||.+..
T Consensus 275 ~~~-------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 275 MKT-------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHH-------------HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHH-------------HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 000 0001111111234567899999999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=394.95 Aligned_cols=268 Identities=29% Similarity=0.449 Sum_probs=215.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 368999999999999999999999999999999986431 1234567889999999999999999999998 45
Q ss_pred CCeEEEEEecCC-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 007050 99 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTREHYQFFLYQLLR 137 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~----------------------------------------~~~lse~~~~~i~~QIl~ 137 (620)
...+|+|||||+ ++|.+++.. ...+++..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 577999999998 699998842 112467888999999999
Q ss_pred HHHHHHhCCcEeecCCCCceEeCCCC--cEEEcccCccccccCCCC-cccccccccCCccccCcccccccCCCCCcccch
Q 007050 138 ALKYIHTANVYHRDLKPKNILANANC--KLKICDFGLARVAFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (620)
Q Consensus 138 aL~yLHs~gIvHrDLKP~NILl~~~~--~lKL~DFGlA~~~~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DI 214 (620)
||.|||+.||+||||||+|||++.++ .+||+|||+++....... ........+||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986543221 111234568999999999986533578999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHH
Q 007050 215 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 294 (620)
Q Consensus 215 WSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI 294 (620)
|||||++|+|++|..||.+.+..+.+..+..... ......+..+++.+.+||
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL----------------------------CFENPNYNVLSPLARDLL 311 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------------------CTTSGGGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc----------------------------ccCCcccccCCHHHHHHH
Confidence 9999999999999999988876655544432111 011122345788999999
Q ss_pred HHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 295 ERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 295 ~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.+||+.||.+|||+.|+|+||||+++..
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=412.42 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=217.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|.+++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 4689999999999999999999999999999999964311 112345788999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||. ++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 7999999997 699999988889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. .....+||+.|+|||++.+. ..++.++||||||||+|+|++|..||.+.+....+..+.+.
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 231 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG------------- 231 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT-------------
T ss_pred c----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------
Confidence 2 23457899999999998762 23478999999999999999999999887655444433221
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. ......+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 232 ---------------~----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 232 ---------------I----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------------C----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------------C----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 01113468899999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=391.96 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=205.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC------
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR------ 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~------ 96 (620)
++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46999999999999999999999999999999997542 33456778999999999999999999998854321
Q ss_pred ----------------------------------------------CCCCeEEEEEecCC-ccHHHHHHhCCC---CCHH
Q 007050 97 ----------------------------------------------RDFKDIYVVFELME-SDLHQVIKANDD---LTRE 126 (620)
Q Consensus 97 ----------------------------------------------~~~~~lylV~E~~~-gdL~~~i~~~~~---lse~ 126 (620)
.....+|+|||||+ ++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 12234899999999 599999987643 5666
Q ss_pred HHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcc---------cccccccCCccccC
Q 007050 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT---------IFWTDYVATRWYRA 197 (620)
Q Consensus 127 ~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~---------~~~~~~~gt~~Y~A 197 (620)
.++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998765432111 12245689999999
Q ss_pred cccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCC
Q 007050 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPV 277 (620)
Q Consensus 198 PEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~ 277 (620)
||++.+ ..++.++|||||||++|+|++|..++... ...+... ...
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~-------------------------~~~--- 289 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDV-------------------------RNL--- 289 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHH-------------------------HTT---
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHh-------------------------hcc---
Confidence 999887 68999999999999999999987665211 1111000 000
Q ss_pred cccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 278 QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 278 ~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+...+...++.+.+||.+||+.||++|||++|+|+||||+++
T Consensus 290 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0111122346788999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.58 Aligned_cols=280 Identities=25% Similarity=0.392 Sum_probs=209.7
Q ss_pred CCCeEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++. +.||+|+||.||+|.++.+++.||||++.... ......+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~ 83 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEE 83 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 3689995 78999999999999999999999999997542 23356788999999885 799999999998 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEcccCcccc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARV 175 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DFGlA~~ 175 (620)
..+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 67999999998 699999988888999999999999999999999999999999999999998776 99999999976
Q ss_pred ccCCCC----cccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccC
Q 007050 176 AFNDTP----TTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 176 ~~~~~~----~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg 248 (620)
...... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------- 235 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-------- 235 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC--------
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc--------
Confidence 532211 11112345799999999998631 134788999999999999999999999876432100
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
....+. ........+..+...........+..+++.+++||.+||..||++|||++|+|+||||++..
T Consensus 236 ~~~~~~-----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 236 WDRGEA-----CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp C----C-----CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccccc-----chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 000000 00001111222222221111223456889999999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=383.44 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=216.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++||||+++++++ .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 80 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH 80 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCE
Confidence 357999999999999999999999999999999997532 22345678999999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---CCCCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999998 5999999888889999999999999999999999999999999999999 778999999999987543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.+.
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~----------- 222 (304)
T 2jam_A 161 NG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG----------- 222 (304)
T ss_dssp CB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC-----------
T ss_pred CC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21 1234579999999999876 67999999999999999999999999887655444333221
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
........++.+++.+.+||.+||..||++|||++|+|+||||++..
T Consensus 223 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 223 -----------------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 11111123457889999999999999999999999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=380.69 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=214.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCC
Confidence 3689999999999999999999999999999999864211 111245678999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+||||++ ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 7999999999 599999988888999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 1 234679999999999877 678999999999999999999999998876554443332210
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
......+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 224 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 --------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred --------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 0112346789999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.33 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=213.9
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.|...+.||+|+||.||+|.++.+|+.||||++.... ......+.+|+.+|+.++||||+++++++. ....+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYL-----VGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 4888999999999999999999999999999987532 233556789999999999999999999984 446799
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 589988764 56999999999999999999999999999999999999999999999999999875433222
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---------------- 256 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---------------- 256 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------
Confidence 245689999999999976 67999999999999999999999999877655443333211
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.+ +.......+++.+.+||.+||+.||++|||++|+|+||||...
T Consensus 257 ------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 257 ------------PP-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ------------SC-CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ------------CC-CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00 0111123568899999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=391.19 Aligned_cols=261 Identities=26% Similarity=0.339 Sum_probs=207.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| |||+++++++ .+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 56899999999999999999988 468899999997655556667788999999999986 9999999998 445
Q ss_pred CeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
..+|+|||++.++|.+++...+.+++.+++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 6799999988889999999999999999999999999999999999999999999999997 678999999999865433
Q ss_pred CCcccccccccCCccccCccccccc---------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChh-HHHHHhhhccCC
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGT 249 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~---------~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~-~~l~~i~~~lg~ 249 (620)
.. .......+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.... ..+..+.
T Consensus 161 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----- 234 (343)
T 3dbq_A 161 TT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII----- 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-----
T ss_pred cc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh-----
Confidence 22 1123456899999999997531 146889999999999999999999999764221 1111111
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..... .......+..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 235 ----------------------~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 ----------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ----------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------cCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 00001 11122356789999999999999999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=398.99 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=212.4
Q ss_pred CCeEE--EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i--~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 34555 67899999999999999999999999999753 335667788999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe--CCCCcEEEcccCccccc
Q 007050 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA--NANCKLKICDFGLARVA 176 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl--~~~~~lKL~DFGlA~~~ 176 (620)
.+|+|||||+ ++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 7999999998 5998888654 469999999999999999999999999999999999999 66789999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ....+||+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+......
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 43322 234579999999999876 67899999999999999999999999988776665555432111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.....++.+++.+++||.+||+.||.+|||++|+|+||||++.
T Consensus 307 ---------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 ---------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1122346789999999999999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=391.98 Aligned_cols=274 Identities=25% Similarity=0.406 Sum_probs=223.3
Q ss_pred CCCCccccccCCCCCCeEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcce
Q 007050 9 NSPEMEFFSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVE 86 (620)
Q Consensus 9 ~~~~~~~~~~~g~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~ 86 (620)
+.+++-|...-...++|.+. +.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.+. ||||++
T Consensus 14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 33444444443445789888 8999999999999999999999999999865544455677889999999995 699999
Q ss_pred eeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC--
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-- 161 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-- 161 (620)
+++++ .+...+|+|||||.+ +|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 94 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 94 LHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp EEEEE-----ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred EEEEE-----EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 99998 455779999999985 999988543 57999999999999999999999999999999999999998
Q ss_pred -CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHH
Q 007050 162 -NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240 (620)
Q Consensus 162 -~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l 240 (620)
++.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp TBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCcEEEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 78999999999987543221 234689999999999976 68999999999999999999999999887766554
Q ss_pred HHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 241 ~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..+...... .....+..+++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus 243 ~~i~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 243 LNISQVNVD----------------------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHTCCC----------------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHhcccc----------------------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 444332111 1123346788999999999999999999999999999999876
Q ss_pred C
Q 007050 321 S 321 (620)
Q Consensus 321 ~ 321 (620)
.
T Consensus 295 ~ 295 (327)
T 3lm5_A 295 D 295 (327)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=385.85 Aligned_cols=283 Identities=31% Similarity=0.524 Sum_probs=227.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC------cceeeeEecCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD------IVEIKHIMLPP 94 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn------Iv~l~~v~~~~ 94 (620)
.++|++++.||+|+||.||+|.+..++ +.||+|++... ......+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~--- 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF--- 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE---
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee---
Confidence 479999999999999999999998887 68999999742 345567788999999997766 88888887
Q ss_pred CCCCCCeEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe-------------
Q 007050 95 SRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA------------- 159 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl------------- 159 (620)
.....+|+|||||+++|.+.+.... .+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 92 --~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 92 --NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp --EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred --eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 4456799999999999998887654 69999999999999999999999999999999999999
Q ss_pred ------CCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 007050 160 ------NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (620)
Q Consensus 160 ------~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g 233 (620)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 567899999999998643221 34579999999999986 6899999999999999999999999999
Q ss_pred CChhHHHHHhhhccCCCChhhhhhhhhc-------------hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhccc
Q 007050 234 KNVVHQLDLMTDLLGTPSLDTISRVVRN-------------DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300 (620)
Q Consensus 234 ~~~~~~l~~i~~~lg~p~~e~i~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~ 300 (620)
.+..+.+..+...++.++...+...... .....+...... ............++.+.+||.+||..
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcC
Confidence 9998888888888888776655443110 011111111100 00001111122356899999999999
Q ss_pred CCCCCCCHHHHHcCCcccCCC
Q 007050 301 DPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 301 DP~~Rpsa~elL~hp~f~~~~ 321 (620)
||++|||++|+|+||||+++.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=390.93 Aligned_cols=269 Identities=24% Similarity=0.353 Sum_probs=215.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence 35789999999999999999999999999999999976433 3344567889999999999999999999885432 122
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
...|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 34699999998 69999999888999999999999999999999999999999999999999999999999999987544
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~------------ 234 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE------------ 234 (311)
T ss_dssp -------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------------
T ss_pred cccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------
Confidence 3332222345679999999999987 68999999999999999999999999887655443332221
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...........+++.+.+||.+||+.||++||++.++|.|+|++..
T Consensus 235 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 ----------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----------------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111122345688999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=408.11 Aligned_cols=254 Identities=17% Similarity=0.223 Sum_probs=202.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHH---HHHhcCCCCcceee-------eE
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIK---LLRLLRHPDIVEIK-------HI 90 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~---iL~~L~HpnIv~l~-------~v 90 (620)
.++|++.+.||+|+||.||+|.++.+|+.||||++... .........+.+|+. +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999999999999999743 233445677889995 45555899999998 44
Q ss_pred ecCCCC-------CCCC-----eEEEEEecCCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCcEeec
Q 007050 91 MLPPSR-------RDFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHYQFFLYQLLRALKYIHTANVYHRD 151 (620)
Q Consensus 91 ~~~~~~-------~~~~-----~lylV~E~~~gdL~~~i~~~~~lse-------~~~~~i~~QIl~aL~yLHs~gIvHrD 151 (620)
+..... .+.. ..|+|||||+|+|.+++...+.+++ ..++.|+.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 422210 0111 3899999999999999987655655 78888999999999999999999999
Q ss_pred CCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCC-----------CCCcccchHhHHHH
Q 007050 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 220 (620)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~-----------~y~~~~DIWSLG~I 220 (620)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985321 2245678 99999999876 4 69999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhccc
Q 007050 221 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300 (620)
Q Consensus 221 lyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~ 300 (620)
+|+|++|+.||.+.+....+..+ ...++.+++.+.+||.+||+.
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWI------------------------------------FRSCKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp HHHHHHSSCCC------CCSGGG------------------------------------GSSCCCCCHHHHHHHHHHTCS
T ss_pred HHHHHHCCCCCcccccccchhhh------------------------------------hhhccCCCHHHHHHHHHHcCC
Confidence 99999999999765432211111 112357789999999999999
Q ss_pred CCCCCCCHHHHHcCCcccCC
Q 007050 301 DPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 301 DP~~Rpsa~elL~hp~f~~~ 320 (620)
||++|||+.|+|+||||+++
T Consensus 347 dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 347 PKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp SGGGCCCHHHHHTSHHHHHH
T ss_pred CchhCCCHHHHhhChHHHHH
Confidence 99999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=397.71 Aligned_cols=260 Identities=27% Similarity=0.361 Sum_probs=208.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.|+ ||||+++++++. +..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 469999999999999999999865 899999999765455566788999999999996 599999999884 445
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|||++.++|.+++.....+++.+++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++......
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 699999977789999999988999999999999999999999999999999999999995 5789999999998754322
Q ss_pred CcccccccccCCccccCccccccc---------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCh-hHHHHHhhhccCCC
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTP 250 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~---------~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~-~~~l~~i~~~lg~p 250 (620)
. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|.+||.+... ...+..+.+
T Consensus 209 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~----- 282 (390)
T 2zmd_A 209 T-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----- 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-----
T ss_pred c-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-----
Confidence 1 1123456899999999998641 13689999999999999999999999976432 111111110
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...... .....+..+.+||.+||..||++|||++|+|+||||+..
T Consensus 283 ----------------------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 ----------------------PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ----------------------TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------ccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 000111 112346789999999999999999999999999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=393.04 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=214.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++. +..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 35699999999999999999999999999999999754322 334567889999999999999999999984 446
Q ss_pred eEEEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||.|+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 799999999999988885 4567999999999999999999999999999999999999999999999999999764321
Q ss_pred CCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...+||+.|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~------------- 267 (348)
T 1u5q_A 208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 267 (348)
T ss_dssp -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------
Confidence 345799999999988421 25789999999999999999999999987765444333321
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
...+. .....+++.+.+||.+||+.||++|||++++|+||||..
T Consensus 268 --------------~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 268 --------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------------SCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------cCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 00110 112356889999999999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=426.30 Aligned_cols=257 Identities=22% Similarity=0.391 Sum_probs=221.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|.++.+++.||||++++.. ........+.+|..+|..+ +||+|+.+++++ ++.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence 468999999999999999999999999999999997531 1122345677899999887 799999999998 556
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 78999999998 59999999888999999999999999999999999999999999999999999999999999986433
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... ....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|...
T Consensus 495 ~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------------ 557 (674)
T 3pfq_A 495 DGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 557 (674)
T ss_dssp TTCC---BCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS------------
T ss_pred CCcc---cccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 2222 356789999999999987 68999999999999999999999999998776665555321
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~elL~hp~f~~~ 320 (620)
.. .....+++++++||++||+.||++|+++ +||++||||+++
T Consensus 558 -----------------~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 558 -----------------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred -----------------CC---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 00 1123578999999999999999999997 999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=376.54 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=222.9
Q ss_pred ccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 17 ~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
.+-...++|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~---- 84 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF---- 84 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee----
Confidence 34456689999999999999999999999999999999986543 2345567788999999999999999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 85 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 85 -EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp -ECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred -ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 45567999999999 6999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 229 (294)
T 2rku_A 164 KVEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--------- 229 (294)
T ss_dssp ECCSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---------
T ss_pred ecccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh---------
Confidence 75432221 244679999999999876 6789999999999999999999999987665433322211
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.. ......+++.+.+||.+||+.||++|||++|+|+||||.....
T Consensus 230 -------------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 -------------------NE----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp -------------------TC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------------------cc----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 00 0112356889999999999999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=374.55 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=207.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.++..+ +||||+++++++ .+...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 579999999999999999999999999999999987655556777889999999999 899999999998 34567
Q ss_pred EEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC--------------
Q 007050 102 IYVVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-------------- 162 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-------------- 162 (620)
+|+|||||++ +|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999985 999999764 679999999999999999999999999999999999999844
Q ss_pred -----CcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChh
Q 007050 163 -----CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237 (620)
Q Consensus 163 -----~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~ 237 (620)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.++|......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999875432 224699999999998762 36778999999999999999999887543221
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. +. ... .......+++.+.+||.+||..||++|||++|+|+||||
T Consensus 238 ~~---~~----------------------------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 238 HE---IR----------------------------QGR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp HH---HH----------------------------TTC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred HH---HH----------------------------cCC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 11 10 000 111224678999999999999999999999999999999
Q ss_pred cCC
Q 007050 318 KGL 320 (620)
Q Consensus 318 ~~~ 320 (620)
...
T Consensus 284 ~~~ 286 (289)
T 1x8b_A 284 LSA 286 (289)
T ss_dssp ---
T ss_pred hhh
Confidence 863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.70 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=198.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+..+|+.||+|++............+.++..+++.++||||+++++++. +...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 46899999999999999999999999999999999765333333344445555688889999999999984 4567
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 102 IYVVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+|+|||||+++|.+++.. ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999988777653 56899999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccc--cCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e 253 (620)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||.... ....+..+..
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 43322 133479999999999631 11578999999999999999999999997632 2211111110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+ ......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 229 -------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 229 -------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 1111 11123578899999999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.30 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=216.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
++|++++.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+|+.++||||+++++++ .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 47999999999999999999999999999999986532211 1356788999999999999999999998 44
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC----cEEEcccCcc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGLA 173 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~lKL~DFGlA 173 (620)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 567999999997 69999998888899999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-- 231 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--
Confidence 86543221 234579999999999876 6799999999999999999999999988776555444432111110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...++.+++.+.+||.+||..||++|||++|+|+||||+.+.
T Consensus 232 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 232 --------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 112346788999999999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=385.22 Aligned_cols=265 Identities=28% Similarity=0.428 Sum_probs=223.6
Q ss_pred cccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007050 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (620)
Q Consensus 16 ~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (620)
.......++|.+++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 110 (335)
T 2owb_A 34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--- 110 (335)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred ecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 334455689999999999999999999999999999999987543 3445567788999999999999999999998
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.+...+|+|||||. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 111 --~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 111 --EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp --ECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred --ecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence 45567999999999 599999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 189 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 255 (335)
T 2owb_A 189 TKVEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-------- 255 (335)
T ss_dssp EECCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------
T ss_pred eecccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--------
Confidence 875432221 244679999999999876 6789999999999999999999999987665433322211
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.. . .....+++.+.+||.+||+.||++|||++|+|+||||.....
T Consensus 256 --------------------~~-~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 256 --------------------NE-Y---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp --------------------TC-C---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------------CC-C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 0 112356889999999999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=403.97 Aligned_cols=261 Identities=32% Similarity=0.516 Sum_probs=204.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH------ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~------~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
.++|.+++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 36899999999999999999999999999999998653211 112235789999999999999999999872
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cEEEcccC
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFG 171 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~lKL~DFG 171 (620)
...+|+|||||. ++|.+++..++.+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 211 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 ---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 245899999998 59999998888999999999999999999999999999999999999997654 59999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccc-cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
+++...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|.+||.+......+....
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i------ 357 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------ 357 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH------
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH------
Confidence 998754321 2345789999999998753 12568899999999999999999999997654322111110
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
...........++.+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 358 ---------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 358 ---------------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 001111112234568899999999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=377.10 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=217.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++ .+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDR 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcC
Confidence 34689999999999999999999999999999999864211 111235688999999999999999999998 445
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. ....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 167 ~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 227 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227 (284)
T ss_dssp SC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred cc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------------
Confidence 21 234679999999999887 67899999999999999999999999876654433332210
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
. . ...+.+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 228 ----------------~-~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 ----------------D-L---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ----------------C-C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ----------------c-c---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0 0 112457889999999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=378.36 Aligned_cols=264 Identities=29% Similarity=0.359 Sum_probs=213.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .......++.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 478999999999999999999999999999999986432 3445567889999999999999999999998 4567
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 89999999985 99999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 165 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~-------------- 226 (294)
T 4eqm_A 165 SLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ-------------- 226 (294)
T ss_dssp ------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--------------
T ss_pred ccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--------------
Confidence 211 1234679999999999887 6789999999999999999999999988765443222211
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...+.......+.+++.+.+||.+||..||.+||+..+.+.+.|..-+.
T Consensus 227 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 -------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111223456889999999999999999999767777777765443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=375.81 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=219.5
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---C----hHHHHHHHHHHHHHHhcC-CCCcceeeeEe
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---H----ISDAARILREIKLLRLLR-HPDIVEIKHIM 91 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---~----~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~ 91 (620)
+..++|++++.||+|+||.||+|.++.+|+.||||++..... . ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345799999999999999999999999999999999964321 1 123456789999999996 99999999998
Q ss_pred cCCCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 92 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
.+...+|+||||++ ++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 45577999999998 599999998888999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccc----cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~ 246 (620)
|++........ ....++|+.|+|||++.+ ....++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99987543221 245679999999998742 1246889999999999999999999999887655444333221
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
........++.+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 245 ----------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 ----------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ----------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ----------------------------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 01111122346788999999999999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=401.15 Aligned_cols=275 Identities=18% Similarity=0.155 Sum_probs=197.5
Q ss_pred ccCCC-CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc--CCCCcceee----
Q 007050 17 SEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL--RHPDIVEIK---- 88 (620)
Q Consensus 17 ~~~g~-~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L--~HpnIv~l~---- 88 (620)
+.++. ...|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.| +||||++++
T Consensus 55 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp ETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred ecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 34443 3459999999999999999999999999999999986543 234455677885555554 699988755
Q ss_pred ---eEecCCCCC------------CCCeEEEEEecCCccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCC
Q 007050 89 ---HIMLPPSRR------------DFKDIYVVFELMESDLHQVIKAND-DLTREHY------QFFLYQLLRALKYIHTAN 146 (620)
Q Consensus 89 ---~v~~~~~~~------------~~~~lylV~E~~~gdL~~~i~~~~-~lse~~~------~~i~~QIl~aL~yLHs~g 146 (620)
+++...... ....+|+|||||+++|.+++...+ .+.+... ..++.||+.||.|||++|
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 333221110 014589999999999999998643 3444444 567799999999999999
Q ss_pred cEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh
Q 007050 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (620)
Q Consensus 147 IvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt 226 (620)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+....|+.++|||||||++|+|++
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999865321 11446779999999986532468999999999999999999
Q ss_pred CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 007050 227 GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 306 (620)
Q Consensus 227 G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp 306 (620)
|+.||.+.+.... ........ ............++.+++.+.+||.+||+.||++||
T Consensus 289 g~~Pf~~~~~~~~-----~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 345 (371)
T 3q60_A 289 LFLPFGLVTPGIK-----GSWKRPSL------------------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345 (371)
T ss_dssp SSCSTTBCCTTCT-----TCCCBCCT------------------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred CCCCCCCcCcccc-----cchhhhhh------------------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCC
Confidence 9999987642110 00000000 000001111123457899999999999999999999
Q ss_pred CHHHHHcCCcccCC
Q 007050 307 TAEEALADPYFKGL 320 (620)
Q Consensus 307 sa~elL~hp~f~~~ 320 (620)
|++|+|+||||+++
T Consensus 346 t~~e~l~hp~f~~~ 359 (371)
T 3q60_A 346 LPLEAMETPEFLQL 359 (371)
T ss_dssp CHHHHTTSHHHHHH
T ss_pred CHHHHhcCHHHHHH
Confidence 99999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=388.54 Aligned_cols=259 Identities=28% Similarity=0.492 Sum_probs=216.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--h----HHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--I----SDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--~----~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
++|++.+.||+|+||.||+|.++.+|+.||||++...... . .....+.+|+.+++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 5799999999999999999999999999999998654321 1 1245677999999999 799999999998
Q ss_pred CCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 96 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 96 ~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
......|+|||||+| +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 445679999999985 999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccccCccccccc----CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~----~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
....... ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~- 323 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ- 323 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 7543322 2456899999999987531 135889999999999999999999999887655544443321111
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
.....+..+++.+.+||.+||..||++|||++|+|+||||+
T Consensus 324 ---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 324 ---------------------------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp ---------------------------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ---------------------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 01112356788999999999999999999999999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=391.75 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=211.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------SDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~------~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|+++.+++.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 368999999999999999999999999999999997542211 1234567899999999999999999998
Q ss_pred CCCCCeEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 96 RRDFKDIYVVFELME-S-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
.+...+|+||||+. | +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 45678999999986 5 99999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCC-CcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y-~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...... ..
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------- 238 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------- 238 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence 87543322 245689999999999876 444 88999999999999999999999652210 00
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. .......+++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 239 --------------------~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 --------------------A-----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp --------------------T-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred --------------------h-----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0 001122478899999999999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=389.36 Aligned_cols=287 Identities=24% Similarity=0.358 Sum_probs=223.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----------CCCcceeeeE
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----------HPDIVEIKHI 90 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-----------HpnIv~l~~v 90 (620)
.++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4789999999999999999999999999999999974 2344566788999998886 8999999999
Q ss_pred ecCCCCCCCCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeC------C
Q 007050 91 MLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILAN------A 161 (620)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~------~ 161 (620)
+.... .+...+++|||++.++|.+++... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++ .
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 85432 233478999999988999999863 4599999999999999999999998 999999999999994 4
Q ss_pred CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC------
Q 007050 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------ 235 (620)
Q Consensus 162 ~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~------ 235 (620)
.+.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 458999999999865432 234579999999999987 679999999999999999999999998754
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCccc-------------CCCCCCCHHHHHHHHHhcccCC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS-------------QKFPNADPSALRLLERLLAFDP 302 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~s~~l~dLI~~mL~~DP 302 (620)
..+.+..+.+.+|.++...+... .....++............ ......++.+.+||.+||+.||
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNG---KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHC---TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred hHHHHHHHHHhcCCCCHHHHhcc---chhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 55677788888888776554322 1111111110000000000 0112346788999999999999
Q ss_pred CCCCCHHHHHcCCcccCCCcC
Q 007050 303 KDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 303 ~~Rpsa~elL~hp~f~~~~~~ 323 (620)
++|||++|+|+||||++....
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTTC
T ss_pred cccCCHHHHhhChhhhcccCc
Confidence 999999999999999976443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=374.29 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=214.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++ .+...+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEE
Confidence 57999999999999999999999999999999986432 224556788999999999999999999998 445678
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+||||+++ +|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999985 9999998777899999999999999999999999999999999999999999999999999976533221
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHH-HHHhhhccCCCChhhhhhhhh
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~-l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.... +..+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------------- 221 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------------- 221 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----------------
Confidence 1123456899999999998762 2347889999999999999999999977543211 1100
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
. .. ......+..+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 222 -------~----~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 222 -------K----EK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp -------H----TT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -------h----hc--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 0 00 011122346788999999999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=375.91 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=191.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 3679999999999999999999999999999999864211 111246788999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 7999999998 5999999875 5799999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 226 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------- 226 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------
Confidence 2211 234579999999999876 5789999999999999999999999977653322211100
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. .......++..+.+||.+||..||++|||++++|+||||...
T Consensus 227 ---------------~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ---------------A----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ---------------S----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ---------------c----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0 001123468899999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=377.30 Aligned_cols=267 Identities=22% Similarity=0.406 Sum_probs=216.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 368999999999999999999999999999999997431 112345678899999999999999999999853 234
Q ss_pred CeEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
..+|+|||||.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 57899999999888888876 4579999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------------ 227 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------------ 227 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc------------
Confidence 32221 12345679999999999875323357899999999999999999999987665443332211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~ 324 (620)
.. ......+++.+.+||.+||..||.+|||++|+|+||||+......
T Consensus 228 ----------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 228 ----------------GS----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ----------------CC----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ----------------CC----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 00 011235788999999999999999999999999999998765443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=413.95 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=215.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence 3467999999999999999999999999999999996431 1112345678999999999999999999998 455
Q ss_pred CeEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..+|+|||||. |+|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 78999999997 69999998754 4999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+.
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------------ 398 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------ 398 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------------
Confidence 43221 245689999999999987 679999999999999999999999998754211111110
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
..+. ..+.. ....+++.+++||.+||+.||.+|| +++|+++||||+++
T Consensus 399 ------------~~i~-~~~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 399 ------------RLVK-EVPEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ------------HHHH-HCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ------------HHhh-ccccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 0000 01111 1245789999999999999999999 89999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=389.74 Aligned_cols=284 Identities=22% Similarity=0.333 Sum_probs=219.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+|+.++||||+++++++. +...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 105 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 105 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCE
Confidence 46899999999999999999999999999999999754 24455677899999999999999999999984 4567
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+|||||++ +|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999985 9999999888899999999999999999999996 9999999999999999999999999999764322
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc-cCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL-LGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~-lg~p~~e~i~~~ 258 (620)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+... .+.+........
T Consensus 186 ~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 186 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp C---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred c-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 1 234689999999999987 68999999999999999999999999887655433222111 111110000000
Q ss_pred -------------hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 -------------VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.........+..+........ ....++..+.+||.+||+.||++|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000111122222222221111 123468899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=410.17 Aligned_cols=261 Identities=22% Similarity=0.334 Sum_probs=214.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence 4689999999999999999999999999999999964321 112345678999999999999999999998 4557
Q ss_pred eEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+|+|||||. |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 7999999998 5999999763 3699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
....... ....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+.......+
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~------------ 401 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL------------ 401 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH------------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH------------
Confidence 5433221 245689999999999987 68999999999999999999999999875421100000
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
...+... .. .....+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 402 ------------~~~i~~~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 402 ------------KQRVLEQ-AV---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ------------HHHHHHC-CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ------------HHHHhhc-cc---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 0011111 11 112467899999999999999999995 5999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=376.84 Aligned_cols=260 Identities=33% Similarity=0.549 Sum_probs=218.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++++++ .+...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCe
Confidence 3689999999999999999999999999999999976544445567788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC---CcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~lKL~DFGlA~~~~ 177 (620)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999998 5999999887889999999999999999999999999999999999999764 469999999998654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 237 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG----------- 237 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 3321 234568999999999875 5899999999999999999999999887655444333221
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
........+..+++.+.+||.+||..||.+|||++|+|+||||+++.
T Consensus 238 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 238 -----------------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -----------------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -----------------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 00011123456789999999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=375.70 Aligned_cols=265 Identities=23% Similarity=0.380 Sum_probs=211.9
Q ss_pred cCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 18 ~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.+...++|++++.||+|+||.||+|.++.+++.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 86 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYY----- 86 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----
Confidence 356678999999999999999999999999999999998753 2234567889999999999999999999984
Q ss_pred CCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...+|+|||||+ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 3457999999998 489888865 56799999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCcccccccccCCccccCcccccc---cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
..... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 237 (302)
T 2j7t_A 167 NLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------ 237 (302)
T ss_dssp HHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred ccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc------
Confidence 32111 11134579999999998731 1157899999999999999999999999877654433322210
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.. ........++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 238 ----------------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 ----------------------DP-PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------CC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------CC-cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00 00011234678999999999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=381.38 Aligned_cols=259 Identities=33% Similarity=0.539 Sum_probs=207.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 579999999999999999999999999999999975321 11223457899999999999999999999832
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEcccCc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGL 172 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DFGl 172 (620)
..+|+|||||. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 ---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ---SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred ---CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 23899999998 599999988889999999999999999999999999999999999999987664 99999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccc-cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHH-HhhhccCCC
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD-LMTDLLGTP 250 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~-~i~~~lg~p 250 (620)
++..... ......+||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+. .+..
T Consensus 164 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----- 234 (322)
T 2ycf_A 164 SKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----- 234 (322)
T ss_dssp CEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-----
T ss_pred ceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-----
Confidence 9865322 11234679999999998742 12578999999999999999999999997654321111 1110
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.........+..+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 235 -----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 235 -----------------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------------CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0001111223567899999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.14 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=206.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence 4689999999999999999999999999999999864211 112245688999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccCCccccCcccccccCCCC-CcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y-~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
. .....++|+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 225 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------------- 225 (276)
T ss_dssp ----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred c----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-------------
Confidence 2 1234578999999999876 344 6899999999999999999999987654433322211
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
... .....++..+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 226 ---------------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 ---------------GVF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ---------------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---------------Ccc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 000 0113467899999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=389.21 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=211.0
Q ss_pred CCeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFE--HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~--~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (620)
++|++++.||+|+||.||+|.+. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-----
Confidence 68999999999999999999984 5899999999874321 112234566899999999 699999999998
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+...+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 44567999999998 59999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..... .......+||+.|+|||++.+....++.++|||||||++|+|++|..||...........+
T Consensus 209 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~------------ 274 (355)
T 1vzo_A 209 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------ 274 (355)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH------------
T ss_pred cccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH------------
Confidence 53222 1123456899999999998753346889999999999999999999999764321111111
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
...+.... ....+.++..+.+||.+||..||++|| |++|+|+||||+.+
T Consensus 275 ------------~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 275 ------------SRRILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ------------HHHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ------------HHHHhccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 00111111 112346788999999999999999999 99999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=376.05 Aligned_cols=265 Identities=23% Similarity=0.407 Sum_probs=209.9
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-C
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-R 97 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~-~ 97 (620)
...++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++..... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 45689999999999999999999999999999999986432 2345678999999999 79999999999865321 1
Q ss_pred CCCeEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 98 DFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 98 ~~~~lylV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
....+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 24679999999985 999999864 479999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
....... .....+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 248 (326)
T 2x7f_A 178 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------ 248 (326)
T ss_dssp ----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------
T ss_pred ecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------
Confidence 6532211 12345799999999998621 14689999999999999999999999987665433322211
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...+ ......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 249 ---------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 ---------------------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------------SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------------Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0000 11234578899999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=370.99 Aligned_cols=259 Identities=30% Similarity=0.459 Sum_probs=215.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++.. .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 468999999999999999999999999999999997655555667788999999999999999999998743 23457
Q ss_pred EEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCceEeCCCCcEEEcccC
Q 007050 102 IYVVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999984 999999753 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------ 230 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 230 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred hheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh------
Confidence 998654322 11234579999999999876 5789999999999999999999999987664433322211
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
... ......+++.+.+||.+||..||++|||++|+|+|+|+.+
T Consensus 231 ----------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 231 ----------------------GKF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----------------------ccc---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 000 1112357889999999999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=377.29 Aligned_cols=272 Identities=28% Similarity=0.418 Sum_probs=194.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++. +..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKD 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEE-----SSS
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecC
Confidence 4578999999999999999999999999999999986432 1234566789999999999999999999984 345
Q ss_pred eEEEEEecCC-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccC
Q 007050 101 DIYVVFELME-SDLHQVIKA--------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~--------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 6999999997 599999874 4569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 172 LARVAFNDTP--TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 172 lA~~~~~~~~--~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
++........ ........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+....... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~ 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-P 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-C
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-C
Confidence 9976543211 11112346799999999988642 368999999999999999999999998766544332221100 0
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+... ...........+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 245 ~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLE---------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCTT---------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred Cccc---------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0000 00011123456789999999999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=378.50 Aligned_cols=277 Identities=21% Similarity=0.355 Sum_probs=210.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... +..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTR 82 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCc
Confidence 45789999999999999999999999999999999975321 23356678999999999999999999988543 234
Q ss_pred eEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----CCCCcEEEcccCc
Q 007050 101 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~lKL~DFGl 172 (620)
.+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999998 69999998644 39999999999999999999999999999999999999 7888899999999
Q ss_pred cccccCCCCcccccccccCCccccCccccccc------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHH-HHHhhh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTD 245 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~------~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~-l~~i~~ 245 (620)
++....... ....+||+.|+|||++... ...++.++|||||||++|+|++|..||...+.... ...+..
T Consensus 163 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 163 ARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred ceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 987644322 2356799999999987521 15789999999999999999999999975432211 111111
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQK-------FPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
++.......+..+... ......+... ...++..+.+||.+||+.||++|||++|+|+||-
T Consensus 239 ~~~~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKA-----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECS-----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcc-----------cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1111111111100000 0001111111 1234567899999999999999999999999973
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=374.33 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=209.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++... .....+.+|+.+++.++||||+++++++. +...
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 98 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTD 98 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence 46899999999999999999999999999999999753 23456789999999999999999999984 4467
Q ss_pred EEEEEecCCc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELMES-DLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999985 9999997 4568999999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 179 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 239 (314)
T 3com_A 179 MA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-------------- 239 (314)
T ss_dssp BS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------
T ss_pred cc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--------------
Confidence 21 1245679999999999877 5789999999999999999999999987654333222111
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..+. .......+++.+.+||.+||..||.+|||++++|+||||+...
T Consensus 240 --------------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 240 --------------NPPP-TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp --------------SCCC-CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred --------------CCCc-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0000 0111234678999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=373.68 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=204.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++ .+...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCc
Confidence 36899999999999999999976 588999999987655666677899999999999999999999998 44456
Q ss_pred EEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 102 IYVVFELME-SDLHQVIKANDD---LTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~---lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+|+|||||. ++|.+++...+. +++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------- 255 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------- 255 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Confidence 432211 1245689999999999987 678999999999999999999999998776544333221100
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CCcccC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFKG 319 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~--hp~f~~ 319 (620)
. .......+++.+.+||.+||..||.+|||++++++ ++|++.
T Consensus 256 -------------------~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 -------------------K---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -------------------C---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 01122467899999999999999999999999987 455543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=370.72 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=216.0
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++. +.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KD 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cC
Confidence 445789999999999999999999999999999999975422 234667889999999999999999999984 44
Q ss_pred CeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 679999999985 99998864 5799999999999999999999999999999999999999999999999999977543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+..
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 221 2245679999999999876 6789999999999999999999999977654333222211
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
..+ ......++..+.+||.+||..||.+|||++|+|+||||..
T Consensus 234 ---------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 ---------------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ---------------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ---------------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 111 1123467889999999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=376.25 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=209.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..++|++++.||+|+||.||+|.++.+++ .||||+++.. ........+.+|+.+|+.++||||+++++++ .
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 35689999999999999999999987665 4999999754 2445567789999999999999999999998 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...+|+|||||+ ++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 4567899999998 5999999754 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-------
Confidence 6544333333344567889999999876 579999999999999999999 999998876554443332210
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ......+++.+.+||.+||..||++|||++++++
T Consensus 272 ---------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ---------------------R---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------C---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 0122467889999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=373.44 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=195.1
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
-..++|++++.||+|+||.||+|.++.++. .||||++............+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999999887775 89999997654455667889999999999999999999999865432
Q ss_pred C-CCCeEEEEEecCC-ccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEc
Q 007050 97 R-DFKDIYVVFELME-SDLHQVIKAND------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 97 ~-~~~~lylV~E~~~-gdL~~~i~~~~------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
. .....|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 1123499999999 49999996532 59999999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhcc
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~l 247 (620)
|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 180 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~- 255 (323)
T 3qup_A 180 DFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG- 255 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred eccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-
Confidence 99999865433221 11233457888999999877 679999999999999999999 99999887654443333210
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHcCCcccCC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-------AEEALADPYFKGL 320 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-------a~elL~hp~f~~~ 320 (620)
. .....+.+++.+.+||.+||..||++||| +++++.|||+...
T Consensus 256 ---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 ---------------------------N---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ---------------------------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ---------------------------C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 01123467889999999999999999999 7888899999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=377.04 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=192.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++. +.
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~ 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----RE 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eC
Confidence 3578999999999999999999999999999999997542 3344455666766 677889999999999984 44
Q ss_pred CeEEEEEecCCccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 100 KDIYVVFELMESDLHQVIKA-----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~-----~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
..+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 67999999999998888863 56799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccc--cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChh-HHHHHhhhccCCC
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTP 250 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~-~~l~~i~~~lg~p 250 (620)
+....... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+.. +.+..+.
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------ 243 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV------ 243 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC------
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh------
Confidence 76543221 234479999999999832 1156899999999999999999999999764321 1111000
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
....+.........+++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 244 ---------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 244 ---------------------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---------------------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------------------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 0001111112235688999999999999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.06 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=202.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 95 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~------- 95 (620)
++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 579999999999999999999999999999999964 2345677889999999999999999999875431
Q ss_pred -CCCCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 96 -RRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 96 -~~~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
..+...+|+|||||+ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 123567999999998 59999998644 688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----------cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCC-ChhHHH
Q 007050 173 ARVAFNDTP-----------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQL 240 (620)
Q Consensus 173 A~~~~~~~~-----------~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~-~~~~~l 240 (620)
+........ ........+||+.|+|||++.+. ..++.++|||||||++|+|++ ||... +....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 976532210 01122456799999999998752 468999999999999999998 45321 111111
Q ss_pred HHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 241 ~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
..+ ...............++.+.+||.+||..||.+|||++++|+||||+.
T Consensus 239 ~~~----------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKL----------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHH----------------------------HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhc----------------------------cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111 111111111123456788999999999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=375.31 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=188.3
Q ss_pred cccCCCCCCeEEEE-EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHH-HHHHhcCCCCcceeeeEecC
Q 007050 16 FSEYGDASRYKIQE-VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI-KLLRLLRHPDIVEIKHIMLP 93 (620)
Q Consensus 16 ~~~~g~~~rY~i~~-~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi-~iL~~L~HpnIv~l~~v~~~ 93 (620)
...+...++|++++ .||+|+||.||+|.++.+|+.||||++... .. ..+|+ ..++.+.||||+++++++..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 34455668999965 699999999999999999999999998642 11 22233 34677899999999999843
Q ss_pred CCCCCCCeEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCcEEE
Q 007050 94 PSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKI 167 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~lKL 167 (620)
.. .+...+|+|||||++ +|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 94 ~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 94 MH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred cc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 21 224568999999985 9999998754 6999999999999999999999999999999999999986 455999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
+|||+++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 173 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 243 (336)
T 3fhr_A 173 TDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-- 243 (336)
T ss_dssp CCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred eccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--
Confidence 9999998654222 234578999999999876 6789999999999999999999999976543221110000
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.+...........+..+++.+.+||.+||..||++|||++|+|+||||++..
T Consensus 244 ----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 ----------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ----------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000111111233467899999999999999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=368.54 Aligned_cols=262 Identities=26% Similarity=0.342 Sum_probs=207.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~--HpnIv~l~~v~~~~~~~~ 98 (620)
..++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++ ||||+++++++. +
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence 4578999999999999999999985 5889999999765555667788899999999997 599999999983 4
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
...+|+|||++.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++....
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 56799999987789999999988999999999999999999999999999999999999996 48999999999986543
Q ss_pred CCCcccccccccCCccccCccccccc---------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChh-HHHHHhhhccC
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLG 248 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~---------~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~-~~l~~i~~~lg 248 (620)
... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.... ..+..+.
T Consensus 179 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---- 253 (313)
T 3cek_A 179 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---- 253 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH----
T ss_pred ccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH----
Confidence 322 1122345799999999998641 136888999999999999999999999664321 1111110
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
..... .......+..+.+||.+||..||++|||++|+|+||||+..
T Consensus 254 -----------------------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 254 -----------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp -----------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred -----------------------hcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00000 11123457889999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.19 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=210.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++. +..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCC
Confidence 35689999999999999999999999999999999864 34566778899999999999999999999984 456
Q ss_pred eEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||+ ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 7999999998 599999987 56799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcc-----------cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 179 DTPTT-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 179 ~~~~~-----------~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------- 231 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------- 231 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-------
Confidence 32211 01125689999999999987 68999999999999999999999999764321100
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........... ...+.+++.+.+||.+||+.||++|||++++++ |++.+
T Consensus 232 ------------~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 232 ------------FGLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp ------------SSBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ------------Hhhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 00001111111 112467788999999999999999999999987 55443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=376.86 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=208.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-------~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (620)
.++|++++.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 468999999999999999999875 34567999999754 3345667889999999999 899999999998
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 44567899999998 59999998753 48999999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865433221 11234567889999999876 679999999999999999999 999998765
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+.+..+.. ... ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKE----------------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHT----------------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhc----------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4433322211 000 11224678899999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.19 Aligned_cols=263 Identities=21% Similarity=0.332 Sum_probs=195.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.++.+|+.||||++............+.++..+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 456899999999999999999999999999999999764333233333445556788889999999999984 446
Q ss_pred eEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+||||+++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 7999999997777666654 56799999999999999999999996 999999999999999999999999999976543
Q ss_pred CCCcccccccccCCccccCcccccc---cCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e~ 254 (620)
... .....+|+.|+|||++.. ....++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 221 234579999999999842 11468899999999999999999999997632 2222211111
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
..+ ........+++.+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 245 -------------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 -------------------EEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -------------------SCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -------------------cCC-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 111 11122346789999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=377.63 Aligned_cols=272 Identities=20% Similarity=0.335 Sum_probs=213.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------------HHHHHHHHHHHHHHhcCCCCcce
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---------------SDAARILREIKLLRLLRHPDIVE 86 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---------------~~~~~i~rEi~iL~~L~HpnIv~ 86 (620)
.++|++++.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46999999999999999999998 89999999986432111 11267889999999999999999
Q ss_pred eeeEecCCCCCCCCeEEEEEecCCc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCc
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQV------IKA--NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKN 156 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~------i~~--~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~N 156 (620)
+++++ .+...+|+|||||++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99998 345679999999995 99988 655 5679999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCc-ccchHhHHHHHHHHHhCCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~-~~DIWSLG~IlyeLltG~~pF~g~~ 235 (620)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999875432 23456899999999998762 25666 9999999999999999999998876
Q ss_pred h-hHHHHHhhhcc-CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 236 V-VHQLDLMTDLL-GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 236 ~-~~~l~~i~~~l-g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. .+.+..+.... ..|... ... . ............+.+++.+.+||.+||+.||.+|||++|+|+
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~--~~~---------~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR--NHF---------L---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS--SSS---------T---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHhccCcCCccch--hhh---------h---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 5 44444443211 111100 000 0 000000011123568899999999999999999999999999
Q ss_pred CCcccCC
Q 007050 314 DPYFKGL 320 (620)
Q Consensus 314 hp~f~~~ 320 (620)
||||++.
T Consensus 323 hp~f~~~ 329 (348)
T 2pml_X 323 HEWLADT 329 (348)
T ss_dssp SGGGTTC
T ss_pred CccccCC
Confidence 9999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.41 Aligned_cols=257 Identities=18% Similarity=0.249 Sum_probs=207.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+||+++++++ .+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCc
Confidence 578999999999999999999999999999999986432 223467899999999 799999999988 4556
Q ss_pred eEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc-----EEEcccCccc
Q 007050 101 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLAR 174 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----lKL~DFGlA~ 174 (620)
..|+||||+.++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 80 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 80 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 799999999889999998754 6999999999999999999999999999999999999987776 9999999998
Q ss_pred cccCCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 175 VAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~------ 231 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE------ 231 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH------
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH------
Confidence 765432211 11245689999999999887 679999999999999999999999998754221111110
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.+ . . ...........+.+++.+.+||.+||..||++|||++++++
T Consensus 232 ------~~-~--------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 232 ------RI-G--------E---KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------HH-H--------H---HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------HH-H--------h---hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 00 0 0 00011112234567899999999999999999999999976
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.27 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=208.1
Q ss_pred CCCeEEEEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~-----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 97 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 97 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence 4689999999999999999998 5567789999999754 3345567789999999999 78999999999843
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCC----------------------------------------------------
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 122 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~---------------------------------------------------- 122 (620)
....+|+|||||. |+|.+++.....
T Consensus 98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 2345899999999 599999986543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCccccccc
Q 007050 123 --------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (620)
Q Consensus 123 --------------lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~ 188 (620)
+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986543322 122345
Q ss_pred ccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHH
Q 007050 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRY 267 (620)
Q Consensus 189 ~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~ 267 (620)
..||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+..+.+.....
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---------------------- 310 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---------------------- 310 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----------------------
Confidence 678999999999876 689999999999999999998 9999987654332211111
Q ss_pred HHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 268 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.... ......+++.+.+||.+||+.||.+|||++|+++|
T Consensus 311 -----~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 311 -----EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----cCCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0000 11123578899999999999999999999999886
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.99 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=204.5
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
+|.....||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++ .+...+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEE
Confidence 344445899999999999999999999999998753 234456788999999999999999999998 3456799
Q ss_pred EEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-CCcEEEcccCccccccC
Q 007050 104 VVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFN 178 (620)
Q Consensus 104 lV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~lKL~DFGlA~~~~~ 178 (620)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 69999998652 5679999999999999999999999999999999999987 89999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... ......||+.|+|||++.+....++.++|||||||++|+|++|..||.+........
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------------- 235 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM----------------- 235 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-----------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-----------------
Confidence 221 124567999999999986532348899999999999999999999996533211100
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
+........ ......+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 236 --------~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 236 --------FKVGMFKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp --------HHHHHHCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred --------Hhhcccccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 000000000 112346789999999999999999999999999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=380.37 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=209.3
Q ss_pred CCCeEEEEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~-----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence 4689999999999999999999 5567889999999753 34455667889999999999999999999984
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC---cE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KL 165 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~-------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~l 165 (620)
+....|+|||||. |+|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 145 -QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred -cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 4456799999997 59999997643 589999999999999999999999999999999999999655 59
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~ 244 (620)
||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999864322111 11234568999999999876 689999999999999999998 999998877655444332
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
.. .. ......+++.+.+||.+||+.||.+|||+++++++.|+.
T Consensus 301 ~~----------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SG----------------------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TT----------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----------------------------CC---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 21 00 011245788999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.43 Aligned_cols=257 Identities=19% Similarity=0.229 Sum_probs=204.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.| +||||+++++++ .+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFG-----PCG 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEE-----EET
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecC
Confidence 34789999999999999999999999999999999864321 23477899999999 899999999998 345
Q ss_pred CeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc-----EEEcccCcc
Q 007050 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLA 173 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----lKL~DFGlA 173 (620)
...|+|||||.++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 67899999998899999986 468999999999999999999999999999999999999999887 999999999
Q ss_pred ccccCCCCccc----ccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCC
Q 007050 174 RVAFNDTPTTI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 174 ~~~~~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
+.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~---- 231 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK---- 231 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH----
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH----
Confidence 87543322111 1245689999999999987 6799999999999999999999999987543222111110
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+ ... ..+.+........+ .+.+||.+||..||.+||+++++++
T Consensus 232 --------i-~~~-----------~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 232 --------I-GDT-----------KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp --------H-HHH-----------HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------H-Hhh-----------hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 000 00000111112233 8999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.56 Aligned_cols=271 Identities=21% Similarity=0.349 Sum_probs=206.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
..++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 35789999999999999999998 667899999999975 3445567889999999999999999999998432
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
+...+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 2245899999997 59999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||...... . ....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccccc
Confidence 76443322222344567888999999877 67999999999999999999999998653211 1 11111111100
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.........+...... .....+++.+.+||.+||..||++|||++|+++
T Consensus 236 -------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 -------MIVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp -------HHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------hhHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011111222221111 123467899999999999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=356.58 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=206.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.++|++++.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++ .+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 3468999999999999999999986 5778999999754322 35688999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 6999999998 5999999754 4689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 224 (269)
T 4hcu_A 159 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 224 (269)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred cc--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc----------
Confidence 21 111234467888999999876 679999999999999999999 999998876554443332210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. .......++.+.+||.+||+.||++|||++|+++|
T Consensus 225 ------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ------------------R---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------c---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 01123468899999999999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=363.57 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=209.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 95 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC----- 95 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence 578999999999999999999983 45689999999754 3445667889999999999999999999998
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHYQFFLYQLLRALKYIHTANVYHRD 151 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~------------------------lse~~~~~i~~QIl~aL~yLHs~gIvHrD 151 (620)
.+...+|+|||||. ++|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 44566899999998 699999987543 89999999999999999999999999999
Q ss_pred CCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCC
Q 007050 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (620)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~p 230 (620)
|||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999865433221 12234567889999999876 578999999999999999999 9999
Q ss_pred CCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007050 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310 (620)
Q Consensus 231 F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 310 (620)
|.+.+.......+.. .. .......+++.+.+||.+||..||.+|||++|
T Consensus 253 ~~~~~~~~~~~~~~~----------------------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 253 YPGIPPERLFNLLKT----------------------------GH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp STTCCGGGHHHHHHT----------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHhhc----------------------------CC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 987664433222211 00 11123467899999999999999999999999
Q ss_pred HHcC
Q 007050 311 ALAD 314 (620)
Q Consensus 311 lL~h 314 (620)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=373.93 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=210.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcC--CCCcceeeeEecCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLR--HPDIVEIKHIMLPP 94 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~rEi~iL~~L~--HpnIv~l~~v~~~~ 94 (620)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++ ||||+++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--- 117 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 117 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence 4578999999999999999999999999999999996532211 12244668999999996 59999999998
Q ss_pred CCCCCCeEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC-CCCcEEEcccC
Q 007050 95 SRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFG 171 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~--gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~lKL~DFG 171 (620)
.+...+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||
T Consensus 118 --~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 118 --ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred --ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 45567999999997 69999999888999999999999999999999999999999999999999 78999999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.. .
T Consensus 196 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~------- 256 (320)
T 3a99_A 196 SGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------I------- 256 (320)
T ss_dssp TCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------H-------
T ss_pred ccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhhh------h-------
Confidence 998754322 2456799999999988752 23478899999999999999999999653210 0
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
. . . ......+++.+.+||.+||..||++|||++|+|+||||++..
T Consensus 257 --------~------------~--~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 257 --------R------------G--Q---VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --------H------------C--C---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------c------------c--c---ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0 0 0 011245788999999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=358.34 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=197.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..++|++++.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 346899999999999999999998754 457999998753 33455677889999999999999999999872
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 245799999999 49999998654 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~--------- 232 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------- 232 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc---------
Confidence 5432211 1233457789999999876 679999999999999999996 9999987765444333321
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ....+.+++.+.+||.+||..||++|||+.|++++
T Consensus 233 -------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 233 -------------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 11235678999999999999999999999999763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=354.43 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=206.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.++ ++..||+|++..... ....+.+|+.+++.++||||+++++++ .+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 3468999999999999999999776 567899999975432 235678999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 7999999998 58999997654 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 221 (268)
T 3sxs_A 157 DQYV--SSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG----------- 221 (268)
T ss_dssp TCEE--ECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----------
T ss_pred hhhh--cccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----------
Confidence 3221 2234456788999999876 578999999999999999999 99999877654433332210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. .......++.+.+||.+||+.||.+|||++|++++
T Consensus 222 -----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 -----------------HR---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----------------CC---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01113457899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=370.84 Aligned_cols=275 Identities=23% Similarity=0.237 Sum_probs=209.5
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
-..++|++++.||+|+||.||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCC
Confidence 34568999999999999999999875 789999999642 234455667999999999999999999986432 123
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeecCCCCceEeCCCCcEEEc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA----------NVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~----------gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
..+|+|||||+ |+|.+++..+ .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 56899999998 5999999775 599999999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccC---CCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhh
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~---~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~ 245 (620)
|||+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+......+.....
T Consensus 174 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred cCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999876443221 1234468999999999987521 2456688999999999999999999988654433333333
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....|..+.+..... .......+...+. ..++.+.+||.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVV-----------HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHT-----------TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhh-----------cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 334444333322211 0111111111111 12456999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.42 Aligned_cols=279 Identities=21% Similarity=0.298 Sum_probs=217.0
Q ss_pred ccccccCCCCCCeEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007050 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 13 ~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
..-+.++-..++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+.+|+.++||||++++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 13 ACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp ----CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 3445555667899999999999999999998 5678999999999753 445567789999999999999999999
Q ss_pred eEecCCCCCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEE
Q 007050 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lK 166 (620)
+++.. .+...+|+|||||+ ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 91 ~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 91 GVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp EEEEC---SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred EEEec---CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEE
Confidence 98854 24467999999997 699999976 45699999999999999999999999999999999999999999999
Q ss_pred EcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc
Q 007050 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 167 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~ 246 (620)
|+|||+++................+|..|+|||++.+ ..++.++|||||||++|+|++|..||........ ..+...
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~ 244 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCE 244 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC--
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhcccc
Confidence 9999999876544433333445678999999999876 5789999999999999999999999965432111 100000
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. ...........+...... ...+.+++.+.+||.+||+.||.+|||++|++++
T Consensus 245 ~------------~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 245 R------------DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp --------------CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c------------ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 001111122222222211 2235678999999999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=358.00 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=204.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++ .+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCC
Confidence 4579999999999999999999876 6778999999754322 35678999999999999999999998 4556
Q ss_pred eEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 7999999997 699999976 45799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 173 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 239 (283)
T 3gen_A 173 DEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------- 239 (283)
T ss_dssp HHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred ccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence 211 11233457788999999876 579999999999999999998 9999988765544433322100
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.......++.+.+||.+||+.||.+|||++++|+|
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 ----------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01123457899999999999999999999999886
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=360.95 Aligned_cols=272 Identities=23% Similarity=0.359 Sum_probs=210.1
Q ss_pred CCCCCeEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
-...+|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED- 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC-
Confidence 345679999999999999999998 67789999999997542 223456788999999999999999999998542
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
+...+|+|||||. ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 96 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 --GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ----CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred --CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 2356899999998 599999954 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+................+|..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~- 245 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHG- 245 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCG-
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccc-
Confidence 876544433233345678999999999876 578899999999999999999998874321 111111121111
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..........+...... ...+.+++.+.+||.+||..||.+|||++++++
T Consensus 246 -------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 -------QMTVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp -------GGHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -------ccCHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11112222222222211 223567899999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.47 Aligned_cols=255 Identities=27% Similarity=0.373 Sum_probs=200.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++ .+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence 34689999999999999999999999999999999975432 333457788999999999999999999998 345
Q ss_pred CeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 100 ~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
..+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 679999999985 9999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 187 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------- 248 (309)
T 2h34_A 187 EKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------------- 248 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH--------------
T ss_pred ccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc--------------
Confidence 221 12245679999999999876 678999999999999999999999998754321111110
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALA 313 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-sa~elL~ 313 (620)
..........+.+++.+.+||.+||..||++|| |++++++
T Consensus 249 ---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 ---------------QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---------------SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---------------cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112233467889999999999999999999 7887765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=365.90 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=208.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
..++|++++.||+|+||.||+|.+. .+++.||||+++.. ........+.+|+.+|+.++||||+++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC---- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence 3478999999999999999999987 45589999999754 2344567788999999999999999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEee
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHR 150 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~------------------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHr 150 (620)
.+...+|+|||||+ ++|.+++... ..+++..++.|+.||+.||.|||+.||+||
T Consensus 120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 34567899999998 5999999864 569999999999999999999999999999
Q ss_pred cCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCC
Q 007050 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (620)
Q Consensus 151 DLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~ 229 (620)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999865332211 11234568899999999876 579999999999999999999 999
Q ss_pred CCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 007050 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 309 (620)
Q Consensus 230 pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ 309 (620)
||.+.+..+.+..+.+ ... ......+++.+.+||.+||..||.+|||+.
T Consensus 276 p~~~~~~~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD----------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp TTTTSCHHHHHHHHHT----------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCCCChHHHHHHHhC----------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 9987665443332211 000 112245788999999999999999999999
Q ss_pred HHHcC
Q 007050 310 EALAD 314 (620)
Q Consensus 310 elL~h 314 (620)
+++++
T Consensus 325 ~~~~~ 329 (343)
T 1luf_A 325 SIHRI 329 (343)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.97 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=200.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+.++|.+.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998765 556899999986555566677899999999999999999999998765443
Q ss_pred CCCeEEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
.....|+||||++ ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999999 599999853 356999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGT 249 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~ 249 (620)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 264 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH---- 264 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc----
Confidence 999865432211 11233467889999999876 689999999999999999999 8999987665433322211
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 265 ------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 ------------------------GHR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------TCC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 11224678899999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.34 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=207.2
Q ss_pred CCCCCeEEEE-EeeecCceEEEEEE--ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 20 GDASRYKIQE-VIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 20 g~~~rY~i~~-~LG~G~~G~V~~a~--d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
-+.++|++.+ .||+|+||.||+|. ++.+++.||||++............+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC----
Confidence 3457899998 99999999999995 4567889999999865444455678899999999999999999999882
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 89 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 --AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 245899999998 69999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 235 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------- 235 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------
T ss_pred eccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 6543332222233456789999999876 578899999999999999999 9999988665433322211
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 236 -------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 -------------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1122467899999999999999999999999976
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=359.06 Aligned_cols=260 Identities=19% Similarity=0.226 Sum_probs=203.0
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
...++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+. .+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEE----EET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeec----CCC
Confidence 34578999999999999999999999999999999875432 2234778999999999988887777663 344
Q ss_pred CeEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---CCCCcEEEcccCcccc
Q 007050 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARV 175 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~lKL~DFGlA~~ 175 (620)
...|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 67899999998899999985 4579999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 176 AFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------- 227 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------- 227 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH--------
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh--------
Confidence 65433211 11235689999999999987 67999999999999999999999999875432111111
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
..+ ... ....+.......+++.+.+||.+||+.||++|||++++++
T Consensus 228 ----~~~---------~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 228 ----ERI---------SEK---KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----HHH---------HHH---HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----hhh---------hcc---cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 000 000 0001111223467889999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=369.98 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=209.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-------GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t-------g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (620)
.++|++++.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+++.+ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee--
Confidence 36899999999999999999997543 357999999754 3445667889999999999 899999999998
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|
T Consensus 145 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ---ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 34566899999998 59999998754 49999999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 12234567889999999877 689999999999999999999 999998876
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+....+.. ... ......+++.+.+||.+||+.||++|||++|++++
T Consensus 299 ~~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKE----------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHT----------------------------TCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHc----------------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5443333221 000 11124578899999999999999999999999885
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.49 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=201.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhc----CCCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLL----RHPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~rEi~iL~~L----~HpnIv~l~~v~~~ 93 (620)
.++|++++.||+|+||.||+|.++.+++.||||++....... .....+.+|+.+++.+ +||||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~-- 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF-- 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE--
Confidence 468999999999999999999999999999999996532211 2233456799999998 899999999998
Q ss_pred CCCCCCCeEEEEEec-CC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC-CCCcEEEccc
Q 007050 94 PSRRDFKDIYVVFEL-ME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDF 170 (620)
Q Consensus 94 ~~~~~~~~lylV~E~-~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~lKL~DF 170 (620)
.+....|+|||+ +. ++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 108 ---~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ---ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ---ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 344668999999 55 69999999888899999999999999999999999999999999999999 8899999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +..
T Consensus 185 g~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~----- 247 (312)
T 2iwi_A 185 GSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE----- 247 (312)
T ss_dssp SSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----
T ss_pred chhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh-----
Confidence 9998754322 2456799999999988752 2335589999999999999999999965311 000
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.. ......+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 248 ----------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 248 ----------------------AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ----------------------TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ----------------------hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 00 011245788999999999999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.02 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=191.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC---CC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS---RR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~---~~ 97 (620)
..+|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3589999999999999999999999999999999854 24455677889999999996 999999999985332 13
Q ss_pred CCCeEEEEEecCCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEcccCc
Q 007050 98 DFKDIYVVFELMESDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~---~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
+...+|+|||||.|+|.+++.. .+.+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4556899999999999998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc---------cccccccCCccccCcccccc-cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007050 173 ARVAFNDTPTT---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (620)
Q Consensus 173 A~~~~~~~~~~---------~~~~~~~gt~~Y~APEvl~~-~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~ 242 (620)
++......... ......+||+.|+|||++.. ....++.++|||||||++|+|++|..||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98754332211 01124569999999999831 115688999999999999999999999966433211100
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp 315 (620)
. .. .......++.+.+||.+||+.||.+|||++|+++|-
T Consensus 265 ~-------------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 K-------------------------------YS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp --------------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred c-------------------------------cc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0 00 011234567789999999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.27 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=208.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 46899999999999999999985 457789999999754 3345567889999999999 899999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 34456899999998 59999998654 48999999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999876543322 12234567889999999876 679999999999999999998 999998765
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
....+..+.. .... ......+++.+.+||.+||..||.+|||++|++++
T Consensus 253 ~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIK---------------------------EGFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHH---------------------------HTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhc---------------------------cCCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4322221111 0000 01124578899999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=383.06 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=194.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.+|.+.+.||+|+||.|+. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++ .+...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTE-----KDRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCE
Confidence 4699999999999999763 4467899999999965321 1245799999999 799999999988 45567
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-----CCcEEEcccCcccc
Q 007050 102 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-----NCKLKICDFGLARV 175 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-----~~~lKL~DFGlA~~ 175 (620)
+|||||||.|+|.+++.... .+.+..++.|+.||+.||.|||+.||+||||||+|||++. ...+||+|||+++.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999999999999998654 4666677899999999999999999999999999999953 23588999999987
Q ss_pred ccCCCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
..............+||++|+|||++.+. ...++.++||||||||+|+|++ |..||...... +...+.. ..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~~~---~~--- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILLG---AC--- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHHTT---CC---
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHHhc---cC---
Confidence 65433222233567899999999998632 2467889999999999999999 88999554322 1111111 00
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...........+..+.+||.+||+.||.+|||++|+|+||||..+
T Consensus 246 ----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 246 ----------------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ----------------------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ----------------------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 000111112235568999999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.54 Aligned_cols=250 Identities=22% Similarity=0.435 Sum_probs=210.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.++.++..||+|++... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 457899999999999999999999999999999999743 34567788999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 7999999999 6999999874 359999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 163 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~----------- 227 (288)
T 3kfa_A 163 GDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 227 (288)
T ss_dssp SSSSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----------
T ss_pred CCccc--cccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 33221 2234567889999999876 679999999999999999999 9999987664433322211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+++.+.+||.+||..||.+|||++++++
T Consensus 228 -----------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 228 -----------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------cCC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 000 1122467889999999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=354.79 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=205.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+. .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~ 78 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 78 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEE----EETT
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCcccccc----CCCC
Confidence 357899999999999999999999999999999998654222 34778999999999998877776653 3446
Q ss_pred eEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC---CCCcEEEcccCccccc
Q 007050 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVA 176 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~lKL~DFGlA~~~ 176 (620)
..|+||||+.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 7899999998899999974 45799999999999999999999999999999999999994 7889999999999876
Q ss_pred cCCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhH---HHHHhhhccCC
Q 007050 177 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLMTDLLGT 249 (620)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~---~l~~i~~~lg~ 249 (620)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 232 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---- 232 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----
T ss_pred cccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc----
Confidence 5433211 11245689999999999987 679999999999999999999999998743211 1111110
Q ss_pred CChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 250 PSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ....+.....+.+++.+.+||.+||+.||++|||++++++
T Consensus 233 --------------------~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 233 --------------------K---KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------H---HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------c---ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 0000111123567899999999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=367.05 Aligned_cols=261 Identities=20% Similarity=0.317 Sum_probs=206.4
Q ss_pred ccccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007050 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 13 ~~~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~----vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
|+.+...-..++|++++.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 3 MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp -CCCCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEE
T ss_pred hHHHHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEE
Confidence 34455555678999999999999999999999988876 6777764321 112234567899999999999999999
Q ss_pred eEecCCCCCCCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEE
Q 007050 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lK 166 (620)
+++. ...+|+|||||. ++|.+++... +.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 82 ~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 82 GLCP------GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp EEEC------BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEE
T ss_pred EEEc------CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEE
Confidence 9872 345899999998 6999999764 5799999999999999999999999999999999999999999999
Q ss_pred EcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhh
Q 007050 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTD 245 (620)
Q Consensus 167 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~ 245 (620)
|+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 156 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 156 VADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp ECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred ECCCCcccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 9999999876433322 22345678889999999876 679999999999999999999 9999987654333222211
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.... .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 233 ----------------------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 233 ----------------------------GERL---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------------------------TCBC---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------------------------CCCC---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1112356678999999999999999999999886
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=360.57 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=201.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
..++|++.+.||+|+||.||+|.++.++ ..||||++... ........+.+|+.+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 115 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI----- 115 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 4679999999999999999999987654 35999999754 2345566788999999999999999999998
Q ss_pred CCCCeEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 97 RDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 97 ~~~~~lylV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+...+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 455679999999985 999999764 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~------- 266 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------- 266 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------
T ss_pred hhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-------
Confidence 76443322222233456889999999876 679999999999999999999 99999876654433322210
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. ......+++.+.+||.+||+.||++||++.+++++
T Consensus 267 ---------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 ---------------------FR---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------CC---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------Cc---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123578899999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.19 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=198.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.+. ..||+|+++...........+.+|+.+|+.++||||++++++. ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSS
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCC
Confidence 3568999999999999999999754 3599999987666667778899999999999999999999965 234
Q ss_pred eEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+++|||||. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 5799999998 699999854 35699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... ........||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 173 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 240 (289)
T 3og7_A 173 WSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----------- 240 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH-----------
T ss_pred ccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc-----------
Confidence 221 1123456799999999988521 156889999999999999999999999876544433222110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
......+......+++.+.+||.+||..||.+|||++++++
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 ---------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11112223334567899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=351.88 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=202.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHH-----HHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-----ARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~-----~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
..++|++.+.||+|+||.||+|.+..+++.||+|++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 4578999999999999999999999999999999986533222211 6788999999999999999999998432
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCc-----EE
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCK-----LK 166 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~-----lK 166 (620)
. ++||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +|
T Consensus 96 ----~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 96 ----P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ----T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ----C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 2 79999998 6998888654 47999999999999999999999999 999999999999988776 99
Q ss_pred EcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhc
Q 007050 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (620)
Q Consensus 167 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~ 246 (620)
|+|||+++..... ....+||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+.....
T Consensus 170 l~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------ 237 (287)
T 4f0f_A 170 VADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK------ 237 (287)
T ss_dssp ECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH------
T ss_pred eCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH------
Confidence 9999999753321 2456899999999998543356889999999999999999999999765432110
Q ss_pred cCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+........ ........+++.+.+||.+||+.||.+|||++|+++
T Consensus 238 --------------------~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 238 --------------------FINMIREEG--LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --------------------HHHHHHHSC--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------HHHHHhccC--CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000000000 001123467899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.98 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=205.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 119 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT--- 119 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 468999999999999999999973 456789999997532 234456788999999999 8999999999984
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRD 151 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~-----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrD 151 (620)
+...+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+|||
T Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 4456899999998 59999998653 279999999999999999999999999999
Q ss_pred CCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCC
Q 007050 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (620)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~p 230 (620)
|||+|||++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999876443322 12234567889999999876 679999999999999999998 9999
Q ss_pred CCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007050 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310 (620)
Q Consensus 231 F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 310 (620)
|.+.+....+..+.. .... ......+++.+.+||.+||..||.+|||+++
T Consensus 275 ~~~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ---------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp STTCCCSHHHHHHHH---------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cccCCcHHHHHHHHh---------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 987653322221111 0000 1112356889999999999999999999999
Q ss_pred HHcCC
Q 007050 311 ALADP 315 (620)
Q Consensus 311 lL~hp 315 (620)
+++|-
T Consensus 325 l~~~l 329 (344)
T 1rjb_A 325 LTSFL 329 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.29 Aligned_cols=253 Identities=19% Similarity=0.359 Sum_probs=208.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++.+.||+|+||.||+|.++ .+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 97 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 97 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-----
Confidence 468999999999999999999886 46788999999754 3345566788999999999999999999998
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~l 165 (620)
.+...+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 34456899999998 5999999752 357999999999999999999999999999999999999999999
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhh
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~ 244 (620)
||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999865432211 11233467889999999876 679999999999999999999 899998766544333322
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. . ........+++.+.+||.+||..||.+|||+.|+++|
T Consensus 255 ~----------------------------~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 E----------------------------G---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp T----------------------------T---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c----------------------------C---CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 0 0111234678899999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.51 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=199.1
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKV----AIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~v----AIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
-..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 34568999999999999999999998888754 77776532 222345678899999999999999999999853
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
...++|+|++. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 89 ----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 ----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ----SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ----CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 23789999998 699999987 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+........ .......+|..|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------- 234 (327)
T 3poz_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------- 234 (327)
T ss_dssp HHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------
T ss_pred eEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-------
Confidence 876433322 12234567889999999887 689999999999999999999 9999987654332222211
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ....+.++..+.+||.+||+.||.+|||+.|++++
T Consensus 235 ---------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 235 ---------------------GER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------TCC---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 11224567899999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.01 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=196.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..++|++.+.||+|+||.||+|.++ .++..||||+++.. ........+.+|+.+|+.++||||+++++++ .
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~ 116 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----T 116 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence 4568999999999999999999887 46778999999754 2445567889999999999999999999998 3
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...+|+|||||+ ++|.+++...+ .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 4467899999997 69999998754 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...............++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------- 267 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------- 267 (373)
T ss_dssp -----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-------
T ss_pred cccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 6443222211223345778999999876 689999999999999999998 999998766544333221100
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ......++..+.+||.+||+.||++||+++++++
T Consensus 268 -------------------~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 -------------------R-----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -------------------E-----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------C-----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 0112357789999999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.71 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=206.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.++.+++.||||+++.. ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCC
Confidence 346899999999999999999999999999999998753 2334456788999999999999999999998 3445
Q ss_pred eEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||+ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 6899999998 69999997644 699999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 266 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 330 (377)
T 3cbl_A 266 GVYAA-SGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------------ 330 (377)
T ss_dssp SEEEC-CSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT------------
T ss_pred Cceee-cCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 21110 0111235678999999876 578999999999999999998 9999988765433322211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... .....+++.+.+||.+||+.||++|||++++++
T Consensus 331 ----------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 ----------------GGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 112346789999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=348.65 Aligned_cols=250 Identities=14% Similarity=0.196 Sum_probs=206.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+. ++.||+|++............+.+|+.+|+.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 3468999999999999999999885 88999999987655666677899999999999999999999998543 235
Q ss_pred eEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 7899999998 59999998765 4899999999999999999999999 99999999999999999999999988754
Q ss_pred ccCCCCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
... ....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 163 ~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 226 (271)
T 3kmu_A 163 FQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE-------- 226 (271)
T ss_dssp TSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS--------
T ss_pred ecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc--------
Confidence 221 234789999999998752 123444899999999999999999999877654433322110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+++.+.+||.+||+.||++|||++|+++
T Consensus 227 -------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 -------------------GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1123467899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=368.46 Aligned_cols=266 Identities=14% Similarity=0.162 Sum_probs=201.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHH---------HHHHHHHHHHHHhcCCCCcceee
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISD---------AARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~---------~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
..++|++++.||+|+||.||+|.+.. ++..+|||++......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 35789999999999999999999987 7889999998753211111 12356788999999999999999
Q ss_pred eEecCCCCCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC--cEE
Q 007050 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC--KLK 166 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~lK 166 (620)
+++.... .+...+|+|||||.++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9985422 3356799999999779999998877899999999999999999999999999999999999998887 999
Q ss_pred EcccCccccccCCCC----cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh-hHHHH
Q 007050 167 ICDFGLARVAFNDTP----TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLD 241 (620)
Q Consensus 167 L~DFGlA~~~~~~~~----~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~-~~~l~ 241 (620)
|+|||+++....... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+.
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999986543211 1111245689999999999887 5799999999999999999999999965321 11111
Q ss_pred HhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 242 LMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 242 ~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ......+..+....+ .+++.+.+||.+||..||++|||++++++
T Consensus 272 ~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKT------------------------NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHH------------------------HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHH------------------------hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1100 000011111111112 67889999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.18 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=208.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (620)
..++|++++.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence 347899999999999999999985 457789999999754 3344566788999999999 79999999999843
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDD----------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~----------------lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (620)
+...+|+|||||+ ++|.+++..... +++..++.++.||+.||.|||+.||+||||||+||
T Consensus 103 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2345899999999 599999987654 89999999999999999999999999999999999
Q ss_pred EeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCh
Q 007050 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (620)
Q Consensus 158 Ll~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~ 236 (620)
|++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543322 122344578899999999876 679999999999999999998 9999977553
Q ss_pred hHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 237 ~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
...+.... ..... ......+++.+.+||.+||..||.+|||++|+++|
T Consensus 257 ~~~~~~~~---------------------------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRL---------------------------KEGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHH---------------------------HHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHh---------------------------ccCcc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22211110 00110 11123578899999999999999999999999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.51 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=196.4
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
...++|++++.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.++||||+++++++. +
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----E 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----E
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----c
Confidence 3456899999999999999999999999999999999753 234456677889999999999999999999984 4
Q ss_pred CCeEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 99 FKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 99 ~~~lylV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
...+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 4679999999995 99998864 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~------------- 244 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y------------- 244 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-H-------------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-H-------------
Confidence 76543221 1234579999999999876 679999999999999999999999997643110 0
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.....+...... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 245 ------------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 245 ------------SLCKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ------------HHHHHHHTTCSC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------HHHHHhhcccCC--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000001010000 01124578899999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=352.21 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=208.8
Q ss_pred CCCCeEEEE-EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQE-VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~-~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..++|.+++ .||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 80 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ----- 80 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----
Confidence 346788887 9999999999999864 56788999999764 34456778899999999999999999999982
Q ss_pred CCCeEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~g-dL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
...+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 81 -AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp -SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 2358999999995 999998653 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--------- 228 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 228 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---------
T ss_pred eccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---------
Confidence 6443322222234457899999999876 578999999999999999998 9999987654433322211
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~ 316 (620)
... ....+.+++.+.+||.+||..||++|||+++++++.+
T Consensus 229 -------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 -------------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -------------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -------------------CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 000 1123467899999999999999999999999998743
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.77 Aligned_cols=245 Identities=18% Similarity=0.284 Sum_probs=200.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-------~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (620)
.++|++.+.||+|+||.||+|.++.++ ..||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV-- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--
Confidence 468999999999999999999998877 47999998653 2344567889999999999999999999984
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc--------
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-------- 164 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------- 164 (620)
+....|+|||||. ++|.+++...+. +++..++.|+.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 ---CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ---CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred ---eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 4456799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred EEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChhHHHHHh
Q 007050 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLM 243 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~pF~g~~~~~~l~~i 243 (620)
+||+|||++...... ....+|+.|+|||++.+. ..++.++|||||||++|+|++|. +||...+........
T Consensus 160 ~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998654221 234688899999988752 46899999999999999999954 555544332221111
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. . .......++.+.+||.+||+.||++|||++|+++|
T Consensus 232 ~~----------------------------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 ED----------------------------R-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HT----------------------------T-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hc----------------------------c-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 0 01123446788999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=347.92 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=193.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 468999999999999999999874 889999998653222 12246788999999999999999999998 344
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCceEeCC--------CCcEEE
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN---VYHRDLKPKNILANA--------NCKLKI 167 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILl~~--------~~~lKL 167 (620)
..+|+||||++ ++|.+++. ...+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 56899999998 58888875 457999999999999999999999999 899999999999986 778999
Q ss_pred cccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhcc
Q 007050 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (620)
Q Consensus 168 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~l 247 (620)
+|||+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 99999976543221 24579999999999876 6799999999999999999999999987665433222211
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.... ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 229 -------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 -------------------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0000 11224578899999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=358.76 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=207.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-------~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (620)
.++|++++.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-- 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE--
Confidence 478999999999999999999986 46678999999754 3445667889999999999 899999999998
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 111 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp ---CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ---ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 34567899999998 59999998654 38999999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999865432211 11234467889999999876 578999999999999999999 999998766
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+....+.. ... ......+++.+.+||.+||..||.+|||++|++++
T Consensus 265 ~~~~~~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKE----------------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHH----------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhc----------------------------CCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5433322211 000 11224678899999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=346.98 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=206.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.++|++++.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++. +..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 4578999999999999999999986 6788999999764332 356889999999999999999999983 445
Q ss_pred eEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 6899999998 5999999865 4689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 157 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~------------ 220 (267)
T 3t9t_A 157 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------ 220 (267)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------------
T ss_pred cc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc------------
Confidence 11 111234467889999999876 678999999999999999999 8999987665443333321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... .......++.+.+||.+||..||++|||+++++++
T Consensus 221 ----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 221 ----------------GFR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCc---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 01123467899999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.71 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=196.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~--L~HpnIv~l~~v~~~~~~~~ 98 (620)
..++|++++.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 356899999999999999999987 6899999998642 34455667777776 79999999999865432 34
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCceEeCCCCcEEEcc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH--------TANVYHRDLKPKNILANANCKLKICD 169 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILl~~~~~lKL~D 169 (620)
...+|+|||||+ ++|.++++. ..+++..++.|+.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 467899999998 599999954 57999999999999999999999 99999999999999999999999999
Q ss_pred cCccccccCCCCcc-cccccccCCccccCcccccccCC----CCCcccchHhHHHHHHHHHhC----------CCCCCCC
Q 007050 170 FGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (620)
Q Consensus 170 FGlA~~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~----~y~~~~DIWSLG~IlyeLltG----------~~pF~g~ 234 (620)
||+++......... ......+||+.|+|||++.+... .++.++|||||||++|||++| ..||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 11234589999999999876211 345789999999999999999 7777543
Q ss_pred ChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 235 ~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... +..+.+... ... ....+..... .....++.+.+||.+||+.||++|||++|+++
T Consensus 237 ~~~~-----------~~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPND-----------PSFEDMRKV---------VCV-DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSS-----------CCHHHHHHH---------HTT-SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCC-----------cchhhhhHH---------Hhc-cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2110 000000000 000 0000000000 01124568999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=360.54 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=205.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~-----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
..++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL--- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc---
Confidence 35799999999999999999998 5678889999999743 34456677889999999999999999999984
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCK 164 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~-------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~ 164 (620)
+...+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. +..
T Consensus 104 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 --QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 4456799999997 69999998753 4899999999999999999999999999999999999994 446
Q ss_pred EEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHh
Q 007050 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i 243 (620)
+||+|||+++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECccccccccccccccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9999999997653322111 1234568899999999876 679999999999999999998 99999877654433332
Q ss_pred hhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
... .. ......+++.+.+||.+||..||.+|||++++++|.|+-
T Consensus 259 ~~~----------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSG----------------------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTT----------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcC----------------------------CC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 210 00 112245788999999999999999999999999998864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=377.57 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=193.1
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (620)
..+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~ 81 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTD 81 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECS
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecC
Confidence 3467888899999999999875 4578999999998642 234567899999876 899999999988 455
Q ss_pred CeEEEEEecCCccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC----------
Q 007050 100 KDIYVVFELMESDLHQVIKANDDL-------TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---------- 162 (620)
Q Consensus 100 ~~lylV~E~~~gdL~~~i~~~~~l-------se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---------- 162 (620)
..+|+|||||+|+|.+++...... ++..++.|+.||+.||.|||+.||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 779999999999999999875433 233457799999999999999999999999999999754
Q ss_pred ---CcEEEcccCccccccCCCCc-ccccccccCCccccCccccccc-----CCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 007050 163 ---CKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (620)
Q Consensus 163 ---~~lKL~DFGlA~~~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~IlyeLlt-G~~pF~ 232 (620)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 48999999999876433221 1122456899999999998641 1468999999999999999999 999996
Q ss_pred CCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 233 GKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 233 g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
+..... ...+......+ .. .......+++++.+||.+||+.||.+|||+.|+|
T Consensus 242 ~~~~~~-~~i~~~~~~~~-------------------------~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 242 DKYSRE-SNIIRGIFSLD-------------------------EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp STTTHH-HHHHHTCCCCC-------------------------CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CchhhH-HHHhcCCCCcc-------------------------cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 643221 11110000000 00 0001123457899999999999999999999999
Q ss_pred cCCcccC
Q 007050 313 ADPYFKG 319 (620)
Q Consensus 313 ~hp~f~~ 319 (620)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=350.41 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=202.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 4689999999999999999998754 3446999998754 344566788999999999999999999999732
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 34699999999 5999999764 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---------- 229 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---------- 229 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH----------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc----------
Confidence 432211 1233467889999999876 679999999999999999998 9999976554333222211
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ......+++.+.+||.+||..||++|||+.|++++
T Consensus 230 ------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 230 ------------------GDR---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 000 01123578899999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.12 Aligned_cols=245 Identities=27% Similarity=0.425 Sum_probs=192.5
Q ss_pred CCCCCCeEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCC
Q 007050 19 YGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 19 ~g~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL-~~L~HpnIv~l~~v~~~~~~ 96 (620)
....++|.++ +.||+|+||.||+|.++.+++.||||++... ..+.+|+.++ +.++||||+++++++....
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~- 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY- 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc-
Confidence 3445678887 7899999999999999999999999998642 3456788887 6669999999999884311
Q ss_pred CCCCeEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCcEEEccc
Q 007050 97 RDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDF 170 (620)
Q Consensus 97 ~~~~~lylV~E~~~g-dL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~lKL~DF 170 (620)
.+...+|+|||||++ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 235679999999984 9999998764 6999999999999999999999999999999999999998 788999999
Q ss_pred CccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 171 GlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
|++.... + ..|+.++|||||||++|+|++|..||.+.+.......+...+..
T Consensus 165 g~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~- 216 (299)
T 3m2w_A 165 GFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM- 216 (299)
T ss_dssp TTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT-
T ss_pred ccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh-
Confidence 9986431 1 35778999999999999999999999776533221111110000
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.........+..+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus 217 -----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 217 -----------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -----------------------TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -----------------------ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 0000001122467899999999999999999999999999999987544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=367.99 Aligned_cols=268 Identities=17% Similarity=0.176 Sum_probs=201.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHH---------HHHHHHHHHHHhcCCCCccee
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDA---------ARILREIKLLRLLRHPDIVEI 87 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~---------~~i~rEi~iL~~L~HpnIv~l 87 (620)
.++|++++.||+|+||.||+|.++.+ ++.||||++.......... ..+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998765 5789999986432111110 123456667778889999999
Q ss_pred eeEecCCCCCCCCeEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC--CCCc
Q 007050 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANCK 164 (620)
Q Consensus 88 ~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~ 164 (620)
++++.... .+...+|||||||.++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99985432 233568999999977999999876 6799999999999999999999999999999999999999 8899
Q ss_pred EEEcccCccccccCCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHH
Q 007050 165 LKICDFGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240 (620)
Q Consensus 165 lKL~DFGlA~~~~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l 240 (620)
+||+|||+++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999998754322111 11234569999999999987 57999999999999999999999999764322221
Q ss_pred HHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 241 ~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....... .......++... + ...++++.+.+||..||..||.+||+++++++
T Consensus 271 ~~~~~~~------------~~~~~~~~~~~~-------~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIR------------YRENIASLMDKC-------F--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHH------------HHHCHHHHHHHH-------S--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHH------------hhhhHHHHHHHh-------c--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111000 000111111110 0 11467889999999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=358.32 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=206.9
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~-----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (620)
..++|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGAC--- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence 35789999999999999999999987765 7999999754 3345567789999999999 899999999998
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKA--------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~--------------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl 159 (620)
.+...+|+|||||+ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 120 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 --THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred --ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 34456899999998 599999964 3468999999999999999999999999999999999999
Q ss_pred CCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhH
Q 007050 160 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 238 (620)
Q Consensus 160 ~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~ 238 (620)
+.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999865433221 12234567889999999876 679999999999999999998 999998765332
Q ss_pred HHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 239 QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 239 ~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.+..+.. . ... .......++.+.+||.+||+.||.+|||++|+++
T Consensus 275 ~~~~~~~------------------------~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVK------------------------D---GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHH------------------------H---TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHh------------------------c---CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2221111 0 000 0112346789999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.42 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=202.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.+... ........+.+|+.+++.++||||+++++++. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cC
Confidence 457999999999999999999976443 36899998753 44456678899999999999999999999864 33
Q ss_pred CCeEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~g-dL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
....|+|||||++ +|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 4568999999995 99999976 446899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCC-cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 177 FNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 177 ~~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
..... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--------
Confidence 43221 1112244578889999999876 679999999999999999999 66788776543332222110
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. ......+++.+.+||.+||..||.+|||++|+++
T Consensus 249 --------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 --------------------RR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0112346789999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.52 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=203.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEE--EEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~v--AIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++.+.||+|+||.||+|.++.++..+ |+|.+... ........+.+|+.+|+.+ +||||+++++++ .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~ 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence 468999999999999999999999998865 99988743 2234456788999999999 899999999998 44
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (620)
...+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 567999999997 59999997654 6999999999999999999999999999999999999999
Q ss_pred CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007050 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 240 (620)
Q Consensus 162 ~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l 240 (620)
++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999999997432111 1133457889999999876 578999999999999999998 99999887654433
Q ss_pred HHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 241 ~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
..+.. ... ......+++.+.+||.+||..||.+|||++|++++
T Consensus 252 ~~~~~----------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQ----------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGG----------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc----------------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33221 000 11223578899999999999999999999999885
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=357.45 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=205.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.++.+++.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 45789999999999999999999999999999999864 34456678889999999999999999999985321 2345
Q ss_pred eEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+|+|||||.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999995 99999875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCcc------cccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccC
Q 007050 176 AFNDTPTT------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 176 ~~~~~~~~------~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg 248 (620)
........ ..+....||+.|+|||++.+. ...++.++|||||||++|+|++|..||......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------- 252 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----------- 252 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-----------
Confidence 43211100 112345679999999998652 123788999999999999999999999431100
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
........ ..... ....+.+++.+.+||.+||+.||.+|||+++++++
T Consensus 253 ------------~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 253 ------------GDSVALAV---QNQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------TSCHHHHH---HCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------cchhhHHh---hccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000000 00000 11235678999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=358.70 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=199.4
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKV----AIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~v----AIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (620)
-..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--
Confidence 44678999999999999999999999888765 66666533 223345678899999999999999999999853
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA 173 (620)
...++|+|++. ++|.+++.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 89 ----~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ----SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ----CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 23789999998 699999976 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------- 234 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------- 234 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------
Confidence 875433221 12234567889999999887 689999999999999999999 9999987654433222211
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. .....+.++..+.+||.+||..||.+|||++|+++
T Consensus 235 ---------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 235 ---------------------GE---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------------TC---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CC---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 01123457889999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.78 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=202.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
-+|.+.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----E 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----C
Confidence 357788999999999999999765554 7999998753 3445667889999999999999999999998432 2
Q ss_pred CeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 33489999997 699999986 4578999999999999999999999999999999999999999999999999997643
Q ss_pred CCCC-cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 178 NDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 178 ~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++| .+||.+.+..+....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC---------
Confidence 3211 1111234578899999999987 6799999999999999999995 5666555443322222110
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. ......+++.+.+||.+||..||.+|||++++++
T Consensus 245 -------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 245 -------------------RR---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CC---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 1112356889999999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=366.03 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=205.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTT
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCC
Confidence 457899999999999999999986 46899999998753 234566788999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 101 DIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 7899999998 59999886543 589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.. .
T Consensus 189 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------~ 256 (321)
T 2qkw_B 189 GTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW---------A 256 (321)
T ss_dssp CSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH---------T
T ss_pred ccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH---------h
Confidence 4322221 12244578999999999876 5799999999999999999999999976543221110000 0
Q ss_pred hhhhhchhHHHHHHhhhcc-CCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 007050 256 SRVVRNDKARRYLTSMRKK-QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp 315 (620)
....... .+... .+.......+..+..+.+||.+||+.||++|||+.|++++-
T Consensus 257 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 257 VESHNNG-------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHTTT-------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccccc-------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000000 00000 00000111223456789999999999999999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=357.53 Aligned_cols=268 Identities=23% Similarity=0.328 Sum_probs=206.3
Q ss_pred CCe-EEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 23 SRY-KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 23 ~rY-~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
++| ++++.||+|+||.||++. +..+++.||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 105 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA--- 105 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---
Confidence 455 999999999999998775 4468899999999764 3445667789999999999999999999998542
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|+|||||. ++|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 2467999999998 5999999765 4999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~--- 254 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQ--- 254 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHH---
T ss_pred cccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccc---
Confidence 544332223345678899999999876 57889999999999999999999999653211 01111111100
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.........+..... ......+++.+.+||.+||+.||++|||++|+++
T Consensus 255 -----~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 255 -----MTVLRLTELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -----HHHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hhHHHHHHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011111111111111 1223467899999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=362.42 Aligned_cols=254 Identities=14% Similarity=0.188 Sum_probs=200.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC--------CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCccee------
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT--------GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI------ 87 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t--------g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l------ 87 (620)
.++|++++.||+|+||.||+|.++.+ ++.||||++... ..+.+|+.+++.++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 47999999999999999999999884 889999998743 357789999999999999984
Q ss_pred ---------eeEecCCCCCCCCeEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 88 ---------KHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 88 ---------~~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
++++. .+...+|+|||||.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred CCccCccchhhccc----cCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 33332 234678999999977999999876 689999999999999999999999999999999999
Q ss_pred eEeCCCC--cEEEcccCccccccCCCCc----ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC
Q 007050 157 ILANANC--KLKICDFGLARVAFNDTPT----TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (620)
Q Consensus 157 ILl~~~~--~lKL~DFGlA~~~~~~~~~----~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p 230 (620)
||++.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 8999999999765432211 111244589999999999987 5799999999999999999999999
Q ss_pred CCCCC-hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCccc---CCCCCCCHHHHHHHHHhcccCCCCCC
Q 007050 231 FPGKN-VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFS---QKFPNADPSALRLLERLLAFDPKDRP 306 (620)
Q Consensus 231 F~g~~-~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~l~dLI~~mL~~DP~~Rp 306 (620)
|.+.. ....+.... ..... .+..+. ..+..+++.+.+||.+||..||++||
T Consensus 268 f~~~~~~~~~~~~~~------------------------~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 268 WTNCLPNTEDIMKQK------------------------QKFVD-KPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp TGGGTTCHHHHHHHH------------------------HHHHH-SCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred cccCCcCHHHHHHHH------------------------HhccC-ChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC
Confidence 97653 111111110 00000 111111 12346789999999999999999999
Q ss_pred CHHHHHc
Q 007050 307 TAEEALA 313 (620)
Q Consensus 307 sa~elL~ 313 (620)
|++++++
T Consensus 323 s~~~l~~ 329 (352)
T 2jii_A 323 PYAMLRN 329 (352)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.41 Aligned_cols=248 Identities=29% Similarity=0.388 Sum_probs=204.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 95 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~------- 95 (620)
++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999999999999997532 24568999999999999999999874311
Q ss_pred ----CCCCCeEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEc
Q 007050 96 ----RRDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 96 ----~~~~~~lylV~E~~~g-dL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
......+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 1224568999999995 999999754 579999999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccC
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg 248 (620)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------------ 226 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSK------------ 226 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHHH------------
Confidence 9999987643322 234579999999999876 6789999999999999999999988732110
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
+...+... .....+++.+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 227 ------------------~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 ------------------FFTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------------------HHHHHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------HHHHhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111110 01234678999999999999999999999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=375.59 Aligned_cols=261 Identities=18% Similarity=0.204 Sum_probs=198.9
Q ss_pred cccCCCC-CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCC-CCccee-----
Q 007050 16 FSEYGDA-SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRH-PDIVEI----- 87 (620)
Q Consensus 16 ~~~~g~~-~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~H-pnIv~l----- 87 (620)
.++.+.. ..|.+.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.+.| .|+..+
T Consensus 70 ~s~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 70 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp EESSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred eccCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 3344433 348899999999999999999999999999999873322 22235678899999999987 322111
Q ss_pred ----eeEe------------cCCCCCCCCeEEEEEecCCccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 007050 88 ----KHIM------------LPPSRRDFKDIYVVFELMESDLHQVIKA-------NDDLTREHYQFFLYQLLRALKYIHT 144 (620)
Q Consensus 88 ----~~v~------------~~~~~~~~~~lylV~E~~~gdL~~~i~~-------~~~lse~~~~~i~~QIl~aL~yLHs 144 (620)
.++. ..........++++|+++.++|.+++.. ...+++..+..|+.||+.||.|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1111 1100111345799999999999998852 2357888899999999999999999
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccc--------cCCCCCcccchHh
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 216 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~--------~~~~y~~~~DIWS 216 (620)
+||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999999998764322 245678 99999999831 1146888999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHH
Q 007050 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 296 (620)
Q Consensus 217 LG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~ 296 (620)
|||++|+|++|+.||.+.+.......+ ...++.+++.+.+||.+
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~ 346 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGSEWI------------------------------------FRSCKNIPQPVRALLEG 346 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCSGGG------------------------------------GSSCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhHHHH------------------------------------HhhcccCCHHHHHHHHH
Confidence 999999999999999775432211111 11234678999999999
Q ss_pred hcccCCCCCCCHHHHHcCCcccC
Q 007050 297 LLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 297 mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
||+.||++|||+.++|+||||+.
T Consensus 347 ~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=350.34 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=199.8
Q ss_pred cCCCCCCeEEEEEeeecCceEEEEEEECC-CCc--EEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007050 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTH-TGE--KVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (620)
Q Consensus 18 ~~g~~~rY~i~~~LG~G~~G~V~~a~d~~-tg~--~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~ 93 (620)
..-..++|++++.||+|+||.||+|.+.. +++ .||+|+++... ........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34456789999999999999999998643 333 68999987532 233456788899999999999999999999843
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccC
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
. ..++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 93 ~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 93 P------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp S------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred C------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence 2 3799999998 6999998764 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
++.................+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--- 241 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG--- 241 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC---
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC---
Confidence 99876544333222344568889999999876 578999999999999999999 999998876544433332110
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. .......+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ------------------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 242 ------------------------E---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------C---CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 01123467899999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=378.45 Aligned_cols=249 Identities=22% Similarity=0.428 Sum_probs=207.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCc
Confidence 467999999999999999999999999999999997542 2356788999999999999999999998 34456
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999999 6999999864 4589999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......++..|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 371 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 434 (495)
T 1opk_A 371 DTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 434 (495)
T ss_dssp CCEE--CCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT------------
T ss_pred Ccee--ecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 2211 1233456788999999876 579999999999999999999 9999988765433322211
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+++.+.+||.+||+.||++|||+.++++
T Consensus 435 ----------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ----------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 000 1122467889999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.46 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=203.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+|+.++||||+++++++. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT------QEP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc------CCC
Confidence 478999999999999999999975 567899999975422 3456889999999999999999999873 234
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999996533 699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------- 226 (279)
T 1qpc_A 162 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (279)
T ss_dssp SCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred cccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----------
Confidence 3211 1234457889999999876 578999999999999999999 99999887654433332210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. ......+++.+.+||.+||..||++|||++++++
T Consensus 227 -----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 -----------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------cC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0112457889999999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=359.91 Aligned_cols=268 Identities=20% Similarity=0.314 Sum_probs=203.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.+++.++||||+++++++. +..
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPT 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSS
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEe-----cCC
Confidence 457899999999999999999975 46899999999753211 12235789999999999999999999984 445
Q ss_pred eEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 101 DIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTA---NVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~----~lse~~~~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
..|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 6799999998 59999998643 499999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh-----hHHHHHhhhcc
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLMTDLL 247 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~-----~~~l~~i~~~l 247 (620)
++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+...+
T Consensus 181 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 181 AKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 987543322 22345679999999999876 5789999999999999999999999953211 00111111000
Q ss_pred CCCChhhhhhhhhchhHHHHHHhhhccCCCcc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
....... ...... ....+..+..+.+||.+||+.||.+|||+.|+|+|-+-.
T Consensus 257 ~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEA-------------------LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTT-------------------SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhh-------------------hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 0000000 000000 011122346799999999999999999999999985543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.55 Aligned_cols=272 Identities=22% Similarity=0.374 Sum_probs=205.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++... +..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCC
Confidence 4578999999999999999999999999999999997532 123356678999999999999999999998543 234
Q ss_pred eEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----CCCCcEEEcccCc
Q 007050 101 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~lKL~DFGl 172 (620)
.+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 6899999998 59999997543 39999999999999999999999999999999999999 7788899999999
Q ss_pred cccccCCCCcccccccccCCccccCccccccc------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCh----hHHHHH
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----VHQLDL 242 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~------~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~----~~~l~~ 242 (620)
++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+... .+.+..
T Consensus 163 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred ceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 98653321 22456799999999987531 03577899999999999999999999965332 122222
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQK-------FPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+.. +.|. ..+..+... ......+... ...++..+.+||.+||..||++|||++|++++
T Consensus 239 ~~~--~~p~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IIT--GKPS-GAISGVQKA-----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHH--SCCT-TCCEEEECS-----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred Hhc--CCCc-ccchhheec-----------cCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 211 2221 111111000 0001111111 12345678999999999999999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.13 Aligned_cols=244 Identities=23% Similarity=0.401 Sum_probs=195.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||++.+. |+.||+|++... .....+.+|+.+++.++||||+++++++.. +..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCC
Confidence 4578999999999999999999874 889999998753 245678899999999999999999998743 334
Q ss_pred eEEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
.+|+||||+++ +|.+++...+. +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 68999999985 99999976543 8999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 169 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----------- 229 (278)
T 1byg_A 169 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 229 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------
T ss_pred ccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 321 23357889999999876 679999999999999999998 9999977654333222211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+++.+.+||.+||..||.+|||+.|+++
T Consensus 230 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 -----------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 000 1123467899999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=368.11 Aligned_cols=244 Identities=24% Similarity=0.401 Sum_probs=201.6
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
..++|++++.||+|+||.||+|.+. |+.||||+++... ....+.+|+.+|+.++||||+++++++.. +..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTS
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCC
Confidence 4578999999999999999999875 7899999997532 34678899999999999999999999743 234
Q ss_pred eEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
.+|+|||||. |+|.+++...+. +++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 6999999998 599999987543 7999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 341 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~----------- 401 (450)
T 1k9a_A 341 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 401 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-----------
T ss_pred ccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence 221 22357889999999976 689999999999999999998 9999987654333322211
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 402 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 402 -----------------GYK---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1122467899999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.44 Aligned_cols=280 Identities=23% Similarity=0.302 Sum_probs=199.8
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHH--HHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE--IKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rE--i~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
..++|++++.||+|+||.||+|.+ +++.||||++... ....+..| +..+..++||||+++++.+......+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 457899999999999999999976 6899999998642 22233334 44455689999999998654433345
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeecCCCCceEeCCCCcEEEc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------NVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
...+|+|||||+ |+|.+++.... +++..++.|+.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 567899999997 59999997654 68999999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCCC-----cccccccccCCccccCcccccccC-----CCCCcccchHhHHHHHHHHHhCCCC-CCCCChh
Q 007050 169 DFGLARVAFNDTP-----TTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVV 237 (620)
Q Consensus 169 DFGlA~~~~~~~~-----~~~~~~~~~gt~~Y~APEvl~~~~-----~~y~~~~DIWSLG~IlyeLltG~~p-F~g~~~~ 237 (620)
|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..| |++.+..
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987543221 111223567999999999986521 2456789999999999999999654 4444322
Q ss_pred HHHHHhh-hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCC---CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 238 HQLDLMT-DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPN---ADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 238 ~~l~~i~-~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.....+. .....|..+.+..... .......+...++. +++.+.+||.+||..||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVS-----------REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHT-----------TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhc-----------ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 2111111 1222333322221110 11111122222222 4567999999999999999999999955
Q ss_pred ------CCcccC
Q 007050 314 ------DPYFKG 319 (620)
Q Consensus 314 ------hp~f~~ 319 (620)
++|-++
T Consensus 312 ~L~~ll~~~~~~ 323 (336)
T 3g2f_A 312 RMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHCCCC-
T ss_pred HHHHHHHHHHhc
Confidence 566553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=384.22 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=202.9
Q ss_pred CeEEE-EEeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 24 RYKIQ-EVIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 24 rY~i~-~~LG~G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.|+||||+++++++. ..
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~ 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AE 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence 34443 4899999999999954 567789999999865555555678999999999999999999999883 23
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||. |+|.+++..+..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 4899999998 599999999889999999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.......+...+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~------------ 588 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------ 588 (635)
T ss_dssp ------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred ccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 322222334567889999999976 689999999999999999998 99999887765444333210
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. ......+++.+.+||.+||..||++|||++++++
T Consensus 589 ----------------~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 ----------------ER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 1112457889999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=371.10 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=204.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++. ...
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 468999999999999999999885 46789999997532 23567889999999999999999999973 245
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+|||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 899999998 6999999754 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .......+|..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 337 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 402 (454)
T 1qcf_A 337 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------- 402 (454)
T ss_dssp HHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----------
T ss_pred Cce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 211 11123456788999999876 679999999999999999999 999998876554443332110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ......+++.+.+||.+||..||++|||++++++
T Consensus 403 ------------------~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 403 ------------------R---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------C---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0 0112357889999999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.05 Aligned_cols=268 Identities=22% Similarity=0.320 Sum_probs=205.7
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
|.....|...+.||+|+||.||+|.+ +++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 27 f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 99 (307)
T 2nru_A 27 FDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS----- 99 (307)
T ss_dssp TCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----
Confidence 45555666779999999999999975 68899999987532 2334567788999999999999999999998
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~---~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
.+...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 100 SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 34457899999997 699999874 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
++....... .......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+...+...
T Consensus 180 ~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 253 (307)
T 2nru_A 180 ARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE-- 253 (307)
T ss_dssp CEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT--
T ss_pred ccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh--
Confidence 986543222 122244679999999998875 58899999999999999999999998765433222221110000
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
......++ ...+.......+..+.+||.+||..||.+|||+++++++
T Consensus 254 --------~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 254 --------EKTIEDYI-------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --------SCCHHHHS-------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------hhhhhhhc-------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000110 000111112345678999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.98 Aligned_cols=243 Identities=30% Similarity=0.457 Sum_probs=193.3
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.++|++.+.||+|+||.||+|.+. ++.||||++... .....+.+|+.+|+.++||||+++++++. .
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~ 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL-------N 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------T
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------C
Confidence 4568999999999999999999874 789999998642 45667889999999999999999999873 2
Q ss_pred eEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeecCCCCceEeCCCCc-EEEcccCc
Q 007050 101 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHT---ANVYHRDLKPKNILANANCK-LKICDFGL 172 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILl~~~~~-lKL~DFGl 172 (620)
.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3699999998 59999998765 47899999999999999999999 89999999999999998886 79999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------------- 211 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------------- 211 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-------------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-------------
Confidence 9754322 134569999999999987 6899999999999999999999999975322110
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
. ......... .......+++.+.+||.+||..||.+|||++++++
T Consensus 212 ~-------------~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 212 R-------------IMWAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp H-------------HHHHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-------------HHHHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 000000111 11223567889999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.95 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=195.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.+|++.+.||+|+||.||+|.+..++ ..||+|.++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CC
Confidence 35889999999999999999875433 46899998753 344567789999999999999999999998743 33
Q ss_pred CeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
...|+|||||+ ++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 56799999998 5999999864 458999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCc-ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 178 NDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---------- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT----------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc----------
Confidence 32211 111234567889999999876 689999999999999999999 7788877654332222211
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ......+++.+.+||.+||..||++|||++|++++
T Consensus 312 ------------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 312 ------------------GRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01123578899999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=370.44 Aligned_cols=258 Identities=18% Similarity=0.255 Sum_probs=203.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|+|++++..+..+. .+...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCE
Confidence 47899999999999999999999999999999988643222 24678999999998865555544442 34567
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---CCCCcEEEcccCcccccc
Q 007050 102 IYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~lKL~DFGlA~~~~ 177 (620)
.|||||||.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 78 ~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 899999998899999985 5579999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 178 NDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 178 ~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
...... ......+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------- 227 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-------- 227 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH--------
T ss_pred CCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH--------
Confidence 433211 11235689999999999987 6799999999999999999999999987543222111110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+ ...... .........+++++.+||.+||..||++||+++++++
T Consensus 228 ----i-~~~~~~-----------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 228 ----I-SEKKVA-----------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ----H-HHHHHH-----------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----H-hhcccc-----------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 000000 0011112456889999999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.42 Aligned_cols=270 Identities=21% Similarity=0.353 Sum_probs=208.1
Q ss_pred CCCeEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence 4679999999999999999998 4678999999999753 345567789999999999999999999988543
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 2346899999998 5999999875 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...............++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+.+..+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQM 267 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHH
T ss_pred ccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhh
Confidence 6543322222234567888999999876 5789999999999999999999998854211 11111121111000
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
........+...... .....+++.+.+||.+||..||++|||+.|+++
T Consensus 268 -------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 -------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp -------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------hHHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001111111111111 123467899999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=357.54 Aligned_cols=245 Identities=15% Similarity=0.174 Sum_probs=194.4
Q ss_pred CCCeEEEEEeeecCceEEEEE-----EECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a-----~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~ 93 (620)
.++|.+.+.||+|+||.||+| .+..+++.||||++... ....+.+|+.+++.++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~- 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL- 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence 468999999999999999999 47788999999999753 2345677888888887 999999999984
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC------
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKA-----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA------ 161 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~-----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~------ 161 (620)
+....|+|||||+ |+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 138 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 138 ----FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ----CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred ----cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 4466899999998 699999973 457999999999999999999999999999999999999998
Q ss_pred -----CCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCCh
Q 007050 162 -----NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236 (620)
Q Consensus 162 -----~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~ 236 (620)
++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976432222 223456789999999999987 5799999999999999999999999954321
Q ss_pred hHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 007050 237 VHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315 (620)
Q Consensus 237 ~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp 315 (620)
... .+ ...+ ... ..++.+.+|+.+||+.+|.+|++..+.|.+.
T Consensus 291 ~~~--~~--------------------------------~~~~-~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 291 GEC--KP--------------------------------EGLF-RRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TEE--EE--------------------------------CSCC-TTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred Cce--ee--------------------------------chhc-ccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 100 00 0000 001 2356788999999999999997655555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=349.75 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=191.9
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~--L~HpnIv~l~~v~~~~~~~ 97 (620)
...++|++++.||+|+||.||+|.+. ++.||||++... ......+|..++.. ++||||+++++++.... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-G 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-G
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-C
Confidence 34478999999999999999999875 899999998642 23344556666555 48999999999985432 2
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCceEeCCCCcEEEc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
....+|+|||||+ ++|.++++.. .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 2367999999998 5999999765 699999999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCCCcc-cccccccCCccccCcccccccCCCCCcc------cchHhHHHHHHHHHhC----------CCCC
Q 007050 169 DFGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG----------KPLF 231 (620)
Q Consensus 169 DFGlA~~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~y~~~------~DIWSLG~IlyeLltG----------~~pF 231 (620)
|||+++......... ......+||+.|+|||++.+ ..++.. +|||||||++|||++| ..||
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999997654332221 11235689999999999876 344444 9999999999999999 5555
Q ss_pred CCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCC--CCCCCHHHHHHHHHhcccCCCCCCCHH
Q 007050 232 PGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQK--FPNADPSALRLLERLLAFDPKDRPTAE 309 (620)
Q Consensus 232 ~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~dLI~~mL~~DP~~Rpsa~ 309 (620)
..... ..+..+.+... . .. ......+... ...+++.+.+||.+||+.||.+|||++
T Consensus 263 ~~~~~-----------~~~~~~~~~~~---------~-~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 263 HDLVP-----------SDPSYEDMREI---------V-CI-KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp TTTSC-----------SSCCHHHHHHH---------H-TT-SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhhcC-----------CCCchhhhHHH---------H-hh-hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 43211 00111111100 0 00 0000011111 123567799999999999999999999
Q ss_pred HHHcC
Q 007050 310 EALAD 314 (620)
Q Consensus 310 elL~h 314 (620)
|+++|
T Consensus 321 ell~~ 325 (337)
T 3mdy_A 321 RVKKT 325 (337)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99885
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.82 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=201.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4679999999999999999999865 46799999975432 24568899999999999999999999832 45
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+|||||. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 899999998 599999964 34699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------- 397 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 397 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1123456788999999876 679999999999999999999 99999887655444333210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CCccc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFK 318 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~--hp~f~ 318 (620)
.. ....+.+++.+.+||.+||..||++|||++++++ ..+|.
T Consensus 398 -----------------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 398 -----------------YR---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----------------CC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 00 0112457889999999999999999999999987 34444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=388.80 Aligned_cols=284 Identities=26% Similarity=0.343 Sum_probs=211.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 100 (620)
.++|++++.||+|+||.||+|.++.+|+.||||++... ........+.+|+.+|+.++||||+++++++.... ..+..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999999999999999998754 34456678899999999999999999999875421 22356
Q ss_pred eEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCc---EEEcccCcc
Q 007050 101 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLA 173 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---lKL~DFGlA 173 (620)
..|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999997 59999998754 6999999999999999999999999999999999999997765 999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..... ....+
T Consensus 172 ~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~ 242 (676)
T 3qa8_A 172 KELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNE 242 (676)
T ss_dssp CBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------
T ss_pred cccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccch
Confidence 87543322 245689999999999876 6899999999999999999999999977543322111110 00000
Q ss_pred hhhhhhhchhHHHHHHhhh-ccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 254 TISRVVRNDKARRYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.+.. ..... .... ...........+.+++.+.+||.+||.+||++|||++|+|+||||+.+.
T Consensus 243 ~~~~--~~~l~----g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 243 HIVV--YDDLT----GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp -CCS--CCCCS----SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhh--hhhhc----cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 0000 00000 0000 0000001112234678899999999999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=374.91 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=199.7
Q ss_pred CCCeEEEE-EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQE-VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~-~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|.+.+ .||+|+||.||+|.++ .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 45566666 8999999999999876 355679999997642 23456778999999999999999999999832
Q ss_pred CCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
..+|+|||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 35899999998 5999998654 46999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
..............+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---------- 554 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 554 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence 433221111123345688999999876 689999999999999999998 9999988765544333321
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ....+.+++.+.+||.+||..||++|||++++++
T Consensus 555 ------------------~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 555 ------------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ------------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1122457899999999999999999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.40 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=203.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4689999999999999999999865 46799999975432 24568899999999999999999999832 45
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|||||||. |+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 899999998 599999964 34699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ........++..|+|||++.. ..++.++|||||||+||||++ |..||.+.+..+.+..+...
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~----------- 480 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 480 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 11 111123456788999999876 679999999999999999999 99999887655444333210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.. ......+++.+.+||.+||..||++|||++++++
T Consensus 481 -----------------~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 481 -----------------YR---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 0112457889999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=343.88 Aligned_cols=261 Identities=24% Similarity=0.293 Sum_probs=198.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~--L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++.||+|+||.||+|.+ +|+.||||++... ....+.+|+.+++. ++||||+++++++.... ...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Ccc
Confidence 36899999999999999999987 5899999998642 34567789999988 78999999999985442 223
Q ss_pred CeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCceEeCCCCcEEEccc
Q 007050 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH--------TANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 100 ~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
..+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 479999999995 999999764 6999999999999999999999 899999999999999999999999999
Q ss_pred CccccccCCCCcc-cccccccCCccccCcccccccCC----CCCcccchHhHHHHHHHHHhC----------CCCCCCCC
Q 007050 171 GLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGKN 235 (620)
Q Consensus 171 GlA~~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~----~y~~~~DIWSLG~IlyeLltG----------~~pF~g~~ 235 (620)
|+++......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998765433211 12245689999999999875211 233689999999999999999 66775432
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhc-cCCCcccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRK-KQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEAL 312 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~elL 312 (620)
.. .+..+.+ ...+.. .....+...+ ...++.+.+||.+||+.||++|||++|++
T Consensus 272 ~~-----------~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 272 PS-----------DPSVEEM------------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CS-----------SCCHHHH------------HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cC-----------cccHHHH------------HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 10 0111111 000000 0011111111 12345789999999999999999999998
Q ss_pred cC
Q 007050 313 AD 314 (620)
Q Consensus 313 ~h 314 (620)
+|
T Consensus 329 ~~ 330 (342)
T 1b6c_B 329 KT 330 (342)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=361.86 Aligned_cols=254 Identities=19% Similarity=0.181 Sum_probs=190.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcC---------CCCcc
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLR---------HPDIV 85 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------~~~~~~~i~rEi~iL~~L~---------HpnIv 85 (620)
..++|++++.||+|+||.||+|++ +|+.||||++..... .......+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 456899999999999999999988 689999999975421 2223467889999998886 77777
Q ss_pred eeeeEecCC-------------------------CCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 007050 86 EIKHIMLPP-------------------------SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 139 (620)
Q Consensus 86 ~l~~v~~~~-------------------------~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL 139 (620)
++.+++... +..+...+|||||||. |++.+.+.. +.+++..++.|+.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 776664311 0113578999999997 555555533 5689999999999999999
Q ss_pred HHHH-hCCcEeecCCCCceEeCCCC--------------------cEEEcccCccccccCCCCcccccccccCCccccCc
Q 007050 140 KYIH-TANVYHRDLKPKNILANANC--------------------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198 (620)
Q Consensus 140 ~yLH-s~gIvHrDLKP~NILl~~~~--------------------~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~AP 198 (620)
.||| +.||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCS
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccCh
Confidence 9999 99999999999999999887 8999999999875421 34799999999
Q ss_pred ccccccCCCCCcccchHhHHHH-HHHHHhCCCCCCCCChhH-HHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCC
Q 007050 199 ELCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQP 276 (620)
Q Consensus 199 Evl~~~~~~y~~~~DIWSLG~I-lyeLltG~~pF~g~~~~~-~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~ 276 (620)
|++.+ .. +.++||||||++ .++++.|..||.+..... ....+.. .. ....
T Consensus 247 E~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~------------------------~~-~~~~ 298 (336)
T 2vuw_A 247 DLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK------------------------QM-TFKT 298 (336)
T ss_dssp GGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH------------------------TC-CCSS
T ss_pred hhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh------------------------hh-ccCc
Confidence 99986 23 889999998777 778888999984321100 0111110 00 0001
Q ss_pred CcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH-cCCccc
Q 007050 277 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL-ADPYFK 318 (620)
Q Consensus 277 ~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL-~hp~f~ 318 (620)
......++.+++++++||++||++| |++|+| +||||+
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1111122346789999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.69 Aligned_cols=260 Identities=21% Similarity=0.264 Sum_probs=201.3
Q ss_pred ccccCC-CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007050 15 FFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (620)
Q Consensus 15 ~~~~~g-~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~ 93 (620)
+..++. ..++|++.+.||+|+||.||+|.+.. .+|+|+++...........+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM- 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-
Confidence 334443 45899999999999999999998854 4999998754333334455678999999999999999999984
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccC
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
+...+|+|||||. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus 100 ----~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 100 ----SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp ----CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ----cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 4456999999998 59999997654 699999999999999999999999999999999999998 6799999999
Q ss_pred ccccccCCCC--cccccccccCCccccCccccccc-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007050 172 LARVAFNDTP--TTIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (620)
Q Consensus 172 lA~~~~~~~~--~~~~~~~~~gt~~Y~APEvl~~~-------~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~ 242 (620)
+++....... .........||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9875432111 11122345689999999998641 13588999999999999999999999987665433322
Q ss_pred hhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 243 MTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 243 i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+.. ... .......++..+.+||.+||..||++|||++++++
T Consensus 255 ~~~----------------------------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 255 MGT----------------------------GMK--PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHT----------------------------TCC--CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred hcc----------------------------CCC--CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 211 000 01112356788999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=370.38 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=203.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 461 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 461 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence 46799999999999999999998754 457999998753 33455677899999999999999999999872
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|+|||||. |+|.+++...+ .+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 234799999999 69999998654 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---------- 607 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------- 607 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH----------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 432211 1233467889999999876 689999999999999999997 9999988765544433321
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
... ....+.+++.+.+||.+||..||.+|||+.|+++
T Consensus 608 ------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 608 ------------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1123467899999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.86 Aligned_cols=227 Identities=17% Similarity=0.101 Sum_probs=185.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++ .+.+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECC
Confidence 47899999999999999999999999999999999765333 44567789999999999999999999998 4456
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+ ++|.++++.+ ..+.++..|+.||+.||.|||+.||+||||||+|||++.++.+||+++|.
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------- 175 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------- 175 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred cEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------
Confidence 7999999998 5999998543 46678899999999999999999999999999999999999999985542
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
++ .++.++|||||||++|+|++|+.||.+.+..+.+.......
T Consensus 176 ----------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------ 218 (286)
T 3uqc_A 176 ----------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT------------ 218 (286)
T ss_dssp ----------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT------------
T ss_pred ----------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh------------
Confidence 22 36889999999999999999999998866432211110000
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
...........+++++.+.+||.+||+.||++| |++|+++
T Consensus 219 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 -------------AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -------------TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -------------ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 001111122345788999999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=372.78 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=199.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++......+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3799999999999999999999986 7899999998753 3344556788999999999999999999998654332223
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|||||||+ ++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 3799999998 488887754 79999999999999999999999999999999999999986 8999999999865332
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+...
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~------ 288 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDD------ 288 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTC------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cccccc------
Confidence 34579999999999875 4589999999999999999999998653210 001000
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.....++.+.+||.+||+.||.+||+..++|.|+|+..
T Consensus 289 ----------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 289 ----------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00113467899999999999999999999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=306.62 Aligned_cols=187 Identities=18% Similarity=0.127 Sum_probs=134.6
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccC--------ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007050 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--------HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 30 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--------~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++.|+.|.+..++....|+.||+|++.+... ...+.+.+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 35567777777777778899999999964321 123445688999999999 699999999998 7778
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|||||||+| +|.++|..++++++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 89999999996 999999999989875 47899999999999999999999999999999999999999999875433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p 230 (620)
.. ..+..+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 22 2356789999999999875 567789999999999888665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-27 Score=265.80 Aligned_cols=190 Identities=19% Similarity=0.259 Sum_probs=141.7
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-h-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-I-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~-----~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
+...+.||+|+||.||+| ...+..+++|+....... . ....++.+|+.+|+.++||||+++..+...
T Consensus 338 ~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----- 410 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----- 410 (540)
T ss_dssp ----------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----
T ss_pred CCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----
Confidence 345679999999999999 556889999987532211 1 123557899999999999999944333321
Q ss_pred CCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
....|||||||+ ++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+++...
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 233599999998 699999865 5689999999999999999999999999999999 99999999998764
Q ss_pred CCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCC
Q 007050 178 NDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (620)
Q Consensus 178 ~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF 231 (620)
...... ......+||++|+|||++......|+..+|+||..+-..+.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 321111 012457899999999998764457888999999998888887777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=219.83 Aligned_cols=160 Identities=18% Similarity=0.203 Sum_probs=122.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------HHHHHHHHHHHHHHhcCCCCcce
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----------------SDAARILREIKLLRLLRHPDIVE 86 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----------------~~~~~i~rEi~iL~~L~HpnIv~ 86 (620)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4566679999999999999999 889999999996421110 13556889999999999 4 56
Q ss_pred eeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcE
Q 007050 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (620)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~l 165 (620)
+.+++. .+..|+|||||+| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.+
T Consensus 166 v~~~~~------~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYA------WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEE------EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEe------ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 666542 1346999999985 8887 42 134557999999999999999999999999999999 9999
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccc--------cCCCCCcccchHh
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 216 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~--------~~~~y~~~~DIWS 216 (620)
||+|||+|+. +..++|||++.. +...|+..+|+|.
T Consensus 232 kl~DFG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 232 WIIDFPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EECCCTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEECCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999999863 234788997643 0124555566665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=189.23 Aligned_cols=140 Identities=17% Similarity=0.152 Sum_probs=110.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcE--EEEEEecCccCCh----------------------HHHHHHHHHHHHHHh
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHI----------------------SDAARILREIKLLRL 78 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~--vAIK~i~~~~~~~----------------------~~~~~i~rEi~iL~~ 78 (620)
.-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3488999999999999999998788999 9999875421110 112357789999999
Q ss_pred cCCCCc--ceeeeEecCCCCCCCCeEEEEEecCCc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEe
Q 007050 79 LRHPDI--VEIKHIMLPPSRRDFKDIYVVFELMES------DLHQVIKANDDLTREHYQFFLYQLLRALKYIH-TANVYH 149 (620)
Q Consensus 79 L~HpnI--v~l~~v~~~~~~~~~~~lylV~E~~~g------dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLH-s~gIvH 149 (620)
|.|++| ..++.. ...||||||+++ .|.+++.. .++..+..++.||+.+|.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 988764 333332 235899999952 67776532 345677899999999999999 999999
Q ss_pred ecCCCCceEeCCCCcEEEcccCccccc
Q 007050 150 RDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 150 rDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.5e-16 Score=168.23 Aligned_cols=137 Identities=16% Similarity=0.163 Sum_probs=98.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---------------ChHH---HH--HHHHHHHHHHhcCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---------------HISD---AA--RILREIKLLRLLRHP 82 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---------------~~~~---~~--~i~rEi~iL~~L~Hp 82 (620)
.-|.+.+.||.|++|.||+|.+. +|+.||||+++.... .... .. ...+|+..|.+|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34999999999999999999974 699999998753110 0000 01 123577777777544
Q ss_pred Ccc--eeeeEecCCCCCCCCeEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe
Q 007050 83 DIV--EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (620)
Q Consensus 83 nIv--~l~~v~~~~~~~~~~~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl 159 (620)
.+. ..++.. ..+|||||++| .|.++. ..+....++.||+.+|.+||++|||||||||.|||+
T Consensus 174 gv~vp~p~~~~---------~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIAQS---------RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEEEE---------TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred CCCCCeeeecc---------CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE
Confidence 432 222221 23799999996 665432 223456788999999999999999999999999999
Q ss_pred CCCC----------cEEEcccCcccc
Q 007050 160 NANC----------KLKICDFGLARV 175 (620)
Q Consensus 160 ~~~~----------~lKL~DFGlA~~ 175 (620)
+.++ .+.|+||+-+..
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 8876 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3e-11 Score=121.48 Aligned_cols=137 Identities=13% Similarity=0.138 Sum_probs=105.9
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.|. +..+.+++++. .+.+..
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCCce
Confidence 588999999999999999964 368999999864221 11235778999999985 67777888876 334678
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT------------------------------------- 144 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs------------------------------------- 144 (620)
|+|||+++| +|.+.+ .+......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999997 776653 1222345678899999999998
Q ss_pred ----------------------CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ----------------------ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ----------------------~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876666799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=4.1e-10 Score=112.13 Aligned_cols=133 Identities=15% Similarity=0.090 Sum_probs=94.9
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~ 100 (620)
..|.+....+.|..+.||++. ..+|..+++|..... ....+.+|+.+|+.+.+.+ +.+++.+. .+.+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSS
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCC
Confidence 356665544566679999995 456778999987643 1234678999999886444 45677765 2335
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--------------------------------- 146 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--------------------------------- 146 (620)
..|+|||+++| +| . . ...+. ..++.++...|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 55 3 1 11222 256677778888888753
Q ss_pred -------------------------cEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 147 -------------------------VYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 147 -------------------------IvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.9e-10 Score=118.53 Aligned_cols=184 Identities=17% Similarity=0.251 Sum_probs=119.9
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCC--cceeeeEecCCCCCCCCeEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD--IVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-Hpn--Iv~l~~v~~~~~~~~~~~lyl 104 (620)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +.. +.+++... .........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 4569999999999872 5688998653 244667889999999884 333 23333322 11112234589
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 007050 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT--------------------------------------- 144 (620)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs--------------------------------------- 144 (620)
|||+++| .|..... ..++.++...++.++...|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 247888888888888888888886
Q ss_pred -------------------CCcEeecCCCCceEeCC--CCcEEEcccCccccccCCCCcccccccccCCccc---cCccc
Q 007050 145 -------------------ANVYHRDLKPKNILANA--NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY---RAPEL 200 (620)
Q Consensus 145 -------------------~gIvHrDLKP~NILl~~--~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y---~APEv 200 (620)
..++|+|++|.||+++. ++.+.|+||+.+...... .. ......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~D-----l~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--ND-----FISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HH-----HHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HH-----HHHHHhhccccCHHH
Confidence 13799999999999998 456889999998753211 10 0111111 22322
Q ss_pred ccccCCCC------------CcccchHhHHHHHHHHHhCCCCC
Q 007050 201 CGSFFSKY------------TPAIDIWSIGCIFAEVLTGKPLF 231 (620)
Q Consensus 201 l~~~~~~y------------~~~~DIWSLG~IlyeLltG~~pF 231 (620)
.......| ..-.+.|++|.++|.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11100111 11258999999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.3e-09 Score=114.99 Aligned_cols=144 Identities=13% Similarity=0.211 Sum_probs=103.7
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCCCC
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~--~~~~~~~~~~~i~rEi~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 100 (620)
..-++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+|+.|. +..+.+++.++... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 334678999999999998643 4688888765 21 11123456788999999997 45577887776332 1224
Q ss_pred eEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 007050 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT----------------------------------- 144 (620)
Q Consensus 101 ~lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs----------------------------------- 144 (620)
..|+|||+++| .+.+. ....+++.+...++.++...|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999997 44221 12347888888999999999999997
Q ss_pred -----------------------CCcEeecCCCCceEeCCCCc--EEEcccCcccc
Q 007050 145 -----------------------ANVYHRDLKPKNILANANCK--LKICDFGLARV 175 (620)
Q Consensus 145 -----------------------~gIvHrDLKP~NILl~~~~~--lKL~DFGlA~~ 175 (620)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999998753 69999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.5e-06 Score=88.02 Aligned_cols=133 Identities=22% Similarity=0.220 Sum_probs=90.9
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC---CcceeeeEecCCCCCCCCeEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP---DIVEIKHIMLPPSRRDFKDIYV 104 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hp---nIv~l~~v~~~~~~~~~~~lyl 104 (620)
++.++.|....||+. |..+++|+... ......+.+|..+|+.|.+. .+.+++.+.. ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 466899999999988 57788998532 23456788999999999753 2344444432 12345689
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007050 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-------------------------------------- 145 (620)
Q Consensus 105 V~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-------------------------------------- 145 (620)
|||+++| .|..... ..++..+...+..++...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 1245555555555555555555542
Q ss_pred ----------------------CcEeecCCCCceEeCC---CCc-EEEcccCcccc
Q 007050 146 ----------------------NVYHRDLKPKNILANA---NCK-LKICDFGLARV 175 (620)
Q Consensus 146 ----------------------gIvHrDLKP~NILl~~---~~~-lKL~DFGlA~~ 175 (620)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999998 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=7.6e-06 Score=82.02 Aligned_cols=133 Identities=18% Similarity=0.222 Sum_probs=93.2
Q ss_pred EEeeecCce-EEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCeEEEEE
Q 007050 29 EVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 29 ~~LG~G~~G-~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (620)
+.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.|. +-.+.+++.+. .+.+.-|+||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvm 99 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLT 99 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEE
Confidence 345556555 689888777788899998642 34567788999999885 33355666665 3345689999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 007050 107 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------------------------------------- 145 (620)
Q Consensus 107 E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---------------------------------------- 145 (620)
|+++| ++.+..... ......+..++...|.-||+.
T Consensus 100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 99997 666655331 222334556666666666632
Q ss_pred ------------------CcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 146 ------------------NVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 146 ------------------gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 179999999999999877777999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.3e-05 Score=85.42 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=48.4
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccC--C---hHHHHHHHHHHHHHHhcCC--CC-cceeeeEecCCCCCC
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--H---ISDAARILREIKLLRLLRH--PD-IVEIKHIMLPPSRRD 98 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--~---~~~~~~i~rEi~iL~~L~H--pn-Iv~l~~v~~~~~~~~ 98 (620)
-++.||.|..+.||++.+..+++.+++|....... . .....++.+|..+|+.+.. |. +.+++.+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d------- 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------- 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------
Confidence 36789999999999997666678999998653211 0 0123456779999888742 33 33454432
Q ss_pred CCeEEEEEecCCc
Q 007050 99 FKDIYVVFELMES 111 (620)
Q Consensus 99 ~~~lylV~E~~~g 111 (620)
....++|||++++
T Consensus 107 ~~~~~lvmE~l~g 119 (397)
T 2olc_A 107 TEMAVTVMEDLSH 119 (397)
T ss_dssp TTTTEEEECCCTT
T ss_pred CCccEEEEEeCCC
Confidence 1224899999985
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=2.7e-05 Score=80.33 Aligned_cols=30 Identities=23% Similarity=0.345 Sum_probs=27.3
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=2.6e-05 Score=81.55 Aligned_cols=85 Identities=8% Similarity=0.146 Sum_probs=52.0
Q ss_pred eEEEEEe-eecCceEEEEEEEC--C----CCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcC-C--CCcceeeeEecC
Q 007050 25 YKIQEVI-GKGSYGVVCSAIDT--H----TGEKVAIKKIHDIFE-HISDAARILREIKLLRLLR-H--PDIVEIKHIMLP 93 (620)
Q Consensus 25 Y~i~~~L-G~G~~G~V~~a~d~--~----tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~-H--pnIv~l~~v~~~ 93 (620)
...++.| +.|..+.+|++... . ++..+++|....... .......+.+|+.+|+.|. + ..+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88889999988643 0 256889997653210 0001134667888888774 2 346667666532
Q ss_pred CCCCCCCeEEEEEecCCc
Q 007050 94 PSRRDFKDIYVVFELMES 111 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~g 111 (620)
.+ ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 12346899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0013 Score=70.47 Aligned_cols=32 Identities=13% Similarity=0.269 Sum_probs=28.2
Q ss_pred HhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 143 HTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 143 Hs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999877 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.002 Score=65.55 Aligned_cols=68 Identities=15% Similarity=0.060 Sum_probs=41.6
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCeEEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~ 106 (620)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+....+ .+++... . ..-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~-----~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--P-----ATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T-----TTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--C-----CCCEEEE
Confidence 788999999999999 5688888754211 11112457877777743222 3444432 1 1126899
Q ss_pred ecC-Cc
Q 007050 107 ELM-ES 111 (620)
Q Consensus 107 E~~-~g 111 (620)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0036 Score=61.02 Aligned_cols=96 Identities=18% Similarity=0.134 Sum_probs=65.6
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCcccccccc
Q 007050 112 DLHQVIKA-NDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189 (620)
Q Consensus 112 dL~~~i~~-~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~ 189 (620)
+|.++++. +.+++|+++|.+++|.+.+|.-+ +.+.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999975 56899999999999999998876 222222334457899999999987764 2211
Q ss_pred cCCccccCcccccccCCCCCcccchHhHHHHHHHHHh
Q 007050 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (620)
Q Consensus 190 ~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt 226 (620)
.....+.+||... ...+.+.=|+|||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 0122356888753 356788999999999999885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0045 Score=63.31 Aligned_cols=152 Identities=13% Similarity=0.119 Sum_probs=80.4
Q ss_pred ccccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEec
Q 007050 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIML 92 (620)
Q Consensus 15 ~~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~ 92 (620)
++..|+. ....-++.|+.|....+|++... +..+++|..... .....+..|+.+++.|.... +.+++...
T Consensus 15 ~l~~~~~-~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~- 86 (322)
T 2ppq_A 15 FLTQYDV-GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK- 86 (322)
T ss_dssp HHTTBCC-CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-
T ss_pred HHHhCCC-CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-
Confidence 3444554 33444677888988999998653 336889988642 12234556888887774222 22332210
Q ss_pred CCC--CCCCCeEEEEEecCCcc-H-----H------H----HHHhCCCC--------CHHHHHHH---------------
Q 007050 93 PPS--RRDFKDIYVVFELMESD-L-----H------Q----VIKANDDL--------TREHYQFF--------------- 131 (620)
Q Consensus 93 ~~~--~~~~~~lylV~E~~~gd-L-----~------~----~i~~~~~l--------se~~~~~i--------------- 131 (620)
.+. ....+..++||++++|. + . . +-.....+ ........
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 000 00124568999999862 1 0 0 10111111 11110000
Q ss_pred HHHHHHHHHHHHh-------CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 132 LYQLLRALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 132 ~~QIl~aL~yLHs-------~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
-..+...+..++. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113344555542 368999999999999987666899999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0047 Score=63.76 Aligned_cols=74 Identities=16% Similarity=0.119 Sum_probs=54.0
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCCeE
Q 007050 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 26 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~~~l 102 (620)
.-++.|+.|....+|+... .+..+++|..... ....+.+|...|+.|. ...+.+++... ......
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCce
Confidence 3467899999999999864 4678889986532 2556778999888884 24566676665 233568
Q ss_pred EEEEecCCc
Q 007050 103 YVVFELMES 111 (620)
Q Consensus 103 ylV~E~~~g 111 (620)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.017 Score=58.23 Aligned_cols=76 Identities=12% Similarity=0.016 Sum_probs=51.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC---CcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP---DIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hp---nIv~l~~v~~~~~~~~~ 99 (620)
.+..-++.+|.|..+.||++.. .+|+.|++|+...... .....+.+|...|+.|..- .+.+++.+-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 3566688999999999999964 5789999998653211 1123466899999988532 234444432
Q ss_pred CeEEEEEecCC
Q 007050 100 KDIYVVFELME 110 (620)
Q Consensus 100 ~~lylV~E~~~ 110 (620)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 1278999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0058 Score=62.97 Aligned_cols=31 Identities=26% Similarity=0.438 Sum_probs=27.1
Q ss_pred CCcEeecCCCCceEeCCC----CcEEEcccCcccc
Q 007050 145 ANVYHRDLKPKNILANAN----CKLKICDFGLARV 175 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~----~~lKL~DFGlA~~ 175 (620)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.013 Score=63.14 Aligned_cols=72 Identities=14% Similarity=0.130 Sum_probs=48.1
Q ss_pred EEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCC
Q 007050 27 IQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRD 98 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~ 98 (620)
-++.|+.|....||++.... .+..+++|+.... .. ...+.+|+.+++.|...++ .+++..+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 35678889999999997642 3578999987432 11 1344579999988853333 5566554 21
Q ss_pred CCeEEEEEecCCc
Q 007050 99 FKDIYVVFELMES 111 (620)
Q Consensus 99 ~~~lylV~E~~~g 111 (620)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.01 Score=60.83 Aligned_cols=76 Identities=13% Similarity=0.062 Sum_probs=45.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCC--CCCCeEEE
Q 007050 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSR--RDFKDIYV 104 (620)
Q Consensus 29 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~--~~~~~lyl 104 (620)
..|+ |....||++.. .+|+.+++|....... ....+..|+.+++.|.... +.+++.. .+.. ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88889998743 3466899999863211 2345667888888774222 3333332 1110 11345688
Q ss_pred EEecCCc
Q 007050 105 VFELMES 111 (620)
Q Consensus 105 V~E~~~g 111 (620)
||++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0053 Score=64.37 Aligned_cols=72 Identities=7% Similarity=0.002 Sum_probs=41.7
Q ss_pred EEEeeecCceEEEEEEECC--------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCC
Q 007050 28 QEVIGKGSYGVVCSAIDTH--------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRD 98 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~--------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~~ 98 (620)
++.|+.|....+|++.... .+..+++|+..... .......+|..+++.|...+ +.+++... .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C-
Confidence 5678888889999997543 13688888865321 11112346888888775333 34555543 1
Q ss_pred CCeEEEEEecCCc
Q 007050 99 FKDIYVVFELMES 111 (620)
Q Consensus 99 ~~~lylV~E~~~g 111 (620)
-++|||+++|
T Consensus 109 ---~~~v~e~i~G 118 (369)
T 3c5i_A 109 ---GGRIEEWLYG 118 (369)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CcEEEEEecC
Confidence 1689999886
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.017 Score=61.10 Aligned_cols=135 Identities=13% Similarity=0.155 Sum_probs=79.1
Q ss_pred EEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007050 28 QEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (620)
++.|..|-...+|++.... +++.+++|+..... .....+.+|..+++.|. +.-..+++..+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVF-----PE- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence 4578888888999987532 35789999864321 12344568999998885 32235555554 22
Q ss_pred CeEEEEEecCCc-cH-----------HHHH---H---hC-----CCC--CHHHHHHHHHHHHH-----------------
Q 007050 100 KDIYVVFELMES-DL-----------HQVI---K---AN-----DDL--TREHYQFFLYQLLR----------------- 137 (620)
Q Consensus 100 ~~lylV~E~~~g-dL-----------~~~i---~---~~-----~~l--se~~~~~i~~QIl~----------------- 137 (620)
.+||||++| .| ..+. . .- ... -...+..|+.++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 299999985 11 1111 1 11 111 13556666655422
Q ss_pred --HHHHHH----h----CCcEeecCCCCceEeCCC----CcEEEcccCccc
Q 007050 138 --ALKYIH----T----ANVYHRDLKPKNILANAN----CKLKICDFGLAR 174 (620)
Q Consensus 138 --aL~yLH----s----~gIvHrDLKP~NILl~~~----~~lKL~DFGlA~ 174 (620)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 2 248999999999999876 789999999774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.093 Score=56.93 Aligned_cols=72 Identities=19% Similarity=0.207 Sum_probs=45.9
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCeEEEEE
Q 007050 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVF 106 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~ 106 (620)
++.|+.|-...+|++.....+..+++|+........-+ ..+|+.+|+.|...++ .+++.++ .+ .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFF-----TN----GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEE
Confidence 56788899999999977544578999987532111111 1479999998865444 4566655 11 2599
Q ss_pred ecCCc
Q 007050 107 ELMES 111 (620)
Q Consensus 107 E~~~g 111 (620)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.027 Score=58.44 Aligned_cols=31 Identities=19% Similarity=0.310 Sum_probs=27.6
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888899999988764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.62 E-value=0.34 Score=51.30 Aligned_cols=28 Identities=32% Similarity=0.456 Sum_probs=24.4
Q ss_pred cEeecCCCCceEe------CCCCcEEEcccCccc
Q 007050 147 VYHRDLKPKNILA------NANCKLKICDFGLAR 174 (620)
Q Consensus 147 IvHrDLKP~NILl------~~~~~lKL~DFGlA~ 174 (620)
++|+|+.+.|||+ +.++.+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 456779999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.09 E-value=1.1 Score=47.98 Aligned_cols=72 Identities=10% Similarity=0.002 Sum_probs=45.0
Q ss_pred EEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007050 28 QEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 28 ~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (620)
++.|..|-...+|++.... .+..+++++....... .....+|..+++.|. +.-..+++..+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF-----PE- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC-
Confidence 5677888888999997652 1578999986432111 111246888888774 22234455433 11
Q ss_pred CeEEEEEecCCc
Q 007050 100 KDIYVVFELMES 111 (620)
Q Consensus 100 ~~lylV~E~~~g 111 (620)
++||||++|
T Consensus 146 ---~~I~efI~G 154 (424)
T 3mes_A 146 ---GRIEEFIDG 154 (424)
T ss_dssp ---EEEEECCCS
T ss_pred ---CEEEEEeCC
Confidence 689999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 620 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-96 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-87 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-87 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-72 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-72 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-68 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-65 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-25 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 296 bits (758), Expect = 5e-96
Identities = 160/343 (46%), Positives = 220/343 (64%), Gaps = 6/343 (1%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY IG+G+YG+VCSA D +VAIKKI FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ I I+ P+ KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N C LKICDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +LG+PS + ++ ++ N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII-N 242
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
KAR YL S+ K V +++ FPNAD AL LL+++L F+P R E+ALA PY +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 364
EP + +F+ E + KE ++ELIF E + P
Sbjct: 303 DPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (701), Expect = 1e-87
Identities = 138/347 (39%), Positives = 211/347 (60%), Gaps = 13/347 (3%)
Query: 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ + RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 135
+ ++H +++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
LR LKYIH+A++ HRDLKP N+ N +C+LKI DFGLAR T T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
+ + ++ AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA
Sbjct: 244 KK-ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 316 YFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
YF + EP P + FE R + ++ + L + E++ + P
Sbjct: 303 YFAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (695), Expect = 9e-87
Identities = 134/341 (39%), Positives = 210/341 (61%), Gaps = 13/341 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ Y+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 83 DIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P + DF D Y+V M +DL +++K ++ L + QF +YQ+L+ L+Y
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRY 136
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N +C+LKI DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWYRAPEVI 190
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP + + R +++
Sbjct: 191 LN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR-LQS 248
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
D+A+ Y+ + + + F+ NA P A+ LLE++L D + R TA EALA PYF+ L
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 322 KVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 362
E EP Q + F+ T ++ + + ++E+L + P
Sbjct: 309 DTEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 3e-77
Identities = 118/355 (33%), Positives = 192/355 (54%), Gaps = 24/355 (6%)
Query: 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
S + RY+ + IG G+ G+VC+A D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 77 RLLRHPDIVEIKHIMLPPSR-RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 135
+ + H +I+ + ++ P +F+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
RAPE+ Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP + +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLERLLAFDPK 303
++ R Y+ + K + F + FP++ A LL ++L DP
Sbjct: 243 KKL--QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 304 DRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREIL 358
R + ++AL PY + P + + + R T E+ +ELI++E++
Sbjct: 301 KRISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 4e-77
Identities = 102/301 (33%), Positives = 149/301 (49%), Gaps = 6/301 (1%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
S+Y+ IG+G++G V A TG+KVA+KK+ E LREIK+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKHIML---PPSRRDFKDIYVVFELMESDLHQV-IKANDDLTREHYQFFLYQLLRA 138
++V + I P R IY+VF+ E DL + T + + LL
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRA 197
L YIH + HRD+K N+L + LK+ DFGLAR + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PEL Y P ID+W GCI AE+ T P+ G HQL L++ L G+ + +
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
V + + +K+ V+ K DP AL L+++LL DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 318 K 318
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 1e-73
Identities = 103/331 (31%), Positives = 165/331 (49%), Gaps = 20/331 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLRA 138
IV +++ ++D + +V + + +++V +A L + + ++YQL R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYIHTANVYHRDLKPKNILANANCKL-KICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PEL YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ + I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
+ N ++ F P P A+ L RLL + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVF---RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 318 KGLSKVEREPSCQPISKMEFEFERRRVTKED 348
L + + F F + ++
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 1e-72
Identities = 65/310 (20%), Positives = 121/310 (39%), Gaps = 27/310 (8%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++ +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV +I + E M+ L QV+K + + +++ L Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 143 HTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERL 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSLDTISRVVR 260
+ Y+ DIWS+G E+ G+ P + +L + G +
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 261 NDKARRYLTSMRKKQPV---------QFSQKFPNA--DPSALRLLERLLAFDPKDRPTAE 309
Y R + + K P+ + + L +P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 310 EALADPYFKG 319
+ + + K
Sbjct: 294 QLMVHAFIKR 303
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 8e-72
Identities = 98/307 (31%), Positives = 153/307 (49%), Gaps = 17/307 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLL--- 79
+Y+ IG+G+YG V A D G VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 137
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P + R
Sbjct: 184 PEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317
V + + K + + D LL + L F+P R +A AL+ PYF
Sbjct: 242 DVALPRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 318 KGLSKVE 324
+ L + +
Sbjct: 297 QDLERCK 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-72
Identities = 110/301 (36%), Positives = 162/301 (53%), Gaps = 14/301 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++ E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKY 141
IV++ ++ +Y+VFE + DL + + A+ + + +L+QLL+ L +
Sbjct: 63 IVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP---GV 230
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321
Y S K FS+ P D LL ++L +DP R +A+ ALA P+F+ ++
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 322 K 322
K
Sbjct: 291 K 291
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 2e-71
Identities = 98/306 (32%), Positives = 149/306 (48%), Gaps = 19/306 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA---RILREIKLLRLLRHPDIV 85
+ +G+G + V A D +T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ +I +VF+ ME+D + + LT H + ++ L+ L+Y+H
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ HRDLKP N+L + N LK+ DFGLA+ + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKA 264
Y +D+W++GCI AE+L P PG + + QL + + LGTP+ + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL--- 231
Query: 265 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 324
+ + + F A L L++ L F+P R TA +AL YF ++
Sbjct: 232 -PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS--NRPG 288
Query: 325 REPSCQ 330
P CQ
Sbjct: 289 PTPGCQ 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 225 bits (573), Expect = 1e-69
Identities = 106/296 (35%), Positives = 155/296 (52%), Gaps = 14/296 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+YGVV A + + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV++ ++ K + +VFE + + + L + FL QLL + Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ V
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV---T 229
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
+ +Y + +P+ + D S + LL ++L DP R TA++AL YFK
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-68
Identities = 104/298 (34%), Positives = 148/298 (49%), Gaps = 12/298 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV + ++ D K V + N DL E + FL+QLL+ L + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFG 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
Y+ +ID+WS GCIFAE+ PLFPG +V QL + LLGTP+ + +
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM---T 231
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320
K Y P + + LL+ LL +P R +AEEAL PYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 7e-68
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 41/295 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDK 263
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----------------------- 225
Query: 264 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
YL + +Q +K L R L D + R +A+E L + K
Sbjct: 226 ---YLIATNGTPELQNPEKLS---AIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 7e-68
Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 38/296 (12%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + + +G+G+YG V A++ T E VA+K + D+ + I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLH-QVIKANDDLTREHYQFFLYQLLRALKYI 142
+V+ + Y+ E I+ + + Q F +QL+ + Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+ +D+WS G + +L G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
K+ + + D + L LL ++L +P R T + D ++
Sbjct: 217 --------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 220 bits (562), Expect = 2e-67
Identities = 92/314 (29%), Positives = 159/314 (50%), Gaps = 25/314 (7%)
Query: 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
E+G+ Y++ +G+G Y V AI+ EKV +K + + + +I REIK+L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILE 84
Query: 78 LLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 135
LR P+I+ + I+ P R +VFE + +D Q+ + LT +F++Y++
Sbjct: 85 NLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEI 138
Query: 136 LRALKYIHTANVYHRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY 194
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLD 253
++ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT L
Sbjct: 195 FKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFP-----NADPSALRLLERLLAFDPKDRPTA 308
+ R+ + + ++ + P AL L++LL +D + R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 309 EEALADPYFKGLSK 322
EA+ PYF + K
Sbjct: 314 REAMEHPYFYTVVK 327
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (560), Expect = 2e-67
Identities = 79/328 (24%), Positives = 138/328 (42%), Gaps = 44/328 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y ++V+G G++ V A D T + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV + I +Y++ +L+ +L I T ++Q+L A+KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + + K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAPE 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ Y+ A+D WSIG I +L G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
+ K + S + + SA + L+ DP+ R T E+AL P+ G
Sbjct: 220 ----------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 320 LSKVEREPSCQPISKMEFEFERRRVTKE 347
+ +++ +++ F + + +
Sbjct: 270 DTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (555), Expect = 1e-66
Identities = 75/353 (21%), Positives = 138/353 (39%), Gaps = 53/353 (15%)
Query: 11 PEM-EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAAR 68
P++ E F + + IG GS+G V A D E VAIKK+ +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 127
I++E++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
+ L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------N 169
Query: 188 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
+V T ++ APE + +Y +D+WS+G E+ KP N
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------- 218
Query: 247 LGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 306
++ + + +N+ + + + ++ L P+DRP
Sbjct: 219 ----AMSALYHIAQNES---------------PALQSGHWSEYFRNFVDSCLQKIPQDRP 259
Query: 307 TAEEALADPYFKGLSKVEREPS-CQPISKMEFEF--ERRRVTKEDIRELIFRE 356
T+E L + ER P+ + + + E + +++++F+E
Sbjct: 260 TSEVLLKHRFVLR----ERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-66
Identities = 72/334 (21%), Positives = 145/334 (43%), Gaps = 49/334 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y I E +G+G +G+V ++T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKY 141
I+ + +++ ++FE + D+ + I + +L +++Q+ AL++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 142 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H+ N+ H D++P+NI+ + +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ + A D+WS+G + +L+G F + ++ + + T
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------- 223
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
+ F A+ ++RLL + K R TA EAL P+ K
Sbjct: 224 --------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK- 262
Query: 320 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELI 353
K+ER S + I ++ + K+D+ ++
Sbjct: 263 -QKIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 215 bits (549), Expect = 5e-66
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 50/308 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-------ARILREIKLL 76
Y+ +E++G+G VV I T ++ A+K I A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
LL + +H N+ HRDLKP+NIL + + +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
Y APE+ Y +D+WS G I +L G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
+ S ++ + + L+ R L P+ R TAEE
Sbjct: 227 --------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266
Query: 311 ALADPYFK 318
ALA P+F+
Sbjct: 267 ALAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 217 bits (553), Expect = 9e-66
Identities = 72/336 (21%), Positives = 127/336 (37%), Gaps = 48/336 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
+V + D ++ +++E M +L + + ++ ++ + ++ Q+ + L +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 142 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H N H DLKP+NI+ + +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPE 195
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ D+WS+G + +L+G F G+N L +
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
F + +LL DP R T +AL P+
Sbjct: 246 --------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
Query: 320 LSKVERE---PSCQPISKMEFEFERRRVTKEDIREL 352
+ R+ PS + + + E + L
Sbjct: 286 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-65
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 46/299 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+I+ + D +Y++ E +++ ++ + ++ +L AL
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LKI DFG + A + TT T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
+ +D+WS+G + E L GKP F ++ + T
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--------- 224
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
A L+ RLL +P RP E L P+
Sbjct: 225 -----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 7e-65
Identities = 61/301 (20%), Positives = 106/301 (35%), Gaps = 44/301 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++I +G G++G V A + T A K I + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALKY 141
IV++ +++++ E + + LT Q Q L AL Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H + HRDLK NIL + +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
SK Y D+WS+G E+ +P N + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
K + + L++ L + R T + L P+
Sbjct: 229 ---------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
Query: 319 G 319
Sbjct: 274 V 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 8e-65
Identities = 84/351 (23%), Positives = 141/351 (40%), Gaps = 47/351 (13%)
Query: 24 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRH 81
YK+ +V+G G G V + T EK A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 138
P IV I + K + +V E ++ +L I+ D T + + A
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 139 LKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPYY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE+ G KY + D+WS+G I +L G P F + + M
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 315
T +R Q + ++ L+ LL +P R T E + P
Sbjct: 226 ------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 316 YFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLK 366
+ +KV + P ++ + ER KE++ + ++Y +K
Sbjct: 274 WIMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (546), Expect = 1e-64
Identities = 74/337 (21%), Positives = 130/337 (38%), Gaps = 46/337 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y I E +G G++GVV ++ TG K I+ + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKY 141
++ + D ++ ++ E + +L I A D ++ ++ Q LK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 142 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+ D+W+IG + +L+G F G++ + L + D
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED------ 250
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319
F + P A ++ LL +P+ R T +AL P+ KG
Sbjct: 251 ----------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
Query: 320 -LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFR 355
S + +K+ + + + + I R
Sbjct: 289 DHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 325
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-64
Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 42/298 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + K I +V ELM S L +K + + + + Q+L+ L+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 144 TAN--VYHRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
T + HRDLK NI +KI D GLA + + + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFMAPEM 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
+ KY ++D+++ G E+ T + + Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318
Y +P F A P ++E + + +R + ++ L +F+
Sbjct: 222 ------YRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-63
Identities = 77/305 (25%), Positives = 119/305 (39%), Gaps = 49/305 (16%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A Y++ IG GSYG G+ + K++ ++ ++ E+ LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----LTREHYQFFLYQLL 136
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 137 RALKYIH-----TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
ALK H V HRDLKP N+ + +K+ DFGLAR+ +DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--------- 225
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 311
+R+ + + ++ ++ R+L RP+ EE
Sbjct: 226 -------------------IREGKFRRIPYRYS---DELNEIITRMLNLKDYHRPSVEEI 263
Query: 312 LADPY 316
L +P
Sbjct: 264 LENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 6e-62
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 48/306 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
V++ +D + +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N + ++I DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
+ D+W++GCI +++ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA------LADP 315
K F +KF P A L+E+LL D R EE A P
Sbjct: 223 -----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
Query: 316 YFKGLS 321
+F+ ++
Sbjct: 269 FFESVT 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-59
Identities = 60/296 (20%), Positives = 106/296 (35%), Gaps = 39/296 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + + IG GS+G V VA+K ++ E+ +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRA 138
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+H ++ HRDLK NI + + +KI DFGLA V + + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + + Y+ D+++ G + E++TG+ + N Q+ M
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
R S+ N + RL+ L +RP + LA
Sbjct: 223 -------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 73/305 (23%), Positives = 118/305 (38%), Gaps = 48/305 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 79
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRA 138
+HP+++ + + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 139 LKYIHTANVYHRDLKPKNILAN----ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
+ APE+ D+WSIG I +L+G F G L ++ +
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--- 236
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
+ F N A + RLL DPK R T +++L
Sbjct: 237 -------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 315 PYFKG 319
P+ K
Sbjct: 272 PWIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (492), Expect = 7e-58
Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 34/294 (11%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
RY++ E++G G V A D VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV + + Y+V E ++ L ++ +T + + +AL +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
H + HRD+KP NI+ +A +K+ DFG+AR + + + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261
D++S+GC+ EVLTG+P F G + V + VR
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---------------SVAYQHVRE 229
Query: 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALAD 314
D P+ S + ++ + LA +P++R TA E AD
Sbjct: 230 D-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-57
Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 58/308 (18%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLR 77
S+Y++ ++G G +G V S I VAIK + + + + R+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 78 LLR--HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLY 133
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
+ V F Q+ L+ LA P DRPT EE
Sbjct: 217 --------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQ 253
Query: 313 ADPYFKGL 320
P+ + +
Sbjct: 254 NHPWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-56
Identities = 61/301 (20%), Positives = 116/301 (38%), Gaps = 46/301 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLL-RLLRH 81
+ + +++GKGS+G V A T + AIK + D+ D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 140
P + + + ++++ V E + DL I++ F+ +++ L+
Sbjct: 63 PFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++H+ + +RDLK NIL + + +KI DFG+ + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260
KY ++D WS G + E+L G+ F G++
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------------------- 213
Query: 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKG 319
+ + + A LL +L +P+ R + P F+
Sbjct: 214 ----------SIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
Query: 320 L 320
+
Sbjct: 261 I 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 68/303 (22%), Positives = 129/303 (42%), Gaps = 49/303 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
+ +++GKG++G V + TG A+K + ++ + A + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ +K+ R + V E L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ +V +RD+K +N++ + + +KI DFGL + +D T + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+ Y A+D W +G + E++ G+ F ++ +L+
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYF 317
+ ++F + P A LL LL DPK R A+E + +F
Sbjct: 218 ----------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 318 KGL 320
+
Sbjct: 265 LSI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 183 bits (466), Expect = 4e-53
Identities = 67/307 (21%), Positives = 116/307 (37%), Gaps = 50/307 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 79
+ + +IG+G +G V TG+ A+K + + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 138
P IV + + P + + + +LM DLH + + + +F+ +++
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H V +RDLKP NIL + + ++I D GLA P T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ Y + D +S+GC+ ++L G F + ++
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALA 313
M V+ F P LLE LL D R A+E
Sbjct: 219 -----------RMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 314 DPYFKGL 320
P+F+ L
Sbjct: 265 SPFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 180 bits (457), Expect = 2e-52
Identities = 80/360 (22%), Positives = 145/360 (40%), Gaps = 65/360 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
++I +G GS+G V H G A+K + +I + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
I+ + +D + I+++ + +E +L +++ + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + N +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262
+ Y +ID WS G + E+L G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYF 317
++F F LL RL+ D R E+ P+F
Sbjct: 214 ----------LNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
Query: 318 KG------LSKVEREPSCQPISKMEF---EFERRRVTKEDIRELIFREILEYHPQLLKDY 368
K LS+ P PI + + +F++ +EDI + E + + L +D+
Sbjct: 261 KEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY--PEEDINYGVQGE--DPYADLFRDF 316
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-51
Identities = 62/296 (20%), Positives = 116/296 (39%), Gaps = 53/296 (17%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ K+ + IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLR 137
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + K+ DFGL + A + T + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTA 168
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE K++ D+WS G + E+ + G+ +P + D +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------------DVVP 211
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
RV + + P P+ +++ D RP+ +
Sbjct: 212 RVEKG---------YKMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-50
Identities = 57/310 (18%), Positives = 116/310 (37%), Gaps = 47/310 (15%)
Query: 21 DASRYKIQE-VIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
D +++ +G G++G V + VA+K + + + +L E +++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 136
L +P IV + I + + +V E+ E L++ ++ N + ++ ++Q+
Sbjct: 64 QLDNPYIVRMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+KY+ +N HRDL +N+L KI DFGL++ D T +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE K++ D+WS G + E + G+ + G +
Sbjct: 178 APECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM------------- 222
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---AL 312
+ K + + P L+ +D ++RP L
Sbjct: 223 ---------------LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRL 264
Query: 313 ADPYFKGLSK 322
+ Y+ +++
Sbjct: 265 RNYYYDVVNE 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 1e-49
Identities = 56/324 (17%), Positives = 117/324 (36%), Gaps = 59/324 (18%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIF 60
+ + +N+ +++ ++ + +G GS+G V +G A+K +
Sbjct: 29 KWETPSQNTAQLD---------QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
+ L E ++L+ + P +V+++ + + V+ + ++ ++
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+ H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
T APE+ S Y A+D W++G + E+ G P F +
Sbjct: 196 WTLCGTP------EALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 241 DLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 300
+ V+F F LL LL
Sbjct: 248 E-----------------------------KIVSGKVRFPSHFS---SDLKDLLRNLLQV 275
Query: 301 DPKDR-----PTAEEALADPYFKG 319
D R + +F
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-49
Identities = 59/309 (19%), Positives = 124/309 (40%), Gaps = 47/309 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIH--DIFEHISDAARILREIKLLRL 78
+++ +V+G G+YG V TG+ A+K + I + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL+++H + +RD+K +NIL ++N + + DFGL++ F T + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
+ G S + A+D WS+G + E+LTG F + +
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------------- 244
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRP-----TAEEA 311
++ ++ +P A L++RLL DPK R A+E
Sbjct: 245 ---------------SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
Query: 312 LADPYFKGL 320
+F+ +
Sbjct: 290 KEHLFFQKI 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-49
Identities = 70/317 (22%), Positives = 113/317 (35%), Gaps = 56/317 (17%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLR 70
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME---SDLHQVIKANDDLTREHYQFFLYQLLR 137
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE ++T D+WS G + E+ T G+ +PG LD + P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--D 314
S L+ + +P++RPT E A +
Sbjct: 241 -------------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 315 PYFKGLSKVEREPSCQP 331
YF EP QP
Sbjct: 270 DYFTST-----EPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 2e-49
Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 52/322 (16%)
Query: 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILRE 72
F++ D S KI++VIG G +G VCS G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PTTIFWTD 188
L + +KY+ N HRDL +NIL N+N K+ DFGL+R +DT PT
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247
+ AP + K+T A D+WS G + EV++ G+ + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
P + +L+ D RP
Sbjct: 251 RLPPPMDCP-------------------------------SALHQLMLDCWQKDRNHRPK 279
Query: 308 AEEALADPYFKGLSKVEREPSC 329
+ + L K+ R P+
Sbjct: 280 FGQIVNT-----LDKMIRNPNS 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-49
Identities = 69/305 (22%), Positives = 112/305 (36%), Gaps = 31/305 (10%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +QE IGKG +G V GE+VA+K + EI +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 141 YIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-IFWTDYVA 191
++H + HRDLK KNIL N I D GLA + T T I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 192 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 248 GTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 307
PS++ + +VV K R + + A +++ + R T
Sbjct: 234 SDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 308 AEEAL 312
A
Sbjct: 285 ALRIK 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 6e-49
Identities = 53/306 (17%), Positives = 98/306 (32%), Gaps = 45/306 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ + +V EL+ S + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 143 HTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAFNDTPTTIFW----TDYVATRWY 195
H+ N HRD+KP N L + I DFGLA+ + + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+ + + D+ S+G + G + G
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA------------------- 218
Query: 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE---EAL 312
K ++Y KK L + D+P +
Sbjct: 219 -----ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 313 ADPYFK 318
+ + +
Sbjct: 274 RNLFHR 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 169 bits (430), Expect = 1e-48
Identities = 47/299 (15%), Positives = 96/299 (32%), Gaps = 44/299 (14%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALK 140
+ + ++ +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YIHTANVYHRDLKPKNILANANC-----KLKICDFGLARVAFNDTPTTIFW----TDYVA 191
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------------- 219
Query: 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310
++Y KKQ + + + P +
Sbjct: 220 ----------TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 68/324 (20%), Positives = 125/324 (38%), Gaps = 70/324 (21%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKL 75
+ +V+G G++G V +A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 76 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------- 122
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 123 ------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170
LT E F YQ+ + ++++ + HRDL +N+L +KICDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
GLAR +D+ + + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPS 289
+PG V ++++N + QP A
Sbjct: 266 PYPGIPVD---------------ANFYKLIQNGF--------KMDQP-------FYATEE 295
Query: 290 ALRLLERLLAFDPKDRPTAEEALA 313
+++ AFD + RP+ +
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-48
Identities = 63/310 (20%), Positives = 115/310 (37%), Gaps = 49/310 (15%)
Query: 24 RYKIQEV-IGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLLR 80
I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRA 138
+P IV + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E K++ D+WS G E L+ G+ + + +
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------------ 227
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALAD 314
R + P P P L+ + +DRP +
Sbjct: 228 ------------GKRMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
Query: 315 PYFKGLSKVE 324
Y+ SKVE
Sbjct: 269 CYYSLASKVE 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-48
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 45/296 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL 79
++ E +G GS+GVV + VA+K + D+ +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLR 137
H +++ + ++L P + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE + ++ A D W G E+ T G+ + G N +
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILH 225
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
++ + + R +P + ++ + A P+DRPT
Sbjct: 226 KIDKEGE--------RLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (427), Expect = 1e-47
Identities = 65/340 (19%), Positives = 111/340 (32%), Gaps = 46/340 (13%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 83 DIVE------------IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF 130
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQLLRALKYIHTA-NVYHRDLKPKNILANAN------CKLKICDFGLARVAFNDTPTT 183
QLL L Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV------V 237
+T+ + TR YR+PE+ + + DIWS C+ E++TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQF----------SQKFPNAD 287
+ + +LLG + +R ++F + +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 288 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 327
L +L DP+ R A + P+ K +E
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-47
Identities = 56/297 (18%), Positives = 104/297 (35%), Gaps = 47/297 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D + +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRA 138
H +V++ + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++Y+ + HRDL +N L N +K+ DFGL+R +D T+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E+ SK++ DIW+ G + E+ + GK + + +
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------- 214
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
+R +P A ++ +RPT + L++
Sbjct: 215 ----------AQGLRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 65/303 (21%), Positives = 111/303 (36%), Gaps = 51/303 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
K+ E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDL---HQVIKANDDLTREHYQFFLYQLLR 137
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ +I N HRDL+ NIL + KI DFGLAR+ ++ T + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE + +T D+WS G + E++T G+ +PG + +
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----------- 225
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--D 314
R +P N +L+ P+DRPT + + +
Sbjct: 226 -------------GYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
Query: 315 PYF 317
+F
Sbjct: 266 DFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 4e-47
Identities = 56/293 (19%), Positives = 114/293 (38%), Gaps = 41/293 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 71
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
Y+ N HRDL +N L N +K+ DFGL+R+ DT T + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259
+K++ D+W+ G + E+ T G +PG ++ +L+
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------------- 229
Query: 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
K ++ + P L+ ++P DRP+ E
Sbjct: 230 ------------EKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-46
Identities = 67/295 (22%), Positives = 110/295 (37%), Gaps = 47/295 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D S + IG G +G+V +KVAIK I E + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLS 58
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRA 138
HP +V++ + L + I +VFE ME + E +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+ A V HRDL +N L N +K+ DFG+ R +D T+ T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT--KFPVKWASP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E+ FS+Y+ D+WS G + EV + GK + ++ ++ +
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------- 215
Query: 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 312
T R +P A +++ P+DRP L
Sbjct: 216 ----------STGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-45
Identities = 67/347 (19%), Positives = 126/347 (36%), Gaps = 59/347 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLR 77
+ +K +V+G G++G V + GE VAIK++ + ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR 137
+ +P + + I L + + + L V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
E YT D+WS G E++T G + G IS
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEIS 223
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 316
++ + R QP P ++ + D RP E + +
Sbjct: 224 SILEKGE--------RLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIE-- 266
Query: 317 FKGLSKVEREPSC----------QPISKMEFEFERRRVTKEDIRELI 353
SK+ R+P S + F R + +ED+ +++
Sbjct: 267 ---FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-45
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 44/299 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLL 76
S Q+VIG G +G V + + K VAIK + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQ 134
H +I+ ++ ++ +K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
+ +KY+ N HRDL +NIL N+N K+ DFGL+RV +D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
+ APE K+T A D+WS G + EV+T + H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
M+ + + +L+ + + RP + ++
Sbjct: 223 ----------------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-44
Identities = 70/300 (23%), Positives = 111/300 (37%), Gaps = 48/300 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLR 77
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQL 135
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE ++T A D+W G E+L G F G D
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---------------DV 218
Query: 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314
I R+ + R P PN P+ L+ + A+DP RP E A
Sbjct: 219 IGRIENGE---------RLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 9e-44
Identities = 65/314 (20%), Positives = 111/314 (35%), Gaps = 64/314 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLL-R 77
D + K Q+VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-------------- 122
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 123 --LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L+ + F + R + Y+ HRDL +NIL N KI DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239
T+ + A E S YT D+WS G + E+++ G + G
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 299
+ + R ++P N D L+ +
Sbjct: 236 YEKLPQ------------------------GYRLEKP-------LNCDDEVYDLMRQCWR 264
Query: 300 FDPKDRPTAEEALA 313
P +RP+ + L
Sbjct: 265 EKPYERPSFAQILV 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-43
Identities = 66/318 (20%), Positives = 114/318 (35%), Gaps = 65/318 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKL 75
+R + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------- 122
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 123 -------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175
L E F YQ+ + + ++ + N HRDL +NIL KICDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
ND+ + + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 294
V + M +++ + + P ++
Sbjct: 252 PVDSKFYKM---------------------------IKEGFRMLSPEHAP---AEMYDIM 281
Query: 295 ERLLAFDPKDRPTAEEAL 312
+ DP RPT ++ +
Sbjct: 282 KTCWDADPLKRPTFKQIV 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 3e-43
Identities = 56/321 (17%), Positives = 105/321 (32%), Gaps = 71/321 (22%)
Query: 23 SRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
+ + IG+G++G V A + VA+K + + A RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172
L+ Q+ + Y+ HRDL +N L N +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+R ++ D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 291
G + + R + + P
Sbjct: 244 YGMAHEEVIYYV----------------------------RDGNILACPENCP---LELY 272
Query: 292 RLLERLLAFDPKDRPTAEEAL 312
L+ + P DRP+
Sbjct: 273 NLMRLCWSKLPADRPSFCSIH 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 45/297 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
EVIG+G +G V A+K ++ I I + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS 86
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ--FFLYQLLRA 138
HP+++ + I L R VV M+ + N+ F Q+ +
Sbjct: 87 HPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRA 197
+K++ + HRDL +N + + +K+ DFGLAR + + + T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
E + K+T D+WS G + E++T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------------- 241
Query: 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313
D L R QP ++ + + RP+ E ++
Sbjct: 242 -----DITVYLLQGRRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 59/320 (18%), Positives = 117/320 (36%), Gaps = 66/320 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREI 73
R + + +G+G++G V A + KVA+K + D + ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 74 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIK------------- 118
+++ + +H +I+ + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 119 ---ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ + +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 294
V + + ++++ R +P N ++
Sbjct: 242 PV----------------EELFKLLKEGH--------RMDKP-------SNCTNELYMMM 270
Query: 295 ERLLAFDPKDRPTAEEALAD 314
P RPT ++ + D
Sbjct: 271 RDCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 53/324 (16%), Positives = 109/324 (33%), Gaps = 63/324 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKL 75
+ + +G+GS+G+V + +VAIK +++ + L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------LT 124
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
++ + Y++ HRDL +N + + +KI DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLM 243
+ + +PE +T D+WS G + E+ T + + G + L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 244 TDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 303
+ K N L+ ++PK
Sbjct: 249 ME-------------------------------GGLLDKPDNCPDMLFELMRMCWQYNPK 277
Query: 304 DRPTAEEALA------DPYFKGLS 321
RP+ E ++ +P F+ +S
Sbjct: 278 MRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 64/315 (20%), Positives = 114/315 (36%), Gaps = 60/315 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKL 75
R K+ + +G+G++G V A T T VA+K + + H A + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-------------- 120
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 --DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
D LT EH + +Q+ + ++++ + HRDL +NIL + +KICDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 237
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 297
+ RR R + P P + +
Sbjct: 244 EEF-----------------------CRRLKEGTRMRAP-------DYTTPEMYQTMLDC 273
Query: 298 LAFDPKDRPTAEEAL 312
+P RPT E +
Sbjct: 274 WHGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 100 bits (250), Expect = 4e-25
Identities = 27/210 (12%), Positives = 62/210 (29%), Gaps = 30/210 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--------DIFEHISDAARILREIKLL 76
I +++G+G V + + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVATRWY 195
+ + + H DL N+L + + I DF + + I D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
Y DI S +L
Sbjct: 173 S---------RTYRTEKDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 620 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.82 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=494.54 Aligned_cols=332 Identities=40% Similarity=0.765 Sum_probs=275.6
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~ 97 (620)
+...++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++|||||+++++|..... .
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 345689999999999999999999999999999999998766666777889999999999999999999999976532 3
Q ss_pred CCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 98 ~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
....+|+|||||+.+|..+++. +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 94 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 4456899999998888888765 569999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. .+..+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..+.+..
T Consensus 173 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred Cc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 32 2456899999999998752 4679999999999999999999999999999999999999999999888776
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhh
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 337 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 337 (620)
. .......+...+.......+...++++++.++|||.+||.+||++|||++|+|+||||+.+...+.++..+. ++.
T Consensus 246 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~---~~~ 321 (346)
T d1cm8a_ 246 L-QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDD 321 (346)
T ss_dssp C-SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCC
T ss_pred h-cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCC---CCC
Confidence 6 555566666666666666777778899999999999999999999999999999999999887777766543 334
Q ss_pred hHHhhcCCHHHHHHHHHHHHHHhCc
Q 007050 338 EFERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 338 ~~e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
.++....+.+++++++++|+++++|
T Consensus 322 ~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 322 SFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC
T ss_pred chhhhhcCHHHHHHHHHHHhhcCCC
Confidence 4555567889999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-58 Score=484.09 Aligned_cols=340 Identities=47% Similarity=0.824 Sum_probs=280.8
Q ss_pred CCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 19 ~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
|...+||++++.||+|+||+||+|+++.+|+.||||++... .......++.+|+.+|+.|+||||+++++++.......
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 34557899999999999999999999999999999999753 34556678899999999999999999999997766666
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
...+|++|++++++|.+++..+ .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6778899888889999999765 699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
...........+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.|..+.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43333344667899999999998553 57899999999999999999999999999999999999999999887765544
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhh
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 338 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 338 (620)
.......+..........++...++++++.+++||.+||+.||++|||++|+|+||||+.......++..... +.++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~ 317 (345)
T d1pmea_ 241 -INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 317 (345)
T ss_dssp -CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C---
T ss_pred -hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCC
Confidence 3344455555555566666777788999999999999999999999999999999999987766655544332 3445
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCchh
Q 007050 339 FERRRVTKEDIRELIFREILEYHPQL 364 (620)
Q Consensus 339 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 364 (620)
.+.....++++++++++|...++|+.
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPGY 343 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTTT
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCCC
Confidence 56667889999999999999998864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-58 Score=469.93 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=215.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCce
Confidence 357999999999999999999999999999999997532 223345688999999999999999999999 45578
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|||||||+ |+|.+++..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999 5999999888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CcccccccccCCccccCcccccccCCC-CCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~-y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
. ....+..+||+.|+|||++.+ .. ++.++|||||||++|+|++|++||.+.+..........
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 2 223456799999999999876 44 46789999999999999999999977553222111100
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
........++.+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 221 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 ---------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------------cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 011112234567899999999999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=478.42 Aligned_cols=331 Identities=41% Similarity=0.800 Sum_probs=278.9
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 98 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~ 98 (620)
...+||++++.||+|+||+||+|+++.+|+.||||++.+.........++.+|+.+|+.|+||||+++++++..... ++
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 34579999999999999999999999999999999998776677777889999999999999999999999876543 33
Q ss_pred CCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
...+|+++++++|+|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 445666666666899998854 5799999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+.....
T Consensus 174 ------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 174 ------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp ------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 23456899999999987652 45789999999999999999999999999999999999999999888776654
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCCCCCCcchhhh
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 338 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 338 (620)
.......+...+.......+...+.+++++++|||.+||++||++|||++|+|+||||+++.....++...+. .++
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~~ 322 (348)
T d2gfsa1 247 -SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQS 322 (348)
T ss_dssp -CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CCG
T ss_pred -cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CCc
Confidence 4445555555555555555556678899999999999999999999999999999999998887777766544 456
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCc
Q 007050 339 FERRRVTKEDIRELIFREILEYHP 362 (620)
Q Consensus 339 ~e~~~~~~e~~~~~~~~ei~~~~~ 362 (620)
++......+++++++++|++++.|
T Consensus 323 ~~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 323 FESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp GGGCCCCHHHHHHHHHHHHHTCCC
T ss_pred ccchhcCHHHHHHHHHHHhhccCC
Confidence 777889999999999999998776
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=461.24 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=219.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 57999999999999999999999999999999986431 1122345678999999999999999999999 45678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999 6999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------- 219 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 219 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 245689999999999987 67999999999999999999999999988766555444221
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
. . .....+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 220 --------------~-~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 --------------E-F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------C-C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------C-C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0 0 012357899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-57 Score=467.10 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=219.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++ .+...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSY-----LVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCE
Confidence 4689999999999999999999999999999999875422 2346788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|||||||+ |+|.+++..+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999 5999988764 69999999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-------------- 231 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-------------- 231 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH--------------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 2 2356789999999999987 68999999999999999999999999887766555444221
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.. ......+.+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 232 -------------~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 232 -------------GT--PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -------------CS--CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -------------CC--CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 00 001123457899999999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=469.93 Aligned_cols=283 Identities=34% Similarity=0.559 Sum_probs=230.2
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH---HHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeEE
Q 007050 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS---DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (620)
Q Consensus 27 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~---~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (620)
.+++||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++|||||++++++ .+...+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 47899999999999999999999999999965322211 234688999999999999999999999 4556799
Q ss_pred EEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCCc
Q 007050 104 VVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (620)
Q Consensus 104 lV~E~~~gdL~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~~ 182 (620)
||||||.+++...+ ..+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99999997555544 44567999999999999999999999999999999999999999999999999999865443222
Q ss_pred ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhch
Q 007050 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRND 262 (620)
Q Consensus 183 ~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~ 262 (620)
....+||++|+|||++... ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|.|..+.+.......
T Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 ---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp ---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2456899999999988652 568999999999999999999999999999999999999999999887665442111
Q ss_pred hHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 263 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
.. .........++...++.+++++++||.+||+.||++|||++|+|+||||++...
T Consensus 233 ~~----~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 DY----VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TC----CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hh----hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 10 001111222333446678999999999999999999999999999999987543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=471.32 Aligned_cols=326 Identities=36% Similarity=0.665 Sum_probs=254.8
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 100 (620)
.++|+++++||+|+||+||+|+|+.+|+.||||++.+.........++.+|+.+|+.++||||++++++|..... ++..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 378999999999999999999999999999999998776666777889999999999999999999999965432 4567
Q ss_pred eEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.+|+|||||.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 899999999998888774 469999999999999999999999999999999999999999999999999988654322
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
..+..++|+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+...++..+...++.|..+.+...
T Consensus 174 ----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 245 (355)
T d2b1pa1 174 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-- 245 (355)
T ss_dssp -----------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS--
T ss_pred ----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh--
Confidence 2356789999999999987 68999999999999999999999999999999999999999999988877654
Q ss_pred chhHHHHHHhhhccCCCcccCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcCcCCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKF------------PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 328 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~~~~~~ 328 (620)
......+...............+ ...++++++||++||.+||++||||+|+|+||||+.....+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~ 325 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTC
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccC
Confidence 22333333332222111111111 124678999999999999999999999999999997654333332
Q ss_pred CCCCcchhhhHHhhcCCHHHHHHHHHHHHH
Q 007050 329 CQPISKMEFEFERRRVTKEDIRELIFREIL 358 (620)
Q Consensus 329 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~ 358 (620)
..+ ...+.+.+++..+.++++++|++|++
T Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 326 PPP-QIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp CCC--------CCCCCCHHHHHHHHHHHHH
T ss_pred CCC-CCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 222 23344567778899999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=457.52 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=209.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++|||||++++++... ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 4679999999999999999999999999999999987655666777899999999999999999999998542 3456
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCceEeCCCCcEEEcccC
Q 007050 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
+|||||||+ |+|.+++.. +..+++..++.|+.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 599998853 467999999999999999999999976 9999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~ 251 (620)
+|+....... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~------ 228 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc------
Confidence 9987643322 2356789999999999977 6899999999999999999999999988776554443321
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcc
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 317 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f 317 (620)
.. +......+|+++.+||.+||+.||++|||++|+|+|||+
T Consensus 229 ----------------------~~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 ----------------------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------CC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 00 111224678999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-57 Score=472.22 Aligned_cols=284 Identities=22% Similarity=0.354 Sum_probs=218.9
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... ......++.+|+.+|+.++|||||+++++| .+...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 357999999999999999999999999999999997543 334567889999999999999999999999 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|||||||. |+|.+++..++.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999 5999999988899999999999999999999997 59999999999999999999999999999875432
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhH-HHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~-~l~~i~~~lg~p~~e~i~~~ 258 (620)
. .+..+||++|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+ ++..+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245799999999999987 689999999999999999999999998765433 23333333333221110000
Q ss_pred h-------------hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 259 V-------------RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 259 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
. ...........+....+.... ...+|++++|||.+||++||++|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 000011111222221111111 12368899999999999999999999999999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=454.14 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=216.2
Q ss_pred CCe-EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+|| ++.+.||+|+||+||+|+++.+++.||+|++............+.+|+++|+.++|||||++++++.... .+...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCE
Confidence 345 7888999999999999999999999999999876556667778999999999999999999999985432 33467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEeC-CCCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN-ANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~-~~~~lKL~DFGlA~~~~ 177 (620)
+|+|||||+ |+|.+++..+..+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999998 599999998889999999999999999999999999 99999999999997 47899999999998643
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+....+...... +
T Consensus 167 ~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~--------- 228 (270)
T d1t4ha_ 167 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G--------- 228 (270)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T---------
T ss_pred CC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-C---------
Confidence 22 1245789999999999864 6999999999999999999999999876543332211110 0
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
..+. ......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 229 ----------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 ----------------VKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------CCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------CCCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0111 11234688999999999999999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=462.57 Aligned_cols=289 Identities=38% Similarity=0.633 Sum_probs=237.8
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|++++|||||++++++ .+...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 589999999999999999999999999999999975433333456788999999999999999999999 455789
Q ss_pred EEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
|+|||||.+++.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887776654 3569999999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.|....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23556899999999987652 4568999999999999999999999999999999999999888888776654422
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
... +...........+...++.+|+++++||++||++||++|||++|+|+||||+++.++
T Consensus 233 ~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STT---CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccc---cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 111 111111122222333456889999999999999999999999999999999987553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-56 Score=463.95 Aligned_cols=259 Identities=30% Similarity=0.475 Sum_probs=206.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 35799999999999999999999999999999999754322 2345677999999999999999999998 55678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC---CCCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~lKL~DFGlA~~~~ 177 (620)
+|||||||+ |+|.+++..++.+++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999 69999999988999999999999999999999999999999999999995 57899999999998654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 162 ~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----------- 224 (307)
T d1a06a_ 162 PGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA----------- 224 (307)
T ss_dssp ---------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-----------
T ss_pred CCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------
Confidence 322 2245789999999999987 68999999999999999999999999887765554444321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........++++|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 225 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 -----------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111123456789999999999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=462.54 Aligned_cols=258 Identities=27% Similarity=0.472 Sum_probs=218.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 56999999999999999999999999999999996431 1222346788999999999999999999998 55678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999 5999999988999999999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 163 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------------- 225 (288)
T d1uu3a_ 163 K-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--------------
T ss_pred c-ccccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 2 222356789999999999987 68999999999999999999999999988766555444320
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE------ALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e------lL~hp~f~~~ 320 (620)
. .. ....+++++++||++||+.||++|||++| +++||||+++
T Consensus 226 --------------~-~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 226 --------------E-YD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp --------------C-CC---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred --------------C-CC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 0 01 12357899999999999999999999987 5889999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=466.61 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=222.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence 57999999999999999999999999999999997532 1223456788999999999999999999999 56678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||+ |+|.+++..++.++++.++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 6999999998999999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--------------- 219 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------- 219 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc---------------
Confidence 2 2356799999999999987 6899999999999999999999999999876554443321
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
. .. .....+|+++++||++||++||++|++ ++|+++||||+++
T Consensus 220 -------------~-~~---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 220 -------------E-EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------C-CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------C-CC---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 11 123468999999999999999999994 9999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=460.38 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=217.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
+.|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||++++++ .+...+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeE
Confidence 5799999999999999999999999999999999753 234456788999999999999999999998 455679
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 103 YVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 103 ylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
|+|||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 99999998 599998765 457999999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccccccCCccccCccccccc---CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~---~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 1123457899999999987421 246899999999999999999999999887766554444221
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
.+ +.....+.+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 231 -----------------~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 -----------------EP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -----------------CC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -----------------CC-CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 11 111223467899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-55 Score=467.05 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=224.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+.+.+|+.+|+.|+|||||++++++ .+.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 46899999999999999999999999999999999753 345667889999999999999999999998 45678
Q ss_pred EEEEEecCC-ccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC--CCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~lKL~DFGlA~~~~ 177 (620)
+|||||||+ |+|.+++. ..+.+++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999998 59999985 4567999999999999999999999999999999999999964 5789999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ....+||++|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|......+
T Consensus 178 ~~~~----~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------- 244 (350)
T d1koaa2 178 PKQS----VKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------- 244 (350)
T ss_dssp TTSC----EEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-------
T ss_pred cccc----cceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 3322 345789999999999987 689999999999999999999999999988776666554321111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
....++.+++++++||.+||+.||++|||++|+|+||||+....
T Consensus 245 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 245 ---------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp ---------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred ---------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 11233567899999999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=457.81 Aligned_cols=289 Identities=34% Similarity=0.593 Sum_probs=237.0
Q ss_pred CCeEEEEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~t-g~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~ 98 (620)
++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++.......
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999766 56799999975433333334466788777766 7999999999986554455
Q ss_pred CCeEEEEEecCCccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~gdL~~~i~--~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...+|++||||++++..+.. ....+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 67899999999976655444 3456999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...++.|..+.+.
T Consensus 167 ~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 167 SFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 322 23456789999999999987 689999999999999999999999999999999999999999999877665
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 322 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~ 322 (620)
....... ..............++.+++.+++||.+||++||++|||++|+|+||||+++..
T Consensus 241 ~~~~~~~-----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 241 RDVALPR-----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TTCSSCG-----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchh-----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 4321111 011122233344456778999999999999999999999999999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-55 Score=466.89 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=224.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+|||||++++++ .+...
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 45799999999999999999999999999999999753 344566788999999999999999999998 55678
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC--CCCcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~lKL~DFGlA~~~~ 177 (620)
+|||||||+ |+|.+.+...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999999 69999876544 699999999999999999999999999999999999998 57899999999998765
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|....
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------- 244 (352)
T d1koba_ 181 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---------- 244 (352)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 4322 345689999999999987 689999999999999999999999999988776665554321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
.......++.+++++++||++||++||++|||++|+|+||||++..
T Consensus 245 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 245 ------------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ------------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------------------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1112234567899999999999999999999999999999998643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=454.34 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=222.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|+.|+|||||++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 46899999999999999999999999999999999643221 12356788999999999999999999999 5
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC----cEEEcccCc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGL 172 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~lKL~DFGl 172 (620)
+...+|||||||+ |+|.++|..++.+++..++.|+.||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 5678999999999 69999999888999999999999999999999999999999999999998876 499999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...-..+.
T Consensus 164 a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~- 236 (293)
T d1jksa_ 164 AHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE- 236 (293)
T ss_dssp CEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-
T ss_pred hhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence 98754322 1245689999999999987 6899999999999999999999999999887766655543211111
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
...++.+|+.+++||++||+.||++|||++|+|+||||+..
T Consensus 237 ---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 237 ---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp ---------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred ---------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11235678999999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-55 Score=452.05 Aligned_cols=284 Identities=38% Similarity=0.639 Sum_probs=235.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 68999999999999999999985 789999999976543334457788999999999999999999999 455679
Q ss_pred EEEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~gdL~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
|+|||++.+++...+ ...+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997555555 5567899999999999999999999999999999999999999999999999999987543322
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhhc
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVRN 261 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~ 261 (620)
.....++++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 22455799999999998753 56799999999999999999999999999999999999999999988776554221
Q ss_pred hhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 262 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
. .+........+.++....+.+++.++|||++||++||++|||++|+|+||||++
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 P---KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp T---TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred h---hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1 111222233344455567788999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-55 Score=453.86 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=216.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+|+.|+|||||++++++. +...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCE
Confidence 4699999999999999999999999999999999754332 344567899999999999999999999984 4567
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||.+ +|..++..++.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999995 67667777788999999999999999999999999999999999999999999999999999864321
Q ss_pred CcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
...+||+.|+|||++.+. ...|+.++|||||||++|||++|..||.+.+..+.+..+..
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-------------- 228 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 228 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------
Confidence 346899999999998642 24689999999999999999999999988776555444322
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
...+. .....+|+.+++||.+||+.||++|||++|+|+||||..
T Consensus 229 -------------~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 229 -------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------SCCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 01111 112357899999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-55 Score=454.30 Aligned_cols=253 Identities=26% Similarity=0.472 Sum_probs=220.3
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 46999999999999999999999999999999996432 1223356788999999999999999999998 45678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999 599999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
.+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 235689999999999987 67999999999999999999999999988766555444320
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. . ...+.+++++++||.+||..||.+|+ |++|+|+||||+++
T Consensus 217 --------------~-~---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 --------------E-L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp --------------C-C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------------C-C---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 0 0 11246789999999999999999996 99999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-55 Score=460.52 Aligned_cols=253 Identities=21% Similarity=0.394 Sum_probs=220.5
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 58999999999999999999999999999999986431 1223356788999999999999999999998 55678
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
+|+|||||. |+|.+.+...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999 599999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 253 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------- 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--------------
Confidence 234689999999999987 68999999999999999999999999988766555544321
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 320 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~ 320 (620)
. ......+++++.+||++||+.||.+|+ |++|+|+||||+++
T Consensus 254 --------------~----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 254 --------------K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------C----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 011246789999999999999999995 99999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-54 Score=441.76 Aligned_cols=262 Identities=28% Similarity=0.451 Sum_probs=222.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-------hHHHHHHHHHHHHHHhcC-CCCcceeeeEecC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-------ISDAARILREIKLLRLLR-HPDIVEIKHIMLP 93 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-------~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~ 93 (620)
.++|++++.||+|+||+||+|+++.+|+.||||++...... .....++.+|+.+|+.|+ ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 46899999999999999999999999999999999653221 112346789999999997 99999999999
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCc
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGl 172 (620)
.+...+|||||||+ |+|.++|+.++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 55678999999998 59999999888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccc----cCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccC
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg 248 (620)
++....... .+..+||+.|+|||++.+ ....|+.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 157 a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 987643322 255789999999998753 1245789999999999999999999999998766655544321
Q ss_pred CCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 249 TPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
........++++|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 231 --------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 --------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp --------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred --------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111122345789999999999999999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=451.98 Aligned_cols=256 Identities=25% Similarity=0.444 Sum_probs=220.4
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++||||+++++++ ++...
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence 36899999999999999999999999999999999753 23445678999999999999999999998 45678
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC--CcEEEcccCcccccc
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~lKL~DFGlA~~~~ 177 (620)
+|||||||+ |+|.++|..++ .+++++++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999 59999998765 79999999999999999999999999999999999999854 589999999998753
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .....++|+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+..+.+..|......+
T Consensus 156 ~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------- 222 (321)
T d1tkia_ 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF------- 222 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-------
T ss_pred cCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 322 2245689999999999887 679999999999999999999999999988776666554321111
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
....++.+|+++++||.+||..||++|||++|+|+||||++
T Consensus 223 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 223 ---------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 11234568999999999999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=454.05 Aligned_cols=285 Identities=35% Similarity=0.601 Sum_probs=233.1
Q ss_pred CeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCCeE
Q 007050 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFKDI 102 (620)
Q Consensus 24 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~~l 102 (620)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.|+||||++++++|.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975322 1247999999999999999999986542 2445678
Q ss_pred EEEEecCCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCcccccc
Q 007050 103 YVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (620)
Q Consensus 103 ylV~E~~~gdL~~~i----~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGlA~~~~ 177 (620)
|+|||||++++.+.+ .....+++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999997665554 3456799999999999999999999999999999999999999875 89999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... .....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|.|..+.+..
T Consensus 175 ~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 332 23457899999999987652 5799999999999999999999999999999999999999999999887765
Q ss_pred hhhchhHHHHHHhhhccCCCccc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCCcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFS-QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 323 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~~~ 323 (620)
...... .. ........++. ...+..++++++||.+||.+||++|||++|+|+||||+++...
T Consensus 250 ~~~~~~-~~---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 250 MNPNYT-EF---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HCC----CC---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccchh-hc---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 421100 00 00111111111 2345689999999999999999999999999999999987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=450.29 Aligned_cols=297 Identities=34% Similarity=0.542 Sum_probs=230.8
Q ss_pred CCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007050 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (620)
Q Consensus 20 g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~--- 96 (620)
.+.++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 44679999999999999999999999999999999997654444556678899999999999999999999865321
Q ss_pred CCCCeEEEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 97 RDFKDIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 97 ~~~~~lylV~E~~~gdL~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.....+|+|||||++++...+. ....+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 2245699999999976665553 456799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCc-ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
....... .......+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+...++.+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 5432221 1223446899999999998753 5799999999999999999999999999999999999999999988776
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 319 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~ 319 (620)
+.......... .+..... ....+...+ ...++.++|||.+||++||++|||++|+|+||||+.
T Consensus 246 ~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYE-KLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC--------CCSS-CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhh-hhccccc-ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 65542211111 1111100 000000000 124778999999999999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-53 Score=454.47 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=213.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. .......+..+|+.+++.++|||||++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 367999999999999999999999999999999986421 1112222334457777788899999999998 4
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
+...+|+|||||+ |+|.++|..+..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 5577999999999 699999998889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
.... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----------- 220 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------- 220 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 4332 2456899999999998642 5699999999999999999999999987643222111100
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCcccCC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 320 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~elL~hp~f~~~ 320 (620)
...........+++++++||.+||+.||++||| ++|+|+||||+++
T Consensus 221 ------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 221 ------------------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ------------------SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred ------------------cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 000111223468999999999999999999999 8999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=435.46 Aligned_cols=287 Identities=35% Similarity=0.565 Sum_probs=238.6
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCeE
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (620)
++|++++.||+|+||+||+|+++.+++.||||+++..........++.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 689999999999999999999999999999999976655566778899999999999999999999999 455679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCCC
Q 007050 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (620)
Q Consensus 103 ylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~~ 181 (620)
++|+|++.+ +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7788888888999999999999999999999999999999999999999999999999999987643322
Q ss_pred cccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChhHHHHHhhhccCCCChhhhhhhhh
Q 007050 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVVR 260 (620)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p-F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~ 260 (620)
......++++|+|||++.+. ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.|....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22445788999999988762 4579999999999999999999866 677888888888888888887765544322
Q ss_pred chhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 261 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...... ..............+.+++.+++||++||+.||++|||++|+|+||||+++.
T Consensus 233 ~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LPDYKP---YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCC---CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccc---cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 111000 0000111223345567899999999999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=446.92 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=218.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~rEi~iL~-~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
++|++++.||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.++. .++||||+++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 57999999999999999999999999999999996431 11223455667777664 78999999999999 5567
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|+|||||+ |+|.+++..+..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 7999999999 599999999889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2356789999999999987 6899999999999999999999999998876655544421
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCCcccCC
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 320 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-elL~hp~f~~~ 320 (620)
..+ .....+|+.+.+||++||+.||++|||++ |+++||||+++
T Consensus 218 --------------~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 218 --------------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp --------------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --------------CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 111 11235789999999999999999999995 89999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=436.10 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=209.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLR--HPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----~~~~~~i~rEi~iL~~L~--HpnIv~l~~v~~~~~ 95 (620)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+.+|+.++ ||||+++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence 46899999999999999999999999999999998643211 112334668999999997 89999999998
Q ss_pred CCCCCeEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCC-CcEEEcccCc
Q 007050 96 RRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGL 172 (620)
Q Consensus 96 ~~~~~~lylV~E~~~--gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~lKL~DFGl 172 (620)
.+...+|+||||+. +++.+++..+..+++++++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred -eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 55678999999997 4889999888899999999999999999999999999999999999999854 7999999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +.
T Consensus 158 a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~-------- 217 (273)
T d1xwsa_ 158 GALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II-------- 217 (273)
T ss_dssp CEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--------
T ss_pred ceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hh--------
Confidence 9864322 23567899999999998752 3356789999999999999999999965321 10
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
+ . .. ...+.+|+++++||++||+.||++|||++|+|+||||+++
T Consensus 218 -------~------------~--~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 218 -------R------------G--QV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -------H------------C--CC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------h------------c--cc---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0 0 00 1124578999999999999999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=447.23 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=209.0
Q ss_pred CCCeEEEE-EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQE-VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~-~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~-~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
.++|++++ .||+|+||+||+|+++.+++.||||++++. ..+.+|+.++. .++|||||+++++|.... ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCC
Confidence 35799875 699999999999999999999999998642 34668999865 458999999999984321 234
Q ss_pred CeEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCcEEEcccCcc
Q 007050 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLA 173 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~lKL~DFGlA 173 (620)
..+|||||||+ |+|.++|... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999998 5999999874 36999999999999999999999999999999999999986 567999999999
Q ss_pred ccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
+....... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+...+..
T Consensus 162 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~---- 231 (335)
T d2ozaa1 162 KETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---- 231 (335)
T ss_dssp EECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS----
T ss_pred eeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc----
Confidence 87544322 245789999999999987 67999999999999999999999999887654433333221110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 320 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~ 320 (620)
.........++.+|+++++||.+||+.||++|||++|+|+||||.+.
T Consensus 232 --------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 232 --------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp --------------------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred --------------------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00000111233578999999999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=439.67 Aligned_cols=290 Identities=31% Similarity=0.574 Sum_probs=226.4
Q ss_pred cccCCCCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007050 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (620)
Q Consensus 16 ~~~~g~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~ 94 (620)
..+++..++|++++.||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+|+.++ ||||+++++++...
T Consensus 28 ~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred ccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 34567778999999999999999999999999999999999752 2456789999999995 99999999998542
Q ss_pred CCCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCC-cEEEcccCc
Q 007050 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGL 172 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~lKL~DFGl 172 (620)
....+|+|||||. ++|.++. +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ---~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 103 ---VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp ---TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred ---CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccc
Confidence 3467999999999 4776653 4699999999999999999999999999999999999998655 699999999
Q ss_pred cccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCC-CChhHHHHHhhhccCCCC
Q 007050 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPS 251 (620)
Q Consensus 173 A~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g-~~~~~~l~~i~~~lg~p~ 251 (620)
|+....... ....++|+.|+|||++.+. ..|+.++|||||||++|+|++|..||.. .+..++...+...+|.|.
T Consensus 177 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~ 251 (328)
T d3bqca1 177 AEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251 (328)
T ss_dssp CEECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ceeccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence 987543322 2456899999999998763 4689999999999999999999999865 456667777777777654
Q ss_pred hhhhhhhhhchhHHHHHHhhhccCCCc-----ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCcccCCC
Q 007050 252 LDTISRVVRNDKARRYLTSMRKKQPVQ-----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~~~~ 321 (620)
...+...........+........... .......++++++|||++||++||++|||++|+|+||||+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 433322211111111111110100001 1112234789999999999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-52 Score=428.46 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=213.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4789999999999999999999999999999999976543 3445667899999999999999999999985432 2334
Q ss_pred eEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
.+|||||||+ ++|.+++...+.+++.++..|+.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 5899999999 599999998889999999999999999999999999999999999999999999999999998765544
Q ss_pred CCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------------- 228 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------- 228 (277)
T ss_dssp --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------------
T ss_pred cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--------------
Confidence 443344566789999999999987 6899999999999999999999999988776554433321
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCccc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 318 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~hp~f~ 318 (620)
..+......++++|+.+.+||.+||+.||.+||+..+.|.|+|++
T Consensus 229 --------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 --------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 222233345678899999999999999999999544445566653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=418.85 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=207.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|+.+ ..||||+++...........+.+|+.+|+.++|||||++++++. ...
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccE
Confidence 568999999999999999999643 46999999765555567788999999999999999999999863 235
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+|||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 6999999754 56999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccCCccccCccccccc-CCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhhhhhh
Q 007050 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (620)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEvl~~~-~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~ 258 (620)
.. ....+..+||+.|+|||++.+. ...|+.++|||||||++|||+||+.||.+.+...++..+...
T Consensus 158 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------------ 224 (276)
T d1uwha_ 158 SG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------ 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------------
T ss_pred CC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 22 1223567899999999998642 245899999999999999999999999887654443322210
Q ss_pred hhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 259 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
......+.....++++.+.+||.+||..||++|||++|++++
T Consensus 225 --------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 --------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112233445788999999999999999999999999886
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=418.32 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=206.0
Q ss_pred eEEE-EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 25 YKIQ-EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 25 Y~i~-~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.+. +.||+|+||.||+|.++ .+++.||||+++...........+.+|+.+|++++|||||++++++.. ..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SS
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CC
Confidence 4444 47999999999999864 456789999997654455566789999999999999999999999832 34
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCCC
Q 007050 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~~ 180 (620)
.|||||||+ |+|.+++..+..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 799999999 6999999998899999999999999999999999999999999999999999999999999998765444
Q ss_pred CcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhhhh
Q 007050 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVV 259 (620)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~~~ 259 (620)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------------- 225 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 33333345679999999999876 679999999999999999998 8999988765544333321
Q ss_pred hchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---HcCCccc
Q 007050 260 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA---LADPYFK 318 (620)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~el---L~hp~f~ 318 (620)
.... .....+++++.+||.+||+.||++|||++++ |+|+|++
T Consensus 226 --------------~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 --------------GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0111 1124578999999999999999999999998 4566654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-50 Score=415.70 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=199.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
+.++|++.+.||+|+||+||+|.++.+++ .||||++... ......+.+.+|+.+|+.|+|||||++++++.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~----- 97 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT----- 97 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----
Confidence 45789999999999999999999987765 5889988653 33455678999999999999999999999983
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...+|+|||||+ |+|.+++... +.+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 4456899999999 5999988764 4799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcc--cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCCh
Q 007050 176 AFNDTPTT--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (620)
Q Consensus 176 ~~~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~ 252 (620)
........ .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+..-
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~------ 249 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD------ 249 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 64432221 11223568999999999876 689999999999999999998 89999887765544433220
Q ss_pred hhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 253 DTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. .....++++.+.+||.+||+.||++|||+.|++++
T Consensus 250 ----------------------~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 250 ----------------------YR---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------CC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 01224578899999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=417.04 Aligned_cols=250 Identities=22% Similarity=0.419 Sum_probs=206.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.++|++++.||+|+||+||+|+++.+++.||||+++.... ..+.+.+|+.+|+.++|||||++++++ .+..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 86 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP 86 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccE-----eeCC
Confidence 35689999999999999999999999999999999975432 345688999999999999999999998 3456
Q ss_pred eEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 7899999999 6999999764 478999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCC-CCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~p-F~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.......+.
T Consensus 167 ~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~------------ 230 (287)
T d1opja_ 167 GDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------ 230 (287)
T ss_dssp SSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------------
T ss_pred CCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh------------
Confidence 43222 2234568899999999887 6899999999999999999996655 54444332222111
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ......+++.+.+||.+||+.||++|||++|+++
T Consensus 231 ----------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 ----------------KDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------cCCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0100 1123467899999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=409.27 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=197.4
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.++|++++.||+|+||.||+|+++ +++.||||+++..... ...+.+|+.+|+.++||||+++++++. +..
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceec-----cCC
Confidence 4578999999999999999999986 5678999999754332 356889999999999999999999984 345
Q ss_pred eEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||+ |+|.+++... ..++++.+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 6899999998 6999988754 5689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+...
T Consensus 154 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~----------- 218 (263)
T d1sm2a_ 154 DQYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------- 218 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-----------
T ss_pred CCcee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-----------
Confidence 32222 234679999999999987 689999999999999999999 56777766654444333210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ......++++.+||.+||+.||++|||++|+|+|
T Consensus 219 -----------------~~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 219 -----------------FRL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 000 1113467899999999999999999999999886
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=414.74 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=213.3
Q ss_pred CCCCeEEEEE-eeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEV-IGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~-LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++.. .......++.+|+.+|++++|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence 3457888885 9999999999998764 4457999999754 344567789999999999999999999998832
Q ss_pred CCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
..+|+|||||+ |+|.+++.. +..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 34899999999 599998765 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
..............+||+.|+|||++.+ ..|+.++|||||||++|||+| |..||.+.+..+.+..|..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~--------- 227 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 227 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---------
T ss_pred ccccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------
Confidence 6554433333445679999999999876 679999999999999999998 8999988765544333321
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---HcCCcccC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA---LADPYFKG 319 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~el---L~hp~f~~ 319 (620)
... ....+.+++++.+||.+||..||++|||+.++ |+|+|+.-
T Consensus 228 -------------------~~~---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 -------------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -------------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------------CCC---CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 000 11234678999999999999999999999888 67888753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=422.46 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=207.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~-----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~---- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC---- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE----
Confidence 3689999999999999999999876554 69999986532 234456788999999998 899999999999
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRD 151 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~-----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrD 151 (620)
.+...+|+|||||+ |+|.++|+.+. .+++..++.|+.||+.||+|||++||+|||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45567999999999 69999997642 489999999999999999999999999999
Q ss_pred CCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCC
Q 007050 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (620)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~p 230 (620)
|||+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999875543322 22345678999999999876 689999999999999999997 8999
Q ss_pred CCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007050 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310 (620)
Q Consensus 231 F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 310 (620)
|.+.+....+..+... ... ......+++++++||.+||+.||++|||++|
T Consensus 267 f~~~~~~~~~~~~~~~---------------------------~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQN---------------------------GFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp STTCCCSHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHhc---------------------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9886654443333210 000 0122457899999999999999999999999
Q ss_pred HHcC
Q 007050 311 ALAD 314 (620)
Q Consensus 311 lL~h 314 (620)
|++|
T Consensus 317 i~~~ 320 (325)
T d1rjba_ 317 LTSF 320 (325)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=410.58 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=206.3
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.. ..
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence 368999999999999999999975 678899999975432 34568899999999999999999998732 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+|||||+ |+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 799999999 6999877432 3699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ....+...||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+..
T Consensus 162 ~~--~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~------------ 225 (272)
T d1qpca_ 162 NE--YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------ 225 (272)
T ss_dssp SC--EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred Cc--cccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------------
Confidence 22 122345679999999999876 6799999999999999999995 566666554443333221
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CCccc
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFK 318 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~--hp~f~ 318 (620)
.... .....+++.+.+||.+||+.||++|||++|+++ |+||.
T Consensus 226 ----------------~~~~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 ----------------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------cCCC---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0000 112457889999999999999999999999998 78875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=423.44 Aligned_cols=265 Identities=23% Similarity=0.387 Sum_probs=215.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEE---CCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRH-PDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d---~~tg~~vAIK~i~~~~--~~~~~~~~i~rEi~iL~~L~H-pnIv~l~~v~~~~~ 95 (620)
-++|++++.||+|+||+||+|.+ +.+|+.||||++++.. ........+.+|+++|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 46799999999999999999997 4578999999987532 122334567899999999976 8999999998
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred -ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 55568999999999 6999999998899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChhh
Q 007050 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
........ ......|++.|+|||++.+....++.++|||||||+||+|++|+.||.+.+..+....+..
T Consensus 178 ~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--------- 246 (322)
T d1vzoa_ 178 EFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246 (322)
T ss_dssp ECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---------
T ss_pred hhcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------
Confidence 65432222 2345689999999999876434688899999999999999999999988654333222211
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCcccCCC
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 321 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~elL~hp~f~~~~ 321 (620)
...... ......+++++++||++||.+||.+|| |++|+|+||||+++.
T Consensus 247 ---------------~~~~~~----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 247 ---------------RILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ---------------HHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---------------hcccCC----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 000000 112346899999999999999999999 589999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=403.07 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=210.2
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (620)
+.++|++++.||+|+||+||+|+++ +++.||||++++.... ...+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEE-----eeCC
Confidence 4578999999999999999999984 7889999999764332 35688999999999999999999998 3456
Q ss_pred eEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 101 ~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
.+|+|||||+ |+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 7999999998 688888764 45799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+.+..
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---------- 218 (258)
T d1k2pa_ 153 DEYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------- 218 (258)
T ss_dssp SSCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred CCce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 3222 2245679999999999987 689999999999999999998 899998887655544442210
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
.. ......++.+.+||.+||+.||++|||++|+|+|
T Consensus 219 ------------------~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 ------------------RL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 1123567899999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=400.90 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=196.1
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg----~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (620)
.+.|++.++||+|+||.||+|.++.++ ..||||++... ........+.+|+.+|+.++|||||++++++ .
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~ 79 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 79 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----e
Confidence 467999999999999999999987655 36999999754 3344566789999999999999999999998 3
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
+...+|+|||||. ++|.+++... ..+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 4467999999999 5788877654 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChhHHHHHhhhccCCCChhh
Q 007050 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLDT 254 (620)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~pF~g~~~~~~l~~i~~~lg~p~~e~ 254 (620)
...............||+.|+|||++.+ ..|+.++|||||||++|||++|. ++|.+.+..+.+..+.+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--------- 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND--------- 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc---------
Confidence 6544333333345678999999999877 68999999999999999999965 55554443333222211
Q ss_pred hhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 255 ISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.... ....++++.+.+||.+||..||++|||+.|+++
T Consensus 229 -------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 -------------------GFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------TCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------cCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1111 122357889999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=402.98 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=197.7
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++. .
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 68999999999999999999987554 46899988653 34455677899999999999999999999983 2
Q ss_pred CeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCcccccc
Q 007050 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~ 177 (620)
..+|+|||||. |+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 45899999999 688887765 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhh
Q 007050 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (620)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~ 256 (620)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+.+
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~----------- 224 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------- 224 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------
Confidence 32221 2244678999999999986 689999999999999999998 8999988766544433321
Q ss_pred hhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 257 RVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ....+++++.+.+||.+||..||++|||++|+++|
T Consensus 225 -----------------~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 225 -----------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 12345788999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=399.29 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=202.7
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++.+.||+|+||.||+|+++.+ +.||||+++..... ...+.+|+.+|++++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 46899999999999999999998755 57999999754332 4568899999999999999999998732 34
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+|||||. |+|..++.. ...+++.++..|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 688887743 35699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.... ..+...||+.|+|||++.. ..++.++|||||||++|||++| .++|.+.+..+.+..+..
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~------------ 229 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 229 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh------------
Confidence 3221 2244679999999999976 6899999999999999999996 455666555444433321
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CCcccCC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFKGL 320 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~--hp~f~~~ 320 (620)
... ....+.+++++++||.+||+.||++|||++++++ ++||...
T Consensus 230 ----------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 ----------------GYR---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------cCC---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111 1123567899999999999999999999999988 8898764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=399.03 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=197.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++++.||+|+||.||+|.+.. +++.||||+++.. ........+.+|..++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc--
Confidence 3689999999999999999999754 4468999998754 3344566778888887776 68999999998743
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 158 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (620)
+...+|+|||||+ |+|.+++... ..+++.++..|+.||+.||+|||++||+||||||+|||
T Consensus 89 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp --TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred --CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 3456899999999 6999999753 24899999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChh
Q 007050 159 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 237 (620)
Q Consensus 159 l~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~ 237 (620)
++.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999875433322 22345689999999999987 6899999999999999999987 5788776543
Q ss_pred HHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 238 HQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 238 ~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+.+..+.. .... ......+++++.+||.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~---------------------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLK---------------------------EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHH---------------------------HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHh---------------------------cCCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 32222111 1111 11224578999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=397.20 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=201.3
Q ss_pred cCCCCCCeEEEEEeeecCceEEEEEEECC-CC--cEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007050 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTH-TG--EKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (620)
Q Consensus 18 ~~g~~~rY~i~~~LG~G~~G~V~~a~d~~-tg--~~vAIK~i~~~~~-~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~ 93 (620)
.+=+.++|++++.||+|+||.||+|+... ++ ..||||+++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445789999999999999999998653 33 3689999875433 33445678999999999999999999999842
Q ss_pred CCCCCCCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccC
Q 007050 94 PSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (620)
Q Consensus 94 ~~~~~~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFG 171 (620)
..+|+|||||+ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 83 ------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp ------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccch
Confidence 34699999999 688877654 4579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCC
Q 007050 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 172 lA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
+++................|+.+|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+....-
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~-- 232 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-- 232 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC--
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC--
Confidence 99987655444444455678899999999987 679999999999999999998 8999998877665554432100
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
.....+++++.+.+||.+||..||++|||++|+++
T Consensus 233 ----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 233 ----------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123567899999999999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=400.70 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=199.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (620)
++|++++.||+|+||+||+|.+..+|+ .||+|+++.. ......+.+.+|+.+|+.++|||||++++++..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----- 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 569999999999999999999988886 5888887643 222345678999999999999999999999843
Q ss_pred CCeEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccc
Q 007050 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (620)
Q Consensus 99 ~~~lylV~E~~~-gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~ 176 (620)
...++|+|+|. ++|.+.+.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred -CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 24677888887 688887765 457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhh
Q 007050 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (620)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i 255 (620)
...... .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+..
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~---------- 228 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---------- 228 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH----------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence 433222 22344578999999999877 689999999999999999998 7899987664433222211
Q ss_pred hhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 256 SRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ....+.+++.+.+||.+||..||++|||+.|+++|
T Consensus 229 ------------------~~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 229 ------------------GER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 000 01224678899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=393.98 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=207.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++++.||+|+||+||+|.++ .+++.||||+++.. .......++.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~---- 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA---- 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec----
Confidence 357999999999999999999875 35678999999753 33445677899999999999999999999984
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHYQFFLYQLLRALKYIHTANVYHRD 151 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~~------------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrD 151 (620)
+...+++|||||. |+|.+++.... .+++..+..|+.||+.||+|||+++|+|||
T Consensus 87 -~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 87 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred -cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 4467899999998 69999996532 388999999999999999999999999999
Q ss_pred CCCCceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CC
Q 007050 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 230 (620)
Q Consensus 152 LKP~NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~p 230 (620)
|||+|||++.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999865433221 22345678999999999987 68999999999999999999985 78
Q ss_pred CCCCChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007050 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 310 (620)
Q Consensus 231 F~g~~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 310 (620)
|.+.+..+.+..+.+ .. .......+++++.+||.+||+.||++|||+.|
T Consensus 243 ~~~~~~~e~~~~v~~----------------------------~~---~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRD----------------------------GN---ILACPENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp TTTSCHHHHHHHHHT----------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHc----------------------------CC---CCCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 888766554443321 00 01123467889999999999999999999999
Q ss_pred HHc
Q 007050 311 ALA 313 (620)
Q Consensus 311 lL~ 313 (620)
+++
T Consensus 292 v~~ 294 (301)
T d1lufa_ 292 IHR 294 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=387.19 Aligned_cols=244 Identities=23% Similarity=0.396 Sum_probs=196.2
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
.++|++++.||+|+||.||+|++ +|..||||++++. ...+.+.+|+++|++++||||+++++++.. +...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCc
Confidence 45799999999999999999987 4789999999753 345678899999999999999999998853 2345
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccC
Q 007050 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~ 178 (620)
+|+|||||+ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 899999998 69999986543 589999999999999999999999999999999999999999999999999986533
Q ss_pred CCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCChhHHHHHhhhccCCCChhhhhh
Q 007050 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
.. ....+|..|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+.+
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------ 215 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence 22 23468899999999876 689999999999999999998 7888877665444333311
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
... ....+.+++.+.+||++||..||++|||+.|++++
T Consensus 216 ----------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ----------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000 11234578999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=388.58 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=203.7
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-------EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 92 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg-------~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~ 92 (620)
..++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|..++..+ +|||||++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3569999999999999999999976654 37999999764 3345567788999998888 7999999999994
Q ss_pred CCCCCCCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 007050 93 PPSRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (620)
Q Consensus 93 ~~~~~~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (620)
+...+|+|||||+ |+|.++|... ..+++..+..|+.||+.||+|||+.+|+||||||+
T Consensus 90 -----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp -----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 4467999999999 6999999754 25899999999999999999999999999999999
Q ss_pred ceEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCC
Q 007050 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (620)
Q Consensus 156 NILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~ 234 (620)
|||++.++.+||+|||+++......... .....++|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 9999999999999999998765433222 2345689999999999877 689999999999999999998 78999877
Q ss_pred ChhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 235 NVVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 235 ~~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+....+..+.+ .... .....+++.+.+||.+||+.||++|||+.|+|+
T Consensus 242 ~~~~~~~~i~~----------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKE----------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHT----------------------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHc----------------------------CCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65433322211 1111 112457899999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=394.72 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=204.0
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~--vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (620)
+.++|++.++||+|+||.||+|.++.+|.. ||||+++... .....+.+.+|+.+|+.+ +|||||++++++.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~----- 81 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACE----- 81 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----
Confidence 346899999999999999999999988874 6778775432 223556789999999998 7999999999994
Q ss_pred CCCeEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeC
Q 007050 98 DFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (620)
Q Consensus 98 ~~~~lylV~E~~~-gdL~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (620)
+...+|+|||||+ |+|.++|..+ ..+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 4567999999999 6999999754 5699999999999999999999999999999999999999
Q ss_pred CCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCC-CCCCCCChhHH
Q 007050 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQ 239 (620)
Q Consensus 161 ~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~-~pF~g~~~~~~ 239 (620)
.++.+||+|||+|+....... .....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp GGGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999976432221 134578999999999976 68999999999999999999975 67877765554
Q ss_pred HHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 240 LDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 240 l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
+..+.+ ... .....++++++.+||.+||+.||++|||++|+|+|
T Consensus 236 ~~~i~~----------------------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 YEKLPQ----------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHGGG----------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHh----------------------------cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 443321 000 11234678999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=388.49 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=204.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+|+.+++.++|+|++..+..+. .+...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~ 77 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 77 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCE
Confidence 4689999999999999999999999999999999865322 234678999999998887666655542 34567
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC---CCcEEEcccCcccccc
Q 007050 102 IYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAF 177 (620)
Q Consensus 102 lylV~E~~~gdL~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~lKL~DFGlA~~~~ 177 (620)
.++|||||+++|.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+...
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 899999999988777764 457999999999999999999999999999999999999864 4579999999998765
Q ss_pred CCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCCChh
Q 007050 178 NDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (620)
Q Consensus 178 ~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p~~e 253 (620)
...... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~------- 228 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------- 228 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-------
Confidence 432211 12245689999999999987 67999999999999999999999999876543322211110
Q ss_pred hhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HHcCCcccC
Q 007050 254 TISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALADPYFKG 319 (620)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e---lL~hp~f~~ 319 (620)
.......+.....+++++++.+||.+||..||++||++++ +|+|+|.+.
T Consensus 229 -----------------~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 229 -----------------SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -----------------HHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------------hcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0000001112234578899999999999999999999875 567877643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=388.22 Aligned_cols=258 Identities=20% Similarity=0.355 Sum_probs=213.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (620)
.++|++++.||+|+||.||+|.++. ++..||||+++.. ........+.+|+.+|++++||||+++++++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~---- 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe----
Confidence 4789999999999999999998753 3578999999754 34456667899999999999999999999983
Q ss_pred CCCCeEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcE
Q 007050 97 RDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (620)
Q Consensus 97 ~~~~~lylV~E~~~-gdL~~~i~~~----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~l 165 (620)
....+++|||||. |+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++++
T Consensus 94 -~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 94 -QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred -cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 4456899999998 7999988642 247899999999999999999999999999999999999999999
Q ss_pred EEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhC-CCCCCCCChhHHHHHhh
Q 007050 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMT 244 (620)
Q Consensus 166 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG-~~pF~g~~~~~~l~~i~ 244 (620)
||+|||+|+....... .......+||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999987543322 222345578999999999887 6899999999999999999998 58898877665554443
Q ss_pred hccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------CCccc
Q 007050 245 DLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA------DPYFK 318 (620)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~------hp~f~ 318 (620)
+. . .....+.+++.+.+||.+||+.||++|||++++++ +|+|+
T Consensus 250 ~~---------------------------~----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 EG---------------------------G----LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp TT---------------------------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred hC---------------------------C----CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 20 0 01122457889999999999999999999999998 56665
Q ss_pred C
Q 007050 319 G 319 (620)
Q Consensus 319 ~ 319 (620)
+
T Consensus 299 ~ 299 (308)
T d1p4oa_ 299 E 299 (308)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=386.43 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=208.6
Q ss_pred CCCeEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (620)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.. ....+...+.+|+.+++.+ +|||||++++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~---- 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence 368999999999999999999863 56678999999754 3455667889999999999 699999999999
Q ss_pred CCCCCeEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 007050 96 RRDFKDIYVVFELME-SDLHQVIKAND------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (620)
Q Consensus 96 ~~~~~~lylV~E~~~-gdL~~~i~~~~------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (620)
.+...+|+|||||+ |+|.+++.... .+++..+..|+.||+.||+|||+++|+||||||+|
T Consensus 97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 44456899999998 69999987543 58999999999999999999999999999999999
Q ss_pred eEeCCCCcEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 007050 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (620)
Q Consensus 157 ILl~~~~~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLlt-G~~pF~g~~ 235 (620)
||++.++.+||+|||+++....... ....+..+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987654332 223355789999999999986 689999999999999999998 677787765
Q ss_pred hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 236 VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 236 ~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
....+..+... .... .....+++.+.+||.+||+.||++|||++++|+
T Consensus 253 ~~~~~~~~i~~---------------------------~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKE---------------------------GFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHH---------------------------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhc---------------------------CCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54433333210 0000 111346889999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-45 Score=378.96 Aligned_cols=257 Identities=18% Similarity=0.243 Sum_probs=205.0
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPPSRRDFK 100 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H-pnIv~l~~v~~~~~~~~~~ 100 (620)
+++|++++.||+|+||+||+|+++.+|+.||||++.... +...+.+|+.+++.|.| +||+.+++++ .+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCC
Confidence 478999999999999999999999999999999886432 22346689999999975 8999999887 4556
Q ss_pred eEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCC-----CCcEEEcccCccc
Q 007050 101 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-----NCKLKICDFGLAR 174 (620)
Q Consensus 101 ~lylV~E~~~gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-----~~~lKL~DFGlA~ 174 (620)
..|+|||||+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 789999999999999997654 7999999999999999999999999999999999999974 5789999999998
Q ss_pred cccCCCCcc----cccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhhccCCC
Q 007050 175 VAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (620)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~~lg~p 250 (620)
......... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~----- 227 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----- 227 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-----
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-----
Confidence 764332211 12345689999999999987 6899999999999999999999999987543222111100
Q ss_pred ChhhhhhhhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 007050 251 SLDTISRVVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 313 (620)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~ 313 (620)
+ .. .+...+..+..+++++++.+|+..|+..+|++||+.+.+.+
T Consensus 228 -------i-~~-----------~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 228 -------I-GE-----------KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -------H-HH-----------HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------H-Hh-----------ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 00 00011122234567889999999999999999999877644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=389.66 Aligned_cols=282 Identities=24% Similarity=0.339 Sum_probs=211.4
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----------CCCcceeeeEe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----------HPDIVEIKHIM 91 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-----------HpnIv~l~~v~ 91 (620)
+||+++++||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5799999999999999999999999999999999753 233456778999988875 47899999887
Q ss_pred cCCCCCCCCeEEEEEecCC--ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEeCCCC---
Q 007050 92 LPPSRRDFKDIYVVFELME--SDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANC--- 163 (620)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~--gdL~~~i~--~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~--- 163 (620)
.. ......++||+++. ++...... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NH---KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EE---EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred ee---ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 43 22345566666654 34433333 34579999999999999999999998 8999999999999998765
Q ss_pred ---cEEEcccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-----
Q 007050 164 ---KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----- 235 (620)
Q Consensus 164 ---~lKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~----- 235 (620)
.+||+|||.+....... ...+||+.|+|||++.. ..|+.++|||||||++++|++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 39999999997643222 34689999999999886 689999999999999999999999997543
Q ss_pred -hhHHHHHhhhccCCCChhhhhhhhhchhHHHHHHhhhccCCCc-------------ccCCCCCCCHHHHHHHHHhcccC
Q 007050 236 -VVHQLDLMTDLLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQ-------------FSQKFPNADPSALRLLERLLAFD 301 (620)
Q Consensus 236 -~~~~l~~i~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~s~~l~dLI~~mL~~D 301 (620)
..+.+..+...+|.++.+.+.... ....++.......... ........++.++|||.+||.+|
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGK---YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCT---THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred chhHHHHHHHHHhCCCCHHHhhccc---ccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 345667777788888776554321 1111111100000000 00112235678999999999999
Q ss_pred CCCCCCHHHHHcCCcccCCC
Q 007050 302 PKDRPTAEEALADPYFKGLS 321 (620)
Q Consensus 302 P~~Rpsa~elL~hp~f~~~~ 321 (620)
|.+|||++|+|+||||++..
T Consensus 316 P~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=379.20 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=199.7
Q ss_pred eEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCe
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.+.++||+|+||+||+|.+..++ ..||||+++.. .......++.+|+++|++++||||+++++++.. ....
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCc
Confidence 344789999999999999987654 36899999753 455677889999999999999999999998743 2357
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEcccCccccccCC
Q 007050 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (620)
Q Consensus 102 lylV~E~~~-gdL~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~DFGlA~~~~~~ 179 (620)
+|+|||||+ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 69999887543 5778889999999999999999999999999999999999999999999999875433
Q ss_pred CCc-ccccccccCCccccCcccccccCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-hhHHHHHhhhccCCCChhhhhh
Q 007050 180 TPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISR 257 (620)
Q Consensus 180 ~~~-~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~IlyeLltG~~pF~g~~-~~~~l~~i~~~lg~p~~e~i~~ 257 (620)
... ........||..|+|||++.+ ..++.++|||||||++|||++|..||.... ..+....+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~------------- 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------- 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 222 222345679999999999876 689999999999999999999877765432 211111110
Q ss_pred hhhchhHHHHHHhhhccCCCcccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 258 VVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
. ...+ ...+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus 249 -----------~---g~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 -----------Q---GRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------T---TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------c---CCCC----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 0111 1123567899999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=380.52 Aligned_cols=272 Identities=24% Similarity=0.271 Sum_probs=196.5
Q ss_pred CCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHH--HHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007050 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL--REIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (620)
Q Consensus 22 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~--rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (620)
+++|.+.+.||+|+||.||+|++ +|+.||||+++.. ...... +|+..++.++||||+++++++.... ...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence 46799999999999999999975 6899999998642 122333 4555566789999999999986543 233
Q ss_pred CeEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeecCCCCceEeCCCCcEEEccc
Q 007050 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT--------ANVYHRDLKPKNILANANCKLKICDF 170 (620)
Q Consensus 100 ~~lylV~E~~~-gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs--------~gIvHrDLKP~NILl~~~~~lKL~DF 170 (620)
..+|+|||||+ |+|.++++.. .++++....++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 56899999998 6999999875 59999999999999999999996 59999999999999999999999999
Q ss_pred CccccccCCCCcc-cccccccCCccccCcccccccCC----CCCcccchHhHHHHHHHHHhCCCCCCCCChhHHHHHhhh
Q 007050 171 GLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (620)
Q Consensus 171 GlA~~~~~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~----~y~~~~DIWSLG~IlyeLltG~~pF~g~~~~~~l~~i~~ 245 (620)
|+++......... ......+||+.|+|||++.+... .++.++|||||||+||||+||.+||........ .....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-~~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-chhhc
Confidence 9998765443322 22345789999999999865211 267789999999999999999988854332110 00000
Q ss_pred ccCCCChhhhhhhhhchhHHHHHHhhhccCCCcccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 007050 246 LLGTPSLDTISRVVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 314 (620)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~elL~h 314 (620)
....+..+.+..... .......+...+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~-----------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVC-----------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCSSCCHHHHHHHHT-----------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHh-----------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111222222211100 000001111111 1123458899999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.2e-24 Score=205.54 Aligned_cols=170 Identities=16% Similarity=0.107 Sum_probs=121.2
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----------------hHHHHHHHHHHHHHHhcCCCCcceee
Q 007050 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----------------ISDAARILREIKLLRLLRHPDIVEIK 88 (620)
Q Consensus 25 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----------------~~~~~~i~rEi~iL~~L~HpnIv~l~ 88 (620)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ......+.+|+..|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 7899999987532100 01123345789999999999999887
Q ss_pred eEecCCCCCCCCeEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEeCCCCcEEEc
Q 007050 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (620)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~gdL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~lKL~ 168 (620)
+.. . .++||||+++... ..+++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec-----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 764 1 2799999996322 125666678899999999999999999999999999999965 59999
Q ss_pred ccCccccccCCCCcccccccccCCccccCcccccccCCCCCcccchHhHHH
Q 007050 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (620)
Q Consensus 169 DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~y~~~~DIWSLG~ 219 (620)
|||+|+......... ++...+. .-.+.+. ..|+.++|+||+.-
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~----~~~~~f~---r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVR----NIITYFS---RTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHH----HHHHHHH---HHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHH----HHHHHHc---CCCCCcccHHHHHH
Confidence 999997643221110 0000000 0011111 46889999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.20 E-value=2e-06 Score=83.42 Aligned_cols=139 Identities=13% Similarity=0.131 Sum_probs=88.1
Q ss_pred CCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCe
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (620)
+.|++++..+.++.+.||+.. .++..+++|+....... ....+.+|..+|+.|. +-.+.+++.+. .+.+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 367777766656667899884 56677888987643221 2334667888888774 33355666554 33466
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 007050 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA----------------------------------- 145 (620)
Q Consensus 102 lylV~E~~~g-dL~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~----------------------------------- 145 (620)
.|+||++++| .+.+..... .. ...+..++...|..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999997 554432111 11 122233344444444421
Q ss_pred ------------------------CcEeecCCCCceEeCCCCcEEEcccCcccc
Q 007050 146 ------------------------NVYHRDLKPKNILANANCKLKICDFGLARV 175 (620)
Q Consensus 146 ------------------------gIvHrDLKP~NILl~~~~~lKL~DFGlA~~ 175 (620)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 279999999999999876667999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.55 E-value=6.5e-05 Score=77.66 Aligned_cols=83 Identities=18% Similarity=0.071 Sum_probs=48.5
Q ss_pred CCCCeEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChHHHHHHHHHHHHHHhcC-C--CCcceeeeEec
Q 007050 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----E-HISDAARILREIKLLRLLR-H--PDIVEIKHIML 92 (620)
Q Consensus 21 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~-~~~~~~~i~rEi~iL~~L~-H--pnIv~l~~v~~ 92 (620)
+..... .+.||.|....||++.+..+++.+++|.-.... . ......+..+|...|+.+. + ..+.+++.+-
T Consensus 25 ~~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d- 102 (392)
T d2pula1 25 SKSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD- 102 (392)
T ss_dssp ---CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-
T ss_pred CCCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-
Confidence 333444 567899999999999887788899999653211 1 1112345667888887763 2 2345555432
Q ss_pred CCCCCCCCeEEEEEecCCc
Q 007050 93 PPSRRDFKDIYVVFELMES 111 (620)
Q Consensus 93 ~~~~~~~~~lylV~E~~~g 111 (620)
....++|||++++
T Consensus 103 ------~~~~~lvmE~L~~ 115 (392)
T d2pula1 103 ------TEMAVTVMEDLSH 115 (392)
T ss_dssp ------TTTTEEEECCCTT
T ss_pred ------CCCCEEEEeccCC
Confidence 1224789999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.34 E-value=0.00017 Score=68.94 Aligned_cols=72 Identities=8% Similarity=0.012 Sum_probs=46.2
Q ss_pred EEeeecCc-eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCeEEEE
Q 007050 29 EVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYVV 105 (620)
Q Consensus 29 ~~LG~G~~-G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lylV 105 (620)
+.+..|.. +.||+... ..+..+++|..... ....+.+|...|+.|.. -.+.+++.+. .+.+..++|
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v 84 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLL 84 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEE
Confidence 35556654 57898864 45667888876532 22345678888887743 2355566654 234568999
Q ss_pred EecCCc
Q 007050 106 FELMES 111 (620)
Q Consensus 106 ~E~~~g 111 (620)
|++++|
T Consensus 85 ~~~i~G 90 (255)
T d1nd4a_ 85 LGEVPG 90 (255)
T ss_dssp EECCSS
T ss_pred EEeeec
Confidence 999986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.51 E-value=0.0038 Score=62.05 Aligned_cols=72 Identities=14% Similarity=0.031 Sum_probs=42.2
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc--ceeeeEecCCCCCCCCeEEEEEecCCc
Q 007050 36 YGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI--VEIKHIMLPPSRRDFKDIYVVFELMES 111 (620)
Q Consensus 36 ~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~HpnI--v~l~~v~~~~~~~~~~~lylV~E~~~g 111 (620)
--.||++.. .+|..|++|+..... .....+..|+..|..|....| +..+..--..........+.|++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999964 578889999876421 234557789988888753222 211111000011233557889998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.45 E-value=0.0069 Score=61.74 Aligned_cols=75 Identities=15% Similarity=0.115 Sum_probs=49.2
Q ss_pred CCeEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007050 23 SRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (620)
Q Consensus 23 ~rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~rEi~iL~~L~-HpnIv~l~~v~~~~ 94 (620)
+..+ ++.|+.|-.-.+|++.... .++.|.+++.... .. .....+|..+++.+. +.-..+++.++
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~--- 114 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF--- 114 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE---
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEc---
Confidence 3444 4688989999999997653 3456777776532 22 223457999998885 43344676665
Q ss_pred CCCCCCeEEEEEecCCc
Q 007050 95 SRRDFKDIYVVFELMES 111 (620)
Q Consensus 95 ~~~~~~~lylV~E~~~g 111 (620)
.+ .+|+||++|
T Consensus 115 --~~----g~I~efi~g 125 (395)
T d1nw1a_ 115 --SG----GRLEEYIPS 125 (395)
T ss_dssp --TT----EEEECCCCE
T ss_pred --CC----ceEEEEecc
Confidence 22 588999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.82 E-value=0.011 Score=57.99 Aligned_cols=30 Identities=30% Similarity=0.293 Sum_probs=26.8
Q ss_pred CCcEeecCCCCceEeCCCCcEEEcccCccc
Q 007050 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (620)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~lKL~DFGlA~ 174 (620)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 369999999999999998777899999874
|